archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,3.3202e-07,1.6202,1.4362,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00022676,1.5121,1.2153,1,1
1,GO MEMBRANE RAFT ASSEMBLY,5.9841e-06,1.4257,1.5296,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,6.5896e-07,1.2317,1.0351,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,5.4977e-07,1.1931,1.0876,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00037661,1.1881,0.92433,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,5.7413e-06,1.1139,0.93694,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.6015e-06,1.1023,0.93513,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00026903,1.0756,0.99079,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,4.3763e-07,1.0692,0.99872,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.4692e-06,1.0451,0.88742,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,2.0033e-05,1.0386,0.93995,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.7118e-05,1.0288,0.89865,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.0198e-07,1.0286,0.99449,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.1788e-07,1.0272,1.0718,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00017186,1.0145,0.84865,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.6015e-06,1.0064,0.87657,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.2366e-07,0.99939,1.0143,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,2.3654e-06,0.98795,0.85679,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00045924,0.96203,0.71444,1,1
1,GO RESPONSE TO INTERFERON ALPHA,5.508e-06,0.94685,1.038,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.7474e-06,0.93268,0.93571,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.2971e-07,0.92007,0.89872,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00030804,0.90973,0.71503,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,1.2962e-05,0.90936,0.83235,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,6.2786e-05,0.90396,0.81338,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.1964e-05,0.89181,0.75812,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.00017186,0.8802,0.692,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.1831e-07,0.87942,0.83308,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.349e-05,0.87587,0.94636,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.7474e-06,0.86993,0.7984,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,1.2308e-06,0.86597,0.88208,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,4.1802e-07,0.86182,0.83025,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.0683e-06,0.85104,0.68467,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,2.6307e-05,0.84298,0.68034,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,4.4712e-06,0.84221,0.79417,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.7343e-05,0.83709,0.87857,1,1
1,GO CD40 SIGNALING PATHWAY,1.071e-07,0.82693,0.77987,1,1
1,GO RESPONSE TO INTERFERON BETA,5.2837e-06,0.81918,0.92851,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,6.5896e-07,0.81777,0.78008,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,3.0576e-06,0.81759,0.89986,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.6455e-05,0.80747,0.80426,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,2.6902e-06,0.80446,0.62773,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,4.1112e-06,0.80137,0.64678,1,1
1,GO ZYMOGEN INHIBITION,2.3975e-07,0.79652,0.83642,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,5.8301e-05,0.79399,0.72113,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.1831e-07,0.79033,0.76255,1,1
1,GO BONE TRABECULA FORMATION,0.00069957,0.78694,0.69894,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.1112e-06,0.78229,0.64479,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,1.0311e-06,0.78147,0.84883,1,1
1,GO PLASMINOGEN ACTIVATION,0.00050664,0.77909,0.5679,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.5816e-05,0.77206,0.634,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.5774e-06,0.76926,0.72213,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4346e-05,0.76869,0.60576,1,1
1,GO HEMIDESMOSOME ASSEMBLY,0.00014935,0.7686,0.84322,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,3.4421e-05,0.76795,0.74319,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0001165,0.76685,0.59805,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00014418,0.76551,0.60018,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.1964e-05,0.76101,0.68517,1,1
1,GO ENDODERM FORMATION,1.8251e-06,0.76072,0.76315,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,2.2524e-05,0.75269,0.74878,1,1
1,GO HIPPO SIGNALING,7.9801e-06,0.75227,0.60477,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,7.5427e-07,0.75166,0.74589,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,3.9418e-06,0.74902,0.79355,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,3.4728e-06,0.74676,0.69154,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,9.0221e-07,0.74649,0.71766,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.74179,0.71117,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.4039e-05,0.73881,0.61619,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.1776e-06,0.73685,0.64433,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,8.1192e-05,0.73063,0.6161,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2879e-07,0.72952,0.64617,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00014418,0.72155,0.53705,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,9.4334e-07,0.72044,0.68836,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,2.4515e-08,0.71993,0.73183,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.9263e-05,0.71488,0.59797,1,1
1,GO EPIBOLY,3.4728e-06,0.71392,0.72712,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6015e-06,0.70893,0.66068,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00044439,0.70781,0.5479,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.0311e-06,0.70342,0.70039,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.6414e-07,0.70001,0.66337,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.0784e-06,0.69595,0.68242,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00079435,0.69499,0.65745,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,1.5691e-07,0.69195,0.68533,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00040247,0.687,0.59632,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00087311,0.68669,0.59062,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,6.0198e-07,0.68664,0.84149,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00098941,0.68562,0.59035,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,7.013e-05,0.68521,0.55664,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,9.389e-05,0.68327,0.52662,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,4.2876e-06,0.68038,0.54567,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,6.0504e-05,0.67994,0.65065,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.6902e-06,0.67893,0.60772,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,4.2876e-06,0.67808,0.58912,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.6455e-05,0.67638,0.60688,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.2862e-06,0.67234,0.71414,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.3218e-05,0.66933,0.63412,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.1776e-06,0.66879,0.67006,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00026003,0.664,0.53942,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.7118e-05,0.66063,0.6135,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.8521e-05,0.66014,0.47834,1,1
1,GO T CELL EXTRAVASATION,0.00012512,0.6594,0.59846,1,1
1,GO REGULATION OF PINOCYTOSIS,7.3528e-06,0.65699,0.65134,1,1
1,GO FIBRINOLYSIS,2.5308e-05,0.65363,0.749,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.3916e-06,0.65247,0.65644,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.4039e-05,0.64875,0.60191,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0011199,0.64802,0.49071,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019079,0.64754,0.60079,1,1
1,GO GAP JUNCTION ASSEMBLY,2.2524e-05,0.64462,0.57288,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.4728e-06,0.63949,0.58867,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.1493e-05,0.63898,0.55196,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,7.2754e-05,0.63785,0.64678,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.001191,0.63741,0.55496,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.5774e-06,0.63346,0.69489,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,2.2524e-05,0.63193,0.59867,1,1
1,GO PIGMENT GRANULE MATURATION,7.0571e-06,0.63117,0.51482,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.4775e-08,0.62907,0.65251,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,2.5308e-05,0.62692,0.53022,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,7.9801e-06,0.62534,0.66645,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,6.7728e-06,0.62153,0.63482,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.4878e-05,0.62039,0.52377,1,1
1,GO ENDODERM DEVELOPMENT,3.6228e-06,0.61775,0.60691,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00057693,0.61669,0.68221,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.001872,0.61593,0.44551,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.6414e-07,0.61556,0.58403,1,1
1,GO DNA DEAMINATION,5.8301e-05,0.61555,0.57708,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00011241,0.61339,0.53799,1,1
1,GO VAGINA DEVELOPMENT,3.4728e-06,0.60935,0.62944,1,1
1,GO SNRNA PROCESSING,0.00026903,0.60934,0.62961,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,3.0689e-05,0.60729,0.46041,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.7145e-05,0.60628,0.64461,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.6228e-06,0.60537,0.54349,1,1
1,GO AMYLOID BETA CLEARANCE,4.1112e-06,0.60412,0.49412,1,1
1,GO VASCULOGENESIS,2.6322e-07,0.60346,0.5975,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,3.6228e-06,0.60224,0.63775,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,3.9926e-07,0.60223,0.63266,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,4.1112e-06,0.60153,0.55657,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.8521e-05,0.59994,0.64154,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00013917,0.59955,0.56995,1,1
1,GO APOPTOTIC CELL CLEARANCE,4.6623e-06,0.59943,0.64568,1,1
1,GO LIVER REGENERATION,1.4963e-07,0.59611,0.57174,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,5.6174e-05,0.59606,0.46471,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.0604e-05,0.59458,0.52106,1,1
1,GO BIOLOGICAL PHASE,0.00029782,0.59458,0.58917,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,9.3916e-06,0.59451,0.49567,1,1
1,GO HEME METABOLIC PROCESS,1.0311e-06,0.59409,0.53592,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,8.6584e-06,0.5935,0.56045,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.2454e-05,0.59316,0.69237,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00010092,0.59284,0.53024,1,1
1,GO MUCUS SECRETION,0.0042883,0.58748,0.45427,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.8521e-05,0.58733,0.53668,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00026903,0.58625,0.4806,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.2367e-06,0.58615,0.56166,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,0.58559,0.58815,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.8379e-05,0.58467,0.56573,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.6597e-05,0.58365,0.47072,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,5.8301e-05,0.58266,0.64745,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.9926e-07,0.58243,0.57181,1,1
1,GO NOTOCHORD DEVELOPMENT,4.8612e-06,0.58159,0.64331,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,3.9926e-07,0.57919,0.60013,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.4674e-06,0.57865,0.62976,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.7806e-05,0.57809,0.5874,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,9.0551e-05,0.57696,0.44772,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00019079,0.57539,0.58192,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.1776e-06,0.57534,0.47668,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.0001547,0.57413,0.54712,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.1663e-05,0.57348,0.60783,1,1
1,GO ENTRY INTO HOST,1.1776e-06,0.57198,0.56652,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.023741,0.57057,0.61,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00028792,0.57034,0.44902,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00016023,0.57033,0.50131,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.0001165,0.56878,0.45342,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.001191,0.56741,0.583,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,6.7596e-05,0.56622,0.52267,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1831e-07,0.5628,0.63608,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.104e-05,0.55959,0.48757,1,1
1,GO CELLULAR RESPONSE TO DSRNA,2.8891e-07,0.557,0.5694,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4878e-05,0.55695,0.49879,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.55675,0.4552,1,1
1,GO SALIVARY GLAND DEVELOPMENT,4.6597e-05,0.55496,0.5346,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.6455e-05,0.55454,0.51078,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,4.8379e-05,0.55336,0.4899,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,3.7791e-06,0.55292,0.53515,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.104e-05,0.5506,0.53847,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,9.7346e-05,0.55056,0.42337,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00010845,0.55054,0.43884,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0081404,0.54968,0.36238,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.0194e-07,0.5495,0.64212,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.9841e-06,0.54924,0.54102,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.3218e-05,0.54867,0.4365,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.2862e-06,0.54697,0.49256,1,1
1,GO RESPONSE TO X RAY,1.1267e-06,0.54565,0.55991,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.4609e-05,0.54202,0.71784,1,1
1,GO REGULATION OF FIBRINOLYSIS,0.00044439,0.54138,0.53885,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0010528,0.54129,0.3874,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,9.0179e-06,0.53874,0.49731,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,6.0504e-05,0.53679,0.44202,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,4.5813e-07,0.53503,0.59445,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,4.0073e-05,0.53437,0.47802,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00032948,0.53361,0.4715,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.7955e-07,0.53268,0.52592,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.7343e-05,0.53245,0.42421,1,1
1,GO COLLAGEN CATABOLIC PROCESS,4.1617e-05,0.53243,0.5315,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,6.4994e-06,0.53206,0.64628,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.0033e-05,0.53094,0.50441,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,2.3418e-05,0.53071,0.56613,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00010845,0.53069,0.44441,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.8612e-06,0.52768,0.53827,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00017186,0.52752,0.41241,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00055855,0.52599,0.38797,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,7.9801e-06,0.52439,0.47803,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.019283,0.52405,0.33231,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.3654e-06,0.5233,0.59314,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.6015e-06,0.52137,0.48725,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,6.7728e-06,0.52046,0.51356,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.4039e-05,0.52022,0.40962,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.7343e-05,0.51977,0.44476,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,6.4994e-06,0.51904,0.54062,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,7.2111e-07,0.51749,0.45706,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00025131,0.51714,0.42685,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.9263e-05,0.51677,0.42816,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.5122e-07,0.51612,0.51129,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00026003,0.51606,0.56815,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00017796,0.51528,0.46398,1,1
1,GO VIRAL GENOME REPLICATION,9.7801e-06,0.51446,0.42498,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00069957,0.51399,0.46521,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00011241,0.51359,0.4824,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.0022992,0.51218,0.63229,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.5201e-05,0.51198,0.58939,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.7323e-05,0.51114,0.44187,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0036303,0.51069,0.39203,1,1
1,GO TOLERANCE INDUCTION,0.00087311,0.51058,0.43682,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0016129,0.50826,0.43075,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00022676,0.50777,0.56699,1,1
1,GO T CELL MEDIATED IMMUNITY,2.3418e-05,0.50749,0.43769,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,5.753e-07,0.50727,0.49158,1,1
1,GO CYTOLYSIS,3.8583e-05,0.50675,0.43174,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00057693,0.50574,0.46028,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,5.2139e-05,0.50512,0.65367,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,4.4878e-05,0.50369,0.46621,1,1
1,GO RESPONSE TO INTERFERON GAMMA,3.5759e-05,0.50278,0.47402,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00037661,0.50157,0.43081,1,1
1,GO GERMINAL CENTER FORMATION,0.00013917,0.50141,0.45343,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,3.9926e-07,0.50099,0.60456,1,1
1,GO NCRNA 3 END PROCESSING,0.0013872,0.50049,0.43331,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.4674e-06,0.49818,0.45041,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,9.0221e-07,0.49805,0.46082,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.0689e-05,0.49796,0.42433,1,1
1,GO SNRNA METABOLIC PROCESS,0.00010462,0.49715,0.50839,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,3.3132e-05,0.49586,0.40269,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,9.0179e-06,0.4958,0.45492,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00081984,0.49536,0.40238,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.906e-06,0.49515,0.46552,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0067808,0.49185,0.36805,1,1
1,GO MATURATION OF SSU RRNA,4.6597e-05,0.4915,0.40794,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0014738,0.49024,0.41457,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0022992,0.49021,0.40018,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,1.9263e-05,0.48967,0.42875,1,1
1,GO STORE OPERATED CALCIUM ENTRY,0.00012964,0.48967,0.3656,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,4.2876e-06,0.48924,0.42344,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,6.7596e-05,0.4887,0.43666,1,1
1,GO LEUKOCYTE AGGREGATION,0.0016129,0.48842,0.49307,1,1
1,GO AORTIC VALVE DEVELOPMENT,6.5149e-05,0.48841,0.43486,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.7791e-06,0.48734,0.45116,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00019753,0.48733,0.38337,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.0683e-06,0.48722,0.43493,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,3.3287e-06,0.4864,0.47088,1,1
1,GO PINOCYTOSIS,7.889e-07,0.48579,0.60371,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0017123,0.48507,0.45987,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00054072,0.48419,0.4515,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.4878e-05,0.48377,0.39176,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00012074,0.48321,0.6634,1,1
1,GO REGULATION OF PROTEIN IMPORT,5.9841e-06,0.48268,0.39678,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00032948,0.48233,0.36686,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.5774e-06,0.48156,0.47655,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00024286,0.48075,0.44886,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,6.6003e-08,0.48066,0.57887,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.2837e-06,0.48051,0.45805,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0029794,0.47825,0.31339,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00074557,0.47813,0.40552,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0013054,0.47791,0.43856,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00012964,0.47666,0.38126,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0022332,0.47626,0.36665,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.00098941,0.47561,0.34341,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,7.2754e-05,0.47557,0.58152,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,6.8936e-07,0.47554,0.40184,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.7118e-05,0.47553,0.39458,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7596e-05,0.47511,0.44037,1,1
1,GO NIK NF KAPPAB SIGNALING,9.0221e-07,0.4751,0.408,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.1112e-06,0.47487,0.47495,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00044439,0.47433,0.40271,1,1
1,GO CYTOKINE METABOLIC PROCESS,2.6902e-06,0.47403,0.40927,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,3.1904e-06,0.47395,0.38615,1,1
1,GO VIRAL RNA GENOME REPLICATION,1.0779e-06,0.47388,0.43464,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00045924,0.47378,0.42782,1,1
1,GO BLOOD VESSEL REMODELING,9.389e-05,0.47255,0.41144,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.0779e-06,0.47243,0.4107,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0011199,0.4724,0.33737,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.7806e-05,0.47216,0.41134,1,1
1,GO HYALURONAN METABOLIC PROCESS,7.3528e-06,0.47151,0.47638,1,1
1,GO REGULATION OF TRANSPOSITION,0.00069957,0.47114,0.42458,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.016734,0.47047,0.38466,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00065623,0.46949,0.47953,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0010859,0.46929,0.37612,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.4346e-05,0.46886,0.42584,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.0833e-05,0.46844,0.46103,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.1904e-06,0.4684,0.5324,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,2.2524e-05,0.46838,0.6771,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,4.3763e-07,0.46825,0.43792,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.1267e-06,0.46814,0.48762,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.9904e-06,0.46744,0.49286,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00074557,0.46737,0.36764,1,1
1,GO REGULATION OF MYOBLAST FUSION,6.5149e-05,0.46731,0.53035,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,5.8301e-05,0.46682,0.44963,1,1
1,GO DEFENSE RESPONSE TO VIRUS,2.7343e-05,0.46678,0.40136,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,7.8282e-05,0.46674,0.41168,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,9.8628e-07,0.46666,0.49769,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00010462,0.46661,0.39897,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.1493e-05,0.4665,0.39669,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0053338,0.46592,0.35163,1,1
1,GO MATURATION OF LSU RRNA,2.0833e-05,0.46526,0.49211,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0022332,0.46469,0.42308,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.8301e-05,0.46466,0.44721,1,1
1,GO RIG I SIGNALING PATHWAY,1.2862e-06,0.46367,0.43252,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.00010092,0.46339,0.48001,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,3.0576e-06,0.46315,0.40855,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0011549,0.46312,0.33122,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,9.3916e-06,0.46301,0.64739,1,1
1,GO REGULATION OF MRNA BINDING,3.4728e-06,0.4627,0.41962,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,8.6584e-06,0.46056,0.41563,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00047456,0.46034,0.44102,1,1
1,GO MACROPHAGE PROLIFERATION,0.00038934,0.46034,0.47275,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,3.4421e-05,0.4603,0.41892,1,1
1,GO RESPONSE TO HYPEROXIA,0.00090094,0.45959,0.41095,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.6623e-06,0.45935,0.44774,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00017186,0.4591,0.39432,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.4963e-07,0.45774,0.51664,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,7.6603e-06,0.45741,0.43839,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0025083,0.45708,0.35969,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0059384,0.45687,0.35265,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.9263e-05,0.45677,0.39253,1,1
1,GO INTERLEUKIN 1 PRODUCTION,5.0226e-05,0.45668,0.44351,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.4039e-05,0.45662,0.39676,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.0571e-06,0.45629,0.43684,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,9.3916e-06,0.45535,0.35882,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,3.5759e-05,0.45515,0.45739,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0032441,0.45446,0.55323,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.8891e-07,0.45439,0.3953,1,1
1,GO PROTEASOME ASSEMBLY,9.7801e-06,0.45437,0.36764,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,1.4674e-06,0.45382,0.44883,1,1
1,GO LYMPHANGIOGENESIS,2.0033e-05,0.45312,0.43975,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00025131,0.45282,0.45804,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00059588,0.45127,0.35528,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,5.4121e-05,0.45117,0.43552,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.7413e-06,0.45052,0.38183,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.010506,0.45033,0.3894,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.1112e-06,0.45007,0.38089,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.3127e-06,0.45002,0.4247,1,1
1,GO ZYMOGEN ACTIVATION,0.00012512,0.4498,0.4771,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00023468,0.44966,0.35812,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.3127e-06,0.44959,0.44345,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.0604e-05,0.44934,0.48788,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0054795,0.44865,0.29104,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00079435,0.4481,0.45429,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00022676,0.44657,0.48237,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,8.2505e-07,0.44643,0.45707,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00020448,0.44599,0.38733,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.2308e-06,0.44463,0.51205,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,6.7728e-06,0.44452,0.36042,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2962e-05,0.44436,0.4276,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00036427,0.4436,0.37761,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00016595,0.44306,0.333,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,3.8583e-05,0.44299,0.44402,1,1
1,GO RETINAL METABOLIC PROCESS,0.0079323,0.44287,0.29179,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,9.8628e-07,0.44172,0.36568,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.3418e-05,0.44166,0.36376,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,7.2754e-05,0.44164,0.40468,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,6.2367e-06,0.44108,0.52833,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.001191,0.44049,0.5116,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,1.5331e-06,0.44026,0.41809,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00021167,0.44006,0.34107,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.7801e-06,0.43934,0.41269,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,5.0683e-06,0.43912,0.44943,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.5691e-07,0.43909,0.41032,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.029068,0.43898,0.30724,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0013457,0.43786,0.51522,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,9.7346e-05,0.43709,0.41802,1,1
1,GO VIRAL TRANSLATION,1.8251e-06,0.4367,0.45906,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.7728e-06,0.4354,0.38808,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0031536,0.43402,0.43609,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,5.7413e-06,0.43381,0.44989,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,6.5149e-05,0.43316,0.4099,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.1237e-07,0.43302,0.43108,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.7343e-05,0.43292,0.46848,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,1.8521e-05,0.43268,0.46721,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00065623,0.43223,0.37355,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0779e-06,0.43174,0.47339,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,9.7801e-06,0.43073,0.6137,1,1
1,GO PROTEIN OXIDATION,0.0032441,0.43055,0.40253,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.8301e-05,0.43033,0.51951,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,6.4994e-06,0.42981,0.49973,1,1
1,GO RECEPTOR CATABOLIC PROCESS,5.508e-06,0.42956,0.4221,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0007696,0.4288,0.39172,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00023468,0.42826,0.44396,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.2524e-05,0.42797,0.32924,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.6902e-06,0.42778,0.47662,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00044439,0.42753,0.48456,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,6.4994e-06,0.42744,0.36407,1,1
1,GO RIBOSOME ASSEMBLY,0.00021167,0.42689,0.37468,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0022332,0.42688,0.42052,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0018173,0.42541,0.34274,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0006154,0.4241,0.36921,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00055855,0.42338,0.38126,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0090226,0.42324,0.5363,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,2.2524e-05,0.42308,0.48312,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,2.0833e-05,0.42291,0.38304,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00025131,0.42232,0.36646,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,2.5308e-05,0.42213,0.4038,1,1
1,GO RESPONSE TO INTERLEUKIN 12,6.5896e-07,0.42189,0.42379,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0022992,0.42075,0.34714,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00044439,0.42074,0.32798,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.7806e-05,0.42048,0.39044,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00010092,0.4201,0.37646,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8251e-06,0.42009,0.41325,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.6623e-06,0.42008,0.40567,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00044439,0.41998,0.34189,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,7.9801e-06,0.41993,0.3972,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00022676,0.41955,0.35959,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.8521e-05,0.41936,0.33443,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.00014935,0.41929,0.39297,1,1
1,GO VIRAL LIFE CYCLE,7.5427e-07,0.41928,0.4102,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,5.0683e-06,0.41924,0.43674,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00020448,0.41923,0.36091,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.8521e-05,0.41881,0.35474,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,5.508e-06,0.4188,0.38957,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,2.8418e-05,0.41838,0.44837,1,1
1,GO ANIMAL ORGAN REGENERATION,3.9418e-06,0.41819,0.45682,1,1
1,GO VASCULAR TRANSPORT,0.0045306,0.41798,0.50067,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00031859,0.41777,0.39554,1,1
1,GO ENAMEL MINERALIZATION,0.0010206,0.4175,0.41342,1,1
1,GO MULTI ORGANISM LOCALIZATION,5.4272e-08,0.41721,0.42193,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.001872,0.41712,0.29734,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00012964,0.41699,0.35853,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00012512,0.41699,0.34179,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.001986,0.41571,0.40466,1,1
1,GO DETECTION OF BIOTIC STIMULUS,0.00012512,0.41491,0.40793,1,1
1,GO REGULATION OF GASTRULATION,3.9418e-06,0.41456,0.38365,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,8.2505e-07,0.4132,0.39297,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00010092,0.41302,0.36691,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.0022992,0.41262,0.36339,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.9301e-06,0.41222,0.39318,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,6.5149e-05,0.41174,0.32491,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0029794,0.41154,0.39769,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00065623,0.41129,0.30028,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00017796,0.41096,0.32882,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0001547,0.41075,0.34247,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00050664,0.41069,0.35495,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.8077e-06,0.41033,0.40603,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.6455e-05,0.40945,0.43424,1,1
1,GO RESPONSE TO SALT STRESS,8.4205e-05,0.40877,0.34065,1,1
1,GO PLATELET AGGREGATION,1.6455e-05,0.40867,0.34724,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00010092,0.408,0.3803,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00010845,0.40672,0.43017,1,1
1,GO IMMATURE T CELL PROLIFERATION,0.00030804,0.40543,0.41853,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.5201e-05,0.4044,0.46508,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00012964,0.40435,0.38109,1,1
1,GO INTERLEUKIN 17 PRODUCTION,7.3528e-06,0.40421,0.46191,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00032948,0.40407,0.26535,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00021909,0.40341,0.34853,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00017186,0.40267,0.41976,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,4.2876e-06,0.40259,0.37617,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.0226e-05,0.40239,0.44418,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,4.0073e-05,0.40234,0.41168,1,1
1,GO FIBROBLAST MIGRATION,8.1192e-05,0.40149,0.37003,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00021909,0.40134,0.3912,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,9.3916e-06,0.40129,0.38261,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0040578,0.40126,0.38794,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.6597e-05,0.40103,0.33629,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.02843,0.40083,0.25444,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,6.2367e-06,0.40039,0.37842,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,5.2533e-07,0.40003,0.36416,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00017796,0.39981,0.30696,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0025817,0.39931,0.36191,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0025083,0.3993,0.37941,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.1888e-05,0.39811,0.32693,1,1
1,GO BONE GROWTH,0.00031859,0.39804,0.39085,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00010462,0.39785,0.36533,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00019753,0.39778,0.38013,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.5201e-05,0.39646,0.4831,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00057693,0.39633,0.41685,1,1
1,GO EMBRYO IMPLANTATION,5.2837e-06,0.3963,0.48212,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.0012662,0.39624,0.50316,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001872,0.39525,0.36031,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,1.2454e-05,0.39518,0.3167,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,3.4728e-06,0.39436,0.4025,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.6623e-06,0.39421,0.40786,1,1
1,GO INTERFERON BETA PRODUCTION,0.00063551,0.39374,0.28077,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0007696,0.39367,0.42434,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.024846,0.39315,0.30733,1,1
1,GO B CELL MEDIATED IMMUNITY,1.1493e-05,0.39219,0.32883,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00035231,0.39213,0.3298,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00050664,0.39208,0.2675,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,9.7801e-06,0.39202,0.4758,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00037661,0.39168,0.41576,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,4.8379e-05,0.39166,0.37296,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.6455e-05,0.39165,0.3247,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,3.5759e-05,0.39052,0.34348,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00044439,0.3896,0.45233,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0024367,0.38956,0.43009,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0014299,0.38939,0.33139,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,7.2111e-07,0.38928,0.34999,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.6455e-05,0.3892,0.31423,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,9.389e-05,0.38866,0.35412,1,1
1,GO INTERACTION WITH HOST,1.2862e-06,0.38851,0.42151,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00081984,0.38813,0.3272,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,6.7596e-05,0.38754,0.32041,1,1
1,GO T CELL APOPTOTIC PROCESS,3.9418e-06,0.38743,0.35291,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.4205e-05,0.38686,0.37502,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,4.8379e-05,0.38665,0.35595,1,1
1,GO RESPONSE TO ESTROGEN,1.906e-06,0.38605,0.37828,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.4039e-05,0.38602,0.50865,1,1
1,GO INTERACTION WITH SYMBIONT,1.6455e-05,0.38551,0.32303,1,1
1,GO MUSCLE FILAMENT SLIDING,1.5816e-05,0.38506,0.37208,1,1
1,GO MATURATION OF 5 8S RRNA,9.0551e-05,0.38425,0.34519,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00021909,0.38396,0.32796,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0018173,0.38332,0.33369,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.0073e-05,0.38263,0.32592,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.2139e-05,0.38235,0.40799,1,1
1,GO PHAGOCYTOSIS RECOGNITION,0.00026003,0.38198,0.52252,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.014138,0.38137,0.29439,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.013139,0.38051,0.31178,1,1
1,GO SPROUTING ANGIOGENESIS,8.1192e-05,0.37991,0.32986,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,2.6902e-06,0.37824,0.3563,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.00067758,0.37799,0.27711,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4878e-05,0.37772,0.374,1,1
1,GO TYPE I INTERFERON PRODUCTION,2.9532e-05,0.37726,0.31876,1,1
1,GO MEMBRANE INVAGINATION,1.1964e-05,0.3772,0.34363,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00013433,0.37719,0.34546,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.0179e-06,0.37689,0.33822,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,0.00010092,0.37681,0.38157,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,9.7801e-06,0.37625,0.32835,1,1
1,GO INTERLEUKIN 8 PRODUCTION,3.8583e-05,0.37584,0.35701,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.5149e-05,0.37455,0.4064,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.8583e-05,0.37424,0.32107,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00031859,0.37418,0.34292,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,2.6307e-05,0.37373,0.35431,1,1
1,GO VIRAL GENE EXPRESSION,2.1663e-05,0.37334,0.37335,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0013872,0.3727,0.31583,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00041602,0.37259,0.29716,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.4712e-06,0.37124,0.3382,1,1
1,GO PLATELET DEGRANULATION,6.5149e-05,0.37045,0.40919,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.1964e-05,0.37029,0.3369,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.104e-05,0.36972,0.4647,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,9.0551e-05,0.36954,0.30813,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00021909,0.36932,0.35715,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00054072,0.36913,0.40699,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.2524e-05,0.36911,0.30422,1,1
1,GO MRNA TRANSCRIPTION,1.7806e-05,0.36896,0.36372,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.349e-05,0.36865,0.3021,1,1
1,GO NCRNA PROCESSING,1.9263e-05,0.36771,0.31399,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,9.389e-05,0.36751,0.31504,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00087311,0.36675,0.27816,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00018427,0.36656,0.29641,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,3.1904e-06,0.36651,0.35304,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010092,0.366,0.31557,1,1
1,GO GLIAL CELL ACTIVATION,0.00044439,0.36566,0.32946,1,1
1,GO INTERLEUKIN 2 PRODUCTION,7.2111e-07,0.365,0.44177,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.0087944,0.36376,0.22442,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.013465,0.36373,0.30771,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00031859,0.36363,0.29242,1,1
1,GO TRANSLATIONAL INITIATION,0.0001547,0.36348,0.33667,1,1
1,GO ERAD PATHWAY,7.9801e-06,0.36313,0.29582,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.1112e-06,0.36285,0.41149,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.8418e-05,0.36247,0.46318,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.4878e-05,0.36238,0.39757,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.001872,0.36203,0.27575,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00010462,0.3613,0.39481,1,1
1,GO REGULATION OF COAGULATION,0.00037661,0.36015,0.36798,1,1
1,GO CRISTAE FORMATION,0.009256,0.35964,0.22802,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.001872,0.35953,0.31081,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0097392,0.35916,0.31665,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0014738,0.35888,0.33366,1,1
1,GO TRANSLATIONAL TERMINATION,0.00021909,0.35841,0.27093,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.35764,0.30135,1,1
1,GO FOCAL ADHESION ASSEMBLY,9.389e-05,0.35761,0.3785,1,1
1,GO RESPONSE TO VIRUS,1.7118e-05,0.35752,0.34657,1,1
1,GO NECROTIC CELL DEATH,4.0073e-05,0.35708,0.41609,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0017123,0.35682,0.32362,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4039e-05,0.35666,0.35925,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,9.0551e-05,0.35633,0.30813,1,1
1,GO RIBOSOME BIOGENESIS,7.2754e-05,0.35553,0.33104,1,1
1,GO FOREGUT MORPHOGENESIS,0.00010092,0.35543,0.40391,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.5331e-06,0.35527,0.37068,1,1
1,GO REGULATION OF PROTEIN MATURATION,5.2837e-06,0.35515,0.35968,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.011904,0.35505,0.37385,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0045306,0.35477,0.28039,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00095906,0.35474,0.33324,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.3132e-05,0.35458,0.30128,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0071468,0.35426,0.27727,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.0226e-05,0.35415,0.32015,1,1
1,GO PEPTIDE CROSS LINKING,0.00024286,0.35394,0.44095,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,3.0689e-05,0.35382,0.38876,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,6.7728e-06,0.35336,0.36328,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00027832,0.35331,0.39877,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.5691e-07,0.35322,0.36299,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025083,0.35315,0.33665,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.041967,0.35312,0.2362,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00028792,0.35273,0.37725,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.0012662,0.35244,0.42826,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0025817,0.3522,0.34755,1,1
1,GO RESPONSE TO MANGANESE ION,5.9841e-06,0.3521,0.35651,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0069616,0.35204,0.41881,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5149e-05,0.35188,0.37408,1,1
1,GO PIGMENT ACCUMULATION,0.00014935,0.35138,0.3236,1,1
1,GO NUCLEOSIDE SALVAGE,0.00041602,0.35108,0.44962,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00010462,0.35032,0.34502,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0016129,0.35017,0.33444,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00013433,0.35016,0.34299,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.00035231,0.34936,0.38277,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.4421e-05,0.3479,0.30679,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0024367,0.34778,0.42897,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0011549,0.34769,0.41889,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.34748,0.34458,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00041602,0.34739,0.28186,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.1888e-05,0.34714,0.4747,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,6.5149e-05,0.3468,0.29437,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.3418e-05,0.34673,0.37001,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00065623,0.34661,0.28408,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00035231,0.34609,0.32,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00059588,0.34549,0.2292,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00021167,0.34546,0.29936,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00021909,0.34517,0.31159,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0079323,0.34493,0.37359,1,1
1,GO COPPER ION HOMEOSTASIS,7.3528e-06,0.34414,0.47299,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0017123,0.34412,0.30437,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00036427,0.34394,0.31658,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0031536,0.34378,0.31795,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.026586,0.34296,0.21288,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00063551,0.3429,0.28975,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00036427,0.34215,0.3514,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00016023,0.34205,0.44895,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.004408,0.342,0.35147,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00010092,0.34182,0.31229,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6584e-06,0.3417,0.37157,1,1
1,GO RRNA METABOLIC PROCESS,9.7346e-05,0.34139,0.31154,1,1
1,GO VESICLE CARGO LOADING,1.0184e-05,0.34124,0.32875,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,6.5149e-05,0.34108,0.34714,1,1
1,GO REGULATION OF PROTEIN FOLDING,1.349e-05,0.34102,0.29653,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00052342,0.34086,0.31719,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00012512,0.34081,0.36769,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.34062,0.36262,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.044685,0.34037,0.22614,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.012508,0.34035,0.38193,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0042883,0.34012,0.38318,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0067808,0.33982,0.22188,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,5.0226e-05,0.33981,0.3449,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0020453,0.33913,0.39154,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00079435,0.33911,0.35645,1,1
1,GO GASTRULATION,8.3127e-06,0.33885,0.34095,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0020453,0.33884,0.44022,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00013433,0.3383,0.36183,1,1
1,GO L GLUTAMATE IMPORT,0.011904,0.33789,0.23794,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.6307e-05,0.33751,0.30925,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.7728e-06,0.33746,0.29111,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0184e-05,0.33709,0.34037,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.0576e-06,0.33696,0.30074,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00012964,0.33696,0.30077,1,1
1,GO NATURAL KILLER CELL ACTIVATION,6.2786e-05,0.33686,0.30309,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0021689,0.33646,0.29674,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00031859,0.33642,0.25182,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.3763e-07,0.33631,0.35125,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0053338,0.33596,0.3458,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00016023,0.33586,0.43706,1,1
1,GO T CELL MIGRATION,0.00031859,0.33584,0.2843,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.5774e-06,0.33546,0.31614,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0017641,0.33538,0.27665,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.001228,0.33513,0.49182,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.349e-05,0.3351,0.30251,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,8.6584e-06,0.33454,0.39701,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.7343e-05,0.33447,0.3496,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.8521e-05,0.33393,0.31592,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,9.0551e-05,0.33321,0.40098,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00037661,0.33299,0.33483,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,3.0576e-06,0.33284,0.29285,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.03939,0.33189,0.32363,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,3.7145e-05,0.33161,0.31189,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0014738,0.33142,0.22507,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.1192e-05,0.33137,0.43228,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0046564,0.33107,0.2759,1,1
1,GO CELL SUBSTRATE ADHESION,7.013e-05,0.3306,0.35529,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00044439,0.33058,0.35979,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00017186,0.33042,0.27253,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.010773,0.33037,0.249,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,4.4878e-05,0.33019,0.26141,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00014418,0.33016,0.26449,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0087944,0.32948,0.27029,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.2754e-05,0.32926,0.27009,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00084609,0.32925,0.24506,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0001547,0.32914,0.36132,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0012662,0.32853,0.22627,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0022332,0.32836,0.38187,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0036303,0.32832,0.27256,1,1
1,GO NCRNA METABOLIC PROCESS,3.7145e-05,0.32832,0.27727,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0014738,0.32812,0.36675,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0097392,0.32801,0.43638,1,1
1,GO MESODERM MORPHOGENESIS,3.1904e-06,0.32796,0.33556,1,1
1,GO PIGMENT METABOLIC PROCESS,1.0604e-05,0.32794,0.30317,1,1
1,GO RRNA MODIFICATION,0.00098941,0.32772,0.25175,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,1.0184e-05,0.32756,0.39456,1,1
1,GO PORE COMPLEX ASSEMBLY,0.00023468,0.32744,0.25747,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00040247,0.327,0.31335,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,2.6307e-05,0.32676,0.4432,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00027832,0.32674,0.29963,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,5.508e-06,0.32652,0.3365,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,7.013e-05,0.32596,0.35476,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00018427,0.32507,0.36277,1,1
1,GO OSTEOCLAST DEVELOPMENT,9.7346e-05,0.32501,0.37156,1,1
1,GO ASYMMETRIC CELL DIVISION,0.00055855,0.32482,0.27799,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00012964,0.32438,0.22331,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00027832,0.32436,0.30495,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.036164,0.32433,0.31728,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,2.9532e-05,0.32429,0.29696,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00081984,0.32418,0.29148,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7596e-05,0.32349,0.26391,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00040247,0.32317,0.24641,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00072223,0.32296,0.33336,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00013433,0.32287,0.34038,1,1
1,GO RNA 5 END PROCESSING,0.00023468,0.3228,0.29001,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00020448,0.32259,0.29729,1,1
1,GO REGULATION OF RNA BINDING,2.2658e-06,0.32229,0.32505,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00014418,0.32219,0.29461,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00026903,0.32185,0.37518,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00016595,0.32183,0.34124,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.001872,0.32181,0.22191,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.025414,0.32172,0.25334,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.547e-05,0.32138,0.28275,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0046564,0.32056,0.21248,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.00040247,0.31984,0.24768,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00065623,0.31974,0.24316,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,6.2786e-05,0.31957,0.29793,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.1904e-06,0.31922,0.30548,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00038934,0.31884,0.32061,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.9418e-06,0.31874,0.32723,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,7.013e-05,0.31863,0.32192,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0020453,0.31854,0.33882,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00027832,0.31836,0.30263,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00016023,0.31827,0.28117,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0038387,0.31825,0.25315,1,1
1,GO HISTONE PHOSPHORYLATION,6.2367e-06,0.31819,0.28825,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.0576e-06,0.31788,0.33809,1,1
1,GO REGENERATION,3.4421e-05,0.3173,0.26578,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00052342,0.3167,0.25541,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0042883,0.31647,0.2907,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00037661,0.3157,0.30648,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.31539,0.3084,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0017641,0.31524,0.31348,1,1
1,GO CYTOKINETIC PROCESS,5.0226e-05,0.31522,0.2914,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.011326,0.31514,0.267,1,1
1,GO CARNITINE METABOLIC PROCESS,0.0090226,0.31511,0.2603,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0017123,0.31497,0.369,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.0689e-05,0.31482,0.3214,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,4.0073e-05,0.31461,0.29221,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.17e-07,0.3146,0.31144,1,1
1,GO INNATE IMMUNE RESPONSE,5.4121e-05,0.31441,0.25849,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.389e-05,0.31346,0.24364,1,1
1,GO GTP METABOLIC PROCESS,4.4878e-05,0.31281,0.3437,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.1888e-05,0.31274,0.3227,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00044439,0.3127,0.28942,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.00024286,0.31231,0.39086,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00050664,0.31185,0.30249,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,4.4878e-05,0.31153,0.36722,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0017123,0.31153,0.28443,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,6.7596e-05,0.31117,0.49981,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00012512,0.3111,0.29046,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00035231,0.311,0.26286,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.2962e-05,0.31063,0.26462,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013798,0.31043,0.28174,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.0033e-05,0.31034,0.28811,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0010859,0.31017,0.29007,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00010092,0.3093,0.26177,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.3418e-05,0.30918,0.28562,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00037661,0.30916,0.29875,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.004408,0.30896,0.27849,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00012512,0.30891,0.28361,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.30883,0.29134,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,3.0689e-05,0.30811,0.33182,1,1
1,GO SYNCYTIUM FORMATION,0.00026903,0.30751,0.29671,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.3654e-06,0.30727,0.27588,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0021062,0.30708,0.29054,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00059588,0.30683,0.24751,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0007696,0.3067,0.32801,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0081404,0.30664,0.40992,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,1.6455e-05,0.30614,0.28907,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00011241,0.30587,0.28784,1,1
1,GO RESPONSE TO INTERLEUKIN 1,9.3916e-06,0.3052,0.33582,1,1
1,GO RESPONSE TO DSRNA,5.2837e-06,0.30518,0.357,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,4.1112e-06,0.30478,0.307,1,1
1,GO ASTROCYTE ACTIVATION,0.009256,0.30474,0.26639,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00055855,0.304,0.21165,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.4039e-05,0.30385,0.3325,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00012074,0.30376,0.32768,1,1
1,GO VASCULATURE DEVELOPMENT,8.1192e-05,0.30356,0.27492,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00098941,0.30355,0.22802,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.6623e-06,0.30344,0.22606,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0021689,0.30333,0.25674,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00026003,0.30326,0.36121,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.349e-05,0.30281,0.31593,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.2876e-06,0.30251,0.4298,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.3132e-05,0.30227,0.26097,1,1
1,GO MACROPHAGE MIGRATION,8.6584e-06,0.30081,0.34824,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,3.3132e-05,0.30068,0.27495,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0030654,0.30062,0.28397,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.012508,0.30021,0.2753,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,5.9841e-06,0.30003,0.30327,1,1
1,GO IRON ION HOMEOSTASIS,3.4728e-06,0.3,0.28187,1,1
1,GO T CELL CYTOKINE PRODUCTION,1.7806e-05,0.29996,0.39954,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.031059,0.29984,0.20422,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0025083,0.2991,0.39088,1,1
1,GO FOAM CELL DIFFERENTIATION,0.0010528,0.29858,0.26572,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.026586,0.29851,0.19626,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0015653,0.29829,0.23703,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.007729,0.29822,0.31839,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.8521e-05,0.29803,0.29953,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00030804,0.29797,0.25484,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.00010092,0.29777,0.2841,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0034322,0.29761,0.29585,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,5.9841e-06,0.29746,0.36336,1,1
1,GO MUSCLE CELL PROLIFERATION,6.5149e-05,0.29704,0.28275,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0015653,0.29696,0.32067,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.00081984,0.2969,0.22919,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,7.013e-05,0.2969,0.32568,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0030654,0.29675,0.2405,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,5.2837e-06,0.2965,0.27684,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00026903,0.29629,0.25313,1,1
1,GO LYMPHOCYTE MIGRATION,0.00074557,0.29593,0.2144,1,1
1,GO RNA CATABOLIC PROCESS,5.2533e-07,0.29577,0.27618,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,7.013e-05,0.29573,0.36098,1,1
1,GO ENDOTHELIAL CELL MIGRATION,0.00016595,0.29565,0.29869,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00055855,0.29535,0.23187,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.4674e-06,0.29489,0.26295,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2876e-06,0.2948,0.27316,1,1
1,GO SELECTIVE AUTOPHAGY,1.0779e-06,0.29472,0.30122,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.3418e-05,0.2947,0.29065,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00069957,0.29467,0.3063,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.016734,0.29463,0.21143,1,1
1,GO REGULATION OF CELL AGING,5.753e-07,0.29407,0.32107,1,1
1,GO SPERM EGG RECOGNITION,3.3132e-05,0.29394,0.25072,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.010773,0.29392,0.27176,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.1493e-05,0.29328,0.25671,1,1
1,GO REPLICATIVE SENESCENCE,0.03939,0.29307,0.31363,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,7.2754e-05,0.29304,0.27968,1,1
1,GO T CELL CHEMOTAXIS,5.0226e-05,0.29304,0.26953,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.015203,0.29269,0.19349,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00012512,0.29263,0.2967,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,2.0833e-05,0.29254,0.28113,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0001165,0.29186,0.31895,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,2.5308e-05,0.29169,0.29962,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0017123,0.29166,0.25128,1,1
1,GO TRABECULA FORMATION,0.0010859,0.29145,0.39756,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0042883,0.29141,0.19981,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0036303,0.29116,0.25375,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00092958,0.2911,0.2366,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00036427,0.29105,0.3014,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00087311,0.29091,0.22607,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,2.7343e-05,0.29086,0.35355,1,1
1,GO HYPOTONIC RESPONSE,0.0028957,0.29084,0.26058,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.017549,0.29056,0.24794,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00036427,0.29039,0.297,1,1
1,GO MYOBLAST DIFFERENTIATION,2.2524e-05,0.29037,0.30526,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.7806e-05,0.29034,0.29898,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.012203,0.29025,0.20024,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.019283,0.2901,0.26415,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00059588,0.29,0.23861,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00020448,0.28993,0.28785,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00014418,0.28974,0.29351,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00084609,0.28969,0.34745,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0037331,0.28912,0.2391,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00035231,0.28892,0.23726,1,1
1,GO GENITALIA MORPHOGENESIS,0.011326,0.28854,0.27539,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0064317,0.28813,0.2952,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.7596e-05,0.28802,0.35661,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00031859,0.28779,0.29811,1,1
1,GO COPPER ION TRANSPORT,5.0226e-05,0.28722,0.31578,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,4.8612e-06,0.28707,0.26501,1,1
1,GO SYMBIOTIC PROCESS,3.8131e-07,0.28705,0.27734,1,1
1,GO CELLULAR RESPONSE TO VIRUS,2.3418e-05,0.28692,0.3008,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00013433,0.28677,0.25906,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.9418e-06,0.2864,0.31489,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00010462,0.28613,0.29907,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.00087311,0.28595,0.28378,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.0015189,0.28589,0.21591,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00032948,0.28566,0.28903,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00035231,0.28517,0.24906,1,1
1,GO PROSTATIC BUD FORMATION,0.017137,0.28454,0.28056,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00095906,0.28453,0.24182,1,1
1,GO RESPONSE TO PROTOZOAN,0.00065623,0.28426,0.29333,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0016129,0.2842,0.29603,1,1
1,GO CELL CELL RECOGNITION,3.6228e-06,0.28408,0.28387,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,3.6228e-06,0.28401,0.26342,1,1
1,GO STEROL TRANSPORT,0.00065623,0.28389,0.2131,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,5.8301e-05,0.2838,0.24879,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.0779e-06,0.28314,0.23966,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,3.1888e-05,0.28304,0.21758,1,1
1,GO TISSUE REGENERATION,0.0010528,0.28297,0.25017,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0013457,0.28287,0.33924,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0083534,0.28279,0.28619,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00065623,0.28245,0.31385,1,1
1,GO RESPONSE TO CYTOKINE,4.0073e-05,0.28227,0.28033,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.28227,0.22105,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00021167,0.28222,0.21241,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.6597e-05,0.2822,0.25978,1,1
1,GO GLAND MORPHOGENESIS,0.0006154,0.28194,0.33519,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.0021062,0.28171,0.27197,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0010859,0.28117,0.29364,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00074557,0.28092,0.26148,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0028141,0.28063,0.25498,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00017186,0.28031,0.20584,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012662,0.28027,0.29063,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,9.7346e-05,0.2802,0.32528,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.1617e-05,0.28018,0.29791,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00024286,0.27967,0.2344,1,1
1,GO CHOLESTEROL EFFLUX,0.00019079,0.27964,0.27133,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0071468,0.27946,0.24034,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0013457,0.27944,0.25378,1,1
1,GO MACROPHAGE DIFFERENTIATION,0.00012512,0.27938,0.34375,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,4.3218e-05,0.27927,0.37133,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0017641,0.27913,0.23424,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00038934,0.27881,0.24693,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00042998,0.27841,0.28363,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,6.7596e-05,0.27776,0.28694,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0059384,0.27774,0.23075,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0011549,0.2776,0.27757,1,1
1,GO DECIDUALIZATION,0.043763,0.27756,0.2536,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0020453,0.27753,0.26354,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0081404,0.27718,0.22394,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4609e-05,0.27713,0.27498,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0013872,0.27711,0.2651,1,1
1,GO CARTILAGE DEVELOPMENT,0.00081984,0.27694,0.23381,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.00045924,0.27682,0.25115,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00050664,0.27652,0.26851,1,1
1,GO KERATINOCYTE MIGRATION,0.00030804,0.27652,0.28497,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00029782,0.2765,0.30265,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00049035,0.27596,0.24546,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.7791e-06,0.27592,0.33516,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00032948,0.27564,0.4147,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.4878e-05,0.27544,0.32869,1,1
1,GO PROTEIN FOLDING,3.1888e-05,0.27443,0.24277,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0018173,0.27424,0.33546,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,6.0504e-05,0.27378,0.21123,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0011199,0.27339,0.206,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.007729,0.27338,0.30936,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00022676,0.27331,0.34406,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00067758,0.27299,0.27558,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.042857,0.27261,0.17261,1,1
1,GO RESPONSE TO THYROID HORMONE,0.0014738,0.27259,0.27932,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0036303,0.27247,0.29946,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0010206,0.27196,0.22905,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00047456,0.27188,0.19685,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,2.4692e-06,0.27113,0.26617,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00029782,0.27082,0.22481,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00079435,0.2708,0.28541,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0028141,0.27065,0.19187,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,9.8628e-07,0.27062,0.34518,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0007696,0.27056,0.36838,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.5201e-05,0.27044,0.23149,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.00017796,0.27043,0.29305,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.27041,0.29844,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.2703,0.33266,1,1
1,GO ASTROCYTE DEVELOPMENT,0.0010528,0.26991,0.28498,1,1
1,GO PLATELET MORPHOGENESIS,0.00013433,0.2699,0.25265,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.011326,0.26967,0.20631,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00010462,0.26924,0.21331,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00092958,0.26909,0.31344,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00038934,0.26858,0.25206,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,5.8301e-05,0.26849,0.27635,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.26815,0.27001,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0006154,0.26799,0.30609,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00052342,0.26793,0.23054,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0041716,0.26779,0.27589,1,1
1,GO RESPONSE TO IONIZING RADIATION,7.6603e-06,0.26769,0.25222,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0010206,0.26744,0.24688,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.7343e-05,0.2674,0.41269,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0045306,0.26713,0.19381,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.011326,0.26704,0.23334,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.2962e-05,0.26688,0.35118,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00019753,0.26676,0.23707,1,1
1,GO COMPLEMENT ACTIVATION,6.2786e-05,0.26652,0.27406,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0025083,0.26639,0.21033,1,1
1,GO MEMBRANE DISASSEMBLY,0.0031536,0.26613,0.25416,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,3.3132e-05,0.26597,0.22613,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,0.26596,0.25532,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.001228,0.26579,0.34035,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00028792,0.26537,0.23284,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0022332,0.26525,0.26284,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0028141,0.26522,0.32015,1,1
1,GO SEQUESTERING OF METAL ION,0.004408,0.26461,0.17079,1,1
1,GO TRANSLATIONAL ELONGATION,0.00079435,0.2646,0.2174,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0017641,0.26387,0.22775,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00098941,0.26343,0.22671,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.0054795,0.26333,0.26495,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.021165,0.26329,0.17077,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.4121e-05,0.26294,0.25865,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0024367,0.26284,0.25246,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00095906,0.2628,0.22473,1,1
1,GO VIRION ASSEMBLY,0.00041602,0.26279,0.19021,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00036427,0.26256,0.23135,1,1
1,GO MUSCLE CELL MIGRATION,0.02843,0.2624,0.21641,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.26204,0.27623,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0016129,0.26203,0.26202,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00031859,0.26192,0.21082,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0011549,0.26192,0.20924,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0017641,0.26161,0.24701,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,0.26153,0.21144,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.007729,0.26127,0.23225,1,1
1,GO OSTEOBLAST DIFFERENTIATION,0.00042998,0.26112,0.24299,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.889e-07,0.26094,0.32356,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.0226e-05,0.2609,0.26072,1,1
1,GO DETECTION OF OTHER ORGANISM,0.024846,0.2608,0.2492,1,1
1,GO AUTOPHAGOSOME MATURATION,9.0551e-05,0.26078,0.25756,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,0.00016023,0.26053,0.28123,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.6015e-06,0.26052,0.21883,1,1
1,GO RNA 3 END PROCESSING,2.3418e-05,0.26012,0.22782,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00041602,0.25986,0.21238,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.6307e-05,0.25973,0.27152,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0081404,0.25969,0.27515,1,1
1,GO RNA DESTABILIZATION,1.8521e-05,0.25959,0.25955,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0037331,0.25909,0.24711,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.034637,0.25901,0.23514,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0025817,0.25898,0.2058,1,1
1,GO REGULATION OF GENE SILENCING,4.4712e-06,0.25818,0.24552,1,1
1,GO RESPONSE TO WOUNDING,0.00042998,0.25803,0.23589,1,1
1,GO WOUND HEALING,0.00030804,0.25787,0.28422,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.7791e-06,0.25786,0.23563,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.6307e-05,0.25781,0.24468,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00063551,0.25753,0.28387,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00040247,0.25725,0.23476,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,0.00072223,0.25665,0.29054,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00092958,0.25663,0.21933,1,1
1,GO TRNA 5 END PROCESSING,0.00034072,0.25637,0.28103,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00020448,0.25612,0.28211,1,1
1,GO CYTOKINE PRODUCTION,7.2754e-05,0.25584,0.24688,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0013457,0.25553,0.24421,1,1
1,GO FATTY ACID BETA OXIDATION,0.0014738,0.2554,0.22345,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.013139,0.25521,0.21637,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00018427,0.25502,0.24922,1,1
1,GO CELL MATRIX ADHESION,0.00049035,0.25483,0.29585,1,1
1,GO RRNA METHYLATION,0.0013054,0.25442,0.22038,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00017796,0.25424,0.21558,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0021062,0.25378,0.3085,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00079435,0.25364,0.30822,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.5816e-05,0.25329,0.25871,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0057817,0.25311,0.36914,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.012203,0.25307,0.25641,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.0067808,0.25295,0.21204,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00017186,0.25285,0.22825,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0012662,0.25276,0.19364,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,3.8583e-05,0.25263,0.23772,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.6307e-05,0.25239,0.38341,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.011326,0.25197,0.25426,1,1
1,GO REGULATION OF HEART GROWTH,0.00025131,0.25195,0.22549,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00040247,0.25186,0.21884,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0067808,0.25178,0.39619,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0023671,0.25097,0.26297,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0019282,0.2507,0.21949,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0024367,0.25035,0.15075,1,1
1,GO ERK1 AND ERK2 CASCADE,0.00010462,0.25018,0.21697,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0011199,0.24977,0.24929,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0047853,0.24977,0.19343,1,1
1,GO REGULATION OF ORGAN GROWTH,3.6228e-06,0.24884,0.28813,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0036303,0.24872,0.23333,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.012203,0.2485,0.25704,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00018427,0.24849,0.21894,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00041602,0.24839,0.26257,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00014935,0.2481,0.20636,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0042883,0.24808,0.16975,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,7.2754e-05,0.24783,0.27522,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00027832,0.24755,0.24645,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0016129,0.24749,0.23049,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.0604e-05,0.24744,0.23538,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.4346e-05,0.24713,0.23604,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.025414,0.24702,0.2113,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.0833e-05,0.24693,0.21822,1,1
1,GO TRNA PROCESSING,0.00035231,0.2469,0.19368,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,5.8301e-05,0.24675,0.24262,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.7118e-05,0.2467,0.32276,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0054795,0.24667,0.25172,1,1
1,GO GONADOTROPIN SECRETION,0.033894,0.24665,0.21891,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00095906,0.24648,0.25305,1,1
1,GO PODOSOME ASSEMBLY,0.00017186,0.24635,0.35559,1,1
1,GO IMMUNE EFFECTOR PROCESS,4.3218e-05,0.24623,0.26165,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00084609,0.24612,0.35889,1,1
1,GO COAGULATION,0.00030804,0.24564,0.25109,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.024288,0.24564,0.32111,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.001872,0.24453,0.16266,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.016339,0.24448,0.22779,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0025083,0.24447,0.24683,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.1663e-05,0.24446,0.2362,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,6.0504e-05,0.24432,0.23126,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.011047,0.24429,0.20124,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0010859,0.24414,0.2383,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.8282e-05,0.24399,0.27417,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,9.0551e-05,0.24384,0.24487,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.010773,0.24382,0.16226,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00072223,0.24362,0.41633,1,1
1,GO TOXIN TRANSPORT,0.010245,0.2436,0.15713,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0010206,0.24348,0.20222,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0038387,0.24302,0.16385,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0027346,0.24271,0.27533,1,1
1,GO TISSUE REMODELING,0.0027346,0.24263,0.2242,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0097392,0.24249,0.16562,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0017641,0.24212,0.24638,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.00079435,0.24204,0.2362,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00029782,0.24163,0.24768,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00069957,0.24163,0.21713,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.015574,0.24161,0.15475,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00069957,0.24144,0.17645,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0042883,0.24137,0.22958,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00052342,0.24124,0.23102,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00020448,0.24123,0.22101,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.02268,0.2411,0.20412,1,1
1,GO RESPONSE TO PROGESTERONE,0.011904,0.24076,0.26244,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0036303,0.24042,0.1661,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.001228,0.24031,0.23036,1,1
1,GO PEPTIDE METABOLIC PROCESS,6.7728e-06,0.24018,0.21786,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00049035,0.24011,0.34328,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,6.5149e-05,0.23988,0.26456,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,4.8379e-05,0.23978,0.21154,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0028141,0.23959,0.20877,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.23955,0.20892,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0030654,0.23946,0.23321,1,1
1,GO PHAGOCYTOSIS,2.0033e-05,0.23925,0.30249,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00025131,0.2392,0.24638,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.017137,0.23915,0.20685,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0011199,0.23905,0.21758,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,5.0226e-05,0.23898,0.23134,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00092958,0.23885,0.24519,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.0226e-05,0.23874,0.37142,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0019282,0.23846,0.17155,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.1493e-05,0.2382,0.23943,1,1
1,GO NUCLEAR EXPORT,5.2837e-06,0.23723,0.21272,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.014841,0.2372,0.18671,1,1
1,GO DNA LIGATION,0.00055855,0.23713,0.27765,1,1
1,GO NEURAL TUBE PATTERNING,0.0083534,0.23708,0.19689,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0027346,0.23693,0.30024,1,1
1,GO HISTONE H2B UBIQUITINATION,0.0023671,0.23682,0.19229,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00040247,0.23659,0.33337,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,3.4421e-05,0.23602,0.21035,1,1
1,GO STRESS FIBER ASSEMBLY,0.0013054,0.23576,0.22434,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0039469,0.23571,0.25188,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.026586,0.23566,0.17032,1,1
1,GO MACROPHAGE CHEMOTAXIS,4.3218e-05,0.2356,0.34053,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.00092958,0.23532,0.24115,1,1
1,GO RNA METHYLATION,0.00016023,0.23524,0.21371,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0022992,0.23508,0.30992,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00017186,0.23507,0.20824,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.4121e-05,0.23496,0.22285,1,1
1,GO REGULATION OF ANOIKIS,0.040234,0.23482,0.22181,1,1
1,GO MESODERM DEVELOPMENT,5.6174e-05,0.23369,0.20374,1,1
1,GO LIPID STORAGE,0.00095906,0.23358,0.22594,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00057693,0.23348,0.21432,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00012512,0.23319,0.32709,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0083534,0.23302,0.26099,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.8418e-05,0.23268,0.34062,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.045624,0.23261,0.23465,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00044439,0.23253,0.29792,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00012512,0.23253,0.19816,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0011549,0.23208,0.26185,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00049035,0.23176,0.34405,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.035393,0.23171,0.18546,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00013433,0.23166,0.27941,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0025817,0.23166,0.23483,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0010528,0.23162,0.21027,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00353,0.23159,0.16492,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0045306,0.23159,0.33442,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00012074,0.23146,0.34564,1,1
1,GO PLATELET ACTIVATION,0.0031536,0.23124,0.19741,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.02843,0.23112,0.23529,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0012662,0.23066,0.24283,1,1
1,GO RNA MODIFICATION,6.2786e-05,0.23061,0.20939,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.0045306,0.23029,0.2233,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,1.2454e-05,0.23022,0.23343,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.029068,0.23012,0.30833,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00034072,0.22989,0.21402,1,1
1,GO PROTEIN TARGETING,0.00019079,0.22982,0.18307,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00010462,0.2298,0.27943,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.036164,0.22971,0.20874,1,1
1,GO HYPEROSMOTIC RESPONSE,0.0051916,0.22955,0.22019,1,1
1,GO HISTONE H4 DEACETYLATION,0.0075304,0.22953,0.2196,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00049035,0.22915,0.19069,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.017969,0.22915,0.14794,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0019282,0.22889,0.24853,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.1964e-05,0.22789,0.23277,1,1
1,GO REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.22775,0.20159,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,8.4205e-05,0.22728,0.25602,1,1
1,GO PLASMA MEMBRANE FUSION,0.035393,0.22722,0.18881,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00090094,0.22714,0.21093,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.1888e-05,0.227,0.23447,1,1
1,GO RNA POLYADENYLATION,0.00019079,0.22693,0.18531,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0013054,0.22681,0.24666,1,1
1,GO TRNA MODIFICATION,0.00050664,0.22664,0.20304,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0064317,0.22658,0.18487,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00014418,0.22657,0.21789,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0054795,0.22625,0.19168,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00092958,0.22612,0.17994,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0067808,0.22579,0.20147,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,8.1192e-05,0.2257,0.26946,1,1
1,GO NEURAL CREST CELL MIGRATION,0.015574,0.22561,0.20388,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0024367,0.2251,0.22696,1,1
1,GO CERAMIDE TRANSPORT,0.045624,0.2242,0.18002,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.0073e-05,0.22419,0.18716,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.010773,0.22419,0.15992,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00092958,0.22411,0.19037,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001872,0.22409,0.21907,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00012512,0.22367,0.23902,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.03939,0.22358,0.14755,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00031859,0.22353,0.19543,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.0010859,0.22329,0.25138,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.01282,0.22307,0.21185,1,1
1,GO OVULATION,0.013798,0.22263,0.24588,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00037661,0.22229,0.20994,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00019753,0.22209,0.20984,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.0012662,0.22208,0.1905,1,1
1,GO BONE MORPHOGENESIS,0.0040578,0.22204,0.21741,1,1
1,GO PROTEIN KINASE B SIGNALING,0.00084609,0.22199,0.17657,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0097392,0.22193,0.17672,1,1
1,GO RESPONSE TO BACTERIUM,0.00012964,0.22176,0.23947,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0069616,0.2217,0.1855,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.010506,0.22156,0.20365,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00021909,0.22142,0.18319,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00072223,0.22109,0.25637,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.22106,0.17536,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0022992,0.22105,0.2769,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0057817,0.22086,0.16308,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,0.00013917,0.22078,0.17533,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.6307e-05,0.22058,0.2073,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.0099891,0.22053,0.12692,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.018836,0.22026,0.21425,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00353,0.22019,0.1918,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0010859,0.21978,0.20809,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,5.4121e-05,0.21976,0.22902,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0014738,0.21975,0.22396,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.015203,0.21963,0.18459,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0010206,0.21961,0.21601,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0059384,0.21936,0.19338,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.03245,0.21918,0.21293,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0030654,0.21901,0.22776,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00090094,0.21901,0.31678,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0012662,0.21889,0.16917,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.023205,0.21887,0.12887,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.024846,0.21884,0.13098,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.017549,0.2188,0.18144,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0053338,0.21859,0.20762,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,6.8936e-07,0.21854,0.17236,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0049174,0.21841,0.254,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00069957,0.21821,0.24446,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00012074,0.2182,0.22626,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0064317,0.21766,0.20158,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00054072,0.21761,0.33478,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.0031536,0.21681,0.23383,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.023741,0.2165,0.15725,1,1
1,GO REGULATION OF URINE VOLUME,0.00074557,0.21647,0.22644,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.4044e-06,0.21628,0.20673,1,1
1,GO TISSUE MIGRATION,0.00032948,0.21609,0.27092,1,1
1,GO RESPONSE TO RETINOIC ACID,0.00095906,0.21608,0.20591,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001662,0.21592,0.20499,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00024286,0.21534,0.2469,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0017123,0.21518,0.18881,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00024286,0.21501,0.24844,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0015189,0.21418,0.18692,1,1
1,GO GRANULOCYTE MIGRATION,0.00092958,0.21414,0.25515,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0010528,0.21411,0.30391,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,0.214,0.2095,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00041602,0.2139,0.23627,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00032948,0.21389,0.24244,1,1
1,GO RNA PROCESSING,6.7596e-05,0.21369,0.18101,1,1
1,GO MRNA TRANSPORT,7.2754e-05,0.21354,0.19429,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00098941,0.2132,0.29917,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00017186,0.21296,0.25407,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00017796,0.21269,0.22819,1,1
1,GO MITOPHAGY,0.00069957,0.21231,0.21924,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00063551,0.21196,0.18897,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00031859,0.21189,0.23558,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0094949,0.21181,0.16669,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0022332,0.21173,0.29168,1,1
1,GO DNA DEALKYLATION,0.0051916,0.21169,0.19897,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0013457,0.21138,0.18677,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,3.3287e-06,0.21113,0.24113,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0015189,0.21078,0.20876,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0028141,0.21055,0.22738,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0039469,0.21033,0.19941,1,1
1,GO RUFFLE ORGANIZATION,0.0013872,0.21008,0.16,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0033369,0.21008,0.19728,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.1663e-05,0.20992,0.18003,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,4.8612e-06,0.2098,0.22414,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0036303,0.2091,0.1752,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0079323,0.20909,0.23674,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0011199,0.20909,0.27014,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0014299,0.20902,0.17006,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0027346,0.20875,0.26504,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.00018427,0.20873,0.25334,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.027803,0.20859,0.16807,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,6.5896e-07,0.20857,0.18134,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0071468,0.20852,0.17955,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,8.3127e-06,0.20805,0.20832,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0090226,0.20792,0.18039,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00034072,0.20752,0.20366,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0021689,0.20734,0.15502,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.001986,0.2069,0.23508,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,5.2139e-05,0.20666,0.21261,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.0011199,0.20659,0.17185,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00035231,0.20658,0.20537,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.001872,0.20655,0.25455,1,1
1,GO PROTEIN DENEDDYLATION,0.014486,0.20629,0.15322,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00087311,0.20599,0.17765,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0031536,0.2057,0.18767,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.024288,0.20552,0.19736,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,8.4205e-05,0.20545,0.19701,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0028141,0.20537,0.19429,1,1
1,GO RNA LOCALIZATION,7.2754e-05,0.20488,0.21001,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00025131,0.2047,0.17973,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,4.0073e-05,0.2041,0.18335,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.024288,0.20391,0.22484,1,1
1,GO TRNA TRANSPORT,0.0045306,0.20381,0.18372,1,1
1,GO DEFENSE RESPONSE,0.00029782,0.20369,0.20284,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0006154,0.20359,0.17767,1,1
1,GO RESPONSE TO GAMMA RADIATION,8.1192e-05,0.20319,0.22332,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.010245,0.20255,0.14809,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0025083,0.20253,0.17454,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00037661,0.20245,0.20501,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,5.4121e-05,0.20228,0.20566,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00090094,0.20228,0.15846,1,1
1,GO PROTEIN AUTOPROCESSING,0.02268,0.20206,0.13976,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.007729,0.20192,0.26843,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0054795,0.20191,0.20765,1,1
1,GO P38MAPK CASCADE,0.0006154,0.20138,0.29126,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0006154,0.20136,0.18714,1,1
1,GO REGULATION OF LIPID STORAGE,0.0014299,0.20122,0.23338,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.022165,0.20082,0.15831,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0041716,0.20072,0.21972,1,1
1,GO REGULATION OF PROTEOLYSIS,0.00021909,0.20056,0.17711,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00057693,0.20037,0.21093,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.4712e-06,0.20027,0.18063,1,1
1,GO MYELOID CELL HOMEOSTASIS,0.00026003,0.20017,0.19025,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.02166,0.19996,0.18332,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0025817,0.19982,0.13712,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0032441,0.19964,0.21694,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,9.0551e-05,0.19935,0.21148,1,1
1,GO MITOTIC CYTOKINESIS,0.0053338,0.19897,0.18318,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00092958,0.19888,0.14788,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.001986,0.19886,0.15915,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0011199,0.19867,0.21459,1,1
1,GO PROTEIN IMPORT,2.7343e-05,0.19864,0.1795,1,1
1,GO MIDBODY ABSCISSION,0.014841,0.19861,0.19748,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.037747,0.19853,0.17831,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.046579,0.19844,0.17788,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,0.00025131,0.19841,0.25338,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0045306,0.1983,0.22474,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00038934,0.19803,0.18438,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00035231,0.19796,0.17181,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.011326,0.19748,0.20946,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.010773,0.19713,0.237,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0010528,0.19671,0.16329,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00084609,0.19664,0.21238,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00074557,0.19663,0.16279,1,1
1,GO LACTATION,0.0040578,0.1965,0.18875,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.024846,0.19637,0.20977,1,1
1,GO RESPONSE TO KETONE,0.018836,0.19627,0.11658,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0071468,0.19587,0.1784,1,1
1,GO VESICLE TARGETING,0.0001165,0.19585,0.21485,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.017969,0.19585,0.15723,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00079435,0.1955,0.18646,1,1
1,GO REGULATION OF HEMOPOIESIS,0.00030804,0.19516,0.17792,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00030804,0.19504,0.15829,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.011904,0.19483,0.17087,1,1
1,GO CELL AGING,6.2367e-06,0.19481,0.21167,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00022676,0.19439,0.19163,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.036948,0.19421,0.20007,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.046579,0.19349,0.1547,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.020205,0.19345,0.15477,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00027832,0.19332,0.21489,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0021689,0.19315,0.19035,1,1
1,GO MEMBRANE BIOGENESIS,0.045624,0.19312,0.17318,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.0784e-06,0.19244,0.1902,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.017549,0.19226,0.16314,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.042857,0.19202,0.27372,1,1
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0017641,0.192,0.22153,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0054795,0.19191,0.17825,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0019282,0.19171,0.14475,1,1
1,GO PROTEIN PROCESSING,0.0014738,0.19168,0.1828,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0069616,0.19166,0.33281,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00038934,0.19155,0.17726,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.017137,0.19113,0.13983,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.6597e-05,0.19112,0.18612,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0020453,0.1911,0.18306,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00030804,0.19102,0.18342,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.017549,0.19097,0.17537,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00072223,0.19066,0.16292,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00079435,0.1906,0.18922,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0053338,0.19035,0.16466,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00041602,0.19033,0.21259,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00079435,0.1903,0.17552,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00018427,0.19027,0.1781,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.7474e-06,0.18985,0.18482,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.9263e-05,0.18978,0.18244,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0006154,0.18977,0.18817,1,1
1,GO T CELL ACTIVATION,0.00054072,0.18962,0.1888,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.00023468,0.18952,0.17337,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.019739,0.18892,0.17892,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00041602,0.18878,0.17133,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.0021062,0.18877,0.17846,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0007696,0.18864,0.14804,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.02166,0.18844,0.16664,1,1
1,GO NUCLEAR TRANSPORT,2.4346e-05,0.18833,0.16069,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,8.1192e-05,0.1883,0.20516,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00038934,0.18798,0.18693,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0073363,0.18797,0.17609,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00052342,0.18772,0.20986,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.001228,0.18757,0.18921,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00028792,0.1872,0.18878,1,1
1,GO CELL ACTIVATION,0.00021167,0.18702,0.20764,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0099891,0.18693,0.17558,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0041716,0.1863,0.19194,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0062634,0.18627,0.24566,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.7118e-05,0.18588,0.21535,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.014486,0.18581,0.18023,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,8.3127e-06,0.18498,0.15435,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00025131,0.18497,0.16707,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,3.3132e-05,0.18486,0.17539,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.010245,0.18485,0.15242,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.013139,0.18482,0.224,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,5.4121e-05,0.18479,0.2081,1,1
1,GO ORGANELLE INHERITANCE,0.0042883,0.18403,0.15861,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.001228,0.1838,0.14694,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.010506,0.18374,0.13998,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0184e-05,0.18342,0.15803,1,1
1,GO INFLAMMATORY RESPONSE,0.0006154,0.18333,0.22019,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0075304,0.18332,0.18162,1,1
1,GO MESENCHYME DEVELOPMENT,0.0032441,0.18252,0.184,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.038561,0.1824,0.20183,1,1
1,GO PROTEIN NEDDYLATION,0.0010859,0.18232,0.19318,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0057817,0.18192,0.2017,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,4.0073e-05,0.18187,0.21687,1,1
1,GO CENTRIOLE ASSEMBLY,0.011047,0.18179,0.12131,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0042883,0.18173,0.15529,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0013457,0.18141,0.15839,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00041602,0.18081,0.14731,1,1
1,GO TUBE MORPHOGENESIS,0.0010859,0.18081,0.18803,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.014138,0.18038,0.15302,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0030654,0.18028,0.17507,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,3.5759e-05,0.18001,0.20774,1,1
1,GO PROTEIN MATURATION,0.00063551,0.17999,0.14183,1,1
1,GO RNA CAPPING,3.5759e-05,0.17984,0.18093,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00079435,0.17948,0.14263,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.024846,0.17885,0.14483,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.029719,0.1785,0.23717,1,1
1,GO FACE DEVELOPMENT,0.001986,0.17832,0.22907,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0090226,0.17826,0.27813,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.026586,0.17788,0.19912,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.033166,0.17747,0.16379,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00023468,0.17718,0.23974,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00029782,0.17714,0.15258,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0037331,0.17713,0.15819,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.001662,0.1764,0.12933,1,1
1,GO RESPONSE TO STEROID HORMONE,0.0042883,0.17635,0.14852,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00054072,0.1761,0.18674,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0022992,0.17593,0.22905,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.0013872,0.17533,0.15618,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.011326,0.17492,0.18565,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0057817,0.17469,0.14603,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,4.1617e-05,0.17459,0.2088,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00044439,0.17438,0.1359,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0028957,0.17427,0.20299,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0014299,0.17413,0.16731,1,1
1,GO GOLGI VESICLE TRANSPORT,5.8301e-05,0.17379,0.16059,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00017796,0.17348,0.17718,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00074557,0.17329,0.17577,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00026003,0.17309,0.18584,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0073363,0.17298,0.15541,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0059384,0.1728,0.20046,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00026003,0.1725,0.22913,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.02068,0.17239,0.15365,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0014738,0.17235,0.20033,1,1
1,GO AGING,0.00042998,0.17234,0.16316,1,1
1,GO RESPONSE TO ISCHEMIA,0.00042998,0.17219,0.1899,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0011549,0.17202,0.24006,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0025083,0.17148,0.1669,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.011904,0.17146,0.16461,1,1
1,GO LYSOSOMAL TRANSPORT,0.0012662,0.17139,0.1612,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0067808,0.17128,0.24452,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0014299,0.17106,0.21399,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.012203,0.17095,0.13097,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0046564,0.1707,0.13167,1,1
1,GO MITOTIC RECOMBINATION,0.0051916,0.1707,0.18694,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00028792,0.17062,0.14817,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0022332,0.17034,0.12988,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00095906,0.17034,0.20275,1,1
1,GO RESPONSE TO CHEMOKINE,0.015953,0.17034,0.19109,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0017641,0.17018,0.14627,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00045924,0.17003,0.20714,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0039469,0.16991,0.18678,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.001228,0.16983,0.15022,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,5.8301e-05,0.16941,0.16845,1,1
1,GO POSITIVE CHEMOTAXIS,0.015953,0.16938,0.2003,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0054795,0.16934,0.16584,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0051916,0.16905,0.1431,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0038387,0.16872,0.15354,1,1
1,GO PEROXISOME ORGANIZATION,0.0026572,0.16869,0.17555,1,1
1,GO MRNA METABOLIC PROCESS,2.7343e-05,0.16862,0.16685,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00029782,0.16856,0.17001,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0016129,0.16852,0.17406,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.0019282,0.16847,0.17446,1,1
1,GO BLASTOCYST GROWTH,0.0059384,0.16823,0.22956,1,1
1,GO VACUOLAR TRANSPORT,0.0017641,0.1682,0.13853,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.02068,0.16812,0.21955,1,1
1,GO IMPORT INTO NUCLEUS,0.00023468,0.16798,0.14576,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.010506,0.16796,0.19485,1,1
1,GO DRUG METABOLIC PROCESS,0.038561,0.16779,0.10459,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.025994,0.16757,0.11483,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.0038387,0.16738,0.11314,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0013872,0.16729,0.16396,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0042883,0.16668,0.1798,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0047853,0.16654,0.17888,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0083534,0.1665,0.12902,1,1
1,GO NEUTROPHIL MIGRATION,0.020205,0.16634,0.20788,1,1
1,GO PROTEIN KINASE A SIGNALING,5.6174e-05,0.16629,0.22147,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00026903,0.16626,0.14566,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00059588,0.16596,0.17619,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00065623,0.16581,0.15737,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0024367,0.16567,0.18407,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.020205,0.16565,0.15313,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.8418e-05,0.16465,0.16689,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0041716,0.16417,0.1508,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.013798,0.16405,0.14177,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.036948,0.16399,0.10833,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,1.104e-05,0.16397,0.15136,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0010206,0.16374,0.17992,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00017796,0.16367,0.14066,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.3418e-05,0.16349,0.22609,1,1
1,GO RESPONSE TO PH,0.045624,0.16319,0.17331,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0059384,0.16317,0.15232,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001986,0.16294,0.17695,1,1
1,GO OSSIFICATION,0.0066042,0.16293,0.16221,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00029782,0.16287,0.15463,1,1
1,GO TRANSLESION SYNTHESIS,0.00353,0.16219,0.14547,1,1
1,GO TELOMERE ORGANIZATION,0.00050664,0.16219,0.13693,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0066042,0.1621,0.14485,1,1
1,GO VACUOLE ORGANIZATION,0.00065623,0.16206,0.13687,1,1
1,GO SPINDLE LOCALIZATION,0.001986,0.16145,0.14183,1,1
1,GO PROTEIN POLYUBIQUITINATION,4.4878e-05,0.161,0.15096,1,1
1,GO GLOMERULUS DEVELOPMENT,0.0012662,0.16071,0.32915,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.0097392,0.16069,0.15819,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.024846,0.16063,0.083591,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00042998,0.16029,0.15349,1,1
1,GO CELL KILLING,0.02166,0.15996,0.12643,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.001872,0.15896,0.15488,1,1
1,GO ACUTE PHASE RESPONSE,0.02268,0.15896,0.22461,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0025817,0.15896,0.15038,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00098941,0.15832,0.26283,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,5.2837e-06,0.15801,0.1627,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0053338,0.15744,0.20701,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.023741,0.1573,0.11337,1,1
1,GO PROTEOLYSIS,0.0001547,0.15686,0.13128,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0011549,0.1568,0.14059,1,1
1,GO ERBB SIGNALING PATHWAY,0.001872,0.15667,0.20485,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0062634,0.1565,0.12681,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0075304,0.15616,0.15126,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.7806e-05,0.15603,0.14411,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0021062,0.15593,0.16158,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.5308e-05,0.15588,0.15012,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,0.15523,0.17054,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0024367,0.15513,0.20935,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00049035,0.15438,0.1412,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00010462,0.15415,0.15423,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0079323,0.15411,0.18356,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,3.1888e-05,0.154,0.15978,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.026586,0.15373,0.14494,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.024846,0.15364,0.18196,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00010845,0.15364,0.15037,1,1
1,GO MAINTENANCE OF LOCATION,0.00016023,0.1534,0.15799,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0025083,0.15331,0.20168,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,7.547e-05,0.15305,0.16852,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.016734,0.1527,0.22123,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0090226,0.15257,0.15517,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0083534,0.15246,0.18106,1,1
1,GO BONE DEVELOPMENT,0.0027346,0.15235,0.18057,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0040578,0.15233,0.15526,1,1
1,GO PROTEIN CATABOLIC PROCESS,2.5308e-05,0.15231,0.13921,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.0039469,0.15227,0.15763,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0014299,0.15189,0.14605,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.9263e-05,0.15177,0.14455,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.045624,0.15162,0.10203,1,1
1,GO B CELL ACTIVATION,0.0023671,0.15151,0.1324,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.035393,0.15142,0.15752,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00042998,0.15101,0.14354,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.7596e-05,0.15091,0.14901,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.025994,0.15085,0.16322,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0041716,0.15055,0.10854,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0013054,0.15024,0.16585,1,1
1,GO REGULATION OF MYELINATION,0.035393,0.15014,0.11144,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0013457,0.14979,0.14527,1,1
1,GO PROTEIN STABILIZATION,0.00081984,0.14976,0.13557,1,1
1,GO REGULATION OF BINDING,0.0034322,0.14932,0.12023,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,1.2962e-05,0.14888,0.16102,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0050528,0.14871,0.13643,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00047456,0.14801,0.14455,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00081984,0.14795,0.13331,1,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.045624,0.14778,0.13469,1,1
1,GO RESPONSE TO UV,0.00090094,0.14777,0.14137,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00038934,0.14743,0.11963,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00037661,0.14727,0.16203,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0087944,0.14723,0.10471,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0051916,0.14709,0.14359,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.013139,0.14682,0.15376,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0010206,0.14649,0.14394,1,1
1,GO HEART VALVE DEVELOPMENT,0.0041716,0.14631,0.22713,1,1
1,GO REGULATION OF CATABOLIC PROCESS,9.0179e-06,0.14626,0.14604,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00095906,0.14624,0.19238,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.001986,0.14606,0.21022,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0011549,0.14597,0.12961,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0064317,0.14597,0.18494,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00026903,0.1453,0.14797,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0075304,0.14529,0.24712,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0045306,0.14513,0.15444,1,1
1,GO NEURAL TUBE FORMATION,0.017969,0.14497,0.15986,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00034072,0.14495,0.13894,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.013465,0.14478,0.13873,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.011612,0.14472,0.14563,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0045306,0.14471,0.1453,1,1
1,GO BODY FLUID SECRETION,0.00047456,0.14469,0.19926,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.001228,0.14467,0.13817,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0079323,0.14467,0.14972,1,1
1,GO NCRNA CATABOLIC PROCESS,0.040234,0.14454,0.14855,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.023741,0.14453,0.15399,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013054,0.14452,0.11892,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.01282,0.14421,0.13661,1,1
1,GO VACUOLAR ACIDIFICATION,0.011047,0.14387,0.14856,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0010206,0.14326,0.14643,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.02166,0.14317,0.16843,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00016595,0.14296,0.16526,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.012203,0.14268,0.13628,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0022992,0.14251,0.10593,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.027188,0.14225,0.11214,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00026003,0.1422,0.18714,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00052342,0.14207,0.15198,1,1
1,GO HISTONE DEACETYLATION,0.0019282,0.14151,0.11478,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.015203,0.1411,0.1172,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0023671,0.14083,0.16764,1,1
1,GO GOLGI ORGANIZATION,0.0022332,0.14082,0.12195,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.0021689,0.14047,0.11036,1,1
1,GO TRABECULA MORPHOGENESIS,0.0097392,0.14038,0.20547,1,1
1,GO GENE SILENCING,6.0504e-05,0.14012,0.13898,1,1
1,GO CELLULAR RESPONSE TO UV,0.0059384,0.13961,0.13052,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.5774e-06,0.13951,0.16256,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00098941,0.1394,0.15761,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0031536,0.13903,0.12868,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.025994,0.13883,0.13241,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00049035,0.1387,0.12962,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,3.8583e-05,0.13859,0.17871,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00010845,0.13742,0.13557,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00045924,0.13732,0.11525,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0017641,0.13719,0.17394,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0085714,0.13709,0.11019,1,1
1,GO POSTREPLICATION REPAIR,0.0022992,0.1364,0.13019,1,1
1,GO NUCLEUS ORGANIZATION,0.0042883,0.13624,0.11853,1,1
1,GO ENDOSOME ORGANIZATION,0.0059384,0.13593,0.13598,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00023468,0.135,0.1355,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0049174,0.13485,0.090557,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.023741,0.13471,0.19406,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0010206,0.13425,0.13726,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0060989,0.13415,0.19709,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,7.8282e-05,0.13409,0.12266,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.011612,0.13398,0.13323,1,1
1,GO REGULATION OF MAPK CASCADE,0.0039469,0.13398,0.12762,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0066042,0.13381,0.11213,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.026586,0.13343,0.12477,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0060989,0.13331,0.16941,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.013139,0.13301,0.15874,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.0024367,0.1328,0.1425,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0029794,0.13261,0.14324,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.015574,0.13249,0.1001,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.0051916,0.13215,0.14529,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.036164,0.13209,0.094694,1,1
1,GO VIRAL BUDDING,0.0097392,0.13148,0.13175,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,9.0551e-05,0.13088,0.1419,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00021167,0.13081,0.15226,1,1
1,GO GENITALIA DEVELOPMENT,0.024288,0.13028,0.09985,1,1
1,GO STEM CELL DIFFERENTIATION,0.00079435,0.13003,0.15378,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00047456,0.13002,0.13104,1,1
1,GO MRNA 3 END PROCESSING,0.0034322,0.12957,0.13049,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.026586,0.1295,0.14574,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.014841,0.12947,0.08906,1,1
1,GO MIRNA METABOLIC PROCESS,0.0049174,0.12895,0.15298,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0059384,0.12849,0.098361,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.0037331,0.12823,0.13032,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0013872,0.12764,0.16598,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0023671,0.12744,0.14008,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0051916,0.12743,0.12081,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.011326,0.1269,0.13384,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.001662,0.1269,0.14045,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0056288,0.12678,0.13169,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0081404,0.12677,0.18129,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038387,0.12635,0.12253,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0021062,0.12631,0.13619,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.046579,0.12612,0.092054,1,1
1,GO BASE EXCISION REPAIR,0.010245,0.1256,0.13917,1,1
1,GO MRNA CLEAVAGE,0.00024286,0.12559,0.14981,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,3.1888e-05,0.12549,0.13787,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00031859,0.12504,0.13384,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.017549,0.12488,0.12256,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.017969,0.12456,0.096426,1,1
1,GO RNA SURVEILLANCE,0.0011199,0.12395,0.20008,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,2.0033e-05,0.12358,0.11727,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011047,0.12333,0.15834,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.016734,0.12289,0.079261,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.024288,0.12251,0.11726,1,1
1,GO ORGAN GROWTH,0.0057817,0.12249,0.16116,1,1
1,GO REGULATION OF DNA REPAIR,0.004408,0.12235,0.10094,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0026572,0.12216,0.11226,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00023468,0.12208,0.10822,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0021689,0.12201,0.11178,1,1
1,GO TUBE DEVELOPMENT,0.0081404,0.12178,0.14091,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0057817,0.12148,0.10437,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.1192e-05,0.12139,0.13679,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.010506,0.12118,0.098401,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013872,0.12103,0.1676,1,1
1,GO RESPONSE TO LIPID,0.0050528,0.12099,0.13855,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0051916,0.12022,0.11553,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.0027346,0.11993,0.13946,1,1
1,GO CELLULAR SENESCENCE,0.0014738,0.11989,0.13232,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.03939,0.11915,0.078736,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.036164,0.11874,0.098434,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0040578,0.11847,0.13759,1,1
1,GO REGULATION OF OSSIFICATION,0.020205,0.11837,0.15274,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0031536,0.11808,0.11777,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.007729,0.11757,0.089514,1,1
1,GO REGULATION OF CELL DEATH,0.0022992,0.11732,0.11088,1,1
1,GO APOPTOTIC PROCESS,0.0014299,0.11701,0.10691,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.043763,0.11686,0.1667,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0087944,0.11682,0.11365,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001872,0.11625,0.1189,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,2.3418e-05,0.11605,0.14955,1,1
1,GO CELL DIVISION,0.020205,0.11603,0.087722,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.020205,0.11599,0.092396,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.024288,0.11537,0.16301,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0081404,0.1146,0.11075,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.015953,0.11422,0.085296,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00057693,0.11359,0.10571,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0062634,0.11331,0.10324,1,1
1,GO MEMBRANE ORGANIZATION,0.0094949,0.11274,0.08457,1,1
1,GO ORGANELLE FISSION,0.040234,0.11178,0.073333,1,1
1,GO FEMALE GAMETE GENERATION,0.011904,0.11153,0.082668,1,1
1,GO RESPONSE TO PEPTIDE,0.0099891,0.11137,0.083111,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.016339,0.11119,0.15225,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0060989,0.11079,0.10978,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0067808,0.10955,0.094662,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.029719,0.10947,0.10963,1,1
1,GO OVULATION CYCLE,0.042857,0.10943,0.13541,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.025994,0.10911,0.10638,1,1
1,GO ORGANELLE DISASSEMBLY,0.00092958,0.10897,0.11451,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0040578,0.1087,0.153,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0025817,0.10861,0.1111,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.013139,0.10854,0.11638,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.010773,0.10851,0.11115,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.045624,0.10823,0.11898,1,1
1,GO MACROAUTOPHAGY,0.00010092,0.10746,0.13027,1,1
1,GO MESENCHYME MORPHOGENESIS,0.027188,0.10713,0.24643,1,1
1,GO REGULATION OF AUTOPHAGY,0.0020453,0.10667,0.10507,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0050528,0.10665,0.099759,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.010773,0.10651,0.085831,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0051916,0.10564,0.18674,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0019282,0.10561,0.10139,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00026903,0.10532,0.095544,1,1
1,GO SULFATE TRANSPORT,0.004408,0.10504,0.12295,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0025083,0.10431,0.17797,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.0085714,0.10415,0.17113,1,1
1,GO PERICARDIUM DEVELOPMENT,0.02268,0.10399,0.1797,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0012662,0.10382,0.07631,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.03939,0.10354,0.09134,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.012508,0.10254,0.11037,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.001662,0.10211,0.083986,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.014841,0.10178,0.074554,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.013798,0.10134,0.12615,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.025414,0.10107,0.091629,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0015189,0.10052,0.13129,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.011612,0.10014,0.13401,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015203,0.1001,0.12259,1,1
1,GO FLUID TRANSPORT,0.018836,0.099557,0.10802,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.02068,0.09938,0.20659,1,1
1,GO MITOTIC CELL CYCLE,0.015203,0.097865,0.089583,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.040234,0.097845,0.10694,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00026003,0.096419,0.10892,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0060989,0.096167,0.10212,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.012508,0.096005,0.089579,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.027803,0.095777,0.069638,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.024288,0.095725,0.086623,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.017137,0.094908,0.094604,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0069616,0.094234,0.084378,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014841,0.094044,0.11393,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0047853,0.094025,0.09543,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.015953,0.093748,0.10165,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.011612,0.092602,0.084102,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.092091,0.14287,1,1
1,GO CELL CYCLE PROCESS,0.025414,0.091379,0.071956,1,1
1,GO RESPONSE TO HORMONE,0.016339,0.091093,0.086917,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.025994,0.0906,0.087667,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00016595,0.090572,0.10882,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.02843,0.09053,0.10956,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.015574,0.090221,0.0992,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0051916,0.089732,0.091377,1,1
1,GO ENDOCYTOSIS,0.0047853,0.088995,0.11,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00019753,0.08863,0.10053,1,1
1,GO RUFFLE ASSEMBLY,0.036948,0.088542,0.10331,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.015953,0.08844,0.10387,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.010506,0.088328,0.12564,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00059588,0.087704,0.08957,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0053338,0.08754,0.072947,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.020205,0.08723,0.082638,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.017969,0.085997,0.077041,1,1
1,GO DNA METABOLIC PROCESS,0.00081984,0.085621,0.091373,1,1
1,GO SNRNA TRANSCRIPTION,0.0041716,0.085252,0.10106,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00030804,0.085186,0.092035,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.030383,0.084262,0.093936,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.019283,0.083716,0.075343,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.016339,0.083705,0.055371,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.016339,0.083256,0.067145,1,1
1,GO CHROMOSOME CONDENSATION,0.0085714,0.080985,0.12162,1,1
1,GO HEART DEVELOPMENT,0.022165,0.080762,0.11261,1,1
1,GO MULTI ORGANISM PROCESS,0.021165,0.080325,0.045216,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.031059,0.076283,0.06717,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.019739,0.075168,0.11763,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.009256,0.074853,0.093269,1,1
1,GO INTRACELLULAR TRANSPORT,0.0038387,0.07238,0.070024,1,1
1,GO CELL CYCLE,0.036164,0.071665,0.05901,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.029068,0.071049,0.054202,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0079323,0.070095,0.085424,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.029068,0.06974,0.068459,1,1
1,GO CHROMOSOME SEPARATION,0.026586,0.067543,0.12303,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.031059,0.064163,0.08662,1,1
1,GO REGULATION OF DNA REPLICATION,0.03939,0.061645,0.077517,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.015953,0.061405,0.11483,1,1
1,GO DNA RECOMBINATION,0.029068,0.059759,0.088278,1,1
1,GO DNA REPAIR,0.010245,0.057119,0.076951,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.007729,0.054613,0.058025,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.018398,0.052138,0.072076,1,1
1,GO ORGANELLE ASSEMBLY,0.041967,0.043742,0.049123,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0010859,0.46966,0.43194,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0018173,0.42166,0.39425,1,0
1,GO REGULATION OF HIPPO SIGNALING,0.0047853,0.39848,0.28207,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.001228,0.39027,0.37126,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.012508,0.39009,0.50896,1,0
1,GO GALACTOSE METABOLIC PROCESS,0.0024367,0.36846,0.28671,1,0
1,GO ACTIN FILAMENT SEVERING,0.036948,0.2893,0.20844,1,0
1,GO MYOBLAST FUSION,0.00079435,0.28309,0.30896,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.012508,0.28115,0.2523,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.024288,0.26018,0.24676,1,0
1,GO EOSINOPHIL MIGRATION,0.036948,0.25685,0.26914,1,0
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.03245,0.25141,0.22139,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.027188,0.24701,0.20966,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.015203,0.24155,0.3019,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0021689,0.23751,0.23578,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.0034322,0.23486,0.21459,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.23224,0.23496,1,0
1,GO CELLULAR KETONE METABOLIC PROCESS,0.00030804,0.2308,0.16925,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.024288,0.22912,0.29883,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0059384,0.22625,0.24117,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.027803,0.22395,0.23018,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00353,0.22158,0.22352,1,0
1,GO CHEMOKINE PRODUCTION,0.0034322,0.21788,0.2334,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.041093,0.21586,0.12049,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0028957,0.21323,0.18141,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0041716,0.21275,0.23255,1,0
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.029719,0.20905,0.1563,1,0
1,GO REGULATION OF VASCULOGENESIS,0.02843,0.20854,0.27051,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00026903,0.20139,0.2445,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.029719,0.20116,0.14508,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.0071468,0.19994,0.22451,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0053338,0.19905,0.32419,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.004408,0.19825,0.22194,1,0
1,GO FATTY ACID CATABOLIC PROCESS,0.016339,0.18988,0.1348,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.018836,0.18524,0.13347,1,0
1,GO REGULATION OF CELL KILLING,0.015203,0.18304,0.17509,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00035231,0.18257,0.21231,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.042857,0.18184,0.15512,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0050528,0.18101,0.19597,1,0
1,GO PEROXISOMAL TRANSPORT,0.0026572,0.17852,0.18494,1,0
1,GO T CELL PROLIFERATION,0.0026572,0.17706,0.18076,1,0
1,GO LEUKOCYTE PROLIFERATION,0.0054795,0.17649,0.15454,1,0
1,GO RETINOL METABOLIC PROCESS,0.009256,0.17599,0.14862,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.041967,0.16853,0.15783,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0057817,0.16261,0.15711,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.043763,0.15887,0.15789,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0045306,0.15695,0.16696,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.035393,0.15615,0.11034,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.018398,0.15383,0.16651,1,0
1,GO POSITIVE REGULATION OF COAGULATION,0.015203,0.15371,0.23592,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.015574,0.15284,0.11913,1,0
1,GO BONE REMODELING,0.016734,0.15253,0.15242,1,0
1,GO FATTY ACID METABOLIC PROCESS,0.012203,0.15117,0.10082,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.011326,0.15028,0.17488,1,0
1,GO GOLGI VESICLE BUDDING,0.0007696,0.14979,0.17377,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.025414,0.14883,0.12343,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00017186,0.14548,0.18713,1,0
1,GO INTEGRIN ACTIVATION,0.03245,0.14543,0.15,1,0
1,GO LEUKOCYTE MIGRATION,0.013798,0.14394,0.15888,1,0
1,GO LEUKOCYTE HOMEOSTASIS,0.0012662,0.1439,0.17055,1,0
1,GO COPII COATED VESICLE BUDDING,0.0015653,0.14234,0.17494,1,0
1,GO RESPONSE TO UV C,0.024288,0.14159,0.17963,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.024846,0.13951,0.12556,1,0
1,GO RESPONSE TO MINERALOCORTICOID,0.0090226,0.13837,0.23178,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.016734,0.13583,0.1075,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.0022332,0.13496,0.16095,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.019739,0.1338,0.10396,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0021689,0.13346,0.21002,1,0
1,GO REGULATION OF CHEMOTAXIS,0.012203,0.13307,0.12611,1,0
1,GO EPITHELIAL CELL PROLIFERATION,0.012508,0.12868,0.15019,1,0
1,GO RESPONSE TO ANTIBIOTIC,0.010773,0.12743,0.15064,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.017549,0.12362,0.15063,1,0
1,GO REGULATION OF CELL ADHESION,0.013139,0.12289,0.15634,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0031536,0.12199,0.31524,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.041093,0.11905,0.1496,1,0
1,GO OXIDATION REDUCTION PROCESS,0.015203,0.11854,0.084477,1,0
1,GO LIPID CATABOLIC PROCESS,0.02268,0.11815,0.078282,1,0
1,GO T CELL DIFFERENTIATION,0.010506,0.11725,0.11884,1,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.02268,0.1135,0.10448,1,0
1,GO AMINE METABOLIC PROCESS,0.029719,0.11325,0.089915,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0036303,0.11039,0.12853,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.021165,0.11015,0.12797,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.036948,0.1092,0.10645,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.03245,0.10818,0.070372,1,0
1,GO CELL CHEMOTAXIS,0.016734,0.10805,0.16466,1,0
1,GO ENDOCRINE PROCESS,0.013798,0.10721,0.13784,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.0037331,0.10679,0.126,1,0
1,GO TRANSITION METAL ION TRANSPORT,0.00353,0.10339,0.080774,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.03245,0.10224,0.063813,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.017969,0.10195,0.078603,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.014138,0.09706,0.1247,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.022165,0.091087,0.12438,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.033894,0.088975,0.10249,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.029068,0.088046,0.055076,1,0
1,GO EXOCYTOSIS,0.012203,0.085608,0.10283,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.025994,0.085261,0.049233,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012508,0.084911,0.067551,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.031059,0.082912,0.056404,1,0
1,GO LIPID METABOLIC PROCESS,0.044685,0.081536,0.050668,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.031748,0.0801,0.15019,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.018836,0.077008,0.059559,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.011612,0.066847,0.10849,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.040234,0.065266,0.087093,1,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.025994,0.060064,0.13997,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.041967,0.058344,0.068405,1,0
1,GO IRON ION TRANSPORT,0.036948,0.05594,0.070954,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.040234,-0.059381,-0.090408,1,0
1,GO PROTEIN ACETYLATION,0.015574,-0.061301,-0.072297,1,0
1,GO ORGANIC ACID TRANSPORT,0.015953,-0.064267,-0.084522,1,0
1,GO REGULATION OF TRANSPORT,0.013465,-0.077886,-0.073458,1,0
1,GO RHYTHMIC PROCESS,0.01282,-0.080227,-0.072608,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.012203,-0.082732,-0.075762,1,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.016339,-0.083027,-0.1885,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.027188,-0.083323,-0.11238,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.024288,-0.083327,-0.14175,1,0
1,GO REGULATION OF TOR SIGNALING,0.013139,-0.08605,-0.079074,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.0062634,-0.090855,-0.094847,1,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.031059,-0.091327,-0.14448,1,0
1,GO PH REDUCTION,0.03245,-0.091786,-0.098551,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0010859,-0.09381,-0.13761,1,0
1,GO REGULATION OF ANION TRANSPORT,0.012203,-0.0946,-0.1362,1,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.035393,-0.09468,-0.11868,1,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.014138,-0.096183,-0.093752,1,0
1,GO ADULT FEEDING BEHAVIOR,0.035393,-0.096581,-0.17107,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012203,-0.096882,-0.13218,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.014841,-0.096939,-0.094711,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.026586,-0.099957,-0.090781,1,0
1,GO MAST CELL ACTIVATION,0.036164,-0.105,-0.15608,1,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.031748,-0.1052,-0.16888,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.00072223,-0.10706,-0.13366,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.02268,-0.10949,-0.14646,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00087311,-0.11262,-0.1601,1,0
1,GO DETECTION OF STIMULUS,0.00095906,-0.11386,-0.095908,1,0
1,GO CIRCADIAN RHYTHM,2.5308e-05,-0.11626,-0.13865,1,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.036948,-0.1169,-0.12842,1,0
1,GO REGULATION OF NEURON MIGRATION,0.024288,-0.12009,-0.18716,1,0
1,GO REGULATION OF ACTIN NUCLEATION,0.009256,-0.12136,-0.1809,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.011904,-0.12199,-0.094167,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.0030654,-0.12204,-0.12441,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.018836,-0.12387,-0.14682,1,0
1,GO PEPTIDE SECRETION,0.00036427,-0.12425,-0.13596,1,0
1,GO ION TRANSPORT,0.00049035,-0.12438,-0.11736,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0017123,-0.12579,-0.12432,1,0
1,GO MOTOR NEURON AXON GUIDANCE,0.0067808,-0.12863,-0.15483,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.046579,-0.13082,-0.12785,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.018398,-0.13127,-0.1414,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0033369,-0.13169,-0.16853,1,0
1,GO MAST CELL MEDIATED IMMUNITY,0.044685,-0.1318,-0.14196,1,0
1,GO POLYOL CATABOLIC PROCESS,0.02166,-0.13598,-0.12662,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00031859,-0.13633,-0.17648,1,0
1,GO REGULATION OF HORMONE LEVELS,0.00025131,-0.13645,-0.16057,1,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.046579,-0.13771,-0.1634,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.0045306,-0.13844,-0.15639,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.00050664,-0.13863,-0.1324,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0032441,-0.13896,-0.21998,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0024367,-0.14095,-0.11018,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.007729,-0.14154,-0.16383,1,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.041093,-0.14422,-0.21343,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.0020453,-0.14502,-0.13317,1,0
1,GO REGULATION OF APPETITE,0.01282,-0.14506,-0.13249,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.011612,-0.14522,-0.12453,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.00032948,-0.14569,-0.13264,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0038387,-0.14668,-0.18169,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00035231,-0.15358,-0.15853,1,0
1,GO CATION TRANSPORT,4.6597e-05,-0.15525,-0.15035,1,0
1,GO CELL MATURATION,0.00018427,-0.15594,-0.16178,1,0
1,GO REGULATION OF RESPIRATORY BURST,0.044685,-0.15911,-0.20219,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.017137,-0.16042,-0.24863,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.00057693,-0.16216,-0.19191,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.01282,-0.16226,-0.16183,1,0
1,GO MULTICELLULAR ORGANISM AGING,0.0046564,-0.16362,-0.15392,1,0
1,GO NOTCH SIGNALING PATHWAY,0.029068,-0.16376,-0.10318,1,0
1,GO SENSORY PERCEPTION,0.00041602,-0.16388,-0.12867,1,0
1,GO CHLORIDE TRANSPORT,0.00087311,-0.16599,-0.14959,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.015574,-0.16653,-0.24763,1,0
1,GO EATING BEHAVIOR,0.0024367,-0.16882,-0.15973,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.029068,-0.1689,-0.11582,1,0
1,GO INTESTINAL ABSORPTION,0.034637,-0.16999,-0.17597,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0034322,-0.17065,-0.18586,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.042857,-0.17145,-0.13798,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,8.7323e-05,-0.17322,-0.1544,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.010245,-0.17362,-0.14917,1,0
1,GO REGULATION OF ACROSOME REACTION,0.024846,-0.17392,-0.24456,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0087944,-0.17522,-0.15769,1,0
1,GO SODIUM ION TRANSPORT,7.547e-05,-0.17548,-0.18871,1,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.025994,-0.17607,-0.14841,1,0
1,GO REGULATION OF SECRETION,2.4692e-06,-0.17623,-0.18155,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.023205,-0.17733,-0.16841,1,0
1,GO WATER HOMEOSTASIS,0.0066042,-0.17753,-0.15558,1,0
1,GO REGULATION OF AXONOGENESIS,8.4205e-05,-0.17871,-0.23033,1,0
1,GO LIPID DROPLET ORGANIZATION,0.0026572,-0.18184,-0.18493,1,0
1,GO REGULATION OF ION TRANSPORT,1.7806e-05,-0.18269,-0.1816,1,0
1,GO POLYOL TRANSPORT,0.018836,-0.18584,-0.17784,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.0033369,-0.18591,-0.23904,1,0
1,GO REGULATION OF BLOOD CIRCULATION,6.2786e-05,-0.1861,-0.19341,1,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.0090226,-0.18673,-0.14684,1,0
1,GO NEURON PROJECTION GUIDANCE,0.00087311,-0.18706,-0.21664,1,0
1,GO PHAGOSOME ACIDIFICATION,0.0059384,-0.18711,-0.17918,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.0022332,-0.18945,-0.21351,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.046579,-0.18991,-0.42415,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00028792,-0.19087,-0.16745,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.036164,-0.19294,-0.18344,1,0
1,GO TELENCEPHALON DEVELOPMENT,5.4121e-05,-0.19349,-0.20775,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.012203,-0.19487,-0.18043,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.7474e-06,-0.19511,-0.20399,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00031859,-0.19576,-0.20592,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0039469,-0.19705,-0.19363,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00049035,-0.20001,-0.1896,1,0
1,GO DIGESTION,0.0036303,-0.20052,-0.16951,1,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.0017641,-0.20189,-0.19178,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0041716,-0.20348,-0.2044,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,2.5308e-05,-0.20545,-0.23925,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.02268,-0.20714,-0.20061,1,0
1,GO RESPONSE TO ALKALOID,8.6584e-06,-0.20821,-0.22305,1,0
1,GO POSTSYNAPSE ORGANIZATION,3.7145e-05,-0.20835,-0.26186,1,0
1,GO HAIR CELL DIFFERENTIATION,0.0054795,-0.20932,-0.24404,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.0047853,-0.2106,-0.22634,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.011612,-0.2112,-0.22667,1,0
1,GO LIPID TRANSLOCATION,0.00353,-0.2115,-0.20062,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0012662,-0.21346,-0.20927,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,4.0073e-05,-0.21351,-0.21971,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.02068,-0.21496,-0.224,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0075304,-0.21513,-0.19775,1,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.040234,-0.21629,-0.15884,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,3.5759e-05,-0.21705,-0.21011,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0001165,-0.21884,-0.2034,1,0
1,GO ACID SECRETION,6.5149e-05,-0.21929,-0.22058,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0085714,-0.2194,-0.18886,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00074557,-0.22018,-0.23436,1,0
1,GO NEURON PROJECTION EXTENSION,0.00045924,-0.22061,-0.21055,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0039469,-0.22106,-0.2605,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00026903,-0.22415,-0.23974,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0036303,-0.22473,-0.215,1,0
1,GO NEURON DIFFERENTIATION,6.2367e-06,-0.22496,-0.23555,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,8.1192e-05,-0.22632,-0.21456,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00081984,-0.2279,-0.22589,1,0
1,GO RESPONSE TO EPINEPHRINE,0.041093,-0.22825,-0.22384,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.00041602,-0.22835,-0.22675,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0099891,-0.23049,-0.2386,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0083534,-0.23183,-0.1822,1,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.023741,-0.2325,-0.15672,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0036303,-0.23264,-0.28184,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.045624,-0.23387,-0.28683,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0030654,-0.23566,-0.22576,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.016339,-0.23604,-0.16229,1,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.025994,-0.24227,-0.18592,1,0
1,GO BILE ACID METABOLIC PROCESS,0.0033369,-0.24305,-0.19949,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.0075304,-0.24593,-0.30297,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.017137,-0.24674,-0.20518,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,9.0551e-05,-0.24679,-0.28754,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.011904,-0.24773,-0.30981,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00044439,-0.24779,-0.31751,1,0
1,GO REGULATION OF HORMONE SECRETION,2.7578e-07,-0.25226,-0.26937,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0015653,-0.25291,-0.24606,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.00067758,-0.25383,-0.2045,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0030654,-0.25512,-0.27743,1,0
1,GO CRANIAL NERVE DEVELOPMENT,4.3218e-05,-0.25697,-0.31272,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,3.0264e-07,-0.2584,-0.24084,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,1.349e-05,-0.25981,-0.26582,1,0
1,GO HORMONE TRANSPORT,1.071e-07,-0.25982,-0.2866,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0047853,-0.26095,-0.24212,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,6.7596e-05,-0.26472,-0.28719,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,2.1663e-05,-0.26488,-0.29358,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0014299,-0.26495,-0.32839,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,3.3132e-05,-0.26626,-0.26411,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.0054795,-0.26678,-0.20951,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.8077e-06,-0.26835,-0.32482,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0042883,-0.27085,-0.23858,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0026572,-0.27259,-0.279,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.016339,-0.27315,-0.20225,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00013433,-0.27399,-0.30232,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.010245,-0.27664,-0.25263,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,4.4878e-05,-0.27682,-0.25626,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.012508,-0.27717,-0.23532,1,0
1,GO SODIUM ION HOMEOSTASIS,6.5149e-05,-0.27818,-0.29049,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00018427,-0.28188,-0.30773,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0012662,-0.28276,-0.262,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0021062,-0.28303,-0.24057,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.0689e-05,-0.28826,-0.41831,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.035393,-0.29008,-0.21808,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0037331,-0.29157,-0.29826,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0032441,-0.29427,-0.22369,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00038934,-0.29512,-0.33392,1,0
1,GO LIPOXYGENASE PATHWAY,0.0062634,-0.29682,-0.30804,1,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.01282,-0.29725,-0.2749,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00038934,-0.29733,-0.26383,1,0
1,GO SIGNAL RELEASE,3.479e-08,-0.29747,-0.30239,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.007729,-0.2977,-0.32446,1,0
1,GO PRESYNAPSE ORGANIZATION,0.00067758,-0.29997,-0.2795,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00011241,-0.30841,-0.54968,1,0
1,GO ENERGY HOMEOSTASIS,0.001986,-0.30937,-0.26265,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.906e-06,-0.31348,-0.3085,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,8.3127e-06,-0.31433,-0.34183,1,0
1,GO SYNAPSE ORGANIZATION,1.4044e-06,-0.31461,-0.32415,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,8.6584e-06,-0.31548,-0.30046,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.0071468,-0.31583,-0.34744,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.2454e-05,-0.31591,-0.29136,1,0
1,GO TUBULIN DEACETYLATION,0.0014299,-0.31625,-0.33004,1,0
1,GO REGULATION OF INSULIN SECRETION,2.2879e-07,-0.31633,-0.3192,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,2.1702e-06,-0.31898,-0.30746,1,0
1,GO DENDRITIC TRANSPORT,0.0071468,-0.31999,-0.2791,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.547e-05,-0.32037,-0.37516,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0029794,-0.32693,-0.27605,1,0
1,GO PEPTIDE HORMONE SECRETION,4.2424e-08,-0.3312,-0.34241,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,8.8325e-08,-0.3316,-0.35979,1,0
1,GO INSULIN SECRETION,8.4155e-08,-0.33443,-0.34059,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,9.389e-05,-0.33487,-0.33657,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.2876e-06,-0.33664,-0.34023,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,7.9801e-06,-0.33767,-0.35366,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.018836,-0.33891,-0.23976,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,4.2424e-08,-0.33966,-0.3301,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,3.3202e-07,-0.34023,-0.36448,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.013798,-0.34292,-0.29613,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0060989,-0.34383,-0.28649,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00010092,-0.3474,-0.35204,1,0
1,GO ASSOCIATIVE LEARNING,4.3763e-07,-0.35167,-0.33417,1,0
1,GO TOXIN METABOLIC PROCESS,0.030383,-0.35235,-0.2254,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,6.7596e-05,-0.3536,-0.39392,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028141,-0.35361,-0.29554,1,0
1,GO ADRENAL GLAND DEVELOPMENT,3.1888e-05,-0.35677,-0.41316,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.00010092,-0.35902,-0.39797,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.00047456,-0.36418,-0.37497,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0013054,-0.36429,-0.26156,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,8.4205e-05,-0.36464,-0.27948,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00052342,-0.36521,-0.3294,1,0
1,GO MEMBRANE DEPOLARIZATION,1.0779e-06,-0.3657,-0.36849,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0051916,-0.36716,-0.2581,1,0
1,GO NERVE DEVELOPMENT,1.4674e-06,-0.36885,-0.3723,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,5.2837e-06,-0.36907,-0.34476,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.4268e-07,-0.37073,-0.41325,1,0
1,GO RESPONSE TO DIETARY EXCESS,7.2754e-05,-0.37244,-0.43382,1,0
1,GO ACTION POTENTIAL,2.1702e-06,-0.37252,-0.35182,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0010206,-0.37293,-0.34187,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,3.4728e-06,-0.37655,-0.44291,1,0
1,GO LIPID DROPLET FORMATION,0.0056288,-0.38293,-0.35341,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.5774e-06,-0.38368,-0.42598,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.0689e-05,-0.3841,-0.43908,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00027832,-0.38459,-0.45039,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,8.2505e-07,-0.3854,-0.41325,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.001872,-0.39505,-0.32114,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,2.8418e-05,-0.39669,-0.37741,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,5.9841e-06,-0.39727,-0.43549,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.0779e-06,-0.3978,-0.43678,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0016129,-0.40175,-0.36814,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,-0.40215,-0.53581,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,7.6603e-06,-0.40284,-0.41085,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,8.628e-07,-0.40323,-0.37068,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,5.2139e-05,-0.4045,-0.49263,1,0
1,GO NEURON MIGRATION,1.5331e-06,-0.40478,-0.41881,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,5.2837e-06,-0.40486,-0.43672,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,6.93e-08,-0.40839,-0.40894,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,6.7596e-05,-0.41082,-0.38451,1,0
1,GO METENCEPHALON DEVELOPMENT,4.7955e-07,-0.41531,-0.40316,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,3.8583e-05,-0.41785,-0.44178,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0007696,-0.42311,-0.45172,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.00024286,-0.42368,-0.51816,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.6597e-05,-0.42556,-0.3936,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.2111e-07,-0.42952,-0.44637,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,9.7346e-05,-0.43056,-0.32701,1,0
1,GO PARENTAL BEHAVIOR,0.00027832,-0.43186,-0.3895,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0014738,-0.43512,-0.4191,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.5122e-07,-0.43851,-0.51783,1,0
1,GO SECRETORY GRANULE LOCALIZATION,5.6174e-05,-0.4407,-0.62267,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,9.7801e-06,-0.44173,-0.43711,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.00017796,-0.44507,-0.49945,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0073363,-0.4456,-0.28938,1,0
1,GO SYNAPSE ASSEMBLY,1.9873e-07,-0.44959,-0.46423,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00030804,-0.45276,-0.43152,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00010845,-0.46242,-0.5548,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0019282,-0.46264,-0.47495,1,0
1,GO SUCKLING BEHAVIOR,2.4346e-05,-0.46444,-0.46585,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00021909,-0.46456,-0.35046,1,0
1,GO OPTIC NERVE DEVELOPMENT,4.8379e-05,-0.46456,-0.47262,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00029782,-0.46566,-0.40672,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.015574,-0.47088,-0.30892,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,8.0176e-08,-0.47778,-0.52195,1,0
1,GO EXOCYTIC PROCESS,4.6826e-08,-0.48015,-0.47562,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,4.0375e-08,-0.48127,-0.47823,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00013433,-0.48161,-0.39846,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.8496e-08,-0.48538,-0.50774,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.00012512,-0.48574,-0.47087,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,2.9532e-05,-0.48778,-0.55814,1,0
1,GO CATECHOLAMINE UPTAKE,7.013e-05,-0.4908,-0.39489,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,6.2786e-05,-0.4922,-0.44284,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,7.2111e-07,-0.49637,-0.5289,1,0
1,GO ENDOCARDIUM DEVELOPMENT,0.001872,-0.49748,-0.36061,1,0
1,GO NEURON MATURATION,3.3202e-07,-0.50011,-0.48649,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,4.7955e-07,-0.50644,-0.51152,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0014299,-0.51424,-0.52065,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.93e-08,-0.51919,-0.50687,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.011612,-0.5202,-0.29433,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.1237e-07,-0.52106,-0.52835,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,5.1671e-08,-0.52415,-0.55242,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.4572e-08,-0.5318,-0.53215,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0045306,-0.53639,-0.3855,1,0
1,GO REGULATION OF VESICLE FUSION,5.7413e-06,-0.54631,-0.52466,1,0
1,GO REGULATION OF NEURON MATURATION,0.00072223,-0.55486,-0.48453,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00016023,-0.55963,-0.45103,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00067758,-0.55983,-0.59723,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,4.4712e-06,-0.56351,-0.54856,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.001228,-0.57012,-0.54681,1,0
1,GO DOPAMINE METABOLIC PROCESS,1.1788e-07,-0.57283,-0.59554,1,0
1,GO CGMP METABOLIC PROCESS,1.5816e-05,-0.57576,-0.50765,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.2505e-07,-0.57753,-0.62536,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,3.1904e-06,-0.58404,-0.61986,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,3.8423e-08,-0.58639,-0.62316,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,6.7728e-06,-0.60295,-0.5814,1,0
1,GO NEUROTRANSMITTER TRANSPORT,9.7275e-08,-0.61572,-0.60526,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,1.9873e-07,-0.62314,-0.62738,1,0
1,GO LUNG CELL DIFFERENTIATION,0.00087311,-0.63486,-0.48073,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,8.6584e-06,-0.64892,-0.59049,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,4.3218e-05,-0.65439,-0.51031,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.2308e-06,-0.66928,-0.60696,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.8418e-05,-0.66962,-0.5658,1,0
1,GO NEUROTRANSMITTER SECRETION,4.2424e-08,-0.67206,-0.68032,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,9.0221e-07,-0.67671,-0.59198,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00026003,-0.70148,-0.55964,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,4.6826e-08,-0.71544,-0.7004,1,0
1,GO NEURONAL ACTION POTENTIAL,4.0375e-08,-0.7157,-0.73571,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,8.8325e-08,-0.72267,-0.67464,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,4.0375e-08,-0.73502,-0.73017,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,3.8423e-08,-0.73541,-0.72756,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.725e-07,-0.74892,-0.72559,1,0
1,GO DENSE CORE GRANULE TRANSPORT,1.6729e-06,-0.76421,-0.96414,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,7.2756e-08,-0.76487,-0.76234,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.6015e-06,-0.78917,-0.74965,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,2.2658e-06,-0.79143,-0.72964,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.1237e-07,-0.80721,-0.83949,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.6414e-07,-0.8381,-0.78019,1,0
1,GO SYNAPSE MATURATION,8.4155e-08,-0.83824,-0.90175,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,7.6379e-08,-0.84036,-0.83554,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,4.4572e-08,-0.84821,-0.90906,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,5.4977e-07,-0.85701,-0.92534,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.00087311,-0.85812,-0.67294,1,0
1,GO SEROTONIN METABOLIC PROCESS,9.0221e-07,-0.88537,-0.72393,1,0
1,GO DENDRITE EXTENSION,3.1491e-08,-0.9014,-0.84008,1,0
1,GO PREPULSE INHIBITION,8.4155e-08,-0.92547,-0.87873,1,0
1,GO PROTEIN LOCALIZATION TO AXON,2.8077e-06,-0.94674,-0.99793,1,0
1,GO VOCALIZATION BEHAVIOR,5.4977e-07,-0.95245,-0.89622,1,0
1,GO REGULATION OF DENDRITE EXTENSION,4.4572e-08,-0.97479,-0.92712,1,0
1,GO DOPAMINE TRANSPORT,5.6999e-08,-0.97561,-0.86985,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.0779e-06,-1.0005,-0.92251,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,4.9191e-08,-1.0472,-1.012,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,6.93e-08,-1.0969,-1.1107,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,8.4155e-08,-1.1642,-1.1742,1,0
1,GO REGULATION OF DOPAMINE SECRETION,5.4272e-08,-1.1705,-1.086,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,3.6563e-08,-1.6192,-1.727,1,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.2,0.39155,0.1832,0,1
1,GO PROGESTERONE METABOLIC PROCESS,0.053746,0.37441,0.13761,0,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.11039,0.36277,0.2449,0,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.11434,0.32463,0.18317,0,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.060602,0.3143,0.18806,0,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.10465,0.30444,0.35733,0,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.19695,0.30384,0.13353,0,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.099158,0.29209,0.19059,0,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.30402,0.29147,0.13219,0,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.17374,0.28447,0.1788,0,1
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,0.28208,0.18452,0,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.085627,0.27359,0.1782,0,1
1,GO PHOSPHOLIPID EFFLUX,0.36991,0.27194,0.19455,0,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.04854,0.27144,0.26296,0,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.19695,0.26879,0.084852,0,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.073629,0.26877,0.19402,0,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.25001,0.26676,0.097612,0,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.17099,0.26671,0.16582,0,1
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.19393,0.26594,0.17474,0,1
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.1028,0.26291,0.17933,0,1
1,GO TRANSPOSITION,0.10654,0.255,0.15564,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.13355,0.25322,0.23621,0,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.052669,0.25089,0.15662,0,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.075049,0.25045,0.20684,0,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.047551,0.24744,0.26614,0,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.047551,0.24698,0.21263,0,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.070855,0.24419,0.13654,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.085627,0.24225,0.10834,0,1
1,GO REGULATION OF RECEPTOR BINDING,0.093897,0.23976,0.24648,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.14048,0.23573,0.14815,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.080955,0.23563,0.16447,0,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.22235,0.23379,0.099097,0,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.060602,0.23255,0.16584,0,1
1,GO MITRAL VALVE DEVELOPMENT,0.17374,0.23057,0.23585,0,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0695,0.22558,0.17442,0,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.26098,0.21924,0.093423,0,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.26471,0.2192,0.089468,0,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.059411,0.21477,0.14667,0,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.099158,0.21001,0.16424,0,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.052669,0.2091,0.15595,0,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.21256,0.20808,0.071976,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.10845,0.20656,0.10784,0,1
1,GO NEGATIVE T CELL SELECTION,0.055956,0.20383,0.16129,0,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.093897,0.2004,0.14285,0,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.054842,0.19484,0.30403,0,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.099158,0.19401,0.20424,0,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.065563,0.19308,0.16711,0,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.073629,0.19222,0.13292,0,1
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.072231,0.19152,0.19013,0,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.13814,0.19143,0.24514,0,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.088862,0.18979,0.13273,0,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.05161,0.18822,0.17864,0,1
1,GO RESPONSE TO REDOX STATE,0.068167,0.18743,0.17936,0,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.05161,0.1781,0.13295,0,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.070855,0.17794,0.1331,0,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.21579,0.17694,0.13636,0,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.066855,0.17515,0.15426,0,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.18508,0.17386,0.13078,0,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.054842,0.172,0.1839,0,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.049546,0.1717,0.19174,0,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.079444,0.17121,0.18837,0,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.10845,0.1689,0.10948,0,1
1,GO RNA INTERFERENCE,0.084046,0.16797,0.13608,0,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.079444,0.16788,0.097414,0,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.36064,0.1613,0.092656,0,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.20309,0.15864,0.088072,0,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.11235,0.15801,0.17505,0,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.085627,0.15712,0.18107,0,1
1,GO COENZYME A METABOLIC PROCESS,0.060602,0.15439,0.11579,0,1
1,GO MUSCLE ADAPTATION,0.073629,0.1542,0.087155,0,1
1,GO REGULATION OF T CELL MIGRATION,0.082489,0.15274,0.11497,0,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.12049,0.15226,0.12868,0,1
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.11841,0.15067,0.08839,0,1
1,GO AMYLOID BETA FORMATION,0.064293,0.14939,0.12901,0,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.087232,0.14828,0.097285,0,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.070855,0.14665,0.22585,0,1
1,GO GOLGI LOCALIZATION,0.40843,0.14502,0.046948,0,1
1,GO CHROMOSOME LOCALIZATION,0.073629,0.14391,0.10366,0,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.061812,0.14294,0.14056,0,1
1,GO RESPONSE TO STEROL,0.0695,0.14152,0.11206,0,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.097379,0.14097,0.092079,0,1
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.060602,0.1408,0.082093,0,1
1,GO EXTRACELLULAR TRANSPORT,0.2,0.14052,0.08331,0,1
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.54321,0.13597,0.01731,0,1
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.28785,0.13535,0.099054,0,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.087232,0.13446,0.087084,0,1
1,GO SECRETION BY TISSUE,0.10465,0.13167,0.10469,0,1
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.095625,0.13152,0.093411,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.76281,0.13006,0.0071513,0,1
1,GO REGULATION OF SENSORY PERCEPTION,0.099158,0.12846,0.089592,0,1
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.46512,0.12715,0.022799,0,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.14048,0.12702,0.077482,0,1
1,GO OXALATE TRANSPORT,0.10465,0.12682,0.083541,0,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.090515,0.12565,0.076765,0,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.093897,0.12551,0.10461,0,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.188,0.12441,0.17753,0,1
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.28785,0.12395,0.075459,0,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.16559,0.12345,0.081856,0,1
1,GO PIRNA METABOLIC PROCESS,0.21905,0.12242,0.16713,0,1
1,GO SPHINGOID METABOLIC PROCESS,0.095625,0.12236,0.07047,0,1
1,GO RESPONSE TO INTERLEUKIN 6,0.29586,0.12206,0.065719,0,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.072231,0.12126,0.098737,0,1
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.38888,0.12101,0.073279,0,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.076492,0.121,0.094768,0,1
1,GO REGULATION OF DNA BINDING,0.27227,0.12024,0.043659,0,1
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,0.11912,0.069243,0,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.42855,0.11901,0.062295,0,1
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.19393,0.11882,0.082158,0,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.053746,0.11815,0.060222,0,1
1,GO HUMORAL IMMUNE RESPONSE,0.059411,0.11726,0.08686,0,1
1,GO CYTOKINESIS,0.05161,0.11682,0.087894,0,1
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.052669,0.11562,0.060292,0,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.080955,0.11547,0.10543,0,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.16032,0.11536,0.1227,0,1
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.22235,0.11447,0.089468,0,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.12473,0.11248,0.11354,0,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.063042,0.11204,0.10376,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.36526,0.11163,0.05749,0,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.049546,0.1113,0.14596,0,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.11039,0.11007,0.13974,0,1
1,GO METAPHASE PLATE CONGRESSION,0.076492,0.11002,0.097241,0,1
1,GO HEART GROWTH,0.05161,0.10984,0.11568,0,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.11434,0.10891,0.16361,0,1
1,GO TRANSCYTOSIS,0.063042,0.10849,0.13142,0,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.27611,0.10755,0.046814,0,1
1,GO CELLULAR PIGMENTATION,0.12259,0.10743,0.0712,0,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.080955,0.1074,0.12457,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.21579,0.10706,0.053728,0,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.050569,0.10445,0.11067,0,1
1,GO SPINDLE ORGANIZATION,0.061812,0.10392,0.085369,0,1
1,GO MACROPHAGE ACTIVATION,0.077957,0.10187,0.13052,0,1
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.15517,0.10146,0.074881,0,1
1,GO NEGATIVE REGULATION OF BINDING,0.077957,0.10024,0.07044,0,1
1,GO HISTONE H3 DEACETYLATION,0.17099,0.099714,0.071091,0,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.1028,0.0997,0.10025,0,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.29992,0.098951,0.058111,0,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.10845,0.098875,0.076299,0,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.070855,0.097632,0.076184,0,1
1,GO REGULATION OF MRNA POLYADENYLATION,0.095625,0.096548,0.087827,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16828,0.095008,0.060927,0,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.19095,0.093787,0.09618,0,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.065563,0.092293,0.094419,0,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.11636,0.091697,0.10081,0,1
1,GO MUSCLE FIBER DEVELOPMENT,0.37932,0.091383,0.027027,0,1
1,GO PIGMENT CELL DIFFERENTIATION,0.47588,0.090835,0.060991,0,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.054842,0.090494,0.076125,0,1
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,0.090074,0.10539,0,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.053746,0.089788,0.079137,0,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.11636,0.089528,0.12563,0,1
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.088862,0.088713,0.14077,0,1
1,GO REGULATION OF GONAD DEVELOPMENT,0.67137,0.088704,-0.084994,0,1
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.38408,0.088084,0.090932,0,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.093897,0.088072,0.12289,0,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.05161,0.087658,0.11324,0,1
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.4598,0.087564,0.033704,0,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.093897,0.087243,0.11491,0,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.30402,0.086746,0.034119,0,1
1,GO VESICLE ORGANIZATION,0.090515,0.086344,0.058904,0,1
1,GO REGULATION OF TELOMERE CAPPING,0.27227,0.08627,0.041274,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.3746,0.085988,0.037603,0,1
1,GO REGULATION OF CELL CYCLE,0.049546,0.085927,0.060029,0,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.11841,0.085813,0.095621,0,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.075049,0.085605,0.10642,0,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.077957,0.084708,0.05653,0,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.066855,0.080782,0.07113,0,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.15264,0.080151,0.067828,0,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.18219,0.079137,0.055982,0,1
1,GO RESPONSE TO ACID CHEMICAL,0.15517,0.078183,0.066272,0,1
1,GO REGULATION OF INTEGRIN ACTIVATION,0.50896,0.078073,0.044363,0,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.097379,0.075628,0.051023,0,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.073629,0.074587,0.11482,0,1
1,GO RECEPTOR RECYCLING,0.057089,0.073908,0.094384,0,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.05824,0.073882,0.082404,0,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.14769,0.073326,0.088917,0,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.12049,0.073167,0.11486,0,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.085627,0.072454,0.070555,0,1
1,GO CELL VOLUME HOMEOSTASIS,0.25729,0.0719,0.04473,0,1
1,GO MACROMOLECULE DEACYLATION,0.080955,0.070098,0.05641,0,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.35607,0.068084,0.080874,0,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.064293,0.067921,0.078142,0,1
1,GO SPINDLE ASSEMBLY,0.075049,0.067873,0.066782,0,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.047551,0.067127,0.11724,0,1
1,GO MRNA PROCESSING,0.11841,0.065998,0.054092,0,1
1,GO FERTILIZATION,0.33812,0.065905,0.022531,0,1
1,GO RNA SPLICING,0.10845,0.065347,0.051258,0,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.095625,0.065118,0.06947,0,1
1,GO RESPONSE TO LEAD ION,0.085627,0.064649,0.11681,0,1
1,GO RESPONSE TO RADIATION,0.050569,0.064521,0.053107,0,1
1,GO CELL CYCLE ARREST,0.17934,0.06167,0.041203,0,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.099158,0.057541,0.066485,0,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.057089,0.057106,0.095159,0,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.072231,0.056552,0.068962,0,1
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.33812,0.056334,0.062002,0,1
1,GO DNA INTEGRITY CHECKPOINT,0.16032,0.054417,0.064884,0,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11235,0.054091,0.04773,0,1
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.188,0.053435,0.04319,0,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.27999,0.053109,0.047873,0,1
1,GO CELL CYCLE CHECKPOINT,0.10096,0.053069,0.060497,0,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.44402,0.051367,0.069461,0,1
1,GO HISTONE EXCHANGE,0.44924,0.051357,0.053977,0,1
1,GO REGULATION OF CELL DIVISION,0.25363,0.051171,0.050832,0,1
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.39371,0.051039,0.027493,0,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.15264,0.050787,0.032614,0,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.10465,0.048891,0.055795,0,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.052669,0.047153,0.081708,0,1
1,GO CHROMOSOME SEGREGATION,0.097379,0.047046,0.072497,0,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,0.046441,0.056557,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.15773,0.045849,0.051559,0,1
1,GO HISTONE H3 ACETYLATION,0.35607,0.044769,0.032673,0,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.15015,0.042387,0.06177,0,1
1,GO SPECIFICATION OF SYMMETRY,0.12259,0.041328,0.060247,0,1
1,GO RESPONSE TO ZINC ION,0.62732,0.03988,0.029815,0,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.41341,0.037183,0.019936,0,1
1,GO EXECUTION PHASE OF APOPTOSIS,0.24643,0.032665,0.037263,0,1
1,GO T CELL MEDIATED CYTOTOXICITY,9.389e-05,0.62256,0.52969,0,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00054072,0.60764,0.50046,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,2.1663e-05,0.53066,0.56167,0,0
1,GO SKIN MORPHOGENESIS,0.00052342,0.49996,0.62505,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,2.9532e-05,0.46232,0.46803,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.0013054,0.44661,0.46887,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.042857,0.40489,0.24337,0,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0013457,0.40023,0.39041,0,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.027188,0.39657,0.28734,0,0
1,GO HAIR FOLLICLE MATURATION,0.0012662,0.39467,0.33269,0,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0028141,0.37989,0.44357,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00025131,0.37959,0.45088,0,0
1,GO ARGININE METABOLIC PROCESS,0.00092958,0.37082,0.36132,0,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.0015189,0.37053,0.32767,0,0
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00011241,0.36623,0.35841,0,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.007729,0.36404,0.31214,0,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00074557,0.36051,0.36201,0,0
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.0010206,0.35092,0.2971,0,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.041967,0.34653,0.24094,0,0
1,GO PROSTANOID METABOLIC PROCESS,0.00017796,0.33415,0.35094,0,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.02843,0.33282,0.32062,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.011612,0.33021,0.31375,0,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,8.7323e-05,0.32837,0.29511,0,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00010845,0.32641,0.41238,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0025817,0.32629,0.2857,0,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.30402,0.32485,0.15517,0,0
1,GO CYCLOOXYGENASE PATHWAY,0.052669,0.32232,0.28227,0,0
1,GO PENTOSE METABOLIC PROCESS,0.0025817,0.31918,0.23806,0,0
1,GO NADPH REGENERATION,0.00049035,0.31742,0.28758,0,0
1,GO ETHANOL OXIDATION,0.029719,0.31682,0.30751,0,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00090094,0.31266,0.35067,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.19695,0.31136,0.19517,0,0
1,GO NUCLEOTIDE SALVAGE,0.020205,0.30522,0.3342,0,0
1,GO GLYCINE METABOLIC PROCESS,0.011326,0.30223,0.24072,0,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.077957,0.30155,0.18555,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00035231,0.30154,0.38013,0,0
1,GO REGULATION OF LIPASE ACTIVITY,5.4121e-05,0.29976,0.25431,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00090094,0.29927,0.24371,0,0
1,GO HEPARIN METABOLIC PROCESS,0.012508,0.29697,0.3242,0,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.001662,0.29622,0.23547,0,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0018173,0.29539,0.33641,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0020453,0.29511,0.26524,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0034322,0.28801,0.23722,0,0
1,GO AMYLOID FIBRIL FORMATION,0.046579,0.28798,0.21218,0,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0014738,0.28736,0.26633,0,0
1,GO PROTEIN HYDROXYLATION,0.014138,0.2873,0.33239,0,0
1,GO LIPID IMPORT INTO CELL,0.024288,0.28723,0.2061,0,0
1,GO TRACHEA MORPHOGENESIS,0.0057817,0.28547,0.23879,0,0
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00020448,0.28441,0.32327,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00353,0.2815,0.24365,0,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.015953,0.27988,0.28551,0,0
1,GO CARDIOBLAST DIFFERENTIATION,0.015203,0.27899,0.28304,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.016339,0.27852,0.3396,0,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.5759e-05,0.27825,0.23552,0,0
1,GO NUCLEOBASE METABOLIC PROCESS,0.00072223,0.27637,0.26645,0,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.016339,0.27516,0.21708,0,0
1,GO CELL REDOX HOMEOSTASIS,2.4346e-05,0.27441,0.28917,0,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0028957,0.27264,0.30921,0,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00031859,0.27263,0.25287,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.041093,0.27253,0.23061,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.013465,0.2722,0.23408,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.017969,0.27014,0.30186,0,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0695,0.26945,0.17119,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0012662,0.26761,0.37259,0,0
1,GO REGULATION OF LIGASE ACTIVITY,0.0053338,0.26747,0.23573,0,0
1,GO FIBROBLAST ACTIVATION,0.0016129,0.26716,0.30796,0,0
1,GO REGULATION OF WOUND HEALING,0.0023671,0.26501,0.25997,0,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0081404,0.26369,0.22848,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.013465,0.26309,0.28038,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00081984,0.26273,0.24808,0,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0085714,0.26262,0.20119,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.01282,0.26242,0.43494,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0012662,0.2612,0.2136,0,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.027188,0.2611,0.27483,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.12473,0.25902,0.17871,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.013798,0.25856,0.42272,0,0
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00081984,0.25546,0.21413,0,0
1,GO RRNA TRANSCRIPTION,0.0014738,0.25457,0.20756,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.030383,0.25134,0.19527,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0018173,0.25077,0.21598,0,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.0099891,0.24969,0.24986,0,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,0.00020448,0.24918,0.31729,0,0
1,GO TRNA METHYLATION,0.00016595,0.24895,0.25021,0,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0042883,0.24838,0.20976,0,0
1,GO FIBROBLAST PROLIFERATION,0.00054072,0.24834,0.2736,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.015574,0.24739,0.19587,0,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.018398,0.24609,0.1826,0,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.16559,0.24383,0.13726,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.001872,0.24371,0.2501,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.044685,0.24318,0.17704,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0012662,0.24189,0.25598,0,0
1,GO LUNG MORPHOGENESIS,0.010506,0.24172,0.22867,0,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0037331,0.24166,0.24714,0,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.013798,0.24128,0.17096,0,0
1,GO OXYGEN TRANSPORT,0.71006,0.23956,0.016858,0,0
1,GO MYOBLAST MIGRATION,0.017549,0.23699,0.35829,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00081984,0.23605,0.34182,0,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.7343e-05,0.23516,0.23222,0,0
1,GO AMINE CATABOLIC PROCESS,0.0069616,0.23235,0.25799,0,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.027803,0.23175,0.30214,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0039469,0.23131,0.25277,0,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00020448,0.23093,0.30309,0,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.011612,0.23089,0.18854,0,0
1,GO GLUTATHIONE METABOLIC PROCESS,0.0018173,0.23027,0.21973,0,0
1,GO LIPID OXIDATION,0.012203,0.22948,0.15661,0,0
1,GO IMP METABOLIC PROCESS,0.11039,0.2292,0.2205,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.068167,0.22862,0.23544,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.05824,0.22758,0.32037,0,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.12908,0.2269,0.12871,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.13814,0.22671,0.12454,0,0
1,GO NADP METABOLIC PROCESS,0.02068,0.22664,0.17216,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.27611,0.22619,0.19003,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0069616,0.22533,0.22062,0,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.02166,0.22526,0.21379,0,0
1,GO MYOBLAST PROLIFERATION,0.11636,0.22521,0.11682,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.20309,0.22226,0.18406,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.099158,0.22149,0.32032,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.007729,0.22126,0.16123,0,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0075304,0.22059,0.29995,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.0032441,0.22049,0.2187,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.19393,0.22048,0.09417,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.043763,0.22001,0.2727,0,0
1,GO METANEPHROS DEVELOPMENT,0.0017123,0.21965,0.2032,0,0
1,GO TONGUE MORPHOGENESIS,0.076492,0.21906,0.22843,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.12473,0.21813,0.11812,0,0
1,GO TRNA METABOLIC PROCESS,0.00067758,0.21758,0.18445,0,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.027188,0.21714,0.1724,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0051916,0.2168,0.23174,0,0
1,GO TRANSEPITHELIAL TRANSPORT,0.00087311,0.21566,0.20627,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.053746,0.21548,0.27869,0,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0085714,0.21541,0.17276,0,0
1,GO URETER DEVELOPMENT,0.053746,0.21539,0.18496,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0042883,0.21479,0.17442,0,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.11039,0.21418,0.12418,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.011047,0.21289,0.17017,0,0
1,GO CELL JUNCTION DISASSEMBLY,0.041093,0.2127,0.15215,0,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00063551,0.21222,0.21046,0,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0033369,0.21141,0.17949,0,0
1,GO AMP METABOLIC PROCESS,0.076492,0.21059,0.23167,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0050528,0.21045,0.25842,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.22235,0.2103,0.11135,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0030654,0.20984,0.19872,0,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0028957,0.20969,0.18741,0,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0038387,0.20959,0.23949,0,0
1,GO SMOOTH MUSCLE CELL MIGRATION,0.072231,0.20898,0.18803,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,0.017137,0.20823,0.2582,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.013465,0.20772,0.2752,0,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00022676,0.20736,0.24874,0,0
1,GO TOOTH MINERALIZATION,0.02166,0.2058,0.23224,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.24643,0.20562,0.17616,0,0
1,GO STEROID ESTERIFICATION,0.12049,0.20559,0.1709,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0020453,0.20513,0.16374,0,0
1,GO PROSTATE GLAND DEVELOPMENT,0.0024367,0.20459,0.30431,0,0
1,GO CELLULAR RESPONSE TO ATP,0.00036427,0.20366,0.20918,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.44924,0.20354,0.084768,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014138,0.2033,0.11651,0,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.024846,0.20272,0.24678,0,0
1,GO AMINO ACID ACTIVATION,0.0083534,0.20154,0.20527,0,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.049546,0.2002,0.19572,0,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.057089,0.19952,0.33659,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.13355,0.19944,0.17475,0,0
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0067808,0.19748,0.1688,0,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.04854,0.1968,0.21124,0,0
1,GO RESPONSE TO CADMIUM ION,0.26098,0.19549,0.097796,0,0
1,GO AMIDE BIOSYNTHETIC PROCESS,6.7596e-05,0.19521,0.1838,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.18219,0.19472,0.07956,0,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.088862,0.19424,0.10585,0,0
1,GO TONGUE DEVELOPMENT,0.050569,0.19356,0.17754,0,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.001191,0.1935,0.17396,0,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.093897,0.19337,0.15779,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.052669,0.19334,0.13058,0,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0050528,0.19286,0.12762,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.22235,0.19239,0.19022,0,0
1,GO TRACHEA DEVELOPMENT,0.035393,0.19225,0.19931,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.11636,0.19145,0.22665,0,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.1313,0.1911,0.13343,0,0
1,GO INTERLEUKIN 5 PRODUCTION,0.054842,0.19106,0.22077,0,0
1,GO ETHANOL METABOLIC PROCESS,0.02166,0.19047,0.22139,0,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0064317,0.19037,0.15966,0,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.059411,0.19003,0.16637,0,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0099891,0.18971,0.17524,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.013798,0.18967,0.2596,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.20937,0.18963,0.17037,0,0
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0097392,0.18956,0.14638,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.090515,0.18905,0.23739,0,0
1,GO HEMOGLOBIN METABOLIC PROCESS,0.052669,0.18885,0.15636,0,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0014299,0.18806,0.16531,0,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00067758,0.18678,0.16477,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.017969,0.18659,0.21074,0,0
1,GO BODY MORPHOGENESIS,0.027803,0.1858,0.14367,0,0
1,GO STEROL IMPORT,0.00081984,0.18388,0.40773,0,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.0097392,0.18222,0.12785,0,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.021165,0.18205,0.20858,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.016339,0.18134,0.1381,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0099891,0.18097,0.22621,0,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.015203,0.18025,0.19709,0,0
1,GO NUCLEUS LOCALIZATION,0.063042,0.17989,0.11775,0,0
1,GO REGULATION OF PLATELET ACTIVATION,0.079444,0.1795,0.12984,0,0
1,GO GAS TRANSPORT,0.29992,0.17923,0.076633,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.093897,0.17916,0.14584,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.11434,0.17813,0.1479,0,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0057817,0.1766,0.26362,0,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0015189,0.1766,0.30382,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.31232,0.17646,0.13211,0,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00035231,0.17587,0.19126,0,0
1,GO HEPATOCYTE DIFFERENTIATION,0.25729,0.17548,0.15736,0,0
1,GO BLASTOCYST FORMATION,0.0022992,0.17525,0.15741,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.01282,0.17354,0.19438,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0085714,0.17337,0.14546,0,0
1,GO SULFUR COMPOUND TRANSPORT,0.00090094,0.17318,0.17484,0,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.10465,0.17286,0.091025,0,0
1,GO CELLULAR EXTRAVASATION,0.0059384,0.17276,0.17601,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.55487,0.17193,0.080158,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0021062,0.17184,0.15685,0,0
1,GO FOLIC ACID METABOLIC PROCESS,0.085627,0.17182,0.12521,0,0
1,GO PROTEIN DEMANNOSYLATION,0.05161,0.17118,0.15078,0,0
1,GO HORMONE BIOSYNTHETIC PROCESS,0.010245,0.17087,0.16396,0,0
1,GO UV PROTECTION,0.25001,0.17021,0.13803,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.2,0.17007,0.082343,0,0
1,GO CHONDROCYTE PROLIFERATION,0.02166,0.16984,0.35506,0,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0019282,0.16977,0.17762,0,0
1,GO ANION HOMEOSTASIS,0.065563,0.16967,0.10252,0,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.02268,0.16959,0.22767,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.015574,0.16904,0.33732,0,0
1,GO RRNA 3 END PROCESSING,0.0017123,0.16903,0.18917,0,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.055956,0.16894,0.16251,0,0
1,GO AXIS ELONGATION,0.031059,0.16866,0.21924,0,0
1,GO ALDITOL METABOLIC PROCESS,0.0066042,0.16864,0.16962,0,0
1,GO AMELOGENESIS,0.073629,0.16861,0.1882,0,0
1,GO XENOBIOTIC TRANSPORT,0.0075304,0.16769,0.2019,0,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00049035,0.1671,0.15237,0,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.076492,0.16683,0.21185,0,0
1,GO DISTAL TUBULE DEVELOPMENT,0.27611,0.16648,0.20734,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.010773,0.16632,0.13357,0,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.025414,0.16616,0.15578,0,0
1,GO PROTEIN REFOLDING,0.046579,0.1656,0.15308,0,0
1,GO HINDLIMB MORPHOGENESIS,0.188,0.16497,0.11403,0,0
1,GO MIDGUT DEVELOPMENT,0.17099,0.16436,0.1744,0,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.021165,0.16421,0.1367,0,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.030383,0.16382,0.12848,0,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.004408,0.16095,0.37827,0,0
1,GO RNA DECAPPING,0.0028141,0.16082,0.16668,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.10845,0.16017,0.13219,0,0
1,GO PLASMA MEMBRANE ORGANIZATION,0.017137,0.15957,0.11473,0,0
1,GO ETHER METABOLIC PROCESS,0.055956,0.1593,0.14352,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.14285,0.15927,0.1067,0,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.090515,0.15891,0.1388,0,0
1,GO REGULATION OF GTP BINDING,0.16828,0.15858,0.15264,0,0
1,GO DETOXIFICATION,0.012203,0.15753,0.13992,0,0
1,GO SERTOLI CELL DIFFERENTIATION,0.015953,0.15702,0.20961,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.30402,0.15701,0.16083,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.042857,0.15699,0.11709,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.31232,0.15662,0.058829,0,0
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0099891,0.15655,0.24326,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0073363,0.1563,0.24965,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.81668,0.15546,-0.00015122,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.010245,0.15539,0.17811,0,0
1,GO FATTY ACID HOMEOSTASIS,0.22568,0.15487,0.085529,0,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.025414,0.15472,0.23112,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.42855,0.15457,0.082473,0,0
1,GO HEART TRABECULA FORMATION,0.19393,0.15432,0.16875,0,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.014138,0.15258,0.16481,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.052669,0.15228,0.39852,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.23589,0.15205,0.079467,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.10845,0.15186,0.1348,0,0
1,GO ANIMAL ORGAN FORMATION,0.064293,0.15173,0.13837,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.042857,0.15161,0.13693,0,0
1,GO PLACENTA DEVELOPMENT,0.009256,0.15129,0.15783,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.31232,0.151,0.13387,0,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.090515,0.15097,0.094283,0,0
1,GO DENDRITIC CELL MIGRATION,0.17934,0.15089,0.12494,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.19095,0.15012,0.091378,0,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0010859,0.14869,0.16786,0,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.02843,0.14857,0.15056,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.004408,0.14831,0.21073,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.068167,0.14788,0.12387,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.30815,0.14763,0.079363,0,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.11841,0.14643,0.11067,0,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.14285,0.14633,0.07667,0,0
1,GO RESPONSE TO INTERLEUKIN 4,0.0028957,0.14597,0.15462,0,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.17374,0.14564,0.081177,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.10845,0.14563,0.15058,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0057817,0.14489,0.24583,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.057089,0.14483,0.13727,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0038387,0.14453,0.15029,0,0
1,GO ASTROCYTE DIFFERENTIATION,0.045624,0.1445,0.13036,0,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0079323,0.14387,0.25862,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.21905,0.14369,0.085118,0,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.10096,0.14359,0.15303,0,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.0079323,0.14338,0.11425,0,0
1,GO CELLULAR RESPONSE TO HEAT,0.0014738,0.14308,0.16525,0,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.19393,0.14292,0.082211,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.040234,0.14188,0.14896,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.072231,0.14186,0.14671,0,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.010773,0.14074,0.20409,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.017969,0.14023,0.2,0,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0028957,0.13995,0.11949,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.082489,0.1399,0.12806,0,0
1,GO MYELIN MAINTENANCE,0.19095,0.13982,0.11058,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.18508,0.13972,0.078363,0,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.0033369,0.13958,0.14633,0,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.060602,0.13892,0.10764,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0087944,0.13865,0.12831,0,0
1,GO ERYTHROCYTE MATURATION,0.023741,0.13842,0.21538,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.092194,0.13812,0.13303,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.16828,0.13812,0.2411,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.017137,0.1381,0.12704,0,0
1,GO ISOPRENOID METABOLIC PROCESS,0.12259,0.13773,0.091098,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.13583,0.13651,0.16657,0,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0097392,0.13601,0.11532,0,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.10096,0.13599,0.13201,0,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.026586,0.13599,0.21869,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.031059,0.13597,0.21031,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.39858,0.13591,0.0054055,0,0
1,GO STEROL HOMEOSTASIS,0.065563,0.1357,0.083301,0,0
1,GO RESPONSE TO ATP,0.0094949,0.13549,0.11548,0,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.37932,0.13541,0.054274,0,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.050569,0.13539,0.34778,0,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.023741,0.13508,0.30129,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.21579,0.13463,0.089113,0,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0079323,0.13461,0.1542,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.057089,0.13436,0.13576,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.04854,0.1341,0.15356,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.35607,0.13397,0.05556,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.29184,0.1337,0.062084,0,0
1,GO RESPONSE TO VITAMIN A,0.12259,0.13347,0.10085,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.3746,0.13333,0.19298,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.17934,0.13289,0.10988,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.02843,0.13283,0.12945,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.070855,0.1327,0.16325,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.031748,0.13238,0.19522,0,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.084046,0.13229,0.11218,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.25729,0.13213,0.15683,0,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.03939,0.13161,0.25167,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.11235,0.13118,0.080069,0,0
1,GO HEAD MORPHOGENESIS,0.013139,0.13067,0.21074,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.027188,0.13053,0.12594,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.020205,0.13034,0.18908,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0038387,0.13032,0.12557,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.14048,0.13027,0.085586,0,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00063551,0.13015,0.13026,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.34702,0.1297,0.041746,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0097392,0.1297,0.10433,0,0
1,GO RESPONSE TO LEPTIN,0.03939,0.12928,0.1696,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.39371,0.12882,0.047082,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.16828,0.12868,0.12947,0,0
1,GO MANGANESE ION TRANSPORT,0.10654,0.12818,0.14171,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.53742,0.12805,0.032627,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.017969,0.12785,0.11894,0,0
1,GO LAMELLIPODIUM ASSEMBLY,0.016339,0.12779,0.14507,0,0
1,GO KINETOCHORE ASSEMBLY,0.12049,0.12764,0.14264,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.035393,0.12759,0.12318,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.23245,0.12745,0.057104,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0090226,0.12687,0.15328,0,0
1,GO LIPID DIGESTION,0.53167,0.12679,0.0085822,0,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00063551,0.12642,0.15859,0,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0050528,0.12633,0.15711,0,0
1,GO RESPONSE TO HEAT,0.00032948,0.12605,0.17303,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.58456,0.12603,0.059725,0,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.02068,0.1259,0.090001,0,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12689,0.12521,0.15014,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.25729,0.12515,0.073019,0,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.016734,0.12504,0.10559,0,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.014486,0.12455,0.098184,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.027188,0.1244,0.12141,0,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.14769,0.12436,0.14631,0,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.047551,0.12401,0.1636,0,0
1,GO DNA DEMETHYLATION,0.25363,0.12339,0.094971,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.060602,0.1229,0.11488,0,0
1,GO TRICARBOXYLIC ACID CYCLE,0.37932,0.12268,0.031278,0,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0094949,0.12177,0.11965,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1,0.12161,-0.051878,0,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.0024367,0.12149,0.15643,0,0
1,GO PROTEIN KINASE C SIGNALING,0.56075,0.12136,0.0060049,0,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.17374,0.12135,0.11013,0,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.1028,0.12126,0.11789,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.19695,0.12098,0.16116,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.017137,0.12098,0.17514,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.21579,0.12093,0.14892,0,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.27611,0.12086,0.041117,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0041716,0.12072,0.13396,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.079444,0.12067,0.13698,0,0
1,GO AEROBIC RESPIRATION,0.04854,0.12046,0.088041,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.21579,0.12014,0.084129,0,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.03245,0.12002,0.10318,0,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0028957,0.11959,0.16764,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.43883,0.11936,0.1237,0,0
1,GO HISTONE ARGININE METHYLATION,0.082489,0.11902,0.089737,0,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.070855,0.11895,0.079602,0,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00047456,0.11811,0.14322,0,0
1,GO LAMELLIPODIUM ORGANIZATION,0.0045306,0.11799,0.18102,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.15015,0.11794,0.14537,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.19393,0.11782,0.14195,0,0
1,GO RENAL FILTRATION,0.17653,0.11754,0.13778,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.065563,0.11742,0.16613,0,0
1,GO NEPHRON TUBULE FORMATION,0.19393,0.11735,0.1392,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.050569,0.11661,0.10987,0,0
1,GO REGULATION OF HAIR CYCLE,0.33373,0.11642,0.1178,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.40843,0.11614,0.056876,0,0
1,GO CELLULAR RESPIRATION,0.027803,0.11606,0.096408,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.35607,0.11524,0.19676,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.64605,0.11489,0.04717,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.16032,0.1142,0.064728,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.11039,0.11396,0.12665,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.44924,0.11386,0.037058,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.013465,0.11345,0.14207,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.20309,0.11337,0.075114,0,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.21256,0.11324,0.056787,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.48678,0.11288,0.041858,0,0
1,GO TISSUE MORPHOGENESIS,0.0034322,0.11287,0.14395,0,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0097392,0.11241,0.13015,0,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.014841,0.1123,0.10174,0,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.053746,0.11229,0.093069,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.031748,0.11221,0.20002,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.14285,0.11218,0.1623,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.052669,0.11207,0.093863,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.001191,0.11183,0.13478,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.22905,0.11182,0.080425,0,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.013465,0.1118,0.085592,0,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00041602,0.11155,0.11234,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0039469,0.11127,0.095161,0,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.079444,0.11125,0.078516,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.15264,0.11102,0.067134,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.29184,0.11101,0.080487,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.12689,0.11088,0.16114,0,0
1,GO ESTROGEN METABOLIC PROCESS,0.019283,0.11086,0.16544,0,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.045624,0.11018,0.071774,0,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.05824,0.10993,0.098933,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.068167,0.10985,0.1046,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.033894,0.1098,0.10828,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.4978,0.10974,0.098604,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.62113,0.10949,0.047928,0,0
1,GO REGULATION OF PROTEIN STABILITY,0.0032441,0.1092,0.097687,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.72969,0.10919,0.0168,0,0
1,GO LIPID HOMEOSTASIS,0.0695,0.10914,0.055904,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.25729,0.10907,0.027498,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.28785,0.10889,0.089299,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.1313,0.10865,0.075421,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.16828,0.10835,0.088525,0,0
1,GO RESPONSE TO TUMOR CELL,0.064293,0.1083,0.15968,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.099158,0.10817,0.18147,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.49227,0.10794,0.027737,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.39371,0.10788,0.0318,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.045624,0.10775,0.11783,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.15264,0.10764,0.10792,0,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0027346,0.10743,0.12474,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.29992,0.10738,0.044066,0,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0036303,0.10709,0.14024,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.18508,0.10696,0.068982,0,0
1,GO REGULATION OF MITOPHAGY,0.055956,0.10691,0.16569,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.049546,0.10673,0.11571,0,0
1,GO LYSINE METABOLIC PROCESS,0.35153,0.10631,0.10498,0,0
1,GO PIGMENT GRANULE ORGANIZATION,0.042857,0.10613,0.17,0,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.39371,0.10603,0.045995,0,0
1,GO OVULATION CYCLE PROCESS,0.14048,0.10602,0.085937,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.56666,0.10582,0.024336,0,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.10096,0.10553,0.071619,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.14048,0.10529,0.15914,0,0
1,GO RNA STABILIZATION,0.025414,0.10522,0.12404,0,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.13583,0.10509,0.063594,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.05824,0.10468,0.10795,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.13583,0.10463,0.065299,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.036948,0.10461,0.14739,0,0
1,GO ATP TRANSPORT,0.47049,0.10422,0.028815,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.76948,0.10409,0.11463,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.40349,0.10377,0.15336,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.22568,0.10369,0.16977,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.40349,0.10361,0.14219,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.04854,0.10346,0.12304,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,0.10312,0.01546,0,0
1,GO RESPONSE TO GONADOTROPIN,0.072231,0.10275,0.17292,0,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.082489,0.10222,0.090098,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.020205,0.10215,0.090531,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.022165,0.10203,0.078389,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.36526,0.10201,0.10619,0,0
1,GO ANOIKIS,0.36526,0.10151,0.089439,0,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.061812,0.1012,0.11267,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.18219,0.10111,0.098087,0,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.02068,0.10095,0.11004,0,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.044685,0.10085,0.076629,0,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.25729,0.10073,0.10102,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.4598,0.10069,0.0084607,0,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.050569,0.10058,0.14477,0,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.077957,0.10057,0.12041,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.099158,0.10048,0.10606,0,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.32506,0.10048,0.075934,0,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.036164,0.10043,0.067798,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.41842,0.1004,0.08717,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0014299,0.10026,0.13639,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.092194,0.10014,0.1142,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.48678,0.10003,0.010099,0,0
1,GO ALCOHOL METABOLIC PROCESS,0.084046,0.10003,0.044016,0,0
1,GO GLIAL CELL MIGRATION,0.15517,0.09957,0.10781,0,0
1,GO FAT CELL DIFFERENTIATION,0.20309,0.099514,0.050984,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.22568,0.099475,0.10618,0,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.05824,0.099393,0.11457,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.084046,0.099125,0.17737,0,0
1,GO RESPONSE TO DRUG,0.090515,0.099066,0.078811,0,0
1,GO THIOESTER METABOLIC PROCESS,0.17934,0.098845,0.060743,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.22905,0.09848,0.064881,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.12689,0.098433,0.11529,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.50337,0.098392,0.046437,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.26098,0.098194,0.087895,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.19095,0.098072,0.052293,0,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.041093,0.098041,0.097671,0,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.063042,0.097892,0.066791,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.33812,0.097829,0.11638,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.043763,0.09767,0.12806,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.10096,0.097647,0.16606,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.24643,0.097103,0.066128,0,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.024846,0.096897,0.11615,0,0
1,GO CAMP METABOLIC PROCESS,0.23589,0.096754,0.13672,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.073629,0.096648,0.17916,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.25363,0.096621,0.12185,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.27611,0.096531,0.086677,0,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.13583,0.09631,0.31055,0,0
1,GO KERATINOCYTE PROLIFERATION,0.025994,0.096294,0.27159,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.81668,0.096226,0.0096717,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.4545,0.095885,0.044385,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.4978,0.095781,0.051602,0,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.05824,0.095772,0.11359,0,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.20937,0.095479,0.075608,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.15015,0.095473,0.12633,0,0
1,GO EMBRYONIC MORPHOGENESIS,0.044685,0.095468,0.09239,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.049546,0.095034,0.0849,0,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.16294,0.094943,0.13396,0,0
1,GO LIPID MODIFICATION,0.050569,0.094776,0.074969,0,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.11039,0.09425,0.12685,0,0
1,GO REGULATION OF TISSUE REMODELING,0.21905,0.094215,0.05108,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.1313,0.094046,0.043176,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.33373,0.093895,0.074862,0,0
1,GO B CELL APOPTOTIC PROCESS,0.59664,0.093761,0.01217,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0062634,0.09351,0.18374,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.52025,0.093484,0.024676,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.35153,0.093319,0.086024,0,0
1,GO COCHLEA MORPHOGENESIS,0.59059,0.093287,0.0074602,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.43883,0.093159,0.077451,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.055956,0.092794,0.14391,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.44402,0.092194,0.06597,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.37932,0.092128,0.027132,0,0
1,GO RESPONSE TO GROWTH FACTOR,0.011047,0.092111,0.12491,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.46512,0.091953,0.03778,0,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.042857,0.091843,0.083158,0,0
1,GO FUCOSE METABOLIC PROCESS,0.36526,0.091794,0.048157,0,0
1,GO DNA REPLICATION INITIATION,0.25001,0.091601,0.040789,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.19095,0.091552,0.17223,0,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.015203,0.091334,0.071057,0,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.014486,0.091321,0.088451,0,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015574,0.091209,0.18767,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.055956,0.091156,0.12346,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.47588,0.091008,0.070736,0,0
1,GO CELLULAR RESPONSE TO PH,0.36526,0.09083,0.062812,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.057089,0.090726,0.12399,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.1028,0.090602,0.13015,0,0
1,GO LIPID LOCALIZATION,0.077957,0.090564,0.054495,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.29992,0.090562,0.050097,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.69061,0.090535,0.12587,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.053746,0.090336,0.14805,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.25729,0.090187,0.10669,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.93377,0.090105,0.01436,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.55487,0.089757,0.10256,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.10465,0.089624,0.27837,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.21905,0.089243,0.049651,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.001662,0.089227,0.11061,0,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.099158,0.08894,0.082071,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.56666,0.08859,-0.0043375,0,0
1,GO OOCYTE MATURATION,0.37932,0.088046,0.020271,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.059411,0.08795,0.16002,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.10654,0.087934,0.33506,0,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.041093,0.087845,0.095306,0,0
1,GO CELLULAR RESPONSE TO KETONE,0.24643,0.087829,0.051687,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.087232,0.087802,0.1053,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.74288,0.087698,-0.023164,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.70355,0.087562,0.029512,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.47588,0.087492,0.082802,0,0
1,GO MYOTUBE DIFFERENTIATION,0.064293,0.087462,0.10856,0,0
1,GO RESPONSE TO VITAMIN,0.44924,0.087443,0.077838,0,0
1,GO REGULATION OF ATP METABOLIC PROCESS,0.16032,0.08743,0.048253,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.62732,0.0874,0.0072538,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.80312,0.087336,-0.02425,0,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.057089,0.087286,0.20639,0,0
1,GO REPLACEMENT OSSIFICATION,0.12259,0.087243,0.16472,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.10465,0.087081,0.085221,0,0
1,GO GLIAL CELL DEVELOPMENT,0.46512,0.087071,0.025189,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.188,0.086524,0.13577,0,0
1,GO MUSCLE ATROPHY,0.19095,0.086402,0.1407,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.36064,0.086393,0.099955,0,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00063551,0.086291,0.097357,0,0
1,GO NEUROBLAST DIVISION,0.24288,0.086195,0.1817,0,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.024288,0.085711,0.083258,0,0
1,GO RESPONSE TO IRON ION,0.17934,0.085685,0.074042,0,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.12259,0.084999,0.11134,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.13814,0.08495,0.11299,0,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.076492,0.084939,0.049187,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.87144,0.084386,0.0097797,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.188,0.084186,0.12892,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.56666,0.083992,0.011888,0,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.11434,0.083955,0.1095,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0037331,0.083924,0.080826,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.073629,0.083851,0.094404,0,0
1,GO HORMONE METABOLIC PROCESS,0.064293,0.083774,0.076788,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.22235,0.083694,0.079837,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.14769,0.083581,0.073329,0,0
1,GO CELL CELL SIGNALING BY WNT,0.052669,0.083516,0.09439,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.1028,0.083423,0.051954,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.44402,0.083294,0.053429,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.44402,0.082999,0.083494,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.21579,0.082826,0.060753,0,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.1313,0.082716,0.076062,0,0
1,GO B CELL PROLIFERATION,0.81668,0.082598,-0.013285,0,0
1,GO NAD METABOLIC PROCESS,0.34702,0.082434,0.070423,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.064293,0.082329,0.083944,0,0
1,GO VIRAL LATENCY,0.52025,0.082292,0.039188,0,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.047551,0.082175,0.075881,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.29992,0.082075,0.090195,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.17374,0.081959,0.052499,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.05824,0.081955,0.11597,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.67137,0.081862,0.050395,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.47588,0.081696,0.12018,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.33812,0.081648,0.027109,0,0
1,GO CENTROSOME DUPLICATION,0.16828,0.081615,0.065637,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.088862,0.08151,0.078713,0,0
1,GO KINETOCHORE ORGANIZATION,0.32506,0.081344,0.077538,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.40843,0.081265,0.089343,0,0
1,GO LEUKOCYTE CHEMOTAXIS,0.14769,0.081232,0.11945,0,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.099158,0.081171,0.072782,0,0
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.16559,0.081115,0.084422,0,0
1,GO RESPONSE TO COPPER ION,0.35153,0.081006,0.095694,0,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.060602,0.080502,0.053397,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00353,0.080478,0.13445,0,0
1,GO CARNITINE SHUTTLE,0.16828,0.080209,0.10759,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.32506,0.080209,0.073894,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.188,0.080004,0.08816,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.36991,0.079948,0.059073,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.16828,0.079923,0.099926,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.25729,0.07979,0.046049,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.35607,0.079776,0.093213,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.32938,0.079467,0.085919,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.44402,0.079255,0.013393,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.13583,0.079231,0.095414,0,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.079444,0.079203,0.088481,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.60272,0.079158,-0.0011326,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.24643,0.07869,0.077955,0,0
1,GO MICROVILLUS ASSEMBLY,0.56075,0.078632,0.046403,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.15517,0.078475,0.068374,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.5726,0.078468,0.1812,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.32506,0.078465,0.049244,0,0
1,GO TERPENOID METABOLIC PROCESS,0.26847,0.078365,0.080194,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.90599,0.078319,-0.041863,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.188,0.078114,0.097024,0,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.12473,0.077889,0.06071,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.41341,0.077719,-0.012201,0,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.26847,0.077531,0.065781,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.4978,0.077484,0.064407,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.97557,0.077465,-0.037118,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.38888,0.077045,0.057816,0,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.087232,0.076992,0.060832,0,0
1,GO AORTA DEVELOPMENT,0.11841,0.07674,0.19485,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.61497,0.076624,0.017359,0,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.73628,0.076619,0.0034224,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.28785,0.076515,0.068324,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.19695,0.076511,0.10366,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.26847,0.076403,0.072657,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.50337,0.076365,0.10668,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.21905,0.076027,0.080889,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.64605,0.075548,0.0098597,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.25363,0.075541,0.066787,0,0
1,GO MAINTENANCE OF CELL NUMBER,0.17653,0.075258,0.096677,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.26847,0.075218,0.10666,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.14285,0.075194,0.10725,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.063042,0.074679,0.070737,0,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.047551,0.074622,0.050087,0,0
1,GO BLASTODERM SEGMENTATION,0.20309,0.074614,0.15341,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.17099,0.074367,0.092958,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.47049,0.074333,-0.0025927,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.11235,0.073896,0.09482,0,0
1,GO TRNA CATABOLIC PROCESS,0.22905,0.073786,0.16348,0,0
1,GO PROTEIN TETRAMERIZATION,0.042857,0.073765,0.069794,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36991,0.073664,0.14886,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.62113,0.073633,0.061823,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.11434,0.073462,0.055995,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.36526,0.073171,0.037738,0,0
1,GO PROTEIN SUMOYLATION,0.095625,0.0731,0.069434,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.20937,0.072555,0.059369,0,0
1,GO RESPIRATORY BURST,0.72313,0.072495,0.0058498,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.12908,0.072486,0.1781,0,0
1,GO NCRNA TRANSCRIPTION,0.036948,0.072448,0.086436,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.78962,0.072031,0.023059,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.39858,0.071716,0.070224,0,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.31653,0.07154,0.045063,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.24643,0.071422,0.048806,0,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.29184,0.071359,0.062688,0,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.9686,0.071333,-0.022842,0,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.041093,0.071319,0.063051,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.064293,0.071315,0.082732,0,0
1,GO REGULATION OF TUBE SIZE,0.087232,0.071264,0.084998,0,0
1,GO RESPONSE TO NUTRIENT,0.28785,0.071042,0.064994,0,0
1,GO HISTONE DEUBIQUITINATION,0.24288,0.071015,0.065031,0,0
1,GO RESPONSE TO UV B,0.46512,0.07095,0.11192,0,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.19695,0.070714,0.078785,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.16032,0.070703,0.11099,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.14526,0.070592,0.18823,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.86455,0.070555,0.062336,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.2839,0.070516,0.11641,0,0
1,GO STEROL METABOLIC PROCESS,0.54321,0.07038,0.0048828,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.23245,0.069979,0.070462,0,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.21256,0.069935,0.05377,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,0.069895,0.0023497,0,0
1,GO DNA GEOMETRIC CHANGE,0.0695,0.069823,0.097788,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.14769,0.0698,0.080375,0,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.033166,0.069692,0.13148,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.34256,0.069553,0.030797,0,0
1,GO STEM CELL PROLIFERATION,0.94073,0.069337,-0.011726,0,0
1,GO SNORNA 3 END PROCESSING,0.4545,0.069327,0.03309,0,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.26098,0.069245,0.042271,0,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.13814,0.068497,0.079826,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.21256,0.068451,0.096935,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.16032,0.068394,0.039227,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.16294,0.068151,0.16065,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.092194,0.067912,0.064917,0,0
1,GO MITOCHONDRION ORGANIZATION,0.0036303,0.067695,0.072204,0,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.088862,0.067642,0.075295,0,0
1,GO CELLULAR RESPONSE TO DRUG,0.093897,0.067579,0.089304,0,0
1,GO NEUTROPHIL CHEMOTAXIS,0.25363,0.067281,0.15797,0,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.055956,0.067277,0.081674,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15773,0.067128,0.072747,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.4545,0.066826,0.034021,0,0
1,GO DIOL METABOLIC PROCESS,0.52025,0.066356,0.02637,0,0
1,GO ACTIN FILAMENT ORGANIZATION,0.11841,0.065829,0.077089,0,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.05161,0.065757,0.051731,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.35153,0.06571,0.062701,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.25001,0.065657,0.052132,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.69707,0.065481,0.011149,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.2839,0.065144,0.057527,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.91293,0.065117,0.036892,0,0
1,GO CHOLESTEROL STORAGE,0.38408,0.065054,0.11351,0,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.10654,0.064949,0.055816,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.32506,0.064784,0.054822,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.16828,0.064383,0.10205,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.48131,0.064293,0.043351,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.42347,0.063969,0.08804,0,0
1,GO VITAMIN D METABOLIC PROCESS,0.23245,0.063876,0.13675,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.23245,0.063637,0.056168,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.47049,0.063555,0.07919,0,0
1,GO MAMMARY GLAND DEVELOPMENT,0.18508,0.063394,0.087935,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.073629,0.063351,0.041525,0,0
1,GO ENSHEATHMENT OF NEURONS,0.35607,0.063347,0.022534,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.10654,0.063244,0.095021,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.59664,0.063094,0.012604,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.29992,0.063038,0.11019,0,0
1,GO TISSUE HOMEOSTASIS,0.1313,0.062816,0.057455,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.60883,0.062704,0.0072336,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.33812,0.062442,0.05736,0,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.26471,0.062353,0.044694,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.046579,0.062342,0.077837,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.049546,0.062293,0.14034,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.16559,0.06224,0.035844,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.2839,0.062168,0.088447,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.50896,0.062128,0.07255,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.29992,0.062121,0.06764,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.31232,0.062075,0.12748,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.61497,0.061868,0.071656,0,0
1,GO FATTY ACID TRANSPORT,0.2,0.061823,0.048556,0,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.018398,0.061569,0.086184,0,0
1,GO ARTERY DEVELOPMENT,0.033894,0.061505,0.2209,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.20937,0.06145,0.090345,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.42347,0.061328,0.050855,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.33812,0.061298,0.090035,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.077957,0.061034,0.088094,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0099891,0.060909,0.12341,0,0
1,GO RESPONSE TO AMYLOID BETA,0.39858,0.060803,0.095689,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.082489,0.0607,0.060241,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.13355,0.060463,0.14992,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.41842,0.06035,0.048938,0,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.085627,0.06028,0.069832,0,0
1,GO GOLGI RIBBON FORMATION,0.5726,0.060013,0.07849,0,0
1,GO GMP METABOLIC PROCESS,0.67776,0.059605,0.016674,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.22235,0.059543,0.067186,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.40349,0.05929,0.089678,0,0
1,GO SNORNA METABOLIC PROCESS,0.42855,0.05908,0.039592,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.65866,0.058707,0.023151,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.22568,0.058649,0.11351,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.17099,0.058469,0.040611,0,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.055956,0.058396,0.078249,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.48678,0.058283,0.027175,0,0
1,GO REGULATION OF MACROAUTOPHAGY,0.011326,0.058212,0.10226,0,0
1,GO NEPHRON DEVELOPMENT,0.095625,0.058185,0.13587,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.29992,0.057848,0.084135,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.20621,0.057624,0.048383,0,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.085627,0.057508,0.079133,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.042857,0.057503,0.12811,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.32938,0.057462,0.093736,0,0
1,GO METHIONINE METABOLIC PROCESS,0.64605,0.057346,-0.01655,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.15517,0.057299,0.065214,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.29992,0.056705,0.056731,0,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.31653,0.056636,0.10541,0,0
1,GO NEURON PROJECTION REGENERATION,0.65234,0.056622,0.0057595,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.50896,0.056529,0.041762,0,0
1,GO PROSTAGLANDIN SECRETION,0.084046,0.056519,0.12185,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.74288,0.056481,0.034529,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.38888,0.056023,0.13667,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.64605,0.055974,0.021689,0,0
1,GO STEROID METABOLIC PROCESS,0.33373,0.055919,0.0078324,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.25729,0.055846,0.076294,0,0
1,GO ODONTOGENESIS,0.099158,0.055814,0.12689,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.25001,0.055521,0.086558,0,0
1,GO BONE RESORPTION,0.097379,0.055497,0.090429,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.14769,0.055413,0.057794,0,0
1,GO AMMONIUM TRANSPORT,0.11434,0.055347,0.13552,0,0
1,GO MUSCLE HYPERTROPHY,0.60272,0.055109,0.027572,0,0
1,GO DNA MODIFICATION,0.040234,0.054972,0.071628,0,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0039469,0.054857,0.077312,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.94769,0.054579,-0.028609,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.4545,0.054531,0.02536,0,0
1,GO RESPONSE TO ACIDIC PH,0.34256,0.0539,0.081877,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.51459,0.053683,0.050207,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.99651,0.053589,0.017995,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.20937,0.05348,0.038135,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.29586,0.053458,0.055849,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.1313,0.053089,0.17474,0,0
1,GO T CELL LINEAGE COMMITMENT,0.17653,0.052976,0.079151,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.25001,0.052963,0.064666,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.18219,0.052936,0.034319,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.38408,0.052883,0.048977,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.085627,0.052815,0.12263,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.28785,0.052335,0.11021,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.4598,0.052035,0.065831,0,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.13355,0.051998,0.068458,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.41341,0.051963,0.10235,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.053746,0.051881,0.051803,0,0
1,GO NEGATIVE REGULATION OF GROWTH,0.20937,0.051856,0.044983,0,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.39858,0.051594,0.075734,0,0
1,GO POLYOL METABOLIC PROCESS,0.082489,0.051378,0.051443,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.36064,0.05133,0.060513,0,0
1,GO KETONE CATABOLIC PROCESS,0.72313,0.051304,-0.041797,0,0
1,GO HOMEOSTATIC PROCESS,0.40349,0.051231,0.013192,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.35153,0.051212,0.020227,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.25363,0.05094,0.074679,0,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.30402,0.050807,0.13929,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.1028,0.050333,0.216,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.28785,0.050143,0.10881,0,0
1,GO HISTONE H2A ACETYLATION,0.4978,0.05014,0.02927,0,0
1,GO ERYTHROCYTE DEVELOPMENT,0.13355,0.050059,0.098388,0,0
1,GO REGULATION OF CELL SHAPE,0.079444,0.050017,0.12692,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.32077,0.049915,0.05934,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.24288,0.049905,0.062419,0,0
1,GO EPITHELIAL TUBE FORMATION,0.17653,0.049829,0.092941,0,0
1,GO PROTEIN DESTABILIZATION,0.50896,0.04981,0.01674,0,0
1,GO HISTONE H3 K27 METHYLATION,0.65866,0.049807,0.027111,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.42347,0.049466,0.021676,0,0
1,GO RECEPTOR INTERNALIZATION,0.23245,0.049404,0.054695,0,0
1,GO CELL MOTILITY,0.11841,0.049224,0.07003,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.079444,0.049102,0.070916,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.26847,0.048889,0.082664,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.39371,0.048877,0.022938,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.97557,0.048757,-0.048134,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.30815,0.048577,0.1518,0,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.11039,0.04846,0.088415,0,0
1,GO MALE SEX DIFFERENTIATION,0.52594,0.048441,0.04702,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.25363,0.048339,0.081151,0,0
1,GO VITAMIN METABOLIC PROCESS,0.085627,0.048156,0.071547,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.11039,0.047968,0.035466,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.80312,0.047893,-0.049794,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.24288,0.047858,0.066226,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.17374,0.047779,0.049636,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.21579,0.047639,0.03936,0,0
1,GO NUCLEAR MIGRATION,0.69061,0.047507,0.033394,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.44924,0.047495,0.050423,0,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.44402,0.047304,0.061624,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.84397,0.047259,0.0058251,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.13355,0.047198,0.061549,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.38888,0.047166,0.080649,0,0
1,GO P BODY ASSEMBLY,0.80989,0.047066,0.013915,0,0
1,GO REGULATION OF CYTOKINESIS,0.4978,0.047043,0.027554,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.87833,0.046982,-0.013297,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.12908,0.046944,0.15526,0,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.16032,0.046603,0.106,0,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.15517,0.046593,0.049052,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.29184,0.046535,0.038384,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.041093,0.046258,0.065361,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.13355,0.046237,0.055657,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.27611,0.046096,0.13992,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.41341,0.045818,0.12609,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.76281,0.045615,-0.011975,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.17653,0.045321,0.11343,0,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,0.045278,0.054494,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.71658,0.045176,0.0025743,0,0
1,GO TUBE FORMATION,0.077957,0.045111,0.10459,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.26847,0.044931,0.035588,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.05824,0.04488,0.1159,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.43883,0.04481,0.077358,0,0
1,GO RESPONSE TO INSULIN,0.41842,0.04469,0.015457,0,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.36064,0.044629,0.047923,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.70355,0.044512,0.033996,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.78289,0.0444,0.027673,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20937,0.044159,0.0207,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.27999,0.043989,0.050438,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.43367,0.04379,0.035651,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.26847,0.043775,0.027191,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.89215,0.043599,-0.0013153,0,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.024846,0.043367,0.090646,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.31653,0.043266,0.04338,0,0
1,GO PRENYLATION,0.76281,0.043209,0.040665,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.75615,0.042959,0.031216,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.36064,0.042912,0.024484,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.60883,0.042884,0.032714,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.27227,0.042832,0.061068,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.20937,0.042261,0.04834,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.26471,0.042237,0.047264,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.60883,0.042183,0.011807,0,0
1,GO REGULATION OF CELL SIZE,0.67776,0.042108,-0.00088618,0,0
1,GO NEGATIVE CHEMOTAXIS,0.17934,0.042085,0.11209,0,0
1,GO DNA METHYLATION,0.63978,0.042061,0.0085369,0,0
1,GO ATP METABOLIC PROCESS,0.12689,0.042027,0.047744,0,0
1,GO INOSITOL METABOLIC PROCESS,0.80312,0.041862,0.011198,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.64605,0.041848,0.02331,0,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.30815,0.041673,0.05203,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.30402,0.041623,0.03601,0,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.17934,0.041264,0.10711,0,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.48131,0.041262,0.024828,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.39371,0.041174,0.16408,0,0
1,GO DNA CONFORMATION CHANGE,0.31653,0.041136,0.044258,0,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.27999,0.040991,0.13246,0,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.17934,0.040901,0.060396,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.68418,0.040792,0.02555,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.87144,0.040695,0.028697,0,0
1,GO RECOMBINATIONAL REPAIR,0.50337,0.040644,0.046616,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.54321,0.040539,0.023106,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.21905,0.040223,0.080759,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.58456,0.040141,0.032387,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.74288,0.040126,0.0046235,0,0
1,GO ACTIN FILAMENT BASED PROCESS,0.16032,0.039949,0.064223,0,0
1,GO MRNA METHYLATION,0.46512,0.039841,0.058142,0,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.42855,0.03979,0.013009,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.60272,0.039577,0.0097932,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.56075,0.039386,0.020015,0,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.11841,0.039342,0.17195,0,0
1,GO EPITHELIUM DEVELOPMENT,0.30402,0.039307,0.052834,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.26098,0.039242,0.10588,0,0
1,GO MITOCHONDRIAL FISSION,0.47049,0.039186,0.035691,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.28785,0.039129,0.1027,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.17653,0.039004,0.076736,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.43367,0.038841,0.023303,0,0
1,GO PRE MIRNA PROCESSING,0.52025,0.038828,0.036607,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.56666,0.0388,0.023058,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.25729,0.038658,0.06014,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.53167,0.038649,0.073009,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.32938,0.038584,0.043321,0,0
1,GO DNA CATABOLIC PROCESS,0.16032,0.038313,0.041615,0,0
1,GO METAL ION HOMEOSTASIS,0.41341,0.038153,0.023056,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.53742,0.038074,-0.0033163,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.63354,0.037614,0.033943,0,0
1,GO POSITIVE REGULATION OF SIGNALING,0.18508,0.037508,0.041722,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.15773,0.037457,0.048673,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.52025,0.03724,0.082206,0,0
1,GO CYTOKINE SECRETION,0.77618,0.037224,0.033448,0,0
1,GO REPRODUCTION,0.2839,0.037114,0.022223,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.79636,0.037055,0.030946,0,0
1,GO SECRETION,0.188,0.037036,0.034583,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.78962,0.036842,0.013834,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.11039,0.036817,0.087523,0,0
1,GO ENDOSOMAL TRANSPORT,0.14285,0.036785,0.055329,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.47049,0.036617,0.068589,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.65234,0.036608,0.040477,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.30402,0.036592,0.089667,0,0
1,GO PROTEIN POLYMERIZATION,0.33812,0.036515,0.0258,0,0
1,GO STEM CELL DIVISION,0.28785,0.036463,0.12877,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.28785,0.036385,0.011333,0,0
1,GO SULFATION,0.71658,0.036169,0.068188,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.94769,0.036169,-0.032622,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.85082,0.036156,0.011041,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.60272,0.035916,0.053308,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.99651,0.035849,0.011543,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.43367,0.035723,0.044015,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.55487,0.035552,0.014759,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.47588,0.03541,0.046722,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.59059,0.035331,0.0067197,0,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.25729,0.035315,0.038827,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.3746,0.035223,0.14799,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.22905,0.034862,0.052888,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.41341,0.034734,0.023021,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.87833,0.034492,-0.021225,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.23937,0.034261,0.11483,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.17099,0.034185,0.10321,0,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.13583,0.034075,0.13776,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.91987,0.033795,-0.013969,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.41341,0.033773,0.040742,0,0
1,GO L SERINE METABOLIC PROCESS,0.43883,0.033719,0.056814,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.38888,0.033668,0.080404,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.43883,0.033414,0.061966,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.2839,0.033125,0.036037,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.26098,0.033088,0.075142,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.72313,0.032916,-0.0086953,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.4598,0.032865,0.09008,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.32938,0.032715,0.034103,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.67776,0.032568,0.029752,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.84397,0.032526,0.018212,0,0
1,GO PROTEIN TRIMERIZATION,0.68418,0.03237,0.044523,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.49227,0.032355,0.061009,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.26847,0.032339,0.038314,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.23245,0.032325,0.036771,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.64605,0.032125,0.0077279,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.65866,0.032082,0.033781,0,0
1,GO JNK CASCADE,0.25001,0.032027,0.035919,0,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.080955,0.031988,0.065652,0,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.22905,0.031954,0.031582,0,0
1,GO MEMBRANE FUSION,0.76281,0.031889,-0.0019659,0,0
1,GO HISTONE UBIQUITINATION,0.30815,0.03156,0.049786,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.96163,0.031228,0.020447,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.91987,0.031218,-0.0049261,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.43883,0.030962,0.042042,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.56666,0.030886,0.000331,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.50337,0.030814,0.025057,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.82348,0.030713,-0.0011831,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.53167,0.030508,0.016261,0,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.1028,0.030496,0.050869,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.33812,0.030101,0.077171,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.44924,0.029976,0.071657,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.59059,0.029807,0.035669,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.44924,0.029663,0.059496,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.61497,0.029399,0.020545,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.31653,0.029213,0.03497,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.27227,0.029192,0.094665,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.22568,0.02904,0.036531,0,0
1,GO LACTATE METABOLIC PROCESS,0.4978,0.029039,0.038563,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.74288,0.029029,0.046806,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.028968,0.019615,0,0
1,GO INTRACELLULAR LIPID TRANSPORT,0.35153,0.028665,0.057291,0,0
1,GO ION HOMEOSTASIS,0.56075,0.028603,0.01383,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.85082,0.028534,0.00021142,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.56075,0.028471,0.048254,0,0
1,GO THYROID GLAND DEVELOPMENT,0.99651,0.028396,-0.0057981,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.52594,0.028221,0.011539,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.4978,0.028097,0.05265,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.39858,0.027851,0.051853,0,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.23245,0.02784,0.031437,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.59664,0.027818,0.025352,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.17374,0.02776,0.092936,0,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.38408,0.027596,0.024332,0,0
1,GO MRNA MODIFICATION,0.44924,0.027591,0.068935,0,0
1,GO HEART MORPHOGENESIS,0.10654,0.027577,0.10276,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.98953,0.027447,0.029889,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.99651,0.027338,-0.021855,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.59059,0.027299,0.013072,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,0.02713,-0.0064125,0,0
1,GO VITAMIN TRANSPORT,0.43883,0.027053,0.044005,0,0
1,GO RRNA CATABOLIC PROCESS,0.63978,0.027047,0.027811,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.55487,0.027035,0.038822,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.99651,0.026947,-0.018286,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.76281,0.026854,-0.064077,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.82348,0.026853,-0.013361,0,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.19695,0.026741,0.088464,0,0
1,GO RESPONSE TO CAMP,0.46512,0.026708,0.045715,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.59664,0.026671,0.033746,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.41341,0.026669,0.039136,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.91987,0.026631,0.023891,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.44924,0.026299,0.076647,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.91293,0.026228,0.0070156,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.58456,0.026207,0.036501,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.72969,0.026094,0.032315,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.61497,0.025991,0.015865,0,0
1,GO BIOLOGICAL ADHESION,0.10096,0.025944,0.086534,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.32506,0.02593,0.069126,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.77618,0.025862,0.08226,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.60272,0.025704,0.027899,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.52594,0.025688,0.1039,0,0
1,GO APPENDAGE DEVELOPMENT,0.89215,0.025667,0.022496,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.78962,0.025588,0.0083451,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.66501,0.025521,0.021766,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.42347,0.025494,0.068225,0,0
1,GO MISMATCH REPAIR,0.62732,0.02548,0.024849,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.40843,0.025365,0.042316,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.88523,0.024966,-7.051e-05,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.15264,0.024946,0.10522,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.69707,0.024472,0.042333,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.48131,0.024374,0.038331,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.89907,0.024349,-0.0052381,0,0
1,GO GLUCOSE IMPORT,0.97557,0.024316,-0.022604,0,0
1,GO EMBRYO DEVELOPMENT,0.31653,0.024158,0.047215,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.67776,0.023909,0.046276,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.28785,0.023862,0.094375,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.84397,0.023812,-0.013772,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.36526,0.02378,0.049095,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.42347,0.023714,0.039464,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.82348,0.023695,0.0028896,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.21905,0.023686,0.10755,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.72313,0.023612,0.023142,0,0
1,GO NADH METABOLIC PROCESS,0.51459,0.02353,0.048073,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.47588,0.023387,0.057535,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.91987,0.023372,-0.010523,0,0
1,GO MICROTUBULE ANCHORING,0.48131,0.023335,0.036245,0,0
1,GO SINGLE FERTILIZATION,0.87144,0.023287,-0.018906,0,0
1,GO MICROTUBULE NUCLEATION,0.88523,0.023004,0.0014197,0,0
1,GO B CELL DIFFERENTIATION,0.079444,0.022996,0.087775,0,0
1,GO TELOMERE CAPPING,0.68418,0.022819,0.01413,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.50896,0.022731,0.028764,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.76281,0.0224,-0.015341,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.96163,0.02218,0.039905,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.67776,0.022111,0.034716,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.67776,0.022096,0.0088513,0,0
1,GO BIOMINERALIZATION,0.2839,0.022037,0.092325,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.89907,0.021805,-0.033284,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.56075,0.021697,0.06986,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.30402,0.021547,0.083721,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.44402,0.021459,0.0058205,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.56075,0.021406,0.049538,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.21905,0.021075,0.062944,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.82348,0.020908,0.0071244,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.40349,0.02088,0.031418,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.56075,0.020828,0.023397,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.46512,0.02076,0.062757,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.7495,0.020593,0.0047002,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.63354,0.020563,-0.047229,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.53742,0.020332,0.015491,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.54903,0.02012,0.039594,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.71006,0.020045,0.041838,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.94769,0.019988,-0.0067945,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.50337,0.019982,0.052587,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.8303,0.019845,0.0028878,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.57857,0.019827,-0.046553,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.40843,0.019649,0.038028,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.71006,0.019596,-0.0037211,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.50896,0.019562,0.024864,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.94769,0.019533,0.020358,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.40843,0.019497,0.052415,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.019439,-0.0066664,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.89215,0.019321,-0.015081,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.7495,0.019108,-0.00036322,0,0
1,GO HISTONE MONOUBIQUITINATION,0.56666,0.018931,0.028849,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.87144,0.01884,0.01001,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.64605,0.018833,0.034574,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.35607,0.018654,0.050887,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.66501,0.018625,0.0096227,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.97557,0.01833,-0.025296,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.32506,0.018282,0.031454,0,0
1,GO CELL PROJECTION ASSEMBLY,0.50337,0.018223,0.028939,0,0
1,GO DNA REPLICATION CHECKPOINT,0.7495,0.017691,0.017937,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.98255,0.01758,-0.00023855,0,0
1,GO SISTER CHROMATID SEGREGATION,0.42347,0.017576,0.042976,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.87144,0.017569,-0.00077761,0,0
1,GO ACTIN NUCLEATION,0.90599,0.017548,-0.027705,0,0
1,GO CELLULAR HOMEOSTASIS,0.34256,0.017506,0.023327,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.47049,0.017494,-0.04811,0,0
1,GO CYTOSOLIC TRANSPORT,0.4598,0.017442,0.03272,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.90599,0.017366,0.023469,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.52025,0.017298,0.024579,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25001,0.017127,0.06792,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.20621,0.017122,0.044515,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.9686,0.016669,0.028287,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.85768,0.016368,-0.0023497,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.36064,0.016351,0.083769,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.4545,0.016278,-0.11851,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.59059,0.016236,-0.0063857,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.38408,0.016082,0.041535,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.86455,0.015978,0.020596,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.43367,0.015977,0.033757,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.19695,0.015565,0.075017,0,0
1,GO NUCLEOTIDE TRANSPORT,0.9686,0.015554,-0.01799,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.60883,0.015403,0.02647,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.29586,0.015127,0.069648,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.72969,0.014805,0.0016951,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.014732,0.0053832,0,0
1,GO PHOTOPERIODISM,0.92682,0.014614,-0.025018,0,0
1,GO MUSCLE SYSTEM PROCESS,0.71658,0.014581,0.012542,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.71006,0.014275,-0.039778,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.36064,0.014209,0.090382,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.71658,0.014118,0.02707,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.68418,0.01409,0.0029001,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.36991,0.0139,0.094427,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.50337,0.013689,0.049336,0,0
1,GO GLYCOSYLATION,0.99651,0.013578,-0.036282,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.72313,0.013572,-0.027092,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.52025,0.013531,0.029641,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.30815,0.012996,0.034095,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.71006,0.012867,0.03331,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.74288,0.012855,0.0036805,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.93377,0.012822,-0.0055685,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.69707,0.012742,-0.017699,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.50896,0.012479,0.020938,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.98953,0.012216,-0.032286,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.16559,0.01199,0.066991,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.71658,0.011855,0.047475,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.93377,0.011725,-0.020446,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.47588,0.011659,0.043332,0,0
1,GO APPENDAGE MORPHOGENESIS,0.81668,0.011655,-0.0067641,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.62732,0.011369,0.019824,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.59059,0.011242,0.021367,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.74288,0.011217,-0.0452,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.9686,0.011175,-0.0010909,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.8303,0.010898,-0.013305,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.52594,0.010844,0.029208,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.59059,0.010836,0.035305,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.90599,0.010802,-0.016213,0,0
1,GO ZINC ION TRANSPORT,0.41842,0.010762,0.051845,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.25001,0.010589,0.052182,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.35153,0.010583,0.088243,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.8303,0.010548,0.021564,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.25729,0.010535,0.074513,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.84397,0.010504,-0.012102,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.20937,0.010349,0.15042,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.9686,0.010168,0.0078954,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.87833,0.0097933,0.0023315,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.4978,0.0095535,-0.003759,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.49227,0.0094272,-0.024718,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.91293,0.0093565,0.016038,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.63354,0.0093522,-0.038736,0,0
1,GO CYTOSKELETON ORGANIZATION,0.46512,0.009311,0.029505,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.29992,0.0092718,0.18975,0,0
1,GO OSTEOBLAST PROLIFERATION,0.46512,0.0091393,0.10859,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.96163,0.0090649,0.014796,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.71658,0.0089561,0.026994,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.98953,0.0086856,0.0045473,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.43883,0.0086104,0.025698,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.53742,0.0084504,0.049169,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.26471,0.0083347,-0.081894,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.89907,0.0082949,0.029077,0,0
1,GO ZINC ION HOMEOSTASIS,0.83713,0.0082495,0.042304,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.98255,0.0082025,0.0026757,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.78289,0.0080602,0.027274,0,0
1,GO DNA REPLICATION,0.36991,0.0078542,0.033822,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.33373,0.0078275,0.037455,0,0
1,GO PANCREATIC JUICE SECRETION,0.56075,0.0077407,-0.023581,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.78962,0.0073707,0.013341,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.96163,0.0072999,-0.0027829,0,0
1,GO ORGAN INDUCTION,0.42855,0.0072145,0.069604,0,0
1,GO ADAPTIVE THERMOGENESIS,0.93377,0.0071635,-0.010886,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.56075,0.0071624,0.033608,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.71658,0.0069352,0.02119,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.58456,0.006897,0.02656,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.51459,0.0068661,0.064173,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.80989,0.0067313,-0.0072097,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.87833,0.0067018,-0.0061308,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.72969,0.0066901,0.0076747,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.90599,0.0066548,-0.013791,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.71658,0.0063566,0.02199,0,0
1,GO CARBOHYDRATE TRANSPORT,0.79636,0.0062451,-0.012359,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.4545,0.0061204,-0.028127,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.92682,0.006109,-0.0042122,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.89907,0.0059997,2.3261e-05,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.40843,0.0059277,0.13842,0,0
1,GO STRESS GRANULE ASSEMBLY,0.50337,0.0056795,-0.040202,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.85768,0.0056082,-0.025904,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.87144,0.0054898,-0.0028756,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.80312,0.005413,0.0080829,0,0
1,GO RESPONSE TO ACTIVITY,0.98255,0.0053043,-0.0085919,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.60883,0.0052667,0.0059317,0,0
1,GO REGULATION OF GROWTH,0.49227,0.0047398,0.017903,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.81668,0.004669,0.029124,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.91987,0.0044088,-0.013497,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.52594,0.0043921,0.1047,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.46512,0.0043224,0.088871,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.4598,0.0042774,0.026142,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.86455,0.0041688,-0.025332,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.92682,0.0041034,0.02958,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.76281,0.0040743,-0.026405,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.70355,0.0037594,-0.067066,0,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.50896,0.0036985,0.024025,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.7495,0.0036567,0.047711,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.89907,0.003638,0.012147,0,0
1,GO SEXUAL REPRODUCTION,0.91293,0.0035844,-0.01006,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.37932,0.0035238,0.061249,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.91293,0.0034753,0.01311,0,0
1,GO RESPONSE TO ALCOHOL,0.7495,0.0033393,0.011493,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.48131,0.0032315,-0.043946,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.68418,0.0031032,-0.013812,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.92682,0.0028732,0.016749,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.48131,0.0027542,-0.071282,0,0
1,GO TRANSFERRIN TRANSPORT,0.87833,0.0025796,-0.0080555,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.54321,0.0025742,0.042232,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.87144,0.0023812,-0.011999,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.64605,0.0023355,0.020699,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.98255,0.0020486,0.022188,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.36064,0.0019989,-0.10867,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.8303,0.0018591,0.014393,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.50896,0.001847,-0.049138,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.78962,0.0018253,-0.0072302,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.50337,0.0017137,0.032465,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.4598,0.0016786,-0.025771,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.68418,0.0016093,-0.043408,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.60883,0.0013746,0.026836,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.81668,0.0013543,0.038142,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.58456,0.0011646,0.034758,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.98953,0.0011268,-0.010645,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.52025,0.001082,-0.05958,0,0
1,GO MYELIN ASSEMBLY,0.9686,0.0008571,0.0069164,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.61497,0.00068242,0.042155,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.70355,0.00057775,-0.041697,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.66501,0.00057755,0.013747,0,0
1,GO CENTROSOME SEPARATION,0.4598,0.00036474,0.060103,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.76281,0.00033211,-0.006402,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.60272,0.00023964,0.078655,0,0
1,GO RESPONSE TO ESTRADIOL,0.36526,-9.5826e-05,0.051469,0,0
1,GO GROWTH,0.4598,-0.00016626,0.022693,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.72313,-0.00040442,0.0032055,0,0
1,GO TAXIS,0.70355,-0.00061046,0.004385,0,0
1,GO GLAND DEVELOPMENT,0.66501,-0.00078003,0.027827,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.38408,-0.00081044,0.073382,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.93377,-0.00081968,0.034116,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.89215,-0.00089993,0.0044396,0,0
1,GO REGULATION OF PH,0.85768,-0.00093359,-0.022672,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.67776,-0.0012403,0.044018,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.78289,-0.0013098,0.028026,0,0
1,GO CHEMICAL HOMEOSTASIS,0.48131,-0.001426,-0.031352,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.36991,-0.0016425,0.095713,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.85082,-0.0020996,0.1259,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.98255,-0.0022372,0.026587,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.90599,-0.0022908,0.00053205,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.83713,-0.0023118,-0.001567,0,0
1,GO RESPONSE TO BMP,0.37932,-0.0029235,0.061951,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.91293,-0.0029491,-0.0021528,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.95466,-0.0030207,0.019694,0,0
1,GO METHYLATION,0.89215,-0.0031648,0.0092994,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.84397,-0.0032741,0.0021015,0,0
1,GO HISTONE H2A UBIQUITINATION,0.94073,-0.0033038,0.011208,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.98953,-0.0034376,-0.0125,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.3746,-0.0034603,0.14192,0,0
1,GO BONE CELL DEVELOPMENT,0.88523,-0.0037316,0.020251,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.66501,-0.0039871,-0.023614,0,0
1,GO CELL CELL ADHESION,0.54903,-0.0039883,0.028466,0,0
1,GO RETINA HOMEOSTASIS,0.89215,-0.0040532,0.021468,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.44924,-0.0040554,0.071915,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.60272,-0.0040767,-0.079456,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.66501,-0.0041661,0.036114,0,0
1,GO ENDOCYTIC RECYCLING,0.59059,-0.004168,0.020442,0,0
1,GO RESPONSE TO WATER,0.76281,-0.004231,-0.038924,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.23245,-0.0042729,0.082521,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.52594,-0.0044206,-0.05182,0,0
1,GO MIDBRAIN DEVELOPMENT,0.67776,-0.0046353,0.040386,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.91987,-0.0049831,-0.0051712,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.51459,-0.0052337,0.073301,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.73628,-0.0053613,-0.04001,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.85768,-0.0054953,-0.015108,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.43883,-0.0056576,-0.038395,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.52594,-0.0058327,0.049011,0,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.40843,-0.0058853,0.042445,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.98255,-0.0059212,0.094693,0,0
1,GO RESPONSE TO COLD,0.43883,-0.0061696,-0.082183,0,0
1,GO MYELOID CELL DEVELOPMENT,0.47588,-0.0062296,0.048471,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.67776,-0.0063449,-0.02752,0,0
1,GO GAMETE GENERATION,0.92682,-0.0064943,-0.0084782,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.82348,-0.0065413,0.047941,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.87144,-0.0065943,-0.064226,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.95466,-0.0070428,0.0019057,0,0
1,GO CYTOPLASM ORGANIZATION,0.67137,-0.0071859,0.068042,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.85082,-0.0075936,-0.014006,0,0
1,GO REGULATION OF RNA SPLICING,0.85082,-0.0076035,-0.020755,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.57857,-0.0076971,-0.061278,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.82348,-0.0077819,-0.011961,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.78289,-0.0078851,-0.035943,0,0
1,GO MEIOTIC CELL CYCLE,0.99651,-0.0081022,0.016774,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.58456,-0.0082448,-0.099091,0,0
1,GO CHROMOSOME ORGANIZATION,0.89215,-0.0082947,0.018686,0,0
1,GO SKIN DEVELOPMENT,0.63354,-0.0083337,0.066082,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.2,-0.0084851,-0.056948,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.63354,-0.0085413,-0.010413,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.62732,-0.0085606,0.19772,0,0
1,GO CELL RECOGNITION,0.41842,-0.0086487,-0.037744,0,0
1,GO REGULATION OF MRNA PROCESSING,1,-0.0087996,-0.011833,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.62732,-0.008991,0.076849,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.47049,-0.0090097,0.027883,0,0
1,GO ARTERY MORPHOGENESIS,0.64605,-0.0090165,0.15409,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.62113,-0.0090263,-0.047991,0,0
1,GO CHROMATIN DISASSEMBLY,0.94769,-0.0090502,-0.029476,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.75615,-0.0092098,-0.041589,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.29992,-0.0092463,-0.079582,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.83713,-0.0095472,0.0017006,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.63978,-0.0099767,0.038765,0,0
1,GO REGULATION OF CELLULAR PH,0.8303,-0.0099831,-0.020141,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.5726,-0.010364,0.072476,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.71006,-0.010464,0.031233,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.86455,-0.010744,0.0032702,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.97557,-0.010744,-0.017876,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.67137,-0.010884,0.035065,0,0
1,GO PROSTATE GLAND GROWTH,0.89215,-0.010952,0.11377,0,0
1,GO LIVER MORPHOGENESIS,0.33812,-0.010969,0.09579,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.60272,-0.010973,-0.0068392,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.74288,-0.011045,-0.051806,0,0
1,GO ARACHIDONIC ACID SECRETION,0.24288,-0.011108,-0.12492,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.5726,-0.011143,-0.058942,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.96163,-0.011174,0.0029176,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.77618,-0.011339,-0.010403,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.81668,-0.01138,0.028567,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.98255,-0.011534,-0.0061737,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.80989,-0.011666,-0.042885,0,0
1,GO DNA STRAND ELONGATION,0.48131,-0.011679,-0.060431,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.72313,-0.01189,-0.010737,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.98255,-0.011898,0.025527,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.59059,-0.012553,-0.033464,0,0
1,GO HISTAMINE TRANSPORT,0.95466,-0.012581,-0.01908,0,0
1,GO RESPONSE TO AXON INJURY,0.59664,-0.012632,-0.058038,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.8303,-0.012935,-0.0088626,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.64605,-0.013291,-0.022282,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.78962,-0.013529,-0.021219,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.91293,-0.014035,0.0031476,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.8303,-0.014131,-0.023557,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.48131,-0.014259,-0.052937,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.84397,-0.01429,0.0027912,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.28785,-0.014502,-0.039897,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.85082,-0.014518,-0.010683,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.34702,-0.014565,-0.17637,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.59664,-0.014632,0.045066,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.34702,-0.014722,-0.044405,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.3746,-0.015037,-0.053871,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.7495,-0.01509,0.044652,0,0
1,GO RESPONSE TO SALT,0.93377,-0.015189,-0.031324,0,0
1,GO LIPID PHOSPHORYLATION,0.69061,-0.015309,-0.01878,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.15015,-0.015337,-0.093998,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.7495,-0.015509,-0.014394,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.62732,-0.015514,-0.01272,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.64605,-0.015642,-0.035367,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.43883,-0.015725,-0.037724,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.64605,-0.015995,-0.014184,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.73628,-0.016032,-0.020564,0,0
1,GO OOGENESIS,0.37932,-0.016298,-0.052746,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.81668,-0.01644,0.0116,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.68418,-0.016473,-0.012293,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.81668,-0.016889,-0.016293,0,0
1,GO MICROVILLUS ORGANIZATION,0.16828,-0.017527,-0.14106,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.86455,-0.017624,-0.0078313,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.64605,-0.017739,0.043769,0,0
1,GO QUINONE METABOLIC PROCESS,0.86455,-0.017886,-0.057222,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.66501,-0.017978,0.025234,0,0
1,GO EXPLORATION BEHAVIOR,0.188,-0.018083,-0.18438,0,0
1,GO RENAL ABSORPTION,0.71658,-0.018212,-0.0752,0,0
1,GO DEPHOSPHORYLATION,0.19695,-0.018712,-0.041842,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.62732,-0.018789,-0.0055406,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.50896,-0.018857,-0.038331,0,0
1,GO EPIDERMIS DEVELOPMENT,0.88523,-0.018939,0.030136,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.71006,-0.018951,-0.046145,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.33373,-0.018979,0.094732,0,0
1,GO MITOCHONDRIAL FUSION,0.70355,-0.019718,0.01742,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.64605,-0.01974,0.0046,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.60272,-0.019855,-0.046651,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.64605,-0.01992,-0.026928,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.60272,-0.02013,-0.022545,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.67776,-0.020166,-0.019989,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.91293,-0.020197,0.027579,0,0
1,GO O GLYCAN PROCESSING,0.49227,-0.0203,-0.081292,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.56666,-0.020312,0.05249,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.58456,-0.020313,-0.05755,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.71006,-0.020397,-0.016088,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.092194,-0.020545,-0.086634,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.58456,-0.020551,-0.080963,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.95466,-0.020878,0.027395,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.70355,-0.02117,-0.030832,0,0
1,GO STEROID CATABOLIC PROCESS,0.93377,-0.021345,-0.0030069,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.69707,-0.021517,-0.020205,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.80312,-0.021829,0.01051,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.71658,-0.022322,-0.002741,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.4978,-0.022577,-0.053889,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.75615,-0.023021,-0.014784,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.80312,-0.023111,0.033604,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.7495,-0.023156,-0.014087,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.83713,-0.023216,-0.049945,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.73628,-0.02325,-0.015656,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.83713,-0.023388,0.015652,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.58456,-0.023407,-0.0052944,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.95466,-0.023836,0.033613,0,0
1,GO MANNOSYLATION,0.83713,-0.023953,0.0013586,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.73628,-0.024066,-0.0088206,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.28785,-0.024096,-0.069116,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.50896,-0.025054,0.054981,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.89907,-0.025314,-0.0027465,0,0
1,GO DRUG CATABOLIC PROCESS,0.92682,-0.025323,0.0055237,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.97557,-0.025424,-0.0096454,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.71006,-0.025485,-0.015949,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.41842,-0.025554,-0.039922,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.39858,-0.025592,-0.085292,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.2839,-0.025693,-0.020369,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.76948,-0.02598,-0.013777,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.67776,-0.025982,-0.036674,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.59059,-0.02615,-0.043433,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.36526,-0.026187,-0.01152,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.88523,-0.026223,0.032434,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.43367,-0.026349,-0.019873,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.97557,-0.026367,0.010952,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.19695,-0.026476,-0.050891,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.80989,-0.026693,-0.032038,0,0
1,GO CONVERGENT EXTENSION,0.93377,-0.02683,-0.018285,0,0
1,GO MALE GAMETE GENERATION,0.63978,-0.027407,-0.022103,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.49227,-0.027555,-0.026455,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.47588,-0.027584,-0.068813,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.96163,-0.02777,0.065199,0,0
1,GO DEVELOPMENTAL GROWTH,0.48678,-0.02788,-0.023873,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.37932,-0.02809,-0.069304,0,0
1,GO FUCOSYLATION,0.42855,-0.028117,-0.054106,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.73628,-0.028225,-0.015651,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.5726,-0.028325,-0.02041,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.98255,-0.028413,-0.022667,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.55487,-0.028512,0.023638,0,0
1,GO REGULATION OF AXON GUIDANCE,0.70355,-0.028579,-0.033994,0,0
1,GO MUSCLE CONTRACTION,0.95466,-0.028625,0.00079767,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.80312,-0.028642,-0.018265,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.75615,-0.028692,0.038125,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.42347,-0.028757,-0.10228,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.34702,-0.028854,-0.078019,0,0
1,GO PHOSPHATE ION TRANSPORT,0.43883,-0.02906,-0.038961,0,0
1,GO NEPHRON MORPHOGENESIS,0.89907,-0.029077,0.0089057,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85768,-0.029495,0.0064409,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.3746,-0.029942,-0.0314,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.61497,-0.030069,-0.032568,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.26471,-0.030151,-0.041436,0,0
1,GO HISTAMINE SECRETION,0.71006,-0.030177,0.027052,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.20621,-0.030278,-0.0678,0,0
1,GO THYMIC T CELL SELECTION,0.32938,-0.030702,-0.040708,0,0
1,GO SECONDARY METABOLIC PROCESS,0.89907,-0.030768,-0.022526,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.65866,-0.031144,-0.01414,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.24643,-0.031185,-0.043933,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.57857,-0.03131,-0.043524,0,0
1,GO EXIT FROM MITOSIS,0.67137,-0.031313,-0.017022,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.62113,-0.031325,-0.026722,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.72969,-0.031508,-0.024281,0,0
1,GO AMINO ACID IMPORT,0.84397,-0.031533,0.025312,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.43883,-0.031685,-0.030382,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.25001,-0.031744,-0.11986,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.38408,-0.031894,-0.064191,0,0
1,GO GLIOGENESIS,0.41341,-0.031936,-0.038644,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.22905,-0.032118,-0.053235,0,0
1,GO LYSOSOME LOCALIZATION,0.17099,-0.032155,-0.065942,0,0
1,GO ORGANELLE LOCALIZATION,0.12689,-0.032192,-0.042771,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.23245,-0.032297,-0.13011,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.33812,-0.032433,-0.10839,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.74288,-0.032499,0.00060007,0,0
1,GO AORTA MORPHOGENESIS,0.85768,-0.032652,0.094409,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.60883,-0.032654,-0.0051553,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.82348,-0.032688,-0.013762,0,0
1,GO ANION TRANSPORT,0.076492,-0.032926,-0.060701,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.27999,-0.033052,-0.022352,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.053746,-0.033326,-0.095545,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.25729,-0.033559,-0.074859,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.35607,-0.033621,-0.04704,0,0
1,GO MICROTUBULE BASED PROCESS,0.28785,-0.033714,-0.046447,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.64605,-0.033775,-0.040117,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.27227,-0.034082,-0.052255,0,0
1,GO BLASTOCYST DEVELOPMENT,0.36991,-0.034196,-0.027044,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.76281,-0.034212,0.015742,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.60883,-0.034276,-0.0021771,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.56666,-0.034279,-0.010024,0,0
1,GO PIGMENTATION,0.53167,-0.034285,-0.0083979,0,0
1,GO ORGANIC ANION TRANSPORT,0.10845,-0.034407,-0.061195,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.23589,-0.034513,-0.11512,0,0
1,GO GLIAL CELL PROLIFERATION,0.91987,-0.034647,0.0081238,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.25729,-0.034795,-0.12381,0,0
1,GO MOLTING CYCLE,0.7495,-0.035489,0.035762,0,0
1,GO B CELL HOMEOSTASIS,0.79636,-0.035535,-0.023037,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.9686,-0.035647,0.0026906,0,0
1,GO BONE MATURATION,0.67137,-0.035674,-0.063964,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.99651,-0.035803,0.0025202,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,1,-0.03597,-0.0080381,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.47588,-0.035984,-0.024128,0,0
1,GO DOSAGE COMPENSATION,0.80312,-0.036021,0.00021757,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.81668,-0.036289,-0.0072644,0,0
1,GO TOR SIGNALING,0.22905,-0.036307,-0.031867,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.75615,-0.036354,-0.0035082,0,0
1,GO MAGNESIUM ION TRANSPORT,0.36991,-0.036399,-0.050488,0,0
1,GO NUCLEOSOME ORGANIZATION,0.34256,-0.036484,-0.03717,0,0
1,GO INORGANIC ANION TRANSPORT,0.14526,-0.03659,-0.056228,0,0
1,GO REPLICATION FORK PROCESSING,0.98953,-0.036658,0.047137,0,0
1,GO CELL GROWTH,0.57857,-0.036691,-0.020614,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.86455,-0.036699,0.04866,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.24643,-0.036705,0.13499,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.29184,-0.036839,-0.032219,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.48678,-0.036863,-0.040032,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.94073,-0.036998,0.025285,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.35153,-0.037118,-0.083819,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.72969,-0.037282,-0.030385,0,0
1,GO RESPONSE TO FATTY ACID,0.53742,-0.037439,-0.01432,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.78289,-0.037509,0.034153,0,0
1,GO CELL CYCLE DNA REPLICATION,0.35153,-0.037617,-0.057747,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.28785,-0.037661,-0.072546,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.4598,-0.037777,-0.045085,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.53167,-0.037998,-0.088096,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.74288,-0.038168,-0.019381,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.97557,-0.038251,0.047128,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.59664,-0.038418,0.002621,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.35153,-0.038515,-0.027955,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.25001,-0.038547,-0.12634,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.54321,-0.038618,-0.069517,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.91293,-0.038638,0.02277,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.28785,-0.038727,-0.067946,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.088862,-0.03907,-0.084073,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.70355,-0.039337,-0.011008,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.67137,-0.039457,-0.0082941,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.46512,-0.039826,-0.046785,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.36064,-0.040137,-0.053829,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.30402,-0.040306,-0.01956,0,0
1,GO SEX DIFFERENTIATION,0.41341,-0.040545,-0.017574,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.40349,-0.041295,-0.045877,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.83713,-0.041782,-0.016929,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.76948,-0.041972,0.070597,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.36526,-0.042022,-0.087922,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.15015,-0.042151,-0.07012,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.69707,-0.042182,0.032824,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.019739,-0.04239,-0.069011,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.95466,-0.042494,0.025405,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.91293,-0.04261,0.015638,0,0
1,GO RESPONSE TO GLUCAGON,0.26098,-0.042652,-0.060853,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.78289,-0.042724,0.02626,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.13355,-0.042849,-0.059129,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.62113,-0.042896,0.00077947,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.22235,-0.042962,-0.057546,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.78289,-0.043003,-0.01095,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.98255,-0.043381,0.016424,0,0
1,GO NODAL SIGNALING PATHWAY,0.96163,-0.043425,0.0088906,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.43367,-0.043481,-0.053785,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.60272,-0.043629,-0.011033,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.80989,-0.043719,0.0024549,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.69061,-0.044343,-0.027776,0,0
1,GO ORGANELLE FUSION,0.25001,-0.044513,-0.061182,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.23245,-0.044603,-0.072232,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.86455,-0.044928,0.098573,0,0
1,GO T CELL SELECTION,0.65234,-0.045103,-0.0021735,0,0
1,GO SPERM MOTILITY,0.13583,-0.045486,-0.081155,0,0
1,GO DNA PACKAGING,0.74288,-0.045514,-0.014861,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.15264,-0.04558,-0.079176,0,0
1,GO MALE MEIOSIS I,0.50896,-0.046327,-0.059663,0,0
1,GO NUCLEOSOME ASSEMBLY,0.24288,-0.046331,-0.064015,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.4978,-0.046362,-0.0026856,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.91987,-0.046363,-0.012062,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.16032,-0.046467,-0.13173,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.70355,-0.046627,0.0043261,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.39371,-0.046698,-0.036573,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.16032,-0.046922,-0.044143,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.34256,-0.047119,-0.038944,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.83713,-0.047212,0.043512,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.5726,-0.047223,-0.053657,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.44924,-0.047361,-0.081241,0,0
1,GO REGULATION OF OOGENESIS,0.19695,-0.047537,-0.04835,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.18508,-0.04755,-0.063384,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.94769,-0.047591,0.026627,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.12049,-0.04773,-0.071078,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.21256,-0.047754,-0.13957,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.69061,-0.047763,-0.022582,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.44924,-0.047826,-0.014528,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.86455,-0.048364,0.011382,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.19393,-0.048468,-0.078664,0,0
1,GO PENILE ERECTION,0.43883,-0.048603,-0.070184,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.50896,-0.04867,-0.085635,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.34256,-0.048789,-0.039323,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.14526,-0.048838,-0.09161,0,0
1,GO BICARBONATE TRANSPORT,0.91987,-0.049155,-0.011493,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.20309,-0.049405,-0.078699,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.1313,-0.049848,-0.074372,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.67776,-0.050351,-0.0066287,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.1028,-0.050393,-0.079946,0,0
1,GO SEGMENTATION,0.27611,-0.050552,-0.043182,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.99651,-0.050655,-0.00075242,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.8303,-0.051146,-0.011412,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.59664,-0.051167,-0.04443,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.97557,-0.05169,0.030461,0,0
1,GO STEROID HORMONE SECRETION,0.43883,-0.051888,-0.077359,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.81668,-0.051899,0.015965,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.11434,-0.052054,-0.091691,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.67137,-0.052154,-0.026747,0,0
1,GO ECTODERM DEVELOPMENT,0.40843,-0.052218,-0.013143,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.48678,-0.05228,-0.048237,0,0
1,GO MICROTUBULE SEVERING,0.16559,-0.052549,-0.10374,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.2839,-0.052592,-0.057995,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.44924,-0.052741,-0.0062173,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.057089,-0.052999,-0.08496,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.13814,-0.053005,-0.10911,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.34256,-0.053061,-0.020964,0,0
1,GO RESPONSE TO STARVATION,0.30402,-0.053148,-0.053693,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.91987,-0.053151,0.050762,0,0
1,GO NEUROBLAST PROLIFERATION,0.14769,-0.053249,-0.14088,0,0
1,GO BONE MINERALIZATION,0.98255,-0.053947,0.047945,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.29992,-0.054139,-0.08117,0,0
1,GO AUTOPHAGIC CELL DEATH,0.74288,-0.054549,-0.020179,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.49227,-0.054887,-0.079112,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.40843,-0.054984,-0.044084,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.9686,-0.05515,0.023112,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.29992,-0.055292,-0.05678,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.72313,-0.05554,0.024114,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.39371,-0.05556,-0.11916,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.17934,-0.055667,-0.2181,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.90599,-0.056078,0.073316,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.87833,-0.056093,-0.0051371,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.96163,-0.056099,0.091617,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.19095,-0.056211,-0.10041,0,0
1,GO AXON EXTENSION,0.25363,-0.056545,-0.061772,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.8303,-0.05665,0.011632,0,0
1,GO GERM CELL DEVELOPMENT,0.13814,-0.057315,-0.065707,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.57857,-0.057461,-0.054646,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.18219,-0.057844,-0.048603,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.72313,-0.058152,-0.011485,0,0
1,GO MEMBRANE DOCKING,0.15264,-0.058383,-0.062988,0,0
1,GO CILIUM MOVEMENT,0.17934,-0.058436,-0.073944,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.084046,-0.05852,-0.069423,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.17934,-0.058692,-0.066222,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.65866,-0.059068,-0.00039944,0,0
1,GO REGULATION OF BONE REMODELING,0.49227,-0.059218,-0.048201,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.057089,-0.059317,-0.12389,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.4598,-0.059438,-0.087567,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.044685,-0.059738,-0.081665,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.095625,-0.059858,-0.10517,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.69707,-0.060035,-0.0099764,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.54903,-0.060146,-0.031909,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.5726,-0.060483,-0.042305,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.90599,-0.060544,0.064327,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.97557,-0.06067,0.024355,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.52594,-0.061075,0.0012078,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.27611,-0.06119,-0.060799,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.16828,-0.061269,-0.18182,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.24643,-0.061341,-0.099601,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.38408,-0.061397,-0.015052,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.064293,-0.061545,-0.067646,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.31653,-0.061591,-0.085804,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.53742,-0.062118,-0.033836,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.71658,-0.062254,-0.024227,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0087944,-0.062265,-0.1324,0,0
1,GO ER OVERLOAD RESPONSE,0.71658,-0.062297,0.042622,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.41842,-0.062347,-0.041639,0,0
1,GO HEART VALVE FORMATION,0.75615,-0.062533,-0.040918,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.38888,-0.062555,-0.011657,0,0
1,GO REGULATION OF FERTILIZATION,0.12908,-0.062559,-0.11965,0,0
1,GO SPLEEN DEVELOPMENT,0.68418,-0.063439,0.00060793,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.04854,-0.063666,-0.076022,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.32077,-0.063669,-0.10789,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.60883,-0.063895,-0.019318,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.52594,-0.063911,-0.020971,0,0
1,GO REGULATION OF ODONTOGENESIS,0.52025,-0.064309,-0.038761,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.37932,-0.064487,-0.10628,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.12049,-0.064569,-0.090852,0,0
1,GO ADULT HEART DEVELOPMENT,0.50896,-0.06472,-0.081244,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.63354,-0.064867,-0.01821,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.35607,-0.065127,-0.055918,0,0
1,GO HISTONE H3 K36 METHYLATION,0.35607,-0.065263,-0.07428,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.20621,-0.065394,-0.1336,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.18508,-0.065431,-0.093965,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.69061,-0.065452,-0.02799,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.099158,-0.06573,-0.17541,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.18508,-0.065883,-0.068667,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.60883,-0.065934,-0.05268,0,0
1,GO LOCOMOTOR RHYTHM,0.62113,-0.06598,-0.033193,0,0
1,GO PRO B CELL DIFFERENTIATION,0.69707,-0.065984,0.018873,0,0
1,GO CHROMATIN ORGANIZATION,0.10096,-0.066084,-0.037135,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.16828,-0.066207,-0.070591,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.56666,-0.066338,0.00060668,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.037747,-0.066695,-0.073389,0,0
1,GO RESPONSE TO METAL ION,0.23245,-0.067214,-0.048356,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.42855,-0.06735,-0.056797,0,0
1,GO REGULATION OF DNA METHYLATION,0.66501,-0.068081,-0.025086,0,0
1,GO RESPONSE TO CALCIUM ION,0.14048,-0.068426,-0.082632,0,0
1,GO POSITIVE T CELL SELECTION,0.53167,-0.068427,0.012906,0,0
1,GO CGMP MEDIATED SIGNALING,0.40349,-0.068463,-0.069897,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.50896,-0.068519,-0.056798,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.16828,-0.068727,-0.11213,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.1313,-0.068985,-0.059091,0,0
1,GO RESPONSE TO ETHANOL,0.090515,-0.069333,-0.074764,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.24288,-0.069402,-0.1277,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.085627,-0.069727,-0.1054,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.049546,-0.069731,-0.086488,0,0
1,GO DRINKING BEHAVIOR,0.11636,-0.069884,-0.15394,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.53742,-0.070081,-0.045611,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.14769,-0.071487,-0.047446,0,0
1,GO PHAGOSOME MATURATION,0.49227,-0.071674,-0.044439,0,0
1,GO ALANINE TRANSPORT,0.29184,-0.071805,-0.071139,0,0
1,GO CARDIAC CHAMBER FORMATION,0.28785,-0.072027,-0.22123,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.43883,-0.072524,-0.014419,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.23245,-0.072584,-0.038253,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.15264,-0.073135,-0.037199,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.52594,-0.07314,-0.0039667,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.33812,-0.073261,-0.05396,0,0
1,GO CILIUM ORGANIZATION,0.39371,-0.073395,-0.030184,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.75615,-0.073401,-0.003451,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.13583,-0.073532,-0.13799,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.079444,-0.073921,-0.23467,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.96163,-0.074351,0.048639,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.11235,-0.074545,-0.076481,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.188,-0.074548,-0.097516,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.25001,-0.074794,-0.089449,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.41341,-0.074809,-0.078759,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.14526,-0.074905,-0.045584,0,0
1,GO OOCYTE DIFFERENTIATION,0.041093,-0.075075,-0.10054,0,0
1,GO SISTER CHROMATID COHESION,0.2839,-0.075287,-0.054706,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.66501,-0.07591,-0.014349,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.70355,-0.076207,-0.04155,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.061812,-0.076311,-0.065636,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.19695,-0.076383,-0.056783,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.43883,-0.076904,-0.018163,0,0
1,GO PARTURITION,0.32506,-0.076936,-0.10397,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.10845,-0.077231,-0.14187,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.066855,-0.077237,-0.10551,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.011904,-0.077314,-0.12933,0,0
1,GO LIPID EXPORT FROM CELL,0.76948,-0.07733,-0.024862,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.49227,-0.077693,-0.024802,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.17099,-0.077801,-0.076108,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.93377,-0.078343,0.036251,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.36064,-0.078382,-0.061532,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.12259,-0.07856,-0.061904,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.087232,-0.07863,-0.092309,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.19695,-0.078727,-0.026873,0,0
1,GO T CELL HOMEOSTASIS,0.020205,-0.079005,-0.10032,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.69707,-0.079157,-0.021451,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.047551,-0.079161,-0.16824,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.14285,-0.079319,-0.19046,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.59059,-0.079617,0.053799,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.068167,-0.080177,-0.08812,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.21256,-0.080272,-0.17929,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.36064,-0.080312,-0.039667,0,0
1,GO WATER TRANSPORT,0.099158,-0.080515,-0.089799,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.21579,-0.080649,-0.093872,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.44924,-0.081144,-0.061212,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.12049,-0.081287,-0.13403,0,0
1,GO CELL MORPHOGENESIS,0.02268,-0.081443,-0.099907,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.054842,-0.081699,-0.1591,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.082489,-0.082039,-0.15519,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.31232,-0.082078,-0.049701,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.079444,-0.082348,-0.09215,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.21905,-0.082909,-0.076755,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.11039,-0.082987,-0.055844,0,0
1,GO SARCOMERE ORGANIZATION,0.99651,-0.083021,0.035287,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.27227,-0.083063,-0.045535,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.093897,-0.083147,-0.095843,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.98255,-0.08354,0.054347,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.82348,-0.083567,0.0030818,0,0
1,GO L AMINO ACID TRANSPORT,0.38408,-0.083583,-0.01069,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.81668,-0.083613,0.023245,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.25001,-0.083642,-0.15491,0,0
1,GO BRAIN MORPHOGENESIS,0.10845,-0.083676,-0.11533,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.14048,-0.083706,-0.13226,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.43883,-0.0838,-0.057705,0,0
1,GO CELL JUNCTION ASSEMBLY,0.16294,-0.083981,-0.054386,0,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.054842,-0.084312,-0.10003,0,0
1,GO INCLUSION BODY ASSEMBLY,0.48131,-0.084572,-0.098912,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.64605,-0.084665,0.0007794,0,0
1,GO LYMPH NODE DEVELOPMENT,0.82348,-0.085721,0.041609,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.40843,-0.086054,-0.033882,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.11636,-0.086063,-0.07277,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.93377,-0.08608,-0.0044738,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.62113,-0.086561,-0.040413,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.027803,-0.086693,-0.12092,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.055956,-0.086815,-0.074535,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.47049,-0.086837,-0.051335,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.052669,-0.086851,-0.10161,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.052669,-0.087115,-0.085475,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.22905,-0.087538,-0.077279,0,0
1,GO SPERM CAPACITATION,0.21579,-0.088133,-0.085336,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.0022332,-0.088996,-0.10461,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.15264,-0.089143,-0.1918,0,0
1,GO PROTEIN MANNOSYLATION,0.50337,-0.089182,-0.042939,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.0083534,-0.089349,-0.12377,0,0
1,GO NEURON DEATH,0.024846,-0.089457,-0.073964,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.47588,-0.089999,-0.041969,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.42347,-0.090271,-0.018715,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.59059,-0.090305,-0.010913,0,0
1,GO VESICLE LOCALIZATION,0.020205,-0.090324,-0.072827,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.33812,-0.090487,-0.056649,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.76948,-0.090493,-0.0071879,0,0
1,GO PROTEIN ACYLATION,0.0021689,-0.090652,-0.095335,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.71006,-0.09078,-0.0058472,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.10654,-0.090966,-0.0974,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.23937,-0.090985,-0.025232,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.12473,-0.091017,-0.078541,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.044685,-0.091035,-0.087959,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.5726,-0.091627,-0.08813,0,0
1,GO DEMETHYLATION,0.12473,-0.092298,-0.039555,0,0
1,GO EYE MORPHOGENESIS,0.47588,-0.092318,-0.02849,0,0
1,GO CHROMATIN REMODELING,0.10465,-0.092353,-0.07171,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.89215,-0.092564,0.088719,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.4545,-0.092844,-0.075049,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.15015,-0.092866,-0.18455,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.23589,-0.093022,-0.094808,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0099891,-0.09313,-0.098889,0,0
1,GO PROTEIN NITROSYLATION,0.20621,-0.09324,-0.15311,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.188,-0.093476,-0.088724,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.14048,-0.093904,-0.088856,0,0
1,GO VASODILATION,0.47049,-0.094248,-0.090806,0,0
1,GO EAR MORPHOGENESIS,0.068167,-0.095117,-0.10558,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.188,-0.095186,-0.064168,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.097379,-0.095333,-0.17749,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.67137,-0.095541,-0.0038278,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.30815,-0.095809,-0.062299,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.19695,-0.095895,-0.067772,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.27611,-0.096039,-0.027311,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.17374,-0.096343,-0.063815,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.068167,-0.096597,-0.11057,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.15264,-0.096796,-0.082538,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.024288,-0.09704,-0.11421,0,0
1,GO LONG TERM MEMORY,0.11636,-0.097207,-0.13103,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.35153,-0.097427,-0.12847,0,0
1,GO CHROMATIN SILENCING,0.33373,-0.097818,-0.02568,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.10845,-0.097832,-0.17375,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.13355,-0.09784,-0.10833,0,0
1,GO ESTROUS CYCLE,0.83713,-0.098024,-0.0095659,0,0
1,GO FEAR RESPONSE,0.0042883,-0.098196,-0.16034,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.87833,-0.098375,0.010752,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.35153,-0.098628,-0.040223,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.188,-0.098907,-0.15468,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.035393,-0.099015,-0.11103,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.52025,-0.099121,-0.056637,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.018836,-0.099387,-0.085167,0,0
1,GO RECEPTOR CLUSTERING,0.019283,-0.099931,-0.16666,0,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.050569,-0.10048,-0.097338,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.59059,-0.10048,-0.034434,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0099891,-0.10056,-0.13147,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.29184,-0.10061,-0.074005,0,0
1,GO MITOTIC DNA REPLICATION,0.20309,-0.10061,-0.077854,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.011612,-0.10065,-0.1016,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.037747,-0.10086,-0.11907,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.50896,-0.10114,-0.041187,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.087232,-0.10116,-0.073298,0,0
1,GO MATING,0.0056288,-0.10132,-0.13904,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.65234,-0.10159,-0.0097537,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.073629,-0.10181,-0.13592,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.20309,-0.102,-0.050595,0,0
1,GO DIET INDUCED THERMOGENESIS,0.029719,-0.102,-0.16282,0,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.0079323,-0.1024,-0.13468,0,0
1,GO RENAL SODIUM EXCRETION,0.17934,-0.10246,-0.081013,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.63354,-0.10264,-0.056868,0,0
1,GO AXO DENDRITIC TRANSPORT,0.024288,-0.10283,-0.16224,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.56666,-0.10348,-0.055998,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.32506,-0.1035,-0.11084,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.016734,-0.10376,-0.10022,0,0
1,GO RENAL SYSTEM PROCESS,0.073629,-0.10402,-0.093234,0,0
1,GO NEURAL CREST FORMATION,0.33373,-0.10437,-0.063791,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.034637,-0.10445,-0.088704,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0079323,-0.10466,-0.15295,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.17653,-0.10485,-0.010383,0,0
1,GO ANIMAL ORGAN MATURATION,0.36991,-0.10489,-0.055698,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.23937,-0.10508,-0.12523,0,0
1,GO PLASMA MEMBRANE REPAIR,0.4978,-0.10546,-0.15962,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.2839,-0.10567,-0.043626,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0094949,-0.10647,-0.10085,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.042857,-0.10652,0.031384,0,0
1,GO MYOFIBRIL ASSEMBLY,0.7495,-0.10655,0.028381,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.02068,-0.10678,-0.076923,0,0
1,GO MESONEPHROS DEVELOPMENT,0.50337,-0.10682,-0.016956,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.32506,-0.10685,-0.07932,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.05824,-0.10704,-0.17927,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.15015,-0.10753,-0.035681,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.65234,-0.10774,-0.0012255,0,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.00063551,-0.1079,-0.13698,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.35153,-0.10913,-0.071636,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.14526,-0.10936,-0.12395,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.32506,-0.10957,-0.072539,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.015574,-0.10957,-0.15904,0,0
1,GO METAL ION TRANSPORT,0.00067758,-0.10961,-0.12013,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.02166,-0.10977,-0.13886,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.026586,-0.10987,-0.12638,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.064293,-0.10988,-0.10092,0,0
1,GO CALCIUM ION IMPORT,0.0094949,-0.11039,-0.1579,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.44924,-0.1104,-0.070755,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.10096,-0.11053,-0.075481,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.0695,-0.1109,-0.1055,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.063042,-0.11101,-0.095789,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.67776,-0.11101,-0.089392,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.17934,-0.11101,-0.087769,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.092194,-0.11188,-0.10972,0,0
1,GO G0 TO G1 TRANSITION,0.084046,-0.11201,-0.069104,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.77618,-0.11202,-0.0017604,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.016734,-0.11219,-0.10627,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.007729,-0.11239,-0.10751,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.04854,-0.1126,-0.14773,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.34702,-0.113,-0.049548,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.0079323,-0.11349,-0.12444,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.04854,-0.11367,-0.11792,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.188,-0.11388,-0.17143,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.15773,-0.11395,-0.066073,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.2,-0.11404,-0.027882,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.21905,-0.11406,-0.058333,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.073629,-0.11409,-0.085846,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.072231,-0.11411,-0.12888,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.20309,-0.11437,0.056045,0,0
1,GO CELL PROJECTION ORGANIZATION,0.001872,-0.11446,-0.12321,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.188,-0.11457,-0.048862,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.52594,-0.11458,-0.078544,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.20309,-0.11469,-0.073989,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.12908,-0.11504,-0.14883,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.077957,-0.11557,-0.12731,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.23245,-0.11564,-0.069154,0,0
1,GO MEMBRANE REPOLARIZATION,0.066855,-0.11565,-0.12642,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0094949,-0.11566,-0.10305,0,0
1,GO EXCRETION,0.047551,-0.11579,-0.087014,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.04854,-0.11586,-0.048869,0,0
1,GO HORMONE CATABOLIC PROCESS,0.29586,-0.11588,-0.10786,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0033369,-0.11593,-0.13866,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.064293,-0.11596,-0.061271,0,0
1,GO GDP METABOLIC PROCESS,0.082489,-0.11608,-0.20584,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.3746,-0.11638,-0.032091,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.25001,-0.11652,-0.11777,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.042857,-0.11683,-0.11973,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.23937,-0.11683,-0.10361,0,0
1,GO SPERMATID DIFFERENTIATION,0.15773,-0.11684,-0.068472,0,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.16032,-0.11725,0.0016438,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00074557,-0.11788,-0.10704,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.079444,-0.11795,-0.24446,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.36064,-0.11804,-0.099407,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.027803,-0.11815,-0.18312,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.24288,-0.11869,-0.07458,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.37932,-0.1188,-0.038784,0,0
1,GO TORC1 SIGNALING,0.0081404,-0.11925,-0.094519,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.20621,-0.11937,-0.074402,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.090515,-0.11958,-0.13756,0,0
1,GO COLLATERAL SPROUTING,0.13814,-0.11966,-0.097956,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.22568,-0.11979,-0.11769,0,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.0037331,-0.12019,-0.12641,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.54321,-0.12033,-0.039187,0,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.049546,-0.12037,-0.11142,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.013139,-0.12068,-0.16056,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.061812,-0.12082,-0.13904,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.28785,-0.12089,-0.055192,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.21905,-0.12127,-0.12763,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.076492,-0.12162,-0.18983,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.090515,-0.12193,-0.13509,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.15264,-0.12193,-0.10871,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.018836,-0.12279,-0.14846,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.42347,-0.12319,-0.082312,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.42855,-0.1238,-0.09326,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.49227,-0.12418,-0.098133,0,0
1,GO MICROTUBULE POLYMERIZATION,0.007729,-0.12438,-0.16608,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.066855,-0.12476,-0.098777,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.036164,-0.12548,-0.092887,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.035393,-0.12554,-0.12526,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.2,-0.12582,-0.10981,0,0
1,GO OXIDATIVE DEMETHYLATION,0.035393,-0.12586,-0.11301,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00018427,-0.12588,-0.1607,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.001662,-0.12597,-0.14211,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.059411,-0.12608,-0.16087,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0040578,-0.1264,-0.12114,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.53167,-0.12683,0.083121,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.19095,-0.12693,-0.1006,0,0
1,GO NEURON APOPTOTIC PROCESS,0.00026003,-0.12694,-0.13516,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.073629,-0.12712,-0.12098,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.15264,-0.12726,-0.065973,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.23937,-0.12731,-0.067625,0,0
1,GO RESPONSE TO INACTIVITY,0.32938,-0.12786,-0.08074,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.4598,-0.12799,-0.015375,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.12908,-0.12812,-0.081302,0,0
1,GO SOMITE DEVELOPMENT,0.0046564,-0.12833,-0.12264,0,0
1,GO DEVELOPMENTAL INDUCTION,0.068167,-0.1284,-0.12147,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.41842,-0.12842,-0.054253,0,0
1,GO HISTONE METHYLATION,0.0083534,-0.1288,-0.11602,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.19095,-0.12915,-0.14834,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0087944,-0.12953,-0.13939,0,0
1,GO PROTEIN DEMETHYLATION,0.027188,-0.12964,-0.15017,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.29586,-0.12975,-0.061497,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.04854,-0.12977,-0.1475,0,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0030654,-0.12998,-0.14728,0,0
1,GO MATING BEHAVIOR,0.015203,-0.1301,-0.17321,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.17653,-0.1303,-0.20649,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.32506,-0.1307,-0.08739,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.11636,-0.13201,-0.18162,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.041967,-0.13205,-0.10298,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.50337,-0.13213,-0.099606,0,0
1,GO PHOTOTRANSDUCTION,0.0083534,-0.13223,-0.0063118,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.10465,-0.13228,-0.077969,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.0027346,-0.1323,-0.1129,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.27999,-0.13254,-0.10079,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.25363,-0.13269,-0.086535,0,0
1,GO PEPTIDYL LYSINE METHYLATION,0.014138,-0.13344,-0.11704,0,0
1,GO GLUTAMATE METABOLIC PROCESS,0.03939,-0.13367,-0.11017,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.031059,-0.13383,-0.14462,0,0
1,GO RESPONSE TO ETHER,0.049546,-0.13433,-0.14977,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.016339,-0.13448,-0.11277,0,0
1,GO HEART INDUCTION,0.76948,-0.13451,-0.011133,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.027803,-0.13459,-0.10749,0,0
1,GO CELL CELL SIGNALING,4.3218e-05,-0.13532,-0.1469,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.32506,-0.13551,-0.045029,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.13355,-0.13555,-0.33321,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.099158,-0.13591,-0.077009,0,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0066042,-0.13595,-0.14962,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.93377,-0.13622,0.050026,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.36526,-0.1364,-0.057119,0,0
1,GO RESPONSE TO FUNGUS,0.070855,-0.13641,-0.11699,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.16294,-0.13661,-0.15365,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.033894,-0.13672,-0.11533,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.019739,-0.13672,-0.12103,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.11039,-0.13722,-0.10236,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.03939,-0.13737,-0.12729,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0071468,-0.13832,-0.16383,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00072223,-0.13856,-0.19567,0,0
1,GO KIDNEY MORPHOGENESIS,0.19393,-0.13888,-0.058107,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.14285,-0.13889,-0.080852,0,0
1,GO FEVER GENERATION,0.20309,-0.13906,-0.00035661,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.029719,-0.13935,-0.19695,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.14048,-0.13938,-0.083844,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.082489,-0.13989,-0.16831,0,0
1,GO METANEPHROS MORPHOGENESIS,0.34256,-0.14022,-0.089497,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12049,-0.14063,-0.087148,0,0
1,GO CELL JUNCTION ORGANIZATION,0.0038387,-0.1408,-0.12358,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.34256,-0.14086,-0.081892,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29184,-0.14118,-0.10249,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.0033369,-0.14161,-0.17382,0,0
1,GO SOMITOGENESIS,0.014138,-0.14167,-0.094754,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.87144,-0.14186,0.03341,0,0
1,GO DENDRITE SELF AVOIDANCE,0.15015,-0.142,-0.13189,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.084046,-0.14237,-0.1193,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0013457,-0.14295,-0.21026,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.040234,-0.14331,-0.15171,0,0
1,GO REGULATION OF BEHAVIOR,0.00353,-0.14395,-0.16699,0,0
1,GO REGULATION OF EXCRETION,0.14769,-0.14403,-0.10693,0,0
1,GO SENSORY PERCEPTION OF TASTE,0.020205,-0.14452,-0.1105,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.046579,-0.14473,-0.13742,0,0
1,GO RESPONSE TO VITAMIN D,0.32506,-0.14476,-0.10132,0,0
1,GO V D J RECOMBINATION,0.22235,-0.14638,-0.073103,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.47049,-0.14659,-0.095162,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.050569,-0.14668,-0.21225,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.14526,-0.14683,-0.13596,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.87144,-0.1472,0.038082,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00019753,-0.14738,-0.16096,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0097392,-0.14739,-0.19655,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.076492,-0.1476,-0.10874,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.15773,-0.14852,-0.07956,0,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.03939,-0.14872,-0.14455,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.32506,-0.14897,-0.050749,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.012508,-0.14911,-0.1264,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,-0.15031,-0.089904,0,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00095906,-0.15052,-0.16045,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.11039,-0.15082,-0.10319,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.22568,-0.15129,-0.14025,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.14526,-0.15141,-0.081532,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0036303,-0.15193,-0.15378,0,0
1,GO DIVALENT METAL ION EXPORT,0.35607,-0.15207,-0.081883,0,0
1,GO DEVELOPMENTAL CELL GROWTH,0.00049035,-0.15211,-0.17905,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.077957,-0.15309,-0.21139,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.16294,-0.15312,-0.14879,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.070855,-0.15359,-0.1134,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.004408,-0.15387,-0.18226,0,0
1,GO INNER EAR MORPHOGENESIS,0.012203,-0.15486,-0.16394,0,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0015189,-0.15499,-0.17876,0,0
1,GO RENAL WATER HOMEOSTASIS,0.0047853,-0.15511,-0.1392,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.092194,-0.15531,-0.087417,0,0
1,GO AXONEME ASSEMBLY,0.05824,-0.15541,-0.16399,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.093897,-0.15547,-0.05491,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.17653,-0.15595,-0.052181,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.15015,-0.156,-0.13964,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.16559,-0.1563,-0.097286,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.073629,-0.15695,-0.14762,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0059384,-0.15702,-0.13128,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.05161,-0.15705,-0.15583,0,0
1,GO AXONAL TRANSPORT,0.0067808,-0.1574,-0.20811,0,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0031536,-0.15749,-0.12067,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.0695,-0.15787,-0.10005,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.41842,-0.15797,-0.069871,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.092194,-0.15816,-0.17211,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.073629,-0.1585,-0.1604,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.16032,-0.15976,-0.15513,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.16032,-0.15991,-0.087194,0,0
1,GO DETECTION OF LIGHT STIMULUS,0.00052342,-0.16027,-0.054252,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.0024367,-0.16034,-0.14932,0,0
1,GO INTRACILIARY TRANSPORT,0.24643,-0.16048,-0.10512,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.23245,-0.16056,-0.091678,0,0
1,GO REGIONALIZATION,0.05824,-0.161,-0.12042,0,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00014935,-0.16116,-0.15235,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.20621,-0.16129,-0.082871,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00030804,-0.16145,-0.15406,0,0
1,GO REGULATION OF SYSTEM PROCESS,4.3218e-05,-0.16164,-0.16636,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.12259,-0.16172,-0.063644,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.015203,-0.16218,-0.15839,0,0
1,GO PROTEIN METHYLATION,0.011326,-0.16261,-0.11808,0,0
1,GO COPULATION,0.11434,-0.16357,-0.11847,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.041967,-0.16428,-0.13018,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.011612,-0.16461,-0.14476,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.32077,-0.16504,-0.0033195,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.088862,-0.16535,-0.1281,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.016734,-0.16571,-0.17652,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.57857,-0.16601,-0.033496,0,0
1,GO HISTONE H4 ACETYLATION,0.001228,-0.1661,-0.14621,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0012662,-0.16618,-0.17768,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.00029782,-0.16622,-0.16811,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.25363,-0.16646,-0.050017,0,0
1,GO REGULATION OF GLIOGENESIS,0.0094949,-0.16718,-0.13294,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.015203,-0.1677,-0.17912,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.014138,-0.16786,-0.16417,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.072231,-0.1679,-0.22108,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.36526,-0.16816,-0.050638,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.065563,-0.16838,-0.18589,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.014841,-0.16855,-0.16051,0,0
1,GO CATION TRANSMEMBRANE TRANSPORT,9.389e-05,-0.16855,-0.15221,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.042857,-0.16881,-0.21909,0,0
1,GO HISTONE H4 K16 ACETYLATION,0.0014299,-0.16885,-0.22533,0,0
1,GO GASTRIC ACID SECRETION,0.27611,-0.16948,-0.067903,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.033894,-0.16962,-0.17267,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.28785,-0.16962,-0.081048,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.057089,-0.17023,-0.09803,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.076492,-0.17029,-0.091629,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.050569,-0.17125,-0.15375,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0069616,-0.17137,-0.21163,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.011047,-0.17195,-0.15559,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.79636,-0.17285,-0.039115,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.17288,-0.14108,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.0022992,-0.17306,-0.17037,0,0
1,GO AXIS SPECIFICATION,0.061812,-0.17315,-0.12674,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.0014738,-0.17455,-0.16507,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.4978,-0.17458,-0.15012,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.014486,-0.17496,-0.23371,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.036948,-0.17512,-0.16476,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.12473,-0.17521,-0.16642,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00020448,-0.17538,-0.17574,0,0
1,GO RHYTHMIC BEHAVIOR,0.0054795,-0.17592,-0.18884,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.10845,-0.17615,-0.1589,0,0
1,GO CELL FATE COMMITMENT,0.0038387,-0.17645,-0.16112,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,3.7145e-05,-0.17715,-0.17843,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.031059,-0.17729,-0.2318,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.082489,-0.17807,-0.10766,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.031748,-0.17828,-0.15168,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0059384,-0.17835,-0.18117,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.13814,-0.17891,-0.12316,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00079435,-0.17904,-0.2165,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.15264,-0.17946,-0.11883,0,0
1,GO MEMBRANE FISSION,0.0050528,-0.17975,-0.22908,0,0
1,GO NEUROGENESIS,5.6174e-05,-0.17994,-0.19174,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.018398,-0.18,-0.15677,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.016734,-0.18018,-0.13108,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.11841,-0.18034,-0.17544,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.012508,-0.18138,-0.16923,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,5.2139e-05,-0.1816,-0.21431,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.0042883,-0.18196,-0.2346,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.43883,-0.18273,-0.044352,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.0051916,-0.18282,-0.12728,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.031748,-0.18302,-0.1582,0,0
1,GO HISTONE H3 K4 METHYLATION,0.0067808,-0.18389,-0.19351,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.36526,-0.18436,-0.076921,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0071468,-0.18441,-0.18851,0,0
1,GO HEAD DEVELOPMENT,0.00031859,-0.18448,-0.17923,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.14048,-0.18484,0.0099435,0,0
1,GO SPERM AXONEME ASSEMBLY,0.11235,-0.18489,-0.15217,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.075049,-0.18535,-0.20858,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.24288,-0.18569,-0.078562,0,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,6.7596e-05,-0.18589,-0.18405,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.19095,-0.18608,-0.074604,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.037747,-0.18691,-0.18065,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.48131,-0.18696,-0.086258,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.11841,-0.18726,-0.094062,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.041967,-0.18759,-0.11803,0,0
1,GO RESPONSE TO FOOD,4.8379e-05,-0.18771,-0.19484,0,0
1,GO IMPORT INTO CELL,0.00353,-0.1881,-0.14004,0,0
1,GO RESPONSE TO AMINE,0.014486,-0.18821,-0.16183,0,0
1,GO RESPONSE TO CAFFEINE,0.32077,-0.18895,-0.066212,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.001191,-0.18895,-0.16508,0,0
1,GO HISTONE H3 K9 METHYLATION,0.00041602,-0.18906,-0.17695,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0066042,-0.18925,-0.23532,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.095625,-0.18933,-0.097066,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.061812,-0.18961,-0.15627,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.0094949,-0.19002,-0.13795,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.0064317,-0.19014,-0.18007,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.077957,-0.19036,-0.12402,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0015189,-0.19052,-0.21874,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.43367,-0.19086,-0.091717,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.11636,-0.19207,-0.15817,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0039469,-0.1925,-0.23934,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00353,-0.19317,-0.31962,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.18219,-0.1934,-0.18042,0,0
1,GO EAR DEVELOPMENT,0.0010859,-0.19449,-0.19151,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.10654,-0.1947,-0.1739,0,0
1,GO STRIATUM DEVELOPMENT,0.0025083,-0.1951,-0.27917,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.1954,-0.16493,0,0
1,GO RESPONSE TO PAIN,0.016339,-0.1954,-0.188,0,0
1,GO DETECTION OF VISIBLE LIGHT,0.0010206,-0.19561,-0.050981,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0022332,-0.19564,-0.16393,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0085714,-0.1972,-0.17312,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0047853,-0.19728,-0.14871,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,7.013e-05,-0.19768,-0.18829,0,0
1,GO FORELIMB MORPHOGENESIS,0.057089,-0.19776,-0.15113,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,2.8418e-05,-0.19785,-0.22965,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0066042,-0.19798,-0.2334,0,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00012074,-0.19857,-0.20211,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.054842,-0.19866,-0.17329,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.014138,-0.1988,-0.17467,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.031748,-0.19948,-0.2472,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.066855,-0.20073,-0.12045,0,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0028957,-0.20084,-0.22696,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.0021062,-0.20106,-0.23449,0,0
1,GO KERATINIZATION,0.077957,-0.20154,-0.11391,0,0
1,GO AXON DEVELOPMENT,0.00019753,-0.2016,-0.22886,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.29586,-0.20162,-0.1471,0,0
1,GO STRIATED MUSCLE CONTRACTION,0.0017123,-0.20304,-0.15938,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,9.389e-05,-0.20312,-0.21478,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.14285,-0.20328,-0.17709,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0039469,-0.20372,-0.22306,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.63354,-0.20461,-0.030051,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.053746,-0.20462,-0.13752,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.036948,-0.2052,-0.19721,0,0
1,GO ORGANIC CATION TRANSPORT,0.00010462,-0.20551,-0.2425,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.044685,-0.20565,-0.16098,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00074557,-0.20596,-0.26723,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.023741,-0.20647,-0.11883,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00098941,-0.20667,-0.19057,0,0
1,GO GENETIC IMPRINTING,0.016734,-0.20695,-0.14494,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00065623,-0.20786,-0.20818,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00065623,-0.20796,-0.19078,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,3.4421e-05,-0.20798,-0.18719,0,0
1,GO HEART PROCESS,0.00012512,-0.20808,-0.18782,0,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00026903,-0.20835,-0.19335,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,3.7145e-05,-0.20874,-0.24515,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.20937,-0.20999,-0.092286,0,0
1,GO NEURON REMODELING,0.25363,-0.21029,-0.10574,0,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00014935,-0.21077,-0.19407,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.063042,-0.21097,-0.13381,0,0
1,GO BRONCHUS DEVELOPMENT,0.3746,-0.21098,-0.12048,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.026586,-0.21104,-0.17414,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.092194,-0.21137,-0.17942,0,0
1,GO CORNIFICATION,0.16294,-0.21143,-0.09301,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00027832,-0.2115,-0.23512,0,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0028957,-0.21182,-0.231,0,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.019739,-0.21252,-0.21942,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.022165,-0.21319,-0.23854,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0027346,-0.21321,-0.25198,0,0
1,GO NEUROMUSCULAR PROCESS,8.1192e-05,-0.21328,-0.23067,0,0
1,GO THYMUS DEVELOPMENT,0.0695,-0.21346,-0.11339,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.015203,-0.2138,-0.19992,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.014138,-0.21393,-0.18359,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0050528,-0.21498,-0.23364,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00054072,-0.21549,-0.19243,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00045924,-0.2156,-0.22678,0,0
1,GO NERVOUS SYSTEM PROCESS,1.9904e-06,-0.21563,-0.20622,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,7.6603e-06,-0.21569,-0.26185,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00055855,-0.21712,-0.17317,0,0
1,GO CELL PART MORPHOGENESIS,2.2524e-05,-0.21811,-0.23865,0,0
1,GO MITOCHONDRION LOCALIZATION,0.0041716,-0.21835,-0.23017,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00057693,-0.21854,-0.2693,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.095625,-0.22067,-0.12526,0,0
1,GO VESICLE DOCKING,0.00012964,-0.22076,-0.2256,0,0
1,GO REGULATION OF CELL MATURATION,0.0069616,-0.22172,-0.18511,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.095625,-0.2224,-0.15343,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.070855,-0.22245,-0.13712,0,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0030654,-0.22329,-0.27548,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.044685,-0.22337,-0.19219,0,0
1,GO SLEEP,2.8418e-05,-0.22339,-0.24039,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.024288,-0.2234,-0.15022,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.009256,-0.22387,-0.18372,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00042998,-0.22489,-0.30648,0,0
1,GO CARTILAGE MORPHOGENESIS,0.2,-0.22499,-0.16322,0,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00019079,-0.22523,-0.2046,0,0
1,GO NEURON DEVELOPMENT,9.3916e-06,-0.22538,-0.23576,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.018836,-0.22623,-0.12798,0,0
1,GO SHORT TERM MEMORY,0.029719,-0.22714,-0.22133,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,5.2139e-05,-0.22764,-0.33346,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.14526,-0.22797,-0.16477,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00026003,-0.22814,-0.18276,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.0030654,-0.23002,-0.25637,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00017796,-0.23014,-0.21942,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0040578,-0.23053,-0.31195,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.025994,-0.23079,-0.26507,0,0
1,GO REPRODUCTIVE BEHAVIOR,2.0833e-05,-0.2312,-0.29437,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.084046,-0.23136,-0.39739,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.010245,-0.23156,-0.24199,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0014299,-0.23214,-0.34752,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00018427,-0.23317,-0.20126,0,0
1,GO UTERUS DEVELOPMENT,0.024288,-0.23345,-0.22812,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00018427,-0.23353,-0.27825,0,0
1,GO DEVELOPMENTAL MATURATION,4.4712e-06,-0.23363,-0.23479,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.32506,-0.23486,-0.087278,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.00038934,-0.23512,-0.17949,0,0
1,GO FOREBRAIN DEVELOPMENT,2.6307e-05,-0.2359,-0.22488,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.00027832,-0.23613,-0.24554,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.012203,-0.23616,-0.24595,0,0
1,GO ACROSOME REACTION,0.0018173,-0.2365,-0.2058,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0047853,-0.23713,-0.21524,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0023671,-0.23742,-0.1968,0,0
1,GO MEMORY,2.9301e-06,-0.23802,-0.26432,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00026903,-0.23898,-0.20074,0,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00034072,-0.24037,-0.18786,0,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,9.7801e-06,-0.24041,-0.26651,0,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,2.2524e-05,-0.2406,-0.22266,0,0
1,GO RESPONSE TO HYDROXYUREA,0.0019282,-0.2407,-0.22475,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.029719,-0.24352,-0.22804,0,0
1,GO SPINAL CORD DEVELOPMENT,9.0551e-05,-0.24452,-0.28328,0,0
1,GO RESPONSE TO AMPHETAMINE,0.00019753,-0.24536,-0.28365,0,0
1,GO RESPONSE TO CATECHOLAMINE,3.7791e-06,-0.2454,-0.27854,0,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.0010206,-0.24636,-0.24727,0,0
1,GO PROTEIN DEPOLYMERIZATION,4.3218e-05,-0.24704,-0.23728,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00028792,-0.2475,-0.22715,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.065563,-0.24897,-0.1234,0,0
1,GO HEART FORMATION,0.040234,-0.24922,-0.16385,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.00017796,-0.24925,-0.22304,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00072223,-0.24956,-0.30147,0,0
1,GO PALLIUM DEVELOPMENT,8.7323e-05,-0.24965,-0.22788,0,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00045924,-0.2501,-0.21338,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0034322,-0.25023,-0.22125,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00010092,-0.25115,-0.25968,0,0
1,GO CELL AGGREGATION,0.019739,-0.25276,-0.18223,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,5.8301e-05,-0.25319,-0.23773,0,0
1,GO FILOPODIUM ASSEMBLY,0.00098941,-0.25352,-0.2302,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,3.8583e-05,-0.25359,-0.27442,0,0
1,GO RESPONSE TO FORSKOLIN,0.030383,-0.25422,-0.21835,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.016734,-0.25481,-0.21323,0,0
1,GO COGNITION,6.0198e-07,-0.25542,-0.26946,0,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010845,-0.2562,-0.20806,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.029068,-0.25655,-0.19967,0,0
1,GO FOREBRAIN CELL MIGRATION,0.0010206,-0.2566,-0.24032,0,0
1,GO REGULATION OF ACTION POTENTIAL,0.011612,-0.25755,-0.17677,0,0
1,GO BEHAVIOR,1.5691e-07,-0.25801,-0.26626,0,0
1,GO AMINO ACID TRANSPORT,6.0504e-05,-0.25993,-0.22288,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00040247,-0.26005,-0.26914,0,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.4712e-06,-0.26034,-0.23286,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00030804,-0.26053,-0.26264,0,0
1,GO VISUAL BEHAVIOR,5.508e-06,-0.26087,-0.25427,0,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,1.5201e-05,-0.26228,-0.23006,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.059411,-0.26255,-0.2747,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.00017796,-0.26256,-0.30156,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00045924,-0.26332,-0.30586,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,7.3528e-06,-0.26457,-0.22326,0,0
1,GO INSEMINATION,0.088862,-0.26515,-0.15017,0,0
1,GO HEAT GENERATION,0.092194,-0.26551,-0.15326,0,0
1,GO FEEDING BEHAVIOR,2.0829e-07,-0.26638,-0.28222,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0050528,-0.26747,-0.27513,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.064293,-0.26795,-0.14276,0,0
1,GO COCHLEA DEVELOPMENT,0.0042883,-0.26882,-0.26064,0,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00047456,-0.26928,-0.29317,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,1.1964e-05,-0.26977,-0.37345,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.29586,-0.27195,-0.13307,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00031859,-0.27424,-0.24262,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.00050664,-0.27572,-0.2742,0,0
1,GO CELL FATE DETERMINATION,0.0057817,-0.27637,-0.24969,0,0
1,GO PANCREAS DEVELOPMENT,0.00022676,-0.27661,-0.24658,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,2.6307e-05,-0.27662,-0.28074,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.25729,-0.27747,-0.13773,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.00098941,-0.27752,-0.20013,0,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00012074,-0.27857,-0.31721,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00010092,-0.28022,-0.26212,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,6.7596e-05,-0.28091,-0.26394,0,0
1,GO ACTIN CROSSLINK FORMATION,0.15015,-0.283,-0.20131,0,0
1,GO HISTONE H4 K5 ACETYLATION,0.0014299,-0.2835,-0.24186,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.010506,-0.28359,-0.19066,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,2.0833e-05,-0.2847,-0.32581,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00017186,-0.28474,-0.30012,0,0
1,GO DETECTION OF ABIOTIC STIMULUS,7.3528e-06,-0.2862,-0.22893,0,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0007696,-0.28765,-0.32249,0,0
1,GO CELL JUNCTION MAINTENANCE,0.0049174,-0.28811,-0.23945,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0023671,-0.28811,-0.3022,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,5.4121e-05,-0.28871,-0.2862,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,7.0571e-06,-0.28941,-0.25279,0,0
1,GO SEX DETERMINATION,0.00044439,-0.29201,-0.2997,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.0087944,-0.29532,-0.22417,0,0
1,GO VASCULAR WOUND HEALING,0.092194,-0.29605,-0.20347,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.6902e-06,-0.29607,-0.31565,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00032948,-0.29634,-0.2773,0,0
1,GO REGULATION OF HEART RATE,0.00012512,-0.29709,-0.24753,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.12473,-0.2978,-0.19544,0,0
1,GO CARDIAC CONDUCTION,9.0179e-06,-0.29885,-0.29445,0,0
1,GO RESPONSE TO DOPAMINE,4.3763e-07,-0.29898,-0.2971,0,0
1,GO PROTEIN PALMITOYLATION,1.5201e-05,-0.29964,-0.29665,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0012662,-0.30045,-0.26844,0,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00055855,-0.30115,-0.29975,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.00087311,-0.30122,-0.25988,0,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00081984,-0.30132,-0.29549,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,2.1663e-05,-0.30212,-0.35474,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.057089,-0.3025,-0.19259,0,0
1,GO WALKING BEHAVIOR,0.00017796,-0.30437,-0.31897,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00028792,-0.30456,-0.36657,0,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0022332,-0.30529,-0.31608,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0018173,-0.30636,-0.26149,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.054842,-0.30642,-0.16585,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0027346,-0.3068,-0.29129,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.11039,-0.30796,-0.18231,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.010773,-0.30812,-0.20918,0,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.009256,-0.30929,-0.27807,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02268,-0.30974,-0.28249,0,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0014299,-0.31074,-0.26522,0,0
1,GO RELAXATION OF MUSCLE,0.0026572,-0.31094,-0.27805,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.00014935,-0.31322,-0.25761,0,0
1,GO SENSORY PERCEPTION OF PAIN,2.0829e-07,-0.31375,-0.3023,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0014738,-0.31486,-0.23978,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.013139,-0.3151,-0.25969,0,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00012512,-0.31525,-0.36046,0,0
1,GO ACROSOME ASSEMBLY,0.00016023,-0.31559,-0.28441,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,2.0784e-06,-0.3167,-0.33664,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0060989,-0.31701,-0.30284,0,0
1,GO CELL FATE SPECIFICATION,0.00021909,-0.31731,-0.3459,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0022992,-0.31758,-0.34419,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0026572,-0.31778,-0.42319,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.1617e-05,-0.31822,-0.3092,0,0
1,GO NOREPINEPHRINE SECRETION,1.5816e-05,-0.3184,-0.3571,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0013457,-0.31859,-0.32796,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00021909,-0.31911,-0.31583,0,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,8.7323e-05,-0.32005,-0.27314,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.26098,-0.32028,-0.13676,0,0
1,GO CELL MIGRATION IN HINDBRAIN,0.00010462,-0.32032,-0.42413,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0021689,-0.32094,-0.30505,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.00079435,-0.32265,-0.25258,0,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.001228,-0.32315,-0.25279,0,0
1,GO HINDBRAIN DEVELOPMENT,8.628e-07,-0.32556,-0.32941,0,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,7.2754e-05,-0.32726,-0.2675,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,4.7955e-07,-0.32738,-0.36197,0,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.011047,-0.32836,-0.26052,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.044685,-0.32982,-0.35646,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,1.7806e-05,-0.33069,-0.26523,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,5.4121e-05,-0.33111,-0.42584,0,0
1,GO POTASSIUM ION HOMEOSTASIS,0.00016595,-0.33138,-0.27731,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.00014935,-0.33177,-0.30025,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.013139,-0.33295,-0.27041,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.12689,-0.33364,-0.29791,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.03245,-0.33404,-0.20676,0,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,3.9418e-06,-0.33463,-0.31144,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.061812,-0.33583,-0.19735,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00020448,-0.3375,-0.31426,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00029782,-0.33852,-0.32072,0,0
1,GO DENDRITE DEVELOPMENT,1.0779e-06,-0.33862,-0.31718,0,0
1,GO GLYCINE TRANSPORT,0.015574,-0.33961,-0.23072,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.033166,-0.33996,-0.23123,0,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0023671,-0.34193,-0.40318,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.020205,-0.34298,-0.31489,0,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,6.7728e-06,-0.34377,-0.33329,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.021165,-0.34391,-0.29904,0,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00019753,-0.34458,-0.31574,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.072231,-0.34642,-0.18435,0,0
1,GO NEUROTRANSMITTER REUPTAKE,0.00012512,-0.34906,-0.34111,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.059411,-0.35007,-0.19884,0,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.00010845,-0.35013,-0.32203,0,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.00016595,-0.35241,-0.33038,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00017796,-0.35327,-0.33526,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,1.7474e-06,-0.35394,-0.35115,0,0
1,GO REGULATION OF MEMBRANE POTENTIAL,5.4272e-08,-0.35396,-0.37047,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.0022332,-0.35475,-0.33893,0,0
1,GO SYNAPTIC VESICLE RECYCLING,6.5896e-07,-0.35485,-0.4019,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.6729e-06,-0.35788,-0.36052,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.22568,-0.3581,-0.13569,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0057817,-0.35817,-0.29412,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,7.2754e-05,-0.35874,-0.3109,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0059384,-0.35882,-0.29993,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0047853,-0.3593,-0.23643,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,5.508e-06,-0.3597,-0.39707,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,8.7323e-05,-0.36004,-0.31514,0,0
1,GO DENDRITE MORPHOGENESIS,2.4692e-06,-0.36036,-0.34114,0,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,7.2754e-05,-0.36178,-0.35305,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.014486,-0.36309,-0.27993,0,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.017549,-0.36502,-0.25105,0,0
1,GO LEARNING,1.3605e-07,-0.36695,-0.37305,0,0
1,GO SKELETAL MUSCLE ADAPTATION,0.0013457,-0.36712,-0.26085,0,0
1,GO POTASSIUM ION TRANSPORT,1.5691e-07,-0.36758,-0.35125,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,2.0833e-05,-0.36957,-0.33286,0,0
1,GO SYNAPTIC SIGNALING,4.9191e-08,-0.37015,-0.37575,0,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,1.7474e-06,-0.37112,-0.3945,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0081404,-0.37129,-0.26492,0,0
1,GO REGULATION OF EXOCYTOSIS,4.6826e-08,-0.37292,-0.3756,0,0
1,GO HEART FIELD SPECIFICATION,0.055956,-0.37362,-0.22592,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00044439,-0.37579,-0.27924,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.5816e-05,-0.37606,-0.39389,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00010092,-0.37977,-0.36053,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,5.8301e-05,-0.38031,-0.34134,0,0
1,GO NOREPINEPHRINE TRANSPORT,0.00018427,-0.38079,-0.31052,0,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,7.2754e-05,-0.38107,-0.38496,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,5.7413e-06,-0.38213,-0.45419,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0012662,-0.38216,-0.40733,0,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.0779e-06,-0.38225,-0.38237,0,0
1,GO RESPONSE TO POTASSIUM ION,0.0067808,-0.38234,-0.31383,0,0
1,GO OTIC VESICLE MORPHOGENESIS,0.02166,-0.38421,-0.37021,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.057089,-0.38641,-0.23027,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00074557,-0.38658,-0.34437,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0031536,-0.39576,-0.31728,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,6.0198e-07,-0.39681,-0.42125,0,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,4.8612e-06,-0.39719,-0.43231,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,9.3916e-06,-0.3994,-0.42883,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,5.9841e-06,-0.39981,-0.3452,0,0
1,GO MRNA SPLICE SITE SELECTION,1.4609e-05,-0.39984,-0.36951,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0060989,-0.40304,-0.3997,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00072223,-0.40456,-0.33431,0,0
1,GO FAT CELL PROLIFERATION,0.00018427,-0.40618,-0.37931,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,1.0779e-06,-0.40674,-0.39772,0,0
1,GO FOREBRAIN REGIONALIZATION,0.00016595,-0.40746,-0.38651,0,0
1,GO LOCOMOTORY BEHAVIOR,4.0375e-08,-0.40932,-0.43118,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.0001165,-0.40956,-0.41572,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.0015189,-0.4122,-0.48722,0,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,9.389e-05,-0.41398,-0.33906,0,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00013433,-0.41413,-0.37303,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00047456,-0.41778,-0.34191,0,0
1,GO N GLYCAN PROCESSING,2.1663e-05,-0.41834,-0.41094,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,4.5813e-07,-0.41998,-0.44047,0,0
1,GO RESPONSE TO NICOTINE,3.5759e-05,-0.4214,-0.32307,0,0
1,GO RESPONSE TO ACETYLCHOLINE,6.4994e-06,-0.42495,-0.43493,0,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0010528,-0.42584,-0.4122,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,1.0604e-05,-0.42601,-0.42905,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00025131,-0.42621,-0.41923,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,6.2786e-05,-0.42675,-0.43574,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,7.8282e-05,-0.42705,-0.38016,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0017123,-0.42866,-0.3376,0,0
1,GO MALE SEX DETERMINATION,0.00032948,-0.42983,-0.38704,0,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.5759e-05,-0.43205,-0.47053,0,0
1,GO SEGMENT SPECIFICATION,6.5149e-05,-0.4322,-0.48237,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.6322e-07,-0.43391,-0.45025,0,0
1,GO SEROTONIN TRANSPORT,1.0779e-06,-0.43436,-0.55924,0,0
1,GO RESPONSE TO COCAINE,6.6003e-08,-0.43526,-0.47008,0,0
1,GO NEURON RECOGNITION,7.9801e-06,-0.43585,-0.46353,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.0016129,-0.43835,-0.32379,0,0
1,GO RESPONSE TO INSECTICIDE,2.7343e-05,-0.43913,-0.43765,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.0066042,-0.44145,-0.43089,0,0
1,GO PITUITARY GLAND DEVELOPMENT,1.104e-05,-0.44463,-0.45989,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,9.7801e-06,-0.4481,-0.59512,0,0
1,GO GROOMING BEHAVIOR,9.3916e-06,-0.44832,-0.43409,0,0
1,GO REGULATION OF AMINO ACID TRANSPORT,4.1802e-07,-0.44908,-0.44945,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.016734,-0.45138,-0.3078,0,0
1,GO DIENCEPHALON DEVELOPMENT,1.2308e-06,-0.45163,-0.42073,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.0057817,-0.45233,-0.31446,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.2308e-06,-0.45289,-0.41206,0,0
1,GO NEUROTRANSMITTER UPTAKE,3.7145e-05,-0.45639,-0.35267,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.025414,-0.45647,-0.41034,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00020448,-0.45885,-0.36113,0,0
1,GO RESPONSE TO LEUCINE,0.00057693,-0.46122,-0.44489,0,0
1,GO ADULT BEHAVIOR,2.7104e-08,-0.46329,-0.52535,0,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.2454e-05,-0.46893,-0.40628,0,0
1,GO LIMB BUD FORMATION,0.017969,-0.4692,-0.31175,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,3.4728e-06,-0.46981,-0.50117,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00010845,-0.47051,-0.42101,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00019079,-0.47106,-0.36803,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,8.628e-07,-0.47722,-0.44145,0,0
1,GO SUBPALLIUM DEVELOPMENT,2.1663e-05,-0.47814,-0.47601,0,0
1,GO ADULT LOCOMOTORY BEHAVIOR,5.4272e-08,-0.48264,-0.47263,0,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.8521e-05,-0.48655,-0.4098,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0032441,-0.48922,-0.4265,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.4963e-07,-0.48946,-0.46821,0,0
1,GO SOMATIC STEM CELL DIVISION,0.027803,-0.49121,-0.26083,0,0
1,GO AXONAL FASCICULATION,0.00028792,-0.49154,-0.49364,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,4.7955e-07,-0.49324,-0.48235,0,0
1,GO NEURAL RETINA DEVELOPMENT,1.7806e-05,-0.49697,-0.43928,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00047456,-0.49718,-0.54302,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.041093,-0.50173,-0.28277,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,1.9873e-07,-0.50635,-0.47546,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.014486,-0.50717,-0.37549,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.349e-05,-0.51129,-0.60403,0,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00017796,-0.51162,-0.39492,0,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1.6455e-05,-0.51427,-0.46902,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.1802e-07,-0.51693,-0.53912,0,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,5.753e-07,-0.52512,-0.53,0,0
1,GO EPITHELIAL CELL MATURATION,1.9263e-05,-0.52705,-0.5084,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,7.013e-05,-0.52944,-0.55905,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,1.104e-05,-0.53557,-0.65029,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,7.889e-07,-0.53741,-0.52774,0,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,5.2533e-07,-0.55245,-0.52279,0,0
1,GO RESPONSE TO L GLUTAMATE,0.00047456,-0.55277,-0.485,0,0
1,GO REGULATION OF HEAT GENERATION,0.010245,-0.55323,-0.35015,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,7.2756e-08,-0.55589,-0.55924,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.2308e-06,-0.5672,-0.55582,0,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,6.2786e-05,-0.56974,-0.50139,0,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,3.9926e-07,-0.5719,-0.54073,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,1.8251e-06,-0.57289,-0.61383,0,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,3.1888e-05,-0.57489,-0.42487,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,6.93e-08,-0.57628,-0.55512,0,0
1,GO DETECTION OF CALCIUM ION,2.1663e-05,-0.57858,-0.5202,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.0264e-07,-0.57859,-0.59899,0,0
1,GO SPINAL CORD PATTERNING,3.7791e-06,-0.57905,-0.59227,0,0
1,GO REFLEX,8.3127e-06,-0.58359,-0.58063,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,1.5201e-05,-0.58461,-0.4967,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,5.508e-06,-0.58525,-0.64709,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00020448,-0.58527,-0.44682,0,0
1,GO CARDIOBLAST PROLIFERATION,0.0079323,-0.58612,-0.4297,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.6563e-08,-0.58619,-0.60133,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,3.9418e-06,-0.58637,-0.60869,0,0
1,GO CEREBELLAR CORTEX FORMATION,3.0264e-07,-0.58696,-0.54294,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,1.2971e-07,-0.59134,-0.64117,0,0
1,GO MAST CELL MIGRATION,9.389e-05,-0.59314,-0.53149,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,4.6826e-08,-0.59338,-0.68489,0,0
1,GO SIALYLATION,6.7728e-06,-0.59554,-0.52512,0,0
1,GO GLUTAMATE SECRETION,1.3605e-07,-0.5963,-0.55242,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,1.2962e-05,-0.59767,-0.57864,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,3.1491e-08,-0.59904,-0.67918,0,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.8131e-07,-0.59941,-0.59821,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.0311e-06,-0.59964,-0.56586,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,3.5759e-05,-0.60134,-0.57646,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.0097392,-0.60603,-0.36419,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0011199,-0.60803,-0.4804,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,1.3605e-07,-0.61049,-0.54568,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.11636,-0.61383,-0.274,0,0
1,GO GROWTH HORMONE SECRETION,4.5813e-07,-0.61447,-0.58831,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,1.7806e-05,-0.61519,-0.49853,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,1.1788e-07,-0.62089,-0.57773,0,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,2.4346e-05,-0.62277,-0.74643,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,5.0683e-06,-0.62931,-0.63684,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,3.17e-07,-0.63701,-0.57088,0,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00040247,-0.64208,-0.52206,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,8.4155e-08,-0.65507,-0.65481,0,0
1,GO STARTLE RESPONSE,5.753e-07,-0.66452,-0.58285,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,5.4977e-07,-0.66841,-0.75638,0,0
1,GO REGULATION OF SYNAPSE MATURATION,3.9926e-07,-0.67521,-0.74223,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.0311e-06,-0.68085,-0.61659,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,1.1964e-05,-0.68215,-0.59975,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,6.0504e-05,-0.69065,-0.54603,0,0
1,GO RESPONSE TO HISTAMINE,7.889e-07,-0.69406,-0.72329,0,0
1,GO RESPONSE TO LITHIUM ION,2.8077e-06,-0.70196,-0.62015,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.0375e-08,-0.70577,-0.72896,0,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.6452e-07,-0.71726,-0.69143,0,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,1.9904e-06,-0.72446,-0.74457,0,0
1,GO THALAMUS DEVELOPMENT,1.6015e-06,-0.72717,-0.63165,0,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,2.0033e-05,-0.73726,-0.69586,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,5.986e-08,-0.74019,-0.81679,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,1.1964e-05,-0.74924,-0.6873,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.2308e-06,-0.7584,-0.7796,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,1.8084e-07,-0.75916,-0.71042,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.013465,-0.76739,-0.47895,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,5.986e-08,-0.76739,-0.80714,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.2533e-07,-0.77265,-0.84385,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,1.2366e-07,-0.77322,-0.73543,0,0
1,GO NEURON FATE COMMITMENT,3.8131e-07,-0.78174,-0.74388,0,0
1,GO INNERVATION,4.5813e-07,-0.78246,-0.74544,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,6.7728e-06,-0.78585,-0.77652,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00057693,-0.7859,-0.67632,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00069957,-0.78731,-0.61643,0,0
1,GO AMINE TRANSPORT,2.9957e-08,-0.78766,-0.70337,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.479e-08,-0.7884,-0.80072,0,0
1,GO SEROTONIN SECRETION,2.3975e-07,-0.79114,-0.70685,0,0
1,GO GLIAL CELL FATE COMMITMENT,8.4205e-05,-0.80511,-0.65594,0,0
1,GO MONOAMINE TRANSPORT,3.479e-08,-0.80517,-0.74401,0,0
1,GO RESPONSE TO AUDITORY STIMULUS,6.2985e-07,-0.81447,-0.71999,0,0
1,GO SYNAPTIC VESICLE DOCKING,8.0176e-08,-0.81637,-0.90385,0,0
1,GO NEURON CELL CELL ADHESION,2.1831e-07,-0.82878,-0.97643,0,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,5.7413e-06,-0.85528,-0.79206,0,0
1,GO SYNAPTIC VESICLE MATURATION,1.2454e-05,-0.85695,-0.83202,0,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.8084e-07,-0.8821,-0.85717,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.4963e-07,-0.89506,-0.86412,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,8.4155e-08,-0.89905,-0.85665,0,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.0779e-06,-0.90075,-0.8242,0,0
1,GO RETINA LAYER FORMATION,1.2454e-05,-0.9051,-0.7108,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,6.2859e-08,-0.92226,-0.86789,0,0
1,GO SYNAPTIC VESICLE PRIMING,3.8423e-08,-0.92581,-0.91683,0,0
1,GO NEURONAL ION CHANNEL CLUSTERING,2.4692e-06,-0.93,-0.84056,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.725e-07,-1.0108,-1.042,0,0
1,GO NEURON FATE SPECIFICATION,2.0829e-07,-1.0126,-1.0065,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,2.2879e-07,-1.0189,-1.0036,0,0
1,GO CATECHOLAMINE SECRETION,3.479e-08,-1.0262,-0.91521,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,5.2533e-07,-1.0616,-0.87099,0,0
1,GO NOSE DEVELOPMENT,2.9301e-06,-1.0699,-0.86831,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,9.2696e-08,-1.0728,-0.93147,0,0
1,GO GANGLION DEVELOPMENT,1.0207e-07,-1.0795,-0.97088,0,0
1,GO MECHANOSENSORY BEHAVIOR,1.2862e-06,-1.1268,-1.0484,0,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,4.2424e-08,-1.1721,-1.1108,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,5.753e-07,-1.2022,-1.044,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,2.8077e-06,-1.3746,-1.2188,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,4.6826e-08,-1.4227,-1.3811,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,1.4268e-07,-1.6695,-1.5157,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0028141,0.85777,0.61039,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00055855,0.77052,0.73588,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0015189,0.72448,0.65131,1,1
2,GO SYNAPSE MATURATION,0.011326,0.66398,0.47096,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0094949,0.63675,0.4498,1,1
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00031859,0.60751,0.48866,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0036303,0.58484,0.45279,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00012074,0.57306,0.62116,1,1
2,GO DENSE CORE GRANULE TRANSPORT,0.001228,0.56705,0.50057,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.0031536,0.55968,0.45714,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.00037661,0.54808,0.58961,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0026572,0.53851,0.44522,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0024367,0.52954,0.45325,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.010773,0.5186,0.35968,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,0.0001165,0.50135,0.41028,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0062634,0.49616,0.33205,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,0.00021909,0.48786,0.38323,1,1
2,GO SECRETORY GRANULE LOCALIZATION,0.00045924,0.48471,0.44533,1,1
2,GO PLASMA MEMBRANE REPAIR,0.012203,0.48326,0.33366,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.0226e-05,0.46631,0.43798,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0094949,0.46573,0.42297,1,1
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014935,0.45371,0.48737,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0060989,0.45026,0.31972,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00353,0.44524,0.33401,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.00026003,0.44324,0.36582,1,1
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0010859,0.42907,0.44681,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0032441,0.42023,0.3143,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.0083534,0.41795,0.3105,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.00067758,0.41401,0.37598,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.038561,0.40252,0.22758,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0025083,0.39694,0.33837,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010845,0.38845,0.41162,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.014486,0.3884,0.30136,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.0090226,0.38838,0.30548,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0020453,0.3833,0.32655,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.019739,0.37803,0.35725,1,1
2,GO SUCKLING BEHAVIOR,1.9263e-05,0.37762,0.41522,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.02068,0.3748,0.257,1,1
2,GO PREPULSE INHIBITION,0.043763,0.37414,0.26678,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0079323,0.37194,0.29316,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.019739,0.36807,0.39298,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0051916,0.36679,0.33878,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00029782,0.36474,0.41958,1,1
2,GO VOCALIZATION BEHAVIOR,0.0073363,0.36361,0.42002,1,1
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0075304,0.36221,0.31731,1,1
2,GO REGULATION OF VESICLE FUSION,0.029719,0.36124,0.1878,1,1
2,GO REGULATION OF NEURON MIGRATION,0.00036427,0.36077,0.29103,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.015953,0.35934,0.24381,1,1
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0090226,0.35887,0.31598,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00016595,0.35784,0.41239,1,1
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0097392,0.35741,0.29928,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,2.6307e-05,0.35732,0.37506,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.024288,0.35275,0.32134,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,5.0226e-05,0.35165,0.31094,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0047853,0.35053,0.31086,1,1
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.004408,0.34638,0.25552,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0060989,0.34054,0.27862,1,1
2,GO ADULT FEEDING BEHAVIOR,0.00052342,0.3397,0.27914,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.010245,0.33152,0.27901,1,1
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0040578,0.33143,0.23422,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0051916,0.32914,0.31937,1,1
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00098941,0.32747,0.33641,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.00026003,0.326,0.2852,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.030383,0.32578,0.25229,1,1
2,GO DENDRITIC SPINE MORPHOGENESIS,0.0051916,0.32196,0.26949,1,1
2,GO NEGATIVE CHEMOTAXIS,0.0054795,0.31776,0.23499,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.015953,0.31735,0.22737,1,1
2,GO CGMP METABOLIC PROCESS,0.015203,0.31671,0.29677,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0033369,0.31578,0.26154,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0059384,0.31381,0.27242,1,1
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0039469,0.31175,0.27715,1,1
2,GO NEURON PROJECTION ORGANIZATION,0.0069616,0.31028,0.22293,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0012662,0.30681,0.29212,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0062634,0.30426,0.40329,1,1
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0060989,0.30264,0.30155,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0060989,0.30139,0.26026,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0045306,0.29916,0.29343,1,1
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00090094,0.29851,0.32004,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0053338,0.2938,0.25831,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00038934,0.29347,0.23589,1,1
2,GO ADULT HEART DEVELOPMENT,0.00098941,0.29328,0.3642,1,1
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.014486,0.29133,0.31581,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.011326,0.291,0.22855,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0094949,0.28856,0.19987,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0046564,0.28741,0.27237,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.013139,0.28732,0.21984,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0022992,0.28216,0.24791,1,1
2,GO UV PROTECTION,0.0026572,0.28123,0.24353,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.013798,0.28111,0.29194,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010245,0.28028,0.22756,1,1
2,GO DENDRITIC TRANSPORT,3.5759e-05,0.2776,0.34404,1,1
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0049174,0.27099,0.24662,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0022992,0.26619,0.25155,1,1
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00069957,0.26492,0.27608,1,1
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0066042,0.26483,0.2243,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0024367,0.26195,0.25355,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00014418,0.26119,0.28029,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.013139,0.26022,0.26732,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.036948,0.25433,0.2541,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.036164,0.25192,0.14948,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,0.0042883,0.25129,0.19595,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0097392,0.25121,0.22172,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0081404,0.25079,0.22414,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.0047853,0.24907,0.20703,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0073363,0.2474,0.21746,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00019079,0.24345,0.24222,1,1
2,GO MOTOR NEURON AXON GUIDANCE,0.00022676,0.24232,0.24072,1,1
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.0013054,0.24219,0.2315,1,1
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.016339,0.24103,0.19965,1,1
2,GO NEURON MIGRATION,0.001662,0.23822,0.22965,1,1
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.033894,0.23808,0.15751,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.02843,0.23445,0.17558,1,1
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.0021689,0.23324,0.19955,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,0.017137,0.23193,0.1953,1,1
2,GO NEURON PROJECTION GUIDANCE,0.001228,0.22938,0.20642,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.029719,0.22818,0.15186,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0069616,0.2277,0.27661,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.02068,0.22557,0.19928,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.001986,0.22508,0.20165,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.02068,0.22481,0.20845,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.011904,0.22269,0.18919,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.025414,0.21658,0.18726,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0062634,0.21597,0.21313,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.013139,0.21553,0.16064,1,1
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0037331,0.2137,0.25044,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.21311,0.20867,1,1
2,GO PRESYNAPSE ORGANIZATION,0.037747,0.21175,0.16234,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0047853,0.20945,0.1837,1,1
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0042883,0.20926,0.24029,1,1
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0022992,0.20913,0.22716,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.036948,0.20903,0.15597,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.045624,0.20601,0.17377,1,1
2,GO SYNAPSE ORGANIZATION,0.0097392,0.2042,0.16129,1,1
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0026572,0.20359,0.24347,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0053338,0.20117,0.34525,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0087944,0.20081,0.17405,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0015189,0.1998,0.19184,1,1
2,GO STRESS GRANULE ASSEMBLY,0.010245,0.19895,0.13678,1,1
2,GO AXON EXTENSION,0.0046564,0.19892,0.17781,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.038561,0.19875,0.16923,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.033166,0.1983,0.19885,1,1
2,GO REGULATION OF AXONOGENESIS,0.0064317,0.19608,0.1864,1,1
2,GO REGULATION OF LYASE ACTIVITY,0.031748,0.19482,0.16327,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.009256,0.19288,0.16936,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.001986,0.19057,0.18506,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.01282,0.18773,0.16237,1,1
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0057817,0.18616,0.18082,1,1
2,GO RNA SURVEILLANCE,0.037747,0.18481,0.1306,1,1
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0081404,0.18202,0.18751,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0067808,0.18111,0.14867,1,1
2,GO HISTONE ARGININE METHYLATION,0.00069957,0.18025,0.16839,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016339,0.17908,0.14394,1,1
2,GO ASSOCIATIVE LEARNING,0.0056288,0.17778,0.1718,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.025994,0.17747,0.1444,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0087944,0.17546,0.11984,1,1
2,GO REGULATION OF AXON GUIDANCE,0.0090226,0.17531,0.17269,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0067808,0.17486,0.22758,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.022165,0.17189,0.18264,1,1
2,GO SYNAPTIC VESICLE LOCALIZATION,0.0038387,0.17151,0.23328,1,1
2,GO TUBULIN DEACETYLATION,0.040234,0.17134,0.17,1,1
2,GO SNORNA METABOLIC PROCESS,0.009256,0.17125,0.19146,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.045624,0.16976,0.19099,1,1
2,GO PROTEIN TRIMERIZATION,0.045624,0.16793,0.18172,1,1
2,GO NEURON PROJECTION EXTENSION,0.0027346,0.16765,0.16986,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0022992,0.167,0.17238,1,1
2,GO PEPTIDYL ARGININE METHYLATION,0.0024367,0.16649,0.1377,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0066042,0.16533,0.153,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.011612,0.16397,0.11962,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.011326,0.16371,0.1419,1,1
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00016023,0.16345,0.18899,1,1
2,GO RESPIRATORY SYSTEM PROCESS,0.031059,0.1625,0.14988,1,1
2,GO NEUROTRANSMITTER SECRETION,0.011904,0.15639,0.22028,1,1
2,GO SYNAPSE ASSEMBLY,0.027188,0.155,0.15438,1,1
2,GO METENCEPHALON DEVELOPMENT,0.011326,0.15458,0.16538,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.014841,0.15402,0.19239,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.015203,0.15065,0.16117,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0053338,0.14703,0.11818,1,1
2,GO PROTEIN O LINKED MANNOSYLATION,0.041967,0.14389,0.099445,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,0.0094949,0.14218,0.1869,1,1
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0066042,0.14163,0.13494,1,1
2,GO NEUROTRANSMITTER TRANSPORT,0.017549,0.14064,0.19322,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.033166,0.13626,0.10181,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.022165,0.13416,0.1837,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.034637,0.13399,0.13545,1,1
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.019283,0.13153,0.11898,1,1
2,GO REGULATION OF NEURON DIFFERENTIATION,0.014486,0.12911,0.11392,1,1
2,GO REPLICATION FORK PROCESSING,0.025414,0.12388,0.11041,1,1
2,GO DNA REPLICATION INITIATION,0.015953,0.12186,0.11614,1,1
2,GO NEURON DIFFERENTIATION,0.015574,0.11662,0.1061,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.0046564,0.1146,0.13304,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.035393,0.11347,0.099916,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0024367,0.11202,0.13569,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0090226,0.10747,0.13207,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.043763,0.10459,0.11592,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.027803,0.10088,0.077101,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.02843,0.10082,0.074038,1,1
2,GO MRNA METHYLATION,0.019283,0.10065,0.16132,1,1
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.037747,0.098442,0.087846,1,1
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.012508,0.096338,0.096869,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.033166,0.09506,0.08738,1,1
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.03245,0.092044,0.10506,1,1
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.013465,0.091494,0.091201,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0083534,0.084844,0.086299,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.041967,0.084552,0.063856,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0083534,0.084293,0.09966,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0062634,0.083789,0.091299,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.045624,0.070779,0.06841,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.017549,0.069687,0.08888,1,1
2,GO MRNA PROCESSING,0.020205,0.067649,0.06358,1,1
2,GO RNA SPLICING,0.015953,0.063078,0.066395,1,1
2,GO PROTEIN ACETYLATION,0.011904,0.060701,0.059436,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.044685,0.050101,0.047045,1,1
2,GO REGULATION OF DOPAMINE SECRETION,0.031059,0.22138,0.32039,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.030383,0.14295,0.12682,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.041093,0.10954,0.12106,1,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.010506,0.10935,0.15412,1,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.034637,0.094605,0.10806,1,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.034637,0.07638,0.13038,1,0
2,GO MRNA 3 END PROCESSING,0.03939,0.069308,0.059561,1,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.040234,-0.028271,-0.047089,1,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.03245,-0.034221,-0.049831,1,0
2,GO MULTI ORGANISM PROCESS,0.034637,-0.03432,-0.060575,1,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.020205,-0.03819,-0.058003,1,0
2,GO ORGANELLE ASSEMBLY,0.02166,-0.040441,-0.048653,1,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.02268,-0.040599,-0.067823,1,0
2,GO INTRACELLULAR TRANSPORT,0.029068,-0.0407,-0.047644,1,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.040234,-0.041578,-0.060904,1,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.040234,-0.041868,-0.1354,1,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0054795,-0.042215,-0.062589,1,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.029719,-0.043902,-0.060795,1,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.046579,-0.044451,-0.079289,1,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0030654,-0.044699,-0.058882,1,0
2,GO PROTEIN STABILIZATION,0.03245,-0.04646,-0.077192,1,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.03245,-0.046582,-0.095352,1,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.029068,-0.046951,-0.10196,1,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0042883,-0.049215,-0.076962,1,0
2,GO CERAMIDE METABOLIC PROCESS,0.03245,-0.049671,-0.10473,1,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.013139,-0.051203,-0.06533,1,0
2,GO REGULATION OF PHAGOCYTOSIS,0.042857,-0.051272,-0.14146,1,0
2,GO ORGANIC ANION TRANSPORT,0.020205,-0.051319,-0.090095,1,0
2,GO DETECTION OF STIMULUS,0.019283,-0.051926,-0.071083,1,0
2,GO HOMEOSTATIC PROCESS,0.0069616,-0.052572,-0.083899,1,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.027803,-0.05323,-0.091036,1,0
2,GO TUBE MORPHOGENESIS,0.023205,-0.053807,-0.11688,1,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0023671,-0.054193,-0.058645,1,0
2,GO ANION TRANSPORT,0.036164,-0.054513,-0.08272,1,0
2,GO MEMBRANE ORGANIZATION,0.035393,-0.054516,-0.07929,1,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.042857,-0.055,-0.086854,1,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.027803,-0.055479,-0.067117,1,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.038561,-0.055516,-0.12189,1,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.024846,-0.05564,-0.074306,1,0
2,GO PROTEIN CATABOLIC PROCESS,0.0053338,-0.055648,-0.077095,1,0
2,GO T CELL LINEAGE COMMITMENT,0.02068,-0.055654,-0.12108,1,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.021165,-0.056267,-0.078509,1,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.038561,-0.056508,-0.078424,1,0
2,GO CIRCADIAN RHYTHM,0.041967,-0.057042,-0.059545,1,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0026572,-0.057381,-0.091137,1,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.0053338,-0.05743,-0.11236,1,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.027188,-0.058635,-0.081985,1,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.016339,-0.05896,-0.09797,1,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.018836,-0.059102,-0.12129,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.0067808,-0.05915,-0.076454,1,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.033894,-0.059259,-0.051854,1,0
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.007729,-0.059833,-0.086989,1,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.027188,-0.059865,-0.082084,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.023205,-0.059981,-0.13627,1,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.018836,-0.060511,-0.095874,1,0
2,GO PROTEIN AUTOUBIQUITINATION,0.042857,-0.060618,-0.068012,1,0
2,GO ORGANELLE INHERITANCE,0.041093,-0.06089,-0.089807,1,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.019739,-0.060939,-0.089949,1,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.03939,-0.061114,-0.076072,1,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0060989,-0.06137,-0.10184,1,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.021165,-0.061532,-0.092405,1,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.044685,-0.061924,-0.11007,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.046579,-0.061981,-0.081807,1,0
2,GO REGULATION OF AUTOPHAGY,0.0085714,-0.061997,-0.087912,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.036948,-0.06283,-0.10427,1,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.025414,-0.063176,-0.08032,1,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.027188,-0.063519,-0.084173,1,0
2,GO MACROAUTOPHAGY,0.00059588,-0.063577,-0.108,1,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.017549,-0.063589,-0.084738,1,0
2,GO PIGMENTATION,0.017549,-0.064092,-0.10629,1,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.010773,-0.064304,-0.11429,1,0
2,GO MACROPHAGE DIFFERENTIATION,0.025994,-0.064404,-0.15885,1,0
2,GO NON RECOMBINATIONAL REPAIR,0.0022332,-0.064791,-0.088607,1,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.018398,-0.064887,-0.14385,1,0
2,GO RESPONSE TO INSULIN,0.027188,-0.064893,-0.088065,1,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.015203,-0.065487,-0.083662,1,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.014841,-0.065628,-0.074555,1,0
2,GO RESPONSE TO PEPTIDE,0.02166,-0.065689,-0.079573,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0064317,-0.065784,-0.080114,1,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.013139,-0.065878,-0.081193,1,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0051916,-0.06689,-0.098718,1,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.024288,-0.067175,-0.073682,1,0
2,GO DNA BIOSYNTHETIC PROCESS,0.029068,-0.0672,-0.060419,1,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.017137,-0.06735,-0.11691,1,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.029719,-0.067471,-0.13881,1,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.0041716,-0.067526,-0.11587,1,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.024846,-0.067615,-0.11256,1,0
2,GO REGULATION OF CELL DEATH,0.0040578,-0.067629,-0.10008,1,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.040234,-0.067633,-0.077998,1,0
2,GO PROTEIN MONOUBIQUITINATION,0.027803,-0.067925,-0.06203,1,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.025994,-0.068217,-0.10808,1,0
2,GO CELL CELL ADHESION,0.011047,-0.068871,-0.12362,1,0
2,GO ENDOSOMAL TRANSPORT,0.0022992,-0.070207,-0.084127,1,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.014138,-0.07035,-0.084817,1,0
2,GO POSITIVE REGULATION OF SIGNALING,0.024846,-0.070478,-0.084493,1,0
2,GO TUBE DEVELOPMENT,0.020205,-0.070645,-0.10949,1,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.037747,-0.07126,-0.098357,1,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.036948,-0.071264,-0.13798,1,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0013872,-0.071778,-0.10839,1,0
2,GO APOPTOTIC PROCESS,0.0023671,-0.071931,-0.10153,1,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.037747,-0.071999,-0.076517,1,0
2,GO VACUOLAR TRANSPORT,0.027188,-0.07202,-0.087564,1,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0071468,-0.07253,-0.095996,1,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0029794,-0.072835,-0.16229,1,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0007696,-0.073202,-0.1423,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.040234,-0.07377,-0.11734,1,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.025414,-0.074075,-0.079619,1,0
2,GO VESICLE ORGANIZATION,0.0020453,-0.07508,-0.11253,1,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0045306,-0.075234,-0.1252,1,0
2,GO LEUKOCYTE DIFFERENTIATION,0.00087311,-0.075328,-0.13675,1,0
2,GO NEURAL TUBE DEVELOPMENT,0.044685,-0.075398,-0.094543,1,0
2,GO REGULATION OF OSSIFICATION,0.019283,-0.075598,-0.12919,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0033369,-0.075845,-0.090831,1,0
2,GO RESPONSE TO HORMONE,0.015574,-0.076721,-0.094419,1,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0083534,-0.077051,-0.1586,1,0
2,GO REGULATION OF ERAD PATHWAY,0.026586,-0.077427,-0.07454,1,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.017137,-0.077562,-0.11457,1,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.042857,-0.07764,-0.068342,1,0
2,GO MUSCLE ADAPTATION,0.015953,-0.077749,-0.11859,1,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.036164,-0.078222,-0.10956,1,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0021689,-0.078293,-0.11811,1,0
2,GO REGULATION OF PHOSPHORYLATION,0.019739,-0.078409,-0.086643,1,0
2,GO CHOLESTEROL EFFLUX,0.041967,-0.078421,-0.12465,1,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.031748,-0.078792,-0.1021,1,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.020205,-0.078939,-0.10102,1,0
2,GO ALCOHOL METABOLIC PROCESS,0.019739,-0.079567,-0.10682,1,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.021165,-0.079629,-0.10378,1,0
2,GO REGULATION OF PROTEIN FOLDING,0.041967,-0.079711,-0.10898,1,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.011904,-0.07979,-0.11807,1,0
2,GO REGULATION OF HORMONE LEVELS,0.031059,-0.080315,-0.09415,1,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.020205,-0.080382,-0.11402,1,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.027803,-0.080552,-0.11303,1,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0069616,-0.081287,-0.10835,1,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.029719,-0.081652,-0.18201,1,0
2,GO RESPONSE TO RETINOIC ACID,0.033166,-0.082659,-0.14712,1,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.020205,-0.083241,-0.098171,1,0
2,GO EPITHELIAL CELL PROLIFERATION,0.0040578,-0.083436,-0.15237,1,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.03939,-0.083673,-0.088902,1,0
2,GO FAT CELL DIFFERENTIATION,0.0056288,-0.083727,-0.13198,1,0
2,GO PROTEIN TARGETING TO VACUOLE,0.034637,-0.083892,-0.1367,1,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0033369,-0.084021,-0.10882,1,0
2,GO LIPID HOMEOSTASIS,0.011612,-0.084265,-0.12333,1,0
2,GO CELL CELL RECOGNITION,0.0083534,-0.08428,-0.1388,1,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.017969,-0.084434,-0.10534,1,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.0097392,-0.084661,-0.13654,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.014841,-0.084754,-0.10774,1,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.019283,-0.084913,-0.099184,1,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.027803,-0.08502,-0.093591,1,0
2,GO RESPONSE TO IONIZING RADIATION,0.0075304,-0.085029,-0.10342,1,0
2,GO PROTEIN POLYUBIQUITINATION,0.00042998,-0.085094,-0.10492,1,0
2,GO NEUTROPHIL MIGRATION,0.02166,-0.085281,-0.1235,1,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.024846,-0.085405,-0.084382,1,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.016339,-0.085491,-0.095821,1,0
2,GO RESPONSE TO STEROID HORMONE,0.0053338,-0.085554,-0.12815,1,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.024288,-0.08596,-0.0965,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.017137,-0.086092,-0.20524,1,0
2,GO SPERM EGG RECOGNITION,0.0075304,-0.086137,-0.13831,1,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0097392,-0.086168,-0.11479,1,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0066042,-0.086312,-0.11433,1,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.0022332,-0.086355,-0.12193,1,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.02268,-0.086386,-0.098209,1,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0050528,-0.086935,-0.091393,1,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.011047,-0.086981,-0.11274,1,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.035393,-0.087138,-0.10368,1,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.017549,-0.087219,-0.10291,1,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.036164,-0.087297,-0.12681,1,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0022332,-0.087346,-0.1323,1,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.020205,-0.087453,-0.087149,1,0
2,GO REGULATION OF LIPID LOCALIZATION,0.035393,-0.087655,-0.11585,1,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.025414,-0.087669,-0.11244,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0066042,-0.087851,-0.14894,1,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.010773,-0.08787,-0.10559,1,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.01282,-0.08796,-0.085659,1,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.023205,-0.088056,-0.14591,1,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.024846,-0.088227,-0.15244,1,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0046564,-0.088254,-0.098771,1,0
2,GO SECRETION,0.0029794,-0.088273,-0.11296,1,0
2,GO OSTEOCLAST DIFFERENTIATION,0.03245,-0.088652,-0.091411,1,0
2,GO MEMBRANE FUSION,0.022165,-0.088962,-0.12329,1,0
2,GO DETECTION OF BIOTIC STIMULUS,0.031748,-0.089008,-0.20624,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.0081404,-0.089107,-0.11257,1,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.035393,-0.089135,-0.13549,1,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.018836,-0.089282,-0.14517,1,0
2,GO LIPID METABOLIC PROCESS,0.0014299,-0.089333,-0.1221,1,0
2,GO LYMPHOCYTE ACTIVATION,0.0016129,-0.089518,-0.13572,1,0
2,GO REGULATION OF CELL ADHESION,0.0041716,-0.089575,-0.1555,1,0
2,GO RESPONSE TO COLD,0.043763,-0.089676,-0.17058,1,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.019283,-0.089709,-0.088797,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.036164,-0.089773,-0.15485,1,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0083534,-0.089942,-0.094621,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0032441,-0.090105,-0.12824,1,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0051916,-0.090387,-0.11519,1,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0087944,-0.090394,-0.076327,1,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0094949,-0.090515,-0.12291,1,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0049174,-0.090544,-0.14818,1,0
2,GO ENDOTHELIUM DEVELOPMENT,0.02166,-0.090607,-0.12708,1,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.017969,-0.09074,-0.10373,1,0
2,GO LIPID CATABOLIC PROCESS,0.011326,-0.09086,-0.1078,1,0
2,GO REGULATION OF RESPONSE TO STRESS,0.00031859,-0.091277,-0.12841,1,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0037331,-0.091287,-0.1443,1,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.010245,-0.091545,-0.139,1,0
2,GO REGULATION OF IMMUNE RESPONSE,0.00098941,-0.091853,-0.15513,1,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.023205,-0.091854,-0.096777,1,0
2,GO PHAGOCYTOSIS,0.02268,-0.092128,-0.13887,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0099891,-0.092218,-0.12793,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0097392,-0.092811,-0.13298,1,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00084609,-0.0929,-0.14193,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0041716,-0.092948,-0.14151,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0032441,-0.093006,-0.10236,1,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.03939,-0.093261,-0.099233,1,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0056288,-0.093264,-0.1126,1,0
2,GO GOLGI VESICLE TRANSPORT,0.0046564,-0.093266,-0.093969,1,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.00081984,-0.093362,-0.12635,1,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00049035,-0.093438,-0.15438,1,0
2,GO PROTEOLYSIS,6.0504e-05,-0.093441,-0.12295,1,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0085714,-0.093471,-0.12155,1,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.029068,-0.09375,-0.13278,1,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00079435,-0.093781,-0.14533,1,0
2,GO PROTEIN MATURATION,0.0028141,-0.093794,-0.12381,1,0
2,GO PEROXISOME ORGANIZATION,0.0057817,-0.093966,-0.13303,1,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.025994,-0.094413,-0.13024,1,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0018173,-0.094576,-0.1137,1,0
2,GO RENAL SYSTEM PROCESS,0.025994,-0.094577,-0.12799,1,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.02843,-0.094829,-0.093758,1,0
2,GO RESPONSE TO ANTIBIOTIC,0.013798,-0.094934,-0.13734,1,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.019283,-0.095126,-0.090505,1,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0079323,-0.095212,-0.13098,1,0
2,GO REGULATION OF PROTEOLYSIS,0.00026903,-0.095242,-0.15424,1,0
2,GO AGING,0.0011199,-0.095495,-0.13096,1,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.0097392,-0.095791,-0.12287,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.014138,-0.096115,-0.138,1,0
2,GO POSTREPLICATION REPAIR,0.0012662,-0.0965,-0.11704,1,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00012512,-0.096532,-0.13324,1,0
2,GO PH REDUCTION,0.0013457,-0.09681,-0.14414,1,0
2,GO TEMPERATURE HOMEOSTASIS,0.015203,-0.097103,-0.10816,1,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0021689,-0.097123,-0.14359,1,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.004408,-0.097216,-0.12196,1,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00092958,-0.097309,-0.10324,1,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.018836,-0.097885,-0.08651,1,0
2,GO ADAPTIVE THERMOGENESIS,0.010773,-0.097897,-0.11637,1,0
2,GO COPII COATED VESICLE BUDDING,0.00095906,-0.098074,-0.13604,1,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0081404,-0.098269,-0.14335,1,0
2,GO T CELL DIFFERENTIATION,0.0032441,-0.098301,-0.13324,1,0
2,GO RESPONSE TO INTERLEUKIN 1,0.0030654,-0.098656,-0.15731,1,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013465,-0.098753,-0.11798,1,0
2,GO REGULATION OF BODY FLUID LEVELS,0.00037661,-0.099037,-0.16852,1,0
2,GO PEPTIDE SECRETION,0.019739,-0.099563,-0.095159,1,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.022165,-0.099615,-0.12236,1,0
2,GO DRUG METABOLIC PROCESS,0.0073363,-0.099896,-0.17442,1,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0025083,-0.10004,-0.1255,1,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.027803,-0.10038,-0.18507,1,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.036164,-0.10093,-0.23138,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.0011549,-0.10104,-0.14755,1,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0010206,-0.10107,-0.10843,1,0
2,GO GOLGI ORGANIZATION,1.9263e-05,-0.10121,-0.15409,1,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.034637,-0.10129,-0.089599,1,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.00069957,-0.10132,-0.16218,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013465,-0.10157,-0.15871,1,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.00095906,-0.1019,-0.14631,1,0
2,GO GLAND DEVELOPMENT,0.001191,-0.10195,-0.13612,1,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.0010206,-0.10196,-0.14126,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0024367,-0.10216,-0.11715,1,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.013465,-0.10229,-0.15234,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.014841,-0.10233,-0.13966,1,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02166,-0.10235,-0.10189,1,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0040578,-0.10256,-0.12537,1,0
2,GO AMINE METABOLIC PROCESS,0.0033369,-0.10271,-0.15118,1,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.011047,-0.10272,-0.10767,1,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.021165,-0.10276,-0.11598,1,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.0034322,-0.10284,-0.090414,1,0
2,GO REGULATION OF ANION TRANSPORT,0.0099891,-0.10284,-0.12027,1,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.025994,-0.10288,-0.12164,1,0
2,GO IRON ION HOMEOSTASIS,0.034637,-0.10291,-0.11738,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.0073363,-0.10293,-0.125,1,0
2,GO CELLULAR PIGMENTATION,0.0066042,-0.10293,-0.11924,1,0
2,GO PEROXISOMAL TRANSPORT,0.0059384,-0.10351,-0.14333,1,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.016734,-0.10368,-0.1119,1,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.015953,-0.10391,-0.15268,1,0
2,GO FACE DEVELOPMENT,0.015574,-0.10415,-0.18909,1,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0090226,-0.10417,-0.20302,1,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.041967,-0.10419,-0.12069,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.040234,-0.1043,-0.1682,1,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.016339,-0.10443,-0.084276,1,0
2,GO GOLGI VESICLE BUDDING,0.00042998,-0.10451,-0.14929,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.001191,-0.10495,-0.18863,1,0
2,GO LIPID MODIFICATION,0.00087311,-0.10499,-0.13999,1,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.044685,-0.10511,-0.079622,1,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00021909,-0.10548,-0.14127,1,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0011549,-0.10553,-0.15133,1,0
2,GO FATTY ACID BETA OXIDATION,0.017137,-0.10559,-0.14245,1,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.015953,-0.10569,-0.1204,1,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00037661,-0.1057,-0.15675,1,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.022165,-0.1058,-0.11792,1,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.011326,-0.1058,-0.1046,1,0
2,GO FATTY ACID TRANSPORT,0.025414,-0.10608,-0.10048,1,0
2,GO EPITHELIUM DEVELOPMENT,0.00024286,-0.10642,-0.14735,1,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0067808,-0.10648,-0.13844,1,0
2,GO RESPONSE TO KETONE,0.0097392,-0.10671,-0.13132,1,0
2,GO REGULATION OF DEFENSE RESPONSE,0.00020448,-0.10675,-0.17591,1,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0026572,-0.10683,-0.12233,1,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.02068,-0.10703,-0.12459,1,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.025414,-0.10708,-0.24282,1,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0083534,-0.10709,-0.12009,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.02843,-0.10733,-0.16514,1,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00059588,-0.10742,-0.16374,1,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.023205,-0.10786,-0.093243,1,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.018398,-0.10789,-0.16509,1,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.02166,-0.10807,-0.18017,1,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.00063551,-0.10813,-0.11701,1,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.011326,-0.10834,-0.1061,1,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001191,-0.1084,-0.14963,1,0
2,GO RENAL TUBULE DEVELOPMENT,0.011904,-0.10876,-0.14614,1,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.041967,-0.10886,-0.11794,1,0
2,GO REGULATION OF CELL ACTIVATION,0.00050664,-0.10906,-0.15563,1,0
2,GO REGULATION OF MAPK CASCADE,0.036164,-0.10906,-0.098606,1,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.023741,-0.10907,-0.12903,1,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0025817,-0.10908,-0.14065,1,0
2,GO TISSUE REGENERATION,0.033894,-0.1092,-0.1512,1,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.037747,-0.10941,-0.17281,1,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00067758,-0.10958,-0.12266,1,0
2,GO EXOCYTOSIS,0.00084609,-0.10963,-0.14616,1,0
2,GO MITOPHAGY,0.0083534,-0.1097,-0.13697,1,0
2,GO LYMPHOCYTE COSTIMULATION,0.010773,-0.10982,-0.13501,1,0
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.7118e-05,-0.11005,-0.1527,1,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02268,-0.11015,-0.13662,1,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.016734,-0.1102,-0.15631,1,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.023741,-0.11032,-0.14709,1,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0021062,-0.11032,-0.12092,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.013798,-0.11055,-0.15017,1,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.031059,-0.11058,-0.27339,1,0
2,GO REGULATION OF CELL CELL ADHESION,0.00074557,-0.11059,-0.16922,1,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.013798,-0.11064,-0.1773,1,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.029068,-0.1108,-0.15061,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.013465,-0.11098,-0.15179,1,0
2,GO REGULATION OF LIPID STORAGE,0.019739,-0.11102,-0.14349,1,0
2,GO ORGANELLE DISASSEMBLY,0.00065623,-0.11106,-0.11291,1,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0049174,-0.11107,-0.12543,1,0
2,GO T CELL CHEMOTAXIS,0.03939,-0.11107,-0.10463,1,0
2,GO STEROL HOMEOSTASIS,0.036164,-0.11109,-0.13546,1,0
2,GO NOTCH SIGNALING PATHWAY,0.015574,-0.11127,-0.12187,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.014138,-0.11131,-0.2245,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0097392,-0.11157,-0.16253,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.036948,-0.11158,-0.16299,1,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.011904,-0.1118,-0.10209,1,0
2,GO CARBOHYDRATE TRANSPORT,0.001872,-0.11191,-0.12984,1,0
2,GO INTERFERON GAMMA PRODUCTION,0.0049174,-0.11207,-0.15207,1,0
2,GO RESPONSE TO LIPID,0.004408,-0.11214,-0.12021,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.0057817,-0.11217,-0.12504,1,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.041967,-0.1125,-0.16396,1,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.044685,-0.1128,-0.15388,1,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.019739,-0.1128,-0.11554,1,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.011047,-0.11301,-0.13905,1,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.010773,-0.11305,-0.16202,1,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.036948,-0.11307,-0.10298,1,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.023205,-0.11319,-0.14464,1,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.023741,-0.11321,-0.10648,1,0
2,GO REGULATION OF BONE DEVELOPMENT,0.037747,-0.11337,-0.096101,1,0
2,GO P38MAPK CASCADE,0.018398,-0.11346,-0.16575,1,0
2,GO RECEPTOR CATABOLIC PROCESS,0.016339,-0.11372,-0.18117,1,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.00011241,-0.11386,-0.16865,1,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.012508,-0.11427,-0.13136,1,0
2,GO ATP BIOSYNTHETIC PROCESS,0.029719,-0.11428,-0.11882,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.023741,-0.11432,-0.093029,1,0
2,GO RESPONSE TO STARVATION,0.010506,-0.11444,-0.11667,1,0
2,GO OXIDATION REDUCTION PROCESS,0.017969,-0.11454,-0.098729,1,0
2,GO NATURAL KILLER CELL ACTIVATION,0.0021689,-0.11455,-0.16688,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00067758,-0.11488,-0.18667,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,4.0073e-05,-0.11528,-0.16067,1,0
2,GO REGULATION OF CHEMOTAXIS,0.010245,-0.11549,-0.12148,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,8.4205e-05,-0.11564,-0.18114,1,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0045306,-0.11564,-0.12793,1,0
2,GO KETONE CATABOLIC PROCESS,0.025414,-0.11573,-0.22529,1,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.007729,-0.11575,-0.22515,1,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.046579,-0.11591,-0.10788,1,0
2,GO REGULATION OF LIPID TRANSPORT,0.043763,-0.11596,-0.11329,1,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0029794,-0.11597,-0.17233,1,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.024288,-0.11604,-0.084368,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00065623,-0.11606,-0.19665,1,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.7118e-05,-0.11628,-0.14427,1,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.013e-05,-0.11637,-0.12979,1,0
2,GO REGULATION OF HEMOPOIESIS,0.0018173,-0.11638,-0.13492,1,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.02166,-0.11653,-0.17616,1,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.00034072,-0.11675,-0.13322,1,0
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0049174,-0.11676,-0.13063,1,0
2,GO REGULATION OF CELLULAR PH,0.00012074,-0.11677,-0.1294,1,0
2,GO DNA DEMETHYLATION,0.017549,-0.11687,-0.12983,1,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.018398,-0.11688,-0.11321,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00054072,-0.1169,-0.18084,1,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0057817,-0.11697,-0.13154,1,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.045624,-0.11711,-0.11863,1,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.011047,-0.11717,-0.17592,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00037661,-0.11741,-0.24698,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0025817,-0.11745,-0.13333,1,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.040234,-0.11746,-0.1046,1,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.037747,-0.11765,-0.1411,1,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0018173,-0.11774,-0.20481,1,0
2,GO NEPHRON DEVELOPMENT,0.018836,-0.11775,-0.13339,1,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.015953,-0.11816,-0.11338,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.016339,-0.11836,-0.13158,1,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.036948,-0.11843,-0.11032,1,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00072223,-0.1185,-0.20918,1,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0085714,-0.11853,-0.16147,1,0
2,GO MESENCHYME MORPHOGENESIS,0.046579,-0.11857,-0.142,1,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.041967,-0.11864,-0.13301,1,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0059384,-0.11872,-0.13977,1,0
2,GO T CELL ACTIVATION,0.00047456,-0.11884,-0.16615,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.014486,-0.1189,-0.12367,1,0
2,GO REGULATION OF PEPTIDE SECRETION,0.0071468,-0.11896,-0.10443,1,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.030383,-0.11925,-0.16719,1,0
2,GO RESPONSE TO INTERLEUKIN 15,0.02843,-0.11926,-0.15077,1,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.023205,-0.11958,-0.13482,1,0
2,GO LIPID LOCALIZATION,0.0011549,-0.11972,-0.15062,1,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0010859,-0.11978,-0.14365,1,0
2,GO GRANULOCYTE CHEMOTAXIS,0.011326,-0.11986,-0.14374,1,0
2,GO POSITIVE CHEMOTAXIS,0.018836,-0.11993,-0.15356,1,0
2,GO TRANSLESION SYNTHESIS,0.00036427,-0.12045,-0.15337,1,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.013139,-0.12059,-0.19416,1,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.029719,-0.12078,-0.1863,1,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00037661,-0.12101,-0.1777,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00012964,-0.12111,-0.17596,1,0
2,GO NIK NF KAPPAB SIGNALING,0.0090226,-0.12137,-0.14511,1,0
2,GO ERAD PATHWAY,0.0026572,-0.12152,-0.12908,1,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.015203,-0.12157,-0.11906,1,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.037747,-0.12168,-0.12025,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0085714,-0.12177,-0.23011,1,0
2,GO CELLULAR RESPONSE TO STARVATION,0.0050528,-0.12177,-0.12837,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,9.0551e-05,-0.12222,-0.17599,1,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0081404,-0.12244,-0.2606,1,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00025131,-0.12275,-0.17536,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00098941,-0.12295,-0.14898,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.012203,-0.12305,-0.19978,1,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00035231,-0.12347,-0.17139,1,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0023671,-0.12349,-0.19528,1,0
2,GO FLUID TRANSPORT,0.010245,-0.1238,-0.14844,1,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0010859,-0.1239,-0.12964,1,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00024286,-0.12391,-0.1731,1,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0001165,-0.12418,-0.16007,1,0
2,GO SYMBIOTIC PROCESS,0.00035231,-0.1242,-0.13843,1,0
2,GO REGULATION OF T CELL ACTIVATION,0.00037661,-0.1242,-0.1641,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0069616,-0.12429,-0.16536,1,0
2,GO REGULATION OF PROTEIN IMPORT,0.0040578,-0.12446,-0.17298,1,0
2,GO CELLULAR RESPONSE TO VIRUS,0.0064317,-0.12448,-0.14938,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00054072,-0.12475,-0.17117,1,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0045306,-0.12481,-0.13437,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.041093,-0.12494,-0.1313,1,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00087311,-0.12508,-0.15615,1,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0012662,-0.12518,-0.20648,1,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.00010845,-0.12521,-0.14616,1,0
2,GO RESPONSE TO OXYGEN RADICAL,0.0060989,-0.12545,-0.14134,1,0
2,GO SECONDARY METABOLIC PROCESS,0.029719,-0.12588,-0.16736,1,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0011199,-0.12596,-0.16789,1,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.027803,-0.12602,-0.091664,1,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.046579,-0.12614,-0.17312,1,0
2,GO APOPTOTIC SIGNALING PATHWAY,3.4421e-05,-0.1263,-0.16353,1,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0059384,-0.12641,-0.16849,1,0
2,GO MESODERM MORPHOGENESIS,0.026586,-0.12642,-0.13022,1,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0015189,-0.12642,-0.13891,1,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0042883,-0.12644,-0.12275,1,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.023741,-0.12651,-0.11689,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.031748,-0.12673,-0.13528,1,0
2,GO VACUOLE ORGANIZATION,0.0029794,-0.12685,-0.12289,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.038561,-0.12692,-0.13704,1,0
2,GO KERATINOCYTE MIGRATION,0.029068,-0.12705,-0.17772,1,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0066042,-0.12732,-0.12157,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00081984,-0.12745,-0.19639,1,0
2,GO O GLYCAN PROCESSING,0.019283,-0.12832,-0.19888,1,0
2,GO DEFENSE RESPONSE,8.4205e-05,-0.12848,-0.18877,1,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,7.547e-05,-0.12868,-0.15462,1,0
2,GO TISSUE HOMEOSTASIS,1.8521e-05,-0.12879,-0.17348,1,0
2,GO GRANULOCYTE MIGRATION,0.0032441,-0.1288,-0.16568,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00014935,-0.12906,-0.18688,1,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.00067758,-0.12923,-0.14254,1,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.0012662,-0.12926,-0.12078,1,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.015203,-0.12946,-0.15339,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.035393,-0.13003,-0.15651,1,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0039469,-0.13004,-0.15071,1,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.0083534,-0.13012,-0.11418,1,0
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.029068,-0.13062,-0.15759,1,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0015653,-0.13064,-0.17044,1,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0011549,-0.13067,-0.18213,1,0
2,GO ENDOCRINE PROCESS,0.0022332,-0.13109,-0.17406,1,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.033166,-0.13132,-0.18561,1,0
2,GO REGULATION OF PH,9.0551e-05,-0.13143,-0.13458,1,0
2,GO PROTEIN PROCESSING,0.00023468,-0.13157,-0.17969,1,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00049035,-0.13161,-0.16312,1,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.031748,-0.1317,-0.1585,1,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.02166,-0.13195,-0.11164,1,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.018836,-0.13238,-0.15986,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.547e-05,-0.13241,-0.1716,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00063551,-0.13273,-0.21022,1,0
2,GO PROTEIN DESTABILIZATION,0.00022676,-0.1328,-0.14828,1,0
2,GO CELL ACTIVATION,0.00016023,-0.13284,-0.17165,1,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.00012964,-0.13289,-0.17677,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0012662,-0.13294,-0.1341,1,0
2,GO CYTOKINE PRODUCTION,3.8583e-05,-0.13308,-0.2053,1,0
2,GO LEUKOCYTE HOMEOSTASIS,0.00087311,-0.13352,-0.17506,1,0
2,GO B CELL ACTIVATION,1.7118e-05,-0.13377,-0.17103,1,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.001986,-0.13389,-0.19429,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00036427,-0.1342,-0.14118,1,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.037747,-0.13451,-0.1998,1,0
2,GO MYOFIBRIL ASSEMBLY,0.024846,-0.13475,-0.10967,1,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0073363,-0.13485,-0.181,1,0
2,GO FATTY ACID METABOLIC PROCESS,0.00098941,-0.13486,-0.15626,1,0
2,GO ENDOCYTIC RECYCLING,0.004408,-0.13491,-0.13881,1,0
2,GO HYALURONAN METABOLIC PROCESS,0.0079323,-0.13496,-0.16782,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.009256,-0.13498,-0.13397,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.033166,-0.13511,-0.10792,1,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0017123,-0.13517,-0.12136,1,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.011904,-0.13547,-0.11285,1,0
2,GO REGULATION OF ACTIN NUCLEATION,0.0025817,-0.13566,-0.17233,1,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.0085714,-0.13582,-0.15689,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0021062,-0.13583,-0.20892,1,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.03939,-0.13584,-0.13541,1,0
2,GO SULFATE TRANSPORT,0.0026572,-0.13614,-0.11408,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0071468,-0.13634,-0.14904,1,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,3.0689e-05,-0.13644,-0.16383,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.024846,-0.13646,-0.15667,1,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0047853,-0.13672,-0.16409,1,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.0041716,-0.13682,-0.17577,1,0
2,GO MYELOID CELL DIFFERENTIATION,4.8612e-06,-0.13682,-0.16788,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.042857,-0.13702,-0.18362,1,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.00020448,-0.13702,-0.18178,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00021909,-0.13711,-0.2174,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0067808,-0.13721,-0.18478,1,0
2,GO RESPONSE TO GAMMA RADIATION,0.00013433,-0.13734,-0.16576,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.1888e-05,-0.13753,-0.16752,1,0
2,GO T CELL SELECTION,0.018398,-0.13754,-0.097207,1,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0057817,-0.13773,-0.14459,1,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.033894,-0.13775,-0.19653,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0014738,-0.13779,-0.1939,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00092958,-0.13782,-0.17538,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.018836,-0.13829,-0.27172,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0041716,-0.13856,-0.14465,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00059588,-0.13861,-0.16636,1,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00027832,-0.13863,-0.13827,1,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0097392,-0.13896,-0.13801,1,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0015189,-0.13931,-0.15706,1,0
2,GO CELLULAR SENESCENCE,0.010245,-0.13941,-0.12049,1,0
2,GO REGULATION OF CENTROSOME CYCLE,0.030383,-0.13943,-0.089115,1,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00010845,-0.13968,-0.185,1,0
2,GO COAGULATION,0.00092958,-0.13999,-0.17894,1,0
2,GO ACTIN NUCLEATION,0.00065623,-0.14006,-0.13581,1,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0024367,-0.14053,-0.15828,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.0015653,-0.14054,-0.16937,1,0
2,GO VIRAL LIFE CYCLE,4.4878e-05,-0.14055,-0.20826,1,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.015953,-0.14074,-0.20929,1,0
2,GO MANGANESE ION TRANSPORT,0.02268,-0.14112,-0.12401,1,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.014138,-0.14112,-0.20484,1,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.0032441,-0.14119,-0.16189,1,0
2,GO T CELL PROLIFERATION,0.00042998,-0.14122,-0.1871,1,0
2,GO STEROL METABOLIC PROCESS,0.023741,-0.14132,-0.10214,1,0
2,GO FATTY ACID CATABOLIC PROCESS,0.0016129,-0.1415,-0.16351,1,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00010462,-0.14182,-0.17347,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00014935,-0.14235,-0.18258,1,0
2,GO VESICLE TARGETING,4.1617e-05,-0.14264,-0.19459,1,0
2,GO CYTOKINE SECRETION,0.00022676,-0.14291,-0.16856,1,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.00353,-0.1435,-0.17366,1,0
2,GO RESPONSE TO CORTICOSTEROID,0.0039469,-0.14353,-0.16337,1,0
2,GO RIG I SIGNALING PATHWAY,0.025994,-0.14356,-0.14838,1,0
2,GO PLATELET DEGRANULATION,0.045624,-0.14366,-0.16269,1,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.038561,-0.14385,-0.22039,1,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00023468,-0.14386,-0.17712,1,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0057817,-0.14389,-0.15016,1,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.00014418,-0.14409,-0.14126,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.020205,-0.14426,-0.16214,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.2205,1,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.00027832,-0.14433,-0.17054,1,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.02843,-0.14441,-0.16162,1,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0064317,-0.14448,-0.27458,1,0
2,GO DIGESTION,0.0015653,-0.14509,-0.19905,1,0
2,GO B CELL DIFFERENTIATION,0.00072223,-0.14516,-0.14574,1,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.033166,-0.14521,-0.18167,1,0
2,GO INTERLEUKIN 12 PRODUCTION,9.0551e-05,-0.14593,-0.20401,1,0
2,GO PINOCYTOSIS,0.0081404,-0.14614,-0.19334,1,0
2,GO ADRENAL GLAND DEVELOPMENT,0.017137,-0.14649,-0.16391,1,0
2,GO RESPONSE TO CYTOKINE,2.7343e-05,-0.1465,-0.20786,1,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.017549,-0.14698,-0.17489,1,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00010092,-0.14707,-0.22429,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.013139,-0.1472,-0.12955,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.0038387,-0.14729,-0.19878,1,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.033894,-0.14733,-0.17238,1,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.041093,-0.14776,-0.11589,1,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0029794,-0.14783,-0.18808,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00023468,-0.1479,-0.18022,1,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,1.6455e-05,-0.14793,-0.19366,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.031059,-0.14812,-0.19896,1,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0056288,-0.14827,-0.22833,1,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0045306,-0.14846,-0.14495,1,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00072223,-0.14853,-0.17701,1,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.00054072,-0.14866,-0.17685,1,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.0064317,-0.14868,-0.12215,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0060989,-0.14869,-0.15419,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.014841,-0.14871,-0.13522,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.00037661,-0.14908,-0.19353,1,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0073363,-0.14928,-0.13891,1,0
2,GO STEROID METABOLIC PROCESS,0.00042998,-0.14953,-0.15695,1,0
2,GO INFLAMMATORY RESPONSE,9.389e-05,-0.15021,-0.1923,1,0
2,GO RESPONSE TO WOUNDING,0.0022992,-0.15044,-0.17161,1,0
2,GO INNATE IMMUNE RESPONSE,8.1192e-05,-0.15057,-0.21434,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.036948,-0.15084,-0.11635,1,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,5.2139e-05,-0.15094,-0.2063,1,0
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.010245,-0.1513,-0.16632,1,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.012508,-0.15138,-0.13589,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.1888e-05,-0.15141,-0.16446,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00017796,-0.15147,-0.21851,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00054072,-0.15166,-0.25071,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.0833e-05,-0.15167,-0.19055,1,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0085714,-0.15205,-0.2089,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0012662,-0.15214,-0.18238,1,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,-0.15243,-0.13325,1,0
2,GO PROTEIN KINASE B SIGNALING,0.00024286,-0.15245,-0.17902,1,0
2,GO CELL AGING,0.0025817,-0.15274,-0.12859,1,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.024288,-0.1537,-0.22842,1,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0016129,-0.15378,-0.16539,1,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0069616,-0.15388,-0.1645,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.026586,-0.15405,-0.20901,1,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00072223,-0.15416,-0.19685,1,0
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0069616,-0.15437,-0.18096,1,0
2,GO RESPONSE TO DEXAMETHASONE,0.0040578,-0.15452,-0.21006,1,0
2,GO INTERLEUKIN 10 PRODUCTION,0.0017123,-0.15452,-0.1783,1,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.0094949,-0.15475,-0.19538,1,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.014486,-0.15478,-0.13199,1,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0013872,-0.15484,-0.17205,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.027803,-0.15485,-0.26048,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.033166,-0.15502,-0.2219,1,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00011241,-0.15507,-0.18864,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0038387,-0.15509,-0.20133,1,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,7.547e-05,-0.15513,-0.19169,1,0
2,GO ENDOSOME ORGANIZATION,5.4121e-05,-0.1552,-0.16365,1,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0097392,-0.15521,-0.1415,1,0
2,GO RESPONSE TO OSMOTIC STRESS,0.00021909,-0.15531,-0.21331,1,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,4.0073e-05,-0.15539,-0.22633,1,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0060989,-0.15553,-0.23642,1,0
2,GO INTERACTION WITH HOST,0.00023468,-0.15553,-0.20735,1,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0017123,-0.15608,-0.17816,1,0
2,GO CYTOKINETIC PROCESS,0.00020448,-0.15655,-0.19539,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.004408,-0.15686,-0.20718,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.029068,-0.15687,-0.1293,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.03939,-0.15689,-0.10662,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00038934,-0.15701,-0.1975,1,0
2,GO HORMONE METABOLIC PROCESS,0.0067808,-0.15719,-0.14388,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,7.2754e-05,-0.15737,-0.21464,1,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.015203,-0.15749,-0.15353,1,0
2,GO PLATELET MORPHOGENESIS,0.0023671,-0.15791,-0.20418,1,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0010859,-0.158,-0.16977,1,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.021165,-0.15812,-0.22111,1,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.041093,-0.15817,-0.25168,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.024846,-0.15863,-0.17755,1,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.0050528,-0.15869,-0.14465,1,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.015574,-0.15869,-0.23932,1,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.016339,-0.15884,-0.13938,1,0
2,GO ERBB SIGNALING PATHWAY,0.00081984,-0.15887,-0.16867,1,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00035231,-0.15898,-0.19896,1,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.042857,-0.15907,-0.12421,1,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0038387,-0.15924,-0.17133,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0046564,-0.15925,-0.25782,1,0
2,GO WOUND HEALING,0.00079435,-0.15941,-0.19667,1,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.0013054,-0.15955,-0.17977,1,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.02843,-0.15992,-0.21776,1,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.018398,-0.15997,-0.1961,1,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.019739,-0.16005,-0.24831,1,0
2,GO VIRAL RNA GENOME REPLICATION,0.0024367,-0.16005,-0.19044,1,0
2,GO RESPONSE TO BACTERIUM,0.00019079,-0.16006,-0.1796,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00049035,-0.16022,-0.19736,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,8.7323e-05,-0.16038,-0.18204,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.00023468,-0.16054,-0.23741,1,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0069616,-0.16055,-0.22486,1,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0010206,-0.16092,-0.15737,1,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0045306,-0.16112,-0.21674,1,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0014299,-0.16137,-0.19755,1,0
2,GO MUSCLE CELL MIGRATION,0.0081404,-0.16145,-0.19098,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.012203,-0.16148,-0.22385,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00023468,-0.16148,-0.21272,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.00028792,-0.16186,-0.21885,1,0
2,GO ALPHA BETA T CELL ACTIVATION,2.1663e-05,-0.16189,-0.21903,1,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.16198,-0.16076,1,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0033369,-0.16216,-0.19602,1,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0022992,-0.16223,-0.20385,1,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0006154,-0.16244,-0.22024,1,0
2,GO INTERLEUKIN 6 PRODUCTION,1.7118e-05,-0.16265,-0.20715,1,0
2,GO VITAMIN D METABOLIC PROCESS,0.0040578,-0.16271,-0.24515,1,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.027188,-0.16273,-0.15577,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00095906,-0.16284,-0.17039,1,0
2,GO EXECUTION PHASE OF APOPTOSIS,6.7728e-06,-0.16291,-0.16951,1,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00027832,-0.16299,-0.17931,1,0
2,GO ARACHIDONIC ACID SECRETION,0.044685,-0.16302,-0.14062,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011199,-0.16388,-0.15168,1,0
2,GO AUTOPHAGY OF NUCLEUS,0.0090226,-0.16395,-0.17355,1,0
2,GO TISSUE MIGRATION,0.0018173,-0.164,-0.18606,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.00050664,-0.16407,-0.21656,1,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0051916,-0.16418,-0.16083,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.7728e-06,-0.1642,-0.22447,1,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.029719,-0.16429,-0.16906,1,0
2,GO B CELL MEDIATED IMMUNITY,0.00052342,-0.1645,-0.22056,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00013917,-0.16467,-0.20408,1,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,7.547e-05,-0.16473,-0.22495,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0025817,-0.16482,-0.16965,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0021062,-0.1653,-0.18625,1,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.00054072,-0.16546,-0.16441,1,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.029068,-0.16559,-0.16647,1,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.2962e-05,-0.16622,-0.18484,1,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.004408,-0.16623,-0.17947,1,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0087944,-0.16632,-0.18114,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0045306,-0.16651,-0.17642,1,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.030383,-0.16659,-0.13403,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.038561,-0.16663,-0.17099,1,0
2,GO NUCLEOTIDE TRANSPORT,0.00081984,-0.16688,-0.15681,1,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00031859,-0.16723,-0.20152,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.1888e-05,-0.16745,-0.18481,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00025131,-0.1675,-0.20884,1,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.010506,-0.16822,-0.18977,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.4421e-05,-0.16827,-0.22811,1,0
2,GO FOAM CELL DIFFERENTIATION,0.0050528,-0.1683,-0.20934,1,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00074557,-0.16841,-0.16694,1,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.043763,-0.16846,-0.28935,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00016595,-0.16857,-0.18535,1,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0011549,-0.16873,-0.19672,1,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.6597e-05,-0.16889,-0.21798,1,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00016595,-0.16949,-0.18892,1,0
2,GO RESPIRATORY BURST,0.00353,-0.16957,-0.2234,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0020453,-0.16959,-0.20314,1,0
2,GO PROTEIN DEGLYCOSYLATION,0.0064317,-0.1697,-0.22064,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0049174,-0.16991,-0.26767,1,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0066042,-0.17039,-0.15233,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,4.0073e-05,-0.17085,-0.22806,1,0
2,GO LEUKOCYTE PROLIFERATION,2.5308e-05,-0.17088,-0.21178,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.00057693,-0.17102,-0.18069,1,0
2,GO IMMUNE EFFECTOR PROCESS,2.7343e-05,-0.17105,-0.21922,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.00019079,-0.17111,-0.24249,1,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.013139,-0.17116,-0.20476,1,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.0087944,-0.17135,-0.195,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.0032441,-0.17151,-0.24164,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00023468,-0.17196,-0.25624,1,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.7145e-05,-0.17199,-0.21851,1,0
2,GO RESPONSE TO MINERALOCORTICOID,0.0064317,-0.1721,-0.18987,1,0
2,GO MONONUCLEAR CELL MIGRATION,0.0066042,-0.17227,-0.18247,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,2.5308e-05,-0.17253,-0.19512,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0066042,-0.17267,-0.27222,1,0
2,GO PROTEIN DEMANNOSYLATION,0.0094949,-0.173,-0.19899,1,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00034072,-0.17338,-0.18173,1,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.7323e-05,-0.17349,-0.19885,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00050664,-0.17351,-0.16919,1,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0049174,-0.1736,-0.2285,1,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00020448,-0.17383,-0.21542,1,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0069616,-0.17413,-0.15896,1,0
2,GO DECIDUALIZATION,0.015574,-0.17437,-0.24268,1,0
2,GO IMMUNOGLOBULIN SECRETION,0.00079435,-0.17456,-0.25702,1,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.00012512,-0.17458,-0.19752,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00016023,-0.1747,-0.28267,1,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.508e-06,-0.17478,-0.20519,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0069616,-0.17487,-0.21211,1,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0037331,-0.17512,-0.19168,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.8379e-05,-0.17517,-0.20953,1,0
2,GO LEUKOCYTE MIGRATION,0.00010092,-0.1754,-0.20758,1,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00021909,-0.17552,-0.18322,1,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,7.013e-05,-0.17552,-0.19854,1,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,7.6603e-06,-0.17567,-0.23566,1,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00019753,-0.17593,-0.20694,1,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0062634,-0.17599,-0.15761,1,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.001662,-0.17605,-0.21624,1,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0066042,-0.1761,-0.15874,1,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.0226e-05,-0.17643,-0.2135,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0010528,-0.17675,-0.24865,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00021167,-0.17682,-0.20944,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00036427,-0.17688,-0.22554,1,0
2,GO HYALURONAN CATABOLIC PROCESS,0.021165,-0.17707,-0.28131,1,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00055855,-0.17721,-0.2595,1,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.023205,-0.17732,-0.17066,1,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00011241,-0.17733,-0.22805,1,0
2,GO PHOSPHOLIPID TRANSPORT,0.00022676,-0.17764,-0.18402,1,0
2,GO RESPONSE TO VIRUS,7.2754e-05,-0.17783,-0.22471,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.024846,-0.17784,-0.1724,1,0
2,GO MYOTUBE DIFFERENTIATION,0.00072223,-0.17793,-0.1675,1,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.0025817,-0.17799,-0.18111,1,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001662,-0.17829,-0.18616,1,0
2,GO CYTOLYSIS,0.0059384,-0.17859,-0.22627,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00098941,-0.1788,-0.23159,1,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.02068,-0.17892,-0.14708,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0031536,-0.17902,-0.21194,1,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.4421e-05,-0.1794,-0.24037,1,0
2,GO REGULATION OF B CELL ACTIVATION,4.1112e-06,-0.17951,-0.21978,1,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0094949,-0.17971,-0.1958,1,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00067758,-0.1801,-0.18915,1,0
2,GO GLOMERULUS DEVELOPMENT,0.0085714,-0.18019,-0.21021,1,0
2,GO INOSITOL METABOLIC PROCESS,0.0064317,-0.18031,-0.18165,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00025131,-0.18033,-0.22486,1,0
2,GO CELL MATRIX ADHESION,0.0026572,-0.18045,-0.18527,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00065623,-0.1806,-0.2215,1,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0057817,-0.18086,-0.1528,1,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00069957,-0.18089,-0.19724,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00035231,-0.1812,-0.1832,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.016734,-0.1817,-0.26192,1,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.009256,-0.18188,-0.19637,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001872,-0.18209,-0.20931,1,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0037331,-0.18231,-0.18013,1,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0017641,-0.18247,-0.28708,1,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0028957,-0.1825,-0.17475,1,0
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0022332,-0.18262,-0.16908,1,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.013465,-0.18265,-0.13709,1,0
2,GO ENDOTHELIAL CELL MIGRATION,0.0012662,-0.1828,-0.1955,1,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00037661,-0.18291,-0.20431,1,0
2,GO SELECTIVE AUTOPHAGY,9.0551e-05,-0.18299,-0.19161,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0011549,-0.18307,-0.20978,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0038387,-0.18316,-0.20055,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0013054,-0.18327,-0.2474,1,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.02268,-0.18345,-0.14584,1,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0047853,-0.1835,-0.15685,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,2.6307e-05,-0.18362,-0.21905,1,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00030804,-0.18371,-0.17573,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0028141,-0.18372,-0.17241,1,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.026586,-0.18417,-0.1891,1,0
2,GO ENTRY INTO HOST,0.00025131,-0.18418,-0.27573,1,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00038934,-0.18431,-0.19423,1,0
2,GO CELLULAR DEFENSE RESPONSE,2.0033e-05,-0.1844,-0.26577,1,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0097392,-0.18444,-0.24678,1,0
2,GO RESPONSE TO ISCHEMIA,0.00072223,-0.18462,-0.18076,1,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.040234,-0.18528,-0.23529,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00023468,-0.18535,-0.22987,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0081404,-0.18559,-0.22411,1,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0021062,-0.18579,-0.21963,1,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.00092958,-0.18612,-0.18922,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0075304,-0.18614,-0.27118,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00019753,-0.18634,-0.21728,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0184e-05,-0.18638,-0.22824,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00018427,-0.18649,-0.21516,1,0
2,GO EPIBOLY,0.0066042,-0.18736,-0.26112,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00019753,-0.18755,-0.21614,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,1.9263e-05,-0.18755,-0.22635,1,0
2,GO RESPONSE TO STEROL DEPLETION,0.029719,-0.18758,-0.19084,1,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.0010528,-0.18766,-0.19233,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.4692e-06,-0.18775,-0.25714,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0017123,-0.18781,-0.19011,1,0
2,GO ERBB2 SIGNALING PATHWAY,0.0022332,-0.18804,-0.20131,1,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.014138,-0.18815,-0.21535,1,0
2,GO MYOBLAST DIFFERENTIATION,0.00092958,-0.18826,-0.19843,1,0
2,GO VIRION ASSEMBLY,5.2139e-05,-0.18847,-0.18346,1,0
2,GO ACTIVATED T CELL PROLIFERATION,0.001872,-0.18849,-0.17369,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00072223,-0.18886,-0.25666,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.0073e-05,-0.18891,-0.24435,1,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.031748,-0.18908,-0.25943,1,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.0051916,-0.18931,-0.2838,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0060989,-0.18936,-0.21503,1,0
2,GO MYOBLAST FUSION,0.010773,-0.18944,-0.18774,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0040578,-0.18948,-0.22889,1,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.4712e-06,-0.18949,-0.26268,1,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0034322,-0.18974,-0.20556,1,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00021167,-0.18989,-0.20458,1,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.6174e-05,-0.19019,-0.24726,1,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00016595,-0.19024,-0.23246,1,0
2,GO T CELL APOPTOTIC PROCESS,0.0038387,-0.19041,-0.17772,1,0
2,GO NEURAL TUBE FORMATION,0.00084609,-0.19044,-0.16207,1,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.001191,-0.19063,-0.25092,1,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00045924,-0.19068,-0.26862,1,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.2524e-05,-0.19077,-0.22405,1,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.033166,-0.19115,-0.28663,1,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00095906,-0.19141,-0.1788,1,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0022332,-0.1916,-0.22829,1,0
2,GO MOVEMENT IN HOST ENVIRONMENT,9.0551e-05,-0.19173,-0.25576,1,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.4039e-05,-0.19176,-0.24737,1,0
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00084609,-0.19236,-0.20332,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.6455e-05,-0.19247,-0.24337,1,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.031748,-0.19258,-0.15494,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.4039e-05,-0.19259,-0.22786,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.016339,-0.1928,-0.16641,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.040234,-0.19293,-0.1811,1,0
2,GO CYTOKINE METABOLIC PROCESS,7.013e-05,-0.19293,-0.23796,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00013433,-0.19295,-0.23332,1,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,7.0571e-06,-0.19301,-0.24091,1,0
2,GO SARCOMERE ORGANIZATION,0.019283,-0.19342,-0.13592,1,0
2,GO B CELL PROLIFERATION,6.7728e-06,-0.19344,-0.21626,1,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00013433,-0.1938,-0.26837,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00069957,-0.19411,-0.28944,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0022332,-0.19442,-0.23288,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00035231,-0.19445,-0.27118,1,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,8.4205e-05,-0.19458,-0.23955,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,4.0073e-05,-0.19461,-0.21951,1,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.00079435,-0.19463,-0.2202,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0034322,-0.19464,-0.19507,1,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00041602,-0.19474,-0.23434,1,0
2,GO CELL KILLING,4.8379e-05,-0.19557,-0.21015,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0010528,-0.19587,-0.23322,1,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.001191,-0.19615,-0.26406,1,0
2,GO RESPONSE TO PROGESTERONE,0.0053338,-0.19621,-0.21442,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00072223,-0.19628,-0.23082,1,0
2,GO CARNITINE METABOLIC PROCESS,0.031059,-0.19645,-0.17669,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.036948,-0.19646,-0.17534,1,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,1.349e-05,-0.19654,-0.21815,1,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0067808,-0.19666,-0.189,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00037661,-0.19725,-0.2022,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00041602,-0.19728,-0.1894,1,0
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00069957,-0.19779,-0.2135,1,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.02268,-0.19793,-0.17753,1,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00041602,-0.19797,-0.214,1,0
2,GO BONE RESORPTION,0.00010092,-0.19815,-0.24914,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00045924,-0.19821,-0.29092,1,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0031536,-0.19854,-0.20591,1,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,3.0689e-05,-0.19873,-0.23229,1,0
2,GO TYPE 2 IMMUNE RESPONSE,0.02268,-0.1991,-0.2315,1,0
2,GO REGULATION OF RESPIRATORY BURST,0.0019282,-0.19929,-0.22521,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00032948,-0.19936,-0.21915,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.4692e-06,-0.19939,-0.23346,1,0
2,GO RESPONSE TO SALT STRESS,0.0028141,-0.19994,-0.18391,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0022332,-0.20028,-0.24184,1,0
2,GO SYNCYTIUM FORMATION,0.009256,-0.20041,-0.16986,1,0
2,GO PLATELET ACTIVATION,4.8379e-05,-0.2005,-0.22781,1,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.007729,-0.20085,-0.21977,1,0
2,GO LEUKOCYTE CHEMOTAXIS,0.00050664,-0.20101,-0.18173,1,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.4878e-05,-0.20101,-0.20883,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,8.7323e-05,-0.20112,-0.22811,1,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,9.0551e-05,-0.2015,-0.2235,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00087311,-0.20153,-0.28789,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0001547,-0.2017,-0.25191,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00090094,-0.20214,-0.27651,1,0
2,GO TRANSCYTOSIS,0.0031536,-0.20224,-0.18865,1,0
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0032441,-0.20326,-0.20099,1,0
2,GO LIPID DROPLET ORGANIZATION,0.0067808,-0.20371,-0.20646,1,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00084609,-0.20385,-0.24792,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0053338,-0.20387,-0.19037,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.019283,-0.20392,-0.23481,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.5308e-05,-0.20407,-0.21732,1,0
2,GO REGULATION OF TISSUE REMODELING,0.00042998,-0.20414,-0.22906,1,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00037661,-0.20418,-0.29123,1,0
2,GO RESPONSE TO DSRNA,2.4346e-05,-0.20421,-0.23345,1,0
2,GO HYPEROSMOTIC RESPONSE,0.010245,-0.20435,-0.22975,1,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00017796,-0.20443,-0.23213,1,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0099891,-0.20449,-0.28059,1,0
2,GO PIGMENT ACCUMULATION,0.0019282,-0.20454,-0.21047,1,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0014738,-0.20495,-0.18685,1,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2367e-06,-0.20496,-0.21023,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.0033e-05,-0.205,-0.23401,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0097392,-0.20506,-0.1892,1,0
2,GO DEFENSE RESPONSE TO VIRUS,1.0604e-05,-0.20507,-0.29132,1,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.02166,-0.20542,-0.16322,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.3218e-05,-0.20602,-0.24133,1,0
2,GO ADAPTIVE IMMUNE RESPONSE,4.8612e-06,-0.20612,-0.27527,1,0
2,GO SECRETION BY TISSUE,0.0051916,-0.20616,-0.19489,1,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.6597e-05,-0.20626,-0.22392,1,0
2,GO T CELL CYTOKINE PRODUCTION,0.0021062,-0.20637,-0.19716,1,0
2,GO RUFFLE ASSEMBLY,2.7343e-05,-0.20656,-0.20142,1,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,6.5149e-05,-0.20679,-0.31758,1,0
2,GO AMYLOID BETA CLEARANCE,0.0013054,-0.20698,-0.22591,1,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.033894,-0.20706,-0.26319,1,0
2,GO LIVER MORPHOGENESIS,0.016734,-0.20716,-0.21557,1,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0059384,-0.20722,-0.19493,1,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.1493e-05,-0.2073,-0.26298,1,0
2,GO RESPONSE TO CORTICOSTERONE,0.025414,-0.20743,-0.18599,1,0
2,GO EPIDERMIS DEVELOPMENT,0.00014418,-0.20756,-0.21713,1,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0036303,-0.20774,-0.25455,1,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0029794,-0.20778,-0.19736,1,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.03245,-0.20785,-0.15697,1,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00027832,-0.20799,-0.23162,1,0
2,GO RETINOL METABOLIC PROCESS,0.004408,-0.20841,-0.21599,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00021167,-0.20845,-0.23333,1,0
2,GO REGULATION OF SYMBIOTIC PROCESS,4.8612e-06,-0.20854,-0.25395,1,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.0001165,-0.2089,-0.22845,1,0
2,GO CELL CHEMOTAXIS,0.00021909,-0.2091,-0.21105,1,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00040247,-0.20925,-0.23282,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00035231,-0.20936,-0.25228,1,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,7.6603e-06,-0.20979,-0.28961,1,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.041967,-0.21002,-0.19789,1,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,2.0033e-05,-0.21005,-0.25845,1,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.02068,-0.2102,-0.15951,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00047456,-0.21072,-0.20916,1,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00032948,-0.21118,-0.19742,1,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0022332,-0.21124,-0.21895,1,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.0059384,-0.212,-0.22873,1,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.035393,-0.21204,-0.21864,1,0
2,GO BONE REMODELING,0.0023671,-0.21257,-0.2058,1,0
2,GO INTEGRIN ACTIVATION,0.0047853,-0.21272,-0.18373,1,0
2,GO MYELOID CELL HOMEOSTASIS,1.3441e-06,-0.2128,-0.23328,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0001547,-0.2128,-0.24527,1,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.024846,-0.213,-0.32162,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0034322,-0.21308,-0.28718,1,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0079323,-0.21327,-0.2765,1,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0014299,-0.21335,-0.21974,1,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.018398,-0.21341,-0.25223,1,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.031059,-0.21353,-0.25526,1,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.033894,-0.21372,-0.3121,1,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.011904,-0.21382,-0.30764,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.349e-05,-0.21411,-0.2275,1,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.5201e-05,-0.21438,-0.23891,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00027832,-0.21478,-0.44378,1,0
2,GO ERYTHROCYTE HOMEOSTASIS,3.9418e-06,-0.2149,-0.21464,1,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0042883,-0.21496,-0.25543,1,0
2,GO EPOXYGENASE P450 PATHWAY,0.027803,-0.21499,-0.20473,1,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.0021689,-0.21525,-0.23076,1,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,2.8077e-06,-0.21602,-0.258,1,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0017123,-0.21623,-0.2002,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0015653,-0.21637,-0.22438,1,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0051916,-0.2164,-0.28379,1,0
2,GO RUFFLE ORGANIZATION,1.8251e-06,-0.2164,-0.23284,1,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0056288,-0.21681,-0.22445,1,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,2.0833e-05,-0.21717,-0.28627,1,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.007729,-0.2172,-0.18972,1,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.038561,-0.21736,-0.12661,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.001872,-0.21745,-0.22633,1,0
2,GO VIRAL RELEASE FROM HOST CELL,3.7145e-05,-0.21746,-0.2249,1,0
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00012074,-0.21762,-0.22916,1,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.027803,-0.21769,-0.2694,1,0
2,GO B CELL HOMEOSTASIS,0.00095906,-0.21798,-0.19803,1,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.00012964,-0.21813,-0.21374,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00072223,-0.21844,-0.38121,1,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,4.6597e-05,-0.21844,-0.27494,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,-0.21881,-0.22821,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00034072,-0.21895,-0.25596,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00057693,-0.21909,-0.2238,1,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.7801e-06,-0.21911,-0.22932,1,0
2,GO SIGNAL PEPTIDE PROCESSING,0.0067808,-0.21924,-0.25348,1,0
2,GO BILE ACID METABOLIC PROCESS,0.00029782,-0.2194,-0.23689,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0013872,-0.21998,-0.21366,1,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.022165,-0.22046,-0.30264,1,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.00063551,-0.22083,-0.25337,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.1888e-05,-0.2211,-0.23803,1,0
2,GO AUTOPHAGOSOME MATURATION,1.5816e-05,-0.22118,-0.24119,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0012662,-0.22119,-0.1921,1,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00057693,-0.22128,-0.23266,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00050664,-0.2215,-0.34457,1,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00047456,-0.22181,-0.30078,1,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.00021909,-0.22208,-0.26744,1,0
2,GO REPLICATIVE SENESCENCE,0.0056288,-0.22224,-0.24502,1,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.041093,-0.22243,-0.17409,1,0
2,GO TYPE I INTERFERON PRODUCTION,1.7806e-05,-0.22249,-0.26177,1,0
2,GO PLASMA MEMBRANE FUSION,0.017137,-0.22282,-0.23327,1,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021167,-0.22296,-0.25183,1,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.001191,-0.2234,-0.27485,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1.2962e-05,-0.22379,-0.25205,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0023671,-0.22396,-0.25787,1,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00037661,-0.22421,-0.28849,1,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.7346e-05,-0.2244,-0.29735,1,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.02068,-0.22446,-0.22039,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.022165,-0.22456,-0.32724,1,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.1964e-05,-0.22495,-0.26598,1,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00063551,-0.22548,-0.24408,1,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0018173,-0.22555,-0.20433,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00037661,-0.22566,-0.27089,1,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.0033369,-0.22573,-0.17479,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.021165,-0.22574,-0.19885,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.4205e-05,-0.22625,-0.25703,1,0
2,GO ICOSANOID METABOLIC PROCESS,3.7145e-05,-0.22668,-0.28532,1,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,4.3218e-05,-0.22675,-0.26395,1,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0037331,-0.22683,-0.32646,1,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.010773,-0.22713,-0.29178,1,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00087311,-0.22774,-0.25064,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.3287e-06,-0.22793,-0.27099,1,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.0060989,-0.22806,-0.16842,1,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.00014418,-0.2281,-0.23263,1,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00021909,-0.22836,-0.24462,1,0
2,GO MAGNESIUM ION TRANSPORT,0.00011241,-0.22871,-0.25318,1,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0021689,-0.22912,-0.2064,1,0
2,GO PEPTIDE CROSS LINKING,0.00074557,-0.2292,-0.27732,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,9.389e-05,-0.22922,-0.25803,1,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,3.3132e-05,-0.22927,-0.25606,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00098941,-0.2299,-0.3001,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.014486,-0.22997,-0.25917,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.8282e-05,-0.22999,-0.25631,1,0
2,GO CELL CELL JUNCTION ASSEMBLY,3.8583e-05,-0.23078,-0.22764,1,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001662,-0.23113,-0.27734,1,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.041093,-0.23137,-0.23616,1,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00055855,-0.23152,-0.25557,1,0
2,GO INTERFERON BETA PRODUCTION,1.0604e-05,-0.23186,-0.27131,1,0
2,GO REGULATION OF COAGULATION,0.00055855,-0.23257,-0.29129,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.6228e-06,-0.23276,-0.25656,1,0
2,GO PARTURITION,0.036948,-0.23293,-0.19116,1,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00098941,-0.23354,-0.19061,1,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.018836,-0.23373,-0.19812,1,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.010773,-0.23411,-0.22207,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.00042998,-0.23433,-0.25572,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.001191,-0.23435,-0.32222,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.2962e-05,-0.23486,-0.29436,1,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0026572,-0.23519,-0.22013,1,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0037331,-0.23594,-0.29573,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.0011549,-0.23638,-0.2515,1,0
2,GO POSITIVE REGULATION OF CELL KILLING,3.7145e-05,-0.23639,-0.27898,1,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.0013457,-0.23647,-0.225,1,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.9801e-06,-0.23665,-0.27186,1,0
2,GO REGULATION OF B CELL PROLIFERATION,2.9301e-06,-0.23679,-0.27059,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0010206,-0.23703,-0.23577,1,0
2,GO LIPID STORAGE,0.0017123,-0.2376,-0.19766,1,0
2,GO TISSUE REMODELING,0.00011241,-0.23801,-0.25066,1,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00028792,-0.23826,-0.27426,1,0
2,GO MAST CELL ACTIVATION,0.00022676,-0.23879,-0.25699,1,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0014299,-0.23884,-0.21735,1,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00016023,-0.23913,-0.24037,1,0
2,GO WATER HOMEOSTASIS,0.0031536,-0.23915,-0.19219,1,0
2,GO GALACTOSE METABOLIC PROCESS,0.0099891,-0.23941,-0.26489,1,0
2,GO RESPONSE TO INTERFERON GAMMA,7.013e-05,-0.2395,-0.34676,1,0
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.018836,-0.23976,-0.21978,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.014138,-0.23977,-0.27635,1,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.104e-05,-0.23987,-0.29836,1,0
2,GO REGULATION OF VASCULOGENESIS,0.0099891,-0.24017,-0.29189,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0062634,-0.2404,-0.24662,1,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0016129,-0.24042,-0.25439,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00022676,-0.24109,-0.24779,1,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0025083,-0.2413,-0.22793,1,0
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00059588,-0.24139,-0.2342,1,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.040234,-0.24174,-0.16518,1,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00054072,-0.24234,-0.35342,1,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.025994,-0.24235,-0.19732,1,0
2,GO RESPONSE TO GROWTH HORMONE,0.0040578,-0.24241,-0.23025,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.24263,-0.23211,1,0
2,GO MONOCYTE CHEMOTAXIS,0.00026003,-0.24264,-0.27423,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.001228,-0.24284,-0.3497,1,0
2,GO REGULATION OF CELL KILLING,4.3218e-05,-0.24302,-0.25466,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.026586,-0.24348,-0.21546,1,0
2,GO BLOOD VESSEL REMODELING,5.8301e-05,-0.24374,-0.28353,1,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.4039e-05,-0.24455,-0.26718,1,0
2,GO MITOTIC CYTOKINETIC PROCESS,9.7346e-05,-0.24498,-0.23374,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0019282,-0.24553,-0.25026,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.035393,-0.24579,-0.15165,1,0
2,GO LIPID TRANSLOCATION,0.00029782,-0.24599,-0.24477,1,0
2,GO T CELL MEDIATED IMMUNITY,1.349e-05,-0.24601,-0.31979,1,0
2,GO SKIN DEVELOPMENT,3.5759e-05,-0.24604,-0.24252,1,0
2,GO RESPONSE TO WATER,0.0073363,-0.24628,-0.263,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0018173,-0.24667,-0.24993,1,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,8.1192e-05,-0.24744,-0.25334,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00055855,-0.24747,-0.22007,1,0
2,GO RESPONSE TO INTERLEUKIN 6,0.00087311,-0.24778,-0.22617,1,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019079,-0.24805,-0.25445,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00021909,-0.24828,-0.28121,1,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.9841e-06,-0.2484,-0.29103,1,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00012964,-0.24848,-0.28253,1,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.00026003,-0.24949,-0.26777,1,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.00037661,-0.24978,-0.23312,1,0
2,GO VIRAL GENOME REPLICATION,6.2786e-05,-0.24984,-0.27489,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00057693,-0.25032,-0.2706,1,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0047853,-0.25033,-0.20898,1,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00037661,-0.25061,-0.26557,1,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.1904e-06,-0.25066,-0.29737,1,0
2,GO REGULATION OF PLATELET AGGREGATION,0.001872,-0.25093,-0.35068,1,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.9263e-05,-0.25098,-0.2357,1,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0021689,-0.25107,-0.2889,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00063551,-0.25169,-0.27116,1,0
2,GO MAST CELL MEDIATED IMMUNITY,0.0010206,-0.25181,-0.24688,1,0
2,GO RENAL ABSORPTION,0.010245,-0.25183,-0.35835,1,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.02268,-0.25234,-0.26027,1,0
2,GO CHEMOKINE PRODUCTION,3.7145e-05,-0.25251,-0.2565,1,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.00010845,-0.25366,-0.2439,1,0
2,GO INTERLEUKIN 1 PRODUCTION,8.7323e-05,-0.25409,-0.29936,1,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.00029782,-0.25432,-0.27075,1,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.019739,-0.25456,-0.27061,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.0184e-05,-0.25471,-0.28118,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00055855,-0.25482,-0.26655,1,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00090094,-0.25546,-0.34097,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.011326,-0.25553,-0.24241,1,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.00021909,-0.25559,-0.22832,1,0
2,GO ZYMOGEN ACTIVATION,0.00063551,-0.25643,-0.35191,1,0
2,GO INTERLEUKIN 8 PRODUCTION,8.6584e-06,-0.25649,-0.29807,1,0
2,GO REGULATION OF PLATELET ACTIVATION,0.00034072,-0.25693,-0.30618,1,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00010845,-0.25695,-0.28695,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0066042,-0.25761,-0.3278,1,0
2,GO ACUTE INFLAMMATORY RESPONSE,5.2139e-05,-0.25783,-0.28276,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00042998,-0.25785,-0.30084,1,0
2,GO ACUTE PHASE RESPONSE,3.4421e-05,-0.25812,-0.27425,1,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0053338,-0.25815,-0.24831,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.7806e-05,-0.25853,-0.28628,1,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0013457,-0.25853,-0.35324,1,0
2,GO VIRAL BUDDING,0.00010462,-0.25912,-0.21591,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0033369,-0.25972,-0.22983,1,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.026586,-0.25999,-0.20943,1,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00014935,-0.26026,-0.20258,1,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0064317,-0.26167,-0.28592,1,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00065623,-0.26212,-0.30209,1,0
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.001872,-0.26253,-0.27278,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00084609,-0.26264,-0.28874,1,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.0023671,-0.26297,-0.25623,1,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.022165,-0.26382,-0.18931,1,0
2,GO CELLULAR RESPONSE TO DSRNA,8.6584e-06,-0.26389,-0.31727,1,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.030383,-0.26523,-0.24227,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,3.0576e-06,-0.26553,-0.32556,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.8418e-05,-0.26567,-0.32682,1,0
2,GO RESPONSE TO TUMOR CELL,0.00032948,-0.26624,-0.29501,1,0
2,GO B CELL APOPTOTIC PROCESS,4.6597e-05,-0.26682,-0.30486,1,0
2,GO REGULATION OF BONE REMODELING,0.001872,-0.26684,-0.22246,1,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.8521e-05,-0.26686,-0.25543,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.1702e-06,-0.26755,-0.30202,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00037661,-0.26779,-0.27761,1,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0059384,-0.26827,-0.32076,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0094949,-0.26859,-0.25972,1,0
2,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26868,-0.26444,1,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0023671,-0.26894,-0.38328,1,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.027803,-0.27031,-0.21638,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.906e-06,-0.27093,-0.32942,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.0198e-07,-0.27118,-0.30341,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00036427,-0.27483,-0.44575,1,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.0013872,-0.27616,-0.38119,1,0
2,GO MYELOID CELL APOPTOTIC PROCESS,4.0073e-05,-0.27655,-0.33597,1,0
2,GO INTESTINAL LIPID ABSORPTION,0.0067808,-0.27675,-0.29693,1,0
2,GO POSITIVE REGULATION OF COAGULATION,2.9532e-05,-0.27791,-0.30138,1,0
2,GO OSTEOBLAST PROLIFERATION,0.001191,-0.27803,-0.26651,1,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00019753,-0.27869,-0.24471,1,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,1.2962e-05,-0.2788,-0.29345,1,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.029719,-0.2789,-0.25312,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00017186,-0.27974,-0.30443,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.00037661,-0.27988,-0.24453,1,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,4.8379e-05,-0.28012,-0.2899,1,0
2,GO SUPEROXIDE ANION GENERATION,0.00063551,-0.28045,-0.32478,1,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0042883,-0.28158,-0.29926,1,0
2,GO ETHER METABOLIC PROCESS,0.00026903,-0.28228,-0.30125,1,0
2,GO CYTOPLASM ORGANIZATION,0.0075304,-0.28238,-0.22968,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0025817,-0.28244,-0.28134,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.00042998,-0.28267,-0.37348,1,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,7.2754e-05,-0.28283,-0.24293,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7145e-05,-0.28424,-0.27678,1,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.010245,-0.2846,-0.23153,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.6307e-05,-0.28535,-0.28893,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00029782,-0.28584,-0.39216,1,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,2.7343e-05,-0.28681,-0.32332,1,0
2,GO VASCULAR WOUND HEALING,0.02268,-0.28691,-0.23404,1,0
2,GO BILE ACID AND BILE SALT TRANSPORT,0.00031859,-0.28802,-0.33909,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.906e-06,-0.28828,-0.33516,1,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.00045924,-0.28897,-0.29257,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.0051916,-0.28909,-0.36048,1,0
2,GO REGULATION OF ICOSANOID SECRETION,0.0028957,-0.28967,-0.25114,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00019079,-0.28992,-0.34639,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.011904,-0.29031,-0.28568,1,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.3127e-06,-0.29078,-0.34771,1,0
2,GO PLATELET AGGREGATION,2.7343e-05,-0.2915,-0.28834,1,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0041716,-0.29222,-0.291,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0001547,-0.29237,-0.28161,1,0
2,GO BLEB ASSEMBLY,0.021165,-0.29254,-0.43374,1,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.014486,-0.29265,-0.31334,1,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00011241,-0.29284,-0.31776,1,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.001228,-0.29358,-0.27892,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.025994,-0.29523,-0.19634,1,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00017186,-0.29525,-0.32582,1,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.037747,-0.29553,-0.35636,1,0
2,GO ANOIKIS,8.7323e-05,-0.29572,-0.28189,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,4.0073e-05,-0.29609,-0.31569,1,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.027188,-0.29624,-0.19287,1,0
2,GO GDP METABOLIC PROCESS,0.0026572,-0.29646,-0.27973,1,0
2,GO RESPONSE TO COPPER ION,0.0079323,-0.29813,-0.33201,1,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00047456,-0.29911,-0.39006,1,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0040578,-0.29949,-0.29456,1,0
2,GO TRANSPOSITION,0.0016129,-0.29961,-0.29168,1,0
2,GO ACTIN FILAMENT SEVERING,0.0026572,-0.29993,-0.29824,1,0
2,GO NEUTROPHIL HOMEOSTASIS,0.00065623,-0.30079,-0.39153,1,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.00019753,-0.30128,-0.31318,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.00047456,-0.30152,-0.38351,1,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00081984,-0.30237,-0.35103,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,6.0504e-05,-0.30278,-0.27319,1,0
2,GO KERATINOCYTE DIFFERENTIATION,0.00010462,-0.30547,-0.28576,1,0
2,GO PROTEIN ADP RIBOSYLATION,0.0001165,-0.307,-0.27518,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00092958,-0.3071,-0.26528,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0006154,-0.30765,-0.37219,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.5816e-05,-0.30819,-0.43685,1,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.001986,-0.30834,-0.28096,1,0
2,GO CELLULAR RESPONSE TO IRON ION,0.00087311,-0.3086,-0.32045,1,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00014418,-0.30888,-0.37632,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.0073e-05,-0.30911,-0.33937,1,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00013917,-0.31018,-0.33938,1,0
2,GO NECROTIC CELL DEATH,6.4994e-06,-0.31051,-0.33546,1,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00030804,-0.31067,-0.29866,1,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00034072,-0.31111,-0.42703,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.3287e-06,-0.31412,-0.31366,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.00090094,-0.3142,-0.27679,1,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00084609,-0.31438,-0.30324,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00081984,-0.31523,-0.33942,1,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,2.1663e-05,-0.31636,-0.36479,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,2.0033e-05,-0.31793,-0.38637,1,0
2,GO GAP JUNCTION ASSEMBLY,0.00014935,-0.31816,-0.43842,1,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00057693,-0.3186,-0.30526,1,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.023741,-0.31958,-0.26532,1,0
2,GO HOMOTYPIC CELL CELL ADHESION,5.6174e-05,-0.31967,-0.31735,1,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0021689,-0.32083,-0.29214,1,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.02843,-0.32136,-0.27037,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,1.0604e-05,-0.32397,-0.34274,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00024286,-0.32402,-0.3184,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,4.0073e-05,-0.32404,-0.54178,1,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.6228e-06,-0.32574,-0.32281,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.6228e-06,-0.32644,-0.36394,1,0
2,GO REGULATION OF TRANSPOSITION,0.00055855,-0.32692,-0.36283,1,0
2,GO GONADOTROPIN SECRETION,0.0087944,-0.32702,-0.24222,1,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0038387,-0.32707,-0.34759,1,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,3.4728e-06,-0.32747,-0.32374,1,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.011326,-0.32833,-0.26214,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,5.7413e-06,-0.32884,-0.4238,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00024286,-0.32924,-0.43751,1,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0027346,-0.32995,-0.29963,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00019079,-0.33079,-0.41558,1,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,2.1663e-05,-0.33282,-0.29763,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00032948,-0.33309,-0.39658,1,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0013054,-0.33423,-0.35427,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.001191,-0.33455,-0.32261,1,0
2,GO LIPOXYGENASE PATHWAY,0.00050664,-0.33473,-0.39203,1,0
2,GO MIDBODY ABSCISSION,6.7596e-05,-0.33492,-0.30642,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00031859,-0.3353,-0.53124,1,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,9.0179e-06,-0.3372,-0.46172,1,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,5.4121e-05,-0.33845,-0.3205,1,0
2,GO INTESTINAL ABSORPTION,6.2786e-05,-0.33876,-0.3703,1,0
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.547e-05,-0.34072,-0.33321,1,0
2,GO NATURAL KILLER CELL PROLIFERATION,0.0014299,-0.34164,-0.32706,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00026903,-0.34171,-0.43721,1,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0027346,-0.34184,-0.28255,1,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0779e-06,-0.34249,-0.37885,1,0
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0018173,-0.34278,-0.30715,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,4.3218e-05,-0.34605,-0.35587,1,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0062634,-0.34641,-0.33224,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.1493e-05,-0.34731,-0.38512,1,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0060989,-0.3483,-0.26928,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.0073e-05,-0.35072,-0.36928,1,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00018427,-0.35131,-0.37935,1,0
2,GO EOSINOPHIL MIGRATION,0.0046564,-0.35155,-0.321,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0016129,-0.35272,-0.31408,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.007729,-0.35371,-0.33735,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.8418e-05,-0.35374,-0.39155,1,0
2,GO KERATINIZATION,0.00026903,-0.35421,-0.30262,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.3528e-06,-0.35437,-0.40299,1,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0056288,-0.35443,-0.38076,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,1.0779e-06,-0.35473,-0.37053,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.00044439,-0.35674,-0.49281,1,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.0016129,-0.35776,-0.32365,1,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,3.0689e-05,-0.35839,-0.32281,1,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.00041602,-0.35972,-0.29556,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.0683e-06,-0.36068,-0.41557,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00026903,-0.3613,-0.41234,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.00012964,-0.3646,-0.38939,1,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0066042,-0.36483,-0.38634,1,0
2,GO DETECTION OF OTHER ORGANISM,4.6623e-06,-0.36562,-0.46289,1,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,7.6603e-06,-0.3669,-0.4956,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.1702e-06,-0.36707,-0.49378,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.029719,-0.36906,-0.20657,1,0
2,GO REGULATION OF ANOIKIS,0.00011241,-0.36981,-0.36547,1,0
2,GO CORNIFICATION,0.00036427,-0.37016,-0.34189,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.8583e-05,-0.37336,-0.45621,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.7343e-05,-0.37925,-0.36735,1,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0010206,-0.38099,-0.37896,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.00041602,-0.38114,-0.53738,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,1.0604e-05,-0.38465,-0.46456,1,0
2,GO APICAL JUNCTION ASSEMBLY,5.7413e-06,-0.38593,-0.39051,1,0
2,GO OLIGOPEPTIDE TRANSPORT,6.5149e-05,-0.38638,-0.43783,1,0
2,GO INTERFERON ALPHA PRODUCTION,1.2454e-05,-0.38657,-0.32424,1,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00040247,-0.38724,-0.35525,1,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,8.1192e-05,-0.38845,-0.38149,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.0001165,-0.39107,-0.34102,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.8251e-06,-0.39145,-0.40578,1,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,6.4994e-06,-0.39183,-0.39224,1,0
2,GO GERMINAL CENTER FORMATION,4.8379e-05,-0.39364,-0.47677,1,0
2,GO LEYDIG CELL DIFFERENTIATION,0.0023671,-0.39401,-0.38681,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.7801e-06,-0.39446,-0.40652,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010462,-0.39481,-0.39775,1,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.00042998,-0.39548,-0.3759,1,0
2,GO MEMBRANE RAFT ASSEMBLY,0.019739,-0.39824,-0.48869,1,0
2,GO REGULATION OF MYOBLAST FUSION,4.1617e-05,-0.3996,-0.40562,1,0
2,GO EOSINOPHIL CHEMOTAXIS,0.011612,-0.40323,-0.33294,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014418,-0.40462,-0.41588,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.011047,-0.40516,-0.29565,1,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.046579,-0.40676,-0.31287,1,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,8.6584e-06,-0.40751,-0.44775,1,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,6.7728e-06,-0.40816,-0.46059,1,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.00012074,-0.40923,-0.4135,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.2876e-06,-0.40947,-0.40041,1,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00044439,-0.41101,-0.45774,1,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00030804,-0.41269,-0.60635,1,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00021167,-0.41522,-0.3872,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.1663e-05,-0.41607,-0.54848,1,0
2,GO HISTAMINE TRANSPORT,0.00010092,-0.42503,-0.47185,1,0
2,GO DNA DEAMINATION,0.001191,-0.42712,-0.38607,1,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.00021909,-0.43395,-0.50248,1,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00069957,-0.43502,-0.44861,1,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.00030804,-0.44016,-0.4417,1,0
2,GO TOLERANCE INDUCTION,3.8583e-05,-0.44313,-0.51541,1,0
2,GO BIOLOGICAL PHASE,0.0050528,-0.44389,-0.40688,1,0
2,GO ZYMOGEN INHIBITION,3.7791e-06,-0.44452,-0.49818,1,0
2,GO POSITIVE REGULATION OF WOUND HEALING,6.0198e-07,-0.44478,-0.47385,1,0
2,GO RESPONSE TO INTERFERON BETA,2.5774e-06,-0.44821,-0.61827,1,0
2,GO RESPONSE TO TYPE I INTERFERON,4.4712e-06,-0.44925,-0.55926,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00054072,-0.44926,-0.49915,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,2.1663e-05,-0.44943,-0.47362,1,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0075304,-0.45269,-0.31441,1,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00065623,-0.45877,-0.43269,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.5759e-05,-0.45926,-0.63722,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0031536,-0.4682,-0.37523,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00050664,-0.47133,-0.41604,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,3.4728e-06,-0.47486,-0.48249,1,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,-0.47721,-0.446,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,9.3916e-06,-0.48359,-0.53091,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.1964e-05,-0.48881,-0.40713,1,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,6.2786e-05,-0.49962,-0.51155,1,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00014418,-0.50237,-0.58789,1,0
2,GO RESPONSE TO INTERLEUKIN 18,1.5816e-05,-0.5088,-0.5858,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,1.2454e-05,-0.519,-0.66002,1,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00038934,-0.52087,-0.51717,1,0
2,GO LIPID DROPLET FORMATION,0.0064317,-0.52117,-0.4289,1,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,2.1663e-05,-0.53081,-0.43475,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,6.7728e-06,-0.55419,-0.51114,1,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.3441e-06,-0.56662,-0.51025,1,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.00037661,-0.57556,-0.44886,1,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.00035231,-0.58769,-0.46311,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,9.7346e-05,-0.58888,-0.49886,1,0
2,GO HISTAMINE SECRETION,1.2454e-05,-0.59036,-0.58409,1,0
2,GO LUNG CELL DIFFERENTIATION,0.00047456,-0.62629,-0.47039,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00035231,-0.63097,-0.71344,1,0
2,GO CYTIDINE TO URIDINE EDITING,7.8282e-05,-0.63265,-0.67873,1,0
2,GO MUCUS SECRETION,0.00010462,-0.68558,-0.61281,1,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,7.013e-05,-0.69048,-0.74776,1,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0001165,-0.73706,-0.68515,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,4.2876e-06,-0.86994,-0.99504,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.4712e-06,-1.1191,-1.248,1,0
2,GO RESPONSE TO HISTAMINE,0.049546,0.53277,0.30137,0,1
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.084046,0.39336,0.25148,0,1
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.20309,0.34816,0.18349,0,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.054842,0.32991,0.23454,0,1
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.093897,0.31521,0.17093,0,1
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0695,0.30143,0.19482,0,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.2839,0.27499,0.1181,0,1
2,GO MYOBLAST PROLIFERATION,0.054842,0.26302,0.13501,0,1
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.05824,0.25864,0.23617,0,1
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.092194,0.24416,0.18718,0,1
2,GO CELL JUNCTION DISASSEMBLY,0.05161,0.23291,0.17602,0,1
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.30402,0.23142,0.12795,0,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.073629,0.22818,0.21803,0,1
2,GO NEURON REMODELING,0.20309,0.22774,0.1083,0,1
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.19095,0.22551,0.13094,0,1
2,GO HEART VALVE FORMATION,0.31653,0.22176,0.10086,0,1
2,GO NEUROTRANSMITTER REUPTAKE,0.11841,0.22068,0.14863,0,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.16032,0.21828,0.070926,0,1
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.05161,0.21772,0.22661,0,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.10845,0.21664,0.16882,0,1
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.11235,0.21649,0.10043,0,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.10465,0.21496,0.12381,0,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.097379,0.20344,0.14495,0,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.068167,0.1989,0.18311,0,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.15517,0.19529,0.096023,0,1
2,GO AORTA DEVELOPMENT,0.12473,0.19436,0.10065,0,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.087232,0.18928,0.11896,0,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.17374,0.18738,0.099407,0,1
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.060602,0.18518,0.11707,0,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.088862,0.18392,0.10925,0,1
2,GO SINGLE STRAND BREAK REPAIR,0.14526,0.18118,0.10661,0,1
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.055956,0.18101,0.14719,0,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.34702,0.17995,0.10562,0,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.11235,0.17738,0.14676,0,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.33373,0.17727,0.076859,0,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.16032,0.17346,0.10761,0,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.23245,0.1722,0.041127,0,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.092194,0.17196,0.1122,0,1
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.17653,0.16627,0.10839,0,1
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.35153,0.16171,0.073783,0,1
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.17099,0.16066,0.11316,0,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.27999,0.15866,0.060125,0,1
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.44924,0.15642,0.011201,0,1
2,GO MESODERMAL CELL FATE COMMITMENT,0.188,0.15622,0.070666,0,1
2,GO CARDIAC CONDUCTION,0.15015,0.1515,0.096507,0,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.057089,0.14937,0.11279,0,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.12473,0.14879,0.075928,0,1
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.15015,0.14817,0.06525,0,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.16559,0.14734,0.13365,0,1
2,GO SECRETORY GRANULE ORGANIZATION,0.25001,0.14552,0.060755,0,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.27227,0.14489,0.074595,0,1
2,GO CENTROMERE COMPLEX ASSEMBLY,0.10096,0.14459,0.091169,0,1
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.054842,0.14309,0.096322,0,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.52594,0.14266,0.032774,0,1
2,GO HISTONE H3 K9 TRIMETHYLATION,0.15264,0.14261,0.071451,0,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.079444,0.14224,0.11794,0,1
2,GO CGMP MEDIATED SIGNALING,0.35607,0.13834,0.053448,0,1
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.063042,0.13709,0.098464,0,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.2,0.13409,0.057862,0,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.61497,0.13361,-0.016946,0,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.31232,0.13289,0.061682,0,1
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.054842,0.13247,0.12642,0,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.14048,0.13195,0.070908,0,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.72313,0.13027,-0.0010541,0,1
2,GO IMPORT INTO CELL,0.20621,0.12412,0.051714,0,1
2,GO DNA REPLICATION CHECKPOINT,0.050569,0.12338,0.088154,0,1
2,GO DENDRITIC SPINE MAINTENANCE,0.32506,0.12077,0.037925,0,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.19095,0.12049,0.079024,0,1
2,GO REGULATION OF RESPONSE TO FOOD,0.48678,0.11998,0.04556,0,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.12049,0.11973,0.074871,0,1
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.11708,0.090912,0,1
2,GO REGULATION OF DNA METHYLATION,0.60883,0.11548,0.0076056,0,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.065563,0.11512,0.19299,0,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.25729,0.11493,0.045901,0,1
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.15264,0.11451,0.05993,0,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.095625,0.11143,0.11223,0,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.14769,0.099377,0.079053,0,1
2,GO NEUROGENESIS,0.053746,0.093867,0.073626,0,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.11434,0.093721,0.077381,0,1
2,GO RNA EXPORT FROM NUCLEUS,0.05161,0.093207,0.063152,0,1
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.082489,0.092782,0.077194,0,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.50337,0.092775,0.041234,0,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.092194,0.092485,0.073606,0,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.24643,0.091635,0.046217,0,1
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.14048,0.090188,0.082708,0,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.11235,0.089488,0.11641,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.1028,0.088518,0.067821,0,1
2,GO CELLULAR RESPONSE TO X RAY,0.3746,0.087734,-0.00032448,0,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.11841,0.083939,0.080709,0,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.22568,0.083312,0.056282,0,1
2,GO CELL MORPHOGENESIS,0.097379,0.082105,0.062956,0,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.057089,0.081648,0.10311,0,1
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.64605,0.07942,-0.010226,0,1
2,GO AMINO ACID TRANSPORT,0.15264,0.079335,0.040105,0,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.052669,0.078407,0.055056,0,1
2,GO DNA GEOMETRIC CHANGE,0.11636,0.077151,0.054321,0,1
2,GO RNA STABILIZATION,0.30815,0.076909,0.034426,0,1
2,GO RNA LOCALIZATION,0.13814,0.074188,0.035966,0,1
2,GO RNA 3 END PROCESSING,0.064293,0.073902,0.048666,0,1
2,GO TRNA TRANSPORT,0.1028,0.07243,0.072342,0,1
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.17374,0.071336,0.052872,0,1
2,GO ORGANIC CATION TRANSPORT,0.94073,0.071326,-0.011248,0,1
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.12473,0.07045,0.064461,0,1
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.079444,0.070072,0.061275,0,1
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.34702,0.06802,0.064091,0,1
2,GO REGULATION OF CELL DEVELOPMENT,0.092194,0.067799,0.061254,0,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.15264,0.066901,0.059168,0,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.95466,0.0669,-0.016688,0,1
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.74288,0.065627,0.004533,0,1
2,GO HISTONE EXCHANGE,0.15264,0.063986,0.062677,0,1
2,GO RNA PROCESSING,0.066855,0.059294,0.053788,0,1
2,GO MITOCHONDRION MORPHOGENESIS,0.14048,0.057204,0.063439,0,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.21256,0.051669,0.03265,0,1
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.23245,0.048677,0.063085,0,1
2,GO MRNA TRANSPORT,0.17374,0.048364,0.036588,0,1
2,GO DNA CONFORMATION CHANGE,0.23937,0.042846,0.028659,0,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.4978,0.038947,0.016034,0,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.26471,0.037603,0.049459,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.32506,0.034169,0.038503,0,1
2,GO DNA REPAIR,0.67137,0.022419,0.0067363,0,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0016129,0.6155,0.45251,0,0
2,GO REGULATION OF SYNAPSE MATURATION,0.0039469,0.5538,0.47863,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00055855,0.53354,0.49923,0,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0010206,0.46676,0.49049,0,0
2,GO RESPONSE TO L GLUTAMATE,8.7323e-05,0.45441,0.48432,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0006154,0.45227,0.48858,0,0
2,GO CARDIAC CHAMBER FORMATION,0.00029782,0.43128,0.51837,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0049174,0.41382,0.38573,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00074557,0.40143,0.36227,0,0
2,GO CARDIOBLAST PROLIFERATION,0.12259,0.39426,0.28046,0,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.036948,0.35962,0.3377,0,0
2,GO SYNAPTIC VESICLE MATURATION,0.017137,0.33628,0.30509,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.014138,0.33368,0.23666,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.034637,0.32775,0.28079,0,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.017549,0.32025,0.31554,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.027803,0.32005,0.22913,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.11434,0.3172,0.18224,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.0022992,0.31068,0.27413,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.016734,0.30835,0.25279,0,0
2,GO SIALYLATION,0.0011199,0.30664,0.43884,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.019283,0.30653,0.19694,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.0015653,0.3061,0.2467,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0022332,0.29522,0.51925,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00016023,0.2901,0.30543,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.00044439,0.2849,0.46152,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.19095,0.28094,0.14611,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.052669,0.278,0.25618,0,0
2,GO NEURON CELL CELL ADHESION,0.11039,0.27728,0.27356,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.014138,0.27701,0.22771,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.041093,0.27624,0.16261,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.010773,0.27572,0.44088,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.027803,0.26235,0.20402,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.010245,0.26229,0.33951,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.3746,0.26195,0.090461,0,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0031536,0.25936,0.25421,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.12689,0.25802,0.11821,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.090515,0.2576,0.22375,0,0
2,GO THALAMUS DEVELOPMENT,0.072231,0.25676,0.19353,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.04854,0.25656,0.27209,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.047551,0.25494,0.23865,0,0
2,GO INNERVATION,0.012508,0.25169,0.31155,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0075304,0.24991,0.29403,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.068167,0.24905,0.23126,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0066042,0.24869,0.33493,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.20621,0.24626,0.15449,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0013054,0.24443,0.29956,0,0
2,GO GLUTAMATE SECRETION,0.044685,0.24399,0.17261,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.0042883,0.23968,0.228,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.063042,0.23896,0.1221,0,0
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.075049,0.23774,0.18345,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.018398,0.23762,0.19948,0,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.011904,0.23737,0.22675,0,0
2,GO EXPLORATION BEHAVIOR,0.052669,0.23331,0.20129,0,0
2,GO SHORT TERM MEMORY,0.031748,0.23118,0.24286,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.011612,0.23098,0.22465,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.045624,0.2247,0.19725,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.064293,0.22412,0.20803,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.17374,0.22338,0.13505,0,0
2,GO MRNA SPLICE SITE SELECTION,0.00037661,0.22235,0.25648,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.21256,0.22042,0.11108,0,0
2,GO LEARNING,0.010773,0.22034,0.19263,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.23589,0.21702,0.12022,0,0
2,GO NEURON RECOGNITION,0.011904,0.21548,0.22282,0,0
2,GO NAD METABOLIC PROCESS,0.1313,0.21357,0.12633,0,0
2,GO DENDRITE SELF AVOIDANCE,0.011612,0.21314,0.21818,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.026586,0.21298,0.24388,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.025414,0.21152,0.21562,0,0
2,GO BONE TRABECULA FORMATION,0.62113,0.21109,-0.017639,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.42347,0.20998,0.065254,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0040578,0.20687,0.18261,0,0
2,GO DENDRITE MORPHOGENESIS,0.0028957,0.20621,0.19703,0,0
2,GO HEPARIN METABOLIC PROCESS,0.39858,0.20542,0.065183,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.020205,0.19881,0.20754,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.014138,0.19869,0.20062,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.041093,0.19804,0.18398,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.0066042,0.19682,0.22617,0,0
2,GO SYNAPTIC VESICLE PRIMING,0.064293,0.19341,0.22133,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.21256,0.19103,0.11054,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.17374,0.19091,0.12492,0,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.015574,0.19085,0.34452,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.076492,0.19081,0.14899,0,0
2,GO DIVALENT METAL ION EXPORT,0.19095,0.19024,0.17024,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0022332,0.18928,0.16413,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.024846,0.18838,0.25557,0,0
2,GO AXONAL FASCICULATION,0.10096,0.18785,0.17302,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.15773,0.18764,0.16925,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.010773,0.1863,0.13363,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.038561,0.18622,0.19748,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0045306,0.18458,0.21904,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.62113,0.18328,0.012693,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.11235,0.18266,0.17317,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.019739,0.18067,0.17552,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.22235,0.18024,0.096065,0,0
2,GO AXON DEVELOPMENT,0.0027346,0.17976,0.18408,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.033166,0.17955,0.25825,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0017641,0.17946,0.18201,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.010245,0.17531,0.26146,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.015574,0.17406,0.22005,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.017137,0.17401,0.13906,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.066855,0.17359,0.209,0,0
2,GO SNORNA 3 END PROCESSING,0.0060989,0.17337,0.22376,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.46512,0.1732,0.12889,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.019739,0.17294,0.16543,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.60883,0.17263,0.0029075,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0090226,0.17136,0.36312,0,0
2,GO MATING BEHAVIOR,0.066855,0.17063,0.12537,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.02843,0.17006,0.13809,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.22905,0.17003,0.090304,0,0
2,GO MITOCHONDRION LOCALIZATION,0.00045924,0.16997,0.17581,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.041967,0.16965,0.18278,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.009256,0.16946,0.23945,0,0
2,GO HISTONE H3 K27 METHYLATION,0.0054795,0.1689,0.14394,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.055956,0.16842,0.24479,0,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.1313,0.16763,0.11936,0,0
2,GO DENDRITE DEVELOPMENT,0.0027346,0.16662,0.16788,0,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.079444,0.16654,0.15063,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.046579,0.16652,0.15649,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.27999,0.16606,0.091508,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.075049,0.16593,0.10874,0,0
2,GO IMP METABOLIC PROCESS,0.31232,0.16585,0.076993,0,0
2,GO FOREBRAIN CELL MIGRATION,0.016734,0.16468,0.17753,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0022992,0.16371,0.12747,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.025994,0.16363,0.17658,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.18219,0.16266,0.14607,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.19095,0.16234,0.10347,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.11434,0.16218,0.17446,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.4978,0.1621,0.080805,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.12473,0.16178,0.071454,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.12908,0.1613,0.10745,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.60883,0.16086,0.11335,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.072231,0.16069,0.18532,0,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.17653,0.16061,0.064117,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.045624,0.16029,0.18737,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.026586,0.15991,0.22355,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.35607,0.15907,0.10061,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.21579,0.15841,0.17567,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.041967,0.15694,0.14381,0,0
2,GO LIMB BUD FORMATION,0.12049,0.15691,0.24924,0,0
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.14769,0.15678,0.10637,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.16828,0.15665,0.10769,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.21905,0.15535,0.11926,0,0
2,GO RECEPTOR CLUSTERING,0.10465,0.15492,0.13761,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.17374,0.15283,0.080996,0,0
2,GO NUCLEAR PORE ORGANIZATION,0.14048,0.15166,0.072155,0,0
2,GO SEROTONIN TRANSPORT,0.13583,0.15149,0.13601,0,0
2,GO FOREBRAIN REGIONALIZATION,0.02843,0.15133,0.21685,0,0
2,GO LONG TERM MEMORY,0.16032,0.1505,0.057058,0,0
2,GO CELLULAR RESPONSE TO PH,0.24643,0.15028,0.072595,0,0
2,GO NADH METABOLIC PROCESS,0.037747,0.15019,0.1643,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.38888,0.1501,0.037969,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.016734,0.14863,0.19493,0,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.087232,0.14687,0.13692,0,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.94073,0.14595,-0.03537,0,0
2,GO CELL PART MORPHOGENESIS,0.0032441,0.14593,0.15822,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.37932,0.14499,0.11076,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.16294,0.14305,0.23324,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.17099,0.14296,0.18154,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.35607,0.14289,0.052134,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0034322,0.14261,0.16579,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.087232,0.14155,0.1152,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0056288,0.13952,0.14807,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.15015,0.13931,0.11591,0,0
2,GO NERVE DEVELOPMENT,0.30815,0.13879,0.060853,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.13355,0.13804,0.18773,0,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.15517,0.13778,0.13655,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.29586,0.13747,0.091878,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.14526,0.1368,0.085261,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.56666,0.13667,0.047511,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.27227,0.13619,0.12447,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.042857,0.13401,0.13074,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.045624,0.13352,0.24848,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.095625,0.13297,0.079335,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.0049174,0.13259,0.24211,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.16559,0.13248,0.085918,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.072231,0.13112,0.10546,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.21256,0.13073,0.10173,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.036164,0.13067,0.1125,0,0
2,GO SYNAPTIC SIGNALING,0.017137,0.12981,0.14825,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.59664,0.1297,-0.011069,0,0
2,GO MEMBRANE DISASSEMBLY,0.19695,0.12854,0.065332,0,0
2,GO GTP METABOLIC PROCESS,0.21256,0.12785,0.092825,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.010506,0.12779,0.11594,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.32506,0.12714,0.065659,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.02166,0.1266,0.097531,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.57857,0.12658,0.011278,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.15773,0.12611,0.090794,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.043763,0.12606,0.16199,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.97557,0.12584,-0.062263,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.59664,0.12584,0.18286,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.092194,0.12541,0.10337,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0045306,0.12532,0.14233,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.0083534,0.12484,0.12493,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.24643,0.12476,0.14932,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.17934,0.12449,0.067333,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.013798,0.12423,0.2395,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.52025,0.1239,0.020295,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.029068,0.12371,0.12713,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0018173,0.12364,0.12066,0,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.53742,0.12358,0.03873,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.034637,0.12293,0.11238,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.33812,0.12292,0.058659,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.05824,0.12291,0.086279,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.033894,0.12282,0.10654,0,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.095625,0.12282,0.14532,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.066855,0.12257,0.1367,0,0
2,GO GANGLION DEVELOPMENT,0.53742,0.12247,0.090972,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.14526,0.12234,0.10831,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.69061,0.12227,0.016703,0,0
2,GO MEMORY,0.13814,0.12163,0.069286,0,0
2,GO STRIATUM DEVELOPMENT,0.35607,0.12162,0.060079,0,0
2,GO RESPONSE TO ACETYLCHOLINE,0.03939,0.12146,0.2112,0,0
2,GO NEURON FATE COMMITMENT,0.21905,0.12144,0.13725,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.24643,0.12136,0.031363,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.2839,0.12131,0.081553,0,0
2,GO AXO DENDRITIC TRANSPORT,0.014138,0.12107,0.12326,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.12473,0.121,0.093138,0,0
2,GO RNA INTERFERENCE,0.1313,0.12077,0.10237,0,0
2,GO AXONAL TRANSPORT,0.010773,0.12066,0.144,0,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.044685,0.1203,0.18113,0,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.068167,0.11959,0.14231,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.11434,0.11946,0.17942,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.17099,0.11936,0.11154,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0057817,0.11883,0.13151,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.049546,0.11872,0.12349,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.018398,0.11851,0.18362,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.2839,0.11805,0.077574,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.11434,0.11789,0.10727,0,0
2,GO MATURATION OF LSU RRNA,0.10654,0.11786,0.12192,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.015574,0.11779,0.12759,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0062634,0.11776,0.1207,0,0
2,GO TELOMERASE RNA LOCALIZATION,0.26098,0.11771,0.089437,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0033369,0.11682,0.1313,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.075049,0.11575,0.14096,0,0
2,GO COLLATERAL SPROUTING,0.050569,0.11538,0.14445,0,0
2,GO SOMATIC STEM CELL DIVISION,0.34256,0.11536,0.11866,0,0
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.27227,0.11522,0.081054,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.10845,0.11515,0.10708,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.47049,0.11512,0.06369,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.44402,0.11433,0.031513,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.090515,0.11419,0.072849,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.073629,0.114,0.11137,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.43883,0.11393,0.060116,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.024846,0.11375,0.10319,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.63354,0.11369,-0.019088,0,0
2,GO STARTLE RESPONSE,0.44402,0.11322,0.098712,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38408,0.11319,0.060513,0,0
2,GO LACTATE METABOLIC PROCESS,0.70355,0.11294,-0.057772,0,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.24288,0.11265,0.093964,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.83713,0.11263,-0.033257,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.61497,0.11235,0.012477,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.3746,0.11212,0.11932,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.052669,0.11181,0.18438,0,0
2,GO NEURAL CREST CELL MIGRATION,0.14048,0.11162,0.095099,0,0
2,GO MEMBRANE DEPOLARIZATION,0.53742,0.11155,0.047151,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.38888,0.11122,0.058053,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.22905,0.111,0.13577,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.20309,0.11058,0.1068,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.38408,0.1103,0.053553,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0081404,0.11013,0.10488,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.38888,0.10994,0.061068,0,0
2,GO L AMINO ACID TRANSPORT,0.73628,0.10982,-0.024244,0,0
2,GO AORTA MORPHOGENESIS,0.9686,0.10972,-0.038968,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.092194,0.10969,0.13227,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.80312,0.10927,-0.030233,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.93377,0.10892,-0.00024692,0,0
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.67137,0.10849,0.012766,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.17653,0.10848,0.080537,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.31653,0.10843,0.048584,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.057089,0.10839,0.13475,0,0
2,GO TELOMERIC LOOP DISASSEMBLY,0.043763,0.10822,0.10151,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.15264,0.10791,0.042662,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.052669,0.10786,0.082376,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.38408,0.10757,0.074944,0,0
2,GO PROTEIN POLYGLUTAMYLATION,0.043763,0.10722,0.12519,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.82348,0.10715,-0.045972,0,0
2,GO DOPAMINE TRANSPORT,0.15517,0.10712,0.19724,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.44402,0.10638,0.059514,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.10845,0.10604,0.10889,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.27611,0.106,0.064002,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.67137,0.10521,0.015249,0,0
2,GO COCHLEA MORPHOGENESIS,0.37932,0.10517,0.051305,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.34702,0.10467,0.12771,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.019283,0.10432,0.15274,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.28785,0.10419,0.099241,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.28785,0.104,0.080923,0,0
2,GO REGULATION OF RNA BINDING,0.29184,0.10383,0.053133,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.188,0.10379,0.08648,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.49227,0.10374,0.045349,0,0
2,GO COCHLEA DEVELOPMENT,0.10845,0.10348,0.092855,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.48131,0.10338,0.024625,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.71658,0.10311,-0.0033107,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.43883,0.10304,0.039512,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.40349,0.10297,0.047106,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.088862,0.10293,0.11668,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0019282,0.10263,0.12845,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.2839,0.10244,0.066915,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.10096,0.10206,0.083007,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.18508,0.10195,0.10474,0,0
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.46512,0.10178,0.040678,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.073629,0.10164,0.15639,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.082489,0.10123,0.28881,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.5726,0.10099,0.036271,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.39858,0.10097,0.07049,0,0
2,GO GROOMING BEHAVIOR,0.46512,0.10089,0.055639,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.77618,0.10088,0.022019,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.46512,0.10073,0.039023,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.73628,0.10073,0.013362,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.11235,0.10039,0.13483,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.038561,0.10029,0.12727,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.78289,0.10026,0.046257,0,0
2,GO GLYCINE METABOLIC PROCESS,0.90599,0.099637,-0.036763,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.13355,0.099555,0.10086,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.050569,0.099514,0.11515,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.85768,0.099351,0.014307,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.016734,0.099204,0.13944,0,0
2,GO NEURON DEVELOPMENT,0.018836,0.098838,0.10712,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.22568,0.098663,0.091095,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.66501,0.098518,0.050384,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.73628,0.098411,0.00014557,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.23937,0.098375,0.065584,0,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.34256,0.098329,0.042394,0,0
2,GO PROTEIN OXIDATION,0.35153,0.098235,0.026553,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.036164,0.097867,0.08769,0,0
2,GO GROWTH HORMONE SECRETION,0.23589,0.097693,0.095681,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.53167,0.097448,0.064929,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.29992,0.097371,0.10909,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.17374,0.097229,0.090523,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.14285,0.097101,0.092218,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.38408,0.097005,0.069319,0,0
2,GO G0 TO G1 TRANSITION,0.036164,0.096783,0.10234,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.43367,0.096779,0.062026,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.090515,0.096753,0.11637,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.10096,0.096653,0.10026,0,0
2,GO RRNA TRANSCRIPTION,0.053746,0.096331,0.10436,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.64605,0.096154,0.054366,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.5726,0.095932,-0.0019176,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.15264,0.095743,0.074907,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.61497,0.095448,0.052234,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.024846,0.095036,0.10125,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.26471,0.094963,0.061494,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.11039,0.094863,0.088655,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.36991,0.094712,0.066584,0,0
2,GO TONGUE MORPHOGENESIS,0.94769,0.094466,-0.021149,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.030383,0.094279,0.12129,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.031748,0.094154,0.092622,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.89907,0.093957,-0.014204,0,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23937,0.093781,0.068519,0,0
2,GO ARTERY DEVELOPMENT,0.40843,0.093255,0.015679,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.17374,0.092919,0.12771,0,0
2,GO BONE GROWTH,0.41842,0.09276,0.051259,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.38888,0.092728,0.091147,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.31653,0.0927,0.087535,0,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.55487,0.092654,0.034645,0,0
2,GO TOOTH MINERALIZATION,0.80312,0.092602,-0.074867,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.38408,0.09254,0.093506,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.12049,0.09237,0.095822,0,0
2,GO COGNITION,0.047551,0.092274,0.11257,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.11039,0.092035,0.10178,0,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.95466,0.092004,-0.02695,0,0
2,GO REGULATION OF HEART RATE,0.80989,0.091942,-0.033562,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.15015,0.091816,0.089002,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.32506,0.091802,0.038463,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.19393,0.091747,0.055111,0,0
2,GO WALKING BEHAVIOR,0.011326,0.09125,0.20292,0,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.11235,0.090729,0.08747,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.55487,0.090493,0.033376,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.04854,0.090201,0.1258,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.11434,0.090167,0.036286,0,0
2,GO ARGININE METABOLIC PROCESS,0.89215,0.090163,0.0071563,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.44924,0.089929,0.031396,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.81668,0.089899,-0.025313,0,0
2,GO MATING,0.11636,0.089686,0.062363,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.59664,0.089553,0.012209,0,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.068167,0.089516,0.26121,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.52594,0.089488,-0.12158,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.28785,0.089018,0.051291,0,0
2,GO NOREPINEPHRINE TRANSPORT,0.15015,0.088655,0.094226,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.49227,0.088466,0.053314,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32506,0.088376,0.057274,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.38408,0.08819,0.082761,0,0
2,GO REGULATION OF MRNA PROCESSING,0.0060989,0.088129,0.097929,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.037747,0.088031,0.15172,0,0
2,GO LEUKOCYTE AGGREGATION,0.32938,0.088003,0.037511,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.38408,0.087559,0.068528,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.61497,0.087533,0.04513,0,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.188,0.087231,0.074857,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.16559,0.087116,0.079467,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.15015,0.086996,0.14961,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13355,0.086884,0.080953,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.27999,0.086553,0.046031,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.22905,0.085967,0.090435,0,0
2,GO CELL CYCLE DNA REPLICATION,0.063042,0.085946,0.089999,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.16294,0.085758,0.17387,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.60883,0.085682,0.022498,0,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.43883,0.085616,0.063951,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0071468,0.085458,0.074997,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.14769,0.085076,0.13619,0,0
2,GO CYTOPLASMIC TRANSLATION,0.61497,0.084964,0.041716,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.31232,0.084854,0.080376,0,0
2,GO NEUROBLAST PROLIFERATION,0.48678,0.084837,0.043888,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.40843,0.084497,0.07873,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.71658,0.084493,0.020573,0,0
2,GO BONE MATURATION,0.43883,0.084141,0.029297,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.16828,0.084138,0.092997,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.014486,0.083916,0.11442,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.13583,0.083807,0.11893,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.89907,0.083577,-0.014779,0,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.97557,0.083572,0.0023642,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.53167,0.08355,0.027457,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.011326,0.083355,0.12531,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.54903,0.083019,0.072902,0,0
2,GO FIBRINOLYSIS,0.85082,0.082688,-0.095092,0,0
2,GO SEQUESTERING OF METAL ION,0.69707,0.082665,-0.0083398,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.10654,0.082583,0.079831,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.97557,0.082517,-0.027761,0,0
2,GO OXIDATIVE DEMETHYLATION,0.040234,0.082307,0.093795,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.28785,0.082233,0.11546,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.26098,0.081961,0.045878,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.063042,0.081806,0.047125,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.80312,0.08151,-0.074737,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.57857,0.081173,0.031138,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.17653,0.081012,0.081547,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.35607,0.080895,0.079776,0,0
2,GO HISTONE MRNA METABOLIC PROCESS,0.11636,0.080647,0.05955,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.31232,0.080547,0.06147,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.50896,0.080409,0.034875,0,0
2,GO CATECHOLAMINE UPTAKE,0.32077,0.080392,0.101,0,0
2,GO RESPONSE TO CAFFEINE,0.92682,0.079994,-0.022809,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.2839,0.079941,0.080592,0,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.72313,0.079868,0.0093865,0,0
2,GO MICROTUBULE POLYMERIZATION,0.036948,0.079783,0.11389,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.71006,0.079675,0.037698,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.31232,0.079647,0.040217,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.40843,0.079538,0.041347,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.27999,0.078935,0.077253,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.70355,0.078635,0.0047102,0,0
2,GO KINETOCHORE ASSEMBLY,0.27999,0.07852,0.068604,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.25001,0.078432,0.059221,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.27611,0.078147,0.077127,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.50896,0.078068,0.010838,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.15773,0.077998,0.1046,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,0.077989,-0.0085771,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.17099,0.077907,0.18491,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.39858,0.077522,0.082304,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.15517,0.077496,0.12054,0,0
2,GO PROTEIN DENEDDYLATION,0.10096,0.077472,0.086013,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.35607,0.0774,0.0228,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.52594,0.077318,0.0060241,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.1313,0.077173,0.095339,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.11841,0.077163,0.080147,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.36064,0.077057,0.034038,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.87833,0.076843,-0.011974,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.4978,0.076804,0.034345,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.44924,0.076799,0.033948,0,0
2,GO PALLIUM DEVELOPMENT,0.016339,0.076775,0.12305,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.13814,0.076425,0.057934,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.30402,0.076241,0.090905,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.90599,0.076184,-0.0010557,0,0
2,GO MYOBLAST MIGRATION,0.91987,0.076089,-0.0022368,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.041093,0.076057,0.10847,0,0
2,GO REGULATION OF MRNA BINDING,0.47588,0.075931,0.033298,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.088862,0.075905,0.1093,0,0
2,GO RNA METHYLATION,0.088862,0.075705,0.066898,0,0
2,GO DNA LIGATION,0.65234,0.075661,0.0281,0,0
2,GO MATURATION OF 5 8S RRNA,0.27999,0.075447,0.059939,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.31653,0.075125,0.06408,0,0
2,GO PROTEIN DEMETHYLATION,0.33812,0.074865,0.055191,0,0
2,GO TRNA PROCESSING,0.17653,0.074834,0.054617,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.11636,0.074457,0.10507,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.65866,0.074226,0.042872,0,0
2,GO RRNA MODIFICATION,0.10465,0.074085,0.11009,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.95466,0.073884,-0.023059,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.10654,0.073792,0.061931,0,0
2,GO RRNA CATABOLIC PROCESS,0.48131,0.073671,0.050535,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.50896,0.073661,0.071714,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.56666,0.073444,0.064579,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.50337,0.073372,0.035273,0,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.47588,0.073246,0.07129,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.87144,0.0732,-0.0026771,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.75615,0.073096,0.0084525,0,0
2,GO RRNA METHYLATION,0.065563,0.072957,0.11108,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.097379,0.072947,0.067381,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.16828,0.072837,0.039947,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.44924,0.072758,0.011627,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.39371,0.072441,0.045392,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.80989,0.072359,-0.018821,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.75615,0.071925,0.028931,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.69707,0.071576,0.01407,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.30402,0.071511,0.06682,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.34702,0.0715,0.065595,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.63978,0.071487,0.03275,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.67776,0.071377,-0.027927,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.95466,0.07118,-0.007895,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.30402,0.071123,0.044633,0,0
2,GO NEURON PROJECTION ARBORIZATION,0.48678,0.071115,0.06318,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.71006,0.070895,0.017831,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.58456,0.070781,0.011617,0,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.29184,0.070754,0.047649,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.50896,0.070326,0.033697,0,0
2,GO KINETOCHORE ORGANIZATION,0.44924,0.070265,0.036243,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.070106,0.069846,0,0
2,GO NEURON MATURATION,0.055956,0.070017,0.16306,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.0695,0.070004,0.12703,0,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.16032,0.069738,0.084585,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.0695,0.069662,0.067192,0,0
2,GO NCRNA PROCESSING,0.15517,0.069405,0.059838,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.88523,0.069292,-0.026546,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.67137,0.069187,0.011305,0,0
2,GO CATECHOLAMINE SECRETION,0.12259,0.069134,0.19831,0,0
2,GO HISTONE H3 K36 METHYLATION,0.4598,0.068873,0.035806,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.71658,0.068774,0.0099286,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.44402,0.068769,0.076255,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.61497,0.068559,0.036896,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.36991,0.068438,0.033127,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.52594,0.068359,0.041659,0,0
2,GO RECOMBINATIONAL REPAIR,0.14285,0.068149,0.041372,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.33373,0.068089,0.040986,0,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.99651,0.067802,-0.028203,0,0
2,GO DEVELOPMENTAL GROWTH,0.27227,0.067716,0.029981,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.97557,0.067193,-0.018246,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.19095,0.066903,0.045418,0,0
2,GO TRANSLATIONAL INITIATION,0.76948,0.066875,0.028758,0,0
2,GO FOREBRAIN DEVELOPMENT,0.061812,0.066812,0.079862,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.46512,0.066723,0.089029,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.25001,0.066281,0.044922,0,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.39858,0.06624,0.039276,0,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.35607,0.066161,0.056128,0,0
2,GO RESPONSE TO INTERLEUKIN 7,0.60883,0.065922,0.018079,0,0
2,GO RRNA METABOLIC PROCESS,0.13814,0.065865,0.084097,0,0
2,GO SEGMENT SPECIFICATION,0.29992,0.065731,0.13283,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.23937,0.065725,0.13103,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.68418,0.065632,0.016597,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.70355,0.065599,0.013958,0,0
2,GO SPINAL CORD DEVELOPMENT,0.090515,0.065513,0.10675,0,0
2,GO FATTY ACID HOMEOSTASIS,0.74288,0.065494,0.013179,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.57857,0.065435,0.034109,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.39371,0.065429,0.016846,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.71006,0.0654,0.043905,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.48131,0.065331,0.035408,0,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.43367,0.065114,0.032626,0,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.89215,0.064934,-0.046826,0,0
2,GO FILOPODIUM ASSEMBLY,0.28785,0.064842,0.0736,0,0
2,GO SISTER CHROMATID COHESION,0.16294,0.064695,0.062556,0,0
2,GO REGULATION OF CELL SIZE,0.052669,0.064674,0.074364,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.11434,0.064648,0.08175,0,0
2,GO NCRNA 3 END PROCESSING,0.11039,0.064499,0.021584,0,0
2,GO HISTONE METHYLATION,0.013465,0.064026,0.075703,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.48131,0.063993,0.039976,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.8303,0.063792,-0.052548,0,0
2,GO FAT CELL PROLIFERATION,0.60272,0.063664,0.014307,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.53167,0.063324,0.025617,0,0
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.62113,0.063055,-0.013157,0,0
2,GO NEUROMUSCULAR PROCESS,0.099158,0.062908,0.096023,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.19695,0.062686,0.08211,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.15517,0.062633,0.069358,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.48131,0.062373,0.042135,0,0
2,GO PROTEIN MANNOSYLATION,0.26471,0.062287,0.050679,0,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.54903,0.062257,0.039714,0,0
2,GO RIBOSOME BIOGENESIS,0.14048,0.061936,0.087867,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.69061,0.06192,0.032835,0,0
2,GO RESPONSE TO DOPAMINE,0.31232,0.061918,0.055902,0,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.38888,0.061792,0.054579,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.32938,0.061675,0.074334,0,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.2,0.061556,0.062675,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.47049,0.061052,0.045294,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.23937,0.06093,0.12268,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.54321,0.06093,0.052044,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.64605,0.060886,0.0081233,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.98953,0.060657,-0.048673,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.54321,0.060269,0.038135,0,0
2,GO NUCLEOSOME ORGANIZATION,0.10096,0.060121,0.055183,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.15773,0.060111,0.048937,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.25729,0.059841,0.061754,0,0
2,GO SOMITE DEVELOPMENT,0.061812,0.059839,0.066344,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.17934,0.059754,0.084009,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.91987,0.059691,-0.12304,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.36526,0.059619,0.05074,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.98953,0.059556,0.001772,0,0
2,GO RESPONSE TO AMPHETAMINE,0.72969,0.059499,-0.065151,0,0
2,GO METAL ION TRANSPORT,0.71006,0.059304,0.0046956,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.077957,0.059152,0.095437,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.32506,0.059076,0.087352,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.15264,0.059014,0.065655,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.53167,0.058816,0.039943,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.34702,0.058406,0.074117,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.055956,0.058042,0.069619,0,0
2,GO MANNOSYLATION,0.59059,0.057805,-0.01019,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.25363,0.05771,0.12698,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.78289,0.057422,0.00090718,0,0
2,GO MRNA MODIFICATION,0.024288,0.057271,0.15871,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.67776,0.057268,0.021491,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.44924,0.057184,0.029703,0,0
2,GO FEAR RESPONSE,0.38408,0.057091,0.053177,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.18508,0.056565,0.053552,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.72313,0.056555,0.010536,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.89907,0.056422,-0.021954,0,0
2,GO POLYOL TRANSPORT,0.48131,0.056379,-0.090843,0,0
2,GO GLIAL CELL MIGRATION,0.72969,0.056249,0.022229,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.29586,0.056187,0.11675,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.24288,0.055901,0.023235,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.8303,0.055858,0.019951,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.80312,0.055724,0.029204,0,0
2,GO NEPHRON TUBULE FORMATION,0.98953,0.055653,0.0052217,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.053746,0.055599,0.088479,0,0
2,GO LOCOMOTORY BEHAVIOR,0.19393,0.055391,0.091724,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.49227,0.055365,0.048838,0,0
2,GO MATURATION OF SSU RRNA,0.19695,0.05533,0.083129,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.30402,0.055256,0.089574,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.46512,0.055106,0.034046,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.34256,0.05497,0.048279,0,0
2,GO CELL RECOGNITION,0.26847,0.054919,0.044663,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1,0.054455,-0.0062907,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.29586,0.054422,0.077862,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.69061,0.054385,0.014129,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.31653,0.054338,0.049918,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.31653,0.054237,0.030945,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.27999,0.053533,0.036577,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.34256,0.053359,0.08922,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.97557,0.053318,-0.0086077,0,0
2,GO TRNA MODIFICATION,0.12908,0.053187,0.072195,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.80989,0.053183,-0.019373,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.36064,0.052875,0.050726,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.26471,0.052756,0.077307,0,0
2,GO MEMBRANE REPOLARIZATION,0.60272,0.052705,0.047604,0,0
2,GO ACROSOME ASSEMBLY,0.23937,0.052507,0.13322,0,0
2,GO SNRNA PROCESSING,0.40843,0.052451,-0.034174,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.54903,0.052425,0.020563,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.20621,0.052179,0.090224,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.11039,0.052111,0.049254,0,0
2,GO NCRNA TRANSCRIPTION,0.03939,0.051581,0.056947,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.3746,0.05153,0.092006,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.65234,0.051421,0.016277,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.82348,0.051362,0.062887,0,0
2,GO RRNA 3 END PROCESSING,0.80312,0.051069,0.0057683,0,0
2,GO RESPONSE TO POTASSIUM ION,0.74288,0.050913,0.024414,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.29586,0.050835,0.040739,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.34256,0.050631,0.064547,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.24288,0.050561,0.086594,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.14048,0.050526,0.10127,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.56075,0.050524,0.008015,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.56075,0.050521,0.032995,0,0
2,GO OOCYTE MATURATION,0.77618,0.050463,0.026847,0,0
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.50896,0.050304,0.050477,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.59059,0.049823,0.02954,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.98953,0.049755,-0.0091053,0,0
2,GO MEMBRANE BIOGENESIS,0.9686,0.049699,-0.018297,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.055956,0.049604,0.074608,0,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.74288,0.049553,-0.0004258,0,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.25363,0.049461,0.062361,0,0
2,GO RESPONSE TO COCAINE,0.25363,0.049458,0.081344,0,0
2,GO CHROMATIN SILENCING,0.054842,0.049444,0.085421,0,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.20309,0.049378,0.093396,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.90599,0.049362,-0.034175,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.40843,0.049349,0.053815,0,0
2,GO TRNA METHYLATION,0.2839,0.049268,0.038683,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.34702,0.049054,0.043514,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.90599,0.049031,-0.0089088,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.40843,0.048895,0.056235,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.14285,0.048855,0.066867,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.42347,0.048768,0.015028,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.35153,0.048681,0.024491,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.63978,0.048535,0.022472,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.50337,0.048435,0.015926,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.69707,0.047905,0.014217,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.14769,0.047886,0.050027,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.29586,0.047805,0.031241,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.75615,0.04765,-0.0014997,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.68418,0.047417,0.013274,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.25729,0.047399,0.11532,0,0
2,GO VISUAL BEHAVIOR,0.89907,0.04735,0.0050425,0,0
2,GO MICROTUBULE NUCLEATION,0.28785,0.047304,0.043587,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.85082,0.047162,-0.0027164,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.56075,0.047067,0.021236,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.31232,0.046996,0.087719,0,0
2,GO CONVERGENT EXTENSION,0.78289,0.046945,0.0087069,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.82348,0.046672,-0.024729,0,0
2,GO RESPONSE TO AMYLOID BETA,0.39858,0.046485,0.021222,0,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.32077,0.046316,0.06348,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.91987,0.046147,-0.049256,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.24288,0.045998,0.048732,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.56666,0.0459,0.020985,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,1,0.04575,0.0044124,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.72313,0.045749,-0.013632,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.41842,0.045673,0.059319,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.94073,0.045422,0.017968,0,0
2,GO PROTEIN PALMITOYLATION,0.69707,0.045186,0.013513,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.63354,0.045179,0.031381,0,0
2,GO HEAD DEVELOPMENT,0.29992,0.045177,0.037157,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.045045,0.11668,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.48131,0.044986,0.052214,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.56666,0.044949,0.036345,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.32938,0.044631,0.059798,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.36064,0.044509,0.052255,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.78289,0.044337,-0.018052,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.94769,0.044249,-0.024361,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.62732,0.044121,0.038938,0,0
2,GO CELL PROJECTION ORGANIZATION,0.24643,0.043999,0.035821,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.23245,0.043744,0.13278,0,0
2,GO HISTONE H3 K4 METHYLATION,0.11636,0.043566,0.082713,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.41341,0.043486,0.028352,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.98953,0.043323,-0.024305,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.49227,0.043018,-0.092387,0,0
2,GO CELL AGGREGATION,0.70355,0.043005,-0.037728,0,0
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.54321,0.042867,-0.10391,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.87833,0.042736,-0.014416,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.89907,0.04272,0.048527,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.51459,0.042707,0.021917,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.72969,0.04256,0.0076573,0,0
2,GO CENTRIOLE ASSEMBLY,0.52594,0.042426,0.025467,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.94769,0.042405,-0.027063,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.63978,0.042322,0.029677,0,0
2,GO CATION TRANSPORT,0.75615,0.042181,0.0028781,0,0
2,GO PSEUDOURIDINE SYNTHESIS,0.52025,0.04203,0.013431,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.8303,0.041991,-0.049322,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.69061,0.041979,0.013893,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.4598,0.041975,0.043639,0,0
2,GO SEGMENTATION,0.17934,0.041874,0.050371,0,0
2,GO BEHAVIOR,0.12689,0.041816,0.075137,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.74288,0.041628,0.037125,0,0
2,GO NCRNA METABOLIC PROCESS,0.21905,0.041569,0.046643,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.69707,0.04156,0.033383,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.47588,0.041408,0.03203,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.53742,0.041349,0.016186,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.94769,0.041281,-0.0035305,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.87833,0.041259,-0.013368,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.66501,0.041207,0.052397,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.89907,0.041132,-0.023405,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.5726,0.04072,0.04017,0,0
2,GO VIRAL TRANSLATION,0.91293,0.040354,0.0042131,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.44924,0.040208,0.060798,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.18508,0.040204,0.038217,0,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.41341,0.039817,0.038001,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.98255,0.039767,0.00023504,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.61497,0.039747,0.028297,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.23589,0.039547,0.025191,0,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.43367,0.039538,0.038909,0,0
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.32077,0.039489,0.067714,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.38408,0.039431,0.058494,0,0
2,GO RNA POLYADENYLATION,0.2,0.039387,0.040525,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.98953,0.039276,-0.011844,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.53167,0.039176,0.037905,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.62113,0.039147,0.029877,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.32938,0.039124,0.0554,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.71658,0.039056,0.019364,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.4545,0.039015,0.032714,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.59664,0.039006,0.03204,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.94073,0.038903,-0.015946,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33373,0.03881,0.071922,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.51459,0.038753,0.054202,0,0
2,GO RECEPTOR INTERNALIZATION,0.47049,0.038706,0.041252,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.05824,0.038701,0.057404,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.75615,0.038642,0.0072551,0,0
2,GO REGULATION OF OOGENESIS,0.8303,0.03858,-0.0057886,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.63354,0.038455,0.012616,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.49227,0.038432,0.054247,0,0
2,GO RESPONSE TO AMINE,0.74288,0.038335,-0.040274,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.17934,0.038283,0.053726,0,0
2,GO SOMITOGENESIS,0.44402,0.038192,0.022139,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.98255,0.038159,-0.016823,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.77618,0.037969,-0.044946,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.85768,0.037897,-0.0036191,0,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.34256,0.037849,0.079743,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.98953,0.03751,-0.0050124,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.7495,0.037496,0.006285,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.44924,0.037478,0.024389,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.83713,0.037432,-0.048954,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.16828,0.037349,0.047407,0,0
2,GO SODIUM ION TRANSPORT,0.96163,0.037213,-0.0063243,0,0
2,GO BONE MORPHOGENESIS,0.60272,0.037116,0.008828,0,0
2,GO RESPONSE TO VITAMIN A,0.87144,0.037105,-0.011722,0,0
2,GO CELL JUNCTION ORGANIZATION,0.59664,0.03705,0.013796,0,0
2,GO PROTEIN NEDDYLATION,0.33812,0.036981,0.038432,0,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.90599,0.036892,-0.051223,0,0
2,GO ADULT BEHAVIOR,0.075049,0.03652,0.14116,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.18219,0.036474,0.10733,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.38888,0.036109,0.031607,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.91293,0.035932,-0.022323,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.7495,0.035884,0.0097294,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.29992,0.035846,0.13708,0,0
2,GO RESPONSE TO NICOTINE,0.44402,0.035782,0.05335,0,0
2,GO BRAIN MORPHOGENESIS,0.38408,0.035745,0.068979,0,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.59059,0.035728,0.071791,0,0
2,GO REGULATION OF ION TRANSPORT,0.83713,0.035697,0.0078291,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.64605,0.035645,0.014505,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.56075,0.035526,0.0050374,0,0
2,GO REGULATION OF GENE SILENCING,0.50337,0.035368,0.011501,0,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.26847,0.035351,0.030171,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.47049,0.035349,0.03579,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.90599,0.035321,-0.012186,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.44924,0.035314,-0.10638,0,0
2,GO CERAMIDE TRANSPORT,0.90599,0.035304,-0.06062,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.51459,0.035285,0.023533,0,0
2,GO THYMUS DEVELOPMENT,0.78962,0.035212,-0.012878,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.50337,0.03517,0.018867,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.097379,0.035087,0.079622,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.58456,0.035005,0.016304,0,0
2,GO RIBOSOME ASSEMBLY,0.34256,0.034817,0.072603,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.88523,0.034755,0.0041915,0,0
2,GO TRNA METABOLIC PROCESS,0.31232,0.034746,0.036995,0,0
2,GO DNA METHYLATION,0.57857,0.034529,0.017125,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.78962,0.034379,-0.002253,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.41341,0.03425,0.025361,0,0
2,GO HISTONE DEUBIQUITINATION,0.54903,0.034175,0.0031895,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.31232,0.034098,0.08517,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.37932,0.034096,0.012599,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.98953,0.034088,-0.013121,0,0
2,GO PROTEIN KINASE A SIGNALING,0.65234,0.033879,0.020485,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.39371,0.033847,0.026651,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.76281,0.033819,0.00094234,0,0
2,GO GRANULOCYTE DIFFERENTIATION,0.73628,0.033736,-0.04328,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.47588,0.033658,0.047868,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.77618,0.033528,-0.026508,0,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.19695,0.033525,0.089207,0,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.86455,0.033337,-0.058782,0,0
2,GO MYELIN MAINTENANCE,0.65866,0.033309,-0.076824,0,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.21905,0.033278,0.092735,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.14769,0.033266,0.047061,0,0
2,GO HINDBRAIN DEVELOPMENT,0.25363,0.033258,0.073449,0,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.4598,0.033138,0.016834,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.53167,0.033108,0.029116,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.83713,0.033103,-0.017198,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.79636,0.033047,0.013649,0,0
2,GO CHROMATIN REMODELING,0.10654,0.03302,0.043903,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.98255,0.033008,-0.017811,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.63354,0.032961,0.073862,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.68418,0.032911,0.013114,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.19695,0.032871,0.083383,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.93377,0.032817,-0.0064261,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.64605,0.032789,0.045278,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.060602,0.032652,0.066763,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.87833,0.032534,-0.02072,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.68418,0.032457,-0.016615,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.37932,0.032425,0.057349,0,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.66501,0.032317,-0.022165,0,0
2,GO DNA REPLICATION,0.25363,0.032265,0.023947,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.54903,0.032263,0.034367,0,0
2,GO ION TRANSPORT,0.68418,0.03214,-0.027714,0,0
2,GO ALDITOL METABOLIC PROCESS,0.99651,0.032016,-0.015168,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.76948,0.031996,-0.056845,0,0
2,GO REGULATION OF GLIOGENESIS,0.9686,0.031916,-0.0014988,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.31653,0.031849,0.040443,0,0
2,GO NUCLEAR EXPORT,0.54903,0.031677,0.0094721,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.47588,0.031655,-0.062366,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.34702,0.03162,0.039418,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.87833,0.03162,0.0082297,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.99651,0.03145,-0.025305,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.87833,0.031423,-0.035067,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.60883,0.031413,0.057833,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.35607,0.031401,0.040607,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.68418,0.031386,-0.035727,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.80989,0.031372,0.0065127,0,0
2,GO ZINC ION TRANSPORT,0.54903,0.030864,0.027859,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.95466,0.030845,-0.01491,0,0
2,GO DENDRITE EXTENSION,0.18219,0.030724,0.1844,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.67137,0.030693,-0.032121,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.65866,0.030689,0.075809,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.40349,0.030615,0.11569,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.87833,0.030451,0.01611,0,0
2,GO DNA PACKAGING,0.30402,0.03044,0.026407,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.37932,0.030432,0.03187,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.48131,0.03033,0.027274,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.98953,0.030325,-0.0040669,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.52594,0.030325,0.11637,0,0
2,GO PROTEIN ACYLATION,0.021165,0.030205,0.050453,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.77618,0.030095,0.016556,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.82348,0.030083,-0.013205,0,0
2,GO NUCLEOSOME ASSEMBLY,0.51459,0.030074,0.029901,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.68418,0.030064,0.018594,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.29586,0.029948,0.092636,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.89215,0.029701,0.010846,0,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.92682,0.029512,0.011763,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.85768,0.029344,-0.018327,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.93377,0.029325,-0.017516,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.67137,0.029309,0.010787,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.39858,0.029235,0.0262,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.99651,0.029159,-0.0055581,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.79636,0.029096,-0.0097576,0,0
2,GO PROTEIN METHYLATION,0.17374,0.029089,0.046177,0,0
2,GO CELL CELL SIGNALING,0.36526,0.028922,0.028963,0,0
2,GO REGULATION OF ACROSOME REACTION,0.66501,0.02885,0.026367,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.71658,0.028844,0.0093054,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.44402,0.028816,0.070172,0,0
2,GO CRISTAE FORMATION,0.64605,0.028781,0.0052775,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.53742,0.028768,0.044714,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.64605,0.028744,0.00022741,0,0
2,GO POLYOL CATABOLIC PROCESS,0.91987,0.028701,-0.024739,0,0
2,GO BONE DEVELOPMENT,0.9686,0.02864,-0.019986,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.32077,0.028435,0.044809,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.41341,0.027953,0.066467,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.70355,0.027948,0.022293,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.55487,0.027937,-0.00013587,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.91293,0.027838,-0.037697,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.36064,0.0278,0.079647,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.85082,0.027623,-0.0052501,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.25729,0.027504,0.040537,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.85082,0.027461,-0.019471,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.35153,0.027398,0.033677,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.22905,0.027294,0.060501,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.4598,0.027264,0.016024,0,0
2,GO RNA MODIFICATION,0.38408,0.027186,0.025892,0,0
2,GO OTIC VESICLE MORPHOGENESIS,0.57857,0.027174,0.088832,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.56666,0.027005,0.02473,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.72313,0.026985,-0.025757,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.76948,0.026977,0.016905,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.54903,0.026962,0.031655,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.94769,0.026884,-0.023132,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.43367,0.026803,0.037812,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.89215,0.026712,0.00032104,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.54903,0.026633,0.055961,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.95466,0.026628,-0.0085442,0,0
2,GO DNA STRAND ELONGATION,0.37932,0.026585,0.071003,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.73628,0.026561,0.0076939,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.31653,0.026426,0.058146,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.94769,0.026254,-0.032524,0,0
2,GO NEURAL TUBE PATTERNING,0.51459,0.02623,0.029866,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.27611,0.026128,0.070968,0,0
2,GO TRANSLATIONAL ELONGATION,0.61497,0.026072,0.030497,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.62113,0.026019,-0.0054045,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.56666,0.025951,0.0031183,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.72313,0.025776,0.0085356,0,0
2,GO FOREGUT MORPHOGENESIS,0.71006,0.025751,-0.0019091,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.28785,0.025746,0.026443,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.7495,0.025699,0.019618,0,0
2,GO MRNA METABOLIC PROCESS,0.20621,0.025643,0.033297,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.63354,0.025626,0.0046148,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.60883,0.02544,0.024266,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.36991,0.025402,-0.06278,0,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.69061,0.025135,0.019326,0,0
2,GO PENTOSE METABOLIC PROCESS,0.90599,0.025047,0.021402,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.89907,0.024987,0.0050345,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.52594,0.02489,0.023071,0,0
2,GO PRE MIRNA PROCESSING,0.84397,0.024708,0.024752,0,0
2,GO SNRNA METABOLIC PROCESS,0.77618,0.024538,-0.040572,0,0
2,GO RESPONSE TO VITAMIN D,0.74288,0.024471,0.051091,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.83713,0.024096,-0.0026219,0,0
2,GO REGULATION OF EXOCYTOSIS,0.43883,0.023905,0.045291,0,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.58456,0.023761,0.01037,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.82348,0.023703,-0.0063556,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.66501,0.023674,0.021348,0,0
2,GO ACTION POTENTIAL,0.59059,0.023533,0.041892,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.49227,0.02334,0.017621,0,0
2,GO LIPID IMPORT INTO CELL,0.69061,0.023335,0.012331,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.89215,0.02333,-0.00038222,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.71658,0.023304,0.015478,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.55487,0.023234,0.012272,0,0
2,GO BASE EXCISION REPAIR,0.41842,0.023198,0.020491,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.32506,0.023187,0.085703,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.58456,0.023146,0.057009,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.7495,0.023124,0.017694,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.72313,0.023061,0.0090328,0,0
2,GO NERVOUS SYSTEM PROCESS,0.33373,0.022883,0.037906,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.4545,0.022873,0.017,0,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.16294,0.022737,0.0461,0,0
2,GO WATER TRANSPORT,0.96163,0.022676,-0.004238,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.47049,0.022637,0.053923,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.69707,0.022558,0.0055215,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.28785,0.022358,0.038474,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.79636,0.022342,-0.02734,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.9686,0.02232,-0.020279,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.80312,0.022302,-0.016878,0,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.77618,0.022241,-0.0046922,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.65234,0.022072,-0.0751,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.81668,0.021907,-0.001673,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.89907,0.021848,-0.0070404,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.33373,0.021688,0.045099,0,0
2,GO CELL CYCLE ARREST,0.65234,0.021579,-0.026714,0,0
2,GO REGULATION OF DNA REPAIR,0.4598,0.021245,0.021686,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.70355,0.021141,-0.016439,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.4598,0.020958,0.05022,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.17653,0.020946,0.099686,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.71658,0.02088,0.015818,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.25363,0.020658,0.042108,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.85768,0.020594,0.0055915,0,0
2,GO MIRNA METABOLIC PROCESS,0.98255,0.020575,-0.00057402,0,0
2,GO MONOAMINE TRANSPORT,0.3746,0.020526,0.12173,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.87144,0.020512,0.0017907,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.72313,0.020492,0.03642,0,0
2,GO NUCLEAR TRANSPORT,0.54903,0.020462,0.007175,0,0
2,GO DRINKING BEHAVIOR,0.71658,0.020318,-0.0749,0,0
2,GO REGULATION OF RNA SPLICING,0.29992,0.020252,0.037806,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.65234,0.0201,0.0049545,0,0
2,GO T CELL HOMEOSTASIS,0.87833,0.020087,-0.0040375,0,0
2,GO DNA METABOLIC PROCESS,0.80989,0.020074,-0.0096085,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.20309,0.019877,-0.14204,0,0
2,GO REGULATION OF HEART GROWTH,0.7495,0.019785,0.0052337,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.42347,0.019328,0.053144,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.90599,0.019327,-0.0062176,0,0
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.81668,0.019257,0.0027535,0,0
2,GO HEART MORPHOGENESIS,0.84397,0.018847,-0.013861,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.96163,0.018828,-0.0019182,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.58456,0.018821,0.015345,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.84397,0.018621,0.0029634,0,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.59059,0.018421,-0.037517,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.42347,0.018417,0.029374,0,0
2,GO PRIMARY MIRNA PROCESSING,0.91293,0.018277,-0.03598,0,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.68418,0.018262,0.012076,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.14769,0.018126,0.044191,0,0
2,GO HISTONE H2A ACETYLATION,0.4545,0.018029,0.061844,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.60883,0.017803,0.030377,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.66501,0.01778,0.017977,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.54903,0.017706,-0.052117,0,0
2,GO AEROBIC RESPIRATION,0.91987,0.017664,-0.0078847,0,0
2,GO PROTEIN NITROSYLATION,0.89215,0.017583,0.031799,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.72313,0.01757,0.023763,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.30402,0.017549,0.031526,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.56666,0.017533,0.030523,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.96163,0.017501,0.00017461,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.99651,0.017449,-0.006187,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.81668,0.017172,0.054855,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.35607,0.01705,0.05041,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.74288,0.016904,-0.0048591,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.26098,0.016798,0.041334,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.92682,0.016773,0.0096632,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.56075,0.016699,0.044798,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.7495,0.016359,0.00059924,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.9686,0.016353,0.010779,0,0
2,GO DNA RECOMBINATION,0.77618,0.016339,-0.0024521,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.65866,0.01632,-0.06405,0,0
2,GO RENAL WATER HOMEOSTASIS,0.85768,0.016253,-0.01563,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.89215,0.016247,-0.011887,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.093897,0.016164,0.039956,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.59059,0.015819,-0.065368,0,0
2,GO AMINO ACID ACTIVATION,0.94769,0.015797,-0.00090366,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.53167,0.015765,0.024383,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.43883,0.015695,-0.057076,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.42347,0.015623,0.037619,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.73628,0.015496,0.001545,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.48131,0.015477,0.031547,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.60272,0.015367,0.022096,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.015347,-0.0080624,0,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.31653,0.015337,0.084362,0,0
2,GO FIBROBLAST ACTIVATION,0.74288,0.015281,-0.0043988,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.90599,0.015256,-0.037492,0,0
2,GO MICROTUBULE BASED PROCESS,0.58456,0.0152,0.014359,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.16559,0.015188,0.07788,0,0
2,GO RESPONSE TO LEAD ION,0.36064,0.015072,0.046681,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.88523,0.014859,-0.11082,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.9686,0.014814,-0.028207,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.80989,0.014655,-0.0057843,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.62732,0.014586,-0.067977,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.74288,0.014463,-0.00027933,0,0
2,GO GLIOGENESIS,0.7495,0.014317,-0.027184,0,0
2,GO ANION HOMEOSTASIS,0.80989,0.014308,-0.017836,0,0
2,GO PROTEIN SUMOYLATION,0.97557,0.014307,-0.0023827,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.71006,0.014105,0.011618,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.91987,0.014102,-0.0044307,0,0
2,GO RNA CAPPING,0.78962,0.014091,0.0030935,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.97557,0.013782,-0.0048371,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.89907,0.013782,-0.017222,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.99651,0.013741,0.00082954,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.52594,0.013522,0.017769,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.96163,0.013491,0.0013288,0,0
2,GO REGULATION OF DNA REPLICATION,0.78962,0.01347,0.0052642,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.59059,0.013381,-0.045534,0,0
2,GO NOREPINEPHRINE SECRETION,0.72313,0.013337,0.0083597,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.72313,0.013325,0.043557,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.79636,0.013313,0.00076372,0,0
2,GO TORC1 SIGNALING,0.76281,0.013297,-0.016376,0,0
2,GO VESICLE DOCKING,0.91293,0.013058,0.010615,0,0
2,GO REGULATION OF DNA BINDING,0.78289,0.012754,-0.0079075,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.75615,0.012743,-0.022983,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.38408,0.012717,0.048304,0,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.89215,0.012507,-0.044575,0,0
2,GO HISTONE H3 K9 METHYLATION,0.62113,0.012478,0.026608,0,0
2,GO CELL CYCLE PROCESS,0.97557,0.012404,-0.0049732,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.91293,0.012149,0.022482,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.9686,0.012137,-0.0089775,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.53742,0.011849,-0.066341,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.95466,0.011735,0.0012839,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.67137,0.011668,-0.039522,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.41842,0.011536,-0.027302,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.76948,0.011522,0.019487,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.68418,0.011465,0.029673,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.82348,0.011425,-0.013953,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.88523,0.01138,-0.011612,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.89215,0.011316,-0.018451,0,0
2,GO REGULATION OF APPETITE,0.65234,0.01114,0.0061512,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.80312,0.010731,-0.012668,0,0
2,GO AUTOPHAGIC CELL DEATH,0.49227,0.010608,-0.059916,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.91293,0.010558,0.022263,0,0
2,GO HYPOTONIC RESPONSE,0.98255,0.010386,0.011533,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.75615,0.010252,-0.087236,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.38408,0.010136,-0.077778,0,0
2,GO COENZYME A METABOLIC PROCESS,0.75615,0.010129,0.040589,0,0
2,GO MITOTIC DNA REPLICATION,0.76948,0.010126,0.060248,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.4545,0.010039,-0.042055,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.32938,0.010039,0.023907,0,0
2,GO RNA CATABOLIC PROCESS,0.98255,0.010006,-0.0058877,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.57857,0.0099549,-0.060592,0,0
2,GO INSEMINATION,0.63354,0.0098809,-0.044498,0,0
2,GO OVULATION CYCLE,0.48678,0.0098553,0.034979,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.56075,0.0098075,-0.023409,0,0
2,GO AMINO ACID IMPORT,0.3746,0.0097327,-0.095148,0,0
2,GO HEART PROCESS,0.99651,0.0096604,-1.8461e-05,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.92682,0.0095807,-0.028834,0,0
2,GO TELOMERE ORGANIZATION,0.98953,0.0095556,-0.009154,0,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.84397,0.0093909,0.014163,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.80312,0.0093893,0.016927,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.85082,0.0093553,0.0071844,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.62113,0.0092161,-0.038399,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.54903,0.0091449,0.041528,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.188,0.0089181,0.086494,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.62113,0.0088972,-0.042868,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.66501,0.0088379,-0.018959,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.48131,0.0088077,-0.031877,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.72969,0.0087779,-0.030016,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.90599,0.0087502,0.0067668,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.59664,0.008677,0.043066,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.54903,0.0086719,-0.11813,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.65866,0.0086509,-0.047076,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.93377,0.0085511,-0.0058468,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.62113,0.0084831,-0.050176,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.95466,0.008479,-0.034241,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.89215,0.0084362,0.00093645,0,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.86455,0.0084304,-0.0264,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.94769,0.0083763,-0.0061139,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.86455,0.0082813,-0.008505,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.89215,0.0081258,0.025855,0,0
2,GO CHROMOSOME ORGANIZATION,0.64605,0.0081241,0.011295,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.81668,0.0080309,-0.016202,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.46512,0.0079215,0.029541,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.65866,0.0079082,0.018905,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,1,0.00789,-0.027425,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.85082,0.0078132,0.024458,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.76948,0.0077927,0.010226,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.33373,0.0077186,-0.14281,0,0
2,GO CHROMATIN ORGANIZATION,0.53742,0.0076606,0.015965,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.94073,0.0076575,-0.0094183,0,0
2,GO BLASTOCYST FORMATION,0.65866,0.0075784,-0.037511,0,0
2,GO METHYLATION,0.17374,0.0075662,0.038901,0,0
2,GO DEVELOPMENTAL MATURATION,0.63978,0.0075599,0.020371,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.65234,0.0075588,-0.044166,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.93377,0.0074763,-0.0053236,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,1,0.0074465,-0.0025798,0,0
2,GO STEM CELL DIVISION,0.54321,0.0074132,-0.057739,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.67776,0.007323,0.014119,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.74288,0.0072341,-0.052146,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.96163,0.0071925,0.0047938,0,0
2,GO OVULATION CYCLE PROCESS,0.52594,0.0071886,0.039814,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.68418,0.0067391,-0.018695,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.77618,0.0066909,-0.040129,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.74288,0.006486,0.0057728,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.82348,0.0064581,-0.065142,0,0
2,GO EXCRETION,0.4545,0.0063055,0.038931,0,0
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.4978,0.0061568,0.10011,0,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.85768,0.0061056,-0.0067753,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.85768,0.0060705,-0.01452,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.44924,0.0060503,-0.057914,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.73628,0.0059652,0.028938,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.85082,0.0059544,-0.017632,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.42855,0.0059308,0.02443,0,0
2,GO NEURON APOPTOTIC PROCESS,1,0.0058247,0.0020222,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.63354,0.0057577,0.057561,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.85768,0.0057473,0.00092434,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.95466,0.0056284,-0.0086526,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.41341,0.0055827,0.007661,0,0
2,GO BLASTOCYST GROWTH,0.85082,0.0055409,-0.034941,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.60272,0.0054547,0.021615,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.89907,0.0054498,-0.018912,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.9686,0.0054248,-0.0058484,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.75615,0.0054208,-0.014165,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.56075,0.0053897,0.017482,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.64605,0.0053687,-0.024525,0,0
2,GO CELLULAR RESPONSE TO UV,0.87833,0.0053539,-0.015146,0,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.89907,0.0053303,-0.001584,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.99651,0.0052834,-0.024213,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.36526,0.005164,-0.056473,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.3746,0.0050254,-0.058171,0,0
2,GO PIRNA METABOLIC PROCESS,0.76281,0.0049965,-0.067728,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.67776,0.0049758,-0.018842,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.63354,0.0048385,-0.063784,0,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.52025,0.0047561,0.024131,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.59664,0.0047222,-0.066239,0,0
2,GO ENERGY HOMEOSTASIS,0.80312,0.0046785,0.023914,0,0
2,GO SISTER CHROMATID SEGREGATION,0.56666,0.0046772,0.025591,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.90599,0.0046525,0.00022112,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.47049,0.004634,-0.05466,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.70355,0.0045263,-0.058993,0,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.8303,0.0044814,0.020409,0,0
2,GO MITOTIC CELL CYCLE,0.81668,0.0044797,-0.012024,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.4545,0.0042998,0.010613,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.73628,0.0042901,0.012765,0,0
2,GO PROTEASOME ASSEMBLY,0.81668,0.0042726,-0.040689,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.84397,0.0041761,-0.0095214,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91293,0.0041524,-0.048701,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.29586,0.004015,-0.054142,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.78289,0.0039757,0.00069815,0,0
2,GO METHIONINE METABOLIC PROCESS,0.66501,0.0036902,-0.04608,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.75615,0.0036781,-0.040962,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.50896,0.0036617,-0.077211,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.78962,0.0035642,-0.026349,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.91293,0.0034904,0.011678,0,0
2,GO MYELIN ASSEMBLY,1,0.0034902,0.00021595,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.44924,0.0034671,-0.02555,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.91293,0.0032875,-0.00058271,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.69707,0.0032858,0.0052805,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.56666,0.0032668,-0.16876,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.34256,0.0032055,-0.074492,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.59664,0.0031827,0.030117,0,0
2,GO TAXIS,0.95466,0.0031526,-0.0091919,0,0
2,GO MAST CELL MIGRATION,0.94769,0.0030541,0.013296,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.77618,0.0029788,-0.048346,0,0
2,GO GENE SILENCING,0.91293,0.0029034,6.693e-05,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.98953,0.0028389,-0.003523,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.77618,0.0027694,0.016921,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.44924,0.0027591,-0.042755,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.90599,0.0027536,0.007229,0,0
2,GO SNRNA TRANSCRIPTION,0.56666,0.0027463,0.011658,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.77618,0.0025711,0.01002,0,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.87144,0.0025199,0.013716,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.56075,0.0024947,0.046166,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.44924,0.0024789,-0.038623,0,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.90599,0.0022408,0.013901,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.22568,0.0022298,-0.11838,0,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.96163,0.0021907,0.0047249,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.92682,0.0021043,0.018102,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.95466,0.0020387,-0.0057855,0,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.72969,0.0020107,0.078074,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.9686,0.0019791,-0.010369,0,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.40349,0.0018576,0.067058,0,0
2,GO MICROTUBULE ANCHORING,0.69061,0.0018466,0.013707,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.72969,0.0018365,0.012295,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.4598,0.0018012,-0.052835,0,0
2,GO TRANSLATIONAL TERMINATION,0.98255,0.0017651,0.0045388,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.4545,0.0015779,-0.092783,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.65234,0.0015649,-0.015136,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.91987,0.0015003,-0.0093078,0,0
2,GO PHOSPHATE ION TRANSPORT,0.73628,0.0014238,-0.032423,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.56666,0.0013915,0.060786,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.56666,0.0013581,-0.030914,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.44402,0.0013451,0.060061,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.98953,0.0012624,-0.036771,0,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.89215,0.0011241,-0.0086107,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.83713,0.0011109,0.00091821,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.97557,0.0011015,-0.0086482,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.73628,0.0010638,0.0060942,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.89907,0.0010598,0.0068341,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.80312,0.0010447,-0.01456,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.9686,0.0010153,-0.0074803,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.65234,0.00092425,-0.039297,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.80312,0.00090854,-0.014493,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.88523,0.00089216,-0.028504,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.78289,0.00087653,0.027475,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.44402,0.00079752,-0.12823,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.86455,0.0007758,-0.010272,0,0
2,GO FEEDING BEHAVIOR,0.50337,0.00069019,0.039695,0,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.94073,0.000632,-0.0070457,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.48131,0.00061643,0.049306,0,0
2,GO GROWTH,0.72969,0.00057462,-0.020575,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.60883,0.00034335,-0.023569,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.44924,0.00034305,-0.038378,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.76281,0.00031298,0.0253,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.72969,0.00026226,-0.00095071,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.76281,0.0002484,-0.03425,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.77618,0.00020692,0.036597,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.95466,0.00011443,-0.044034,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.87144,3.8118e-05,-0.031067,0,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.94073,-5.946e-05,-0.041841,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.62732,-0.00022124,0.01811,0,0
2,GO CELLULAR RESPONSE TO DRUG,0.67776,-0.00023148,-0.036764,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.41842,-0.00030454,-0.030751,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.98953,-0.00038119,-0.0069659,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.98255,-0.00039158,-0.0091685,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.83713,-0.0004749,0.0092763,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.68418,-0.00048398,-0.032777,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.80312,-0.00065102,-0.021238,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.54321,-0.00077555,-0.065844,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.9686,-0.00094954,-0.0052239,0,0
2,GO POTASSIUM ION TRANSPORT,0.43367,-0.0010668,0.044096,0,0
2,GO REGULATION OF CYTOKINESIS,0.91293,-0.0011133,-0.011306,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.80312,-0.0011469,-0.027704,0,0
2,GO PROSTATIC BUD FORMATION,0.62732,-0.0011713,-0.087014,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.87833,-0.0011718,0.0017677,0,0
2,GO CELLULAR RESPIRATION,0.91987,-0.001275,0.0011293,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.59664,-0.0013603,-0.042918,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.95466,-0.0014872,-0.0060598,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.87144,-0.0014886,-0.0066927,0,0
2,GO NODAL SIGNALING PATHWAY,0.69707,-0.0015357,0.017404,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.69061,-0.0015388,-0.030155,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.85082,-0.0018206,-0.0027675,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.32506,-0.0018327,0.06282,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.58456,-0.0018846,-0.027667,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.59664,-0.0019104,-0.043842,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.43367,-0.0019716,-0.098296,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.13355,-0.0020685,-0.085596,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.86455,-0.0022328,0.0057784,0,0
2,GO EXOCYTIC PROCESS,0.93377,-0.002245,0.015113,0,0
2,GO VESICLE CARGO LOADING,0.60272,-0.0023234,-0.076278,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.29992,-0.0023655,-0.093258,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.54321,-0.0024532,-0.026437,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,1,-0.0024742,-0.00907,0,0
2,GO ODONTOGENESIS,0.53742,-0.0025701,-0.048377,0,0
2,GO REGULATION OF T CELL MIGRATION,0.22568,-0.002709,-0.074574,0,0
2,GO HEART GROWTH,0.67137,-0.0027366,0.019194,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.93377,-0.0028474,-0.0048732,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.62113,-0.0028519,-0.0248,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.56075,-0.0032524,-0.02941,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.96163,-0.0032936,0.0073668,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.71006,-0.0033312,-0.01457,0,0
2,GO REGULATION OF MYELINATION,0.78962,-0.003369,-0.010556,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.83713,-0.0033994,-0.022968,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.54903,-0.0034015,-0.071376,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.60272,-0.0034079,-0.041,0,0
2,GO ENAMEL MINERALIZATION,0.36064,-0.0034834,-0.15898,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.78962,-0.0034916,-0.040437,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.89907,-0.003532,-0.0075317,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.62732,-0.0035582,0.15611,0,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.98953,-0.0036388,0.0023581,0,0
2,GO RENAL FILTRATION,0.36526,-0.0036397,-0.15571,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.58456,-0.0036843,-0.032148,0,0
2,GO L GLUTAMATE IMPORT,0.89907,-0.0037478,0.010168,0,0
2,GO ENDODERM FORMATION,0.46512,-0.0037724,-0.12021,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.62113,-0.0038489,-0.046982,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.32938,-0.0038818,-0.035068,0,0
2,GO RECEPTOR RECYCLING,0.74288,-0.0040364,-0.017233,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.91293,-0.0043112,-0.015908,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.90599,-0.0043192,-0.0072174,0,0
2,GO CELL CELL SIGNALING BY WNT,0.67776,-0.0043304,-0.022936,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.82348,-0.0043497,-0.0091134,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.88523,-0.00435,0.002756,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.99651,-0.0044204,0.040224,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.64605,-0.0044339,-0.071286,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.54903,-0.0044759,0.046699,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.77618,-0.0045155,0.0037242,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.58456,-0.0046549,-0.028088,0,0
2,GO T CELL MIGRATION,0.17374,-0.0047552,-0.10178,0,0
2,GO VIRAL GENE EXPRESSION,0.99651,-0.0047663,-0.0081545,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.52594,-0.0048259,-0.03395,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.92682,-0.0050234,-0.0079278,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.76281,-0.0050413,0.013238,0,0
2,GO MACROMOLECULE DEACYLATION,0.87144,-0.0050672,-0.0040088,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.81668,-0.0051226,-0.035232,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.70355,-0.0051255,-0.022749,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.73628,-0.0053667,-0.023694,0,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.56666,-0.005388,-0.025664,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.22235,-0.0054034,-0.054303,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.78289,-0.0054319,-0.014242,0,0
2,GO SPINDLE ASSEMBLY,0.22568,-0.0054398,-0.040971,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.64605,-0.0055575,-0.043885,0,0
2,GO MRNA CLEAVAGE,0.9686,-0.0056684,0.0082375,0,0
2,GO PROSTATE GLAND GROWTH,0.62113,-0.0056881,-0.076677,0,0
2,GO PRO B CELL DIFFERENTIATION,0.61497,-0.005766,-0.055228,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.96163,-0.0058098,-0.0083435,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.74288,-0.0059028,-0.013085,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.88523,-0.0059808,0.025366,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.62732,-0.006037,0.024496,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.71006,-0.006048,-0.023318,0,0
2,GO HIPPO SIGNALING,0.52594,-0.0060952,0.017891,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.52025,-0.0061134,-0.0488,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.59059,-0.0063901,-0.034681,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.89907,-0.0063907,-0.015934,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.54321,-0.0064052,0.03707,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,1,-0.0064094,-0.011768,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.63354,-0.0064462,-0.01878,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.75615,-0.0064985,0.020316,0,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.56666,-0.0066384,-0.092249,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.47049,-0.0066446,-0.02769,0,0
2,GO RENAL SODIUM EXCRETION,0.53742,-0.006676,-0.059032,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.87833,-0.0068639,-0.035096,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.49227,-0.0070066,-0.043167,0,0
2,GO PROTEIN TARGETING,0.54321,-0.007045,-0.034005,0,0
2,GO CELL JUNCTION ASSEMBLY,0.32938,-0.0070676,-0.047556,0,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.67137,-0.0070967,0.021894,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.99651,-0.0071098,-0.0058847,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.73628,-0.0071166,-0.013729,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.4545,-0.0071247,0.11103,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.94769,-0.0071528,-0.0079711,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.83713,-0.0071727,-0.029097,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.67776,-0.0071967,-0.032659,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.85082,-0.0072587,-0.0056307,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.91293,-0.0072776,-0.012721,0,0
2,GO HEAD MORPHOGENESIS,0.17099,-0.0076318,-0.13176,0,0
2,GO FEMALE SEX DIFFERENTIATION,1,-0.0076784,-0.010969,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.52594,-0.0077868,-0.020937,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.48131,-0.0078088,-0.041302,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.59664,-0.0078764,-0.051339,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.54321,-0.0079311,-0.036475,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.28785,-0.0080215,-0.035302,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.75615,-0.0080345,-0.050982,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.47049,-0.0081366,-0.089011,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.72969,-0.0082883,-0.032841,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.97557,-0.0084005,0.004775,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.98953,-0.0084886,-0.0091168,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.26847,-0.0086252,-0.032009,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.80989,-0.0086637,-0.012804,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,-0.0088233,-0.091922,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.25001,-0.0088476,-0.14825,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.89907,-0.0088645,-0.0030617,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.72969,-0.0089322,0.04324,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.60272,-0.0089782,0.020225,0,0
2,GO CHROMOSOME SEGREGATION,0.64605,-0.0090329,0.013231,0,0
2,GO CHLORIDE TRANSPORT,0.32077,-0.00906,-0.06236,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.89907,-0.0091356,-0.014657,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.188,-0.0092042,-0.13082,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.76948,-0.0092331,-0.033731,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.70355,-0.0092878,-0.041767,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98255,-0.0094769,-0.01019,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.82348,-0.0095025,-0.0091723,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.83713,-0.0095208,-0.014435,0,0
2,GO L SERINE METABOLIC PROCESS,0.67776,-0.0096111,0.052575,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.60883,-0.009625,-0.059307,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.44924,-0.0096433,-0.061128,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.054842,-0.0096818,-0.06623,0,0
2,GO PERICARDIUM DEVELOPMENT,0.5726,-0.0097832,0.057632,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.2839,-0.009828,-0.13288,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.39858,-0.0098498,-0.15295,0,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.74288,-0.0098913,-0.074224,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.79636,-0.010122,-0.013408,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.62732,-0.010251,-0.056199,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.39858,-0.010453,-0.03805,0,0
2,GO CHROMOSOME CONDENSATION,0.84397,-0.010454,-0.0030233,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.68418,-0.010513,-0.015741,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.010527,-0.010956,0,0
2,GO REGULATION OF CELL DIVISION,0.41341,-0.010546,-0.030497,0,0
2,GO ATP METABOLIC PROCESS,0.88523,-0.01055,0.0048364,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.74288,-0.010587,-0.0375,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.38888,-0.01066,-0.06686,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.49227,-0.010882,0.06781,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.29586,-0.01091,-0.034175,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.26847,-0.010935,-0.081025,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.82348,-0.010958,-0.0035243,0,0
2,GO RESPONSE TO CALCIUM ION,0.69707,-0.010966,-0.030228,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.69061,-0.011044,0.016458,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.81668,-0.011123,-0.023181,0,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.80989,-0.011161,-0.018829,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.62732,-0.011281,-0.023273,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.83713,-0.011405,-0.014065,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.25363,-0.011561,-0.050025,0,0
2,GO POSITIVE REGULATION OF BINDING,0.63978,-0.011642,-0.030274,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.89215,-0.011875,-0.021232,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.70355,-0.0119,-0.041221,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.98255,-0.011941,-0.018299,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.32506,-0.012001,-0.040013,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.71658,-0.01207,-0.034157,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.99651,-0.012189,-0.0068256,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.81668,-0.012232,-0.037181,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.91987,-0.012294,0.0018829,0,0
2,GO MITOCHONDRIAL TRANSLATION,0.92682,-0.012343,0.0023094,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,1,-0.012366,-0.0012611,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.72969,-0.012368,-0.060462,0,0
2,GO HISTONE H3 ACETYLATION,0.87833,-0.01237,0.0070118,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.68418,-0.01238,0.02228,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.34702,-0.012447,-0.050135,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.88523,-0.012595,0.0118,0,0
2,GO HINDLIMB MORPHOGENESIS,0.78962,-0.012615,-0.032487,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.29586,-0.012619,-0.059016,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13355,-0.012776,-0.11162,0,0
2,GO CELL DIVISION,0.4978,-0.012801,-0.020408,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.18508,-0.012819,-0.094904,0,0
2,GO REGULATION OF BINDING,0.21579,-0.012877,-0.04626,0,0
2,GO COMPLEMENT ACTIVATION,0.38888,-0.012971,-0.082489,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.73628,-0.013178,-0.03615,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.63978,-0.013207,-0.031575,0,0
2,GO SODIUM ION HOMEOSTASIS,0.32506,-0.013273,-0.048734,0,0
2,GO FUCOSYLATION,0.44402,-0.013275,-0.070975,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.94769,-0.013497,0.011861,0,0
2,GO REGULATION OF FERTILIZATION,0.74288,-0.013594,-0.036886,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.31653,-0.013691,-0.077985,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.31232,-0.013726,-0.032543,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.79636,-0.013839,0.012397,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.22235,-0.013874,-0.050163,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.95466,-0.014013,-0.0043955,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.20937,-0.014014,-0.080239,0,0
2,GO LACTATION,0.84397,-0.014202,-0.021574,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.51459,-0.014204,-0.032521,0,0
2,GO VESICLE LOCALIZATION,0.23245,-0.014286,-0.037704,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.46512,-0.014291,-0.030305,0,0
2,GO MUSCLE SYSTEM PROCESS,0.29992,-0.014363,-0.047774,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.73628,-0.014379,-0.0076126,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.94769,-0.014463,-0.002143,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.29992,-0.014913,-0.060561,0,0
2,GO ENDODERM DEVELOPMENT,0.34256,-0.015499,-0.12492,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.48678,-0.015507,-0.042274,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.19095,-0.015557,-0.050433,0,0
2,GO HISTONE H4 ACETYLATION,0.51459,-0.015643,0.04826,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.43883,-0.015653,-0.033701,0,0
2,GO CELL GROWTH,0.94769,-0.015744,-0.00804,0,0
2,GO CELL FATE COMMITMENT,0.95466,-0.015789,-0.0073374,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.42347,-0.015807,-0.082556,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.40843,-0.015895,-0.042202,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.53742,-0.015961,-0.083438,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.36526,-0.016028,-0.051169,0,0
2,GO VIRAL LATENCY,0.87144,-0.016123,0.0058289,0,0
2,GO SPINDLE ORGANIZATION,0.47588,-0.016137,-0.02506,0,0
2,GO RNA 5 END PROCESSING,0.85082,-0.016184,-0.02578,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.5726,-0.016192,-0.042696,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.67137,-0.016212,-0.041555,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.2839,-0.016247,-0.059069,0,0
2,GO REGULATION OF EXCRETION,0.70355,-0.01636,-0.024631,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.99651,-0.016467,-0.00021386,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.80312,-0.016526,-0.037694,0,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.54321,-0.01654,-0.061656,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.47588,-0.016572,-0.05224,0,0
2,GO CHROMOSOME SEPARATION,0.58456,-0.016631,0.026153,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.78289,-0.016652,0.029803,0,0
2,GO ASYMMETRIC CELL DIVISION,0.43883,-0.016713,-0.07574,0,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.70355,-0.016788,-0.023692,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.17374,-0.016872,-0.062941,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.21579,-0.016935,-0.096507,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.88523,-0.017054,-0.01899,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.85082,-0.017077,-0.035221,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.60272,-0.017191,-0.042179,0,0
2,GO RESPONSE TO UV B,0.78289,-0.017254,-0.027499,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.55487,-0.01736,-0.067438,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.55487,-0.017402,-0.023984,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.42855,-0.017402,-0.059848,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.22905,-0.017414,-0.080481,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.93377,-0.017427,0.0036819,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.52025,-0.017462,-0.065116,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.99651,-0.017486,0.013582,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.80312,-0.017526,-0.02142,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.98953,-0.017549,-0.018865,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.74288,-0.017576,-0.041973,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.70355,-0.017583,-0.017658,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.59664,-0.017617,-0.03829,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.62732,-0.017666,-0.030463,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.58456,-0.017858,-0.032548,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.017892,-0.025506,0,0
2,GO OOGENESIS,0.36991,-0.018076,-0.034402,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.57857,-0.018114,-0.045851,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.87144,-0.018125,0.016004,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.74288,-0.018239,-0.026024,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.20937,-0.018279,-0.12908,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.9686,-0.018324,0.015524,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.12049,-0.018363,-0.12151,0,0
2,GO HEART DEVELOPMENT,0.4978,-0.018377,-0.038812,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.22905,-0.018454,-0.09783,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.54321,-0.018488,0.03313,0,0
2,GO GLIAL CELL DEVELOPMENT,0.38888,-0.018499,-0.067071,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.4978,-0.018698,-0.045987,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.96163,-0.018758,-0.0046541,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.21579,-0.018787,-0.027054,0,0
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.69707,-0.018896,0.022642,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.43367,-0.018994,-0.09148,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.35153,-0.01902,-0.17282,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22905,-0.019065,-0.066484,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.68418,-0.019311,-0.021561,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32938,-0.019425,-0.050901,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.47049,-0.019599,-0.036315,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.27227,-0.019638,-0.086325,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.36991,-0.019698,-0.042227,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.94073,-0.019828,-0.033257,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.43883,-0.019965,-0.067515,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.2839,-0.020112,-0.054466,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.99651,-0.020124,0.0073315,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.47588,-0.020129,-0.047821,0,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.85768,-0.020243,-0.02788,0,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.72969,-0.020252,-0.0029901,0,0
2,GO RESPONSE TO UV,0.34256,-0.020271,-0.03233,0,0
2,GO LIPID PHOSPHORYLATION,0.23589,-0.020367,-0.050897,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.29992,-0.02053,-0.029231,0,0
2,GO MALE GAMETE GENERATION,0.17374,-0.02061,-0.041572,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.26471,-0.020631,-0.03811,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.64605,-0.020642,-0.048771,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.58456,-0.0207,-0.024344,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.85768,-0.020702,-0.0065963,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.31232,-0.020717,-0.066496,0,0
2,GO LYMPH NODE DEVELOPMENT,0.32077,-0.020769,-0.082366,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.25001,-0.020827,-0.099376,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.39858,-0.020879,-0.051511,0,0
2,GO LIVER REGENERATION,0.53167,-0.020983,-0.083767,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.38888,-0.021023,-0.048915,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.32077,-0.021049,-0.043617,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.39371,-0.021067,-0.027498,0,0
2,GO GLIAL CELL PROLIFERATION,0.38888,-0.021072,-0.064267,0,0
2,GO METAL ION HOMEOSTASIS,0.12473,-0.021095,-0.07126,0,0
2,GO REGULATION OF GROWTH,0.29586,-0.02114,-0.042937,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.9686,-0.021216,-0.013982,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.9686,-0.02128,0.013794,0,0
2,GO LYMPHOCYTE MIGRATION,0.093897,-0.021307,-0.11204,0,0
2,GO SEX DETERMINATION,0.36526,-0.021339,-0.084606,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.48131,-0.021403,-0.058898,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.36526,-0.021415,-0.089252,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.072231,-0.021469,-0.075044,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.56666,-0.021498,-0.11378,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.70355,-0.021575,-0.028098,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.22235,-0.021645,-0.044644,0,0
2,GO AMYLOID BETA FORMATION,0.52025,-0.021654,-0.076545,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,-0.021716,-0.036718,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.58456,-0.021759,0.10795,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.26471,-0.021775,-0.051822,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.38408,-0.021902,-0.0351,0,0
2,GO PROTEIN IMPORT,0.23245,-0.021966,-0.045143,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.67776,-0.022077,-0.017778,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.092194,-0.022085,-0.068317,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.53167,-0.02209,0.08014,0,0
2,GO IMPORT INTO NUCLEUS,0.42347,-0.022139,-0.031043,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.76281,-0.022141,0.091689,0,0
2,GO MESENCHYME DEVELOPMENT,0.43367,-0.022206,-0.057298,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.62732,-0.022323,-0.026495,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.36064,-0.022332,-0.12336,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.69061,-0.022367,-0.022779,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.50337,-0.022374,-0.078471,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.39858,-0.022468,-0.039347,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.87144,-0.022508,-0.00064182,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.56666,-0.02271,-0.01971,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.41341,-0.022713,-0.035278,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.11636,-0.022719,-0.11433,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.58456,-0.022725,-0.056738,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.83713,-0.022781,-0.012846,0,0
2,GO REGULATION OF CELL CYCLE,0.19695,-0.02281,-0.027447,0,0
2,GO NEURON PROJECTION REGENERATION,0.8303,-0.022859,0.0089463,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.27611,-0.022914,-0.086146,0,0
2,GO REGULATION OF CELL MATURATION,0.27227,-0.023028,-0.047588,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.54321,-0.023069,-0.059147,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.85768,-0.02307,-0.025201,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.28785,-0.023151,-0.070857,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.43883,-0.023334,-0.049559,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.60272,-0.023357,-0.026477,0,0
2,GO CYTOKINESIS,0.26098,-0.023384,-0.039865,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.91987,-0.023525,-0.0053848,0,0
2,GO NUCLEOSIDE SALVAGE,0.69061,-0.023545,-0.032753,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.97557,-0.023582,-0.0027179,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.8303,-0.023728,0.017858,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.13814,-0.023799,-0.057713,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.9686,-0.0238,-0.0083151,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.56666,-0.02382,-0.027969,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.37932,-0.023872,-0.056265,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.39858,-0.023877,-0.036758,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,-0.023956,-0.075239,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.084046,-0.024038,-0.060494,0,0
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.80989,-0.024042,0.027504,0,0
2,GO OSSIFICATION,0.092194,-0.024085,-0.093226,0,0
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.53167,-0.024122,-0.072571,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.69707,-0.024129,-0.0062411,0,0
2,GO MISMATCH REPAIR,0.85768,-0.024148,0.00060435,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.97557,-0.02416,0.031406,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.56075,-0.024175,-0.065744,0,0
2,GO CHROMATIN DISASSEMBLY,0.52594,-0.024273,0.091901,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.19695,-0.024277,-0.093598,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.53167,-0.024328,-0.019914,0,0
2,GO CHEMICAL HOMEOSTASIS,0.05824,-0.024356,-0.079287,0,0
2,GO MAINTENANCE OF LOCATION,0.10845,-0.024575,-0.06862,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.36991,-0.024587,-0.0621,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.42855,-0.024623,-0.032387,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.15517,-0.024643,-0.091283,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.47588,-0.024693,-0.050028,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.64605,-0.024737,-0.025977,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.085627,-0.024923,-0.051649,0,0
2,GO PRENYLATION,0.38408,-0.024967,-0.080262,0,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.33373,-0.024987,-0.060213,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.59059,-0.025026,-0.032819,0,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.65866,-0.02523,-0.043841,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.82348,-0.025251,-0.0086377,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.62732,-0.02547,-0.017304,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.92682,-0.025505,-0.0015481,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.96163,-0.025533,-0.012665,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.87833,-0.025547,-0.0015148,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.53742,-0.025553,-0.027682,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.12049,-0.025585,-0.064378,0,0
2,GO MITOTIC RECOMBINATION,0.77618,-0.025838,0.014095,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.38888,-0.025852,-0.099455,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.14769,-0.025858,-0.0942,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.56666,-0.025868,-0.029663,0,0
2,GO NEPHRON MORPHOGENESIS,0.4598,-0.026039,-0.048864,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.95466,-0.026051,-0.003549,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.30402,-0.026056,-0.084093,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.16828,-0.026072,-0.06358,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.068167,-0.026086,-0.052376,0,0
2,GO RESPONSE TO BMP,0.27227,-0.026125,-0.069793,0,0
2,GO SEROTONIN SECRETION,0.87144,-0.026177,0.047073,0,0
2,GO ECTODERM DEVELOPMENT,0.19095,-0.0262,-0.075644,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.02633,-0.051155,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.16828,-0.026376,-0.052759,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.47049,-0.026448,-0.045882,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.91987,-0.026456,-0.016436,0,0
2,GO CELLULAR HOMEOSTASIS,0.2839,-0.026544,-0.046218,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.38408,-0.026696,-0.064599,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.31653,-0.02675,-0.060568,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.073629,-0.026812,-0.10265,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.23589,-0.026829,-0.045022,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.17099,-0.026885,-0.02886,0,0
2,GO AXIS SPECIFICATION,0.42855,-0.027023,-0.031555,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.1313,-0.027133,-0.048026,0,0
2,GO TOR SIGNALING,0.10845,-0.027173,-0.044954,0,0
2,GO ION HOMEOSTASIS,0.16032,-0.027177,-0.06198,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.35153,-0.027193,-0.039549,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.23589,-0.027222,-0.074341,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.30815,-0.027283,-0.052944,0,0
2,GO MACROPHAGE CHEMOTAXIS,0.25729,-0.027294,-0.08763,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.188,-0.02733,-0.064981,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.93377,-0.027335,-0.057221,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.64605,-0.02741,-0.038719,0,0
2,GO RESPONSE TO CAMP,0.87833,-0.027438,-0.009898,0,0
2,GO HISTONE UBIQUITINATION,0.29586,-0.027502,-0.030951,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.72313,-0.027769,-0.038391,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.95466,-0.027772,-0.00047425,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.42347,-0.027803,-0.051622,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.11434,-0.027828,-0.066886,0,0
2,GO LYMPHANGIOGENESIS,0.71006,-0.027947,-0.040172,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.32077,-0.027967,-0.037687,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.80312,-0.028119,-0.011485,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.57857,-0.028139,-0.063304,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.28785,-0.028173,-0.069892,0,0
2,GO NEURON DEATH,0.59664,-0.028182,-0.016771,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.39858,-0.028286,-0.062771,0,0
2,GO THYMIC T CELL SELECTION,0.21905,-0.028375,-0.05681,0,0
2,GO CYTOSKELETON ORGANIZATION,0.14526,-0.028395,-0.04305,0,0
2,GO THYROID GLAND DEVELOPMENT,0.80989,-0.028415,-0.001684,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.080955,-0.02844,-0.042611,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0695,-0.02847,-0.096791,0,0
2,GO MRNA TRANSCRIPTION,0.99651,-0.028518,-0.0065388,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.60272,-0.028741,-0.041565,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.75615,-0.028765,-0.022584,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,0.80312,-0.028781,0.012845,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.8303,-0.028846,-0.020601,0,0
2,GO ORGAN GROWTH,0.78962,-0.028908,-0.018068,0,0
2,GO PROTEIN TETRAMERIZATION,0.75615,-0.028965,-0.010349,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,-0.028968,0.0029639,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.02909,-0.042614,0,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.21905,-0.029161,-0.10886,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.43883,-0.029281,-0.053441,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.66501,-0.029353,-0.039701,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.17099,-0.029398,-0.10478,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.42855,-0.029411,-0.021711,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.17374,-0.02943,-0.048945,0,0
2,GO AMP METABOLIC PROCESS,0.52025,-0.029453,-0.075748,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.72313,-0.029518,0.032518,0,0
2,GO RHYTHMIC PROCESS,0.4545,-0.029666,-0.024601,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.21579,-0.029727,-0.13851,0,0
2,GO RESPONSE TO HYDROXYUREA,0.54321,-0.029882,-0.01315,0,0
2,GO NUCLEUS ORGANIZATION,0.32506,-0.029924,-0.030098,0,0
2,GO PEPTIDE METABOLIC PROCESS,0.46512,-0.029995,-0.039606,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.7495,-0.030015,-0.010852,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.18219,-0.030067,-0.032434,0,0
2,GO SULFATION,0.64605,-0.030164,-0.030181,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.43883,-0.030288,-0.037662,0,0
2,GO CELL CYCLE,0.25363,-0.030472,-0.023745,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.98953,-0.030508,-0.016327,0,0
2,GO INORGANIC ANION TRANSPORT,0.13355,-0.030594,-0.087776,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.34702,-0.030726,-0.031163,0,0
2,GO ORGAN INDUCTION,0.29184,-0.03093,-0.090342,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.67137,-0.030932,-0.039827,0,0
2,GO REGULATION OF GASTRULATION,0.26098,-0.030936,-0.08419,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.79636,-0.031103,0.037751,0,0
2,GO STEROL TRANSPORT,0.14048,-0.031192,-0.096528,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.21905,-0.031205,-0.049607,0,0
2,GO FEMALE GAMETE GENERATION,0.16828,-0.031334,-0.050374,0,0
2,GO STEM CELL DIFFERENTIATION,0.29586,-0.031364,-0.041812,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.080955,-0.03143,-0.063423,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.24288,-0.031636,-0.040066,0,0
2,GO ZINC ION HOMEOSTASIS,0.33373,-0.031849,-0.13341,0,0
2,GO ORGANELLE LOCALIZATION,0.10845,-0.031966,-0.029447,0,0
2,GO RESPONSE TO ETHANOL,0.42347,-0.031994,-0.041226,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.15015,-0.032154,-0.061919,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.79636,-0.0322,-0.028333,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.24643,-0.032207,-0.070102,0,0
2,GO METAPHASE PLATE CONGRESSION,0.39858,-0.032292,-0.033224,0,0
2,GO ORGANIC ACID TRANSPORT,0.20621,-0.032301,-0.055664,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.032306,-0.093866,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.44924,-0.032329,-0.069857,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.44402,-0.032399,-0.033687,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.29992,-0.032404,-0.071516,0,0
2,GO SENSORY PERCEPTION,0.50896,-0.032604,-0.017637,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.49227,-0.032705,-0.11608,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.49227,-0.032784,-0.069667,0,0
2,GO GLIAL CELL ACTIVATION,0.34702,-0.032877,-0.080564,0,0
2,GO MICROVILLUS ASSEMBLY,0.21905,-0.0329,-0.15061,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.67776,-0.032976,-0.049159,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.78962,-0.033001,-0.032408,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.14285,-0.033244,-0.088233,0,0
2,GO REGULATION OF URINE VOLUME,0.57857,-0.033402,-0.049966,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.26471,-0.033559,-0.053021,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.030383,-0.033628,-0.10881,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.25001,-0.033674,-0.079268,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.88523,-0.033769,0.00032655,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.65866,-0.033836,-0.060137,0,0
2,GO AMINE TRANSPORT,0.85768,-0.033854,0.071516,0,0
2,GO POLYOL METABOLIC PROCESS,0.20937,-0.033858,-0.056424,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.41341,-0.033971,-0.053771,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.34256,-0.034161,-0.062167,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.12259,-0.034179,-0.10695,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.83713,-0.034281,-0.0039124,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.063042,-0.034336,-0.073902,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.034352,-0.018196,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.52594,-0.034393,-0.031048,0,0
2,GO DNA MODIFICATION,0.16032,-0.034422,-0.037681,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.88523,-0.034474,-0.056245,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.51459,-0.034531,-0.060488,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.052669,-0.034612,-0.073596,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.52025,-0.034701,-0.048097,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.36064,-0.03473,-0.075366,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.14769,-0.034758,-0.08594,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.36064,-0.03478,-0.097598,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.39858,-0.034783,-0.091037,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.82348,-0.034857,0.029543,0,0
2,GO BICARBONATE TRANSPORT,0.18508,-0.034939,-0.10879,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.3746,-0.034952,-0.023836,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.61497,-0.034984,0.026281,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.37932,-0.035033,-0.035192,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.40349,-0.035063,-0.063098,0,0
2,GO RESPONSE TO PAIN,0.4978,-0.035119,-0.080176,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.14285,-0.035156,-0.04865,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.29992,-0.035161,-0.074632,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.20309,-0.03519,-0.055018,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.44924,-0.035209,-0.043542,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.33812,-0.035244,-0.068743,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.90599,-0.03526,0.039524,0,0
2,GO ANIMAL ORGAN FORMATION,0.80989,-0.035294,-0.017462,0,0
2,GO CALCIUM ION IMPORT,0.95466,-0.035397,0.016871,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.50337,-0.03541,-0.039396,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.047551,-0.035422,-0.069041,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.44402,-0.035445,-0.023608,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.10845,-0.035451,-0.039384,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.37932,-0.035566,-0.062006,0,0
2,GO DOSAGE COMPENSATION,0.38408,-0.035615,-0.033248,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.05824,-0.035618,-0.065096,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.087232,-0.035813,-0.044947,0,0
2,GO TRABECULA MORPHOGENESIS,0.52594,-0.035933,-0.049469,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.11841,-0.035938,-0.082271,0,0
2,GO PORE COMPLEX ASSEMBLY,0.092194,-0.035975,-0.11502,0,0
2,GO DNA CATABOLIC PROCESS,0.11039,-0.036018,-0.039969,0,0
2,GO CHYLOMICRON ASSEMBLY,0.52594,-0.036033,-0.066903,0,0
2,GO BODY FLUID SECRETION,0.057089,-0.036103,-0.10147,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.54903,-0.036203,-0.030631,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.3746,-0.036238,-0.036219,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.011612,-0.036259,-0.06191,0,0
2,GO RESPONSE TO AXON INJURY,0.87144,-0.036316,-0.01685,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.30815,-0.03654,-0.05924,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.12049,-0.036918,-0.055838,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.053746,-0.036969,-0.068165,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.42855,-0.037006,-0.040062,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.86455,-0.037054,0.0037458,0,0
2,GO RESPONSE TO ETHER,0.3746,-0.037146,-0.039712,0,0
2,GO MACROPHAGE MIGRATION,0.30402,-0.03715,-0.087957,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.22235,-0.037214,-0.060997,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.092194,-0.037277,-0.033857,0,0
2,GO NEGATIVE T CELL SELECTION,0.26471,-0.03729,-0.098819,0,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.077957,-0.037306,-0.12646,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.21579,-0.03747,-0.14706,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.40843,-0.037504,-0.043547,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.10845,-0.037591,-0.064235,0,0
2,GO BLASTOCYST DEVELOPMENT,0.04854,-0.0376,-0.064666,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.15264,-0.037679,-0.068776,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.22568,-0.037683,-0.070819,0,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.73628,-0.037711,-0.028096,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.064293,-0.037751,-0.076002,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.93377,-0.037753,-0.002376,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.052669,-0.037777,-0.11276,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.26847,-0.037791,-0.063622,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.72313,-0.037824,-0.051903,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.47049,-0.037917,-0.040821,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.064293,-0.037941,-0.14913,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.63978,-0.037949,-0.018105,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.36064,-0.037973,-0.025825,0,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.32938,-0.037998,-0.075107,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.48131,-0.038007,-0.062411,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.14048,-0.038046,-0.073606,0,0
2,GO EMBRYO DEVELOPMENT,0.097379,-0.038103,-0.060383,0,0
2,GO ANIMAL ORGAN MATURATION,0.34256,-0.038129,-0.068964,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.39371,-0.038157,-0.067494,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.16828,-0.0382,-0.031403,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.093897,-0.038227,-0.076158,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.47588,-0.038349,-0.052436,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.70355,-0.038366,0.0023224,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.49227,-0.038429,-0.018867,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.054842,-0.03847,-0.069588,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.41341,-0.038571,-0.04933,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72313,-0.03859,-0.022313,0,0
2,GO TONGUE DEVELOPMENT,0.47588,-0.038608,-0.080973,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.47588,-0.038609,-0.04265,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.43367,-0.038702,-0.058023,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.24643,-0.038753,-0.094635,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.1313,-0.038782,-0.064837,0,0
2,GO RESPONSE TO ATP,0.71658,-0.038831,0.0278,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.33373,-0.038866,-0.043574,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.31232,-0.038872,-0.061001,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.10465,-0.038873,-0.053899,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.39371,-0.038888,-0.11391,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.39858,-0.039016,-0.032864,0,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.24288,-0.039159,-0.062304,0,0
2,GO HISTONE DEACETYLATION,0.21579,-0.039188,-0.046311,0,0
2,GO SEXUAL REPRODUCTION,0.095625,-0.039242,-0.043161,0,0
2,GO LYSOSOMAL TRANSPORT,0.22568,-0.039273,-0.061546,0,0
2,GO RESPONSE TO HEAT,0.5726,-0.039338,-0.02769,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.99651,-0.039372,-0.016225,0,0
2,GO PROTEIN FOLDING,0.35607,-0.039429,-0.055212,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.28785,-0.039431,-0.056953,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.24643,-0.039488,-0.054035,0,0
2,GO CARTILAGE MORPHOGENESIS,0.60883,-0.039492,0.077323,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.47049,-0.039535,-0.028332,0,0
2,GO SEX DIFFERENTIATION,0.17934,-0.039604,-0.058025,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.085627,-0.039695,-0.086706,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.24643,-0.039744,-0.073215,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.36526,-0.039912,-0.15192,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.30815,-0.039918,-0.034563,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.61497,-0.039925,-0.038707,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.12473,-0.040012,-0.12017,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.44924,-0.040026,-0.055343,0,0
2,GO CELLULAR EXTRAVASATION,0.41341,-0.040033,-0.044211,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.39371,-0.040102,-0.050056,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.079444,-0.040258,-0.071628,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.32077,-0.040319,-0.055066,0,0
2,GO HEART FORMATION,0.98255,-0.040342,0.010532,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.83713,-0.040357,-0.025189,0,0
2,GO P BODY ASSEMBLY,0.11039,-0.04068,-0.060609,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72313,-0.040707,-0.021462,0,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.25729,-0.040725,-0.17171,0,0
2,GO REGULATION OF ORGAN GROWTH,0.52025,-0.0408,-0.043052,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.98953,-0.040849,-0.0069199,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.97557,-0.040929,0.0083294,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.29992,-0.040949,-0.06869,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.4598,-0.040964,-0.019233,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.48131,-0.041022,-0.070187,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.25363,-0.041074,-0.04599,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.67137,-0.0411,-0.01861,0,0
2,GO GAS TRANSPORT,0.60272,-0.041147,-0.078411,0,0
2,GO REGULATION OF BEHAVIOR,0.99651,-0.041165,0.014727,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.19695,-0.041182,-0.086055,0,0
2,GO HISTONE H3 DEACETYLATION,0.50896,-0.041199,-0.033727,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.036948,-0.041209,-0.085284,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.56666,-0.041235,-0.041272,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.92682,-0.041286,-0.01753,0,0
2,GO RESPONSE TO SALT,0.28785,-0.041347,-0.051822,0,0
2,GO TERPENOID METABOLIC PROCESS,0.24288,-0.041363,-0.077094,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.040234,-0.041367,-0.092328,0,0
2,GO ACROSOME REACTION,0.71006,-0.04142,-0.020954,0,0
2,GO MICROTUBULE SEVERING,0.89215,-0.041431,-0.011372,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.78289,-0.041485,-0.019036,0,0
2,GO MUSCLE CONTRACTION,0.47588,-0.041559,-0.038299,0,0
2,GO MITOTIC CYTOKINESIS,0.12259,-0.041622,-0.070845,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.25729,-0.041646,-0.034327,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.20937,-0.041659,-0.044311,0,0
2,GO HEART VALVE DEVELOPMENT,0.51459,-0.041763,-0.055457,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.97557,-0.041828,0.020562,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.061812,-0.041912,-0.11308,0,0
2,GO CHROMOSOME LOCALIZATION,0.40349,-0.041977,-0.033315,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.2,-0.04201,-0.12677,0,0
2,GO MALE MEIOSIS I,0.67137,-0.042016,-0.053666,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.042079,-0.020177,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.65866,-0.042367,-0.012683,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.18508,-0.042368,-0.055061,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.63978,-0.042438,-0.11638,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.076492,-0.042557,-0.11098,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.015574,-0.042616,-0.065353,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.51459,-0.042638,-0.048166,0,0
2,GO TISSUE MORPHOGENESIS,0.041093,-0.042667,-0.085713,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.31232,-0.042679,-0.072405,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.019283,-0.042717,-0.058268,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.23937,-0.042761,-0.040914,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.76948,-0.042767,-0.0021188,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.28785,-0.042841,-0.049275,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.20937,-0.042866,-0.14105,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.34702,-0.042892,-0.018393,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.71658,-0.042941,0.022828,0,0
2,GO TRNA 5 END PROCESSING,0.28785,-0.043018,-0.068762,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.070855,-0.043027,-0.076654,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.21256,-0.043054,-0.10174,0,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.27611,-0.043146,-0.044603,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.050569,-0.043317,-0.12287,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.62113,-0.043372,-0.080129,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.42347,-0.043382,-0.034235,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.80312,-0.043411,0.014274,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.94073,-0.043424,0.0093204,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.19393,-0.043534,-0.14318,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.10845,-0.043554,-0.096218,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.188,-0.043565,-0.10063,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.8303,-0.043622,-0.013141,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.073629,-0.043633,-0.074456,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.10096,-0.043637,-0.11767,0,0
2,GO ORGANELLE FISSION,0.18508,-0.043777,-0.033204,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.80312,-0.043783,0.019652,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.11434,-0.04386,-0.039407,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.19695,-0.043887,-0.069063,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.04854,-0.044008,-0.057673,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.62113,-0.044032,-0.03219,0,0
2,GO RESPONSE TO GLUCAGON,0.37932,-0.044059,-0.038083,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.27999,-0.044082,-0.13994,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.81668,-0.044261,-0.0085257,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.16828,-0.044506,-0.035928,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.9686,-0.044514,-0.00025007,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.21579,-0.044613,-0.045665,0,0
2,GO CELL CYCLE CHECKPOINT,0.22905,-0.044623,-0.034685,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.10654,-0.044732,-0.071374,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.4545,-0.044776,-0.061012,0,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.060602,-0.044789,-0.092567,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,1,-0.044848,0.0066125,0,0
2,GO CYTOSOLIC TRANSPORT,0.10096,-0.044938,-0.051829,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.27999,-0.044951,-0.032327,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.11235,-0.04505,-0.096329,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.77618,-0.04507,-0.035349,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.070855,-0.045078,-0.11462,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.188,-0.045083,-0.090448,0,0
2,GO REGULATION OF TOR SIGNALING,0.087232,-0.045154,-0.054977,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.41842,-0.045186,-0.096394,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.073629,-0.045196,-0.078964,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.46512,-0.045282,-0.090841,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.9686,-0.045296,0.00979,0,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.20309,-0.045335,-0.11357,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.76281,-0.045337,-0.043098,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.23589,-0.04536,-0.07538,0,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.50337,-0.045379,-0.10778,0,0
2,GO REGULATION OF TRANSPORT,0.26471,-0.045408,-0.038485,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.22905,-0.045429,-0.072825,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.19695,-0.045462,-0.022179,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.27227,-0.04568,-0.0609,0,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.27611,-0.045697,-0.088871,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.12689,-0.045804,-0.080878,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.38888,-0.045807,-0.07816,0,0
2,GO MESODERM DEVELOPMENT,0.16294,-0.045821,-0.057585,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.050569,-0.045953,-0.056496,0,0
2,GO APOPTOTIC CELL CLEARANCE,0.2839,-0.045964,-0.14019,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.39858,-0.046017,-0.093494,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.25729,-0.046078,-0.099636,0,0
2,GO EPITHELIAL CELL MATURATION,0.50337,-0.04609,-0.03714,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.13355,-0.046103,-0.061317,0,0
2,GO RESPONSE TO ESTROGEN,0.23937,-0.046171,-0.095538,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.33812,-0.046261,-0.044875,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.12049,-0.046352,-0.067671,0,0
2,GO TOXIN TRANSPORT,0.22905,-0.046439,-0.066992,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.11636,-0.046526,-0.078518,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.18508,-0.04661,-0.039922,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.62113,-0.046636,-0.036389,0,0
2,GO SIGNAL RELEASE,0.66501,-0.046664,-0.007329,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.046764,-0.039466,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.073629,-0.04681,-0.077072,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.10096,-0.046897,-0.11321,0,0
2,GO RHYTHMIC BEHAVIOR,0.1028,-0.046907,-0.10726,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.16032,-0.046987,-0.074874,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.16828,-0.047002,-0.036329,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.56666,-0.047072,-0.010309,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.25363,-0.047079,-0.0615,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.41341,-0.047097,-0.0594,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.21579,-0.047366,-0.14914,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.052669,-0.047368,-0.048437,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.30815,-0.047395,-0.082519,0,0
2,GO REGULATION OF PINOCYTOSIS,0.11434,-0.047412,-0.154,0,0
2,GO FUCOSE METABOLIC PROCESS,0.35153,-0.047503,-0.089335,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.20937,-0.04753,-0.047282,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.29184,-0.047559,-0.083719,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.20621,-0.047566,-0.091687,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.62732,-0.047582,-0.038068,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.3746,-0.047602,-0.069467,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.50896,-0.047681,-0.045956,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.36991,-0.047743,-0.095391,0,0
2,GO ENDOCYTOSIS,0.188,-0.047782,-0.057459,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.087232,-0.047873,-0.081472,0,0
2,GO MEMBRANE DOCKING,0.29586,-0.047908,-0.024125,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.33373,-0.048011,-0.057391,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.29586,-0.048062,-0.024648,0,0
2,GO RESPONSE TO DRUG,0.12259,-0.04817,-0.076589,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.1313,-0.048179,-0.066227,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.50896,-0.048179,-0.010514,0,0
2,GO REGULATION OF PROTEIN BINDING,0.11841,-0.048185,-0.069923,0,0
2,GO BIOLOGICAL ADHESION,0.057089,-0.048271,-0.10444,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.22905,-0.048287,-0.050557,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.56075,-0.048289,-0.050944,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.52594,-0.048302,-0.059192,0,0
2,GO VACUOLAR ACIDIFICATION,0.11039,-0.048499,-0.11301,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.188,-0.048502,-0.077357,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.031748,-0.048594,-0.076014,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.17653,-0.048661,-0.070097,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.33373,-0.048693,-0.056866,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.11434,-0.048765,-0.048596,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.19095,-0.048787,-0.052473,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.26471,-0.048792,-0.054854,0,0
2,GO EAR DEVELOPMENT,0.42855,-0.048811,-0.022668,0,0
2,GO GAMETE GENERATION,0.075049,-0.048839,-0.04643,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.80989,-0.048983,-0.081877,0,0
2,GO HISTONE PHOSPHORYLATION,0.095625,-0.049,-0.075883,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.98255,-0.049042,-0.001316,0,0
2,GO VASCULATURE DEVELOPMENT,0.055956,-0.049085,-0.11,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.42855,-0.0492,-0.061763,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.099158,-0.049229,-0.097747,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.42347,-0.049319,-0.039277,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.26471,-0.049345,-0.02814,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.50896,-0.049345,-0.082801,0,0
2,GO RESPONSE TO ZINC ION,0.43883,-0.04956,-0.084543,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.10845,-0.049611,-0.060851,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.188,-0.049693,-0.12915,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.33812,-0.049706,-0.06143,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.53742,-0.049732,-0.031228,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.079444,-0.04978,-0.14306,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12049,-0.0498,-0.12268,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.52025,-0.0498,-0.046177,0,0
2,GO HISTONE H2B UBIQUITINATION,0.14769,-0.049803,-0.080802,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.23937,-0.049821,-0.080354,0,0
2,GO CHOLESTEROL STORAGE,0.43883,-0.049912,-0.083419,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.64605,-0.049924,-0.02227,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.035393,-0.049935,-0.072189,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.2839,-0.049962,-0.093095,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.080955,-0.049987,-0.051286,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.26847,-0.049999,-0.084284,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.084046,-0.05007,-0.080823,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.48678,-0.050089,-0.059424,0,0
2,GO CELLULAR RESPONSE TO ATP,0.97557,-0.050095,-0.00026799,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.25363,-0.050125,-0.070755,0,0
2,GO INTRACILIARY TRANSPORT,0.47049,-0.050195,-0.048543,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.46512,-0.050235,-0.057214,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.31232,-0.050238,-0.069222,0,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.74288,-0.050377,-0.15582,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.9686,-0.050405,-0.00020873,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.44402,-0.050442,-0.0083683,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.52025,-0.05046,-0.06684,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.47588,-0.050497,-0.032875,0,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.11039,-0.050508,-0.14104,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.068167,-0.050534,-0.1377,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.60883,-0.050558,-0.04766,0,0
2,GO BIOMINERALIZATION,0.15773,-0.050584,-0.08317,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.050569,-0.050598,-0.053632,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.075049,-0.050749,-0.063625,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.99651,-0.050825,-0.014107,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.090515,-0.050849,-0.16143,0,0
2,GO RESPONSE TO ACTIVITY,0.073629,-0.050912,-0.093752,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.077957,-0.050936,-0.045131,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.16032,-0.050939,-0.043654,0,0
2,GO RESPONSE TO STEROL,0.25001,-0.050944,-0.092912,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.077957,-0.050949,-0.04725,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.088862,-0.050976,-0.13261,0,0
2,GO HISTONE MONOUBIQUITINATION,0.079444,-0.05099,-0.054809,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.044685,-0.051001,-0.078502,0,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.81668,-0.051149,0.018538,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.53742,-0.051193,-0.041386,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.22235,-0.05121,-0.13156,0,0
2,GO GERM CELL DEVELOPMENT,0.085627,-0.051236,-0.049009,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.26847,-0.051326,-0.091024,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.12908,-0.051339,-0.16304,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.39858,-0.051395,-0.058496,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.71658,-0.051475,-0.040915,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.13814,-0.051613,-0.069736,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.33812,-0.05167,-0.044678,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.80989,-0.051671,-0.021941,0,0
2,GO INNER EAR MORPHOGENESIS,0.54903,-0.051677,-0.032006,0,0
2,GO DRUG CATABOLIC PROCESS,0.50896,-0.051699,-0.028131,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.043763,-0.051721,-0.052665,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.82348,-0.051856,-0.048043,0,0
2,GO DEMETHYLATION,0.10654,-0.051857,-0.054665,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.34256,-0.051939,-0.036162,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.36991,-0.05195,-0.036149,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.16559,-0.051977,-0.068018,0,0
2,GO AMMONIUM TRANSPORT,0.41341,-0.052136,-0.071082,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.39371,-0.052178,-0.05411,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.10465,-0.052248,-0.10243,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.16828,-0.052271,-0.068616,0,0
2,GO MIDBRAIN DEVELOPMENT,0.16032,-0.052459,-0.065063,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.36526,-0.052461,-0.045885,0,0
2,GO ACTIN FILAMENT ORGANIZATION,0.066855,-0.052539,-0.08026,0,0
2,GO SPECIFICATION OF SYMMETRY,0.10845,-0.052543,-0.056039,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.47049,-0.052562,-0.033495,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.24643,-0.052574,-0.14093,0,0
2,GO GASTRULATION,0.15517,-0.052598,-0.092784,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.12908,-0.052633,-0.066174,0,0
2,GO RESPONSE TO FATTY ACID,0.24643,-0.052772,-0.069433,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.78962,-0.052796,0.027768,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.31232,-0.052823,-0.11744,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.30815,-0.052904,-0.09109,0,0
2,GO PROTEIN POLYMERIZATION,0.48131,-0.052922,-0.020616,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.30402,-0.052962,-0.036111,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.19095,-0.053065,-0.11322,0,0
2,GO METANEPHROS DEVELOPMENT,0.10654,-0.053094,-0.1036,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.054842,-0.053245,-0.056872,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.74288,-0.053348,-0.051807,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.1028,-0.053408,-0.079075,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.12473,-0.053438,-0.065896,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.21905,-0.053441,-0.059614,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.26847,-0.053487,-0.055173,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.092194,-0.053558,-0.057896,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.2839,-0.053579,-0.070234,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.21256,-0.053587,-0.07156,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.20309,-0.053656,-0.10487,0,0
2,GO CILIUM ORGANIZATION,0.1028,-0.053662,-0.057604,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.26471,-0.053672,-0.062175,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.19393,-0.053682,-0.11679,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.85768,-0.053791,0.012852,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.31653,-0.053883,-0.08357,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.22905,-0.053933,-0.058503,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.44402,-0.054061,-0.039811,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.018836,-0.054086,-0.071995,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.23245,-0.054091,-0.09848,0,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.27611,-0.05421,-0.10704,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.7495,-0.054214,-0.043766,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.16294,-0.054321,-0.075418,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.10465,-0.054559,-0.1259,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.1028,-0.054615,-0.071893,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.65234,-0.05466,-0.021471,0,0
2,GO REGULATION OF SECRETION,0.20309,-0.054841,-0.047587,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.71658,-0.054884,0.018279,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.53167,-0.054886,-0.022621,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.43367,-0.054887,-0.043319,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0051916,-0.055008,-0.064906,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.60883,-0.055128,-0.040776,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.031059,-0.055179,-0.082885,0,0
2,GO RNA DESTABILIZATION,0.71658,-0.055246,-0.018667,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.43367,-0.055299,-0.023665,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.11235,-0.055299,-0.061438,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.62732,-0.055309,-0.027003,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.20309,-0.055373,-0.080812,0,0
2,GO CARTILAGE DEVELOPMENT,0.32938,-0.055397,-0.063477,0,0
2,GO BONE CELL DEVELOPMENT,0.073629,-0.055518,-0.10563,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.19393,-0.055519,-0.093129,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.23245,-0.055593,-0.0473,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.49227,-0.055601,-0.033243,0,0
2,GO CELL FATE SPECIFICATION,0.86455,-0.055644,2.1365e-05,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.17099,-0.055676,-0.061929,0,0
2,GO METANEPHROS MORPHOGENESIS,0.63978,-0.05568,-0.049168,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.24643,-0.055747,-0.066161,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.29184,-0.055804,-0.10004,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.32077,-0.055818,-0.03361,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.34702,-0.055851,-0.063719,0,0
2,GO THIOESTER METABOLIC PROCESS,0.36991,-0.055885,-0.045954,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.23937,-0.055901,-0.047156,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.17374,-0.056012,-0.057324,0,0
2,GO MITOCHONDRIAL FUSION,0.31232,-0.056027,-0.045348,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.64605,-0.056042,-0.024853,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.063042,-0.056044,-0.094924,0,0
2,GO RESPONSE TO RADIATION,0.017969,-0.05611,-0.049327,0,0
2,GO CELL PROJECTION ASSEMBLY,0.016734,-0.056169,-0.075712,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.41842,-0.056225,-0.049851,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.15517,-0.056288,-0.061814,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.69707,-0.056326,-0.061992,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.1028,-0.056447,-0.052155,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.30402,-0.056501,-0.08415,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.097379,-0.056654,-0.077771,0,0
2,GO PROTEIN AUTOPROCESSING,0.42347,-0.056665,-0.06682,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.092194,-0.056756,-0.07878,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.34702,-0.056764,-0.065282,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.22905,-0.056785,-0.053776,0,0
2,GO IRON ION TRANSPORT,0.12259,-0.05682,-0.078062,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.090515,-0.056904,-0.073079,0,0
2,GO SPERM MOTILITY,0.13583,-0.056907,-0.031592,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.25729,-0.056914,-0.041763,0,0
2,GO EMBRYO IMPLANTATION,0.17099,-0.056948,-0.11768,0,0
2,GO JNK CASCADE,0.024288,-0.056981,-0.089857,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.16032,-0.057252,-0.081101,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.89215,-0.057298,-0.0015255,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.98255,-0.057396,0.010814,0,0
2,GO RESPONSE TO TESTOSTERONE,0.20621,-0.057452,-0.091039,0,0
2,GO BLASTODERM SEGMENTATION,0.93377,-0.057563,0.0058608,0,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.30402,-0.057687,-0.059295,0,0
2,GO GLYCOSYLATION,0.12259,-0.057763,-0.075931,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.41842,-0.057844,-0.056952,0,0
2,GO DE NOVO PROTEIN FOLDING,0.15015,-0.057945,-0.079099,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.023205,-0.057946,-0.097984,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.17099,-0.057997,-0.048176,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.76281,-0.058013,-0.020899,0,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.20621,-0.058193,-0.063236,0,0
2,GO PROTEIN HYDROXYLATION,0.25001,-0.058353,-0.12808,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.48131,-0.058648,-0.02359,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.049546,-0.058704,-0.059886,0,0
2,GO MEMBRANE INVAGINATION,0.049546,-0.058716,-0.11501,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.087232,-0.058725,-0.068651,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.23589,-0.058779,-0.067272,0,0
2,GO RESPONSE TO PH,0.17099,-0.059117,-0.07944,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.4598,-0.059132,-0.015884,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.23589,-0.059167,-0.060596,0,0
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.76948,-0.059372,0.020192,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1,-0.059588,-0.0070817,0,0
2,GO XENOBIOTIC TRANSPORT,0.27999,-0.059628,-0.096901,0,0
2,GO BODY MORPHOGENESIS,0.11039,-0.059642,-0.11619,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.19095,-0.059646,-0.091238,0,0
2,GO PHAGOSOME MATURATION,0.18508,-0.05968,-0.077175,0,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.33373,-0.059717,-0.048684,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.17374,-0.059768,-0.096522,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.25001,-0.059805,-0.10836,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.54321,-0.05993,-0.034095,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.65234,-0.059981,-0.022578,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.38408,-0.059985,-0.063179,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.7495,-0.060091,-0.059779,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.080955,-0.060153,-0.11684,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.19393,-0.060184,-0.060793,0,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.14048,-0.060189,-0.09921,0,0
2,GO STEROID HORMONE SECRETION,0.35153,-0.060294,-0.088987,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.21256,-0.060521,-0.077133,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.20621,-0.060717,-0.057976,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.076492,-0.060819,-0.051841,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.068167,-0.060855,-0.093829,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.055956,-0.060939,-0.12482,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.10654,-0.061087,-0.093088,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.042857,-0.061131,-0.081534,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.061812,-0.061227,-0.087996,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0083534,-0.061247,-0.088274,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.17099,-0.061283,-0.096511,0,0
2,GO VASCULOGENESIS,0.34702,-0.061303,-0.10427,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.31232,-0.061384,-0.059951,0,0
2,GO RESPONSE TO METAL ION,0.031748,-0.061385,-0.10502,0,0
2,GO CELL MATURATION,0.22905,-0.061427,-0.042202,0,0
2,GO NUCLEUS LOCALIZATION,0.69707,-0.061534,-0.0086321,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.28785,-0.061793,-0.063434,0,0
2,GO BONE MINERALIZATION,0.22568,-0.061921,-0.075955,0,0
2,GO NEUTROPHIL CHEMOTAXIS,0.068167,-0.061926,-0.088765,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.36526,-0.061966,-0.074044,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.11841,-0.061974,-0.059137,0,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.17099,-0.062228,-0.07789,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.21256,-0.062256,-0.089751,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.13583,-0.062261,-0.087983,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.068167,-0.062268,-0.10993,0,0
2,GO FEVER GENERATION,0.43367,-0.062358,-0.079297,0,0
2,GO RESPONSE TO ACIDIC PH,0.41842,-0.062421,-0.079908,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.85768,-0.06265,-0.016626,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.48678,-0.062743,-0.034351,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.17099,-0.062787,-0.12499,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.22568,-0.062844,-0.09697,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.10845,-0.062878,-0.087738,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.05161,-0.062889,-0.13356,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.084046,-0.063161,-0.062679,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.099158,-0.063248,-0.067457,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.2,-0.063281,-0.065803,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.10096,-0.063396,-0.060332,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.15015,-0.063567,-0.08573,0,0
2,GO ENSHEATHMENT OF NEURONS,0.63354,-0.063594,-0.037145,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.29184,-0.063853,-0.06002,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.15015,-0.063966,-0.05518,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.28785,-0.064016,-0.079964,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.055956,-0.064044,-0.10474,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.76281,-0.064082,-0.0083481,0,0
2,GO KIDNEY MORPHOGENESIS,0.20621,-0.064097,-0.077161,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.60883,-0.064187,-0.07677,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.097379,-0.06436,-0.064556,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.34702,-0.064385,-0.044835,0,0
2,GO RESPONSE TO FOOD,0.28785,-0.064406,-0.046498,0,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.84397,-0.064423,0.020653,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.40843,-0.064572,-0.040556,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.34702,-0.064586,-0.056366,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.085627,-0.064588,-0.0842,0,0
2,GO MITOCHONDRION ORGANIZATION,0.084046,-0.064599,-0.050226,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.18219,-0.064612,-0.089834,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.17099,-0.064666,-0.065849,0,0
2,GO VASODILATION,0.21256,-0.064695,-0.15968,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.093897,-0.064704,-0.091424,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.17653,-0.064764,-0.078397,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.35153,-0.064905,-0.062837,0,0
2,GO FERTILIZATION,0.015953,-0.064908,-0.079198,0,0
2,GO RESPONSE TO EPINEPHRINE,0.80989,-0.064927,-0.011872,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.16559,-0.064928,-0.074424,0,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.8303,-0.064932,0.042851,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.20621,-0.06497,-0.082532,0,0
2,GO HISTONE H2A UBIQUITINATION,0.14526,-0.065026,-0.056602,0,0
2,GO REGENERATION,0.075049,-0.06506,-0.10356,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.047551,-0.06509,-0.077511,0,0
2,GO PROTEIN KINASE C SIGNALING,0.18219,-0.065364,-0.1204,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.14526,-0.06544,-0.098365,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.026586,-0.065582,-0.08968,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.14526,-0.065595,-0.071453,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.0695,-0.065634,-0.090943,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.36991,-0.065698,-0.047308,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.72313,-0.065703,-0.062421,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.11841,-0.06573,-0.094735,0,0
2,GO COPPER ION HOMEOSTASIS,0.29586,-0.065759,-0.1233,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.27999,-0.065908,-0.042067,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.20937,-0.06594,-0.053565,0,0
2,GO MEIOTIC CELL CYCLE,0.024846,-0.065976,-0.059922,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.022165,-0.066124,-0.079485,0,0
2,GO MUSCLE FILAMENT SLIDING,0.48131,-0.066212,-0.048998,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.15517,-0.066344,-0.055027,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.22568,-0.066455,-0.058749,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38888,-0.066492,-0.093546,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.90599,-0.066521,-0.010062,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.91987,-0.066522,0.0087221,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.19393,-0.066539,-0.082047,0,0
2,GO CILIUM MOVEMENT,0.064293,-0.066643,-0.061353,0,0
2,GO EATING BEHAVIOR,0.077957,-0.066717,-0.10364,0,0
2,GO FIBROBLAST MIGRATION,0.097379,-0.066909,-0.10332,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.66501,-0.066951,-0.023641,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.092194,-0.066966,-0.13164,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.10465,-0.067059,-0.10203,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.087232,-0.067072,-0.096344,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.030383,-0.067413,-0.12685,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.64605,-0.067471,-0.029712,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.16294,-0.067486,-0.059471,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.14769,-0.067544,-0.085421,0,0
2,GO RESPONSE TO ALKALOID,0.39858,-0.067572,-0.043448,0,0
2,GO DEPHOSPHORYLATION,0.068167,-0.067583,-0.053453,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.60883,-0.067676,-0.058783,0,0
2,GO PANCREATIC JUICE SECRETION,0.47588,-0.067698,-0.071327,0,0
2,GO MUSCLE HYPERTROPHY,0.14769,-0.067852,-0.082811,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.32077,-0.067997,-0.052503,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.10465,-0.06806,-0.14443,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.86455,-0.068104,-0.011548,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.47588,-0.068152,-0.043225,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.76281,-0.068187,-0.018853,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.05161,-0.068282,-0.06055,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.12689,-0.068284,-0.060377,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.17374,-0.068358,-0.1161,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.21256,-0.068399,-0.11389,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.20937,-0.068402,-0.12735,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.14769,-0.068477,-0.071011,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.050569,-0.068521,-0.072545,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.068167,-0.06869,-0.094488,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.69707,-0.068701,-0.011653,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.83713,-0.068705,0.019349,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.22568,-0.068716,-0.10624,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.085627,-0.068752,-0.077977,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.15773,-0.068766,-0.068962,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.3746,-0.068846,-0.052155,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.13583,-0.068876,-0.069031,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.14048,-0.068894,-0.11776,0,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.18508,-0.068944,-0.16626,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.087232,-0.069025,-0.10909,0,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.075049,-0.069035,-0.30462,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.14285,-0.069047,-0.074857,0,0
2,GO CD40 SIGNALING PATHWAY,0.10465,-0.069155,-0.16729,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.0695,-0.069167,-0.080753,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.56075,-0.069171,-0.056222,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.11235,-0.069237,-0.085897,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.060602,-0.069358,-0.12954,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.14526,-0.069501,-0.084262,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.13814,-0.069656,-0.086415,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.188,-0.06967,-0.20762,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.74288,-0.069701,0.0026255,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.18508,-0.069758,-0.047516,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.22235,-0.069825,-0.063991,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.65234,-0.06984,-0.019816,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.060602,-0.070026,-0.064098,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.1313,-0.070204,-0.075924,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0040578,-0.070259,-0.07624,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0053338,-0.070327,-0.10256,0,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.19095,-0.070515,-0.11061,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.25363,-0.07056,-0.098205,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.66501,-0.070645,-0.007927,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.46512,-0.070679,-0.06654,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.35607,-0.070679,-0.049828,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.36991,-0.07073,-0.062669,0,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.53742,-0.070748,-0.03896,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.15773,-0.070772,-0.10043,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.17653,-0.071037,-0.18491,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.11841,-0.071097,-0.064698,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.075049,-0.071234,-0.15638,0,0
2,GO STEM CELL PROLIFERATION,0.2839,-0.071248,-0.056832,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.055956,-0.071373,-0.20195,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.027188,-0.071443,-0.13037,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.05824,-0.07149,-0.090331,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.14285,-0.071501,-0.08911,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.21579,-0.071548,-0.056835,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.22905,-0.071573,-0.093264,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.86455,-0.071738,0.035625,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.14769,-0.071761,-0.10611,0,0
2,GO TRNA CATABOLIC PROCESS,0.39858,-0.07187,-0.10746,0,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.44924,-0.072012,-0.049099,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.56666,-0.07203,-0.025181,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.093897,-0.072045,-0.096149,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.085627,-0.072078,-0.075326,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.01282,-0.072081,-0.11761,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.44402,-0.07223,-0.13563,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.71658,-0.072366,-0.071325,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.16294,-0.072431,-0.12482,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.065563,-0.072449,-0.14469,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.03245,-0.0725,-0.068439,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.55487,-0.072556,-0.073604,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.52594,-0.072718,0.17343,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.11841,-0.072754,-0.062438,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.10654,-0.072758,-0.043471,0,0
2,GO NCRNA CATABOLIC PROCESS,0.63354,-0.072816,-0.023067,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.02843,-0.07282,-0.085642,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.066855,-0.072968,-0.06541,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.62113,-0.072983,-0.018453,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.16294,-0.073053,-0.063886,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.72969,-0.073086,-0.027164,0,0
2,GO POSITIVE REGULATION OF SECRETION,0.065563,-0.073091,-0.074286,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.035393,-0.07351,-0.111,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.78962,-0.073529,-0.0096996,0,0
2,GO NADP METABOLIC PROCESS,0.19695,-0.07353,-0.1041,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.23245,-0.073585,-0.10487,0,0
2,GO FIBROBLAST PROLIFERATION,0.053746,-0.073675,-0.15004,0,0
2,GO TRABECULA FORMATION,0.26847,-0.073744,-0.11892,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.16294,-0.073964,-0.19199,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0099891,-0.073979,-0.090352,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.25729,-0.074056,-0.050258,0,0
2,GO REPRODUCTION,0.0054795,-0.074076,-0.080686,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.47588,-0.074136,-0.065927,0,0
2,GO PODOSOME ASSEMBLY,0.22235,-0.074162,-0.085101,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.14285,-0.074163,-0.10856,0,0
2,GO DEVELOPMENTAL INDUCTION,0.18508,-0.074207,-0.10916,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.16559,-0.074222,-0.074222,0,0
2,GO ARTERY MORPHOGENESIS,0.19695,-0.074321,-0.088202,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.064293,-0.074376,-0.10239,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.029719,-0.074396,-0.083735,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.050569,-0.07441,-0.078943,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.15264,-0.074428,-0.060973,0,0
2,GO SPINAL CORD PATTERNING,0.80312,-0.07446,0.067631,0,0
2,GO RESPONSE TO GONADOTROPIN,0.27999,-0.074507,-0.088789,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.16032,-0.074526,-0.11508,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.090515,-0.074534,-0.063342,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.74288,-0.074588,-0.0088848,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.045624,-0.074614,-0.0735,0,0
2,GO ACID SECRETION,0.15015,-0.07462,-0.10381,0,0
2,GO SPINDLE LOCALIZATION,0.080955,-0.074692,-0.072823,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.31232,-0.074839,-0.039657,0,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.16294,-0.074861,-0.060921,0,0
2,GO RETINA HOMEOSTASIS,0.013798,-0.074886,-0.096364,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.15773,-0.074967,-0.085492,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.43367,-0.075098,-0.15992,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.019739,-0.075123,-0.087417,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.012203,-0.075257,-0.1283,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.19393,-0.075385,-0.12043,0,0
2,GO CELL MOTILITY,0.033166,-0.075548,-0.091282,0,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.93377,-0.075723,0.010763,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.23937,-0.075885,-0.078639,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.18219,-0.075915,-0.094934,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.28785,-0.075938,-0.081102,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.14048,-0.076026,-0.098767,0,0
2,GO PHOTOTRANSDUCTION,0.14285,-0.076126,-0.079603,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.17099,-0.076151,-0.14102,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.33373,-0.076345,-0.038415,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.011047,-0.076354,-0.080753,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.084046,-0.076365,-0.14317,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.44402,-0.076374,-0.081345,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.072231,-0.076768,-0.072173,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.17374,-0.076842,-0.10127,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.17374,-0.076891,-0.051279,0,0
2,GO GENITALIA DEVELOPMENT,0.21256,-0.076921,-0.059823,0,0
2,GO RESPONSE TO THYROID HORMONE,0.075049,-0.076954,-0.18101,0,0
2,GO ORGANELLE FUSION,0.14048,-0.076956,-0.076097,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.10096,-0.077011,-0.12825,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0083534,-0.077259,-0.10444,0,0
2,GO EAR MORPHOGENESIS,0.34702,-0.077261,-0.048724,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.12689,-0.077278,-0.099826,0,0
2,GO RESPONSE TO X RAY,0.24288,-0.07729,-0.10437,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.045624,-0.077292,-0.096317,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.77618,-0.077538,-0.01476,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.22905,-0.077631,-0.1148,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.038561,-0.077743,-0.10595,0,0
2,GO ACTIN CROSSLINK FORMATION,0.87833,-0.077822,0.064207,0,0
2,GO NEUROBLAST DIVISION,0.42347,-0.078043,-0.10191,0,0
2,GO ANIMAL ORGAN REGENERATION,0.10096,-0.078044,-0.13299,0,0
2,GO RESPONSE TO UV C,0.20937,-0.078113,-0.094311,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.097379,-0.078137,-0.12201,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.31232,-0.078154,-0.08399,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.49227,-0.0783,-0.038452,0,0
2,GO ATP TRANSPORT,0.099158,-0.078304,-0.078919,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.25001,-0.078405,-0.055852,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.11235,-0.078409,-0.10641,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.59664,-0.078458,-0.024078,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.0017123,-0.078615,-0.095316,0,0
2,GO PIGMENT GRANULE MATURATION,0.057089,-0.078623,-0.18858,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.14526,-0.078624,-0.071139,0,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.53167,-0.078642,-0.04943,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.27611,-0.078743,-0.055181,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.02068,-0.078816,-0.10328,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.25729,-0.078838,-0.12293,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.045624,-0.078873,-0.13436,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.62732,-0.078874,-0.023917,0,0
2,GO PENILE ERECTION,0.33373,-0.078885,-0.085255,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.090515,-0.078939,-0.12153,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.007729,-0.07895,-0.12896,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.29586,-0.078987,-0.17506,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.39858,-0.079155,-0.079098,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.16032,-0.079264,-0.10344,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.4545,-0.079419,-0.076953,0,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.63978,-0.079501,-0.026814,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.30815,-0.079585,-0.051729,0,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.077957,-0.079595,-0.073031,0,0
2,GO MUSCLE CELL PROLIFERATION,0.04854,-0.079629,-0.11338,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.010245,-0.079829,-0.082151,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.56075,-0.079902,-0.046022,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.1028,-0.080082,-0.13179,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.05824,-0.080082,-0.12855,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.087232,-0.080218,-0.12443,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.26847,-0.080291,-0.068763,0,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.19393,-0.080298,-0.078289,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.27999,-0.08032,-0.047323,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.041093,-0.080422,-0.10435,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.95466,-0.080493,-0.0015915,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.40843,-0.080577,-0.054777,0,0
2,GO GLYCINE TRANSPORT,0.40349,-0.08072,-0.13011,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.18219,-0.080738,-0.064908,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.51459,-0.080991,-0.045332,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.12049,-0.081019,-0.081706,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.8303,-0.081036,0.0074924,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.075049,-0.081092,-0.11358,0,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.36526,-0.081152,-0.1485,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.090515,-0.081222,-0.087495,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.04854,-0.081391,-0.10435,0,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.065563,-0.081413,-0.10924,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.16828,-0.081524,-0.056752,0,0
2,GO REGULATION OF HORMONE SECRETION,0.16032,-0.08157,-0.059317,0,0
2,GO OOCYTE DIFFERENTIATION,0.049546,-0.081632,-0.089119,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.82348,-0.081763,-0.026598,0,0
2,GO HISTONE H4 DEACETYLATION,0.20621,-0.081768,-0.11404,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.18508,-0.081924,-0.10544,0,0
2,GO CELL SUBSTRATE ADHESION,0.070855,-0.081937,-0.1355,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.066855,-0.082079,-0.10326,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.033166,-0.082349,-0.087946,0,0
2,GO ERK1 AND ERK2 CASCADE,0.061812,-0.082354,-0.11803,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.55487,-0.082511,-0.056754,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0071468,-0.082672,-0.10787,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.061812,-0.082742,-0.10324,0,0
2,GO MICROTUBULE BUNDLE FORMATION,0.15264,-0.082762,-0.053515,0,0
2,GO MACROPHAGE ACTIVATION,0.097379,-0.08288,-0.097619,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.53742,-0.08294,-0.051443,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.47049,-0.082955,-0.068955,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.087232,-0.083082,-0.087735,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.16828,-0.083123,-0.086988,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.059411,-0.08314,-0.153,0,0
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.27227,-0.083232,-0.14811,0,0
2,GO RESPONSE TO INACTIVITY,0.03245,-0.083269,-0.15686,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0057817,-0.083289,-0.085751,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.24288,-0.083327,-0.08795,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.35607,-0.083412,-0.06902,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.91987,-0.08367,-0.016624,0,0
2,GO RESPONSE TO MANGANESE ION,0.25001,-0.0837,-0.096356,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.32938,-0.083717,-0.077673,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.0085714,-0.083782,-0.11784,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.27999,-0.083838,-0.17062,0,0
2,GO TRNA 5 LEADER REMOVAL,0.13355,-0.083935,-0.1092,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.69061,-0.084036,-0.012924,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.049546,-0.084272,-0.09319,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.014138,-0.084315,-0.12788,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.031748,-0.084427,-0.10111,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.67776,-0.08448,-0.026649,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.33373,-0.084493,-0.13487,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.12049,-0.084564,-0.060179,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.14048,-0.084971,-0.095586,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.28785,-0.085091,-0.057267,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.10654,-0.085129,-0.14091,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.37932,-0.085172,-0.18854,0,0
2,GO REGULATION OF GTP BINDING,0.9686,-0.085237,0.0058093,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94073,-0.085276,0.043501,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,-0.085309,-0.071938,0,0
2,GO REPLACEMENT OSSIFICATION,0.14769,-0.085375,-0.12875,0,0
2,GO NEURAL CREST FORMATION,0.33812,-0.085446,-0.096889,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.65234,-0.085479,-0.06943,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.64605,-0.085489,-0.029832,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.072231,-0.085507,-0.11752,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.072231,-0.085628,-0.10948,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.22235,-0.085669,-0.089165,0,0
2,GO PLASMINOGEN ACTIVATION,0.52025,-0.085752,-0.14663,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.19393,-0.085758,-0.075212,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.035393,-0.085783,-0.071483,0,0
2,GO N GLYCAN PROCESSING,0.23589,-0.085826,-0.13053,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.23245,-0.085841,-0.10852,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.29586,-0.085912,-0.048387,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.026586,-0.085953,-0.10435,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.24643,-0.085993,-0.049331,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.070855,-0.08604,-0.13252,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.022165,-0.086074,-0.10124,0,0
2,GO NADPH REGENERATION,0.31653,-0.086107,-0.099685,0,0
2,GO APPENDAGE MORPHOGENESIS,0.21256,-0.08644,-0.082824,0,0
2,GO STRESS FIBER ASSEMBLY,0.05161,-0.086462,-0.12758,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.099158,-0.0865,-0.10938,0,0
2,GO EXIT FROM MITOSIS,0.085627,-0.08652,-0.067681,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.21256,-0.08672,-0.083488,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.11841,-0.086797,-0.13315,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.188,-0.086836,-0.11118,0,0
2,GO TUBE FORMATION,0.044685,-0.086992,-0.093883,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.2839,-0.087026,-0.069179,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.18508,-0.087047,-0.1049,0,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.04854,-0.087105,-0.12212,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.13814,-0.08729,-0.081142,0,0
2,GO HAIR CELL DIFFERENTIATION,0.21579,-0.087361,-0.038639,0,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.016339,-0.087377,-0.19127,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.084046,-0.087421,-0.14109,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.05824,-0.08757,-0.094703,0,0
2,GO NUCLEAR MIGRATION,0.69707,-0.087602,-0.0055309,0,0
2,GO LYSOSOME LOCALIZATION,0.047551,-0.087805,-0.10505,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.024846,-0.087827,-0.086698,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.12689,-0.087831,-0.14534,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.25729,-0.087911,-0.099101,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.10845,-0.087979,-0.1088,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.023205,-0.088023,-0.14715,0,0
2,GO GENITALIA MORPHOGENESIS,0.27227,-0.088072,-0.084794,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.22568,-0.088088,-0.1239,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.030383,-0.088244,-0.14189,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.095625,-0.088381,-0.078184,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.097379,-0.088586,-0.09727,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.1028,-0.088611,-0.088402,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.98255,-0.08866,0.017614,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.038561,-0.088694,-0.13713,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.093897,-0.088703,-0.12016,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.059411,-0.088712,-0.10737,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.16294,-0.088857,-0.1179,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.018836,-0.089173,-0.1092,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.12473,-0.089246,-0.097634,0,0
2,GO RESPONSE TO FUNGUS,0.13814,-0.089423,-0.09093,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.29586,-0.089484,-0.092247,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.090515,-0.089516,-0.17123,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.038561,-0.089572,-0.13352,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.15517,-0.08961,-0.076751,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.068167,-0.089618,-0.10325,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0054795,-0.089751,-0.10343,0,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.14769,-0.089772,-0.15593,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.053746,-0.089783,-0.099923,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.04854,-0.089817,-0.117,0,0
2,GO SLEEP,0.188,-0.089875,-0.08591,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.085627,-0.089899,-0.066767,0,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.02843,-0.090003,-0.12166,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.14769,-0.090361,-0.12149,0,0
2,GO GLAND MORPHOGENESIS,0.082489,-0.090375,-0.15439,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.23937,-0.090498,-0.076206,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.12908,-0.090507,-0.12087,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.4545,-0.090528,-0.045106,0,0
2,GO MITOCHONDRIAL FISSION,0.36991,-0.090613,-0.028867,0,0
2,GO VITAMIN METABOLIC PROCESS,0.049546,-0.090656,-0.10096,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.052669,-0.090723,-0.10774,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.30402,-0.090904,-0.089157,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.21905,-0.090954,-0.1623,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.44402,-0.091207,-0.083678,0,0
2,GO SPERMATID DIFFERENTIATION,0.060602,-0.091256,-0.05884,0,0
2,GO SINGLE FERTILIZATION,0.0041716,-0.091356,-0.097751,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.060602,-0.091407,-0.10371,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.12473,-0.091418,-0.16162,0,0
2,GO VITAMIN TRANSPORT,0.075049,-0.09142,-0.12406,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.15517,-0.091536,-0.11026,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.23937,-0.091552,-0.087011,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.064293,-0.091608,-0.15908,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.20937,-0.091714,-0.084934,0,0
2,GO INTERACTION WITH SYMBIONT,0.065563,-0.091717,-0.098395,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.057089,-0.091738,-0.072939,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.031059,-0.091771,-0.21444,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.22905,-0.091982,-0.099429,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.26847,-0.092056,-0.071289,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.085627,-0.092174,-0.062272,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.088862,-0.092205,-0.13179,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.052669,-0.09231,-0.11033,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.049546,-0.092412,-0.10044,0,0
2,GO REGULATION OF INSULIN SECRETION,0.4978,-0.092512,-0.024511,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.19695,-0.092594,-0.06731,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.17099,-0.092734,-0.088171,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.092194,-0.092742,-0.12051,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.12259,-0.092869,-0.071901,0,0
2,GO DETOXIFICATION,0.049546,-0.093191,-0.14655,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.0049174,-0.093267,-0.10249,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.10465,-0.093421,-0.091824,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.11841,-0.093481,-0.066928,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.55487,-0.093678,-0.051508,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.17653,-0.093685,-0.11256,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.12259,-0.093696,-0.07652,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.047551,-0.093734,-0.13215,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.29992,-0.09393,-0.07985,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.090515,-0.094016,-0.072343,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.14048,-0.094116,-0.086873,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.063042,-0.09423,-0.12935,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.041093,-0.094539,-0.10028,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.20937,-0.094811,-0.047303,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.12049,-0.09489,-0.074501,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.22568,-0.094893,-0.13997,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.22905,-0.094959,-0.10324,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.16828,-0.094971,-0.12097,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.049546,-0.095038,-0.1278,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.21256,-0.095073,-0.098524,0,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.56075,-0.095125,-0.062362,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.25729,-0.095158,-0.099351,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.020205,-0.095366,-0.08465,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.36064,-0.095369,-0.1285,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0057817,-0.095428,-0.091539,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.041093,-0.095754,-0.12276,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.75615,-0.095779,-0.024734,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.070855,-0.095842,-0.12133,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.38408,-0.095996,-0.049486,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.31232,-0.096015,-0.070977,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.061812,-0.096133,-0.10438,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.11039,-0.096168,-0.10376,0,0
2,GO RELAXATION OF MUSCLE,0.52025,-0.096244,-0.051912,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.072231,-0.096244,-0.1405,0,0
2,GO LIPID OXIDATION,0.0053338,-0.096263,-0.14813,0,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.050569,-0.096488,-0.12173,0,0
2,GO MITOCHONDRIAL TRANSCRIPTION,0.94073,-0.096497,-0.0034512,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.30402,-0.096512,-0.067762,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.12049,-0.096699,-0.12129,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.20309,-0.09671,-0.072079,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0090226,-0.096962,-0.13276,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0046564,-0.097019,-0.11204,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.33812,-0.097032,-0.11788,0,0
2,GO HEART FIELD SPECIFICATION,0.24288,-0.097038,-0.11537,0,0
2,GO GLUCOSE IMPORT,0.082489,-0.097148,-0.080807,0,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.05161,-0.097161,-0.15966,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0097392,-0.09717,-0.14109,0,0
2,GO RNA DECAPPING,0.0021689,-0.097265,-0.12556,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.53167,-0.097347,-0.061781,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0042883,-0.097643,-0.079625,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.12689,-0.097844,-0.13867,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.66501,-0.097854,-0.092322,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.057089,-0.097861,-0.087662,0,0
2,GO NEURONAL ACTION POTENTIAL,0.35153,-0.097929,-0.055759,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.50337,-0.09794,-0.067594,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.17653,-0.097956,-0.1839,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.19095,-0.098068,-0.10879,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.047551,-0.098121,-0.093502,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.10465,-0.098122,-0.074238,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.052669,-0.098159,-0.12754,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.47588,-0.098206,-0.040186,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.42347,-0.098355,-0.075029,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.10654,-0.09861,-0.10387,0,0
2,GO CELLULAR ANION HOMEOSTASIS,0.62732,-0.098654,-0.0104,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.41341,-0.098851,-0.031613,0,0
2,GO PHAGOSOME ACIDIFICATION,0.068167,-0.099003,-0.1336,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.0087944,-0.099005,-0.12086,0,0
2,GO SPROUTING ANGIOGENESIS,0.0695,-0.099316,-0.10661,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.25729,-0.099344,-0.14158,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,3.8583e-05,-0.099381,-0.15149,0,0
2,GO MALE SEX DIFFERENTIATION,0.0056288,-0.099386,-0.12906,0,0
2,GO CELL JUNCTION MAINTENANCE,0.05824,-0.099503,-0.14972,0,0
2,GO PEPTIDE HORMONE SECRETION,0.34702,-0.099609,-0.037372,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.4978,-0.099706,-0.12434,0,0
2,GO ERYTHROCYTE MATURATION,0.13355,-0.099752,-0.09741,0,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.031748,-0.099762,-0.10007,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.088862,-0.099802,-0.12922,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.71006,-0.099844,-0.034219,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.33812,-0.099907,-0.11013,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0695,-0.099926,-0.18045,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.036948,-0.10009,-0.096705,0,0
2,GO RESPONSE TO CHEMOKINE,0.064293,-0.10013,-0.097854,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.22568,-0.10014,-0.099898,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.029719,-0.10014,-0.085633,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.1313,-0.10016,-0.12514,0,0
2,GO TRANSFERRIN TRANSPORT,0.049546,-0.1002,-0.11377,0,0
2,GO DNA DEALKYLATION,0.087232,-0.10025,-0.09675,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.088862,-0.10029,-0.079392,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.19095,-0.10031,-0.08272,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.050569,-0.10057,-0.062571,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.20309,-0.10094,-0.10465,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.049546,-0.101,-0.10153,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.0695,-0.10142,-0.11435,0,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.021165,-0.10151,-0.10976,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.27611,-0.10155,-0.098172,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.52594,-0.10158,-0.087349,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.23245,-0.10158,-0.080011,0,0
2,GO HORMONE TRANSPORT,0.12689,-0.10171,-0.068147,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.15264,-0.10186,-0.10928,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.23589,-0.10223,-0.16099,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.4978,-0.10229,-0.049222,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,-0.1025,-0.14905,0,0
2,GO PARENTAL BEHAVIOR,0.53167,-0.10257,-0.069903,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.12259,-0.10265,-0.088215,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.22905,-0.10273,-0.15657,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.20621,-0.10276,-0.06618,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0047853,-0.10281,-0.13359,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.021165,-0.10316,-0.1204,0,0
2,GO SPERM AXONEME ASSEMBLY,0.32077,-0.10317,-0.075181,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.12259,-0.10318,-0.15922,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0090226,-0.10336,-0.077746,0,0
2,GO QUINONE METABOLIC PROCESS,0.054842,-0.10346,-0.21312,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.36526,-0.10346,-0.1011,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.097379,-0.10347,-0.098479,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.012203,-0.10348,-0.10589,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.24288,-0.1036,-0.088202,0,0
2,GO SENSORY PERCEPTION OF TASTE,0.064293,-0.10379,-0.090952,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.070855,-0.10385,-0.11395,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0054795,-0.10395,-0.11941,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.25363,-0.1041,-0.12604,0,0
2,GO APPENDAGE DEVELOPMENT,0.20621,-0.10415,-0.086669,0,0
2,GO VAGINA DEVELOPMENT,0.22905,-0.10427,-0.11898,0,0
2,GO STEROID CATABOLIC PROCESS,0.057089,-0.10456,-0.16517,0,0
2,GO V D J RECOMBINATION,0.40349,-0.10472,-0.071601,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.32506,-0.10477,-0.05229,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.085627,-0.1048,-0.12559,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.63978,-0.10484,-0.048533,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.15773,-0.10489,-0.068128,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.32077,-0.10503,-0.04809,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.076492,-0.10506,-0.15654,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.085627,-0.10539,-0.11447,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.21256,-0.10576,-0.079746,0,0
2,GO REGULATION OF CELL AGING,0.090515,-0.10584,-0.09132,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.20309,-0.10586,-0.10027,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.21256,-0.10589,-0.087017,0,0
2,GO NEGATIVE REGULATION OF SECRETION,0.035393,-0.10591,-0.083414,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.035393,-0.10625,-0.08398,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.10465,-0.10625,-0.19396,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.34702,-0.10641,-0.10807,0,0
2,GO PIGMENT METABOLIC PROCESS,0.068167,-0.10648,-0.1136,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.188,-0.10654,-0.12545,0,0
2,GO PHOTOPERIODISM,0.046579,-0.10655,-0.096059,0,0
2,GO RESPONSE TO ESTRADIOL,0.022165,-0.10682,-0.11238,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.030383,-0.10688,-0.1619,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.26847,-0.10702,-0.11149,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.076492,-0.10726,-0.23492,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.017549,-0.10743,-0.1428,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00079435,-0.10747,-0.15753,0,0
2,GO RESPONSE TO NUTRIENT,0.036164,-0.10752,-0.10894,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.087232,-0.10753,-0.087992,0,0
2,GO DETECTION OF CALCIUM ION,0.56666,-0.10754,-0.058881,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.013139,-0.10756,-0.13579,0,0
2,GO POSITIVE T CELL SELECTION,0.060602,-0.10787,-0.087376,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.068167,-0.10787,-0.11108,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.98255,-0.10793,0.0070274,0,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0028141,-0.10803,-0.12431,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.10845,-0.10815,-0.14022,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.045624,-0.10835,-0.14732,0,0
2,GO CAMP METABOLIC PROCESS,0.48678,-0.10847,-0.055267,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.066855,-0.10849,-0.15675,0,0
2,GO UTERUS DEVELOPMENT,0.32938,-0.10872,-0.065019,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.02843,-0.10878,-0.11144,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.25729,-0.10879,-0.088991,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.014841,-0.10886,-0.10916,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.014841,-0.10891,-0.14564,0,0
2,GO REGIONALIZATION,0.13814,-0.10902,-0.055372,0,0
2,GO RESPONSE TO LEUCINE,0.36526,-0.10909,-0.071303,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.090515,-0.10911,-0.10002,0,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0025083,-0.10931,-0.17118,0,0
2,GO RESPONSE TO ALCOHOL,0.016339,-0.10934,-0.095166,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.025414,-0.1094,-0.1311,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.38888,-0.10966,-0.08184,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.026586,-0.10974,-0.16621,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.52025,-0.10988,-0.10885,0,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.66501,-0.11002,0.010212,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.12908,-0.11002,-0.13742,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.12049,-0.11005,-0.11776,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.052669,-0.11015,-0.17594,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.28785,-0.11043,-0.068139,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.013139,-0.11055,-0.11224,0,0
2,GO CENTROSOME DUPLICATION,0.10096,-0.11082,-0.069014,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.42347,-0.11084,-0.073263,0,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0083534,-0.11157,-0.090478,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.16032,-0.11163,-0.10824,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.30815,-0.11169,-0.13523,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.29184,-0.11174,-0.080735,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0025817,-0.11271,-0.14927,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.13355,-0.11285,-0.19283,0,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,4.0073e-05,-0.1132,-0.13363,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.25729,-0.11321,-0.089232,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.088862,-0.11372,-0.12034,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.068167,-0.11387,-0.12128,0,0
2,GO COPULATION,0.24288,-0.11392,-0.072207,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.56075,-0.11406,-0.041082,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.11235,-0.11419,-0.089878,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.055956,-0.11419,-0.11505,0,0
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0081404,-0.1142,-0.14795,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.016339,-0.11435,-0.17661,0,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.22235,-0.11437,-0.15784,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.64605,-0.11454,-0.083342,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.00072223,-0.11456,-0.14872,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.023205,-0.11473,-0.11258,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.064293,-0.11474,-0.14026,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.35153,-0.11479,-0.10478,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.15264,-0.11487,-0.12035,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.65866,-0.11508,0.00083927,0,0
2,GO RESPONSE TO LIGHT INTENSITY,0.41341,-0.11525,-0.046259,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.065563,-0.11532,-0.083238,0,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.27611,-0.11534,-0.19323,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.23245,-0.11535,-0.047759,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.35153,-0.11536,-0.088065,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.24288,-0.11549,-0.12059,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.10096,-0.11553,-0.1131,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.51459,-0.11566,-0.035121,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.20309,-0.11591,-0.13737,0,0
2,GO LIPID EXPORT FROM CELL,0.017549,-0.11591,-0.14976,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.053746,-0.11592,-0.19288,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.060602,-0.11595,-0.096514,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.099158,-0.11599,-0.15762,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.092194,-0.11608,-0.1493,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.16828,-0.11617,-0.095733,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.16032,-0.11623,-0.14796,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.047551,-0.11626,-0.20498,0,0
2,GO MYELOID CELL DEVELOPMENT,0.0025083,-0.11626,-0.12736,0,0
2,GO NEURON FATE SPECIFICATION,0.85768,-0.11632,0.065464,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.10465,-0.11633,-0.066845,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0066042,-0.1167,-0.10925,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.093897,-0.1167,-0.088114,0,0
2,GO EYE MORPHOGENESIS,0.080955,-0.11676,-0.08489,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.10096,-0.11676,-0.11092,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.014486,-0.11686,-0.12879,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.065563,-0.11711,-0.17269,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.13583,-0.11712,-0.1066,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.043763,-0.11713,-0.16926,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0062634,-0.11713,-0.13891,0,0
2,GO RESPONSE TO PROTOZOAN,0.085627,-0.11718,-0.12951,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0071468,-0.11735,-0.14049,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.17099,-0.11745,-0.078039,0,0
2,GO TELOMERE CAPPING,0.050569,-0.11749,-0.083112,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.57857,-0.11765,-0.023856,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.030383,-0.11783,-0.15662,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.015574,-0.11792,-0.14054,0,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.11434,-0.11853,-0.1316,0,0
2,GO INCLUSION BODY ASSEMBLY,0.41341,-0.11856,-0.062576,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.74288,-0.11898,-0.02659,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.019739,-0.11915,-0.13933,0,0
2,GO FORELIMB MORPHOGENESIS,0.17374,-0.1192,-0.10608,0,0
2,GO SKIN MORPHOGENESIS,0.19095,-0.11936,-0.17621,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.17653,-0.11947,-0.20841,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.042857,-0.11958,-0.12767,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.12049,-0.11968,-0.1251,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.25729,-0.11972,-0.065527,0,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0057817,-0.11973,-0.1435,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.11235,-0.11977,-0.11939,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.87144,-0.11995,-0.0011063,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.0069616,-0.12004,-0.16622,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.060602,-0.12017,-0.14016,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.39371,-0.12052,-0.065929,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.087232,-0.12063,-0.14962,0,0
2,GO MATURE B CELL DIFFERENTIATION,0.11636,-0.12065,-0.15867,0,0
2,GO ESTROUS CYCLE,0.19095,-0.12065,-0.12092,0,0
2,GO GOLGI RIBBON FORMATION,0.052669,-0.12082,-0.13021,0,0
2,GO KERATINOCYTE PROLIFERATION,0.05824,-0.12088,-0.1803,0,0
2,GO PROSTAGLANDIN SECRETION,0.21905,-0.12092,-0.10932,0,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.35153,-0.12095,-0.070889,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.14048,-0.12117,-0.10426,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.19095,-0.12157,-0.14673,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00012074,-0.12158,-0.15656,0,0
2,GO MUSCLE ATROPHY,0.1313,-0.12175,-0.14624,0,0
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.011326,-0.12188,-0.14294,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0010206,-0.12202,-0.18448,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.32938,-0.12205,-0.10769,0,0
2,GO NUCLEOTIDE SALVAGE,0.26847,-0.12248,-0.13404,0,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.073629,-0.12251,-0.097697,0,0
2,GO HEME METABOLIC PROCESS,0.064293,-0.12251,-0.18408,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.15264,-0.12258,-0.092212,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.031748,-0.1226,-0.12681,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.42347,-0.12281,-0.089896,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.42347,-0.12324,-0.069968,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.22905,-0.12326,-0.092931,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.42855,-0.12374,-0.096759,0,0
2,GO AMELOGENESIS,0.22235,-0.12391,-0.17104,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.14285,-0.12408,-0.10841,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.27611,-0.12445,-0.085227,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.0017641,-0.12459,-0.1437,0,0
2,GO GENETIC IMPRINTING,0.27227,-0.12462,-0.048195,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.24288,-0.12466,-0.16889,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.32077,-0.12495,-0.073002,0,0
2,GO RESPONSE TO VITAMIN,0.088862,-0.12497,-0.10815,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.097379,-0.12515,-0.14736,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.047551,-0.12534,-0.15426,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.090515,-0.12551,-0.1014,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.079444,-0.12564,-0.15204,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.017549,-0.12588,-0.12564,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.11039,-0.12592,-0.081448,0,0
2,GO MESONEPHROS DEVELOPMENT,0.1313,-0.12603,-0.099568,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.084046,-0.12605,-0.093447,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.36526,-0.12628,-0.091135,0,0
2,GO EPITHELIAL TUBE FORMATION,0.0099891,-0.1264,-0.11652,0,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.014841,-0.12649,-0.12951,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.029068,-0.12656,-0.12954,0,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0075304,-0.12667,-0.22124,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.050569,-0.12692,-0.16655,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.097379,-0.12699,-0.15688,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.11841,-0.12728,-0.15088,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.35153,-0.12731,-0.068769,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.18219,-0.12744,-0.18713,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.065563,-0.1278,-0.11122,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.10654,-0.12781,-0.12002,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.087232,-0.12804,-0.11928,0,0
2,GO MOLTING CYCLE,0.0094949,-0.12816,-0.13165,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.11235,-0.12817,-0.23001,0,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.188,-0.12834,-0.14826,0,0
2,GO REGULATION OF ODONTOGENESIS,0.095625,-0.12879,-0.12844,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.041967,-0.1288,-0.14159,0,0
2,GO HEAT GENERATION,0.13583,-0.12909,-0.10511,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.13355,-0.12911,-0.087977,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.19393,-0.12924,-0.086103,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.14526,-0.12949,-0.11379,0,0
2,GO TOXIN METABOLIC PROCESS,0.05161,-0.12964,-0.20067,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.038561,-0.12982,-0.091788,0,0
2,GO PROTEIN REFOLDING,0.042857,-0.1299,-0.14178,0,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.064293,-0.13019,-0.14802,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.02843,-0.13025,-0.19962,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.036948,-0.1304,-0.21728,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.16828,-0.13048,-0.10643,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.38888,-0.1306,-0.081381,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.088862,-0.13094,-0.1856,0,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.16032,-0.13106,-0.12577,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.034637,-0.13106,-0.13358,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.0695,-0.13111,-0.1706,0,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.031748,-0.13113,-0.25957,0,0
2,GO AXIS ELONGATION,0.17099,-0.13116,-0.1097,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.05161,-0.13127,-0.15556,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.052669,-0.13145,-0.18317,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.13583,-0.13145,-0.076669,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0069616,-0.13153,-0.16763,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.053746,-0.13186,-0.20158,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.068167,-0.13208,-0.15337,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.27227,-0.13208,-0.11765,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.13355,-0.13216,-0.090228,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.14526,-0.13238,-0.12965,0,0
2,GO INSULIN SECRETION,0.22905,-0.13255,-0.050023,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0012662,-0.13257,-0.15004,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.12049,-0.1332,-0.088911,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.20937,-0.13327,-0.062841,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.070855,-0.13372,-0.11157,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.03245,-0.13395,-0.12095,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.15517,-0.13453,-0.15514,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.24288,-0.13455,-0.12013,0,0
2,GO PHOSPHOLIPID EFFLUX,0.068167,-0.13457,-0.19787,0,0
2,GO DENDRITIC CELL MIGRATION,0.0071468,-0.13458,-0.20904,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.35153,-0.13486,-0.10731,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.12259,-0.13498,-0.11794,0,0
2,GO RESPONSE TO IRON ION,0.0053338,-0.13504,-0.22871,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.052669,-0.13521,-0.27514,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.053746,-0.13553,-0.13398,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.21256,-0.13558,-0.11503,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.02268,-0.1357,-0.14316,0,0
2,GO ER OVERLOAD RESPONSE,0.084046,-0.13601,-0.16982,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.11636,-0.13622,-0.1173,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0085714,-0.13655,-0.12349,0,0
2,GO L PHENYLALANINE METABOLIC PROCESS,0.12259,-0.13673,-0.16529,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.13814,-0.13692,-0.07267,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.059411,-0.13734,-0.26785,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.080955,-0.13805,-0.24503,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.065563,-0.13819,-0.091157,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0040578,-0.13826,-0.12108,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.1313,-0.13848,-0.15772,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0042883,-0.13865,-0.16276,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.023205,-0.13875,-0.12418,0,0
2,GO RESPONSE TO HYPEROXIA,0.15773,-0.13899,-0.14714,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.05824,-0.13911,-0.17114,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.030383,-0.13952,-0.16351,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.24643,-0.13961,-0.17929,0,0
2,GO REGULATION OF NEURON MATURATION,0.39371,-0.14032,-0.054409,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.073629,-0.14034,-0.2281,0,0
2,GO CARNITINE SHUTTLE,0.05824,-0.14059,-0.14253,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.084046,-0.14059,-0.16819,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.060602,-0.14067,-0.090841,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.017137,-0.14088,-0.10056,0,0
2,GO CELL REDOX HOMEOSTASIS,0.03245,-0.14121,-0.14567,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.31232,-0.14137,-0.15699,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.013139,-0.14157,-0.14442,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.35607,-0.14182,-0.086977,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0039469,-0.14198,-0.18354,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12689,-0.14239,-0.14172,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.64605,-0.1424,-0.048728,0,0
2,GO OXALATE TRANSPORT,0.0064317,-0.14254,-0.16252,0,0
2,GO RESPONSE TO LEPTIN,0.0033369,-0.14256,-0.20244,0,0
2,GO REGULATION OF HEAT GENERATION,0.25363,-0.14283,-0.10532,0,0
2,GO ALANINE TRANSPORT,0.10096,-0.1429,-0.12664,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.17099,-0.14312,-0.10254,0,0
2,GO DIET INDUCED THERMOGENESIS,0.56666,-0.14329,0.004164,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.026586,-0.1434,-0.12553,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.055956,-0.14356,-0.11064,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.0015653,-0.14386,-0.13047,0,0
2,GO CENTROSOME SEPARATION,0.073629,-0.14436,-0.10485,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.11039,-0.1444,-0.10464,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.014138,-0.14443,-0.18627,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.054842,-0.14454,-0.19155,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.18508,-0.14454,-0.084469,0,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.036948,-0.14457,-0.14786,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0053338,-0.14483,-0.12708,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00098941,-0.14503,-0.15202,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.065563,-0.14516,-0.12393,0,0
2,GO HORMONE CATABOLIC PROCESS,0.061812,-0.14525,-0.19421,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.27999,-0.1454,-0.051312,0,0
2,GO REGULATION OF TUBE SIZE,0.0060989,-0.1455,-0.13422,0,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0059384,-0.14558,-0.17305,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00074557,-0.1456,-0.14475,0,0
2,GO NOTOCHORD DEVELOPMENT,0.070855,-0.14567,-0.21915,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11841,-0.14579,-0.15559,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.42855,-0.14614,-0.11385,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.001986,-0.14619,-0.16125,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.18219,-0.14642,-0.10688,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.23589,-0.14646,-0.13184,0,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.12259,-0.14655,-0.11349,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.25001,-0.1466,-0.10136,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.055956,-0.14691,-0.11985,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.24288,-0.14705,-0.076408,0,0
2,GO RESPONSE TO REDOX STATE,0.088862,-0.14705,-0.14302,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.001228,-0.14728,-0.1828,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0066042,-0.14735,-0.12194,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.22235,-0.14749,-0.13125,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.60883,-0.14754,-0.12496,0,0
2,GO RESPONSE TO CADMIUM ION,0.016734,-0.14804,-0.19418,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.14811,-0.13548,0,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.080955,-0.14841,-0.23996,0,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.060602,-0.14856,-0.25286,0,0
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.1028,-0.14862,-0.15144,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.57857,-0.14863,-0.034636,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.017137,-0.1491,-0.14646,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.11434,-0.14917,-0.066272,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.082489,-0.14945,-0.13787,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.19695,-0.14981,-0.11954,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.44402,-0.15017,-0.03613,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.018836,-0.15022,-0.19,0,0
2,GO CELL FATE DETERMINATION,0.16559,-0.15048,-0.084563,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.014486,-0.15087,-0.13941,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.0021689,-0.15094,-0.1447,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.029068,-0.15119,-0.14833,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.053746,-0.15128,-0.12245,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.00029782,-0.15141,-0.1576,0,0
2,GO STEROL IMPORT,0.099158,-0.1518,-0.16672,0,0
2,GO REGULATION OF CELL SHAPE,0.0087944,-0.15195,-0.13191,0,0
2,GO RESPONSE TO INSECTICIDE,0.23245,-0.15198,-0.097678,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.052669,-0.15227,-0.18369,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.031059,-0.15278,-0.18232,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.010245,-0.15285,-0.12859,0,0
2,GO CYCLOOXYGENASE PATHWAY,0.22568,-0.15343,-0.17383,0,0
2,GO ASTROCYTE DEVELOPMENT,0.2,-0.1538,-0.1179,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.061812,-0.15381,-0.13003,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.011612,-0.154,-0.23347,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.02166,-0.15411,-0.19527,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.14048,-0.15455,-0.16968,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.10096,-0.1553,-0.094685,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.012203,-0.1556,-0.14821,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.10465,-0.15564,-0.13967,0,0
2,GO CHONDROCYTE PROLIFERATION,0.21256,-0.15572,-0.13656,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.025414,-0.15603,-0.26734,0,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.042857,-0.15609,-0.12756,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.17653,-0.1561,-0.21199,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.024846,-0.15669,-0.13039,0,0
2,GO REGULATION OF HAIR CYCLE,0.024288,-0.15697,-0.18294,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0075304,-0.15711,-0.17157,0,0
2,GO DIOL METABOLIC PROCESS,0.031059,-0.15723,-0.14917,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.21905,-0.15748,-0.11501,0,0
2,GO MEMBRANE FISSION,0.060602,-0.1582,-0.12963,0,0
2,GO COPPER ION TRANSPORT,0.065563,-0.1583,-0.13427,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.42855,-0.15879,-0.16857,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.068167,-0.15935,-0.11679,0,0
2,GO GOLGI LOCALIZATION,0.0028141,-0.15942,-0.18825,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0039469,-0.15949,-0.18008,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.010773,-0.15972,-0.16349,0,0
2,GO GASTRIC ACID SECRETION,0.02268,-0.1604,-0.18337,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.13355,-0.16056,-0.0903,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.072231,-0.16114,-0.14586,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.068167,-0.1613,-0.12581,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.20621,-0.16174,-0.15035,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.041093,-0.16178,-0.16829,0,0
2,GO ASTROCYTE ACTIVATION,0.11039,-0.16229,-0.1493,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.014138,-0.16231,-0.17075,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0059384,-0.16241,-0.16105,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54321,-0.16247,-0.061721,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.0050528,-0.16252,-0.16574,0,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.050569,-0.16317,-0.17988,0,0
2,GO HEART INDUCTION,0.05824,-0.16319,-0.20095,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.17934,-0.16324,-0.13683,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0081404,-0.16326,-0.22098,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.0090226,-0.16358,-0.24361,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.54321,-0.16382,-0.14441,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.05824,-0.16383,-0.16515,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.009256,-0.16387,-0.17655,0,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.099158,-0.16412,-0.17953,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.013798,-0.16455,-0.16209,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.011612,-0.165,-0.17187,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.05161,-0.16549,-0.22364,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.13583,-0.16556,-0.10705,0,0
2,GO HAIR FOLLICLE MATURATION,0.041967,-0.16598,-0.18339,0,0
2,GO TRACHEA DEVELOPMENT,0.059411,-0.16622,-0.17959,0,0
2,GO AMYLOID FIBRIL FORMATION,0.14285,-0.16632,-0.20145,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.047551,-0.16675,-0.15126,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.14526,-0.16678,-0.079702,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0090226,-0.16678,-0.14974,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.064293,-0.16701,-0.1195,0,0
2,GO SPLEEN DEVELOPMENT,0.00019753,-0.16711,-0.20106,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001872,-0.16717,-0.22667,0,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00081984,-0.16726,-0.18166,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.4545,-0.16752,-0.14717,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.097379,-0.16763,-0.20646,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.022165,-0.16786,-0.22962,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.017969,-0.16796,-0.18769,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.007729,-0.16829,-0.17017,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.24288,-0.16859,-0.10865,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.049546,-0.16877,-0.1808,0,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0023671,-0.16919,-0.16739,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.0015189,-0.16951,-0.16331,0,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.05161,-0.16988,-0.13562,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.017549,-0.17012,-0.13232,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.093897,-0.17051,-0.20109,0,0
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.17934,-0.17069,-0.17397,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0012662,-0.17073,-0.1901,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0010206,-0.17075,-0.16533,0,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.91293,-0.17083,0.041774,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.21579,-0.17084,-0.10181,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.27611,-0.17092,-0.091899,0,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.12908,-0.17138,-0.14807,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0007696,-0.17153,-0.19217,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.1313,-0.17161,-0.16938,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.19695,-0.17161,-0.093452,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.077957,-0.17187,-0.11955,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0059384,-0.17209,-0.15011,0,0
2,GO GMP METABOLIC PROCESS,0.041967,-0.17227,-0.15192,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0022332,-0.17319,-0.24413,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.023741,-0.17326,-0.12258,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.041967,-0.1735,-0.16125,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.1739,-0.16099,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.27227,-0.17406,-0.15105,0,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.43883,-0.17448,-0.066286,0,0
2,GO REFLEX,0.087232,-0.17519,-0.19165,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.075049,-0.17533,-0.13427,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.00087311,-0.17549,-0.23182,0,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.39858,-0.17567,-0.11321,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.03245,-0.17584,-0.24032,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.33812,-0.1761,-0.1008,0,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0032441,-0.17612,-0.18261,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.15264,-0.17648,-0.12195,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.044685,-0.17648,-0.14599,0,0
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.076492,-0.1765,-0.13575,0,0
2,GO LUNG MORPHOGENESIS,0.0056288,-0.17686,-0.20023,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.18219,-0.17713,-0.15621,0,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.01282,-0.17717,-0.20851,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0036303,-0.17771,-0.14847,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.052669,-0.17873,-0.23925,0,0
2,GO URETER DEVELOPMENT,0.20937,-0.17887,-0.079116,0,0
2,GO OXYGEN TRANSPORT,0.4545,-0.17892,-0.1286,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.014486,-0.17919,-0.15789,0,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.042857,-0.17989,-0.21614,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.018836,-0.18003,-0.17364,0,0
2,GO PANCREAS DEVELOPMENT,0.010245,-0.1804,-0.16393,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.16032,-0.18048,-0.25858,0,0
2,GO LOCOMOTOR RHYTHM,0.047551,-0.18094,-0.14407,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.017137,-0.18096,-0.16721,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.092194,-0.18115,-0.12166,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.32077,-0.18157,-0.10811,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.029719,-0.18167,-0.15132,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.17653,-0.18179,-0.12966,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.080955,-0.18206,-0.18257,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.001228,-0.18232,-0.26717,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0010206,-0.18239,-0.21379,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.10096,-0.18305,-0.19369,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.064293,-0.18331,-0.18602,0,0
2,GO T CELL EXTRAVASATION,0.057089,-0.18379,-0.27086,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.057089,-0.18379,-0.18728,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.077957,-0.18423,-0.11499,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.060602,-0.18433,-0.21746,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.037747,-0.18473,-0.14922,0,0
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0011549,-0.18476,-0.27415,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.35153,-0.18485,-0.054355,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0038387,-0.18491,-0.20982,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.0099891,-0.18523,-0.2602,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00026903,-0.18545,-0.18885,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.090515,-0.1856,-0.13455,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.070855,-0.18589,-0.21345,0,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0015189,-0.18609,-0.24307,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.061812,-0.18663,-0.18399,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.029068,-0.18666,-0.18604,0,0
2,GO AXONEME ASSEMBLY,0.02268,-0.18679,-0.15629,0,0
2,GO MIDGUT DEVELOPMENT,0.14769,-0.18715,-0.1929,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.036164,-0.18742,-0.1553,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.085627,-0.18769,-0.14027,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.12259,-0.18839,-0.11399,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0034322,-0.18889,-0.14856,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10465,-0.1891,-0.16388,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.02268,-0.18923,-0.20614,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.89907,-0.18955,-0.012154,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.00044439,-0.18979,-0.16223,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.0050528,-0.18981,-0.30093,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.20621,-0.19007,-0.10716,0,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0042883,-0.19079,-0.22088,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.22568,-0.19153,-0.35511,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.11434,-0.19188,-0.12459,0,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0087944,-0.19238,-0.24076,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0085714,-0.19306,-0.17754,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.063042,-0.19371,-0.1905,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.29586,-0.19556,-0.093408,0,0
2,GO REGULATION OF MITOPHAGY,0.0064317,-0.19561,-0.15967,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.18219,-0.19581,-0.13455,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.013465,-0.19636,-0.17653,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.1028,-0.19643,-0.18686,0,0
2,GO LIPID DIGESTION,0.025414,-0.19656,-0.25101,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0059384,-0.1966,-0.25921,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.12689,-0.19721,-0.13236,0,0
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.010245,-0.1974,-0.16767,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0060989,-0.19868,-0.24524,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.015574,-0.19913,-0.18843,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.1313,-0.19976,-0.17064,0,0
2,GO MICROVILLUS ORGANIZATION,0.0057817,-0.19986,-0.25501,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.060602,-0.20176,-0.19554,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.018398,-0.20367,-0.16073,0,0
2,GO RETINAL METABOLIC PROCESS,0.066855,-0.20379,-0.22605,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0041716,-0.20459,-0.19618,0,0
2,GO OVULATION,0.15264,-0.20468,-0.1203,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.26471,-0.20487,-0.10274,0,0
2,GO PLACENTA DEVELOPMENT,7.8282e-05,-0.20535,-0.21852,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.21905,-0.20567,-0.085817,0,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00013917,-0.20643,-0.20912,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.16828,-0.20656,-0.085063,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.11636,-0.20671,-0.12115,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0087944,-0.20825,-0.19153,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.034637,-0.20825,-0.23447,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.00044439,-0.20843,-0.24505,0,0
2,GO SPERM CAPACITATION,0.00017796,-0.20926,-0.19733,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.064293,-0.20957,-0.21201,0,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.092194,-0.20986,-0.28811,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.052669,-0.21053,-0.11732,0,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.0018173,-0.21056,-0.22106,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.042857,-0.2106,-0.11767,0,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0021689,-0.21084,-0.17659,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0064317,-0.21123,-0.22584,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.095625,-0.2116,-0.11219,0,0
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0050528,-0.21195,-0.22269,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.046579,-0.21195,-0.15113,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.017549,-0.21221,-0.12882,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0032441,-0.21397,-0.26218,0,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.00010462,-0.21423,-0.22202,0,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0099891,-0.21428,-0.20566,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0028141,-0.21552,-0.17745,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017137,-0.21619,-0.18475,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.054842,-0.21667,-0.14213,0,0
2,GO NOSE DEVELOPMENT,0.10096,-0.21731,-0.20338,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00090094,-0.21805,-0.18876,0,0
2,GO MALE SEX DETERMINATION,0.0051916,-0.22036,-0.23943,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.12259,-0.2209,-0.11748,0,0
2,GO HEART TRABECULA FORMATION,0.090515,-0.22114,-0.16029,0,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0015189,-0.22205,-0.23542,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.011904,-0.22233,-0.20512,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.011904,-0.22297,-0.16621,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.085627,-0.22487,-0.22929,0,0
2,GO ETHANOL METABOLIC PROCESS,0.0022332,-0.22574,-0.29484,0,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0015653,-0.22608,-0.2152,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.065563,-0.22675,-0.15345,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.0064317,-0.22679,-0.20181,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0097392,-0.22829,-0.20241,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.0010528,-0.2284,-0.28169,0,0
2,GO MACROPHAGE PROLIFERATION,0.2839,-0.23004,-0.12143,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.087232,-0.23093,-0.17416,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.016734,-0.23243,-0.19776,0,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.16828,-0.23346,-0.23629,0,0
2,GO RETINA LAYER FORMATION,0.082489,-0.2335,-0.17827,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.15517,-0.23379,-0.14262,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.029068,-0.23434,-0.23574,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.05824,-0.23474,-0.23318,0,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00027832,-0.2348,-0.25861,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.099158,-0.23507,-0.13592,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00055855,-0.23515,-0.2773,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.0034322,-0.23669,-0.27511,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00030804,-0.23702,-0.23515,0,0
2,GO STEROID ESTERIFICATION,0.0064317,-0.23749,-0.29357,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.033894,-0.23772,-0.2933,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.011047,-0.23831,-0.15446,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00098941,-0.23881,-0.26953,0,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0059384,-0.23905,-0.28359,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00042998,-0.24025,-0.22225,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.65866,-0.24089,-0.053252,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.27611,-0.24347,-0.14521,0,0
2,GO ETHANOL OXIDATION,0.0040578,-0.24398,-0.40972,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.057089,-0.24427,-0.12024,0,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.014138,-0.24456,-0.25337,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.05824,-0.24498,-0.1666,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.099158,-0.24797,-0.15957,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,2.4346e-05,-0.24886,-0.26669,0,0
2,GO VASCULAR TRANSPORT,0.087232,-0.24972,-0.2142,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.14526,-0.25021,-0.14958,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0064317,-0.251,-0.32888,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.011047,-0.25383,-0.27293,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.0226e-05,-0.25406,-0.27957,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0695,-0.25512,-0.15899,0,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.1028,-0.25646,-0.16155,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.033166,-0.25708,-0.18094,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0011549,-0.25847,-0.27392,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.13355,-0.25886,-0.16117,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.063042,-0.25893,-0.25023,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00017796,-0.25951,-0.26741,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.017137,-0.25971,-0.2438,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0033369,-0.26082,-0.27239,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.02843,-0.26139,-0.22636,0,0
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00084609,-0.26239,-0.2665,0,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.00029782,-0.2631,-0.37999,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.21256,-0.26377,-0.16831,0,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.046579,-0.26562,-0.17969,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.10096,-0.26573,-0.1564,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.015203,-0.26804,-0.20661,0,0
2,GO TRACHEA MORPHOGENESIS,0.017137,-0.26957,-0.21248,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.25729,-0.26984,-0.12624,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.02068,-0.27046,-0.1981,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.015953,-0.27156,-0.24954,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.00092958,-0.27183,-0.23639,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,8.1192e-05,-0.2721,-0.24703,0,0
2,GO EXTRACELLULAR TRANSPORT,0.011326,-0.27219,-0.16901,0,0
2,GO POSITIVE REGULATION OF CELL SIZE,8.4205e-05,-0.27619,-0.33152,0,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.001228,-0.27784,-0.31747,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.0057817,-0.27913,-0.26847,0,0
2,GO AMINE CATABOLIC PROCESS,0.0054795,-0.27977,-0.2687,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,3.1888e-05,-0.28106,-0.33257,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.059411,-0.28127,-0.24426,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0018173,-0.28193,-0.29307,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.029068,-0.28369,-0.32636,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.012508,-0.2846,-0.22499,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.033166,-0.28566,-0.21224,0,0
2,GO REGULATION OF WOUND HEALING,7.2754e-05,-0.28711,-0.29808,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.012203,-0.28795,-0.20522,0,0
2,GO LYSINE METABOLIC PROCESS,0.0062634,-0.29059,-0.30566,0,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00067758,-0.29095,-0.32177,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00055855,-0.29144,-0.36222,0,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.044685,-0.29296,-0.30752,0,0
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00034072,-0.29325,-0.3748,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.27227,-0.29514,-0.15043,0,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00014418,-0.29597,-0.32438,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00010462,-0.29751,-0.27555,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0037331,-0.30121,-0.31127,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00027832,-0.30372,-0.32229,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2308e-06,-0.30794,-0.31601,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.014138,-0.30875,-0.2066,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.0032441,-0.3089,-0.41539,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.017137,-0.3139,-0.26817,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0015653,-0.31514,-0.29255,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.44402,-0.31706,-0.12062,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00012074,-0.32344,-0.34512,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.076492,-0.32677,-0.22305,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0010528,-0.32724,-0.41325,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.02268,-0.3277,-0.35669,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0031536,-0.32899,-0.33618,0,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.017137,-0.3349,-0.24337,0,0
2,GO RESPONSE TO FORSKOLIN,0.017549,-0.33923,-0.224,0,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.001662,-0.34031,-0.33266,0,0
2,GO T CELL MEDIATED CYTOTOXICITY,1.8521e-05,-0.34331,-0.46376,0,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.077957,-0.34385,-0.24514,0,0
2,GO PROSTANOID METABOLIC PROCESS,0.00023468,-0.34391,-0.37117,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0038387,-0.3464,-0.25751,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.0090226,-0.34774,-0.30787,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00050664,-0.35225,-0.33915,0,0
2,GO BRONCHUS DEVELOPMENT,0.0012662,-0.35289,-0.43191,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00052342,-0.35472,-0.34043,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011047,-0.36011,-0.25695,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.040234,-0.36517,-0.28338,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00074557,-0.3655,-0.35004,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.0012662,-0.3662,-0.31032,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00049035,-0.38464,-0.36853,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00023468,-0.38471,-0.38379,0,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00074557,-0.38643,-0.35788,0,0
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.022165,-0.38911,-0.20916,0,0
2,GO PSEUDOPODIUM ORGANIZATION,0.0038387,-0.39041,-0.34317,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0011199,-0.39569,-0.34735,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0025083,-0.4105,-0.33029,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.2754e-05,-0.41186,-0.41978,0,0
2,GO RESPONSE TO LITHIUM ION,0.0020453,-0.41358,-0.29975,0,0
2,GO HEPATOCYTE DIFFERENTIATION,4.4878e-05,-0.41681,-0.39863,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.00031859,-0.42419,-0.33934,0,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.8077e-06,-0.42671,-0.56003,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.00016595,-0.46006,-0.51997,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.48455,-0.57093,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0069616,-0.49884,-0.33606,0,0
2,GO EPITHELIAL CELL CELL ADHESION,1.2962e-05,-0.51808,-0.53814,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0081404,-0.56072,-0.36228,0,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.1112e-06,1.2701,1.1307,1,1
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00012964,0.8674,0.66755,1,1
3,GO CYTIDINE TO URIDINE EDITING,0.00030804,0.75149,0.63041,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.9841e-06,0.75103,0.59634,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,7.547e-05,0.74274,0.68595,1,1
3,GO HISTAMINE SECRETION,2.8077e-06,0.70099,0.69335,1,1
3,GO LIPID DROPLET FORMATION,4.1112e-06,0.68312,0.64627,1,1
3,GO TOLERANCE INDUCTION,0.00016023,0.67628,0.59641,1,1
3,GO EOSINOPHIL CHEMOTAXIS,6.0504e-05,0.66143,0.50601,1,1
3,GO SEROTONIN METABOLIC PROCESS,1.7118e-05,0.6427,0.64502,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,1.4039e-05,0.63619,0.47988,1,1
3,GO EOSINOPHIL MIGRATION,0.00012512,0.62288,0.46883,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00028792,0.61796,0.46172,1,1
3,GO HISTAMINE TRANSPORT,5.2837e-06,0.61771,0.63475,1,1
3,GO RESPONSE TO INTERFERON BETA,0.001872,0.59599,0.41556,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,4.6597e-05,0.59308,0.49074,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00032948,0.59093,0.48715,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0028957,0.58718,0.3847,1,1
3,GO RESPONSE TO TYPE I INTERFERON,8.7323e-05,0.58387,0.52479,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0010859,0.57127,0.45273,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00055855,0.57016,0.44165,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,7.3528e-06,0.56359,0.56606,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.023741,0.55186,0.28443,1,1
3,GO DETECTION OF OTHER ORGANISM,2.3418e-05,0.54486,0.51061,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.017137,0.54382,0.37041,1,1
3,GO KETONE CATABOLIC PROCESS,6.0504e-05,0.53568,0.49072,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.53438,0.47051,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.1702e-06,0.53172,0.52067,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,0.00016023,0.52905,0.42839,1,1
3,GO REGULATION OF PLATELET AGGREGATION,6.5149e-05,0.52876,0.4638,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,8.1192e-05,0.52313,0.49496,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.3916e-06,0.52056,0.48606,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,8.3127e-06,0.51746,0.48251,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.001662,0.51313,0.3721,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00052342,0.51192,0.38703,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.00014418,0.50517,0.52597,1,1
3,GO O GLYCAN PROCESSING,6.7728e-06,0.50443,0.44832,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00065623,0.50336,0.35955,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.6174e-05,0.49563,0.4607,1,1
3,GO RENAL ABSORPTION,0.00054072,0.49553,0.48977,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,5.4121e-05,0.49511,0.48864,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,3.6228e-06,0.4886,0.46425,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,0.00019079,0.48576,0.57577,1,1
3,GO RESPONSE TO COLD,1.6455e-05,0.4803,0.39486,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0006154,0.4785,0.36428,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.001228,0.47707,0.33636,1,1
3,GO GERMINAL CENTER FORMATION,0.00055855,0.47296,0.45279,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010092,0.47279,0.44816,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00098941,0.47018,0.46243,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00031859,0.46824,0.43125,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0064317,0.46211,0.2931,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.7145e-05,0.45949,0.47566,1,1
3,GO CELLULAR RESPONSE TO ZINC ION,0.042857,0.45632,0.4566,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,1.349e-05,0.45453,0.43092,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0006154,0.45331,0.39152,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00098941,0.44882,0.4067,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00013433,0.44675,0.50318,1,1
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00025131,0.44608,0.48542,1,1
3,GO TOXIN METABOLIC PROCESS,5.0226e-05,0.44581,0.41931,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.001228,0.44317,0.35288,1,1
3,GO REGULATION OF VASCULOGENESIS,0.00063551,0.44133,0.41837,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00074557,0.44121,0.37297,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0034322,0.44002,0.43641,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00087311,0.43969,0.3054,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,1.4609e-05,0.43957,0.52505,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,5.9841e-06,0.43676,0.42966,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00012074,0.43498,0.50834,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.1888e-05,0.4344,0.40361,1,1
3,GO LIPOXYGENASE PATHWAY,0.0054795,0.43431,0.33435,1,1
3,GO INTESTINAL ABSORPTION,4.6623e-06,0.43417,0.45355,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00017796,0.43324,0.47563,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00014935,0.43307,0.40916,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00026903,0.43283,0.34995,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,9.7346e-05,0.43262,0.40048,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0021689,0.43249,0.31327,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,8.7323e-05,0.42973,0.4227,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.0073e-05,0.42936,0.34589,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,0.0001165,0.42859,0.41705,1,1
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.013139,0.42809,0.31317,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0032441,0.42492,0.28665,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.1112e-06,0.42438,0.54379,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00087311,0.41995,0.39719,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0083534,0.41948,0.33016,1,1
3,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,0.41792,0.38281,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00023468,0.41758,0.4261,1,1
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00055855,0.41635,0.43569,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,5.2139e-05,0.41484,0.37128,1,1
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.013139,0.41161,0.28321,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0083534,0.41009,0.32358,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,6.5896e-07,0.40629,0.44932,1,1
3,GO B CELL APOPTOTIC PROCESS,3.8583e-05,0.40366,0.39471,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00063551,0.40191,0.29814,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,5.6174e-05,0.40132,0.36782,1,1
3,GO RESPONSE TO REDOX STATE,0.0017123,0.39936,0.30242,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017641,0.39895,0.29734,1,1
3,GO RESPONSE TO MUSCLE STRETCH,0.00044439,0.3961,0.38948,1,1
3,GO REGULATION OF NEURON MATURATION,0.00052342,0.39567,0.32495,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00050664,0.3942,0.40955,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00092958,0.3936,0.25741,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00026003,0.39276,0.32235,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00090094,0.39245,0.347,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00038934,0.39114,0.33296,1,1
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00044439,0.39085,0.31147,1,1
3,GO INSEMINATION,0.0025817,0.39037,0.34197,1,1
3,GO RESPONSE TO DIETARY EXCESS,0.00052342,0.3899,0.36061,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0013457,0.38964,0.32896,1,1
3,GO LIVER MORPHOGENESIS,0.00031859,0.38951,0.38443,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0025083,0.38745,0.26665,1,1
3,GO LUNG CELL DIFFERENTIATION,0.00098941,0.38716,0.42022,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00069957,0.38684,0.29055,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019079,0.38575,0.32693,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0013054,0.38567,0.24782,1,1
3,GO CELLULAR DEFENSE RESPONSE,6.0504e-05,0.38294,0.31042,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00063551,0.38139,0.40116,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7343e-05,0.38112,0.41551,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,4.4878e-05,0.38111,0.35734,1,1
3,GO ZYMOGEN ACTIVATION,0.0047853,0.3797,0.2521,1,1
3,GO RESPONSE TO WATER,0.0034322,0.37937,0.30652,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0013054,0.37898,0.29834,1,1
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00081984,0.37898,0.43238,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.03245,0.37885,0.24271,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0006154,0.37839,0.27505,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0056288,0.37777,0.34385,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,3.7145e-05,0.37632,0.35977,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.010245,0.37592,0.51209,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,3.3132e-05,0.37553,0.34416,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,3.1888e-05,0.37551,0.33391,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00057693,0.37421,0.28381,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,1.5816e-05,0.37408,0.35829,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0049174,0.37378,0.34709,1,1
3,GO ADRENAL GLAND DEVELOPMENT,6.2786e-05,0.37354,0.43367,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0012662,0.37281,0.32258,1,1
3,GO MATURE B CELL DIFFERENTIATION,0.001191,0.37274,0.34386,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.0833e-05,0.37151,0.31621,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0006154,0.37136,0.26547,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0011549,0.36919,0.28934,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00019753,0.36918,0.34903,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.0011199,0.36862,0.26072,1,1
3,GO LIPID TRANSLOCATION,3.7145e-05,0.36702,0.3066,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.016734,0.36436,0.33361,1,1
3,GO RESPONSE TO COPPER ION,0.00037661,0.36221,0.49199,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.014486,0.3613,0.23879,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0015653,0.3585,0.26253,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,4.6597e-05,0.35826,0.30916,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.4609e-05,0.35719,0.35541,1,1
3,GO REGULATION OF RESPIRATORY BURST,4.4712e-06,0.35648,0.40669,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,2.0033e-05,0.3562,0.32298,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,0.00014935,0.3556,0.39068,1,1
3,GO REGULATION OF ANOIKIS,0.00067758,0.35555,0.40976,1,1
3,GO GALACTOSE METABOLIC PROCESS,0.027188,0.3554,0.24718,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.029719,0.35536,0.23341,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.004408,0.35536,0.37706,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00063551,0.35328,0.29118,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0028141,0.35306,0.30219,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0047853,0.35294,0.27024,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.0073363,0.35059,0.34233,1,1
3,GO HEART INDUCTION,0.02843,0.34981,0.28264,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00050664,0.34972,0.30404,1,1
3,GO PARENTAL BEHAVIOR,0.021165,0.34839,0.23753,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00017186,0.34741,0.28349,1,1
3,GO PHOSPHOLIPID EFFLUX,0.0032441,0.34741,0.22593,1,1
3,GO INTESTINAL LIPID ABSORPTION,0.00028792,0.34683,0.4207,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0056288,0.34679,0.29344,1,1
3,GO BONE RESORPTION,7.2754e-05,0.3465,0.27313,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.00023468,0.34594,0.2953,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0001165,0.34549,0.43131,1,1
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0010528,0.34525,0.32951,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00087311,0.34434,0.292,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.046579,0.34353,0.19017,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.0017123,0.34283,0.3801,1,1
3,GO MYOBLAST FUSION,0.0013872,0.34153,0.25463,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00045924,0.34135,0.35044,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,8.4205e-05,0.33996,0.29022,1,1
3,GO RESPONSE TO INTERFERON GAMMA,0.00084609,0.33976,0.28174,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0073363,0.3396,0.29285,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.0013054,0.33879,0.24568,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.01282,0.33821,0.18094,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0023671,0.33761,0.35314,1,1
3,GO RESPONSE TO INTERLEUKIN 2,3.4421e-05,0.33761,0.30309,1,1
3,GO REGULATION OF B CELL PROLIFERATION,2.4346e-05,0.33755,0.3267,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00019079,0.3375,0.3512,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0056288,0.33734,0.27589,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0017641,0.33584,0.24201,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.0038387,0.33461,0.25162,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.6455e-05,0.33435,0.27437,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0060989,0.33426,0.25576,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4421e-05,0.33205,0.33312,1,1
3,GO QUINONE METABOLIC PROCESS,0.0017641,0.3319,0.33455,1,1
3,GO VIRAL GENOME REPLICATION,0.00098941,0.33156,0.23005,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00036427,0.33102,0.28814,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,5.8301e-05,0.33063,0.37247,1,1
3,GO REGULATION OF TISSUE REMODELING,0.0001165,0.33003,0.2755,1,1
3,GO VITAMIN D METABOLIC PROCESS,0.00019079,0.32987,0.29259,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0031536,0.32974,0.29778,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.045624,0.32927,0.25089,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0016129,0.32907,0.30424,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,4.4878e-05,0.32844,0.27764,1,1
3,GO TISSUE REMODELING,0.00032948,0.32842,0.23141,1,1
3,GO DEFENSE RESPONSE TO VIRUS,0.0012662,0.32768,0.22303,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.013465,0.32647,0.21943,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.013e-05,0.32643,0.36626,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00063551,0.32599,0.31313,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.017549,0.32563,0.21982,1,1
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0001547,0.32535,0.38152,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,0.00024286,0.32526,0.24502,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.7323e-05,0.32495,0.3257,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0011199,0.32462,0.34391,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0028957,0.32444,0.25485,1,1
3,GO NEURONAL ACTION POTENTIAL,0.00057693,0.32443,0.4066,1,1
3,GO ETHER METABOLIC PROCESS,0.0056288,0.32382,0.20886,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,3.0689e-05,0.32373,0.29721,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.2754e-05,0.32372,0.29321,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00044439,0.32202,0.29638,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0015189,0.32153,0.2019,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.046579,0.32098,0.23312,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.0057817,0.31983,0.25868,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.0689e-05,0.31964,0.29994,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0014738,0.31855,0.26648,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.010773,0.31846,0.21396,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00026003,0.3174,0.31157,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31645,0.23516,1,1
3,GO PROTEIN DEMANNOSYLATION,0.00035231,0.31641,0.28714,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0021062,0.31633,0.22686,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00025131,0.31567,0.30021,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00017186,0.31542,0.28083,1,1
3,GO PLASMA MEMBRANE FUSION,0.0021689,0.31527,0.23841,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.014138,0.31483,0.22471,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.001191,0.31452,0.25655,1,1
3,GO RELAXATION OF CARDIAC MUSCLE,0.0041716,0.31374,0.31395,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.0012662,0.31261,0.27105,1,1
3,GO LUNG ALVEOLUS DEVELOPMENT,5.6174e-05,0.31255,0.31017,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0085714,0.31137,0.3067,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.040234,0.31092,0.17432,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.9418e-06,0.31078,0.34347,1,1
3,GO SECONDARY METABOLIC PROCESS,0.0026572,0.31054,0.24201,1,1
3,GO RESPONSE TO MAGNESIUM ION,0.00087311,0.31049,0.3566,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0011199,0.30993,0.38213,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.019283,0.30989,0.33531,1,1
3,GO RESPONSE TO STEROL DEPLETION,0.00026903,0.30929,0.32208,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.012508,0.30845,0.25182,1,1
3,GO ANOIKIS,0.00017186,0.3084,0.3417,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00040247,0.30767,0.28369,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00047456,0.30748,0.24431,1,1
3,GO VASODILATION,0.01282,0.30745,0.18962,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.027803,0.30744,0.24944,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0038387,0.30712,0.26985,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0034322,0.30697,0.22931,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,0.00032948,0.30632,0.30171,1,1
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.010245,0.30514,0.25935,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00017186,0.30435,0.33252,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,7.8282e-05,0.30312,0.3084,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.045624,0.30281,0.25849,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.001662,0.30275,0.24875,1,1
3,GO INTERLEUKIN 12 PRODUCTION,3.3132e-05,0.30274,0.29195,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0015189,0.30233,0.30613,1,1
3,GO TRNA CATABOLIC PROCESS,0.013139,0.30221,0.30519,1,1
3,GO RESPONSE TO CAFFEINE,0.001986,0.30171,0.24632,1,1
3,GO MAST CELL ACTIVATION,9.389e-05,0.30157,0.27214,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.00012964,0.30146,0.25428,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.8418e-05,0.3008,0.272,1,1
3,GO SEQUESTERING OF ACTIN MONOMERS,0.036948,0.30041,0.27765,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00029782,0.29983,0.22861,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.0010528,0.29946,0.24853,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0017123,0.29932,0.28624,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0020453,0.29925,0.18282,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00010462,0.29923,0.31128,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00021909,0.29911,0.21892,1,1
3,GO ADHESION OF SYMBIONT TO HOST,0.00353,0.29903,0.34304,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00014418,0.29804,0.24345,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0094949,0.29788,0.33129,1,1
3,GO REGULATION OF BONE REMODELING,0.0001165,0.29667,0.29577,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,0.0090226,0.2966,0.2619,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.00041602,0.29635,0.2925,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00028792,0.29621,0.24778,1,1
3,GO REGULATION OF TRANSPOSITION,0.0081404,0.29572,0.27152,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0037331,0.29557,0.192,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00026003,0.29522,0.30086,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00079435,0.29511,0.27468,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0066042,0.29429,0.30505,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00037661,0.29423,0.30561,1,1
3,GO T CELL MEDIATED IMMUNITY,0.0021062,0.29413,0.2265,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0021689,0.29333,0.1869,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0015653,0.29245,0.32655,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.29239,0.27632,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.0021062,0.29177,0.33352,1,1
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.024288,0.29152,0.2701,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00057693,0.29129,0.20498,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00029782,0.29045,0.23051,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.017549,0.29022,0.21733,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00036427,0.2893,0.32337,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,8.1192e-05,0.2892,0.25015,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0041716,0.28865,0.2728,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.00034072,0.28796,0.23717,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.2879,0.22418,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.00074557,0.28774,0.3118,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00012074,0.28755,0.29642,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0037331,0.28686,0.33617,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0045306,0.28658,0.1932,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0017641,0.28651,0.28619,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.012508,0.28621,0.17224,1,1
3,GO B CELL HOMEOSTASIS,0.00021909,0.28615,0.24911,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,7.8282e-05,0.28611,0.28536,1,1
3,GO INTERLEUKIN 10 PRODUCTION,0.00010092,0.2859,0.25942,1,1
3,GO TRANSPOSITION,0.001662,0.28564,0.30253,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0023671,0.2854,0.25936,1,1
3,GO BONE REMODELING,0.00059588,0.28503,0.23615,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0001165,0.28492,0.27314,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.001191,0.28451,0.18635,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.036948,0.28437,0.23002,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,9.0551e-05,0.28383,0.23236,1,1
3,GO LYTIC VACUOLE ORGANIZATION,4.1112e-06,0.28372,0.25881,1,1
3,GO PHAGOSOME ACIDIFICATION,5.6174e-05,0.28322,0.24588,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0056288,0.28318,0.20167,1,1
3,GO METHIONINE METABOLIC PROCESS,0.0027346,0.28315,0.19924,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.010506,0.2831,0.23902,1,1
3,GO REGULATION OF DENDRITE EXTENSION,0.001191,0.28289,0.3579,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0037331,0.28275,0.24517,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.3132e-05,0.28251,0.23279,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.0021062,0.28146,0.22077,1,1
3,GO REGULATION OF RECEPTOR CLUSTERING,0.03245,0.28085,0.27427,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.023205,0.28074,0.25016,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0025083,0.28036,0.22338,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,0.0028141,0.28033,0.22263,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00087311,0.28001,0.23327,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0010528,0.27992,0.2093,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.025414,0.27955,0.294,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0020453,0.27949,0.26971,1,1
3,GO POLYOL TRANSPORT,0.0057817,0.27931,0.20263,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0022992,0.27897,0.24533,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00081984,0.27864,0.23407,1,1
3,GO APICAL JUNCTION ASSEMBLY,0.00010092,0.27855,0.29454,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0025083,0.27816,0.21029,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.021165,0.27768,0.29884,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.0015653,0.27716,0.24482,1,1
3,GO REGULATION OF ICOSANOID SECRETION,2.4346e-05,0.27692,0.31193,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0042883,0.27611,0.2099,1,1
3,GO RESPIRATORY BURST,0.0025083,0.27503,0.22702,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.001986,0.275,0.17952,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00041602,0.27459,0.30809,1,1
3,GO CELL KILLING,0.00013433,0.27435,0.21532,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00057693,0.27433,0.30792,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.029719,0.27423,0.21294,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.0081404,0.27417,0.21032,1,1
3,GO INTERLEUKIN 8 PRODUCTION,0.0015653,0.27402,0.20882,1,1
3,GO REGULATION OF CELL KILLING,0.00054072,0.27395,0.24695,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00047456,0.27367,0.24734,1,1
3,GO MUSCLE ATROPHY,0.0083534,0.27332,0.24101,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,9.7346e-05,0.27254,0.25583,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0023671,0.27233,0.28063,1,1
3,GO REGULATION OF ACROSOME REACTION,0.016339,0.27219,0.20828,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.009256,0.27199,0.19941,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00025131,0.27195,0.20652,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0073363,0.27182,0.26162,1,1
3,GO RESPONSE TO VIRUS,0.001986,0.27174,0.18532,1,1
3,GO HEART TRABECULA FORMATION,0.011904,0.2712,0.27294,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.012508,0.27114,0.19768,1,1
3,GO B CELL PROLIFERATION,4.6597e-05,0.27108,0.25023,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0069616,0.27077,0.20025,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0036303,0.27042,0.22544,1,1
3,GO SUPEROXIDE ANION GENERATION,0.011612,0.27009,0.21376,1,1
3,GO HAIR CELL DIFFERENTIATION,0.00024286,0.26977,0.22824,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.010773,0.26947,0.25881,1,1
3,GO CORNIFICATION,0.00010845,0.26926,0.27346,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0018173,0.26892,0.19987,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00014935,0.26837,0.28262,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0054795,0.26754,0.18721,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00079435,0.26733,0.27431,1,1
3,GO RETINAL METABOLIC PROCESS,0.017549,0.26692,0.28786,1,1
3,GO GLYCOSYLATION,0.00019079,0.26665,0.22127,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00013433,0.26609,0.23421,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0039469,0.26601,0.20522,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,0.26593,0.29635,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.00012964,0.26552,0.23076,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.001228,0.26414,0.23025,1,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.012508,0.264,0.19054,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0007696,0.26372,0.17104,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0026572,0.26328,0.21112,1,1
3,GO STEROL METABOLIC PROCESS,0.00035231,0.26244,0.19739,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.0099891,0.26243,0.1904,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00057693,0.26224,0.27952,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0047853,0.26189,0.1806,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00057693,0.26147,0.19058,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00069957,0.26141,0.23438,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0010206,0.26131,0.19539,1,1
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0017641,0.26101,0.22193,1,1
3,GO REGULATION OF COAGULATION,0.0097392,0.26097,0.18236,1,1
3,GO UBIQUINONE METABOLIC PROCESS,0.00050664,0.26091,0.18076,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,0.00024286,0.26086,0.26354,1,1
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.010245,0.26063,0.25208,1,1
3,GO FOAM CELL DIFFERENTIATION,0.00045924,0.26026,0.28773,1,1
3,GO REGULATION OF B CELL ACTIVATION,5.8301e-05,0.26019,0.2384,1,1
3,GO PARTURITION,0.034637,0.26012,0.2373,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00035231,0.26001,0.30268,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0038387,0.25991,0.16588,1,1
3,GO INNATE IMMUNE RESPONSE,0.00052342,0.25971,0.18883,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00092958,0.25943,0.21174,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.013465,0.25924,0.19093,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0025817,0.25915,0.22813,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.001228,0.25871,0.2508,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0033369,0.25869,0.22297,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0017641,0.25861,0.33377,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0025817,0.25794,0.16911,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00041602,0.25782,0.2277,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0041716,0.25773,0.20439,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0013054,0.25757,0.22957,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.012203,0.25702,0.29682,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.010773,0.2567,0.21133,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.0045306,0.2567,0.18242,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00012512,0.25643,0.2417,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.02843,0.25635,0.17458,1,1
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.02843,0.25622,0.15905,1,1
3,GO KERATINIZATION,8.1192e-05,0.25569,0.2515,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00095906,0.25532,0.26721,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0014738,0.25481,0.17621,1,1
3,GO GDP METABOLIC PROCESS,0.0075304,0.25339,0.25695,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,0.25336,0.18434,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00023468,0.25325,0.23972,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.4121e-05,0.25232,0.23154,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00019753,0.25207,0.26338,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013872,0.2519,0.37392,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00040247,0.25143,0.18219,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00353,0.25094,0.19974,1,1
3,GO NERVE DEVELOPMENT,0.0014738,0.25047,0.22338,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.019739,0.25018,0.16979,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013054,0.2501,0.19511,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0011549,0.24984,0.25175,1,1
3,GO LEUKOCYTE PROLIFERATION,0.0007696,0.24956,0.17804,1,1
3,GO IMMUNE EFFECTOR PROCESS,0.00079435,0.24917,0.18159,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00034072,0.24908,0.22889,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.025414,0.24904,0.16842,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010245,0.24903,0.14492,1,1
3,GO STEROID METABOLIC PROCESS,0.00012512,0.24882,0.20247,1,1
3,GO LIPID DROPLET ORGANIZATION,8.4205e-05,0.24874,0.25727,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0060989,0.24806,0.18695,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0028141,0.24805,0.19224,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00032948,0.24784,0.19758,1,1
3,GO ACTIN FILAMENT SEVERING,0.014841,0.24766,0.25454,1,1
3,GO PROTEIN KINASE C SIGNALING,0.0022992,0.24714,0.26391,1,1
3,GO STEROL HOMEOSTASIS,0.0025083,0.24672,0.1769,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.00059588,0.24661,0.21234,1,1
3,GO WATER HOMEOSTASIS,0.00052342,0.24651,0.23019,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,6.2786e-05,0.24649,0.24819,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.004408,0.24602,0.17848,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.001228,0.24586,0.25361,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00028792,0.24566,0.23659,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00087311,0.24561,0.23472,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00067758,0.24501,0.20397,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.24473,0.31751,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0017123,0.24433,0.20888,1,1
3,GO TRANSFERRIN TRANSPORT,4.1617e-05,0.24383,0.20703,1,1
3,GO INTEGRIN ACTIVATION,0.00022676,0.24334,0.25197,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00017796,0.24317,0.21997,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0011549,0.24256,0.18684,1,1
3,GO CYTOPLASM ORGANIZATION,0.0007696,0.2423,0.22023,1,1
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0010859,0.24218,0.20335,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00079435,0.24157,0.22177,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.041093,0.24117,0.14752,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00045924,0.241,0.22367,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,7.013e-05,0.24076,0.20876,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00026903,0.24021,0.24549,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00026003,0.24017,0.23203,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,0.00095906,0.23999,0.29119,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00095906,0.23954,0.24804,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0013457,0.23916,0.19618,1,1
3,GO ESTROUS CYCLE,0.029068,0.23893,0.18636,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0014299,0.23879,0.27261,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.00031859,0.23864,0.20089,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00047456,0.23857,0.18945,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0062634,0.23847,0.15798,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00010845,0.2384,0.22283,1,1
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0013457,0.23839,0.23692,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0064317,0.2383,0.2331,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0010528,0.23809,0.1954,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.001662,0.23798,0.18129,1,1
3,GO DIGESTION,0.00023468,0.23757,0.22526,1,1
3,GO CRANIAL NERVE DEVELOPMENT,0.00353,0.23744,0.21054,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0018173,0.23724,0.2229,1,1
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0099891,0.23698,0.18529,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.03939,0.23665,0.1806,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00050664,0.23642,0.20868,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0038387,0.23621,0.19331,1,1
3,GO NATURAL KILLER CELL PROLIFERATION,0.009256,0.23617,0.27016,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0010528,0.23576,0.17107,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.027188,0.23566,0.16479,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.027803,0.23543,0.24491,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.011047,0.23525,0.19916,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,0.00010092,0.23523,0.25894,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.014841,0.23517,0.22671,1,1
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0046564,0.23479,0.22009,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00079435,0.23473,0.18365,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00019753,0.23468,0.19372,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0028957,0.23437,0.2023,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0049174,0.23421,0.18748,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.007729,0.23412,0.18824,1,1
3,GO POSITIVE CHEMOTAXIS,0.0085714,0.23404,0.14645,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0015653,0.2338,0.30869,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.017137,0.23359,0.15346,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.010773,0.23326,0.21052,1,1
3,GO CELL CHEMOTAXIS,0.00057693,0.23292,0.17972,1,1
3,GO SYNCYTIUM FORMATION,0.0056288,0.23287,0.17126,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0024367,0.23286,0.18898,1,1
3,GO VACUOLAR ACIDIFICATION,0.00012074,0.23271,0.20445,1,1
3,GO REGULATION OF CELL CELL ADHESION,0.00095906,0.23263,0.18154,1,1
3,GO RESPONSE TO GROWTH HORMONE,0.0011199,0.23261,0.22519,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.010506,0.23253,0.16795,1,1
3,GO INTERLEUKIN 6 PRODUCTION,0.00023468,0.23249,0.19589,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.0025817,0.2322,0.16819,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.0041716,0.23219,0.15906,1,1
3,GO GRANULOCYTE MIGRATION,0.0014299,0.23178,0.15458,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0090226,0.23171,0.18542,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0010859,0.23164,0.18505,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00010092,0.23123,0.30186,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.7118e-05,0.23109,0.23722,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00069957,0.2309,0.26093,1,1
3,GO CERAMIDE METABOLIC PROCESS,0.00032948,0.23081,0.18255,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.012203,0.23068,0.14569,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00055855,0.23058,0.22665,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00014418,0.23033,0.20562,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.0013054,0.23011,0.19687,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.011612,0.23007,0.16312,1,1
3,GO ENDOTHELIUM DEVELOPMENT,0.0046564,0.23006,0.15755,1,1
3,GO ENERGY HOMEOSTASIS,0.0024367,0.2299,0.21322,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.0013872,0.22982,0.14479,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0097392,0.22958,0.21852,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,0.00014935,0.22917,0.19124,1,1
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.02166,0.22869,0.13627,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.012508,0.22863,0.24193,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00021167,0.22861,0.18629,1,1
3,GO INTERFERON ALPHA PRODUCTION,0.00029782,0.22845,0.23012,1,1
3,GO BILE ACID METABOLIC PROCESS,0.00030804,0.22831,0.21846,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.00055855,0.22827,0.2043,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.0042883,0.22816,0.25858,1,1
3,GO CHEMOKINE PRODUCTION,0.0050528,0.22778,0.17072,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.031059,0.22742,0.23067,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00026903,0.22733,0.19319,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0054795,0.22716,0.24724,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.004408,0.22716,0.16565,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.010773,0.22698,0.13861,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0041716,0.22685,0.1701,1,1
3,GO LEUKOCYTE CHEMOTAXIS,0.00098941,0.22647,0.17025,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0017123,0.22611,0.18151,1,1
3,GO RESPONSE TO TUMOR CELL,0.0047853,0.22586,0.20182,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00055855,0.22586,0.19669,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.029719,0.22563,0.18676,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00042998,0.22532,0.18717,1,1
3,GO REGULATION OF RESPONSE TO FOOD,0.029719,0.22493,0.1164,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.045624,0.22483,0.21844,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.019283,0.22452,0.15241,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00072223,0.22446,0.20375,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0028141,0.22445,0.16925,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0031536,0.22444,0.17962,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0041716,0.22434,0.18051,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.011326,0.22424,0.19297,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00353,0.22397,0.2855,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.00098941,0.22368,0.18067,1,1
3,GO REGULATION OF FERTILIZATION,0.0024367,0.22356,0.18565,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0045306,0.22311,0.19286,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.00034072,0.22279,0.20215,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00031859,0.22267,0.1977,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.001872,0.22242,0.20342,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.0033369,0.22238,0.24964,1,1
3,GO SECRETION BY TISSUE,0.0057817,0.22219,0.18979,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0013054,0.22202,0.21449,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0015653,0.22202,0.29195,1,1
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.046579,0.22183,0.17764,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0025083,0.22171,0.16808,1,1
3,GO LEUKOCYTE MIGRATION,0.0012662,0.22154,0.1759,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00022676,0.22148,0.26753,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.00059588,0.22127,0.20774,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0090226,0.22109,0.14319,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,6.2786e-05,0.22105,0.25855,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.00027832,0.22071,0.18718,1,1
3,GO DEFENSE RESPONSE,0.00047456,0.22069,0.16948,1,1
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0025083,0.22067,0.37566,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00065623,0.22031,0.19027,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00057693,0.21998,0.19762,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.035393,0.21993,0.14661,1,1
3,GO AMYLOID BETA FORMATION,0.017549,0.21989,0.16808,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00037661,0.21974,0.16342,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0006154,0.21962,0.189,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0013872,0.21929,0.20076,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0007696,0.21869,0.19832,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0031536,0.21831,0.15109,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00026903,0.21825,0.19296,1,1
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.040234,0.21801,0.18628,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00057693,0.21794,0.18703,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00098941,0.21763,0.20565,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0064317,0.21745,0.23717,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0017123,0.21731,0.19965,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0045306,0.2171,0.30247,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00035231,0.21677,0.22192,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.00019079,0.21661,0.20643,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.041093,0.21651,0.14496,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.0028141,0.21614,0.21131,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0039469,0.21567,0.16648,1,1
3,GO ALANINE TRANSPORT,0.040234,0.21532,0.14551,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00072223,0.21499,0.29702,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0083534,0.21492,0.19931,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0010206,0.21448,0.19234,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0013872,0.21401,0.18231,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,0.21377,0.1971,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00098941,0.21372,0.15015,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.031748,0.21358,0.17513,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.012203,0.21355,0.17354,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0031536,0.21353,0.19238,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.014841,0.21351,0.23817,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,9.389e-05,0.21349,0.20107,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.013798,0.21311,0.20728,1,1
3,GO MYOTUBE DIFFERENTIATION,0.00084609,0.21295,0.17725,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.00081984,0.21274,0.26606,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0021062,0.21209,0.16556,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0030654,0.21208,0.16014,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0013872,0.21199,0.17365,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00098941,0.21185,0.24922,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0032441,0.21161,0.18906,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.018836,0.21158,0.19726,1,1
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00021909,0.21102,0.19063,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0085714,0.21089,0.17037,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00030804,0.21017,0.22936,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,2.0033e-05,0.21012,0.21071,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0034322,0.20954,0.14582,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00090094,0.20951,0.20336,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0017641,0.2095,0.16668,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0017641,0.20931,0.21241,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0040578,0.20926,0.16376,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.018398,0.20916,0.17835,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,0.0013054,0.20891,0.14662,1,1
3,GO MUSCLE HYPERTROPHY,0.0024367,0.20864,0.16542,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.0022992,0.20847,0.16749,1,1
3,GO NUCLEOTIDE TRANSPORT,0.00038934,0.20817,0.17161,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00018427,0.20796,0.19261,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.011612,0.20762,0.14818,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0027346,0.20748,0.17766,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.0083534,0.2073,0.16401,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0010528,0.2069,0.1739,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0050528,0.20687,0.18726,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00019079,0.20665,0.15807,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.00020448,0.20664,0.19545,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017549,0.20649,0.21376,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.004408,0.20621,0.1539,1,1
3,GO SKIN DEVELOPMENT,0.0013872,0.20621,0.1601,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0034322,0.20618,0.14749,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.044685,0.20609,0.12248,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00059588,0.20596,0.20558,1,1
3,GO T CELL PROLIFERATION,0.001228,0.20568,0.17661,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,0.00014418,0.20566,0.20113,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0028957,0.20501,0.13608,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0010206,0.20473,0.1589,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.0053338,0.20454,0.28134,1,1
3,GO RESPONSE TO CYTOKINE,0.001662,0.20436,0.14532,1,1
3,GO CYTOKINE PRODUCTION,0.0016129,0.20422,0.15997,1,1
3,GO NEURON MATURATION,0.0049174,0.20385,0.20024,1,1
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.011612,0.20337,0.17351,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0051916,0.20332,0.13908,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.037747,0.20297,0.32466,1,1
3,GO SIGNAL PEPTIDE PROCESSING,0.00090094,0.20295,0.28289,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0075304,0.20237,0.1611,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0031536,0.20166,0.19381,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.018836,0.20154,0.18291,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.004408,0.20112,0.20545,1,1
3,GO REGULATION OF APPETITE,0.0067808,0.20084,0.13756,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0075304,0.2007,0.14492,1,1
3,GO ACUTE PHASE RESPONSE,0.0025817,0.20065,0.17692,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0046564,0.20063,0.13662,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.024846,0.20061,0.13583,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.02166,0.20034,0.19159,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.014486,0.20031,0.15001,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.5308e-05,0.20027,0.22727,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00055855,0.19994,0.19009,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0030654,0.19991,0.1613,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.009256,0.19981,0.17281,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,9.0551e-05,0.19975,0.18605,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,0.00026003,0.19969,0.19474,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.017549,0.19935,0.14738,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00025131,0.19923,0.17852,1,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.02268,0.19913,0.19677,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0013054,0.19889,0.16407,1,1
3,GO METANEPHROS MORPHOGENESIS,0.0053338,0.19869,0.19581,1,1
3,GO EPIDERMIS DEVELOPMENT,0.00079435,0.19854,0.16497,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.025994,0.1984,0.17377,1,1
3,GO MEMBRANE DEPOLARIZATION,0.0031536,0.19829,0.21737,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0010528,0.19823,0.23289,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0051916,0.19816,0.16369,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.027803,0.19787,0.1607,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,0.00035231,0.19786,0.18703,1,1
3,GO LIPID STORAGE,0.011047,0.1978,0.1542,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0085714,0.19767,0.14195,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.001986,0.19752,0.1518,1,1
3,GO AMINE METABOLIC PROCESS,6.0504e-05,0.19748,0.18701,1,1
3,GO LIPID LOCALIZATION,0.00040247,0.19732,0.16723,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.019739,0.19728,0.14597,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00019753,0.19706,0.20714,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00353,0.19699,0.25941,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,0.00092958,0.19696,0.17591,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0033369,0.1969,0.16392,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,0.001872,0.19652,0.15247,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.0019282,0.1964,0.23501,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00026003,0.19621,0.18502,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0034322,0.19613,0.16849,1,1
3,GO MULTICELLULAR ORGANISM AGING,0.00017796,0.1959,0.18883,1,1
3,GO LYMPHOCYTE MIGRATION,0.010506,0.19581,0.13539,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00084609,0.19579,0.16434,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.012508,0.19555,0.14833,1,1
3,GO TISSUE HOMEOSTASIS,0.0014738,0.19554,0.13904,1,1
3,GO MONOCYTE CHEMOTAXIS,0.046579,0.19528,0.12244,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00042998,0.1952,0.19521,1,1
3,GO DOPAMINE TRANSPORT,0.0064317,0.19519,0.31045,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.031059,0.19512,0.12991,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.016734,0.19491,0.15122,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.0028141,0.19483,0.19748,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0051916,0.19479,0.21913,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.19456,0.21585,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.0014299,0.19451,0.16488,1,1
3,GO T CELL ACTIVATION,0.0016129,0.19442,0.1488,1,1
3,GO B CELL DIFFERENTIATION,0.00019753,0.19408,0.16414,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.046579,0.194,0.14217,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0010206,0.19396,0.17996,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0028957,0.19394,0.15021,1,1
3,GO MEMBRANE FUSION,0.0028957,0.19393,0.14365,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.0020453,0.19325,0.22422,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00092958,0.19309,0.18332,1,1
3,GO ENDOCYTIC RECYCLING,0.0029794,0.19294,0.14412,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0026572,0.19277,0.22713,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0041716,0.19266,0.13618,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,0.001191,0.19254,0.23266,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.036164,0.19253,0.10937,1,1
3,GO STEROL TRANSPORT,0.0027346,0.19243,0.16462,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0046564,0.1923,0.13337,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0062634,0.19192,0.15367,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.020205,0.19146,0.12267,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00016595,0.19141,0.18441,1,1
3,GO NEUTROPHIL MIGRATION,0.0017641,0.19139,0.13966,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0027346,0.19136,0.16195,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0041716,0.19128,0.12407,1,1
3,GO ENDOCRINE PROCESS,0.026586,0.19126,0.13702,1,1
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.009256,0.19106,0.23896,1,1
3,GO INFLAMMATORY RESPONSE,0.0011549,0.19092,0.15506,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0034322,0.19077,0.20239,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0094949,0.19066,0.19139,1,1
3,GO RESPONSE TO STEROL,0.0064317,0.19064,0.163,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0021689,0.19063,0.19779,1,1
3,GO B CELL ACTIVATION,0.00028792,0.19044,0.17336,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.0021689,0.19027,0.15578,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00017796,0.1901,0.20526,1,1
3,GO FATTY ACID CATABOLIC PROCESS,0.0028141,0.18974,0.15089,1,1
3,GO EATING BEHAVIOR,0.00353,0.18964,0.17069,1,1
3,GO CATECHOLAMINE UPTAKE,0.018398,0.18934,0.21523,1,1
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.031748,0.18926,0.16799,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0030654,0.18881,0.15146,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00353,0.18875,0.16609,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0024367,0.18857,0.13645,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,6.2786e-05,0.18848,0.16383,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,0.0007696,0.1883,0.1725,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.02166,0.18814,0.11903,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00047456,0.18812,0.16482,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0060989,0.18798,0.18408,1,1
3,GO MANNOSYLATION,0.00021909,0.18788,0.19447,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00017186,0.18776,0.17877,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.025994,0.18776,0.13942,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00036427,0.18737,0.20916,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.007729,0.18732,0.18924,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.1873,0.11973,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0015189,0.18712,0.15631,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.014841,0.18699,0.25659,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0022332,0.18686,0.1395,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0051916,0.18636,0.15874,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.013139,0.18606,0.12392,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0051916,0.186,0.1812,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0054795,0.18572,0.14084,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0090226,0.18504,0.13259,1,1
3,GO PLATELET ACTIVATION,0.0034322,0.18493,0.15244,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00057693,0.18485,0.15284,1,1
3,GO HUMORAL IMMUNE RESPONSE,0.00012964,0.18482,0.17617,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.033894,0.18457,0.10472,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0013457,0.18424,0.13543,1,1
3,GO REGULATION OF CELL ACTIVATION,0.0057817,0.18403,0.1248,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.018836,0.18393,0.13271,1,1
3,GO CYTOKINE SECRETION,0.00054072,0.18391,0.17693,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0028957,0.18383,0.16596,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00016595,0.18382,0.23276,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0097392,0.18363,0.12634,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00079435,0.18348,0.13919,1,1
3,GO DEVELOPMENTAL INDUCTION,0.0023671,0.18345,0.17963,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.014138,0.18343,0.16936,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0027346,0.18338,0.13138,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.043763,0.18328,0.1293,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00013433,0.18326,0.21668,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.0066042,0.18268,0.14308,1,1
3,GO ACTIN NUCLEATION,0.00030804,0.18267,0.18146,1,1
3,GO PEPTIDE SECRETION,0.00038934,0.18234,0.15511,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00069957,0.18234,0.15785,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00353,0.18228,0.18546,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.019283,0.18221,0.11811,1,1
3,GO CARBOHYDRATE TRANSPORT,0.00010845,0.18215,0.16186,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0006154,0.18195,0.18953,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00081984,0.18139,0.14924,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.01282,0.18122,0.19113,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.001872,0.18097,0.19665,1,1
3,GO LYMPHOCYTE ACTIVATION,0.0036303,0.18095,0.12205,1,1
3,GO INOSITOL METABOLIC PROCESS,0.026586,0.18089,0.15603,1,1
3,GO PIGMENTATION,0.0032441,0.18048,0.11714,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,0.00087311,0.18048,0.18935,1,1
3,GO HEART TRABECULA MORPHOGENESIS,0.041093,0.18044,0.12171,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.02166,0.17992,0.16306,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00012512,0.17981,0.20792,1,1
3,GO RETINOL METABOLIC PROCESS,0.01282,0.17961,0.15709,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0081404,0.17937,0.2095,1,1
3,GO EXOCYTOSIS,0.0013054,0.17875,0.14404,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.00090094,0.17868,0.13545,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0073363,0.17856,0.15942,1,1
3,GO SODIUM ION HOMEOSTASIS,0.0041716,0.17848,0.16933,1,1
3,GO TRANSCYTOSIS,0.023205,0.17829,0.13523,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.001986,0.17822,0.18082,1,1
3,GO MUSCLE ADAPTATION,0.0046564,0.17813,0.14524,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00353,0.17707,0.14022,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0085714,0.17705,0.14781,1,1
3,GO CELL ACTIVATION,0.0024367,0.1767,0.137,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0007696,0.17662,0.12732,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0018173,0.17641,0.15139,1,1
3,GO DEFENSE RESPONSE TO FUNGUS,0.0021062,0.17639,0.157,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.007729,0.17635,0.13969,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00014418,0.17625,0.15508,1,1
3,GO REGULATION OF PEPTIDE SECRETION,0.00014418,0.17619,0.15973,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0071468,0.17585,0.16361,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,0.00055855,0.17573,0.18041,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.0042883,0.17535,0.12638,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,0.024846,0.17459,0.14299,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0029794,0.17447,0.1646,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.017549,0.17431,0.18447,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.0085714,0.1743,0.17873,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.0040578,0.17405,0.14167,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.001191,0.17372,0.16393,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.0097392,0.17348,0.14384,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.011047,0.17337,0.13793,1,1
3,GO VESICLE TARGETING,0.023205,0.17319,0.10354,1,1
3,GO REGULATION OF CELL ADHESION,0.009256,0.17311,0.12958,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.011326,0.17308,0.15217,1,1
3,GO HORMONE TRANSPORT,0.0010528,0.17295,0.15964,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.011612,0.17289,0.10214,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.018836,0.17287,0.099371,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.015203,0.17275,0.12317,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.0024367,0.17258,0.12444,1,1
3,GO RESPONSE TO ALKALOID,0.0054795,0.17249,0.1405,1,1
3,GO REGULATION OF HEMOPOIESIS,0.0014738,0.17241,0.12536,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.011047,0.17193,0.17202,1,1
3,GO CELL CELL ADHESION,0.014138,0.17169,0.12513,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.0045306,0.17133,0.13787,1,1
3,GO RENAL SYSTEM PROCESS,0.02268,0.17117,0.11314,1,1
3,GO RESPONSE TO GONADOTROPIN,0.018398,0.17104,0.14338,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0075304,0.17102,0.12031,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.03245,0.17102,0.13144,1,1
3,GO INSULIN SECRETION,0.0024367,0.17085,0.15307,1,1
3,GO REGULATION OF PH,0.00016023,0.17051,0.13024,1,1
3,GO VACUOLE ORGANIZATION,9.7346e-05,0.1705,0.15171,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0031536,0.16985,0.15634,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0046564,0.16977,0.11531,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0079323,0.16972,0.26148,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0090226,0.16966,0.11322,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0015653,0.16956,0.13622,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.03939,0.16946,0.12453,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.024846,0.16945,0.18246,1,1
3,GO CHOLESTEROL STORAGE,0.015574,0.16938,0.17327,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00019079,0.16937,0.20672,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00026903,0.16933,0.138,1,1
3,GO RESPONSE TO FUNGUS,0.00021167,0.16914,0.17463,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.036948,0.16905,0.11352,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018398,0.16866,0.17502,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0037331,0.16856,0.13972,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00095906,0.16832,0.17651,1,1
3,GO T CELL DIFFERENTIATION,0.0013872,0.16816,0.12894,1,1
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.025414,0.16728,0.13642,1,1
3,GO REGULATION OF IMMUNE RESPONSE,0.0038387,0.16716,0.125,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0018173,0.16708,0.15457,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.040234,0.1669,0.11136,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.02068,0.16684,0.11426,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0046564,0.16677,0.18224,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0059384,0.16662,0.1804,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0013054,0.16653,0.14853,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,0.00079435,0.16637,0.17957,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,9.0551e-05,0.16609,0.15582,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.001191,0.16594,0.13332,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,0.012508,0.16574,0.21058,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0099891,0.16562,0.14705,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.0022992,0.16545,0.14845,1,1
3,GO REGULATION OF HORMONE LEVELS,0.00090094,0.16544,0.14658,1,1
3,GO VASCULAR WOUND HEALING,0.0097392,0.16522,0.30025,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0066042,0.16512,0.1754,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0045306,0.16495,0.24241,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0029794,0.16459,0.11433,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015653,0.16433,0.16798,1,1
3,GO REGULATION OF DEFENSE RESPONSE,0.00079435,0.16408,0.1468,1,1
3,GO DNA DEMETHYLATION,0.016734,0.16403,0.15393,1,1
3,GO PROTEIN PROCESSING,0.0011549,0.16338,0.15784,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.025994,0.16327,0.13637,1,1
3,GO PEPTIDE HORMONE SECRETION,0.0018173,0.16228,0.15574,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.035393,0.16208,0.14246,1,1
3,GO CELLULAR RESPONSE TO STARVATION,8.4205e-05,0.16187,0.19202,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0016129,0.16184,0.13757,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.001986,0.16143,0.15714,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.01282,0.16141,0.1314,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.0069616,0.16121,0.16313,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.02166,0.16093,0.12869,1,1
3,GO NECROTIC CELL DEATH,0.0018173,0.16082,0.21734,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0025083,0.16063,0.15267,1,1
3,GO GOLGI RIBBON FORMATION,0.029068,0.16054,0.12243,1,1
3,GO CELLULAR PIGMENTATION,0.0067808,0.16051,0.11203,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0020453,0.16043,0.15349,1,1
3,GO NEPHRON DEVELOPMENT,0.02843,0.16027,0.096836,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.001872,0.16024,0.11461,1,1
3,GO POSITIVE REGULATION OF SECRETION,0.00034072,0.1602,0.15901,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.023205,0.16019,0.12853,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0027346,0.16004,0.13433,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.02268,0.15974,0.10202,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.00067758,0.15957,0.14492,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0097392,0.15942,0.18031,1,1
3,GO GOLGI VESICLE BUDDING,0.0031536,0.1591,0.10832,1,1
3,GO WOUND HEALING,0.040234,0.1589,0.088092,1,1
3,GO GLOMERULUS DEVELOPMENT,0.015203,0.15864,0.15557,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.0010859,0.15863,0.17675,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.00041602,0.15849,0.13522,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.013139,0.1584,0.20657,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.00049035,0.15825,0.11561,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.010773,0.15817,0.13432,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0062634,0.1577,0.15034,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0038387,0.1576,0.14018,1,1
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0073363,0.15742,0.19053,1,1
3,GO PH REDUCTION,0.00054072,0.15719,0.14351,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.010245,0.15715,0.11485,1,1
3,GO RESPONSE TO BACTERIUM,0.004408,0.15678,0.12977,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0010206,0.15649,0.11397,1,1
3,GO REGULATION OF T CELL MIGRATION,0.044685,0.15637,0.15729,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0041716,0.15612,0.14413,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.043763,0.15598,0.11074,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.0039469,0.15596,0.12213,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0013457,0.15578,0.13341,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0053338,0.15574,0.13994,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.018398,0.15562,0.13906,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.019283,0.15559,0.1293,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.027188,0.1547,0.09858,1,1
3,GO REGULATION OF HORMONE SECRETION,0.0026572,0.15461,0.14358,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.00079435,0.15431,0.13214,1,1
3,GO INTERFERON BETA PRODUCTION,0.019283,0.15388,0.1336,1,1
3,GO FLUID TRANSPORT,0.020205,0.15344,0.10857,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0039469,0.15316,0.11823,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0020453,0.15287,0.13305,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0087944,0.15272,0.10763,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072223,0.15259,0.19891,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0049174,0.15241,0.13074,1,1
3,GO ORGANIC ANION TRANSPORT,0.0017641,0.15227,0.10528,1,1
3,GO REGULATION OF CELLULAR PH,6.5149e-05,0.15199,0.13675,1,1
3,GO RRNA CATABOLIC PROCESS,0.017137,0.15179,0.15172,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,6.2786e-05,0.15176,0.16927,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,1.349e-05,0.15158,0.15259,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0018173,0.15155,0.13606,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0011549,0.15155,0.16502,1,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.046579,0.15147,0.13742,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0022992,0.15128,0.11372,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0054795,0.15114,0.1267,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0013457,0.15113,0.19601,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.001191,0.15098,0.17566,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.013798,0.15093,0.11631,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0094949,0.15091,0.11431,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.019283,0.15079,0.10476,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.013139,0.15056,0.12665,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0028141,0.15029,0.12123,1,1
3,GO REGULATION OF BLOOD PRESSURE,0.0051916,0.15012,0.12446,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.043763,0.15009,0.17676,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0024367,0.14996,0.11337,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.029719,0.14993,0.12028,1,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0073363,0.14967,0.2036,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0097392,0.14963,0.1514,1,1
3,GO ADAPTIVE THERMOGENESIS,9.0551e-05,0.14949,0.17846,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.026586,0.14919,0.10418,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.020205,0.14908,0.12722,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.011047,0.14872,0.16092,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0020453,0.14847,0.13664,1,1
3,GO REGULATION OF GLUCONEOGENESIS,0.0025083,0.14846,0.13528,1,1
3,GO LIPID METABOLIC PROCESS,0.0027346,0.14843,0.11338,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025994,0.14822,0.11473,1,1
3,GO FAT CELL DIFFERENTIATION,0.0060989,0.14812,0.1488,1,1
3,GO REGULATION OF BLOOD CIRCULATION,0.038561,0.14804,0.097056,1,1
3,GO COPII COATED VESICLE BUDDING,0.0067808,0.14794,0.094581,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.019283,0.14772,0.12169,1,1
3,GO TRANSLESION SYNTHESIS,0.0083534,0.14767,0.11195,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.036948,0.1475,0.17367,1,1
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.025994,0.147,0.13598,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0027346,0.14696,0.13364,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0034322,0.14693,0.11685,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.016339,0.14693,0.12228,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.0025817,0.14543,0.11942,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.007729,0.14537,0.21171,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.038561,0.14501,0.10062,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0015653,0.14478,0.15807,1,1
3,GO GLAND DEVELOPMENT,0.0039469,0.14452,0.11203,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.046579,0.14423,0.11911,1,1
3,GO REGULATION OF CHEMOTAXIS,0.016339,0.14407,0.10524,1,1
3,GO PROTEIN AUTOPROCESSING,0.019739,0.14375,0.14384,1,1
3,GO LIPID HOMEOSTASIS,0.016734,0.14337,0.10222,1,1
3,GO CELL MATURATION,0.0016129,0.14327,0.12854,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0053338,0.14307,0.16313,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.023741,0.1429,0.15468,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.010245,0.1428,0.17282,1,1
3,GO SECRETION,0.0021689,0.14267,0.12111,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0081404,0.14266,0.15036,1,1
3,GO REGULATION OF PROTEOLYSIS,0.011904,0.1426,0.094517,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,0.0066042,0.14242,0.16235,1,1
3,GO SENSORY PERCEPTION OF SMELL,0.00065623,0.14236,0.13674,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.010245,0.1423,0.13352,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.02166,0.14195,0.15454,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0033369,0.14186,0.21437,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0085714,0.14179,0.16739,1,1
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.022165,0.14175,0.10801,1,1
3,GO DNA CATABOLIC PROCESS,0.00044439,0.1413,0.13432,1,1
3,GO ORGANELLE FUSION,0.016339,0.141,0.09906,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.044685,0.14054,0.14807,1,1
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.017137,0.14046,0.17262,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.033894,0.14031,0.097509,1,1
3,GO MANGANESE ION TRANSPORT,0.026586,0.14025,0.10047,1,1
3,GO ANDROGEN METABOLIC PROCESS,0.0069616,0.14019,0.15702,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.033894,0.13988,0.16438,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016339,0.13977,0.09951,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.010245,0.1396,0.14402,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.0047853,0.13932,0.13456,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0060989,0.13851,0.1586,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.0051916,0.13848,0.10994,1,1
3,GO CHLORIDE TRANSPORT,0.0081404,0.1384,0.11849,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.001986,0.1383,0.13067,1,1
3,GO FATTY ACID TRANSPORT,0.037747,0.13825,0.090126,1,1
3,GO CHEMICAL HOMEOSTASIS,0.0021689,0.13802,0.10877,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.035393,0.13776,0.1322,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00084609,0.13773,0.11732,1,1
3,GO RESPONSE TO STARVATION,0.00023468,0.13749,0.17478,1,1
3,GO SODIUM ION TRANSPORT,0.0083534,0.13746,0.13307,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0066042,0.13742,0.24846,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.034637,0.1373,0.12305,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.01282,0.13706,0.17764,1,1
3,GO PROTEIN DESTABILIZATION,0.0027346,0.13666,0.14258,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0010206,0.13654,0.14152,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00027832,0.13651,0.15223,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0028957,0.13638,0.1444,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.13627,0.1174,1,1
3,GO REGULATION OF SECRETION,0.0029794,0.13587,0.11897,1,1
3,GO ACTION POTENTIAL,0.023741,0.13568,0.14317,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.014138,0.13552,0.10708,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.036164,0.13551,0.10245,1,1
3,GO LYSOSOME LOCALIZATION,0.016339,0.13535,0.11945,1,1
3,GO REGULATION OF ANION TRANSPORT,0.0094949,0.13508,0.12766,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.03245,0.13452,0.093164,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0010859,0.13445,0.13596,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0036303,0.13428,0.12952,1,1
3,GO RESPONSE TO ISCHEMIA,0.014841,0.13418,0.12263,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.040234,0.13392,0.090789,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.02843,0.13374,0.13483,1,1
3,GO ANION TRANSPORT,0.0021689,0.13322,0.099835,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.0087944,0.13283,0.1085,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.041093,0.13228,0.10088,1,1
3,GO BIOMINERALIZATION,0.016339,0.13209,0.1297,1,1
3,GO RESPONSE TO FATTY ACID,0.042857,0.13185,0.11105,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.013798,0.13172,0.11086,1,1
3,GO ARACHIDONIC ACID SECRETION,0.016734,0.13154,0.13747,1,1
3,GO RESPONSE TO UV C,0.019283,0.1309,0.12306,1,1
3,GO IRON ION TRANSPORT,0.00074557,0.13076,0.11948,1,1
3,GO EPITHELIAL CELL PROLIFERATION,0.042857,0.13036,0.091064,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0079323,0.13023,0.09886,1,1
3,GO T CELL SELECTION,0.0039469,0.13011,0.11596,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.019739,0.1296,0.094801,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0060989,0.12954,0.10698,1,1
3,GO LIPID CATABOLIC PROCESS,0.0016129,0.12937,0.11896,1,1
3,GO REGULATION OF ION TRANSPORT,0.040234,0.12928,0.081858,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.03245,0.12901,0.13308,1,1
3,GO CIRCADIAN RHYTHM,0.00069957,0.12886,0.12925,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0026572,0.12882,0.12499,1,1
3,GO REGULATION OF INSULIN SECRETION,0.0060989,0.12856,0.13096,1,1
3,GO DETECTION OF STIMULUS,0.00065623,0.1285,0.1105,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.020205,0.12832,0.095021,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.011326,0.1282,0.11105,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.00081984,0.12806,0.14623,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.017549,0.12713,0.10827,1,1
3,GO RESPONSE TO DRUG,0.044685,0.12695,0.088668,1,1
3,GO ENDOSOME ORGANIZATION,0.0038387,0.12664,0.10921,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0040578,0.12656,0.13041,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.024288,0.12648,0.12908,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00353,0.12564,0.18993,1,1
3,GO ORGAN INDUCTION,0.017549,0.12559,0.1108,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0042883,0.12541,0.13972,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.046579,0.12501,0.11679,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.001872,0.12499,0.12581,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0010859,0.1249,0.11083,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0099891,0.12489,0.12942,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.035393,0.12452,0.092084,1,1
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.019283,0.12451,0.1298,1,1
3,GO PROTEIN MATURATION,0.0051916,0.12433,0.11076,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0011199,0.1243,0.1295,1,1
3,GO ACID SECRETION,0.02843,0.12428,0.12168,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0016129,0.12402,0.12153,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.02268,0.12326,0.075131,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0022332,0.1231,0.17069,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.011904,0.12302,0.081685,1,1
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02268,0.12301,0.11632,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0090226,0.12276,0.11624,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.013465,0.1224,0.095474,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0018173,0.12222,0.1038,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.02068,0.12207,0.080806,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0099891,0.12205,0.081848,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.024846,0.12148,0.075913,1,1
3,GO T CELL LINEAGE COMMITMENT,0.0033369,0.12133,0.13621,1,1
3,GO RESPONSE TO INSULIN,0.0024367,0.12099,0.1181,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.013798,0.11992,0.11318,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.012508,0.11979,0.1148,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0031536,0.11957,0.11486,1,1
3,GO METAL ION HOMEOSTASIS,0.0090226,0.11943,0.090441,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.015574,0.11878,0.1466,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0087944,0.11855,0.13284,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0097392,0.11849,0.093647,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.021165,0.11841,0.13083,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.0064317,0.11836,0.12148,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00047456,0.11805,0.14459,1,1
3,GO RESPONSE TO HORMONE,0.037747,0.11776,0.073183,1,1
3,GO ORGANIC ACID TRANSPORT,0.0069616,0.11744,0.07846,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.011612,0.11723,0.11472,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.015953,0.11686,0.14651,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.11683,0.11675,1,1
3,GO PROTEOLYSIS,0.0040578,0.11622,0.084392,1,1
3,GO BONE MINERALIZATION,0.025414,0.11604,0.12451,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.020205,0.11577,0.091807,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.017137,0.11566,0.089757,1,1
3,GO REGULATION OF TOR SIGNALING,0.00010845,0.11548,0.12976,1,1
3,GO VESICLE ORGANIZATION,0.011612,0.11539,0.099519,1,1
3,GO RESPONSE TO CHEMOKINE,0.012203,0.11498,0.10795,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.021165,0.11445,0.12906,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.022165,0.11443,0.13302,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.034637,0.11417,0.09407,1,1
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.019283,0.11391,0.10936,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.017137,0.11375,0.089579,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.010773,0.1137,0.1011,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0050528,0.11327,0.12333,1,1
3,GO REGULATION OF CELL DEATH,0.029068,0.11325,0.068066,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0023671,0.11319,0.16985,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0028957,0.11302,0.10898,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,0.00084609,0.113,0.10969,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0014299,0.11286,0.11383,1,1
3,GO HORMONE METABOLIC PROCESS,0.016339,0.1125,0.12773,1,1
3,GO SARCOMERE ORGANIZATION,0.038561,0.11241,0.10837,1,1
3,GO ION HOMEOSTASIS,0.0099891,0.11198,0.086406,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.017969,0.11198,0.098038,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029794,0.11192,0.11282,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0075304,0.11106,0.10013,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0022992,0.111,0.10381,1,1
3,GO OXIDATION REDUCTION PROCESS,0.011612,0.11095,0.091224,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.044685,0.11047,0.15011,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.033894,0.11037,0.0747,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.027188,0.10982,0.09235,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0081404,0.10951,0.094302,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.013139,0.10949,0.10718,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.02068,0.10882,0.10635,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.0047853,0.10835,0.11837,1,1
3,GO RESPONSE TO CALCIUM ION,0.012203,0.10773,0.1374,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0047853,0.10766,0.10494,1,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.033894,0.10758,0.10876,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.0030654,0.10737,0.089452,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0051916,0.10717,0.10359,1,1
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.027188,0.10714,0.14167,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.029068,0.10707,0.089309,1,1
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.033166,0.10689,0.094089,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.030383,0.10678,0.11041,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.029719,0.1055,0.09373,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0032441,0.10526,0.12142,1,1
3,GO TOR SIGNALING,0.00010092,0.10524,0.1049,1,1
3,GO APOPTOTIC PROCESS,0.017969,0.10488,0.072129,1,1
3,GO POSTREPLICATION REPAIR,0.045624,0.10488,0.066554,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.022165,0.10389,0.10184,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0032441,0.10314,0.10834,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.02843,0.10258,0.079399,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.00067758,0.10258,0.10052,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.014138,0.10204,0.088533,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.035393,0.10194,0.074841,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.025994,0.10176,0.089526,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.013798,0.10164,0.087549,1,1
3,GO LIPID MODIFICATION,0.015953,0.10136,0.087629,1,1
3,GO SIGNAL RELEASE,0.013465,0.10115,0.10877,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0062634,0.10092,0.086663,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.042857,0.10047,0.076077,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.015574,0.10019,0.089021,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.029719,0.10009,0.1195,1,1
3,GO RESPONSE TO PEPTIDE,0.036948,0.099986,0.072294,1,1
3,GO ION TRANSPORT,0.0069616,0.099772,0.093232,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.02166,0.098395,0.086818,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.043763,0.098174,0.09606,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0051916,0.098154,0.10298,1,1
3,GO INORGANIC ANION TRANSPORT,0.0097392,0.098154,0.099251,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.017137,0.09808,0.13728,1,1
3,GO POSITIVE T CELL SELECTION,0.024846,0.097813,0.088104,1,1
3,GO POLYOL CATABOLIC PROCESS,0.010773,0.096915,0.12921,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.017549,0.096242,0.083147,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.029719,0.096205,0.079861,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.0087944,0.096196,0.097742,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.038561,0.095411,0.067532,1,1
3,GO EXOCYTIC PROCESS,0.045624,0.095397,0.13131,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.045624,0.095393,0.07815,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.027188,0.095072,0.085879,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.017137,0.095011,0.074156,1,1
3,GO HOMEOSTATIC PROCESS,0.0037331,0.094988,0.084623,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.0083534,0.094754,0.083237,1,1
3,GO PEROXISOME ORGANIZATION,0.027803,0.094009,0.097731,1,1
3,GO REGULATION OF OSSIFICATION,0.021165,0.093912,0.11698,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.0085714,0.093813,0.087546,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.02166,0.092518,0.071824,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.02268,0.092377,0.073951,1,1
3,GO MYOFIBRIL ASSEMBLY,0.040234,0.091765,0.08171,1,1
3,GO PEROXISOMAL TRANSPORT,0.02268,0.091756,0.1096,1,1
3,GO SENSORY PERCEPTION,0.016734,0.091406,0.071638,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.03939,0.091116,0.059229,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0019282,0.090983,0.099709,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.022165,0.090048,0.077196,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0046564,0.087999,0.10607,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,0.0079323,0.087897,0.089652,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.019283,0.087895,0.072633,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.02068,0.087843,0.083751,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.023205,0.087732,0.071256,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.029719,0.08537,0.10052,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.036948,0.084929,0.070012,1,1
3,GO CATION TRANSPORT,0.031748,0.084517,0.076801,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.038561,0.083098,0.078379,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.030383,0.083095,0.093181,1,1
3,GO DENDRITE EXTENSION,0.025994,0.081657,0.23483,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.011047,0.081462,0.095993,1,1
3,GO ENDOSOMAL TRANSPORT,0.0083534,0.081148,0.064312,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.016339,0.080482,0.076212,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0087944,0.079578,0.11458,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.031059,0.078625,0.071065,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.031059,0.078276,0.10517,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.0053338,0.077992,0.072514,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.013465,0.077152,0.081649,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.035393,0.076427,0.077565,1,1
3,GO RHYTHMIC PROCESS,0.036948,0.07599,0.069537,1,1
3,GO CYTOSOLIC TRANSPORT,0.033166,0.075683,0.049324,1,1
3,GO REGULATION OF TRANSPORT,0.027188,0.074921,0.067796,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.026586,0.072968,0.074108,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02166,0.072573,0.075087,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.036164,0.070072,0.061013,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.027188,0.070053,0.10007,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.042857,0.069841,0.068245,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.03939,0.069758,0.06302,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.02068,0.067387,0.07375,1,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.040234,0.06736,0.087542,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.033894,0.066423,0.075795,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.030383,0.064691,0.088434,1,1
3,GO HISTONE H2B UBIQUITINATION,0.025414,0.063589,0.099915,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.025414,0.062684,0.062868,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.044685,0.055313,0.060545,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.025994,0.051496,0.058436,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.041093,0.043644,0.086016,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0015189,1.126,0.96333,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.001228,0.89772,0.78592,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00038934,0.73694,0.72536,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.02268,0.7203,0.40099,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.031748,0.61305,0.33027,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.0094949,0.57095,0.32586,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.001986,0.54832,0.43798,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.043763,0.52074,0.26033,1,0
3,GO MUCUS SECRETION,0.0034322,0.49595,0.4774,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0046564,0.48749,0.32408,1,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00034072,0.46897,0.43357,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0025083,0.45962,0.30104,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00087311,0.45237,0.35781,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0022992,0.4452,0.32508,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.0022332,0.42883,0.33389,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0050528,0.4095,0.28513,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0040578,0.38434,0.26851,1,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.024846,0.37192,0.24593,1,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.001662,0.36635,0.44907,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0029794,0.36613,0.32445,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0034322,0.36101,0.29722,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.011047,0.34264,0.45228,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0012662,0.33444,0.31937,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00092958,0.32868,0.269,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.007729,0.32274,0.20645,1,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.019739,0.31805,0.21032,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0027346,0.30965,0.21041,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.01282,0.30303,0.2099,1,0
3,GO BLOOD VESSEL REMODELING,0.0015653,0.30204,0.21791,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0069616,0.30143,0.19568,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.035393,0.29938,0.14678,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.017969,0.29817,0.2734,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.0066042,0.29738,0.27873,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0060989,0.29117,0.18593,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.02268,0.29021,0.17681,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.001662,0.28741,0.20298,1,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.010506,0.28685,0.25104,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.010773,0.28629,0.20809,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.013465,0.28559,0.25445,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0075304,0.28395,0.16727,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.001662,0.27893,0.28095,1,0
3,GO REGULATION OF MYOBLAST FUSION,0.0028957,0.27468,0.26344,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.017549,0.27405,0.20458,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0038387,0.27348,0.18916,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.011047,0.27152,0.31986,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0033369,0.27088,0.17621,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.017549,0.26675,0.14748,1,0
3,GO ZYMOGEN INHIBITION,0.0066042,0.26144,0.19285,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.019739,0.25736,0.21321,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00063551,0.25708,0.22103,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.034637,0.25634,0.25222,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.011047,0.25547,0.17105,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0010528,0.25518,0.18598,1,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.02068,0.25365,0.18213,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.015953,0.25261,0.1714,1,0
3,GO B CELL MEDIATED IMMUNITY,0.0022992,0.25193,0.1982,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.011326,0.25146,0.17226,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.018398,0.25108,0.14891,1,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.040234,0.24893,0.1413,1,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.016339,0.24674,0.25603,1,0
3,GO CERAMIDE CATABOLIC PROCESS,0.031748,0.24561,0.21433,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.0042883,0.24516,0.17429,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0026572,0.24507,0.17254,1,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.020205,0.2429,0.18815,1,0
3,GO PLATELET DEGRANULATION,0.010245,0.23782,0.15589,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0062634,0.23674,0.17418,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.029068,0.23419,0.13543,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0034322,0.23395,0.17467,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.010506,0.23281,0.18869,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.00353,0.23152,0.15509,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.00353,0.2304,0.13943,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.023205,0.22994,0.13037,1,0
3,GO ENTRY INTO HOST,0.0071468,0.22943,0.1547,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,0.0071468,0.22531,0.14341,1,0
3,GO HYALURONAN METABOLIC PROCESS,0.011326,0.22247,0.11514,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.011326,0.217,0.15282,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0056288,0.21557,0.14954,1,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.024288,0.21416,0.18544,1,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.014486,0.21373,0.16209,1,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0037331,0.20991,0.13468,1,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.014486,0.20896,0.1685,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00067758,0.20841,0.19739,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.00353,0.20823,0.22687,1,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.041967,0.2051,0.14288,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.040234,0.20415,0.19497,1,0
3,GO DETECTION OF BIOTIC STIMULUS,0.017137,0.20332,0.17467,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.023741,0.20232,0.10452,1,0
3,GO DNA DEAMINATION,0.007729,0.19978,0.31758,1,0
3,GO CD40 SIGNALING PATHWAY,0.010773,0.19852,0.12927,1,0
3,GO PLATELET AGGREGATION,0.009256,0.19792,0.16487,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.010245,0.19703,0.13322,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00024286,0.19675,0.22192,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.021165,0.19644,0.13527,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.004408,0.19635,0.14219,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0060989,0.1954,0.15196,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.024288,0.19378,0.13076,1,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.022165,0.19255,0.12505,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0059384,0.19186,0.16859,1,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.045624,0.19168,0.12576,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.041967,0.18795,0.16011,1,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0031536,0.18612,0.20492,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.042857,0.18539,0.09991,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.025994,0.18531,0.21212,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.014486,0.18471,0.14043,1,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.017137,0.18377,0.17993,1,0
3,GO RESPONSE TO THYROID HORMONE,0.03939,0.18271,0.20175,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02166,0.18199,0.09796,1,0
3,GO RESPONSE TO PROTOZOAN,0.010506,0.18178,0.15078,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.038561,0.18011,0.11463,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.004408,0.17919,0.15956,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.011047,0.17789,0.14436,1,0
3,GO MIDBODY ABSCISSION,0.0018173,0.17682,0.2072,1,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.046579,0.17522,0.11709,1,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.030383,0.17516,0.21233,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.046579,0.17276,0.086112,1,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.046579,0.17181,0.10125,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.016339,0.17176,0.21416,1,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0060989,0.17048,0.13879,1,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.015953,0.16921,0.14865,1,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.023205,0.16892,0.11496,1,0
3,GO CELL CELL RECOGNITION,0.0026572,0.16742,0.15526,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.009256,0.167,0.18428,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0081404,0.16681,0.22327,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0079323,0.16658,0.14979,1,0
3,GO VIRAL LIFE CYCLE,0.0066042,0.16559,0.12152,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.040234,0.16351,0.12653,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02843,0.16193,0.12443,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0056288,0.16138,0.12545,1,0
3,GO RESPONSE TO INTERLEUKIN 1,0.010506,0.16051,0.099124,1,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.025994,0.16016,0.1499,1,0
3,GO SPERM EGG RECOGNITION,0.015574,0.15874,0.10662,1,0
3,GO COAGULATION,0.025994,0.15815,0.09616,1,0
3,GO RESPONSE TO DSRNA,0.0056288,0.157,0.13374,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.026586,0.15694,0.097718,1,0
3,GO NIK NF KAPPAB SIGNALING,0.017137,0.15671,0.093031,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.010506,0.15624,0.15132,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.011904,0.15545,0.1193,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.03245,0.15479,0.18676,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.02268,0.15474,0.1116,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.0026572,0.15335,0.11692,1,0
3,GO INTERACTION WITH HOST,0.0099891,0.14801,0.11707,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.035393,0.14659,0.12351,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0032441,0.14406,0.11775,1,0
3,GO AMYLOID BETA CLEARANCE,0.018398,0.14169,0.13497,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.033894,0.13931,0.082097,1,0
3,GO RESPONSE TO DEXAMETHASONE,0.034637,0.13736,0.11651,1,0
3,GO AUTOPHAGOSOME MATURATION,0.017969,0.13682,0.12456,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.019739,0.13554,0.1555,1,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0024367,0.1351,0.12886,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.025994,0.13477,0.12023,1,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.015203,0.13335,0.16196,1,0
3,GO MITOPHAGY,0.011047,0.13131,0.12426,1,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.027188,0.12923,0.08372,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.037747,0.12868,0.10755,1,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.022165,0.12763,0.097532,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.037747,0.1257,0.15166,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0053338,0.12412,0.098959,1,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.011904,0.1204,0.095028,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.034637,0.12028,0.070675,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.013465,0.11904,0.10197,1,0
3,GO CYTOKINETIC PROCESS,0.033894,0.11895,0.09523,1,0
3,GO AGING,0.02068,0.1186,0.075988,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.02843,0.11654,0.091731,1,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.043763,0.11622,0.11681,1,0
3,GO DRUG METABOLIC PROCESS,0.0042883,0.11499,0.19687,1,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.036164,0.11424,0.09347,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0064317,0.11241,0.12131,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.034637,0.11218,0.11174,1,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.041967,0.11188,0.10766,1,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.042857,0.10562,0.12455,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.019283,0.1056,0.12408,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.0083534,0.10522,0.11075,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.029068,0.10322,0.11539,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.02843,0.10268,0.06611,1,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.010245,0.10102,0.098127,1,0
3,GO REGULATION OF LIPID TRANSPORT,0.019739,0.097195,0.11865,1,0
3,GO MYELOID CELL HOMEOSTASIS,0.017137,0.094071,0.10128,1,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.040234,0.093669,0.083145,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.027803,0.091521,0.12796,1,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.022165,0.090117,0.14206,1,0
3,GO GOLGI ORGANIZATION,0.0028141,0.089825,0.091628,1,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.037747,0.089146,0.070891,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,0.013798,0.08681,0.10274,1,0
3,GO VACUOLAR TRANSPORT,0.040234,0.083514,0.062771,1,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.044685,0.082941,0.049464,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0083534,0.080199,0.11039,1,0
3,GO ORGANELLE DISASSEMBLY,0.019283,0.074145,0.078823,1,0
3,GO SELECTIVE AUTOPHAGY,0.025414,0.073864,0.086784,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.044685,0.071089,0.086437,1,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.015203,0.068512,0.098545,1,0
3,GO UV DAMAGE EXCISION REPAIR,0.027188,0.06827,0.096385,1,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.046579,0.064857,0.073907,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0039469,0.058964,0.076799,1,0
3,GO REGULATION OF AUTOPHAGY,0.012508,0.056856,0.074258,1,0
3,GO PROTEIN CATABOLIC PROCESS,0.029719,0.054737,0.050035,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.030383,0.047227,0.044526,1,0
3,GO MACROAUTOPHAGY,0.023741,0.037194,0.058817,1,0
3,GO MRNA METABOLIC PROCESS,0.021165,-0.051386,-0.089504,1,0
3,GO DOUBLE STRAND BREAK REPAIR,0.026586,-0.054802,-0.070988,1,0
3,GO SNRNA TRANSCRIPTION,0.034637,-0.055214,-0.066691,1,0
3,GO MRNA PROCESSING,0.0099891,-0.064286,-0.075111,1,0
3,GO RNA LOCALIZATION,0.02068,-0.065213,-0.096429,1,0
3,GO NEURON PROJECTION GUIDANCE,0.034637,-0.065346,-0.151,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0085714,-0.065447,-0.098736,1,0
3,GO BASE EXCISION REPAIR,0.013798,-0.065763,-0.091375,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.029068,-0.068153,-0.09238,1,0
3,GO RESPONSE TO UV,0.026586,-0.068962,-0.06735,1,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.01282,-0.069037,-0.10109,1,0
3,GO RNA SPLICING,0.0050528,-0.071689,-0.083954,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.015574,-0.072831,-0.085594,1,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.046579,-0.073999,-0.062218,1,0
3,GO RNA PROCESSING,0.01282,-0.076943,-0.099031,1,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.0056288,-0.077485,-0.0698,1,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.03939,-0.077793,-0.075821,1,0
3,GO TELOMERE ORGANIZATION,0.024288,-0.081445,-0.084769,1,0
3,GO MRNA TRANSPORT,0.044685,-0.083599,-0.079764,1,0
3,GO MRNA EXPORT FROM NUCLEUS,0.013798,-0.086338,-0.089285,1,0
3,GO REGULATION OF MYELINATION,0.033166,-0.086617,-0.10239,1,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0038387,-0.090139,-0.098293,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.031748,-0.093353,-0.069805,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.023741,-0.09712,-0.18399,1,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.037747,-0.097388,-0.10669,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.013798,-0.099092,-0.11281,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.03939,-0.09993,-0.13048,1,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00055855,-0.10081,-0.1106,1,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.030383,-0.10099,-0.14212,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.01282,-0.1015,-0.13567,1,0
3,GO CELLULAR RESPONSE TO X RAY,0.010773,-0.1016,-0.18927,1,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.015953,-0.10224,-0.23058,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0011199,-0.10246,-0.11043,1,0
3,GO RNA SURVEILLANCE,0.017137,-0.10342,-0.14241,1,0
3,GO RRNA METABOLIC PROCESS,0.034637,-0.10443,-0.14899,1,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.026586,-0.10464,-0.092187,1,0
3,GO CELLULAR RESPONSE TO UV,0.0083534,-0.10502,-0.10036,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.020205,-0.10507,-0.12832,1,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0097392,-0.107,-0.15144,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0006154,-0.10715,-0.13247,1,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0054795,-0.10832,-0.11313,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.027188,-0.10899,-0.19698,1,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.030383,-0.10964,-0.12071,1,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.010773,-0.10969,-0.17954,1,0
3,GO RNA CAPPING,0.019739,-0.11028,-0.092577,1,0
3,GO REGULATION OF DNA REPAIR,0.00026003,-0.11029,-0.11549,1,0
3,GO CENTRIOLE ASSEMBLY,0.036948,-0.11121,-0.090566,1,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0027346,-0.11137,-0.10712,1,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0010528,-0.1143,-0.12279,1,0
3,GO DNA DEPENDENT DNA REPLICATION,0.0039469,-0.11434,-0.10545,1,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.024846,-0.11543,-0.1511,1,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00012964,-0.11567,-0.13634,1,0
3,GO REPLICATION FORK PROCESSING,0.0071468,-0.11627,-0.12863,1,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.019739,-0.11719,-0.093475,1,0
3,GO STRESS GRANULE ASSEMBLY,0.00353,-0.11812,-0.15744,1,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.00067758,-0.11844,-0.14903,1,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.024846,-0.11884,-0.076845,1,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.018398,-0.12024,-0.20453,1,0
3,GO SEQUESTERING OF METAL ION,0.027803,-0.12146,-0.1677,1,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.03939,-0.12312,-0.1714,1,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.038561,-0.12366,-0.18472,1,0
3,GO MITOCHONDRION DISTRIBUTION,0.0066042,-0.12402,-0.15668,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.011904,-0.12419,-0.17734,1,0
3,GO TRNA MODIFICATION,0.013139,-0.12422,-0.13343,1,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.024288,-0.12516,-0.10798,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0050528,-0.12594,-0.16879,1,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.030383,-0.12606,-0.12727,1,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.033894,-0.12649,-0.17349,1,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0045306,-0.12676,-0.13027,1,0
3,GO NEURON PROJECTION ORGANIZATION,0.031748,-0.12766,-0.15593,1,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.025994,-0.12778,-0.10727,1,0
3,GO NCRNA PROCESSING,0.019283,-0.12923,-0.14478,1,0
3,GO BONE MORPHOGENESIS,0.036164,-0.13015,-0.14746,1,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.040234,-0.13336,-0.084748,1,0
3,GO TRNA PROCESSING,0.019283,-0.13436,-0.11717,1,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.025994,-0.1361,-0.1339,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00081984,-0.13725,-0.13241,1,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.036948,-0.13739,-0.13011,1,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.017969,-0.13814,-0.22296,1,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.03245,-0.14013,-0.19618,1,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.034637,-0.14032,-0.12336,1,0
3,GO MEMBRANE DISASSEMBLY,0.010773,-0.14034,-0.17811,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0013457,-0.14036,-0.16697,1,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0071468,-0.1411,-0.083264,1,0
3,GO REGULATION OF LYASE ACTIVITY,0.010773,-0.14198,-0.14068,1,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.025994,-0.14241,-0.26697,1,0
3,GO CHROMOSOME SEPARATION,0.014841,-0.14313,-0.093027,1,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.044685,-0.14427,-0.18502,1,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.017137,-0.14451,-0.21634,1,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,7.547e-05,-0.14457,-0.13724,1,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.013139,-0.14586,-0.17925,1,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.020205,-0.1461,-0.17326,1,0
3,GO RRNA METHYLATION,0.016734,-0.14629,-0.14843,1,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.019283,-0.14636,-0.11085,1,0
3,GO PROTEIN DENEDDYLATION,0.029068,-0.14649,-0.13655,1,0
3,GO RIBOSOME BIOGENESIS,0.015953,-0.14748,-0.18023,1,0
3,GO AXON EXTENSION,0.010773,-0.14833,-0.18402,1,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0099891,-0.14857,-0.13214,1,0
3,GO TROPHOBLAST CELL MIGRATION,0.033894,-0.14919,-0.25252,1,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0015653,-0.14924,-0.16644,1,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.016734,-0.15157,-0.22519,1,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0059384,-0.15268,-0.17569,1,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0073363,-0.15349,-0.15103,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0024367,-0.15555,-0.12455,1,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0090226,-0.1572,-0.20554,1,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.017549,-0.15925,-0.15488,1,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0015189,-0.15941,-0.19005,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.03245,-0.15999,-0.12341,1,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.013798,-0.16013,-0.11634,1,0
3,GO RIBOSOME ASSEMBLY,0.019283,-0.16021,-0.23813,1,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.009256,-0.16201,-0.1398,1,0
3,GO RESPIRATORY SYSTEM PROCESS,0.0015189,-0.16521,-0.20998,1,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.01282,-0.16549,-0.16559,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0083534,-0.16589,-0.2698,1,0
3,GO DNA REPLICATION INITIATION,0.00017186,-0.16594,-0.19176,1,0
3,GO MATURATION OF 5 8S RRNA,0.035393,-0.16619,-0.16825,1,0
3,GO RRNA MODIFICATION,0.019739,-0.16652,-0.16403,1,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.013139,-0.16765,-0.19074,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.017549,-0.16833,-0.15505,1,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0062634,-0.16941,-0.19792,1,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.029068,-0.17424,-0.14258,1,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.045624,-0.17478,-0.21291,1,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.01282,-0.17624,-0.18369,1,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.036164,-0.17681,-0.2267,1,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.029068,-0.17752,-0.22881,1,0
3,GO REGULATION OF AXON GUIDANCE,0.0064317,-0.17841,-0.2022,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.036948,-0.17888,-0.14007,1,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.030383,-0.18137,-0.24178,1,0
3,GO BLASTOCYST GROWTH,0.00026003,-0.18151,-0.20497,1,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.016339,-0.18162,-0.18205,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00031859,-0.18251,-0.23412,1,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.0021689,-0.18373,-0.18981,1,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0087944,-0.18441,-0.21755,1,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.013798,-0.18507,-0.28457,1,0
3,GO MATURATION OF LSU RRNA,0.017969,-0.18655,-0.24973,1,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.013139,-0.18776,-0.17517,1,0
3,GO REGULATION OF NEURON MIGRATION,0.010773,-0.19037,-0.22334,1,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.011612,-0.19057,-0.20822,1,0
3,GO NUCLEAR PORE ORGANIZATION,0.019739,-0.19062,-0.17406,1,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0075304,-0.1918,-0.2066,1,0
3,GO MATURATION OF SSU RRNA,0.0046564,-0.19215,-0.23083,1,0
3,GO LATERAL MESODERM DEVELOPMENT,0.0036303,-0.19637,-0.31264,1,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0073363,-0.19836,-0.17708,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.2754e-05,-0.19889,-0.23461,1,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00012512,-0.19902,-0.2145,1,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0079323,-0.20172,-0.19584,1,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.017969,-0.20215,-0.20431,1,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0071468,-0.20224,-0.22323,1,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0018173,-0.20287,-0.23489,1,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00079435,-0.20358,-0.24401,1,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0032441,-0.20419,-0.20832,1,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.014486,-0.20727,-0.14457,1,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0036303,-0.20988,-0.26349,1,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.036164,-0.21089,-0.14978,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.041093,-0.21192,-0.16718,1,0
3,GO REGULATION OF HIPPO SIGNALING,0.0099891,-0.21325,-0.23842,1,0
3,GO FOREBRAIN MORPHOGENESIS,0.022165,-0.2134,-0.18933,1,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.013139,-0.21496,-0.2462,1,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00055855,-0.21603,-0.19124,1,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0040578,-0.21644,-0.2709,1,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.007729,-0.21997,-0.23059,1,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.009256,-0.22008,-0.21549,1,0
3,GO NEURAL CREST CELL MIGRATION,0.0027346,-0.2222,-0.25256,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.015203,-0.22326,-0.17251,1,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0087944,-0.22429,-0.24402,1,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0053338,-0.22545,-0.23626,1,0
3,GO HIPPO SIGNALING,0.0022332,-0.22621,-0.26437,1,0
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.02166,-0.2267,-0.19774,1,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0083534,-0.22929,-0.21069,1,0
3,GO BONE GROWTH,0.0039469,-0.22999,-0.25616,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0053338,-0.2349,-0.30492,1,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0027346,-0.23554,-0.2643,1,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0014299,-0.23624,-0.19768,1,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.0045306,-0.23776,-0.26893,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0013054,-0.23837,-0.22249,1,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.017969,-0.24037,-0.32253,1,0
3,GO VIRAL TRANSLATION,0.014841,-0.2405,-0.22944,1,0
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.015574,-0.24206,-0.22923,1,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.00014418,-0.24471,-0.24826,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0079323,-0.24635,-0.26005,1,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.045624,-0.24904,-0.21508,1,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0054795,-0.24976,-0.27401,1,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0057817,-0.25064,-0.16654,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.033166,-0.25115,-0.33697,1,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0073363,-0.2526,-0.23571,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.018836,-0.25701,-0.3023,1,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.011326,-0.25763,-0.21687,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,3.1888e-05,-0.27079,-0.235,1,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.0017641,-0.27796,-0.19255,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.025994,-0.28194,-0.26696,1,0
3,GO TELOMERASE RNA LOCALIZATION,0.00090094,-0.28312,-0.29358,1,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0041716,-0.28377,-0.24976,1,0
3,GO ADULT HEART DEVELOPMENT,0.00037661,-0.28463,-0.2859,1,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0024367,-0.28557,-0.26997,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0027346,-0.2883,-0.32802,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0056288,-0.28964,-0.26361,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.0056288,-0.29012,-0.36105,1,0
3,GO SECRETORY GRANULE LOCALIZATION,0.0079323,-0.29109,-0.26164,1,0
3,GO DENDRITIC TRANSPORT,0.0083534,-0.29128,-0.20902,1,0
3,GO UV PROTECTION,0.0073363,-0.29479,-0.25089,1,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0028957,-0.29673,-0.27971,1,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.030383,-0.3,-0.19828,1,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.009256,-0.3042,-0.23425,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.027188,-0.31273,-0.28202,1,0
3,GO GTP METABOLIC PROCESS,0.0024367,-0.31299,-0.25117,1,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.004408,-0.31329,-0.39767,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0016129,-0.32121,-0.27913,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0029794,-0.32712,-0.22585,1,0
3,GO BONE TRABECULA FORMATION,0.0032441,-0.32721,-0.43479,1,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0021062,-0.34043,-0.33546,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.038561,-0.34424,-0.33439,1,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00022676,-0.36046,-0.33231,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0021689,-0.36693,-0.30052,1,0
3,GO CORPUS CALLOSUM DEVELOPMENT,0.0033369,-0.37501,-0.3074,1,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0056288,-0.39226,-0.2601,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.025414,-0.39642,-0.3258,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.00022676,-0.42231,-0.38232,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0024367,-0.43072,-0.37968,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0066042,-0.45251,-0.49746,1,0
3,GO CARDIAC VENTRICLE FORMATION,0.00031859,-0.47059,-0.51627,1,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0075304,-0.47614,-0.35334,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,7.8282e-05,-0.53014,-0.54953,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0056288,-0.54452,-0.53433,1,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.057089,0.47979,0.24607,0,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.05161,0.37876,0.23545,0,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.093897,0.37331,0.1904,0,1
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.050569,0.35981,0.30237,0,1
3,GO MECHANOSENSORY BEHAVIOR,0.35153,0.33175,0.1441,0,1
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.10845,0.31628,0.2461,0,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.082489,0.29987,0.1537,0,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.055956,0.28354,0.23732,0,1
3,GO RESPONSE TO FORSKOLIN,0.055956,0.27933,0.21292,0,1
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.087232,0.267,0.15494,0,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.10465,0.26004,0.15005,0,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.11039,0.25769,0.1419,0,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.05161,0.25382,0.15936,0,1
3,GO FUCOSYLATION,0.047551,0.25286,0.11929,0,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,0.24976,0.1289,0,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.072231,0.24551,0.17747,0,1
3,GO RESPONSE TO AMPHETAMINE,0.15517,0.2431,0.1461,0,1
3,GO MALE MEIOSIS I,0.21256,0.24107,0.12576,0,1
3,GO PARAXIAL MESODERM DEVELOPMENT,0.17374,0.23929,0.11195,0,1
3,GO FUCOSE METABOLIC PROCESS,0.14285,0.23656,0.11287,0,1
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.055956,0.23101,0.1772,0,1
3,GO BONE CELL DEVELOPMENT,0.04854,0.22905,0.14596,0,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.14285,0.22306,0.13155,0,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.092194,0.22218,0.16526,0,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.10465,0.21932,0.18403,0,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.054842,0.21524,0.14973,0,1
3,GO REGULATION OF RECEPTOR BINDING,0.26471,0.21181,0.10638,0,1
3,GO MEMBRANE FISSION,0.10465,0.20911,0.13927,0,1
3,GO PROSTANOID METABOLIC PROCESS,0.12049,0.20556,0.12173,0,1
3,GO PANCREATIC JUICE SECRETION,0.065563,0.20496,0.13894,0,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.11636,0.20472,0.11725,0,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.068167,0.20389,0.11401,0,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.4598,0.20246,0.064467,0,1
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.10845,0.20244,0.091943,0,1
3,GO GLIAL CELL PROLIFERATION,0.11039,0.19437,0.11188,0,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.15264,0.193,0.090192,0,1
3,GO EPOXYGENASE P450 PATHWAY,0.092194,0.18974,0.18009,0,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.13355,0.1897,0.10407,0,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.05824,0.18964,0.17049,0,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.13583,0.18797,0.1066,0,1
3,GO CELLULAR RESPONSE TO KETONE,0.04854,0.18778,0.10791,0,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.1028,0.18739,0.11909,0,1
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.10654,0.18736,0.10811,0,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.19393,0.1863,0.10128,0,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.059411,0.18601,0.12596,0,1
3,GO LOCOMOTOR RHYTHM,0.12689,0.18461,0.10215,0,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.27227,0.18398,0.05572,0,1
3,GO T CELL MIGRATION,0.11434,0.18398,0.10124,0,1
3,GO RESPONSE TO MUSCLE INACTIVITY,0.10845,0.18353,0.17315,0,1
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.10096,0.18205,0.21312,0,1
3,GO MAGNESIUM ION HOMEOSTASIS,0.47588,0.18124,0.052811,0,1
3,GO REGULATION OF ACTION POTENTIAL,0.065563,0.18079,0.12989,0,1
3,GO LACTATE METABOLIC PROCESS,0.12473,0.1793,0.12426,0,1
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.073629,0.17738,0.17266,0,1
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.073629,0.17637,0.23236,0,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.48678,0.17468,0.012814,0,1
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.17653,0.17347,0.15066,0,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.055956,0.17192,0.13096,0,1
3,GO AMYLOID FIBRIL FORMATION,0.04854,0.17155,0.15978,0,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.14769,0.16994,0.12703,0,1
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.16828,0.16925,0.11596,0,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.061812,0.16812,0.13089,0,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.27999,0.16684,0.098876,0,1
3,GO MONONUCLEAR CELL MIGRATION,0.061812,0.1658,0.087649,0,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.070855,0.1653,0.11983,0,1
3,GO NEURAL NUCLEUS DEVELOPMENT,0.055956,0.16455,0.15823,0,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.047551,0.16346,0.18028,0,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.082489,0.16335,0.081657,0,1
3,GO GLIAL CELL DEVELOPMENT,0.059411,0.16215,0.10711,0,1
3,GO COPULATION,0.063042,0.16167,0.14136,0,1
3,GO INTERLEUKIN 13 PRODUCTION,0.17653,0.16144,0.13114,0,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.082489,0.16085,0.096774,0,1
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.15773,0.16005,0.16652,0,1
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.055956,0.16001,0.13381,0,1
3,GO STARTLE RESPONSE,0.25001,0.15985,0.094409,0,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.054842,0.15717,0.094364,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.35607,0.15705,0.097855,0,1
3,GO RESPONSE TO NUTRIENT,0.082489,0.15691,0.086141,0,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.055956,0.15604,0.10951,0,1
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.32938,0.15588,0.046455,0,1
3,GO MACROPHAGE CHEMOTAXIS,0.052669,0.15388,0.10082,0,1
3,GO SERTOLI CELL DIFFERENTIATION,0.065563,0.15338,0.16055,0,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.12259,0.15328,0.071839,0,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.12259,0.15303,0.08599,0,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.16828,0.15216,0.064497,0,1
3,GO REGULATION OF GTP BINDING,0.42347,0.15212,0.051788,0,1
3,GO GROOMING BEHAVIOR,0.084046,0.15162,0.15569,0,1
3,GO PIRNA METABOLIC PROCESS,0.26471,0.15089,0.04887,0,1
3,GO AMELOGENESIS,0.075049,0.14953,0.16105,0,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.073629,0.14919,0.093523,0,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.079444,0.14902,0.10228,0,1
3,GO BIOLOGICAL ADHESION,0.057089,0.14881,0.089448,0,1
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.13355,0.14833,0.097979,0,1
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.11841,0.14827,0.088903,0,1
3,GO PLATELET MORPHOGENESIS,0.054842,0.14711,0.12518,0,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.18219,0.14554,0.07995,0,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.13814,0.14546,0.10759,0,1
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.21905,0.14532,0.049481,0,1
3,GO DEVELOPMENTAL PIGMENTATION,0.065563,0.14512,0.07242,0,1
3,GO METANEPHROS DEVELOPMENT,0.14769,0.14478,0.081178,0,1
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.17374,0.14428,0.095439,0,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.075049,0.14404,0.10568,0,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.23589,0.14399,0.081441,0,1
3,GO POTASSIUM ION HOMEOSTASIS,0.072231,0.14187,0.10111,0,1
3,GO RESPONSE TO IRON ION,0.087232,0.14026,0.11071,0,1
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.047551,0.13966,0.12708,0,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.22905,0.13935,0.091882,0,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.12049,0.1388,0.068032,0,1
3,GO RESPONSE TO LIGHT INTENSITY,0.13355,0.13835,0.11174,0,1
3,GO FEMALE GENITALIA DEVELOPMENT,0.57857,0.13748,0.028575,0,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.092194,0.13727,0.088562,0,1
3,GO RESPONSE TO PROGESTERONE,0.064293,0.13711,0.093789,0,1
3,GO ER OVERLOAD RESPONSE,0.063042,0.13646,0.13365,0,1
3,GO RESPONSE TO CATECHOLAMINE,0.068167,0.13608,0.10255,0,1
3,GO MAMMARY GLAND DEVELOPMENT,0.0695,0.13595,0.079169,0,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.082489,0.13527,0.15574,0,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.054842,0.13452,0.096319,0,1
3,GO MUSCLE CELL MIGRATION,0.10465,0.13318,0.091831,0,1
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.15264,0.13222,0.11277,0,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.14769,0.13211,0.064193,0,1
3,GO AMMONIUM TRANSPORT,0.27999,0.13208,0.07827,0,1
3,GO SLEEP,0.099158,0.13069,0.093106,0,1
3,GO TISSUE MIGRATION,0.076492,0.13019,0.092726,0,1
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.42855,0.13015,0.10239,0,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.12259,0.13003,0.099598,0,1
3,GO RESPONSE TO CORTICOSTEROID,0.070855,0.12993,0.089905,0,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.12689,0.12933,0.097123,0,1
3,GO HEART PROCESS,0.064293,0.12914,0.084609,0,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.19393,0.12857,0.082768,0,1
3,GO ASTROCYTE ACTIVATION,0.37932,0.12802,0.053009,0,1
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.082489,0.12748,0.093816,0,1
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.18508,0.12723,0.062499,0,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.066855,0.12719,0.12878,0,1
3,GO CELL MATRIX ADHESION,0.064293,0.12709,0.088515,0,1
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.25001,0.12709,0.064923,0,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.085627,0.12619,0.11771,0,1
3,GO RESPONSE TO COCAINE,0.082489,0.12534,0.11587,0,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.050569,0.12415,0.11637,0,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.10845,0.12408,0.099817,0,1
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.19393,0.12343,0.047506,0,1
3,GO RESPONSE TO LIPID,0.047551,0.1231,0.081937,0,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.10096,0.12062,0.081691,0,1
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.36991,0.11986,0.053032,0,1
3,GO REGULATION OF TUBE SIZE,0.066855,0.11942,0.076475,0,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.10096,0.11916,0.080185,0,1
3,GO DETECTION OF TEMPERATURE STIMULUS,0.21256,0.11882,0.15525,0,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.05161,0.11855,0.086991,0,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.21905,0.11744,0.056121,0,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.19095,0.11722,0.080109,0,1
3,GO RESPONSE TO ETHANOL,0.11636,0.11708,0.072813,0,1
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.055956,0.11653,0.086627,0,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.39858,0.11627,0.042048,0,1
3,GO REGULATION OF CELL MATURATION,0.087232,0.11581,0.086065,0,1
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.076492,0.11578,0.073098,0,1
3,GO CELL MOTILITY,0.076492,0.11498,0.071828,0,1
3,GO OUTER DYNEIN ARM ASSEMBLY,0.14048,0.11426,0.08036,0,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.188,0.11372,0.088527,0,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.084046,0.11371,0.067991,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.18508,0.11367,0.062111,0,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.04854,0.1133,0.08459,0,1
3,GO SINGLE FERTILIZATION,0.065563,0.11304,0.063393,0,1
3,GO GLIAL CELL DIFFERENTIATION,0.17374,0.113,0.077242,0,1
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.084046,0.11273,0.06734,0,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.047551,0.11208,0.12003,0,1
3,GO STRIATED MUSCLE CONTRACTION,0.15773,0.11208,0.061878,0,1
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.066855,0.112,0.084436,0,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.061812,0.11139,0.13303,0,1
3,GO PHOTOTRANSDUCTION,0.059411,0.11097,0.05969,0,1
3,GO PROTEIN PALMITOYLATION,0.084046,0.11093,0.094162,0,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.097379,0.11033,0.10869,0,1
3,GO KERATINOCYTE MIGRATION,0.13814,0.11028,0.081755,0,1
3,GO CALCIUM ION IMPORT,0.18219,0.10984,0.061047,0,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.14285,0.1092,0.085714,0,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.097379,0.10883,0.073496,0,1
3,GO TERPENOID METABOLIC PROCESS,0.093897,0.10774,0.092072,0,1
3,GO RESPONSE TO STEROID HORMONE,0.095625,0.10767,0.068817,0,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0695,0.10727,0.07085,0,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.072231,0.10674,0.1371,0,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.8303,0.10661,-0.0083011,0,1
3,GO FEEDING BEHAVIOR,0.17934,0.10627,0.057816,0,1
3,GO MUSCLE CELL DIFFERENTIATION,0.12049,0.10549,0.062951,0,1
3,GO REGULATION OF CELL FATE COMMITMENT,0.10096,0.10529,0.085059,0,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.072231,0.10528,0.074843,0,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.1313,0.10525,0.071251,0,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.2,0.10523,0.076515,0,1
3,GO ORGANELLE INHERITANCE,0.049546,0.10494,0.075583,0,1
3,GO DETECTION OF MECHANICAL STIMULUS,0.22568,0.10408,0.068979,0,1
3,GO REGULATION OF MITOPHAGY,0.054842,0.1038,0.10624,0,1
3,GO FIBROBLAST PROLIFERATION,0.22905,0.10374,0.062058,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.3746,0.10352,0.068038,0,1
3,GO CELL JUNCTION ASSEMBLY,0.11039,0.10273,0.074612,0,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.11636,0.10266,0.077978,0,1
3,GO REGULATION OF CELL FATE SPECIFICATION,0.16828,0.10121,0.08512,0,1
3,GO RUFFLE ORGANIZATION,0.064293,0.10112,0.0958,0,1
3,GO DRUG CATABOLIC PROCESS,0.047551,0.10046,0.13488,0,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.064293,0.10028,0.068836,0,1
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.51459,0.10028,0.029136,0,1
3,GO CHROMATIN SILENCING AT TELOMERE,0.27227,0.10011,0.052874,0,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.32506,0.099643,0.038096,0,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.052669,0.0992,0.075145,0,1
3,GO ACTIN FILAMENT BASED PROCESS,0.22568,0.09918,0.039896,0,1
3,GO REGULATION OF SYSTEM PROCESS,0.090515,0.099062,0.063414,0,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.080955,0.09854,0.051793,0,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.04854,0.098428,0.074974,0,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.052669,0.098015,0.12625,0,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.049546,0.097513,0.073974,0,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.088862,0.096324,0.066975,0,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.076492,0.096314,0.069176,0,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.20937,0.096217,0.048583,0,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.095625,0.096129,0.060978,0,1
3,GO MEMBRANE ORGANIZATION,0.052669,0.09602,0.065092,0,1
3,GO RESPONSE TO KETONE,0.063042,0.095768,0.078091,0,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.063042,0.095717,0.066724,0,1
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.48678,0.095608,0.046978,0,1
3,GO DEVELOPMENTAL MATURATION,0.084046,0.09481,0.081546,0,1
3,GO REGULATION OF BONE DEVELOPMENT,0.19695,0.094741,0.068165,0,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0695,0.093837,0.12011,0,1
3,GO NEGATIVE REGULATION OF SECRETION,0.12049,0.093619,0.046294,0,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.29992,0.093291,0.037727,0,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.066855,0.092776,0.060231,0,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.059411,0.092584,0.063614,0,1
3,GO METAL ION TRANSPORT,0.047551,0.092546,0.068952,0,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.077957,0.092493,0.07844,0,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.088862,0.092292,0.12169,0,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.29184,0.092097,0.042324,0,1
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.15015,0.091627,0.043986,0,1
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.13355,0.090819,0.068206,0,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.063042,0.090726,0.066538,0,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.20621,0.09054,0.049289,0,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.2839,0.09044,0.061963,0,1
3,GO CELLULAR RESPONSE TO LIPID,0.087232,0.089922,0.06971,0,1
3,GO MEMBRANE BIOGENESIS,0.91293,0.089855,-0.022091,0,1
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.052669,0.089614,0.073057,0,1
3,GO GLIOGENESIS,0.19095,0.088875,0.068092,0,1
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.16294,0.088456,0.060504,0,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.4978,0.088369,0.026469,0,1
3,GO RESPONSE TO AMINO ACID STARVATION,0.085627,0.088366,0.088571,0,1
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.15264,0.088157,0.063151,0,1
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.26847,0.087638,0.056619,0,1
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.14048,0.087623,0.075431,0,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.05161,0.087513,0.065995,0,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.070855,0.08735,0.064722,0,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.076492,0.086564,0.064096,0,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.077957,0.086456,0.062803,0,1
3,GO THYMIC T CELL SELECTION,0.11841,0.085548,0.063005,0,1
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.063042,0.085354,0.086143,0,1
3,GO RETINOIC ACID METABOLIC PROCESS,0.52025,0.085257,0.034036,0,1
3,GO REGULATION OF EXOCYTOSIS,0.04854,0.085234,0.10081,0,1
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.12908,0.084644,0.093592,0,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.061812,0.084089,0.066292,0,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.19695,0.08403,0.070724,0,1
3,GO REGULATION OF LIPID STORAGE,0.049546,0.083835,0.11747,0,1
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.13583,0.083048,0.065836,0,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.057089,0.083042,0.067279,0,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.16559,0.082697,0.053226,0,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.11235,0.082103,0.059885,0,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.26847,0.081073,0.021568,0,1
3,GO JNK CASCADE,0.072231,0.080431,0.07296,0,1
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.52025,0.080303,0.021786,0,1
3,GO POTASSIUM ION TRANSPORT,0.0695,0.079567,0.10314,0,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.079444,0.079542,0.079044,0,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.073629,0.079295,0.057257,0,1
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.12473,0.077436,0.1163,0,1
3,GO POLYOL METABOLIC PROCESS,0.090515,0.07743,0.05961,0,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.050569,0.076975,0.069446,0,1
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.19695,0.076843,0.054956,0,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.04854,0.07666,0.065209,0,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.26098,0.076613,0.030549,0,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.068167,0.076406,0.071142,0,1
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.12689,0.076187,0.063625,0,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.085627,0.075557,0.056534,0,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.24288,0.075062,0.055817,0,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.061812,0.074844,0.077343,0,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.11636,0.074796,0.054498,0,1
3,GO EXCRETION,0.19095,0.074668,0.051348,0,1
3,GO RESPONSE TO ESTRADIOL,0.41341,0.074667,0.021003,0,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.20309,0.074622,0.050865,0,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.087232,0.074555,0.084965,0,1
3,GO STRESS FIBER ASSEMBLY,0.47049,0.074073,0.029503,0,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.05824,0.072987,0.085194,0,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.049546,0.072003,0.071573,0,1
3,GO SOMITOGENESIS,0.05824,0.071706,0.066061,0,1
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.061812,0.071664,0.057161,0,1
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.087232,0.071424,0.062753,0,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.11434,0.071373,0.050509,0,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.50896,0.070694,0.027462,0,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.070855,0.068716,0.058757,0,1
3,GO ALCOHOL CATABOLIC PROCESS,0.15015,0.068676,0.046986,0,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.188,0.068246,0.03633,0,1
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.19393,0.068222,0.040408,0,1
3,GO SENSORY PERCEPTION OF PAIN,0.15773,0.068018,0.079548,0,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.055956,0.067993,0.070305,0,1
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.26098,0.067944,0.034616,0,1
3,GO CELLULAR HOMEOSTASIS,0.054842,0.067644,0.059047,0,1
3,GO DNA MODIFICATION,0.082489,0.067586,0.046078,0,1
3,GO BEHAVIOR,0.58456,0.067145,0.021498,0,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.064293,0.067074,0.069238,0,1
3,GO REGULATION OF CELL DIFFERENTIATION,0.25729,0.066052,0.041143,0,1
3,GO FERTILIZATION,0.11636,0.06505,0.04568,0,1
3,GO DETECTION OF ABIOTIC STIMULUS,0.18508,0.064986,0.058185,0,1
3,GO RESPONSE TO CARBOHYDRATE,0.10465,0.06459,0.065005,0,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.068167,0.064298,0.056716,0,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.21579,0.06369,0.035073,0,1
3,GO RESPONSE TO ACTIVITY,0.39371,0.063571,0.03999,0,1
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.38888,0.063524,0.026234,0,1
3,GO CELLULAR EXTRAVASATION,0.93377,0.062819,-0.0058008,0,1
3,GO REGULATION OF MAPK CASCADE,0.085627,0.06273,0.069453,0,1
3,GO ENDOCYTOSIS,0.29992,0.06147,0.040683,0,1
3,GO RECEPTOR RECYCLING,0.48131,0.061313,0.023606,0,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.087232,0.060996,0.053586,0,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.23245,0.060494,0.042663,0,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.16032,0.060307,0.03731,0,1
3,GO RESPONSE TO ACID CHEMICAL,0.1313,0.059634,0.059381,0,1
3,GO GROWTH,0.56075,0.058589,0.013487,0,1
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.57857,0.057137,0.014893,0,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.052669,0.056888,0.060656,0,1
3,GO RESPONSE TO AXON INJURY,0.59059,0.056734,0.035842,0,1
3,GO REGULATION OF PROTEIN STABILITY,0.072231,0.056366,0.045502,0,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.44924,0.056272,0.020391,0,1
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.39371,0.055153,0.016772,0,1
3,GO DETECTION OF LIGHT STIMULUS,0.16559,0.054523,0.023777,0,1
3,GO REGULATION OF GROWTH,0.33373,0.054443,0.033876,0,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0695,0.054182,0.062403,0,1
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.56075,0.054104,0.012033,0,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.14285,0.053937,0.043671,0,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.25729,0.052806,0.034362,0,1
3,GO DEPHOSPHORYLATION,0.12908,0.052691,0.040858,0,1
3,GO NERVOUS SYSTEM PROCESS,0.23245,0.052266,0.038404,0,1
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.26098,0.050807,0.027792,0,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.11039,0.050659,0.050814,0,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.26098,0.050506,0.039642,0,1
3,GO NEGATIVE REGULATION OF GROWTH,0.2,0.049927,0.050249,0,1
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.44402,0.048941,0.026585,0,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.04854,0.048259,0.054324,0,1
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.30402,0.046075,0.031619,0,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.22905,0.045955,0.04195,0,1
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.87833,0.043429,-0.014355,0,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.2839,0.038318,0.08988,0,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00072223,0.52061,0.49787,0,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.0031536,0.4907,0.34681,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.14526,0.48614,0.53701,0,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0066042,0.48409,0.39519,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.10845,0.47836,0.22345,0,0
3,GO PROGESTERONE METABOLIC PROCESS,0.0025817,0.45028,0.47131,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.018398,0.4085,0.34674,0,0
3,GO RESPONSE TO PAIN,7.8282e-05,0.39009,0.35463,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.041967,0.3881,0.30053,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0037331,0.38732,0.37265,0,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.26098,0.38694,0.11317,0,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.04854,0.3733,0.2505,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.023741,0.36881,0.31217,0,0
3,GO REFLEX,0.0042883,0.36687,0.37405,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00010462,0.36225,0.44274,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0014299,0.35301,0.33829,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0038387,0.35168,0.38467,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.011047,0.34999,0.29143,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.044685,0.33513,0.20683,0,0
3,GO LIPID DIGESTION,0.001228,0.33396,0.35036,0,0
3,GO RESPONSE TO LITHIUM ION,0.00017186,0.33286,0.39088,0,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.016339,0.3237,0.26345,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0047853,0.31325,0.30777,0,0
3,GO DETECTION OF CALCIUM ION,0.00084609,0.31038,0.3791,0,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.03939,0.30577,0.25317,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.034637,0.30147,0.19566,0,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.021165,0.3005,0.29142,0,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32506,0.30044,0.13111,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.23245,0.30017,0.15098,0,0
3,GO RESPONSE TO HISTAMINE,0.066855,0.29616,0.31804,0,0
3,GO N GLYCAN PROCESSING,0.0056288,0.29398,0.29531,0,0
3,GO T CELL EXTRAVASATION,0.15015,0.29365,0.11056,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.029068,0.28513,0.2443,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.11841,0.28087,0.18329,0,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.00095906,0.27727,0.33826,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0057817,0.27482,0.26007,0,0
3,GO SEGMENT SPECIFICATION,0.0695,0.27427,0.19007,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.022165,0.26853,0.1935,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.057089,0.26289,0.12538,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.017969,0.2624,0.27244,0,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.053746,0.26184,0.22675,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.055956,0.26151,0.17015,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.024846,0.25864,0.19323,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.029068,0.25803,0.31134,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.080955,0.2578,0.14249,0,0
3,GO NEURON CELL CELL ADHESION,0.34256,0.25734,0.15246,0,0
3,GO VITAMIN CATABOLIC PROCESS,0.05161,0.25246,0.1763,0,0
3,GO MICROVILLUS ORGANIZATION,0.0039469,0.24906,0.29913,0,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.025994,0.24868,0.20066,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.0085714,0.24839,0.23965,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.34702,0.24774,0.082563,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.010773,0.2472,0.20308,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.023741,0.24587,0.22794,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.12259,0.2455,0.17087,0,0
3,GO SPINAL CORD PATTERNING,0.16294,0.24394,0.151,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.079444,0.24392,0.15503,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.02068,0.24205,0.13604,0,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.030383,0.24138,0.2035,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.014486,0.23981,0.23433,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.025414,0.23923,0.25173,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.12259,0.23862,0.36498,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.10465,0.23855,0.14322,0,0
3,GO MALE SEX DETERMINATION,0.033166,0.23839,0.19644,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.055956,0.23831,0.15121,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.055956,0.23751,0.15448,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.16559,0.23707,0.19588,0,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.031059,0.23566,0.17152,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.15773,0.23443,0.24985,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.24643,0.23347,0.086726,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.027188,0.23281,0.28306,0,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.0013872,0.23172,0.26222,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.13814,0.22926,0.11535,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.007729,0.2292,0.26865,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.070855,0.22818,0.16865,0,0
3,GO DIOL METABOLIC PROCESS,0.00090094,0.2272,0.23317,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.064293,0.22658,0.14553,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.060602,0.22435,0.1379,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.070855,0.2237,0.24956,0,0
3,GO BLEB ASSEMBLY,0.23589,0.22127,0.071498,0,0
3,GO DIET INDUCED THERMOGENESIS,0.0019282,0.22042,0.23803,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.019739,0.22024,0.1925,0,0
3,GO GLYCINE TRANSPORT,0.34256,0.21997,0.11274,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0022332,0.21928,0.22394,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.085627,0.2188,0.18856,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.10096,0.21879,0.17803,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.22905,0.21862,0.10503,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.014841,0.21783,0.23054,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.013798,0.21627,0.2736,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.099158,0.21595,0.1782,0,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.050569,0.21527,0.10098,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.025994,0.21425,0.17501,0,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.12259,0.21256,0.13959,0,0
3,GO REGULATION OF SYNAPSE MATURATION,0.24643,0.21245,0.11965,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.05824,0.21193,0.14823,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.082489,0.2119,0.13348,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.027188,0.21174,0.23378,0,0
3,GO STEROID ESTERIFICATION,0.007729,0.21157,0.23105,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.068167,0.21145,0.17126,0,0
3,GO PRO B CELL DIFFERENTIATION,0.023741,0.2113,0.19465,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.036164,0.20986,0.21515,0,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0075304,0.20971,0.172,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0031536,0.20922,0.19602,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.25363,0.2092,0.075903,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.32077,0.20892,-0.0017841,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.054842,0.20833,0.15343,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.05824,0.20829,0.1522,0,0
3,GO PLASMINOGEN ACTIVATION,0.080955,0.20738,0.12611,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.20657,-0.028087,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.047551,0.20651,0.14132,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0011549,0.2055,0.20845,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0017641,0.2049,0.26477,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.097379,0.20486,0.14143,0,0
3,GO HORMONE CATABOLIC PROCESS,0.10465,0.2042,0.099388,0,0
3,GO DENDRITIC CELL MIGRATION,0.10845,0.20334,0.10615,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.017969,0.20283,0.18185,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.055956,0.2023,0.11482,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.027188,0.20201,0.14415,0,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.12908,0.20185,0.19066,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.060602,0.20122,0.18955,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.068167,0.20117,0.21446,0,0
3,GO MICROVILLUS ASSEMBLY,0.040234,0.20082,0.21209,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.011326,0.20021,0.22005,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.0054795,0.2,0.18481,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.17099,0.19947,0.070645,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.51459,0.1988,0.097522,0,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.072231,0.19683,0.26725,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0047853,0.19559,0.17457,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.15264,0.19441,0.10607,0,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.25729,0.19332,0.10363,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.29992,0.19243,0.14873,0,0
3,GO GAP JUNCTION ASSEMBLY,0.055956,0.19189,0.16207,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.068167,0.19111,0.14937,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.12473,0.19105,0.12945,0,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.036948,0.19014,0.15853,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.44402,0.19007,0.061407,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.33812,0.18965,0.071564,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.26847,0.18868,0.066228,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.59059,0.18863,0.053674,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.1028,0.18743,0.1157,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.018836,0.18602,0.14575,0,0
3,GO REGULATION OF WOUND HEALING,0.0067808,0.18585,0.18559,0,0
3,GO PODOSOME ASSEMBLY,0.31232,0.18555,0.053526,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.20309,0.18555,0.10023,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,0.18553,0.11396,0,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.057089,0.18536,0.093284,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.088862,0.18486,0.11715,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.24643,0.18479,0.08308,0,0
3,GO RESPONSE TO CADMIUM ION,0.020205,0.18468,0.2043,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.25729,0.18453,0.10965,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.26847,0.1843,0.10954,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.14048,0.18408,0.1835,0,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.072231,0.18401,0.12686,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.4978,0.18395,0.070173,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.093897,0.18263,0.11914,0,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.075049,0.18244,0.12037,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.024846,0.18147,0.17896,0,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.088862,0.18112,0.23994,0,0
3,GO FAT CELL PROLIFERATION,0.19695,0.18072,0.13361,0,0
3,GO STEROID HORMONE SECRETION,0.085627,0.18035,0.14462,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.17934,0.17881,0.11553,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.068167,0.17835,0.12606,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.061812,0.17828,0.12291,0,0
3,GO CAMP METABOLIC PROCESS,0.16032,0.17805,0.087194,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.43367,0.17776,0.094066,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0067808,0.17738,0.14334,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.019283,0.17731,0.35143,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.085627,0.17661,0.074389,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.018398,0.17661,0.14023,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.018836,0.17588,0.18788,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0041716,0.17436,0.17102,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.02068,0.17388,0.15138,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.188,0.17333,0.12722,0,0
3,GO PANCREAS DEVELOPMENT,0.035393,0.17308,0.12439,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.57857,0.17253,0.037916,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0083534,0.1725,0.16809,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.011326,0.17226,0.20223,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.064293,0.17224,0.12285,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.060602,0.17213,0.32015,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.025414,0.17198,0.22941,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.033894,0.17159,0.15524,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.56075,0.17148,-0.014904,0,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.25729,0.17096,0.066931,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.076492,0.17052,0.16528,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.12259,0.17017,0.14633,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.043763,0.1698,0.21056,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,0.16957,0.22324,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.031059,0.16884,0.16502,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.082489,0.16874,0.10721,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0083534,0.16706,0.12214,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.22905,0.16686,0.12221,0,0
3,GO GAMMA DELTA T CELL ACTIVATION,0.016339,0.16633,0.23194,0,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.097379,0.16618,0.20536,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.188,0.16558,0.12264,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.15773,0.16498,0.055739,0,0
3,GO AORTA MORPHOGENESIS,0.095625,0.16453,0.090676,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.037747,0.16427,0.13616,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.092194,0.16423,0.20808,0,0
3,GO PROTEIN HYDROXYLATION,0.22568,0.16362,0.09971,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.98953,0.16318,-0.010564,0,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.0022332,0.16305,0.20331,0,0
3,GO PLACENTA DEVELOPMENT,0.16828,0.16224,0.076876,0,0
3,GO SEX DETERMINATION,0.0097392,0.16191,0.16355,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.24643,0.16154,0.28973,0,0
3,GO RETINA LAYER FORMATION,0.10096,0.16102,0.21654,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.070855,0.1608,0.08273,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.25001,0.16073,0.044641,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.097379,0.16056,0.12454,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.00098941,0.16047,0.17069,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.05824,0.16023,0.11658,0,0
3,GO T CELL CYTOKINE PRODUCTION,0.050569,0.15991,0.11669,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.10096,0.15979,0.072006,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.1028,0.15972,0.11303,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.042857,0.15924,0.12522,0,0
3,GO SYNAPSE MATURATION,0.50896,0.15837,0.10797,0,0
3,GO REGULATION OF HEART RATE,0.024288,0.15793,0.14936,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.11636,0.1575,0.077975,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0032441,0.15672,0.22708,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.21579,0.1567,0.14738,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.23589,0.15611,0.11966,0,0
3,GO NEURON FATE SPECIFICATION,0.40349,0.15609,0.16515,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.065563,0.15605,0.12208,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.28785,0.15568,0.095368,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.068167,0.15559,0.13069,0,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.05161,0.15555,0.181,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.41341,0.15554,0.14082,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.17374,0.15452,0.12723,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.16828,0.15342,0.12301,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.11841,0.15334,0.13425,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.04854,0.15332,0.10017,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.072231,0.15309,0.11233,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.03939,0.15281,0.16449,0,0
3,GO GLAND MORPHOGENESIS,0.099158,0.15234,0.087622,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.023205,0.15224,0.16227,0,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.097379,0.15201,0.10458,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.16828,0.15194,0.14659,0,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.19695,0.15138,0.11988,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.013465,0.15133,0.12826,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.22235,0.15131,0.04217,0,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.15015,0.1512,0.044555,0,0
3,GO KERATINOCYTE PROLIFERATION,0.044685,0.15094,0.13782,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.15517,0.15053,0.084706,0,0
3,GO CELL FATE DETERMINATION,0.11636,0.14999,0.1202,0,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,0.1497,0.14156,0,0
3,GO RESPONSE TO METAL ION,0.00037661,0.14959,0.16648,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.2,0.14956,0.056391,0,0
3,GO HETEROTYPIC CELL CELL ADHESION,0.029719,0.14955,0.14442,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.19695,0.14912,0.069894,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.04854,0.14909,0.17885,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.05161,0.14895,0.088658,0,0
3,GO NOSE DEVELOPMENT,0.14769,0.1488,0.26296,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.023205,0.14879,0.17719,0,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.0026572,0.14872,0.12446,0,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.073629,0.14871,0.12157,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.40349,0.14843,0.092536,0,0
3,GO AXONEME ASSEMBLY,0.046579,0.14829,0.13384,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.052669,0.14787,0.11083,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.025414,0.14759,0.12435,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.015203,0.14757,0.11257,0,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.11841,0.14714,0.093182,0,0
3,GO INCLUSION BODY ASSEMBLY,0.29586,0.14701,0.08003,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.14526,0.14682,0.093152,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.19095,0.1468,0.10324,0,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.40349,0.14674,0.037309,0,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.019283,0.14658,0.23069,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.33373,0.14594,0.046474,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.56666,0.14563,0.039701,0,0
3,GO RESPONSE TO UV B,0.38408,0.14556,0.065954,0,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.10096,0.14524,0.17767,0,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.061812,0.1452,0.24977,0,0
3,GO ZINC ION HOMEOSTASIS,0.075049,0.14509,0.22715,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.013798,0.1449,0.11832,0,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.71658,0.14488,0.015513,0,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.49227,0.14484,0.076061,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.14048,0.14459,0.092022,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.13355,0.14456,0.17875,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.088862,0.14399,0.17058,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.23245,0.14341,0.035523,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.26471,0.14325,0.016541,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0094949,0.14268,0.18355,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.047551,0.14249,0.15558,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.070855,0.14234,0.1032,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.11434,0.14232,0.089491,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.077957,0.14209,0.28216,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.013139,0.14208,0.12435,0,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.010773,0.14165,0.16118,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0042883,0.14145,0.15397,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.042857,0.14074,0.14124,0,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.026586,0.14037,0.10277,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.017549,0.14034,0.10061,0,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.11039,0.13984,0.099779,0,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.16032,0.13984,0.078989,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.20309,0.13981,0.10005,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.10465,0.13954,0.12968,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.44924,0.13849,0.078863,0,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.04854,0.13841,0.10139,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.39371,0.13771,0.080095,0,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.080955,0.13712,0.09611,0,0
3,GO RESPONSE TO LEPTIN,0.016734,0.13698,0.13573,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.16032,0.13661,0.1282,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0094949,0.13649,0.21107,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.19695,0.13646,0.079458,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.20309,0.13611,0.074981,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.23589,0.13591,0.08527,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.28785,0.13576,0.1568,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.04854,0.13566,0.087614,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.30402,0.13547,0.033913,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.079444,0.13541,0.15547,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.13583,0.13541,0.10608,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.085627,0.13506,0.076444,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.009256,0.13498,0.13899,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.11434,0.13491,0.15814,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.31653,0.13484,0.031698,0,0
3,GO SEROTONIN SECRETION,0.23589,0.13482,0.11289,0,0
3,GO RESPONSE TO AMINE,0.43883,0.13442,0.048536,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.15015,0.13438,0.18226,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.17374,0.13434,0.19964,0,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.29184,0.1343,0.053618,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.23245,0.13419,0.099857,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.024288,0.13411,0.12162,0,0
3,GO RIG I SIGNALING PATHWAY,0.11235,0.13388,0.069255,0,0
3,GO MYELIN ASSEMBLY,0.087232,0.13386,0.15329,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.10465,0.13354,0.077579,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.10465,0.13304,0.08852,0,0
3,GO MYELIN MAINTENANCE,0.12908,0.1327,0.15455,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.15264,0.13247,0.15678,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.11235,0.13235,0.088362,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.16294,0.13224,0.1141,0,0
3,GO RESPONSE TO ACIDIC PH,0.084046,0.13217,0.14343,0,0
3,GO REPLICATIVE SENESCENCE,0.14526,0.13203,0.0901,0,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.053746,0.13181,0.10067,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.10096,0.13174,0.1791,0,0
3,GO PROTEIN KINASE B SIGNALING,0.063042,0.13162,0.081167,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12908,0.13159,0.13634,0,0
3,GO ANIMAL ORGAN REGENERATION,0.055956,0.13141,0.082813,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.099158,0.13121,0.1183,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.04854,0.13064,0.15889,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.27227,0.13052,0.072275,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.052669,0.13051,0.11361,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.21579,0.13048,0.087251,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.27611,0.13041,0.1225,0,0
3,GO PHAGOSOME MATURATION,0.0028141,0.13032,0.14216,0,0
3,GO CELL REDOX HOMEOSTASIS,0.084046,0.13024,0.089447,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.19393,0.13009,0.1313,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0075304,0.12962,0.12398,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12689,0.1295,0.064286,0,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.10845,0.12948,0.099524,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.13583,0.12947,0.084662,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.38888,0.12936,0.12595,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0075304,0.12909,0.1576,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.10465,0.12887,0.12763,0,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.21256,0.1288,0.099031,0,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.27999,0.12844,0.077131,0,0
3,GO RESPONSE TO WOUNDING,0.065563,0.1282,0.083469,0,0
3,GO VAGINA DEVELOPMENT,0.51459,0.12791,0.012892,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.65234,0.12778,0.0072785,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.11841,0.12715,0.13597,0,0
3,GO MESONEPHROS DEVELOPMENT,0.015574,0.12705,0.12684,0,0
3,GO EAR DEVELOPMENT,0.043763,0.12704,0.085097,0,0
3,GO NOTCH RECEPTOR PROCESSING,0.090515,0.12677,0.26757,0,0
3,GO AMINE TRANSPORT,0.029068,0.1267,0.20265,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.68418,0.12664,-0.011209,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.4545,0.1266,0.078504,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.16032,0.12657,0.093092,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.052669,0.12623,0.14401,0,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.060602,0.12619,0.10865,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.10465,0.12602,0.058651,0,0
3,GO RESPONSE TO HYPEROXIA,0.89215,0.12598,-0.028693,0,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.047551,0.1258,0.08705,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.11841,0.12576,0.099161,0,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.18508,0.12509,0.051368,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.20937,0.12495,0.055087,0,0
3,GO SENSORY PERCEPTION OF TASTE,0.0069616,0.12491,0.13382,0,0
3,GO LIPID IMPORT INTO CELL,0.23589,0.12479,0.092635,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.22235,0.12434,0.074838,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.043763,0.12391,0.1066,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.22905,0.12374,0.056078,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.11235,0.12368,0.114,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.050569,0.12357,0.12365,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.037747,0.12337,0.10793,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0045306,0.12272,0.13522,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.11841,0.1227,0.094147,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.090515,0.12269,0.10127,0,0
3,GO EPITHELIAL CELL CELL ADHESION,0.15264,0.12249,0.15132,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.057089,0.12242,0.081669,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.24288,0.12242,0.1451,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.21579,0.12236,0.070783,0,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.097379,0.12224,0.17301,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.26847,0.12221,0.019967,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.066855,0.12212,0.11364,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.38888,0.1221,0.058445,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.0099891,0.12195,0.12821,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.29586,0.12179,0.073212,0,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.1028,0.12172,0.11089,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.080955,0.12159,0.092723,0,0
3,GO MACROPHAGE MIGRATION,0.11039,0.12147,0.068803,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.17934,0.12142,0.16125,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.10845,0.12132,0.076177,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.054842,0.1213,0.11744,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.66501,0.1212,0.022596,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.073629,0.1211,0.15394,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.67776,0.12094,0.046736,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.0097392,0.12086,0.1746,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.030383,0.12081,0.15884,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.4545,0.12067,0.037107,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.057089,0.12056,0.16181,0,0
3,GO MONOAMINE TRANSPORT,0.03245,0.12046,0.21227,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.016734,0.12036,0.096585,0,0
3,GO MEMBRANE REPOLARIZATION,0.064293,0.11979,0.12192,0,0
3,GO GLUCOSE METABOLIC PROCESS,0.00054072,0.11974,0.13958,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.29184,0.11967,0.044247,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.031748,0.11946,0.15553,0,0
3,GO HEPATOCYTE DIFFERENTIATION,0.12689,0.11939,0.13,0,0
3,GO COPPER ION HOMEOSTASIS,0.095625,0.11937,0.11221,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.072231,0.11933,0.27089,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.055956,0.11922,0.05178,0,0
3,GO T CELL APOPTOTIC PROCESS,0.085627,0.11907,0.095021,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.33373,0.119,0.075061,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.20621,0.11877,0.066778,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.4978,0.11876,0.063663,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.19095,0.11868,0.051441,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.4978,0.11862,0.042857,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.65234,0.11852,0.034173,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.30402,0.11788,0.099508,0,0
3,GO FIBROBLAST ACTIVATION,0.42855,0.11788,0.040909,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.072231,0.11785,0.10009,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.41341,0.1175,0.064706,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.26847,0.11737,0.089933,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.054842,0.11731,0.082041,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.22568,0.11727,0.11422,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.042857,0.11724,0.23894,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.030383,0.11702,0.10491,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.14048,0.11672,0.06057,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.02166,0.11653,0.11527,0,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.059411,0.11625,0.091654,0,0
3,GO NADP METABOLIC PROCESS,0.12049,0.11609,0.10727,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.059411,0.11584,0.1022,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.20309,0.11564,0.080754,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.26471,0.11537,0.1352,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.27227,0.11531,0.071203,0,0
3,GO CHOLESTEROL EFFLUX,0.072231,0.11464,0.076215,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.32077,0.11407,0.04544,0,0
3,GO MITOTIC DNA REPLICATION,0.10845,0.11399,0.095945,0,0
3,GO PROTEIN LOCALIZATION TO AXON,0.16294,0.11372,0.21046,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.040234,0.11371,0.13944,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0057817,0.11353,0.20899,0,0
3,GO LIPID OXIDATION,0.023741,0.11353,0.10568,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.018836,0.11332,0.093128,0,0
3,GO VASCULAR TRANSPORT,0.37932,0.11314,0.056631,0,0
3,GO MACROPHAGE ACTIVATION,0.030383,0.11293,0.10623,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.12473,0.11292,0.093584,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.38408,0.11285,0.022195,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.36064,0.11275,0.076897,0,0
3,GO DRINKING BEHAVIOR,0.67776,0.1127,0.063747,0,0
3,GO CYTOLYSIS,0.14285,0.11233,0.083613,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.050569,0.11227,0.12598,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.057089,0.11218,0.099521,0,0
3,GO LEFT RIGHT PATTERN FORMATION,0.41842,0.11216,0.051575,0,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.0056288,0.11216,0.10773,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.31653,0.11199,0.074595,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.063042,0.11187,0.094298,0,0
3,GO INNERVATION,0.16828,0.11159,0.18551,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.21256,0.1115,0.12836,0,0
3,GO OOCYTE DIFFERENTIATION,0.023205,0.11106,0.10692,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.054842,0.1109,0.13138,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.22235,0.11089,0.071998,0,0
3,GO RESPONSE TO PH,0.049546,0.11079,0.10601,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.11636,0.11075,0.1041,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00057693,0.11068,0.17946,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.073629,0.11043,0.082268,0,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.1028,0.11041,0.089638,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.18219,0.1104,0.069727,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.035393,0.11019,0.10734,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.23245,0.11017,0.12355,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.079444,0.11002,0.057024,0,0
3,GO EPITHELIAL CELL MATURATION,0.10845,0.1099,0.15805,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.48678,0.10976,0.022909,0,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.25363,0.10963,0.13543,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.13814,0.10957,0.18509,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.27611,0.10929,0.070576,0,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.41341,0.10914,0.022328,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.95466,0.10863,-0.030897,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.21256,0.10847,0.066679,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.22235,0.10838,0.081557,0,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.093897,0.10815,0.071811,0,0
3,GO GASTRIC ACID SECRETION,0.22235,0.10811,0.094632,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.16559,0.1081,0.096435,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.89907,0.10799,-0.022151,0,0
3,GO SHORT TERM MEMORY,0.56666,0.10794,0.037345,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.055956,0.10788,0.11463,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.25729,0.10776,0.049553,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.061812,0.10772,0.12686,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.15015,0.10751,0.057687,0,0
3,GO LUNG MORPHOGENESIS,0.2839,0.10751,0.044876,0,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.087232,0.10743,0.073627,0,0
3,GO LOCOMOTORY BEHAVIOR,0.2,0.10727,0.081694,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.15517,0.10724,0.098657,0,0
3,GO NUCLEOTIDE SALVAGE,0.35153,0.10699,0.067619,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.14285,0.10672,0.054013,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.29184,0.10668,0.070661,0,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.13583,0.10631,0.15603,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.015203,0.10627,0.14421,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.033894,0.10622,0.098756,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.090515,0.10597,0.07531,0,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.02268,0.10597,0.090604,0,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.03939,0.10579,0.090183,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.035393,0.10574,0.15005,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.23245,0.10572,0.092573,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.17934,0.10553,0.186,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.085627,0.10546,0.06608,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.1028,0.10523,0.19221,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.17653,0.10481,0.040815,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.54903,0.10446,0.053299,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.16559,0.10439,0.065789,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.037747,0.10407,0.10448,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.080955,0.10396,0.22737,0,0
3,GO HEART FIELD SPECIFICATION,0.4545,0.10388,0.074505,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.27999,0.10377,0.058112,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.42347,0.1036,0.081629,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.057089,0.10329,0.098392,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.20621,0.10286,0.088317,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.0075304,0.10275,0.15338,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.084046,0.10275,0.089303,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.059411,0.10264,0.06914,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.055956,0.1026,0.092255,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.73628,0.10254,-0.01154,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.65866,0.10254,0.016249,0,0
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.30402,0.1025,0.063123,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.038561,0.10236,0.08694,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.16032,0.10226,0.10302,0,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.015574,0.10222,0.086667,0,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.035393,0.10201,0.17176,0,0
3,GO SYMBIOTIC PROCESS,0.05824,0.10191,0.058268,0,0
3,GO INNER EAR MORPHOGENESIS,0.33812,0.10189,0.043657,0,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.085627,0.10177,0.068161,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.080955,0.10175,0.12219,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.082489,0.10165,0.076788,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.19393,0.1015,0.13071,0,0
3,GO RESPONSE TO INSECTICIDE,0.03939,0.10121,0.19588,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.36991,0.10113,0.15996,0,0
3,GO T CELL HOMEOSTASIS,0.084046,0.10097,0.077586,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.046579,0.1009,0.090672,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.32077,0.10088,0.078518,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.60272,0.10077,0.059013,0,0
3,GO REGULATION OF GLIOGENESIS,0.05161,0.10057,0.1061,0,0
3,GO ACTIN FILAMENT ORGANIZATION,0.11636,0.10052,0.056064,0,0
3,GO OXALATE TRANSPORT,0.035393,0.10048,0.12426,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.9686,0.10043,-0.037089,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.90599,0.1004,-0.024925,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.15015,0.10038,0.04655,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.35153,0.10033,0.10583,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.15264,0.10033,0.090673,0,0
3,GO RESPONSE TO INACTIVITY,0.046579,0.10032,0.17582,0,0
3,GO INTERLEUKIN 4 PRODUCTION,0.11636,0.10025,0.13413,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.03939,0.099361,0.10193,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.18219,0.099288,0.064408,0,0
3,GO SPLEEN DEVELOPMENT,0.050569,0.099247,0.11103,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.33812,0.09888,0.04933,0,0
3,GO GLIAL CELL MIGRATION,0.31653,0.098874,0.031218,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.48678,0.098572,0.036766,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.188,0.098502,0.077185,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78289,0.098181,-0.063766,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.15015,0.097764,0.07188,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.42347,0.097538,0.044938,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.10096,0.097445,0.095328,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.21256,0.097356,0.070965,0,0
3,GO ENAMEL MINERALIZATION,0.48678,0.097342,0.067663,0,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.014138,0.09733,0.1018,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.20309,0.097324,0.075347,0,0
3,GO GROWTH HORMONE SECRETION,0.095625,0.097284,0.17089,0,0
3,GO PHAGOCYTOSIS,0.05824,0.097276,0.08371,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.05824,0.097183,0.10976,0,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.14769,0.096573,0.11127,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.093897,0.096512,0.08921,0,0
3,GO RNA INTERFERENCE,0.54321,0.096453,0.028663,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.0071468,0.096051,0.14509,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.33373,0.09604,0.050879,0,0
3,GO FATTY ACID BETA OXIDATION,0.14526,0.095999,0.056141,0,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.14526,0.095778,0.14853,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.4598,0.095768,0.012238,0,0
3,GO REGIONALIZATION,0.11841,0.095714,0.067003,0,0
3,GO XENOBIOTIC TRANSPORT,0.11039,0.095679,0.059801,0,0
3,GO SPERM CAPACITATION,0.087232,0.095657,0.083993,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.2839,0.095604,0.089031,0,0
3,GO RESPONSE TO TESTOSTERONE,0.23245,0.095523,0.070833,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.12473,0.095283,0.079055,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.055956,0.095281,0.12628,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.19695,0.095191,0.037072,0,0
3,GO NUCLEOSIDE SALVAGE,0.57857,0.095137,0.011384,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.13814,0.094453,0.055668,0,0
3,GO MOLTING CYCLE,0.063042,0.094385,0.069752,0,0
3,GO REGULATION OF VESICLE FUSION,0.2839,0.094335,0.10828,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.59664,0.094332,0.03544,0,0
3,GO VASCULOGENESIS,0.85768,0.094292,-0.014155,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.035393,0.094272,0.072816,0,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.050569,0.094246,0.098536,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.71658,0.094082,0.012631,0,0
3,GO EAR MORPHOGENESIS,0.29586,0.093983,0.033268,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.019283,0.093841,0.14996,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.21256,0.093793,0.058752,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.042857,0.093587,0.14573,0,0
3,GO THYMUS DEVELOPMENT,0.26471,0.093529,0.054505,0,0
3,GO CELL AGGREGATION,0.70355,0.093359,0.0044328,0,0
3,GO MUSCLE CELL PROLIFERATION,0.29586,0.092999,0.029919,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.27611,0.092752,0.099742,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.11434,0.09268,0.040942,0,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.26471,0.092656,0.068956,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.092602,-0.0088947,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.20309,0.09243,0.064716,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.52025,0.092424,0.047677,0,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.10096,0.092326,0.049621,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.011904,0.092108,0.11064,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.40349,0.091895,0.078131,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.18219,0.091744,0.063281,0,0
3,GO DNA DEALKYLATION,0.049546,0.091729,0.11033,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.27999,0.09165,0.12168,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.49227,0.091369,0.060561,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.37932,0.091317,0.063714,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.007729,0.091289,0.082113,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.054842,0.091275,0.09973,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.67137,0.091266,-0.077181,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.86455,0.091207,-0.079329,0,0
3,GO REGULATION OF PROTEIN BINDING,0.093897,0.090935,0.067565,0,0
3,GO KIDNEY MORPHOGENESIS,0.049546,0.090855,0.097503,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.10096,0.090693,0.081744,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.12908,0.090656,0.074294,0,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.052669,0.090573,0.12696,0,0
3,GO PROTEIN OXIDATION,0.52594,0.090503,0.0088866,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.22568,0.090498,0.17658,0,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.057089,0.09046,0.091032,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.46512,0.090433,0.014079,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.35153,0.090203,0.049969,0,0
3,GO MYELOID CELL DEVELOPMENT,0.049546,0.090189,0.08512,0,0
3,GO EXPLORATION BEHAVIOR,0.76948,0.090186,-0.10524,0,0
3,GO MALE GENITALIA DEVELOPMENT,0.085627,0.090141,0.12845,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.065563,0.090108,0.075355,0,0
3,GO RESPONSE TO AMYLOID BETA,0.32077,0.089935,0.059467,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.11636,0.089931,0.085602,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.11636,0.089877,0.063338,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.19095,0.089865,0.14676,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.4545,0.089864,0.031871,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.14769,0.089843,0.11981,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.1313,0.089811,0.045528,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.50896,0.089681,0.019795,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.065563,0.089626,0.092844,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.26098,0.089401,0.088026,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.3746,0.089387,0.054569,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.061812,0.089358,0.1192,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.55487,0.089278,0.017271,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.3746,0.089167,0.053322,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.60883,0.089147,0.029413,0,0
3,GO AMINO ACID IMPORT,0.48131,0.089119,0.030704,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.059411,0.089118,0.068973,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.054842,0.089,0.12177,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.38888,0.08893,0.046393,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.072231,0.0887,0.11703,0,0
3,GO MATING BEHAVIOR,0.55487,0.08864,0.020993,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.0695,0.088629,0.087994,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.40843,0.088326,0.015716,0,0
3,GO TISSUE MORPHOGENESIS,0.13583,0.088288,0.044563,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.32077,0.088277,0.077406,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.64605,0.088092,0.018072,0,0
3,GO ERBB SIGNALING PATHWAY,0.25363,0.088078,0.040254,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.041967,0.087889,0.091332,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.02268,0.087869,0.13617,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.27611,0.087835,0.050038,0,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.2,0.087735,0.10107,0,0
3,GO OSSIFICATION,0.068167,0.087689,0.076969,0,0
3,GO VIRAL RELEASE FROM HOST CELL,0.079444,0.087684,0.078615,0,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.29992,0.08767,0.088652,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.13355,0.087426,0.10561,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.39858,0.087127,0.060139,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.89215,0.087014,0.0064267,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.02166,0.086987,0.11243,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.082489,0.086958,0.14308,0,0
3,GO RESPONSE TO ETHER,0.15015,0.086927,0.092661,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.5726,0.086868,0.014745,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.29586,0.086807,0.10449,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.22235,0.086718,0.10743,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1,0.086691,-0.033756,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.16032,0.086668,0.053368,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.14285,0.086569,0.11093,0,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.2839,0.086445,0.059234,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.036948,0.086421,0.10906,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.038561,0.08633,0.08427,0,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.22235,0.086267,0.077095,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.50896,0.086232,0.021973,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.39371,0.08621,0.026783,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.58456,0.08605,-0.0063519,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.63978,0.086033,0.083358,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.16559,0.085911,0.11406,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.065563,0.085801,0.06356,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.13583,0.085786,0.089307,0,0
3,GO RESPONSE TO ZINC ION,0.12259,0.085679,0.14947,0,0
3,GO PSEUDOPODIUM ORGANIZATION,0.22905,0.085604,0.13865,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.36991,0.085496,0.060688,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.69061,0.085387,0.026103,0,0
3,GO ORGANIC CATION TRANSPORT,0.060602,0.085385,0.13918,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.60883,0.085171,0.025318,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.11841,0.085062,0.071277,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.44924,0.08499,0.066125,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.063042,0.084925,0.14794,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.15264,0.084832,0.071431,0,0
3,GO CARNITINE SHUTTLE,0.36526,0.084744,0.056902,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.1313,0.084731,0.14895,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.3746,0.084731,0.043739,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.57857,0.084649,0.096521,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.81668,0.08435,0.0098205,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.14285,0.084218,0.05086,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.079444,0.084092,0.065176,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.052669,0.083862,0.074382,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.10465,0.083849,0.068109,0,0
3,GO GLIAL CELL ACTIVATION,0.40843,0.083833,0.031054,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.11235,0.083789,0.083254,0,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.088862,0.083781,0.089217,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.076492,0.083414,0.094545,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.13583,0.08333,0.1203,0,0
3,GO THALAMUS DEVELOPMENT,0.2,0.083228,0.16131,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.44924,0.083052,0.069112,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.05824,0.08302,0.098998,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.11434,0.082348,0.036419,0,0
3,GO CELLULAR ANION HOMEOSTASIS,0.81668,0.082124,-0.017876,0,0
3,GO SPERM AXONEME ASSEMBLY,0.15517,0.082023,0.11118,0,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.047551,0.081678,0.062683,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.13814,0.081668,0.089204,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.17374,0.081598,0.03622,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.43367,0.081386,0.045698,0,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.082489,0.081298,0.084481,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.29184,0.081276,0.072292,0,0
3,GO P38MAPK CASCADE,0.43367,0.081236,0.043299,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.079444,0.081133,0.090442,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.36064,0.081064,0.036526,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.080955,0.080799,0.097394,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.12689,0.080719,0.088027,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.52025,0.080549,0.058265,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.68418,0.080257,-0.0046264,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.073629,0.080243,0.12184,0,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.77618,0.080095,-0.005673,0,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.047551,0.080068,0.10052,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.22235,0.080019,0.040314,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.75615,0.079941,-0.03473,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.13814,0.079904,0.065757,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.48131,0.079634,0.049566,0,0
3,GO RESPONSE TO ALCOHOL,0.036948,0.07958,0.093913,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10096,0.079475,0.093669,0,0
3,GO RETINA HOMEOSTASIS,0.21905,0.079383,0.033034,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.22905,0.079049,0.055813,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.37932,0.079033,0.074646,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.14526,0.078691,0.050074,0,0
3,GO TAXIS,0.55487,0.078663,0.010077,0,0
3,GO FACE DEVELOPMENT,0.85768,0.078409,-0.020845,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.82348,0.078298,-0.058688,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.085627,0.077839,0.050922,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.20937,0.077677,0.091511,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.48131,0.077493,0.019971,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.31232,0.07748,0.053056,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.32077,0.077347,0.046103,0,0
3,GO NCRNA CATABOLIC PROCESS,0.15517,0.077178,0.076916,0,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.4598,0.077001,-0.02977,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.053746,0.076812,0.066745,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.12049,0.076757,0.05323,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.092194,0.076626,0.060971,0,0
3,GO TUBE MORPHOGENESIS,0.14526,0.076549,0.054462,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.63354,0.076498,0.020712,0,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.4598,0.076159,0.0043319,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.055956,0.076076,0.094574,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.15264,0.076029,0.054727,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.91293,0.07588,-0.024211,0,0
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.28785,0.075826,0.10488,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.25363,0.075791,0.057661,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.16032,0.075775,0.06049,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.20309,0.07564,0.17474,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.20309,0.075627,0.051398,0,0
3,GO ANIMAL ORGAN MATURATION,0.15517,0.075622,0.10535,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.077957,0.075473,0.10252,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.088862,0.075423,0.065861,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.21579,0.074842,0.065466,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.7495,0.074761,0.035131,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.19695,0.07476,0.10625,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.99651,0.074581,-0.013908,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.10465,0.074404,0.049674,0,0
3,GO RESPONSE TO SALT,0.21579,0.074402,0.059891,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.68418,0.074013,0.0037637,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.085627,0.073963,0.048037,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.2839,0.073885,0.051195,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.75615,0.073882,0.013485,0,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.31653,0.073732,0.11926,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.14048,0.073565,0.11843,0,0
3,GO PERICARDIUM DEVELOPMENT,0.97557,0.073507,-0.035526,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.2,0.073412,0.077391,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.56666,0.073206,0.043248,0,0
3,GO REGULATION OF CELL SHAPE,0.21256,0.073113,0.041447,0,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.14769,0.073108,0.06901,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.27227,0.073077,0.092457,0,0
3,GO DE NOVO PROTEIN FOLDING,0.35607,0.073067,0.03813,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.022165,0.072921,0.065864,0,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.23937,0.072398,0.08099,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.18508,0.072374,0.058288,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.38408,0.072349,0.030955,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.37932,0.072327,0.01111,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.11841,0.07221,0.095579,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.31232,0.072196,0.026214,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.36064,0.07215,0.028305,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.11235,0.072041,0.061438,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17374,0.071962,0.046612,0,0
3,GO NEGATIVE T CELL SELECTION,0.23589,0.071921,0.028181,0,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.87833,0.071918,-0.064638,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.71658,0.071436,-0.0026834,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.40349,0.071432,0.03206,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.092194,0.071284,0.095123,0,0
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.44402,0.071245,0.016382,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.39858,0.071228,0.01338,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.37932,0.071082,0.050403,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.13814,0.071002,0.046524,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.54321,0.070964,0.046397,0,0
3,GO MAINTENANCE OF LOCATION,0.088862,0.07089,0.06301,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.17099,0.070842,0.040109,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.33812,0.070731,0.051109,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.11636,0.070724,0.080262,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.4545,0.070588,-0.00041843,0,0
3,GO ASSOCIATIVE LEARNING,0.41842,0.070542,0.036885,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.15264,0.07053,0.057709,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.53742,0.070504,0.042356,0,0
3,GO FIBROBLAST MIGRATION,0.2839,0.070486,0.040287,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.057089,0.07044,0.13911,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.65866,0.070053,-0.002855,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15015,0.069956,0.097823,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.11841,0.069769,0.069725,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.082489,0.069586,0.11021,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.52594,0.069572,0.037373,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.16294,0.069551,0.062135,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.21256,0.069477,0.02241,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.78962,0.069466,-0.0087955,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.064293,0.069438,0.072087,0,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.21579,0.069354,0.061695,0,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.42855,0.069311,0.03474,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.50896,0.069255,0.037783,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.12473,0.069202,0.048649,0,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.32938,0.069088,0.064148,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.43883,0.069025,0.02333,0,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.35607,0.069023,0.023183,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.31653,0.068973,0.07709,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.91987,0.06882,-0.037175,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.090515,0.068727,0.098327,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.32506,0.068692,0.042867,0,0
3,GO ARTERY MORPHOGENESIS,0.14285,0.068662,0.033955,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.04854,0.068525,0.099476,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.11636,0.068501,0.060954,0,0
3,GO BICARBONATE TRANSPORT,0.19695,0.068314,0.099194,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.21256,0.068287,0.042354,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.070855,0.068243,0.071354,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.22905,0.068133,0.038822,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.37932,0.06809,0.027737,0,0
3,GO CARDIAC CONDUCTION,0.19695,0.068061,0.075285,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.17099,0.068045,0.080692,0,0
3,GO RENAL WATER HOMEOSTASIS,0.74288,0.067995,0.0026647,0,0
3,GO EPITHELIAL TUBE FORMATION,0.23937,0.067992,0.02368,0,0
3,GO ERAD PATHWAY,0.085627,0.067934,0.038834,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.12908,0.067902,0.058768,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.69707,0.067771,0.0090007,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.72969,0.067542,0.010113,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.17374,0.067541,0.098896,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.56666,0.067509,0.023187,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.35607,0.067446,0.020865,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.050569,0.067405,0.065802,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.65866,0.067308,0.0013217,0,0
3,GO PROTEIN MANNOSYLATION,0.077957,0.067247,0.1046,0,0
3,GO HINDBRAIN DEVELOPMENT,0.22905,0.067207,0.071753,0,0
3,GO COMPLEMENT ACTIVATION,0.18219,0.067157,0.074706,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.085627,0.06711,0.071252,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.33373,0.067098,0.041347,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.52025,0.067084,0.016661,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.27611,0.067053,0.04668,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.12049,0.067036,0.048939,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.1313,0.067011,0.086995,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.26847,0.067011,0.042529,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.18508,0.066994,0.090737,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.3746,0.066924,0.063857,0,0
3,GO PHOTOPERIODISM,0.25729,0.066771,0.086982,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.54903,0.066708,0.12653,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.63354,0.066697,0.019565,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.22905,0.066696,0.11015,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.079444,0.066482,0.087415,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.14526,0.066373,0.090906,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.24288,0.066302,0.066352,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.20621,0.066276,0.038198,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.88523,0.066168,-0.010164,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.15264,0.06605,0.087365,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.10096,0.066016,0.12524,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.21579,0.065966,0.044228,0,0
3,GO GMP METABOLIC PROCESS,0.36064,0.065959,0.070551,0,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.11039,0.065822,0.047701,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.56075,0.065817,0.01865,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.53167,0.06575,0.032464,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.46512,0.065409,0.035535,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.54321,0.065263,0.060485,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.60883,0.065131,0.067892,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.94769,0.065108,-0.015863,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.58456,0.064932,0.02074,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.090515,0.064844,0.059822,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.22905,0.06484,0.062908,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.18219,0.064839,0.086136,0,0
3,GO RESPONSE TO FOOD,0.36526,0.064799,0.036228,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.17374,0.064799,0.12609,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.24288,0.064774,0.074939,0,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.070855,0.064688,0.069426,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.065563,0.064627,0.073446,0,0
3,GO ERK1 AND ERK2 CASCADE,0.46512,0.064612,0.040865,0,0
3,GO TUBE DEVELOPMENT,0.092194,0.064506,0.064598,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.2839,0.064405,0.045202,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.44924,0.064334,0.031519,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.5726,0.064197,0.041537,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.11636,0.064113,0.050846,0,0
3,GO REGULATION OF HAIR CYCLE,0.30402,0.064104,0.032352,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.7495,0.064074,0.013419,0,0
3,GO TRNA 5 LEADER REMOVAL,0.72969,0.063849,-0.00074102,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.7495,0.063822,0.0060706,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.27227,0.063803,0.039712,0,0
3,GO VIRAL BUDDING,0.047551,0.063639,0.1136,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.59664,0.063619,0.047893,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.62113,0.063514,0.027569,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.20309,0.063498,0.063879,0,0
3,GO COLLATERAL SPROUTING,0.66501,0.063431,-0.064851,0,0
3,GO VIRION ASSEMBLY,0.052669,0.063405,0.078626,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.20309,0.063273,0.045365,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.32938,0.063108,0.030336,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.57857,0.06308,0.025953,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.64605,0.062966,0.018985,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.12689,0.062814,0.063366,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.188,0.062798,0.11086,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.2839,0.06279,0.064398,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.05161,0.062686,0.097775,0,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.65866,0.062624,0.010081,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.85082,0.062602,-0.056917,0,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.28785,0.062562,0.045738,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.94769,0.062289,-0.025362,0,0
3,GO COCHLEA DEVELOPMENT,1,0.062211,-0.0049833,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.36991,0.062051,0.07563,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22905,0.062005,0.075606,0,0
3,GO OOGENESIS,0.52025,0.061967,0.033892,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.53742,0.061965,0.02444,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14285,0.061927,0.052897,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.33373,0.061858,0.11975,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.2839,0.061726,0.094354,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.061695,-0.018053,0,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.25001,0.061665,0.031827,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.12473,0.061556,0.098531,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.25001,0.061536,0.030849,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.19695,0.061418,0.065746,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.10096,0.061413,0.076746,0,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.066855,0.06131,0.079197,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.72969,0.061205,-0.0057799,0,0
3,GO BODY FLUID SECRETION,0.34702,0.0612,0.025203,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.13355,0.061155,0.049869,0,0
3,GO RHYTHMIC BEHAVIOR,0.17099,0.061049,0.08363,0,0
3,GO DETOXIFICATION,0.52025,0.060936,0.032482,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10096,0.06092,0.10272,0,0
3,GO MALE SEX DIFFERENTIATION,0.033166,0.060909,0.09106,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.63978,0.060905,0.018443,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.36991,0.060847,0.036116,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.18219,0.060821,0.065654,0,0
3,GO RELAXATION OF MUSCLE,0.34702,0.060702,0.073536,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.24643,0.060679,0.070122,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.20937,0.060559,0.060815,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.17934,0.060549,0.088114,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.94769,0.060525,-0.028846,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.12473,0.060524,0.1723,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.16032,0.060477,0.065892,0,0
3,GO MEMBRANE INVAGINATION,0.22905,0.060394,0.045481,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.54903,0.060215,0.043177,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.17374,0.060138,0.056203,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.34256,0.060105,0.072753,0,0
3,GO SKIN MORPHOGENESIS,0.54321,0.060082,-0.156,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.8303,0.060009,-0.04252,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.50337,0.059992,0.01479,0,0
3,GO MEMORY,0.51459,0.059895,0.035511,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.19393,0.059828,0.055169,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.97557,0.059813,-0.026262,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.077957,0.059753,0.05114,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.40349,0.059724,0.064804,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.37932,0.059718,0.070479,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.20621,0.059674,0.066363,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.25363,0.059661,0.041667,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.43883,0.059653,0.016365,0,0
3,GO PYRUVATE METABOLIC PROCESS,0.55487,0.059634,0.024014,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.34256,0.059519,0.10325,0,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.25729,0.059457,0.070768,0,0
3,GO AMINE CATABOLIC PROCESS,0.27611,0.059387,0.052277,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.34702,0.05921,0.085307,0,0
3,GO GONADOTROPIN SECRETION,0.21579,0.059158,0.094801,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.48131,0.059136,0.020577,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.084046,0.059092,0.073311,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.21905,0.058939,0.060941,0,0
3,GO BRONCHUS DEVELOPMENT,0.67776,0.058884,0.037772,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.065563,0.058851,0.081127,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.43367,0.058259,0.041897,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.14769,0.058246,0.065697,0,0
3,GO VITAMIN METABOLIC PROCESS,0.15264,0.058194,0.067545,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.52594,0.05811,-0.029371,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.24643,0.058016,0.044896,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.41341,0.057986,0.043923,0,0
3,GO VISUAL BEHAVIOR,0.22905,0.057949,0.063211,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.021165,0.057937,0.1417,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.070855,0.057827,0.049786,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.2,0.057808,0.18162,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22905,0.057562,0.047322,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.31653,0.057542,0.053856,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.15517,0.057476,0.074866,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.53167,0.057419,0.010808,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.022165,0.057361,0.098358,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.59664,0.057303,0.028893,0,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.38888,0.057264,0.039934,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.21256,0.057185,0.062876,0,0
3,GO RESPONSE TO NICOTINE,0.50337,0.057102,0.049012,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.13583,0.057035,0.060423,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.5726,0.056993,0.048223,0,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.77618,0.056594,0.0033239,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.44402,0.056552,0.017407,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.075049,0.056433,0.059217,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.56075,0.056331,-0.0063492,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.88523,0.056319,-0.052515,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.67137,0.056298,0.042114,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.39858,0.056271,0.026693,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.48131,0.056267,0.0059049,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.48678,0.056254,0.019544,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.10465,0.056134,0.096877,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.30815,0.056121,0.036883,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.049546,0.056118,0.060475,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.10845,0.055966,0.07418,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.87144,0.055927,0.0079661,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.36064,0.055848,0.036766,0,0
3,GO VASCULATURE DEVELOPMENT,0.41842,0.055812,0.020066,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.87833,0.055801,-0.020002,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.21256,0.055774,0.11114,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.84397,0.055712,0.0081906,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.21579,0.055688,0.050261,0,0
3,GO CELL SUBSTRATE ADHESION,0.42347,0.055574,0.020596,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.91987,0.055559,-0.0018513,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.99651,0.055518,-0.024509,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.32506,0.05543,0.032235,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13355,0.055331,0.052641,0,0
3,GO NEPHRON MORPHOGENESIS,0.16032,0.055286,0.066341,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.47049,0.055174,0.053596,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.093897,0.055023,0.078952,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.97557,0.054991,-0.10937,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.40349,0.05499,0.037861,0,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.079444,0.054987,0.06894,0,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.75615,0.054885,-0.0010282,0,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.27999,0.054875,0.025065,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.73628,0.054851,0.0099994,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.22568,0.054831,0.038987,0,0
3,GO COPPER ION TRANSPORT,0.20937,0.05474,0.10428,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.4978,0.054678,0.033875,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.42855,0.054549,0.050011,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.18508,0.05454,0.058702,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.54321,0.054505,0.02534,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.19695,0.054276,0.061367,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.1028,0.054193,0.065674,0,0
3,GO NOTOCHORD DEVELOPMENT,0.98953,0.054162,-0.068078,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.50896,0.05413,0.0088347,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.25001,0.054049,0.035474,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.060602,0.053958,0.065322,0,0
3,GO ACROSOME REACTION,0.12259,0.053893,0.10143,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.17934,0.053628,0.04206,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.55487,0.053549,0.036122,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.21579,0.053269,0.038367,0,0
3,GO NEURON REMODELING,0.60272,0.053239,0.055615,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.47588,0.053236,0.026001,0,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.055956,0.05322,0.092728,0,0
3,GO CILIUM MOVEMENT,0.13814,0.053168,0.04231,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.54903,0.053144,0.040967,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.88523,0.053058,-0.028979,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.76281,0.052934,0.0062196,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.67776,0.052845,0.064574,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.7495,0.052716,0.010859,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.95466,0.052672,-0.0090995,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.25363,0.052633,0.042566,0,0
3,GO EXTRACELLULAR TRANSPORT,0.35607,0.0526,0.05415,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.079444,0.052565,0.075715,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.91293,0.052434,-0.010245,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.98255,0.052338,-0.021906,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.17099,0.052293,0.056052,0,0
3,GO RESPONSE TO ANGIOTENSIN,0.50896,0.052262,0.00796,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.52594,0.052259,0.016465,0,0
3,GO TUBE FORMATION,0.42855,0.052222,0.011592,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.96163,0.052193,0.009886,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.27611,0.052157,0.076194,0,0
3,GO TRABECULA MORPHOGENESIS,0.53742,0.052152,0.0062029,0,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.18219,0.052107,0.038274,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.37932,0.052107,0.026035,0,0
3,GO THIOESTER METABOLIC PROCESS,0.12259,0.052068,0.059811,0,0
3,GO ZINC ION TRANSPORT,0.20937,0.052056,0.051363,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.21905,0.051816,0.073588,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.29992,0.051799,0.069911,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.54903,0.051739,0.041544,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.51459,0.05173,0.021792,0,0
3,GO RESPONSE TO CAMP,0.48678,0.051604,0.022085,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.33373,0.051367,0.095662,0,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.26847,0.051338,0.029668,0,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.80989,0.05129,-0.023,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.74288,0.051219,-0.11295,0,0
3,GO SEROTONIN TRANSPORT,0.71658,0.05116,0.046365,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.40349,0.05114,0.029294,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.29992,0.051122,0.14814,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.60272,0.051093,0.030493,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.12689,0.051069,0.074407,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.74288,0.051068,0.018335,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.12908,0.051036,0.099532,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.44402,0.050879,0.020374,0,0
3,GO GENITALIA DEVELOPMENT,0.36064,0.050786,0.041226,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.82348,0.050751,0.0055121,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.56075,0.050703,0.024294,0,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.68418,0.050604,0.01037,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.44402,0.050447,0.053588,0,0
3,GO CELL GROWTH,0.65234,0.050393,0.012341,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.54321,0.050378,0.031845,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.83713,0.04994,-0.049659,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.54903,0.049822,0.035794,0,0
3,GO MUSCLE SYSTEM PROCESS,0.24288,0.049693,0.040805,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.44924,0.049679,0.0092996,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.29184,0.04966,0.043254,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.23589,0.049646,0.050662,0,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.13355,0.049602,0.093711,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.23937,0.049559,0.038603,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.29184,0.049318,0.020694,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.23245,0.049182,0.04689,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.25363,0.049067,0.024851,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.30402,0.048912,0.041766,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.56075,0.04883,-0.10577,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.63354,0.048697,0.00441,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.2,0.048691,0.045745,0,0
3,GO GENETIC IMPRINTING,0.53167,0.048684,0.062167,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.40349,0.048541,0.032389,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.79636,0.048429,0.00069191,0,0
3,GO LIPID EXPORT FROM CELL,0.30815,0.04815,0.07369,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.13355,0.047942,0.054377,0,0
3,GO CATECHOLAMINE SECRETION,0.11841,0.047818,0.2082,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.89907,0.047629,-0.012549,0,0
3,GO RESPONSE TO DOPAMINE,0.29992,0.047592,0.057056,0,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.9686,0.047555,-0.058581,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.19095,0.047514,0.10874,0,0
3,GO VESICLE DOCKING,0.83713,0.047498,0.010999,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.39371,0.04744,0.036933,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.38408,0.047427,0.060075,0,0
3,GO PIGMENT METABOLIC PROCESS,0.76948,0.047231,-0.0081423,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.27227,0.047225,0.046635,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.86455,0.046895,-0.033725,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.36064,0.046777,0.061087,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.13583,0.046774,0.042363,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.22568,0.046642,0.097848,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.30815,0.046547,0.072765,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.20937,0.046404,0.05727,0,0
3,GO REGULATION OF BINDING,0.17653,0.046246,0.047094,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.20937,0.046246,0.04039,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.77618,0.046238,-0.033141,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33812,0.0462,0.033206,0,0
3,GO PRESYNAPSE ORGANIZATION,0.85082,0.046166,-0.037436,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.55487,0.046145,0.010743,0,0
3,GO EYE MORPHOGENESIS,0.61497,0.046089,0.011555,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.23937,0.04607,0.063369,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.24643,0.046002,0.08549,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.42347,0.045953,0.019447,0,0
3,GO PROSTAGLANDIN SECRETION,0.30815,0.045889,0.082224,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.16032,0.04586,0.04293,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.22235,0.04579,0.03364,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.33373,0.045787,0.033975,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.11434,0.045748,0.052911,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.16294,0.04564,0.048393,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.26098,0.045614,0.031981,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.30815,0.045568,0.0451,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.077957,0.045558,0.041291,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.73628,0.045544,0.0031643,0,0
3,GO MYOBLAST DIFFERENTIATION,0.34256,0.04541,0.027015,0,0
3,GO RESPONSE TO VITAMIN,0.95466,0.04537,-0.01139,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.33812,0.045309,0.048823,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.13814,0.04519,0.028796,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.32077,0.045098,0.029642,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.92682,0.044983,-0.044525,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.3746,0.044945,0.019886,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.80989,0.04492,-0.022129,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.22235,0.044915,0.055964,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.91293,0.044755,0.015225,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.32506,0.044679,0.048805,0,0
3,GO INTERLEUKIN 17 PRODUCTION,0.2839,0.044619,0.072798,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.085627,0.044617,0.042302,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.37932,0.044406,0.029997,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.4978,0.044335,0.022003,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.99651,0.044167,-0.021763,0,0
3,GO GOLGI VESICLE TRANSPORT,0.1028,0.044166,0.036872,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.37932,0.044108,0.032694,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.46512,0.044094,0.040087,0,0
3,GO SEX DIFFERENTIATION,0.31653,0.044007,0.042619,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.065563,0.043942,0.070371,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.48131,0.043886,0.018696,0,0
3,GO EMBRYO DEVELOPMENT,0.69061,0.043858,0.0068371,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.23937,0.043851,0.053977,0,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.27999,0.043753,0.032362,0,0
3,GO CARNITINE METABOLIC PROCESS,0.53167,0.04363,0.062792,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.095625,0.043562,0.076639,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.33373,0.043508,0.039144,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.31232,0.043499,0.03813,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.31653,0.043447,0.18552,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.22905,0.043387,0.038243,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.4598,0.043386,0.070452,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.48131,0.043368,0.029665,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.82348,0.043319,-0.03834,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.27999,0.043272,0.051368,0,0
3,GO VITAMIN TRANSPORT,0.46512,0.043256,0.035469,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.25729,0.043107,0.046802,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.72969,0.043082,0.011771,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.59664,0.042967,0.07805,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.23937,0.042907,0.12737,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.79636,0.042893,0.00015611,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.8303,0.042858,-0.041439,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.19393,0.042796,0.065407,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.90599,0.042763,-0.0065203,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.097379,0.042698,0.052135,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33812,0.042537,0.031007,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.31653,0.042527,0.029217,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.47588,0.042526,0.018513,0,0
3,GO REGULATION OF HEAT GENERATION,0.63354,0.042335,0.068732,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.51459,0.04229,-0.0013096,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.87144,0.0422,-0.0046079,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.17934,0.042173,0.062849,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.76948,0.042119,0.0051319,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.8303,0.041953,0.011108,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.39371,0.04177,0.037828,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.53167,0.041676,0.0069605,0,0
3,GO NADPH REGENERATION,0.91987,0.041566,-0.01427,0,0
3,GO VESICLE LOCALIZATION,0.44924,0.041565,0.023732,0,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.44924,0.041547,0.02496,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.16828,0.041387,0.068415,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.71006,0.041351,-0.0047988,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.12689,0.041333,0.054002,0,0
3,GO DEVELOPMENTAL GROWTH,0.88523,0.04122,-0.021553,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.25363,0.041004,0.068141,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.53167,0.040964,0.033232,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.89907,0.040929,-0.00052207,0,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.093897,0.040843,0.055227,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.44924,0.040686,0.012771,0,0
3,GO OOCYTE MATURATION,0.81668,0.040683,0.009708,0,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.20621,0.040656,0.045507,0,0
3,GO RESPONSE TO BMP,0.11636,0.040628,0.065593,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.89215,0.040527,-0.038761,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.69707,0.040329,0.0043273,0,0
3,GO REPRODUCTION,0.087232,0.04029,0.056967,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.97557,0.040201,-0.0090523,0,0
3,GO MAST CELL MIGRATION,0.98953,0.040077,-0.028847,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.16559,0.040046,0.03193,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.29184,0.040045,0.028134,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.36526,0.040007,0.038022,0,0
3,GO MITOCHONDRIAL RNA PROCESSING,0.89907,0.03983,0.015798,0,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.11841,0.039813,0.050783,0,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.34702,0.039798,0.085347,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.77618,0.03963,-0.0017149,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.38408,0.039626,0.051593,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.087232,0.039487,0.028315,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.76281,0.039477,-0.036928,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.36526,0.039467,0.056,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.099158,0.039287,0.10064,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.90599,0.039233,0.0014442,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.21256,0.039198,0.095179,0,0
3,GO IRON ION HOMEOSTASIS,0.30815,0.039183,0.036008,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.3746,0.039033,0.074198,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.4545,0.03899,0.022496,0,0
3,GO MITOCHONDRIAL TRNA PROCESSING,0.73628,0.038826,0.051986,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.65866,0.038681,-0.005437,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.76948,0.038626,-0.01001,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.50896,0.038575,0.024328,0,0
3,GO RESPONSE TO HYDROXYUREA,0.20937,0.038541,0.084316,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.97557,0.038505,-0.038417,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.29992,0.038462,0.10474,0,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.26471,0.038453,0.057719,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.36064,0.038423,0.05823,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.40843,0.038413,0.0046145,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.54321,0.038373,-0.0020479,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.53742,0.038325,0.020956,0,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.84397,0.038272,-0.042418,0,0
3,GO ETHANOL OXIDATION,0.87144,0.038253,-0.0038948,0,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.13355,0.038251,0.068951,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.98953,0.038179,-0.0073181,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.079444,0.038165,0.071817,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.80312,0.037992,0.011192,0,0
3,GO ADULT BEHAVIOR,0.29184,0.037977,0.086024,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.32077,0.037926,0.23246,0,0
3,GO RNA DESTABILIZATION,0.72969,0.037723,-0.039412,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.20309,0.037675,0.04721,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.30402,0.037649,0.029597,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.30402,0.037543,0.030237,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.22235,0.03737,0.072695,0,0
3,GO SPROUTING ANGIOGENESIS,0.94769,0.037351,-0.020682,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.46512,0.037268,0.032726,0,0
3,GO CYTOSKELETON ORGANIZATION,0.71006,0.03703,0.0079037,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.054842,0.036943,0.065645,0,0
3,GO ACTIN CROSSLINK FORMATION,0.89907,0.036921,-0.028269,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.82348,0.036897,-0.014215,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.87144,0.036882,0.0071791,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.095625,0.036882,0.042232,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.72313,0.036827,-0.045238,0,0
3,GO GLUCOSE IMPORT,0.19095,0.036675,0.059499,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.69061,0.036673,-0.028803,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.87144,0.036651,-0.011111,0,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.86455,0.036646,0.0016352,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.24288,0.036565,0.036273,0,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.73628,0.036556,-0.0050599,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.57857,0.036548,0.024909,0,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.44924,0.036453,0.017122,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.43883,0.036325,0.10609,0,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.12473,0.036306,0.069274,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.60272,0.036295,0.048882,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.27611,0.036261,0.060915,0,0
3,GO CELL JUNCTION ORGANIZATION,0.51459,0.036014,0.020991,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.65234,0.035997,0.026423,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.85768,0.035937,-0.009783,0,0
3,GO HISTONE H3 K36 METHYLATION,0.85082,0.035864,0.0041631,0,0
3,GO GOLGI LOCALIZATION,0.59664,0.035852,0.025844,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.46512,0.035786,0.015325,0,0
3,GO HEART FORMATION,0.96163,0.035536,0.00043076,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.71658,0.035497,0.047628,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.60883,0.035466,0.010494,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.17099,0.035385,0.1426,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.89215,0.035283,-0.030671,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.54321,0.035263,0.070693,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.21905,0.035033,0.031496,0,0
3,GO MISMATCH REPAIR,0.24288,0.035026,0.033371,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.88523,0.034911,-0.011641,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.82348,0.03488,-0.0029919,0,0
3,GO TONGUE MORPHOGENESIS,0.7495,0.034844,-0.031339,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.56666,0.034822,0.011681,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.59059,0.034776,0.0069994,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.85082,0.034663,-0.029344,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.13355,0.034632,0.079157,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.61497,0.034621,0.011295,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.75615,0.034582,0.0045852,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.36991,0.034575,0.023824,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.67137,0.034489,-0.012918,0,0
3,GO CHYLOMICRON ASSEMBLY,0.69707,0.03444,-0.011515,0,0
3,GO HEAT GENERATION,0.56666,0.034394,0.043971,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.88523,0.034362,-0.038037,0,0
3,GO LYSOSOMAL TRANSPORT,0.30815,0.034315,0.038114,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.28785,0.034285,0.02234,0,0
3,GO SPERM MOTILITY,0.38888,0.034252,0.032959,0,0
3,GO REGULATION OF ODONTOGENESIS,0.82348,0.034223,0.017194,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.66501,0.033961,0.021456,0,0
3,GO ASTROCYTE DEVELOPMENT,0.73628,0.03396,0.02363,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.98953,0.033957,-0.0081019,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.41341,0.033895,0.064311,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.64605,0.033883,0.0091843,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.33812,0.033676,0.049539,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.65866,0.033545,0.0035062,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.48678,0.033423,0.017269,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.75615,0.033329,-0.033113,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.19393,0.033303,0.032035,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.92682,0.033136,-0.0034423,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.25729,0.03312,0.023648,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.33373,0.033062,0.034525,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.42855,0.033005,0.050678,0,0
3,GO RESPONSE TO RADIATION,0.46512,0.032936,0.010139,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.63978,0.03281,-0.087109,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.19695,0.032809,0.072479,0,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.24288,0.032796,0.054909,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.53742,0.032787,0.019955,0,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.65234,0.03272,0.0044895,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.36526,0.032681,0.067909,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.48131,0.032668,0.012906,0,0
3,GO AUTOPHAGIC CELL DEATH,0.25729,0.032626,0.069797,0,0
3,GO LYMPH NODE DEVELOPMENT,0.47049,0.032601,0.041817,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.43883,0.032529,0.013239,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.59664,0.032494,0.01159,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.72969,0.032492,0.013997,0,0
3,GO MUSCLE CONTRACTION,0.43367,0.032251,0.024973,0,0
3,GO PROTEIN FOLDING,0.49227,0.032059,0.015808,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.52594,0.032035,0.01904,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.99651,0.031949,-0.01531,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.67137,0.031895,0.034299,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,0.031866,0.098491,0,0
3,GO RESPONSE TO INTERLEUKIN 7,0.59664,0.031839,0.022573,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.84397,0.031833,-0.0598,0,0
3,GO NEURON DEATH,0.13355,0.031806,0.045352,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.79636,0.031751,-0.086528,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.60272,0.03175,0.01044,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.3746,0.031659,0.019663,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.32506,0.031587,0.15558,0,0
3,GO BLASTOCYST DEVELOPMENT,0.11434,0.031488,0.05044,0,0
3,GO REGENERATION,0.40843,0.031469,0.028583,0,0
3,GO POSITIVE REGULATION OF BINDING,0.55487,0.031452,0.015861,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.47049,0.031401,0.017971,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.80312,0.031376,0.0047825,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.31232,0.031374,0.016844,0,0
3,GO CELL CELL SIGNALING,0.47588,0.031367,0.022743,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.86455,0.031287,-0.0043813,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.69707,0.031237,0.017245,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.98953,0.031222,-0.0048416,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.67137,0.031193,-0.050255,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.39371,0.031155,0.049802,0,0
3,GO TOXIN TRANSPORT,0.96163,0.031111,-0.0034839,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.69707,0.030991,0.0094401,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.030989,0.014989,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.91293,0.030862,-0.015255,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.96163,0.030679,-0.0088671,0,0
3,GO GERM CELL DEVELOPMENT,0.33812,0.030517,0.03479,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.44402,0.030418,0.036695,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.39371,0.030311,0.033651,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.62732,0.030282,0.032518,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.88523,0.030251,-0.0028063,0,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.2,0.030129,0.042786,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.56666,0.02997,0.032569,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.71658,0.029865,0.0076546,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.9686,0.029634,0.018752,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.2,0.029595,0.089577,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.65866,0.029531,-0.038166,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.96163,0.029472,-0.036675,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.50337,0.029459,-0.14815,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.59664,0.029455,0.019979,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.36526,0.029433,0.0614,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.94769,0.029326,-0.0035842,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.46512,0.029305,0.036228,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.81668,0.0292,-0.07087,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.55487,0.029145,-0.04414,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.095625,0.029099,0.027723,0,0
3,GO ATP METABOLIC PROCESS,0.39371,0.029084,0.028603,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.62732,0.029062,0.018623,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.40349,0.029046,0.016127,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.94073,0.028937,0.0016502,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.42347,0.028931,0.029106,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.47049,0.028905,0.038671,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.90599,0.028679,-0.0044638,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.53742,0.028664,0.076561,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.3746,0.028663,0.10129,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.85082,0.028503,-0.0018576,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.97557,0.02844,-0.0078675,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.75615,0.028357,-0.067702,0,0
3,GO INTRACELLULAR TRANSPORT,0.2,0.028287,0.019683,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.188,0.028087,0.019638,0,0
3,GO MEIOTIC CELL CYCLE,0.22905,0.028022,0.036913,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.36064,0.027978,0.07601,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91987,0.027977,-0.016274,0,0
3,GO SPERMATID DIFFERENTIATION,0.33812,0.027913,0.030915,0,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.3746,0.027907,0.027792,0,0
3,GO AXIS SPECIFICATION,0.56075,0.027884,0.035182,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.50896,0.027599,0.048781,0,0
3,GO BLASTODERM SEGMENTATION,0.61497,0.027364,-0.092326,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.30402,0.027264,0.060889,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.70355,0.027249,0.036626,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.30815,0.027217,0.021544,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.67776,0.027187,-0.023873,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.88523,0.027161,-0.0063127,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.93377,0.027132,-0.0090418,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.80312,0.027099,-0.0082882,0,0
3,GO ANION HOMEOSTASIS,0.97557,0.026957,-0.0097532,0,0
3,GO ENDODERM DEVELOPMENT,0.58456,0.026927,-0.094,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.91293,0.026879,0.010059,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.47588,0.026869,0.035451,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.65866,0.026851,0.012917,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.62113,0.026813,0.0094317,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.7495,0.02669,0.0050915,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.85768,0.026662,0.016494,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.4545,0.026652,0.01153,0,0
3,GO NUCLEOSOME ASSEMBLY,0.83713,0.026521,-0.012749,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.63978,0.026287,0.0044955,0,0
3,GO STEROL IMPORT,0.81668,0.026268,-0.022062,0,0
3,GO CELL PROJECTION ASSEMBLY,0.62732,0.026247,0.019458,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.92682,0.026056,-0.032684,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.68418,0.025993,0.046387,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.61497,0.025906,0.013451,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.87144,0.025896,0.0056027,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.85082,0.025893,-0.052832,0,0
3,GO PREPULSE INHIBITION,0.94073,0.025845,0.015336,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.68418,0.025842,0.013778,0,0
3,GO NEURAL TUBE FORMATION,0.59664,0.025816,0.0076466,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.78962,0.025806,-0.0037664,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.91987,0.025778,-0.015142,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.62113,0.025659,0.054781,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.76948,0.025654,0.035475,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.30402,0.025599,0.052051,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.87833,0.025511,0.0040536,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.97557,0.025489,-0.0080818,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.92682,0.025455,-0.015252,0,0
3,GO SOMITE DEVELOPMENT,0.22905,0.025434,0.034542,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.94769,0.025384,-0.0037439,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.88523,0.025381,-0.022704,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.68418,0.025361,0.0070132,0,0
3,GO CELLULAR RESPIRATION,0.59059,0.025349,0.01623,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.37932,0.025318,0.031596,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.025221,0.15012,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.61497,0.025197,0.043488,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.31232,0.025187,0.019404,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.85768,0.025149,-0.04055,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.64605,0.025122,0.044648,0,0
3,GO MATING,0.12908,0.024877,0.072871,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.19095,0.024873,0.030763,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.94073,0.024853,-0.020018,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,1,0.024818,-0.027403,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.78289,0.024738,0.0047819,0,0
3,GO HISTONE EXCHANGE,0.69061,0.024684,-0.025653,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.50337,0.024585,0.016786,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.55487,0.024271,0.013424,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.42855,0.02408,0.033336,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.11434,0.024066,0.036464,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.65234,0.024043,0.010418,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.51459,0.023996,0.041355,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.89907,0.023984,-0.025149,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.62732,0.023742,0.016448,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.8303,0.023731,0.0043906,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.36526,0.023671,0.052653,0,0
3,GO FEAR RESPONSE,0.83713,0.023595,0.0093869,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.36526,0.023562,0.029056,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.53742,0.023553,0.027513,0,0
3,GO RESPONSE TO RETINOIC ACID,0.60272,0.023446,0.019841,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.94769,0.023435,0.0089769,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.82348,0.023298,0.0029588,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.99651,0.023235,-0.0073389,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.38888,0.023191,0.026811,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.67137,0.023171,0.015615,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.27611,0.023073,0.03877,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.82348,0.022742,0.0059467,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.72313,0.02271,-0.038695,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.55487,0.022623,0.035657,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.79636,0.022592,0.023529,0,0
3,GO MIDGUT DEVELOPMENT,0.62732,0.022528,0.041104,0,0
3,GO RESPONSE TO ESTROGEN,0.52025,0.022432,-0.062416,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.86455,0.02236,-0.011775,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.73628,0.022312,-0.045592,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.59059,0.022057,0.024055,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.48131,0.022035,0.022543,0,0
3,GO TORC1 SIGNALING,0.23937,0.021848,0.050309,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.93377,0.0218,-0.028453,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.37932,0.021752,0.15007,0,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.5726,0.021744,0.01412,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.30815,0.021715,0.033633,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.47049,0.021699,0.020578,0,0
3,GO DEVELOPMENTAL CELL GROWTH,0.52594,0.021641,-0.053822,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.89907,0.021603,-0.0046135,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.93377,0.021544,-0.0036508,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.188,0.021519,0.054798,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.99651,0.021439,0.0072958,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.55487,0.021342,0.019483,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.63978,0.021263,0.011867,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.84397,0.02108,0.0059788,0,0
3,GO OVULATION CYCLE,0.79636,0.021077,-0.021805,0,0
3,GO STEM CELL PROLIFERATION,0.94073,0.021075,-0.0016627,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.32938,0.021063,0.027289,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.35607,0.021037,0.021608,0,0
3,GO L AMINO ACID TRANSPORT,0.85768,0.020961,-0.016371,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.50337,0.020948,-0.042533,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.82348,0.020934,-0.019486,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.61497,0.0209,-0.032727,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.60883,0.020821,0.010247,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.95466,0.020793,-0.038392,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.59664,0.020595,-0.077981,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.63354,0.020536,-0.0022072,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.65234,0.020534,-0.061761,0,0
3,GO RUFFLE ASSEMBLY,0.48131,0.020509,0.049201,0,0
3,GO OVULATION,0.90599,0.020487,-0.044377,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.56666,0.020441,0.011157,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.88523,0.020422,0.0022974,0,0
3,GO IMPORT INTO CELL,0.43883,0.020289,0.039494,0,0
3,GO FEMALE GAMETE GENERATION,0.79636,0.020124,0.0085976,0,0
3,GO TOOTH MINERALIZATION,0.76948,0.020077,0.016542,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.95466,0.020067,-0.0013057,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.31232,0.019973,0.067132,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.5726,0.019971,0.038123,0,0
3,GO PRIMARY MIRNA PROCESSING,0.79636,0.019718,-0.00061427,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1,0.01971,-0.0015319,0,0
3,GO FACIAL NERVE MORPHOGENESIS,0.78962,0.019643,0.016448,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.76948,0.019642,0.0050169,0,0
3,GO TISSUE REGENERATION,0.20309,0.019606,0.08935,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.17099,0.019587,0.039735,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.43883,0.019488,0.07558,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.41341,0.019482,0.013732,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.50337,0.019394,0.0065861,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.4545,0.019315,0.032905,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.78289,0.0193,0.014682,0,0
3,GO AEROBIC RESPIRATION,0.52594,0.019171,0.019534,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.61497,0.0191,-0.090062,0,0
3,GO CELL CELL SIGNALING BY WNT,0.86455,0.019032,0.0018192,0,0
3,GO PROTEIN TETRAMERIZATION,0.77618,0.01899,-0.018368,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.9686,0.018972,-0.018573,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.32938,0.018939,-0.078958,0,0
3,GO SEXUAL REPRODUCTION,0.15015,0.018811,0.040926,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.95466,0.018767,-0.012731,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.32506,0.0187,0.037078,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.58456,0.018615,0.019859,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.86455,0.018611,-0.01136,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.94769,0.018589,-0.017812,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.77618,0.018549,-0.042918,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.34256,0.018379,0.084942,0,0
3,GO SYNAPSE ASSEMBLY,0.77618,0.018367,0.018219,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.67776,0.018313,0.011126,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.40349,0.018305,0.031578,0,0
3,GO CELL FATE COMMITMENT,0.44402,0.018264,0.025886,0,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.70355,0.018197,-0.026016,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.22568,0.018069,0.11764,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.79636,0.018046,-0.0226,0,0
3,GO ASYMMETRIC CELL DIVISION,0.26098,0.018005,0.11056,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.82348,0.017887,-0.0093762,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.52025,0.017689,0.058765,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.82348,0.017648,-0.010541,0,0
3,GO NEUROMUSCULAR PROCESS,0.84397,0.017586,-0.02355,0,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.38888,0.017537,0.022225,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.91293,0.017476,0.00036474,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.66501,0.01743,-0.00039717,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.5726,0.017282,-0.044828,0,0
3,GO HISTONE H3 K4 METHYLATION,0.73628,0.017278,-0.0068644,0,0
3,GO LIPID PHOSPHORYLATION,0.83713,0.017276,0.0095307,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.19695,0.017198,0.15338,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.72313,0.017176,-0.021189,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.65866,0.017097,0.010117,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.64605,0.017091,0.087063,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.83713,0.016991,0.0069037,0,0
3,GO RRNA 3 END PROCESSING,0.63978,0.01695,-0.035346,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.29992,0.016863,0.029343,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.89907,0.016861,-0.019767,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.91293,0.016845,-0.012948,0,0
3,GO MESENCHYME DEVELOPMENT,0.73628,0.016731,-0.042263,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.89215,0.016703,-0.010472,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.97557,0.016614,-0.010938,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.91987,0.016533,-0.016456,0,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.63978,0.016382,-0.029466,0,0
3,GO MIDBRAIN DEVELOPMENT,0.73628,0.016263,0.0064492,0,0
3,GO RESPONSE TO LEUCINE,0.39371,0.01624,0.089176,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.59059,0.016215,-0.046008,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.60272,0.016206,-0.0038321,0,0
3,GO MALE GAMETE GENERATION,0.36526,0.015993,0.031343,0,0
3,GO ENSHEATHMENT OF NEURONS,0.51459,0.015909,0.036882,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.97557,0.015879,-0.0049268,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.67137,0.015867,0.0096702,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.23589,0.015808,0.055853,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.93377,0.015722,-0.059713,0,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.57857,0.015645,0.0252,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.56666,0.015583,-0.027247,0,0
3,GO MACROMOLECULE DEACYLATION,0.63978,0.015581,0.012911,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.49227,0.01557,-0.069342,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.84397,0.015514,-0.0054246,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.92682,0.01548,0.012261,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.29184,0.015311,0.037234,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.71006,0.015275,-0.03396,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.70355,0.015233,0.038301,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.54321,0.015232,0.032613,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.4978,0.015203,0.020852,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.94073,0.015201,-0.015859,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.48678,0.015199,0.02704,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.95466,0.015154,-0.027534,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.77618,0.01486,-0.014314,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.73628,0.01486,-0.022928,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.84397,0.014839,0.011819,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.72969,0.01463,0.016153,0,0
3,GO MESODERM MORPHOGENESIS,0.82348,0.014622,-0.0048945,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.66501,0.01462,0.024225,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.71006,0.014594,0.0093466,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.91293,0.014569,0.0039885,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.43367,0.014538,0.051078,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.7495,0.014509,-0.025894,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.84397,0.014436,-0.000202,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.71658,0.014326,0.0071091,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.55487,0.014279,0.027999,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.86455,0.014238,-0.017489,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.4598,0.014214,0.061924,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.71006,0.014058,0.012868,0,0
3,GO HEART MORPHOGENESIS,0.83713,0.014049,-0.029896,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.91987,0.014005,-0.018998,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.78962,0.013975,-0.020223,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.44924,0.013967,0.072796,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.56666,0.013914,0.01603,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.90599,0.013901,0.0024717,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.82348,0.013896,0.018838,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.89215,0.013887,-0.010686,0,0
3,GO PINOCYTOSIS,0.93377,0.0138,-0.051803,0,0
3,GO HISTONE DEACETYLATION,0.77618,0.01377,0.003238,0,0
3,GO MACROPHAGE PROLIFERATION,0.34702,0.013553,0.083589,0,0
3,GO MULTI ORGANISM PROCESS,0.24288,0.013512,0.039319,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.22235,0.013502,0.13871,0,0
3,GO HISTONE H3 K9 METHYLATION,0.7495,0.013458,0.0089551,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.57857,0.013368,0.076898,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.7495,0.013223,0.010347,0,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.86455,0.013161,-0.00022165,0,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.82348,0.013103,0.0038382,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.83713,0.013031,0.0035526,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.80989,0.012695,-0.010843,0,0
3,GO MITOCHONDRION ORGANIZATION,0.43367,0.012668,0.016608,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.7495,0.01263,0.0092426,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.67137,0.01261,0.0039545,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.36526,0.012435,0.012484,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.48131,0.012326,0.041866,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.78289,0.012295,0.013372,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.86455,0.012271,-0.0065688,0,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.35153,0.012237,0.031942,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.72313,0.012177,0.023269,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.73628,0.012122,-0.066979,0,0
3,GO AMINO ACID TRANSPORT,0.78962,0.012101,0.022241,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.47588,0.011988,0.063712,0,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.69707,0.011985,0.0051995,0,0
3,GO MESENCHYME MORPHOGENESIS,0.92682,0.011967,-0.034194,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.95466,0.011961,-0.012143,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.9686,0.011948,-0.034374,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.77618,0.01186,-0.025563,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.39371,0.011823,-0.12505,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.93377,0.011766,-0.0097177,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.87833,0.01152,-0.0050489,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.71658,0.011519,-0.0045763,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.8303,0.011383,-0.0057024,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.82348,0.011363,0.00090329,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.54321,0.011354,0.022384,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.95466,0.011351,-0.010145,0,0
3,GO REGULATION OF PINOCYTOSIS,0.61497,0.011296,-0.089384,0,0
3,GO HEART GROWTH,0.86455,0.011288,-0.016389,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.9686,0.011191,-0.053496,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.84397,0.011133,-0.0039368,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.76281,0.011098,-0.027066,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.80989,0.010997,-0.003366,0,0
3,GO ORGANELLE LOCALIZATION,0.71006,0.010984,0.012547,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.53742,0.01096,0.011489,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.94073,0.010819,-0.0098993,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.83713,0.010721,-0.013473,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.85082,0.010716,-0.013479,0,0
3,GO CELL CYCLE ARREST,0.91293,0.010707,-0.0014766,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.48131,0.010651,0.059614,0,0
3,GO AORTA DEVELOPMENT,0.68418,0.010585,-0.068935,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.91987,0.010569,-0.010928,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.36526,0.010531,-0.062237,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.65234,0.010521,-0.029108,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.46512,0.010452,0.033351,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.8303,0.010399,-0.0070326,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.66501,0.010221,0.014446,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.87833,0.010117,0.02364,0,0
3,GO WATER TRANSPORT,0.36064,0.0098168,0.016079,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.94073,0.0098011,0.0033157,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.63978,0.0097629,-0.036851,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.69707,0.0097067,0.018181,0,0
3,GO METENCEPHALON DEVELOPMENT,0.86455,0.0096392,0.014584,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.49227,0.0093538,0.045399,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.99651,0.0091894,-0.0055227,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.75615,0.0090838,-0.010154,0,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.67776,0.0090282,-0.037088,0,0
3,GO REGULATION OF DNA BINDING,0.63978,0.0090058,0.028019,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.75615,0.0089955,0.053949,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.7495,0.0089871,0.0067522,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.65866,0.0088656,0.018701,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.63978,0.0088571,0.03733,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.89215,0.0088198,-0.021869,0,0
3,GO HEAD MORPHOGENESIS,0.58456,0.0086596,-0.070429,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.92682,0.0085682,0.0041802,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.73628,0.0085176,0.017033,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.47588,0.0082518,-0.019244,0,0
3,GO CARTILAGE DEVELOPMENT,0.96163,0.0082319,-0.015197,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.52594,0.0081544,-0.023269,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.89215,0.0080746,0.00079746,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.61497,0.0080584,0.023479,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.87144,0.0080472,-0.021085,0,0
3,GO CELL MORPHOGENESIS,0.53167,0.0079726,-0.039493,0,0
3,GO NEUROGENESIS,0.78289,0.0076619,-0.023919,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.9686,0.0075994,-0.0056633,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.92682,0.0075825,-0.011032,0,0
3,GO METHYLATION,0.56666,0.0073044,-0.024906,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.26847,0.0071725,0.093849,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.79636,0.0071211,-0.0041655,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.54903,0.0069594,0.039771,0,0
3,GO DEMETHYLATION,0.46512,0.0068863,0.027999,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.46512,0.006835,0.022972,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.62732,0.0067849,-0.033042,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.84397,0.0067548,-0.04486,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.7495,0.0065831,-0.011999,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.75615,0.0065645,0.011322,0,0
3,GO NEURON APOPTOTIC PROCESS,0.86455,0.0064092,0.008326,0,0
3,GO HEART DEVELOPMENT,0.93377,0.0063791,-0.0043646,0,0
3,GO BODY MORPHOGENESIS,0.9686,0.0063036,-0.009135,0,0
3,GO FIBRINOLYSIS,0.98255,0.0062454,-0.08854,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.65234,0.0062383,0.011724,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.58456,0.006148,-0.018956,0,0
3,GO MIRNA METABOLIC PROCESS,0.38888,0.0061274,-0.060589,0,0
3,GO EPIBOLY,0.84397,0.0061151,-0.024873,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.98953,0.0060863,-0.00018274,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.59664,0.0060098,-0.014465,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.79636,0.0059374,0.011644,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.71658,0.0059161,0.033484,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.87833,0.0059025,0.00051958,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.82348,0.0058446,-0.020309,0,0
3,GO HEPARIN METABOLIC PROCESS,0.80312,0.0058243,0.0099864,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.59059,0.0057607,0.020982,0,0
3,GO RENAL SODIUM EXCRETION,0.65866,0.0057016,0.031267,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.38888,0.0055215,-0.055334,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.74288,0.0054773,0.001634,0,0
3,GO HISTONE MONOUBIQUITINATION,0.9686,0.005439,0.0037232,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.67137,0.0052457,0.0625,0,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.47588,0.0052018,0.033056,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.41842,0.0051925,-0.059326,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.83713,0.005058,0.042319,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.52025,0.0050115,-0.069919,0,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.71658,0.0049688,-0.0011718,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.7495,0.0049682,-0.00034911,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.97557,0.0049643,-0.020765,0,0
3,GO CENTROSOME SEPARATION,0.83713,0.0049136,0.030279,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.34256,0.0048027,-0.076327,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.71658,0.0047368,-0.031048,0,0
3,GO SYNAPTIC SIGNALING,0.51459,0.0047103,-0.038936,0,0
3,GO GAMETE GENERATION,0.32077,0.0046759,0.031332,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.82348,0.0046412,-0.020999,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.0045736,-0.022315,0,0
3,GO PROTEIN STABILIZATION,0.65234,0.0045355,0.0060833,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.99651,0.004493,-0.0070065,0,0
3,GO TRNA 5 END PROCESSING,0.61497,0.0044446,-0.049757,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.29184,0.0044319,0.047607,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.85082,0.004254,-0.010197,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.78289,0.0041982,0.019963,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.62732,0.004192,0.018259,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.69061,0.0041842,-0.021629,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.40349,0.004149,-0.058672,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.64605,0.0039346,0.036266,0,0
3,GO NEURON FATE COMMITMENT,0.91987,0.0039162,0.044864,0,0
3,GO PROTEIN POLYMERIZATION,0.98255,0.0037683,-0.0069665,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.91293,0.0037098,-0.0033037,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.93377,0.0036194,-0.018565,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.36064,0.0035332,-0.048466,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.87833,0.0034601,0.037924,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.92682,0.0033489,-0.0085465,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.67137,0.0033154,0.015691,0,0
3,GO PROTEIN TARGETING,0.50896,0.0033041,-0.034967,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.72313,0.0032296,0.0064494,0,0
3,GO RESPONSE TO POTASSIUM ION,0.83713,0.0032238,-0.012541,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.92682,0.00322,-0.00078964,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.53742,0.0031901,-0.055385,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.96163,0.0031174,-0.0056724,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.83713,0.0030465,0.0048782,0,0
3,GO PORE COMPLEX ASSEMBLY,0.65234,0.0030176,-0.045686,0,0
3,GO ALDITOL METABOLIC PROCESS,1,0.0029638,-0.0096384,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.80989,0.0029435,0.017044,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.69061,0.0028716,0.0051338,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.87833,0.0028582,-0.030063,0,0
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.43883,0.0028289,0.071676,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.91987,0.0026787,-0.021435,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.95466,0.0026238,0.0013476,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.48131,0.0026063,-0.047671,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.38408,0.0024465,0.086698,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.82348,0.0023428,0.012288,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.97557,0.0022843,-0.02306,0,0
3,GO CELL RECOGNITION,0.89907,0.0022374,0.0049796,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1,0.0021306,0.00072888,0,0
3,GO CYTOKINESIS,0.8303,0.0021196,-0.0081712,0,0
3,GO NON RECOMBINATIONAL REPAIR,0.85768,0.0020675,-0.01464,0,0
3,GO MITOTIC CYTOKINESIS,0.88523,0.0020523,-0.01121,0,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.63354,0.0020074,0.029069,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.87833,0.0019757,0.012019,0,0
3,GO REGULATION OF DNA METHYLATION,0.94073,0.0019156,0.01302,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.60883,0.001878,0.016828,0,0
3,GO CELL FATE SPECIFICATION,0.91987,0.0018618,0.00032175,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.49227,0.0018554,-0.10108,0,0
3,GO AXONAL FASCICULATION,0.58456,0.0018092,-0.058299,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.92682,0.0016216,0.015395,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.65234,0.0015879,-0.036633,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.61497,0.0015768,-0.00062529,0,0
3,GO P BODY ASSEMBLY,0.59059,0.0015014,0.01793,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.35607,0.0013996,-0.044201,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.75615,0.0013136,0.028696,0,0
3,GO T CELL CHEMOTAXIS,0.65234,0.0012771,-0.040478,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.53742,0.0012317,-0.021888,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.97557,0.0011253,0.008767,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.36991,0.0010809,-0.036669,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.76281,0.00098277,0.010479,0,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.89215,0.00096306,0.0021494,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.59664,0.00088272,-0.058044,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.59059,0.00082454,-0.059818,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.65866,0.00073266,0.03185,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.78962,0.00070468,0.0047291,0,0
3,GO HEAD DEVELOPMENT,0.93377,0.00066754,0.001366,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.85082,0.00054505,-0.025946,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.65234,0.0005153,-0.0032246,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.69061,0.00038066,-0.035716,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.33812,0.00032584,-0.051182,0,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.23589,0.00028269,-0.16409,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.91293,-3.587e-05,-0.03598,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.36064,-0.00010891,-0.13656,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.81668,-0.00012915,-0.021572,0,0
3,GO RESPONSE TO HEAT,0.38888,-0.00017115,-0.039835,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.74288,-0.00019507,-0.0071045,0,0
3,GO HISTONE H3 DEACETYLATION,0.72313,-0.00019553,-0.016958,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.39371,-0.00029505,0.033043,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.57857,-0.00041905,0.074194,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.5726,-0.00048334,-0.061884,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.59059,-0.00054554,0.022492,0,0
3,GO PIGMENT ACCUMULATION,0.75615,-0.00079011,-0.034266,0,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.91293,-0.00081348,0.019517,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.94769,-0.00094614,0.025265,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.98953,-0.00095498,-0.069367,0,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.35607,-0.0009837,-0.073417,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.63354,-0.001062,0.029596,0,0
3,GO COGNITION,0.63978,-0.0011149,-0.032819,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.63978,-0.0011237,0.05563,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.93377,-0.0011313,-0.00082049,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.48131,-0.0012078,-0.085893,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.69061,-0.0012251,-0.016028,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.91293,-0.0012342,-0.017715,0,0
3,GO SUCKLING BEHAVIOR,0.67137,-0.0012796,-0.056766,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.69707,-0.001431,0.027484,0,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.9686,-0.0014374,0.042598,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.77618,-0.0015043,0.008116,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.97557,-0.0015926,0.011323,0,0
3,GO MICROTUBULE ANCHORING,0.36526,-0.0018467,-0.040706,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.26471,-0.0019052,-0.10173,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.57857,-0.0021124,-0.026539,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,-0.002128,-0.048692,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.98255,-0.0021901,0.0077899,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.54903,-0.002261,-0.053573,0,0
3,GO RECEPTOR INTERNALIZATION,0.42855,-0.0022673,-0.053531,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.80312,-0.0025533,-0.012382,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.76281,-0.0027595,0.020593,0,0
3,GO STRIATUM DEVELOPMENT,0.77618,-0.0027939,0.02307,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.89215,-0.0028882,0.0055576,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.98953,-0.0028982,0.013975,0,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.86455,-0.0030181,0.032559,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.35607,-0.0030354,0.028058,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.94073,-0.003046,0.0057906,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.96163,-0.0030783,0.0078678,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.50337,-0.0030917,-0.073849,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.75615,-0.0031114,-0.043658,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.78289,-0.0031357,-0.058667,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.98953,-0.0031359,0.015284,0,0
3,GO CELL AGING,0.88523,-0.0032472,-0.0017361,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.53742,-0.0033493,-0.061626,0,0
3,GO NUCLEUS ORGANIZATION,0.81668,-0.0033867,-0.013424,0,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.96163,-0.0034439,0.0035966,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.55487,-0.0034921,-0.040771,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.85768,-0.0035868,0.0027261,0,0
3,GO ERYTHROCYTE DEVELOPMENT,0.53742,-0.0035982,-0.034446,0,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.54903,-0.0036303,-0.049651,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.29184,-0.0036478,-0.13661,0,0
3,GO MEMBRANE DOCKING,0.79636,-0.0036911,0.0058232,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.86455,-0.0037417,-0.010653,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.48678,-0.003761,-0.088124,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.78962,-0.0038738,-0.015357,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.72313,-0.0038786,0.0048768,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.62113,-0.0039016,0.025687,0,0
3,GO REPLACEMENT OSSIFICATION,0.43367,-0.0039053,-0.079697,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.91987,-0.0041846,0.0077834,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.71658,-0.0042543,-0.038263,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.47049,-0.0042844,-0.046236,0,0
3,GO HEME METABOLIC PROCESS,0.78962,-0.0042895,-0.073407,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.87144,-0.004297,-0.01072,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.47049,-0.0043616,0.091115,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.98255,-0.0043996,-0.027009,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.58456,-0.0045809,-0.052714,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.35153,-0.0046584,-0.046191,0,0
3,GO GENITALIA MORPHOGENESIS,0.89907,-0.0047053,-0.021801,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.59059,-0.0047627,-0.046006,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.82348,-0.0051652,0.021187,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.33812,-0.0051897,-0.1647,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.91987,-0.0052938,-0.0060368,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.55487,-0.0053081,-0.054615,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.48678,-0.0053219,-0.058487,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.98255,-0.0053533,-0.010438,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.60883,-0.0054084,0.030219,0,0
3,GO STEROID CATABOLIC PROCESS,0.29586,-0.0054693,0.085072,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.9686,-0.0055289,-0.0014462,0,0
3,GO DECIDUALIZATION,0.33812,-0.0055702,-0.11268,0,0
3,GO BONE DEVELOPMENT,0.25363,-0.0057079,-0.074096,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.72969,-0.005767,-0.023447,0,0
3,GO CELL PROJECTION ORGANIZATION,0.81668,-0.0058037,-0.014621,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.78962,-0.0058243,-0.0019618,0,0
3,GO REGULATION OF BEHAVIOR,0.66501,-0.0059552,-0.027899,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.92682,-0.0059672,-0.0037483,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.98953,-0.0060926,0.0054437,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.72313,-0.0061147,0.0058448,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.78289,-0.0061732,-0.043535,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.31653,-0.0063217,-0.071874,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.95466,-0.0063646,-0.004908,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.83713,-0.0064562,0.0040324,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.75615,-0.0065932,0.025515,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.82348,-0.0065961,0.006409,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.87833,-0.0068018,-0.029356,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.38408,-0.006831,-0.11016,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.77618,-0.0069615,-0.014363,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.40349,-0.0069909,-0.12321,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.60883,-0.0071173,-0.06656,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.72313,-0.0071709,-0.021531,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.90599,-0.0071876,-0.030701,0,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.82348,-0.0072222,-0.063464,0,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.32506,-0.00734,-0.061584,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.65234,-0.0075133,-0.05238,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.7495,-0.0075588,0.064644,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.55487,-0.0076442,-0.07603,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.60883,-0.0077188,-0.046405,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.78289,-0.007729,-0.043362,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.76281,-0.0077988,0.0094145,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.60883,-0.0078163,-0.016417,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.78962,-0.0078165,-0.032223,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.71658,-0.0079843,-0.032039,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.40843,-0.0080535,-0.083438,0,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.89907,-0.0081346,-0.050064,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.82348,-0.0082222,-0.057964,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.44402,-0.0082334,-0.060195,0,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.66501,-0.0083819,-0.01106,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.71658,-0.0085301,-0.02296,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.90599,-0.0088023,-0.0095997,0,0
3,GO SEGMENTATION,0.88523,-0.0088074,0.0045427,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.74288,-0.008927,-0.050251,0,0
3,GO REGULATION OF CELL SIZE,0.25729,-0.0089959,-0.077806,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.88523,-0.0090118,-0.0069688,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.44402,-0.009286,-0.037337,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.4598,-0.0092923,-0.03916,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.98953,-0.0093784,-0.013205,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.43883,-0.0093982,-0.020431,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.97557,-0.0094415,-0.0011676,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.3746,-0.0096937,-0.039103,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.70355,-0.009761,-0.015582,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.50896,-0.0098141,-0.044575,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.26098,-0.0099479,-0.052736,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.90599,-0.010001,-0.013972,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.34256,-0.010054,-0.094658,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.18219,-0.010061,-0.047266,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.59059,-0.010258,-0.026898,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,-0.010359,-0.086816,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.89907,-0.010464,-0.0078679,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.34256,-0.010551,-0.074398,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.85768,-0.010634,-0.044457,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.55487,-0.011148,-0.057135,0,0
3,GO CELLULAR SENESCENCE,0.68418,-0.011194,-0.016277,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.3746,-0.011303,-0.089097,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.67137,-0.011479,-0.026145,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.53167,-0.011605,-0.020725,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.91987,-0.011682,-0.01304,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.87833,-0.011735,-0.041994,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.47049,-0.011832,-0.047912,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.72969,-0.011922,-0.0086371,0,0
3,GO ORGANELLE ASSEMBLY,0.70355,-0.011948,-0.0072435,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.79636,-0.01196,0.033055,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.36064,-0.011971,-0.032878,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.56075,-0.012054,-0.052395,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.99651,-0.012186,0.00052499,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.38408,-0.012208,-0.04686,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.62113,-0.012388,-0.054886,0,0
3,GO REGULATION OF CELL DIVISION,0.87144,-0.012574,-0.0049385,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.39858,-0.01261,-0.071776,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.98953,-0.012818,-0.031206,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.53167,-0.012872,-0.026826,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.32938,-0.01293,-0.043836,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.83713,-0.012951,-0.020756,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.80989,-0.012982,-0.0031409,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.32506,-0.012982,-0.024146,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.89907,-0.013053,-0.025057,0,0
3,GO REGULATION OF CELL CYCLE,0.80312,-0.013274,0.0044215,0,0
3,GO FOREBRAIN CELL MIGRATION,0.40843,-0.013335,-0.066817,0,0
3,GO DNA METHYLATION,0.89215,-0.013439,-0.005976,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.75615,-0.013538,-0.070141,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.36526,-0.013565,-0.030205,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.48678,-0.013755,-0.034055,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.92682,-0.013761,0.021353,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.98255,-0.013868,0.028416,0,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.56666,-0.013888,-0.14622,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.88523,-0.013929,-0.0021186,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.9686,-0.013937,-0.016541,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.98953,-0.014004,-0.051265,0,0
3,GO CHROMATIN ORGANIZATION,0.21256,-0.014139,-0.030151,0,0
3,GO DOSAGE COMPENSATION,0.80312,-0.014245,-0.0050895,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.31653,-0.014286,-0.070272,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.81668,-0.014311,-0.026686,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.9686,-0.014366,-0.010223,0,0
3,GO CILIUM ORGANIZATION,1,-0.014421,0.0026747,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.87833,-0.014511,0.0090842,0,0
3,GO REGULATION OF URINE VOLUME,0.4978,-0.014621,-0.053726,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.38408,-0.014843,-0.034291,0,0
3,GO GENE SILENCING,0.76948,-0.01489,-0.020359,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.50896,-0.0149,-0.049405,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.67137,-0.014904,-0.021459,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.29586,-0.015312,-0.054251,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.97557,-0.015519,-0.014434,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.50896,-0.015578,-0.082639,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.30402,-0.015634,-0.09579,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.87833,-0.015785,-0.029243,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.98255,-0.015887,0.00082226,0,0
3,GO GASTRULATION,0.76948,-0.015905,-0.036229,0,0
3,GO MUSCLE FILAMENT SLIDING,0.39858,-0.015908,-0.081442,0,0
3,GO PROTEIN REFOLDING,0.67137,-0.016203,0.02284,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1,-0.016205,-0.0080106,0,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.75615,-0.016214,0.017023,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.17653,-0.01622,-0.13327,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.4598,-0.016288,0.17843,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.33812,-0.016348,-0.077657,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.46512,-0.016393,-0.050127,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.89907,-0.016426,-0.027159,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.5726,-0.016486,-0.077997,0,0
3,GO PROTEIN IMPORT,0.28785,-0.01654,-0.042888,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.49227,-0.016561,-0.048596,0,0
3,GO RESPONSE TO MANGANESE ION,0.72969,-0.01673,-0.035625,0,0
3,GO EXIT FROM MITOSIS,0.99651,-0.0169,-0.003415,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.60883,-0.017077,-0.012957,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.89907,-0.017077,-0.017276,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.40843,-0.01718,-0.036314,0,0
3,GO ARTERY DEVELOPMENT,0.42347,-0.017242,-0.068699,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.89215,-0.017295,-0.016881,0,0
3,GO NEURON DIFFERENTIATION,0.63354,-0.017376,-0.032936,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.84397,-0.017399,-0.016203,0,0
3,GO PROTEIN ACYLATION,0.40349,-0.017423,-0.013348,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58456,-0.017496,-0.055228,0,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.11841,-0.017567,-0.065085,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.3746,-0.017693,-0.028186,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.81668,-0.018,-0.0060215,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.4545,-0.018049,-0.029045,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.52594,-0.018111,0.099243,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.42347,-0.018122,-0.033155,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.27611,-0.018189,-0.064265,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,1,-0.018478,0.0054982,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.82348,-0.018726,0.013563,0,0
3,GO HYPOTONIC RESPONSE,0.60272,-0.018737,-0.041624,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.69707,-0.018821,-0.014225,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.2,-0.019071,-0.031332,0,0
3,GO SULFATE TRANSPORT,0.87144,-0.019154,0.030096,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.69061,-0.01924,0.053693,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.25001,-0.019293,-0.063005,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.36991,-0.019454,-0.0782,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.33812,-0.019488,-0.081416,0,0
3,GO CELLULAR RESPONSE TO ATP,0.58456,-0.019504,-0.02339,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.51459,-0.019641,-0.02424,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.66501,-0.02007,-0.037839,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.14048,-0.020139,-0.084303,0,0
3,GO ANIMAL ORGAN FORMATION,0.58456,-0.020271,-0.054614,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.3746,-0.020356,-0.026453,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.85768,-0.02043,0.012124,0,0
3,GO ORGANELLE FISSION,0.47049,-0.020464,-0.013963,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.38408,-0.020615,-0.081212,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.95466,-0.020674,-0.0016562,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.40843,-0.020721,-0.061143,0,0
3,GO NCRNA 3 END PROCESSING,0.38888,-0.020744,-0.098476,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.67137,-0.020763,-0.020089,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.62732,-0.021072,-0.040097,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.98255,-0.021321,0.0051438,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.23937,-0.021409,-0.079032,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.44402,-0.021484,-0.059221,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.25363,-0.021601,-0.025929,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.54903,-0.021617,-0.017299,0,0
3,GO THYROID GLAND DEVELOPMENT,0.69061,-0.021674,-0.01653,0,0
3,GO DNA PACKAGING,0.26847,-0.021722,-0.032275,0,0
3,GO REGULATION OF AXONOGENESIS,0.18508,-0.021756,-0.1256,0,0
3,GO PROTEIN METHYLATION,0.78962,-0.021847,-0.0090049,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.24288,-0.022091,-0.031008,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.72969,-0.022258,-0.11631,0,0
3,GO NEURON DEVELOPMENT,0.56075,-0.022614,-0.035698,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.10465,-0.022673,-0.028811,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.87833,-0.022699,-0.0085011,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.38888,-0.022759,-0.045049,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.022825,-0.049636,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.79636,-0.022876,-0.031079,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.91293,-0.02292,0.016999,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.43883,-0.023028,-0.052115,0,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.11434,-0.023054,-0.053972,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.83713,-0.023151,-0.038278,0,0
3,GO HISTONE METHYLATION,0.58456,-0.023196,-0.018461,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.71658,-0.023275,0.024785,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.54321,-0.023312,-0.098497,0,0
3,GO MITOTIC CELL CYCLE,0.24288,-0.023352,-0.023993,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.32077,-0.023414,-0.056174,0,0
3,GO LIVER REGENERATION,0.50896,-0.023446,-0.089824,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.71006,-0.023492,0.020892,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.86455,-0.023495,-0.0047067,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.4598,-0.023497,-0.085284,0,0
3,GO COENZYME A METABOLIC PROCESS,0.92682,-0.023509,0.00082069,0,0
3,GO HISTONE H4 ACETYLATION,0.69061,-0.023817,-0.0019151,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.46512,-0.023838,-0.070686,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.19393,-0.023935,-0.029389,0,0
3,GO DNA CONFORMATION CHANGE,0.12259,-0.023952,-0.049956,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.67137,-0.024001,-0.0088626,0,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.66501,-0.024057,0.053377,0,0
3,GO MRNA TRANSCRIPTION,0.35607,-0.024095,-0.064311,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.43367,-0.02417,-0.054903,0,0
3,GO ORGAN GROWTH,0.29184,-0.024288,-0.057886,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.10465,-0.024326,-0.068331,0,0
3,GO REGULATION OF ORGAN GROWTH,0.16828,-0.024525,-0.08048,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.53742,-0.024606,-0.0435,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.42855,-0.02463,-0.059182,0,0
3,GO ONE CARBON COMPOUND TRANSPORT,0.95466,-0.024889,-0.038816,0,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.66501,-0.02492,-0.013104,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.98953,-0.024947,-0.058656,0,0
3,GO HISTONE H2A UBIQUITINATION,0.28785,-0.025237,-0.045555,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.31653,-0.025264,-0.021188,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.61497,-0.025384,0.0073922,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.62732,-0.025411,-0.028721,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.94073,-0.025588,-0.0084774,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.43367,-0.025671,-0.078553,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.29184,-0.02592,-0.092111,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.11636,-0.026012,-0.055131,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.95466,-0.02603,-0.0080993,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.54903,-0.026098,-0.042714,0,0
3,GO RESPONSE TO VITAMIN A,0.35607,-0.026174,-0.089607,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.32938,-0.026236,-0.070998,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.52594,-0.026352,-0.034846,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.20309,-0.026379,-0.062808,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.65866,-0.026451,-0.068656,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.9686,-0.026457,-0.023969,0,0
3,GO INTERACTION WITH SYMBIONT,0.62732,-0.026533,-0.051622,0,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.27611,-0.026646,-0.067545,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.17653,-0.026731,-0.036667,0,0
3,GO AMP METABOLIC PROCESS,0.78289,-0.026791,-0.025446,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.67137,-0.026801,-0.026248,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.56666,-0.026887,-0.061115,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.7495,-0.02689,0.0041169,0,0
3,GO CELL CYCLE,0.63978,-0.027082,-0.0092442,0,0
3,GO AXIS ELONGATION,0.72969,-0.027178,-0.04669,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.68418,-0.02723,-0.085382,0,0
3,GO ODONTOGENESIS,0.4545,-0.027247,-0.061938,0,0
3,GO PROTEIN SUMOYLATION,0.17934,-0.027282,-0.040811,0,0
3,GO IMPORT INTO NUCLEUS,0.14048,-0.027343,-0.056177,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.97557,-0.027494,0.0026499,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.1028,-0.027551,-0.14174,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.3746,-0.027572,-0.061553,0,0
3,GO STEM CELL DIFFERENTIATION,0.19695,-0.027588,-0.045882,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.86455,-0.027713,0.012541,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.92682,-0.027873,-0.0023706,0,0
3,GO SYNAPTIC VESICLE DOCKING,0.92682,-0.027911,0.055736,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.76948,-0.028094,-0.015331,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.90599,-0.028119,0.0022406,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.093897,-0.028139,-0.11618,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.76281,-0.028254,-0.015856,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.90599,-0.028261,0.022105,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.27999,-0.028297,-0.08288,0,0
3,GO MESODERM DEVELOPMENT,0.50896,-0.028324,-0.041536,0,0
3,GO CELL CYCLE CHECKPOINT,0.36991,-0.028352,-0.023792,0,0
3,GO VIRAL LATENCY,0.24643,-0.028423,-0.10199,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.19095,-0.028436,-0.030174,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.25363,-0.028618,-0.035109,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.17099,-0.028695,-0.11903,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.26847,-0.028732,-0.081338,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.69707,-0.028781,0.036145,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.91293,-0.028799,-0.015663,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.56666,-0.028981,-0.017897,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.088862,-0.029088,-0.12676,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.31232,-0.029154,-0.052511,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.40843,-0.029197,-0.060021,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.4978,-0.02921,-0.010558,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.19695,-0.029339,-0.048002,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.95466,-0.029339,-0.023077,0,0
3,GO ARGININE METABOLIC PROCESS,0.91987,-0.029388,-0.034432,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.46512,-0.029525,-0.018843,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.53742,-0.029553,-0.042293,0,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.81668,-0.029764,-0.033076,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.30815,-0.029878,-0.12529,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.94769,-0.029891,0.0057886,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.11039,-0.029914,-0.074908,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.42855,-0.030148,-0.066576,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.20309,-0.030159,-0.054963,0,0
3,GO DNA METABOLIC PROCESS,0.18219,-0.030288,-0.031076,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.35153,-0.03032,-0.11579,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.14048,-0.03048,-0.15572,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.56075,-0.030508,-0.012461,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.82348,-0.030558,0.027776,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.56075,-0.030642,-0.025413,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.4978,-0.030681,-0.045709,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.47588,-0.030909,-0.050636,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.38888,-0.030966,-0.045017,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.97557,-0.03109,0.014328,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.59664,-0.031147,-0.041271,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.3746,-0.031275,-0.057849,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.90599,-0.031373,-0.014636,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.23937,-0.031384,-0.11964,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.98255,-0.031435,0.010737,0,0
3,GO RNA CATABOLIC PROCESS,0.188,-0.031554,-0.079532,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.95466,-0.031566,-0.011005,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.77618,-0.031676,0.043234,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.25729,-0.031778,-0.05779,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.17099,-0.03179,-0.12266,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.26471,-0.031929,-0.16944,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.097379,-0.032038,-0.051312,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.91293,-0.032124,-0.0049036,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.29586,-0.032143,-0.088392,0,0
3,GO NEURON PROJECTION REGENERATION,0.4598,-0.032145,-0.074937,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.26847,-0.032203,-0.11983,0,0
3,GO SYNAPSE ORGANIZATION,0.33373,-0.032219,-0.061432,0,0
3,GO FATTY ACID HOMEOSTASIS,0.67137,-0.032223,-0.034993,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.22235,-0.032281,-0.051743,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.98255,-0.032283,-0.01766,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.69707,-0.03233,-0.021802,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.99651,-0.032337,-0.031208,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.23589,-0.032384,-0.10578,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.50896,-0.032397,-0.043822,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.46512,-0.032452,-0.04719,0,0
3,GO ADULT FEEDING BEHAVIOR,0.24288,-0.032711,-0.11274,0,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.38888,-0.032892,-0.045526,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.91293,-0.032897,0.055582,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.049546,-0.032996,-0.058066,0,0
3,GO MITOCHONDRIAL FUSION,0.59664,-0.033087,-0.028349,0,0
3,GO CELL CYCLE PROCESS,0.13355,-0.033172,-0.028592,0,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.2,-0.033273,-0.057327,0,0
3,GO NEURON RECOGNITION,0.38408,-0.033415,-0.085744,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.26847,-0.033491,-0.037422,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.48678,-0.033527,-0.1109,0,0
3,GO ATP TRANSPORT,0.80312,-0.033686,0.013498,0,0
3,GO FOREGUT MORPHOGENESIS,0.38888,-0.033726,-0.081268,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.27999,-0.033779,-0.052696,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.58456,-0.033798,-0.047399,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.51459,-0.033845,-0.084786,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.34256,-0.033866,-0.065671,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.44924,-0.033866,-0.024174,0,0
3,GO REGULATION OF CYTOKINESIS,0.42347,-0.034325,-0.019775,0,0
3,GO ECTODERM DEVELOPMENT,0.84397,-0.034343,-0.0017296,0,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.55487,-0.034377,-0.031074,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.2,-0.034425,-0.080804,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.50896,-0.034665,-0.022589,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.21256,-0.034757,-0.085342,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.96163,-0.034794,-0.015379,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.57857,-0.034801,-0.041219,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.12908,-0.034968,-0.099681,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.63354,-0.035012,-0.04058,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.46512,-0.035019,-0.040217,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.15517,-0.035253,-0.052396,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.62113,-0.035336,-0.030671,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.3746,-0.035338,-0.11621,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.43367,-0.035529,-0.092709,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.85768,-0.035547,-0.0060266,0,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.21256,-0.035589,-0.061144,0,0
3,GO PROTEASOME ASSEMBLY,0.41842,-0.035606,-0.076682,0,0
3,GO NUCLEAR EXPORT,0.084046,-0.035674,-0.068973,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.70355,-0.035723,-0.020991,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.93377,-0.035747,-0.016684,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.95466,-0.035832,-0.020748,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.93377,-0.035868,0.02484,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.40843,-0.036143,-0.048975,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.080955,-0.036263,-0.070067,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.58456,-0.036297,-0.059178,0,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.092194,-0.036527,-0.11721,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.47049,-0.036539,-0.062168,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.70355,-0.036581,-0.032619,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.36064,-0.036622,-0.039999,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.52594,-0.03664,-0.037631,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.13583,-0.036697,-0.10967,0,0
3,GO PROTEIN NITROSYLATION,0.25363,-0.036814,-0.14611,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.38408,-0.036933,-0.05304,0,0
3,GO MICROTUBULE BASED PROCESS,0.084046,-0.036967,-0.042271,0,0
3,GO CGMP MEDIATED SIGNALING,0.3746,-0.037154,-0.055706,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.20309,-0.03717,-0.041059,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.63978,-0.037181,-0.026014,0,0
3,GO METAPHASE PLATE CONGRESSION,0.64605,-0.037209,-0.0027661,0,0
3,GO CRISTAE FORMATION,0.50337,-0.037626,-0.058897,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.037875,-0.079286,0,0
3,GO REGULATION OF CELL AGING,0.31653,-0.037918,-0.059081,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.38408,-0.03801,-0.049577,0,0
3,GO RNA POLYADENYLATION,0.077957,-0.038296,-0.075222,0,0
3,GO DNA REPAIR,0.080955,-0.038338,-0.043467,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.31653,-0.038347,-0.070542,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.57857,-0.038504,-0.060802,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.38408,-0.038565,-0.10701,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.05824,-0.038703,-0.094021,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.12689,-0.038842,-0.1,0,0
3,GO CHROMOSOME LOCALIZATION,0.67776,-0.038939,-0.002383,0,0
3,GO SPINDLE ASSEMBLY,0.12259,-0.039064,-0.048512,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.18219,-0.039259,-0.10843,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.53167,-0.039272,-0.058377,0,0
3,GO URETER DEVELOPMENT,0.75615,-0.039276,-0.05141,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.32938,-0.039402,-0.027389,0,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.16559,-0.039499,-0.036617,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.20621,-0.039702,-0.092623,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.42855,-0.039846,-0.075666,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.32938,-0.039939,-0.093267,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.39858,-0.040098,-0.080473,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.25001,-0.040111,-0.12165,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.36991,-0.040184,-0.046743,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.4978,-0.040199,-0.069246,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.59059,-0.040241,-0.022969,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.54903,-0.040328,-0.083699,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.027188,-0.040344,-0.089328,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.0695,-0.040425,-0.10695,0,0
3,GO CHROMATIN SILENCING,0.24288,-0.040452,-0.057043,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.17934,-0.04053,-0.027626,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.85082,-0.040579,-0.014089,0,0
3,GO PROTEIN ACETYLATION,0.087232,-0.040582,-0.03158,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.16032,-0.040637,-0.075971,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.41341,-0.040665,-0.12708,0,0
3,GO ENDODERM FORMATION,0.28785,-0.040823,-0.15677,0,0
3,GO SPINAL CORD DEVELOPMENT,0.67776,-0.041177,-0.033312,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.73628,-0.041296,-0.014242,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.080955,-0.041303,-0.071374,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.57857,-0.041436,-0.021374,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.67776,-0.041445,-0.023189,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.70355,-0.041528,0.092461,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.41341,-0.041585,-0.050332,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.96163,-0.041602,0.0035881,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.25363,-0.041841,-0.097961,0,0
3,GO NUCLEAR TRANSPORT,0.053746,-0.041843,-0.061479,0,0
3,GO PENILE ERECTION,0.61497,-0.041942,-0.054083,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.68418,-0.042069,-0.020477,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.30815,-0.042207,-0.092264,0,0
3,GO OVULATION CYCLE PROCESS,0.28785,-0.042298,-0.059583,0,0
3,GO SPECIFICATION OF SYMMETRY,0.17374,-0.042427,-0.055337,0,0
3,GO NUCLEOSOME ORGANIZATION,0.052669,-0.042535,-0.066757,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.073629,-0.042847,-0.043505,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.65234,-0.042932,-0.026837,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.35607,-0.042951,-0.071884,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.93377,-0.043042,0.012272,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.7495,-0.043071,-0.036499,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.32938,-0.043088,-0.11917,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.62113,-0.043133,-0.015462,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.97557,-0.043151,0.02708,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.62113,-0.043293,-0.036199,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.81668,-0.043303,-0.05128,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.32077,-0.043387,-0.073115,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.80312,-0.043388,-0.027747,0,0
3,GO SNRNA PROCESSING,0.082489,-0.043693,-0.13167,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.32077,-0.043876,-0.087517,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.62732,-0.044484,0.041271,0,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.16828,-0.044572,-0.087135,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.50896,-0.0446,-0.056117,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.065563,-0.044604,-0.079452,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.41842,-0.044606,-0.059975,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.40843,-0.044649,-0.089252,0,0
3,GO CONVERGENT EXTENSION,0.51459,-0.04466,-0.080368,0,0
3,GO HISTONE PHOSPHORYLATION,0.11636,-0.044776,-0.076282,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.56666,-0.044955,-0.042925,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.99651,-0.045223,0.0080621,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.52594,-0.045402,-0.030674,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.79636,-0.045424,-0.037621,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.95466,-0.045571,0.0021858,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63354,-0.04575,-0.019509,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72313,-0.045843,-0.046013,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.33812,-0.046303,-0.078129,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.20621,-0.046609,-0.13587,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.38408,-0.046642,-0.055111,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.63354,-0.046655,-0.065189,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.16559,-0.046762,-0.081786,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.12049,-0.046845,-0.11355,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.60272,-0.046915,-0.0073029,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.32938,-0.04709,-0.041933,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.26098,-0.047384,-0.065878,0,0
3,GO HISTONE H4 DEACETYLATION,0.33373,-0.047442,-0.076695,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.39858,-0.047542,-0.066373,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.18219,-0.047627,-0.1763,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.077957,-0.047683,-0.037679,0,0
3,GO PRE MIRNA PROCESSING,0.35153,-0.047689,-0.068502,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.8303,-0.0477,-0.0082753,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18508,-0.047846,-0.064974,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.29184,-0.047952,-0.06699,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.27611,-0.048059,-0.045167,0,0
3,GO LEARNING,0.19695,-0.048183,-0.087792,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.10845,-0.048285,-0.059825,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.56075,-0.048296,-0.067932,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.48131,-0.048551,-0.068057,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.62732,-0.048557,-0.021672,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.053746,-0.048713,-0.053073,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.87833,-0.048819,0.0068405,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.073629,-0.048867,-0.08489,0,0
3,GO RNA STABILIZATION,0.087232,-0.048993,-0.09798,0,0
3,GO HEART VALVE DEVELOPMENT,0.54903,-0.049015,-0.063355,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.21579,-0.049119,-0.084229,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.18508,-0.049207,-0.046236,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.097379,-0.049235,-0.065386,0,0
3,GO TRNA METABOLIC PROCESS,0.14526,-0.049283,-0.067758,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.41341,-0.049341,-0.041166,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.17374,-0.04951,-0.074746,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.12908,-0.049594,-0.052039,0,0
3,GO CHROMOSOME ORGANIZATION,0.088862,-0.049697,-0.036821,0,0
3,GO INTRACILIARY TRANSPORT,0.70355,-0.049823,-0.017188,0,0
3,GO HISTONE UBIQUITINATION,0.060602,-0.050158,-0.055659,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.54321,-0.050552,-0.074419,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.26098,-0.050666,-0.10363,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.65866,-0.050676,-0.0050577,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.093897,-0.0507,-0.067911,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.12908,-0.050879,-0.071845,0,0
3,GO PHOSPHATE ION TRANSPORT,0.5726,-0.051317,0.04831,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.14048,-0.051436,-0.14545,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.13355,-0.051767,-0.044948,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69061,-0.051821,0.0037134,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.13583,-0.051823,-0.082379,0,0
3,GO FOREBRAIN DEVELOPMENT,0.43883,-0.051927,-0.024187,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.036164,-0.051931,-0.10654,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.41341,-0.051962,-0.030275,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.41341,-0.051984,-0.06961,0,0
3,GO CELL CYCLE DNA REPLICATION,0.14048,-0.052044,-0.066509,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.040234,-0.052107,-0.091617,0,0
3,GO HYPEROSMOTIC RESPONSE,0.71658,-0.052326,-0.044396,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.12473,-0.052328,-0.056628,0,0
3,GO REGULATION OF GENE SILENCING,0.085627,-0.052426,-0.084432,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.16032,-0.052748,-0.037198,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.42855,-0.052872,-0.013679,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.41341,-0.052906,-0.034529,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.36526,-0.053073,0.0011475,0,0
3,GO BIOLOGICAL PHASE,0.59059,-0.053164,-0.099284,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.72969,-0.053368,-0.034438,0,0
3,GO NADH METABOLIC PROCESS,0.50896,-0.053432,-0.033433,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.74288,-0.053692,-0.037786,0,0
3,GO RNA MODIFICATION,0.188,-0.053864,-0.061256,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.36526,-0.053928,-0.054459,0,0
3,GO RESPONSE TO GLUCAGON,0.23937,-0.054097,-0.062273,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.31653,-0.054247,-0.045993,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.19695,-0.054262,-0.092179,0,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.32938,-0.054296,-0.13647,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.16294,-0.054465,-0.07463,0,0
3,GO REGULATION OF RNA SPLICING,0.023741,-0.054545,-0.058425,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.065563,-0.05458,-0.085328,0,0
3,GO CELL DIVISION,0.19393,-0.054647,-0.03585,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.24288,-0.054675,-0.040049,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.39858,-0.054748,-0.05079,0,0
3,GO PEPTIDE CROSS LINKING,0.88523,-0.054898,-0.047298,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.53167,-0.054951,-0.061835,0,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.15773,-0.055014,-0.092312,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.26471,-0.055022,-0.080129,0,0
3,GO FILOPODIUM ASSEMBLY,0.50896,-0.05504,-0.047064,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.38888,-0.055127,-0.052891,0,0
3,GO TRABECULA FORMATION,0.82348,-0.055155,-0.03917,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.26847,-0.055364,-0.063389,0,0
3,GO DNA REPLICATION,0.093897,-0.055446,-0.051549,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.073629,-0.055705,-0.11252,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.86455,-0.055827,-0.0046436,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.36526,-0.055963,-0.075636,0,0
3,GO MRNA CLEAVAGE,0.11434,-0.055998,-0.059875,0,0
3,GO RNA DECAPPING,0.52594,-0.056111,-0.017613,0,0
3,GO CHROMATIN REMODELING,0.03245,-0.056206,-0.054894,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.50337,-0.056369,-0.04385,0,0
3,GO CELL PART MORPHOGENESIS,0.13355,-0.056501,-0.09055,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.43883,-0.056577,-0.091995,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.03939,-0.056704,-0.11223,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.21905,-0.05722,-0.064209,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.33812,-0.057245,-0.10011,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.34702,-0.057435,-0.057773,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.92682,-0.057441,0.0036157,0,0
3,GO MITOTIC RECOMBINATION,0.4598,-0.057576,-0.049879,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.21256,-0.05781,-0.099045,0,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.072231,-0.058116,-0.21098,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.26471,-0.058172,-0.058034,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.079444,-0.058251,-0.11221,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.41842,-0.058325,-0.041792,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.46512,-0.058378,-0.068867,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.35607,-0.058391,-0.11192,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.37932,-0.058439,-0.040217,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.67776,-0.058552,-0.054376,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.17099,-0.058604,-0.05051,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.42855,-0.058616,-0.071173,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.59059,-0.058795,-0.018422,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,-0.058906,-0.052921,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.38888,-0.058919,-0.16487,0,0
3,GO REGULATION OF ERAD PATHWAY,0.20621,-0.059078,-0.048056,0,0
3,GO AXON DEVELOPMENT,0.1028,-0.059102,-0.12192,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.87144,-0.059308,-0.0017477,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.14769,-0.059524,-0.11723,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.036164,-0.059613,-0.11767,0,0
3,GO TELENCEPHALON REGIONALIZATION,0.41341,-0.060035,-0.10497,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.013465,-0.060148,-0.075104,0,0
3,GO HISTONE ARGININE METHYLATION,0.12689,-0.060672,-0.079397,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.043763,-0.060875,-0.084802,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.22568,-0.060956,-0.067208,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.69707,-0.060982,-0.036919,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.041967,-0.06119,-0.10753,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.38888,-0.061353,-0.024914,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.41842,-0.061442,-0.1074,0,0
3,GO MRNA METHYLATION,0.059411,-0.061641,-0.12425,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.29184,-0.061646,-0.085105,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.51459,-0.061672,-0.015147,0,0
3,GO FOREBRAIN REGIONALIZATION,0.56075,-0.061686,-0.024953,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.48678,-0.061754,-0.071987,0,0
3,GO BONE MATURATION,0.72969,-0.061821,-0.025871,0,0
3,GO HISTONE H3 ACETYLATION,0.17099,-0.061822,-0.043054,0,0
3,GO TUBULIN DEACETYLATION,0.9686,-0.0619,0.011078,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.10654,-0.062011,-0.10273,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.20621,-0.062098,-0.046073,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.65866,-0.062204,-0.026606,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.47049,-0.062261,-0.096757,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.12908,-0.062436,-0.09702,0,0
3,GO MICROTUBULE POLYMERIZATION,0.087232,-0.062558,-0.088476,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.43883,-0.06262,-0.065463,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.049546,-0.062623,-0.10922,0,0
3,GO PROTEIN NEDDYLATION,0.15264,-0.062631,-0.074433,0,0
3,GO TRANSLATIONAL TERMINATION,0.23589,-0.062643,-0.080199,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.7495,-0.062847,-0.030384,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.71658,-0.062868,-0.022626,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.16559,-0.062869,-0.032353,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.32938,-0.062872,-0.045551,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.72969,-0.063017,-0.050703,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.25001,-0.063044,-0.092156,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.36991,-0.063348,-0.021346,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.89907,-0.063552,0.0072343,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.31232,-0.063711,-0.11634,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.88523,-0.063796,-0.011589,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.77618,-0.06389,-0.018008,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.91987,-0.063955,0.014322,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.80312,-0.064064,-0.027862,0,0
3,GO CERAMIDE TRANSPORT,0.75615,-0.064094,-0.033874,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.63354,-0.064225,-0.069347,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.097379,-0.064235,-0.12072,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.50337,-0.064302,-0.073103,0,0
3,GO SPINDLE LOCALIZATION,0.25729,-0.064416,-0.034689,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.69061,-0.06443,-0.022579,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.093897,-0.064614,-0.22908,0,0
3,GO DNA RECOMBINATION,0.050569,-0.06463,-0.049567,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.14526,-0.064641,-0.069595,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.11235,-0.064705,-0.10694,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.066855,-0.064744,-0.11906,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.47049,-0.064759,-0.050757,0,0
3,GO CELL JUNCTION MAINTENANCE,0.2,-0.064933,-0.1017,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.1313,-0.065073,-0.094287,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.73628,-0.065196,-0.014425,0,0
3,GO DNA GEOMETRIC CHANGE,0.027803,-0.065217,-0.089631,0,0
3,GO STEM CELL DIVISION,0.44402,-0.065346,-0.046128,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.059411,-0.065528,-0.12318,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.29184,-0.065684,-0.069862,0,0
3,GO FEVER GENERATION,0.56075,-0.065694,-0.053941,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.16294,-0.065742,-0.11284,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.36526,-0.065787,-0.07973,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.27227,-0.065854,-0.11836,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.11235,-0.065901,-0.10677,0,0
3,GO APPENDAGE DEVELOPMENT,0.49227,-0.065989,-0.035537,0,0
3,GO CENTROSOME DUPLICATION,0.60883,-0.066097,-0.012965,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.090515,-0.066199,-0.087407,0,0
3,GO NEUROTRANSMITTER SECRETION,0.27999,-0.066206,-0.020926,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.29992,-0.066359,-0.075129,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.35607,-0.066561,-0.077923,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.093897,-0.066564,-0.050787,0,0
3,GO NEURON PROJECTION EXTENSION,0.22568,-0.066583,-0.090595,0,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.34256,-0.066721,-0.089232,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.48131,-0.066795,-0.030805,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.22235,-0.06684,-0.1094,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.75615,-0.066954,-0.051539,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.066855,-0.066984,-0.15841,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.29992,-0.066993,-0.071227,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.51459,-0.067072,-0.075019,0,0
3,GO RESPONSE TO ATP,0.63354,-0.067114,-0.022439,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.079444,-0.067143,-0.068118,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.13583,-0.067244,-0.076053,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.15264,-0.067311,-0.11885,0,0
3,GO LONG TERM MEMORY,0.41842,-0.067372,-0.072664,0,0
3,GO REGULATION OF GASTRULATION,0.17653,-0.067378,-0.097636,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.15517,-0.06755,-0.13828,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.093897,-0.067651,-0.082308,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.5726,-0.067684,-0.072682,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.80989,-0.067711,-0.0021129,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.76281,-0.068058,0.011108,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.084046,-0.068065,-0.11525,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30815,-0.068124,-0.094719,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.13355,-0.068361,-0.11842,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.59059,-0.06843,-0.057786,0,0
3,GO OXYGEN TRANSPORT,0.4545,-0.068761,-0.15747,0,0
3,GO SOMATIC STEM CELL DIVISION,0.33812,-0.068768,-0.12229,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.05824,-0.069003,-0.046643,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.22568,-0.069006,-0.11508,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.20309,-0.069176,-0.072579,0,0
3,GO RESPONSE TO VITAMIN D,0.188,-0.06926,-0.13331,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.12259,-0.069297,-0.079447,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.034637,-0.069555,-0.073548,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,-0.069771,-0.085603,0,0
3,GO PIGMENT GRANULE MATURATION,0.17653,-0.069772,-0.14291,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.90599,-0.069787,-0.023315,0,0
3,GO BLASTOCYST FORMATION,0.67776,-0.069791,-0.019457,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.15773,-0.069837,-0.081117,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.061812,-0.069909,-0.077879,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.15517,-0.069961,-0.10881,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.7495,-0.070101,-0.028612,0,0
3,GO ACROSOME ASSEMBLY,0.14769,-0.070122,-0.09328,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0695,-0.07026,-0.08068,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.25363,-0.070462,-0.032347,0,0
3,GO HISTONE H2A ACETYLATION,0.27611,-0.070527,-0.052645,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.53742,-0.070699,-0.04849,0,0
3,GO SISTER CHROMATID SEGREGATION,0.12049,-0.070962,-0.052906,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.12908,-0.071228,-0.13929,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.03245,-0.07127,-0.10438,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.23245,-0.071367,-0.056519,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.99651,-0.071376,0.016152,0,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.32077,-0.071469,-0.053724,0,0
3,GO PROSTATIC BUD FORMATION,0.33373,-0.071475,-0.16757,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.31232,-0.071669,-0.050132,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.093897,-0.071715,-0.11358,0,0
3,GO REGULATION OF RNA BINDING,0.084046,-0.071756,-0.12704,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.042857,-0.0718,-0.11652,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.94769,-0.07182,0.026125,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.38408,-0.071972,-0.044362,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.26847,-0.072011,-0.080557,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.69061,-0.072026,-0.011315,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.05824,-0.072202,-0.05181,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.23589,-0.072246,-0.15111,0,0
3,GO MRNA 3 END PROCESSING,0.088862,-0.07238,-0.063194,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.3746,-0.07272,-0.05359,0,0
3,GO LYMPHANGIOGENESIS,0.060602,-0.072775,-0.15578,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.49227,-0.072789,-0.056581,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.36064,-0.072827,-0.042746,0,0
3,GO NEUROBLAST PROLIFERATION,0.32506,-0.072837,-0.067334,0,0
3,GO CHROMOSOME CONDENSATION,0.21256,-0.072939,-0.049653,0,0
3,GO NOREPINEPHRINE SECRETION,0.31653,-0.072963,-0.077267,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63978,-0.072974,-0.092014,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.03245,-0.073081,-0.0985,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.23937,-0.073092,-0.03692,0,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.097379,-0.073191,-0.092889,0,0
3,GO LACTATION,0.27227,-0.073276,-0.06595,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.53167,-0.073368,-0.076708,0,0
3,GO PROTEIN KINASE A SIGNALING,0.05824,-0.073551,-0.097534,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.073629,-0.073785,-0.06241,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.8303,-0.073965,0.034623,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.092194,-0.074083,-0.067328,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.63354,-0.074086,-0.044125,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.095625,-0.074096,-0.09374,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.7495,-0.074109,-0.003744,0,0
3,GO PYRAMIDAL NEURON DIFFERENTIATION,0.26847,-0.07419,-0.12556,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.74288,-0.074579,-0.061439,0,0
3,GO NEPHRON TUBULE FORMATION,0.35607,-0.074632,-0.086996,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.052669,-0.07469,-0.16815,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.36064,-0.074821,-0.086039,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.34256,-0.074921,-0.037922,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.050569,-0.075054,-0.10062,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.40349,-0.07509,-0.078813,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.91987,-0.07511,-0.011459,0,0
3,GO SPINDLE ORGANIZATION,0.024846,-0.075128,-0.069549,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.04854,-0.075155,-0.12178,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.26847,-0.075164,-0.10301,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.43367,-0.075321,-0.014457,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.41341,-0.075594,-0.047606,0,0
3,GO REGULATION OF OOGENESIS,0.36526,-0.075663,-0.049526,0,0
3,GO RNA 5 END PROCESSING,0.30402,-0.075862,-0.074137,0,0
3,GO TELOMERE CAPPING,0.073629,-0.07591,-0.051891,0,0
3,GO SYNAPTIC VESICLE PRIMING,0.69707,-0.076005,0.035046,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.17374,-0.076619,-0.15013,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.0695,-0.076809,-0.072019,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.084046,-0.076818,-0.096893,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.13583,-0.076829,-0.1238,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.42855,-0.077071,-0.065445,0,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.14769,-0.077192,-0.10333,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.2839,-0.077438,-0.042007,0,0
3,GO RNA METHYLATION,0.10845,-0.077707,-0.08083,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.085627,-0.077807,-0.10842,0,0
3,GO TRNA METHYLATION,0.092194,-0.078066,-0.090939,0,0
3,GO CELLULAR RESPONSE TO PH,0.16294,-0.078242,-0.087291,0,0
3,GO PENTOSE METABOLIC PROCESS,0.13355,-0.078252,-0.11944,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.50337,-0.078658,-0.063297,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.05161,-0.078696,-0.10664,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.12689,-0.078736,-0.1405,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25363,-0.078754,-0.062103,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.188,-0.078791,-0.090684,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.32506,-0.078881,-0.080514,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.33373,-0.078951,-0.069963,0,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.12689,-0.079024,-0.10633,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.1313,-0.079157,-0.083543,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.12259,-0.079271,-0.1028,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.066855,-0.079457,-0.14931,0,0
3,GO RESPONSE TO SALT STRESS,0.15773,-0.079604,-0.1187,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.26098,-0.079723,-0.092892,0,0
3,GO CARDIOBLAST PROLIFERATION,0.44924,-0.080354,-0.15299,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.023205,-0.080484,-0.079613,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.15517,-0.080498,-0.22212,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.31653,-0.080535,-0.054605,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.40349,-0.080669,-0.11176,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.011904,-0.080732,-0.077128,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.085627,-0.081133,-0.061683,0,0
3,GO HEART VALVE FORMATION,0.27611,-0.081265,-0.14209,0,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.035393,-0.081632,-0.11306,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.17934,-0.081692,-0.099837,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.11636,-0.0817,-0.12012,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.081713,-0.080648,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.43367,-0.081983,-0.11949,0,0
3,GO SISTER CHROMATID COHESION,0.22235,-0.082135,-0.051622,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.10654,-0.082151,-0.054221,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.03245,-0.082195,-0.16806,0,0
3,GO GAS TRANSPORT,0.31653,-0.082339,-0.14613,0,0
3,GO HAIR FOLLICLE MATURATION,0.25363,-0.082467,-0.12327,0,0
3,GO REGULATION OF MRNA BINDING,0.076492,-0.082483,-0.15904,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.22235,-0.082679,-0.062358,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.22235,-0.082699,-0.059511,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.044685,-0.082797,-0.17835,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.91293,-0.082863,-0.020767,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.188,-0.082863,-0.068566,0,0
3,GO NCRNA METABOLIC PROCESS,0.054842,-0.083052,-0.11177,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.4978,-0.083132,-0.054614,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.70355,-0.083157,-0.038638,0,0
3,GO SULFATION,0.044685,-0.083427,-0.12904,0,0
3,GO SNRNA METABOLIC PROCESS,0.099158,-0.08359,-0.10822,0,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.69707,-0.083677,0.032181,0,0
3,GO MICROTUBULE NUCLEATION,0.027188,-0.083684,-0.089839,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.18219,-0.083752,-0.063519,0,0
3,GO TRNA TRANSPORT,0.047551,-0.083888,-0.11812,0,0
3,GO RNA 3 END PROCESSING,0.057089,-0.08391,-0.080825,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.68418,-0.083935,-0.040766,0,0
3,GO REGULATION OF EXCRETION,0.50896,-0.084087,-0.056308,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.23937,-0.084224,-0.098034,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.0024367,-0.084304,-0.096944,0,0
3,GO L GLUTAMATE IMPORT,0.23589,-0.084326,-0.096596,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.068167,-0.084778,-0.13827,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.095625,-0.085059,-0.10151,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.42347,-0.085419,-0.044293,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.12689,-0.085438,-0.14547,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.010773,-0.085781,-0.11315,0,0
3,GO PROTEIN TRIMERIZATION,0.18508,-0.086014,-0.12865,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.188,-0.086067,-0.050362,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.22568,-0.08619,-0.05558,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.35607,-0.086276,-0.057603,0,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.22568,-0.086788,-0.080881,0,0
3,GO NEURAL TUBE PATTERNING,0.065563,-0.086908,-0.12445,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.4598,-0.086936,-0.071924,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.027188,-0.087081,-0.10035,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.5726,-0.087167,-0.095611,0,0
3,GO CHROMOSOME SEGREGATION,0.065563,-0.0872,-0.048645,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.37932,-0.087327,-0.026671,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.059411,-0.087336,-0.1004,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.28785,-0.087917,-0.11615,0,0
3,GO NUCLEUS LOCALIZATION,0.055956,-0.087966,-0.11663,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.0695,-0.087995,-0.14224,0,0
3,GO MITOCHONDRIAL FISSION,0.20937,-0.088124,-0.060279,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.20937,-0.088157,-0.057848,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.021165,-0.088185,-0.071992,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.59664,-0.08828,-0.03666,0,0
3,GO REGULATION OF DNA REPLICATION,0.18219,-0.088667,-0.04681,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.31653,-0.088731,-0.10307,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0014299,-0.088799,-0.11864,0,0
3,GO HINDLIMB MORPHOGENESIS,0.077957,-0.089062,-0.14458,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.24288,-0.089274,-0.12232,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.29184,-0.089311,-0.091171,0,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.017549,-0.089382,-0.10068,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.20937,-0.089482,-0.053258,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.38408,-0.089488,-0.02641,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.20621,-0.089735,-0.11076,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.043763,-0.089963,-0.089799,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.42855,-0.090085,-0.081929,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.32938,-0.090373,-0.096931,0,0
3,GO REGULATION OF HEART GROWTH,0.19393,-0.090406,-0.077735,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.5726,-0.09052,-0.043782,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.85768,-0.090541,0.0099228,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.042857,-0.090754,-0.10851,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.092194,-0.09115,-0.17092,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.070855,-0.091314,-0.11927,0,0
3,GO LYSINE METABOLIC PROCESS,0.38408,-0.091476,-0.086658,0,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.004408,-0.091532,-0.10954,0,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.15015,-0.091589,-0.13262,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.3746,-0.091911,-0.027646,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.16294,-0.092123,-0.12329,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.19695,-0.092174,-0.09786,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.17099,-0.092456,-0.10639,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.27227,-0.09251,-0.06776,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.10465,-0.092535,-0.14171,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.75615,-0.092796,0.007297,0,0
3,GO RECEPTOR CLUSTERING,0.13583,-0.092867,-0.11635,0,0
3,GO VIRAL GENE EXPRESSION,0.18219,-0.092898,-0.13623,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.40843,-0.092986,-0.04482,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.11636,-0.093175,-0.10964,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.13583,-0.093487,-0.1487,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.087232,-0.093677,-0.084225,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.14048,-0.093728,-0.20004,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.36991,-0.093924,-0.059823,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.32077,-0.093987,-0.087386,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.076492,-0.094254,-0.12165,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.21905,-0.094375,-0.06986,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.12689,-0.094668,-0.069831,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.17934,-0.094717,-0.08805,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.29586,-0.095216,-0.062412,0,0
3,GO NAD METABOLIC PROCESS,0.35607,-0.095244,-0.063125,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.21579,-0.095463,-0.052935,0,0
3,GO NCRNA TRANSCRIPTION,0.0026572,-0.095812,-0.10429,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.42855,-0.096666,-0.037611,0,0
3,GO DENDRITE DEVELOPMENT,0.21579,-0.096754,-0.060397,0,0
3,GO MITOCHONDRION LOCALIZATION,0.0079323,-0.096776,-0.11046,0,0
3,GO TRANSLATIONAL INITIATION,0.092194,-0.096836,-0.17758,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.17099,-0.096848,-0.16628,0,0
3,GO REGULATION OF MRNA PROCESSING,0.0083534,-0.097432,-0.086304,0,0
3,GO VESICLE CARGO LOADING,0.25001,-0.097457,-0.067059,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.072231,-0.097498,-0.11237,0,0
3,GO GANGLION DEVELOPMENT,0.98255,-0.097521,0.068822,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.61497,-0.097567,-0.034811,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.25001,-0.098081,-0.081103,0,0
3,GO FORELIMB MORPHOGENESIS,0.25363,-0.098488,-0.096685,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.093897,-0.098514,-0.096251,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.080955,-0.098518,-0.11981,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.24643,-0.098543,-0.064736,0,0
3,GO G0 TO G1 TRANSITION,0.044685,-0.098991,-0.083272,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.2839,-0.099149,-0.083064,0,0
3,GO CYTOPLASMIC TRANSLATION,0.084046,-0.099237,-0.19513,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0067808,-0.099676,-0.125,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.082489,-0.099787,-0.12526,0,0
3,GO POSTSYNAPSE ORGANIZATION,0.064293,-0.10043,-0.1328,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.25363,-0.10053,-0.13898,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.061812,-0.10053,-0.12255,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.21905,-0.10068,-0.19758,0,0
3,GO APPENDAGE MORPHOGENESIS,0.33373,-0.10089,-0.060478,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.053746,-0.10106,-0.091542,0,0
3,GO TRANSLATIONAL ELONGATION,0.12689,-0.10112,-0.093426,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.011612,-0.10131,-0.10411,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.53167,-0.10138,-0.015735,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.0071468,-0.10139,-0.11036,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.084046,-0.10147,-0.12407,0,0
3,GO NEUROBLAST DIVISION,0.30815,-0.1015,-0.10818,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00042998,-0.10254,-0.1138,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.061812,-0.10287,-0.086102,0,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.0038387,-0.103,-0.13545,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.11636,-0.1035,-0.062503,0,0
3,GO AMINO ACID ACTIVATION,0.76281,-0.10362,-0.020962,0,0
3,GO NODAL SIGNALING PATHWAY,0.17374,-0.10376,-0.060623,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.20621,-0.10395,-0.096259,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.18219,-0.10416,-0.15174,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.021165,-0.10432,-0.10767,0,0
3,GO RECOMBINATIONAL REPAIR,0.0066042,-0.10434,-0.091309,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.14048,-0.10464,-0.090368,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.03939,-0.10474,-0.1324,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.11636,-0.10516,-0.11315,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.076492,-0.10532,-0.18307,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.014138,-0.10576,-0.10108,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.32077,-0.10618,-0.09197,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.088862,-0.10619,-0.09504,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.37932,-0.10658,-0.039194,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.31653,-0.10699,-0.14777,0,0
3,GO MICROTUBULE SEVERING,0.59059,-0.10717,-0.052686,0,0
3,GO ETHANOL METABOLIC PROCESS,0.78962,-0.10721,-0.042409,0,0
3,GO TRACHEA MORPHOGENESIS,0.20621,-0.10735,-0.10685,0,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.093897,-0.10771,-0.13041,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.59059,-0.10884,-0.043211,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.088862,-0.10942,-0.141,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.62732,-0.10972,-0.040102,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.034637,-0.10981,-0.15121,0,0
3,GO PALLIUM DEVELOPMENT,0.188,-0.10986,-0.053698,0,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.22235,-0.10995,-0.11338,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.12689,-0.11001,-0.16926,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.27227,-0.11002,-0.010248,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.12049,-0.11009,-0.14871,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.20309,-0.11039,-0.15307,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.011904,-0.11053,-0.095521,0,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.53167,-0.11055,-0.048766,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.28785,-0.11062,-0.15655,0,0
3,GO NOREPINEPHRINE TRANSPORT,0.47049,-0.11149,-0.050553,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.23937,-0.11201,-0.087085,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.1028,-0.11228,-0.079751,0,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.05824,-0.11228,-0.14539,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.4545,-0.11262,-0.065208,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.02268,-0.11282,-0.13613,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.099158,-0.11308,-0.079705,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.50896,-0.11312,-0.062729,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35607,-0.11338,-0.075393,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0021689,-0.11356,-0.12328,0,0
3,GO PEPTIDYL ARGININE N METHYLATION,0.25729,-0.11379,-0.083492,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.15773,-0.11391,-0.12031,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.65234,-0.11437,-0.028609,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.30402,-0.11449,-0.064147,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.12689,-0.11451,-0.099915,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.090515,-0.11493,-0.090756,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.054842,-0.11507,-0.092252,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.31653,-0.11526,-0.099814,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.041967,-0.11539,-0.10467,0,0
3,GO DNA STRAND ELONGATION,0.015574,-0.1154,-0.11986,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.072231,-0.11565,-0.07736,0,0
3,GO COCHLEA MORPHOGENESIS,0.19695,-0.11577,-0.085759,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.14048,-0.11581,-0.13211,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.11636,-0.11599,-0.14031,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.1028,-0.11606,-0.11492,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.015953,-0.11625,-0.08081,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.082489,-0.11639,-0.13972,0,0
3,GO NEGATIVE CHEMOTAXIS,0.087232,-0.11681,-0.17702,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.40349,-0.11699,-0.053601,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.05824,-0.11717,-0.18426,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.14285,-0.11773,-0.15371,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.4545,-0.11809,-0.1003,0,0
3,GO OXIDATIVE DEMETHYLATION,0.0081404,-0.11847,-0.10457,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.072231,-0.11864,-0.096886,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.049546,-0.11881,-0.11761,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.13583,-0.11882,-0.10968,0,0
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.13814,-0.11884,-0.10582,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.59059,-0.11896,-0.028274,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.39858,-0.11947,-0.090792,0,0
3,GO WALKING BEHAVIOR,0.007729,-0.11967,-0.17415,0,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.20937,-0.11977,-0.1586,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.088862,-0.11978,-0.14734,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.41842,-0.11997,-0.048317,0,0
3,GO RESPONSE TO X RAY,0.04854,-0.12031,-0.14578,0,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.15015,-0.12058,-0.13629,0,0
3,GO PRENYLATION,0.14285,-0.1206,-0.11668,0,0
3,GO GLUTAMATE SECRETION,0.30815,-0.12062,-0.051518,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.39371,-0.12129,-0.11989,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.072231,-0.12217,-0.14683,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.085627,-0.12231,-0.15496,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.035393,-0.12261,-0.12504,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.40843,-0.12331,-0.076832,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.13814,-0.12395,-0.13587,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.073629,-0.12426,-0.074459,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.51459,-0.12473,-0.079704,0,0
3,GO RENAL FILTRATION,0.8303,-0.12473,-0.0048451,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.023205,-0.125,-0.18667,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.18219,-0.12504,-0.13094,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.087232,-0.12538,-0.16417,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.0041716,-0.12557,-0.12595,0,0
3,GO EMBRYO IMPLANTATION,0.25363,-0.12581,-0.11007,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.009256,-0.1259,-0.14373,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.095625,-0.12693,-0.11871,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.015203,-0.12715,-0.11132,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.15015,-0.12738,-0.11346,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.045624,-0.12791,-0.091316,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.29586,-0.12813,-0.046773,0,0
3,GO NUCLEAR MIGRATION,0.079444,-0.12824,-0.11664,0,0
3,GO LEUKOCYTE AGGREGATION,0.40843,-0.12833,-0.14794,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.2,-0.1286,-0.1071,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0014299,-0.12901,-0.15655,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.077957,-0.12916,-0.16944,0,0
3,GO HISTONE H3 K27 METHYLATION,0.093897,-0.12917,-0.10064,0,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.52025,-0.13008,-0.089603,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.15517,-0.13009,-0.087423,0,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00029782,-0.13031,-0.17707,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.012508,-0.1306,-0.13616,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.068167,-0.13249,-0.18331,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.48678,-0.13283,-0.042268,0,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.0025083,-0.13305,-0.17549,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.37932,-0.13314,-0.078814,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.047551,-0.13317,-0.12362,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.04854,-0.13335,-0.12094,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.41341,-0.13336,-0.089021,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.054842,-0.13392,-0.20715,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.059411,-0.13411,-0.16952,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.017137,-0.13416,-0.15066,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.099158,-0.13425,-0.10277,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.066855,-0.13438,-0.1621,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.60272,-0.13446,-0.034681,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00018427,-0.13465,-0.15349,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.024846,-0.13468,-0.18572,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.043763,-0.13469,-0.085711,0,0
3,GO DIVALENT METAL ION EXPORT,0.070855,-0.13482,-0.22873,0,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.093897,-0.13488,-0.146,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.045624,-0.13509,-0.13202,0,0
3,GO ERYTHROCYTE MATURATION,0.010245,-0.13528,-0.18774,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.1028,-0.13541,-0.20421,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.20309,-0.1357,-0.16021,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.009256,-0.13649,-0.16047,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.066855,-0.1367,-0.15547,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.085627,-0.13677,-0.10206,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.22905,-0.13728,-0.19371,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.12689,-0.13733,-0.10422,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.32077,-0.13804,-0.089368,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.049546,-0.13879,-0.10955,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.10096,-0.13899,-0.1021,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.090515,-0.13918,-0.20494,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.13814,-0.13919,-0.10665,0,0
3,GO DENDRITE MORPHOGENESIS,0.088862,-0.1394,-0.10866,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.54321,-0.1396,-0.027002,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.1028,-0.13996,-0.13156,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.05824,-0.14005,-0.11088,0,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.022165,-0.14006,-0.22419,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.088862,-0.14054,-0.11822,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.072231,-0.14055,-0.13262,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.12908,-0.14206,-0.16287,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.16294,-0.14233,-0.21114,0,0
3,GO HISTONE DEUBIQUITINATION,0.0029794,-0.14237,-0.11212,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.15517,-0.14242,-0.17141,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.061812,-0.14293,-0.1636,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.077957,-0.14309,-0.1721,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.080955,-0.14323,-0.18141,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.12049,-0.1434,-0.073164,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.15264,-0.14343,-0.11346,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.050569,-0.14351,-0.17124,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.045624,-0.14432,-0.15922,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00026003,-0.14469,-0.13808,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.19695,-0.14517,-0.1503,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.087232,-0.14519,-0.11901,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.054842,-0.14621,-0.1561,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.2,-0.14676,-0.12162,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0071468,-0.14744,-0.18101,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.045624,-0.14744,-0.16257,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.26847,-0.1478,-0.079921,0,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.034637,-0.14828,-0.15892,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,-0.14867,-0.15599,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.63978,-0.14942,-0.065161,0,0
3,GO ERBB2 SIGNALING PATHWAY,0.16032,-0.14959,-0.099545,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.060602,-0.15051,-0.078865,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.041093,-0.15095,-0.14236,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.05161,-0.15148,-0.17079,0,0
3,GO RESPONSE TO LEAD ION,0.007729,-0.15224,-0.145,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0695,-0.15232,-0.29426,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.090515,-0.15431,-0.11637,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.23245,-0.15474,-0.18818,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.25001,-0.15475,-0.13112,0,0
3,GO KINETOCHORE ASSEMBLY,0.87833,-0.15512,-0.0047831,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.20621,-0.15663,-0.15781,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,4.3218e-05,-0.15727,-0.16196,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.060602,-0.15727,-0.16308,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.080955,-0.15743,-0.090985,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.34702,-0.15755,-0.10293,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.26471,-0.15799,-0.13915,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0039469,-0.1581,-0.16296,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.05161,-0.15818,-0.17684,0,0
3,GO KINETOCHORE ORGANIZATION,0.61497,-0.15941,2.1856e-05,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.029068,-0.15959,-0.1849,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.27611,-0.16054,-0.10989,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.10654,-0.1613,-0.10127,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.045624,-0.16133,-0.14304,0,0
3,GO NEURON MIGRATION,0.14769,-0.1621,-0.1032,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0006154,-0.16294,-0.16269,0,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.052669,-0.16367,-0.20161,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0028957,-0.1639,-0.231,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.090515,-0.16443,-0.22173,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.035393,-0.1645,-0.17853,0,0
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.065563,-0.16498,-0.111,0,0
3,GO AXO DENDRITIC TRANSPORT,0.0023671,-0.1659,-0.1414,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.47049,-0.16638,-0.089473,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.049546,-0.16682,-0.23146,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0029794,-0.16716,-0.11562,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0045306,-0.16717,-0.16615,0,0
3,GO SIALYLATION,0.66501,-0.16753,-0.053219,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0022332,-0.16762,-0.19213,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.016339,-0.16829,-0.17698,0,0
3,GO RRNA TRANSCRIPTION,0.0056288,-0.1696,-0.18101,0,0
3,GO TELOMERIC LOOP DISASSEMBLY,0.00050664,-0.17103,-0.2039,0,0
3,GO MRNA MODIFICATION,0.02166,-0.17159,-0.16011,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.059411,-0.17271,-0.16198,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0015653,-0.1739,-0.17945,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.15015,-0.17427,-0.22926,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0054795,-0.17461,-0.14574,0,0
3,GO PLASMA MEMBRANE REPAIR,0.20621,-0.17547,-0.13164,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,5.8301e-05,-0.17595,-0.26616,0,0
3,GO MYOBLAST MIGRATION,0.13583,-0.17641,-0.18663,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.010773,-0.17706,-0.15039,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.022165,-0.1771,-0.19537,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.033894,-0.17817,-0.13753,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00032948,-0.17836,-0.22061,0,0
3,GO V D J RECOMBINATION,0.0057817,-0.17839,-0.21346,0,0
3,GO SNORNA METABOLIC PROCESS,0.060602,-0.17893,-0.16564,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.11636,-0.1791,-0.20813,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.037747,-0.17969,-0.23342,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.27227,-0.18025,-0.081784,0,0
3,GO MRNA SPLICE SITE SELECTION,0.009256,-0.18095,-0.14953,0,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.26098,-0.18136,-0.11933,0,0
3,GO BRAIN MORPHOGENESIS,0.017969,-0.18443,-0.13591,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.084046,-0.18469,-0.15461,0,0
3,GO RESPONSE TO L GLUTAMATE,0.059411,-0.18631,-0.19955,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.060602,-0.18638,-0.23274,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.007729,-0.18644,-0.13259,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.037747,-0.1865,-0.19916,0,0
3,GO AXONAL TRANSPORT,0.00090094,-0.18686,-0.16532,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0051916,-0.18716,-0.20163,0,0
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0036303,-0.18802,-0.18092,0,0
3,GO UTERUS DEVELOPMENT,0.1313,-0.18809,-0.14181,0,0
3,GO VOCALIZATION BEHAVIOR,0.25363,-0.18834,-0.17356,0,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.00028792,-0.18855,-0.22599,0,0
3,GO CGMP METABOLIC PROCESS,0.67137,-0.18884,-0.035672,0,0
3,GO SNORNA 3 END PROCESSING,0.036948,-0.18904,-0.17801,0,0
3,GO MYOBLAST PROLIFERATION,0.0011549,-0.18941,-0.24936,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0039469,-0.18977,-0.2139,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.033894,-0.19015,-0.2273,0,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0094949,-0.1902,-0.33325,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.0015189,-0.19148,-0.21073,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.19695,-0.19211,-0.13642,0,0
3,GO SYNAPTIC VESICLE MATURATION,0.061812,-0.19456,-0.14967,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0037331,-0.19498,-0.17046,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.050569,-0.19584,-0.14144,0,0
3,GO DNA REPLICATION CHECKPOINT,0.0085714,-0.19662,-0.17503,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.22568,-0.19677,-0.098676,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.072231,-0.19693,-0.17343,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0033369,-0.19766,-0.21617,0,0
3,GO DNA LIGATION,0.075049,-0.19874,-0.13205,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.21256,-0.19912,-0.20339,0,0
3,GO PROTEIN DEMETHYLATION,0.011047,-0.19962,-0.14882,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.19393,-0.20125,-0.23528,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.050569,-0.20133,-0.20241,0,0
3,GO TONGUE DEVELOPMENT,0.12259,-0.20185,-0.14843,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.00027832,-0.20223,-0.23482,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.14526,-0.20289,-0.16818,0,0
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.00090094,-0.20428,-0.31255,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.049546,-0.20532,-0.23745,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.015953,-0.20561,-0.23405,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.099158,-0.20611,-0.24107,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.055956,-0.20636,-0.17674,0,0
3,GO CARTILAGE MORPHOGENESIS,0.02268,-0.20636,-0.28094,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0049174,-0.20755,-0.17442,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.070855,-0.2082,-0.1445,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.070855,-0.20821,-0.19034,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.20309,-0.20917,-0.13984,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.00353,-0.21033,-0.24611,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.05161,-0.21115,-0.13604,0,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013465,-0.21172,-0.22753,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.099158,-0.2121,-0.17576,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.14285,-0.21335,-0.21126,0,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0081404,-0.2175,-0.20998,0,0
3,GO NEURAL CREST FORMATION,0.013139,-0.22003,-0.22723,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.11841,-0.22236,-0.19173,0,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.015953,-0.22262,-0.18382,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.049546,-0.2245,-0.16684,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.052669,-0.22507,-0.29968,0,0
3,GO IMP METABOLIC PROCESS,0.052669,-0.22606,-0.21595,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.072231,-0.22685,-0.20084,0,0
3,GO CHONDROCYTE PROLIFERATION,0.031059,-0.2296,-0.20974,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.012508,-0.23244,-0.28835,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0075304,-0.23281,-0.22616,0,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.49227,-0.23345,0.0029882,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.052669,-0.23564,-0.20902,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.0069616,-0.24076,-0.24864,0,0
3,GO GLYCINE METABOLIC PROCESS,0.0060989,-0.24096,-0.23665,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.087232,-0.24435,-0.13561,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.060602,-0.24642,-0.20737,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.0097392,-0.24709,-0.31103,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.00034072,-0.24753,-0.26776,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.0026572,-0.24757,-0.27953,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.22905,-0.2482,-0.17181,0,0
3,GO LIMB BUD FORMATION,0.042857,-0.24983,-0.24123,0,0
3,GO TRACHEA DEVELOPMENT,0.022165,-0.25053,-0.18687,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.047551,-0.25229,-0.24106,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0056288,-0.25544,-0.30113,0,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0015189,-0.25822,-0.33542,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0012662,-0.26176,-0.29908,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.02068,-0.26235,-0.26297,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.40349,-0.26661,-0.07236,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.11434,-0.26891,-0.15953,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.14285,-0.27292,-0.12965,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.00021909,-0.27344,-0.23649,0,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00019753,-0.27483,-0.40134,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.052669,-0.27486,-0.21444,0,0
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.00012512,-0.27499,-0.28588,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0037331,-0.27796,-0.31597,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.079444,-0.27857,-0.18514,0,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.029719,-0.27935,-0.17719,0,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.011612,-0.27936,-0.23024,0,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00012074,-0.28042,-0.34292,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.13355,-0.28183,-0.25139,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.050569,-0.28213,-0.22653,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.031059,-0.28603,-0.2632,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,7.0571e-06,-0.28988,-0.39934,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.10654,-0.2918,-0.21826,0,0
3,GO RETROGRADE AXONAL TRANSPORT,1.8521e-05,-0.30705,-0.31916,0,0
3,GO CHROMATIN DISASSEMBLY,2.8418e-05,-0.30839,-0.28662,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.013465,-0.31039,-0.2805,0,0
3,GO PROSTATE GLAND GROWTH,0.0031536,-0.32016,-0.30327,0,0
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,1.104e-05,-0.32085,-0.40157,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.004408,-0.33573,-0.28955,0,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.001986,-0.34046,-0.4066,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0045306,-0.34113,-0.40637,0,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.020205,-0.3504,-0.3388,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00054072,-0.35273,-0.3697,0,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,2.9532e-05,-0.35927,-0.45043,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.001662,-0.36156,-0.30793,0,0
3,GO DENDRITE SELF AVOIDANCE,0.0085714,-0.3621,-0.24731,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00044439,-0.37441,-0.41657,0,0
3,GO L SERINE METABOLIC PROCESS,0.019739,-0.39862,-0.28339,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0051916,-0.4075,-0.31971,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00052342,-0.46058,-0.43278,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00042998,-0.47293,-0.49461,0,0
3,GO CARDIAC CHAMBER FORMATION,0.00014935,-0.47904,-0.52798,0,0
3,GO LATERAL VENTRICLE DEVELOPMENT,3.0689e-05,-0.50587,-0.44756,0,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0015189,-0.51928,-0.38137,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.0094949,-0.52879,-0.383,0,0
